Browse by Poster Presenter

Schedule at a Glance

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Browse by Poster Presenter

Type here to filter the list

Špíšek, Radek

SOTIO Biotech a.s.
(P 257) TARGETING LEUCINE-RICH REPEAT-CONTAINING PROTEIN 15 (LRRC15): SOT106 ANTIBODY-DRUG CONJUGATE FOR SOFT TISSUE SARCOMA AND OSTEOSARCOMA TREATMENT
Radek Špíšek
Favorite
A
Abatini, Carlo

Fondazione Policlinico Universitario A. Gemelli IRCCS
(P 328) INNOVATING SARCOMA EDUCATION: EARLY OUTCOMES OF THE ITALIAN SOCIETY OF SURGICAL ONCOLOGY (SICO) SARCOMA SOCIAL MULTI-PLATFORM JOURNAL CLUB INITIATIVE
Carlo Abatini
Favorite
Abdel Nour, George

Medical University of Vienna
(P 86) CARBON FIBRE-REINFORCED PEEK IMPLANTS FOR TUMORS OF THE SPINE
George Abdel Nour
Favorite
Abdon Lopes de Mello, Celso

A.C.Camargo Cancer Center
(P 278) NEOADJUVANT HYPOFRACTIONATED RADIOTHERAPY AND CHEMOTHERAPY IN EXTREMITY SOFT TISSUE SARCOMAS
Celso Abdon Lopes de Mello
Favorite
Abell, Kathryn

Cell Signaling Technology
(P 198) EXPLOITING METABOLIC DYSREGULATION IN SUCCINATE DEHYDROGENASE-DEFICIENT GASTROINTESTINAL STROMAL TUMOR
Kathryn Abell
Favorite
Abrams, Hannah

Fred Hutchinson Cancer Center
(P 287) A PHASE 1 STUDY OF NEOADJUVANT CABOZANTINIB IN COMBINATION WITH RADIATION THERAPY FOR SARCOMAS OF THE EXTREMITIES
Hannah Abrams
Favorite
Abufares, Sabria

Indian University School of Medicine
(P 269) INCIDENCE OF MALIGNANCY IN BIOPSIED PEDIATRIC SOFT TISSUE MASSES
Sabria Abufares
Favorite
Acharya, Suryakanta

Assam Cancer Care Foundation
(P 363) TEMPERATURE CHANGES IN THE IRRADIATED SKIN OF SOFT TISSUE SARCOMA PATIENTS
Suryakanta Acharya
Favorite
ADAM, Diane

Institut Bergonié
(P 390) USE OF DERMAL TEMPLATE FOR NERVE PROTECTION IN LIMB-SPARING SURGERY FOR SOFT TISSUE SARCOMAS: PRELIMINARY EXPERIENCE FROM INSTITUT BERGONIE
Diane ADAM
Favorite
Adams, Jacob

University of Kansas School of Medicine
(P 359) EVALUATION OF PREOPERATIVE MYXOFIBROSARCOMA GROWTH AND SURGICAL MORBIDITY AFTER NEOADJUVANT RADIATION USING SEMI-AUTOMATED VOLUMETRIC ANALYSIS
Jacob Adams
Favorite
(P 382) METHOD FOR VOLUMETRIC ASSESMENT OF TUMOR RESPONSE FOLLOWING NEOADJUVANT RADIATION IN PRIMARY MYXOFIBROSARCOMA
Jacob Adams
Favorite
Adkins, Irena

SOTIO Biotech a.s.
(P 257) TARGETING LEUCINE-RICH REPEAT-CONTAINING PROTEIN 15 (LRRC15): SOT106 ANTIBODY-DRUG CONJUGATE FOR SOFT TISSUE SARCOMA AND OSTEOSARCOMA TREATMENT
Irena Adkins
Favorite
Adriazola Vicente, Paul

Hospital Nacional Edgardo Rebagliati Martins Universidad Ricardo Palma
(P 306) PROGNOSTIC NUTRITIONAL INDEX PREDICTS MAJOR POSTOPERATIVE COMPLICATIONS IN RETROPERITONEAL SARCOMA: RESULTS FROM THE LATAMSARC COHORT
Paul Adriazola Vicente
Favorite
Affar, El Bachir

Centre de recherche Maisonneuve-Rosemont
(P 46) INVESTIGATING THE IMPACT OF SARCOMA FUSION PROTEINS ON EPIGENETIC AND DNA-DEPENDENT PROCESSES THROUGH INTERACTOME PROFILING
El Bachir Affar
Favorite
Agaram, Narasimhan

Memorial Sloan Kettering Cancer Center
(P 421) CHARACTERIZING THE IMMUNE RESPONSE TO INTRATUMORAL TIGILANOL TIGLATE (TT) IN PATIENTS WITH ADVANCED AND/OR METASTATIC SOFT TISSUE SARCOMA (STS) IN A PHASE IIA TRIAL (NCT05755113)
Narasimhan Agaram
Favorite
Agarwal, Anmol

Sarcoma Oncology Center
(P 233) DNG64-CAR-V+ REGIMEN SHOWS CLINICAL BENEFIT IN PATIENTS WITH ADVANCED CCNG1 ONCOGENE EXPRESSING SARCOMAS (NCT04091295)
Anmol Agarwal
Favorite
(P 388) TRIAL IN PROGRESS: A PHASE 2 STUDY OF METRONOMIC TRABECTEDIN, GEMCITIBAINE, AND DACARBAZINE IN PREVIOUSLY TREATED ADVANCED SOFT TISSUE SARCOMA (NCT04535271)
Anmol Agarwal
Favorite
(P 396) EVALUATING THE SAFETY AND EFFICACY OF METRONOMIC GEMCITABINE, DOXORUBICIN, AND DOCETAXEL PLUS NIVOLUMAB IN PREVIOUSLY TREATED ADVANCED LEIOMYOSARCOMA AND LIPOSARCOMA: A PHASE 2 STUDY (NCT04535713)
Anmol Agarwal
Favorite
(P 398) INVESTIGATING THE SAFETY AND EFFICACY OF LURBINECTEDIN WITH IPILIMUMAB AND NIVOLUMAB FOR ADVANCED SOFT TISSUE SARCOMA: LINNOVATE PHASE 1/2 STUDY (NCT05876715)
Anmol Agarwal
Favorite
Aggerholm-Pedersen, Ninna

Department of Oncology, Aarhus University Hospital
(P 05) CONCORDANCE OF GENOMIC ALTERATIONS WITH CIRCULATING TUMOR DNA: INITIAL FINDINGS FROM A PILOT STUDY
Ninna Aggerholm-Pedersen
Favorite
(P 319) CARDIOTOXICITY AND OVERALL SURVIVAL IN PATIENTS WITH SARCOMA TREATED WITH DOXORUBICIN, OLARATUMAB AND DEXRAZOXANE: A REAL-WORLD EXPERIENCE IN DENMARK
Ninna Aggerholm-Pedersen
Favorite
(P 444) HEALTH-RELATED QUALITY OF LIFE (HRQOL) CHALLENGES IN PATIENTS WITH EPITHELIOID HEMANGIOENDOTHELIOMA (EHE): ANALYSIS OF AN ULTRA-RARE SARCOMA GROUP
Ninna Aggerholm-Pedersen
Favorite
Agnello, Giulia

Deciphera Pharmaceuticals, LLC
(P 422) EFFICACY WITH VIMSELTINIB IN PATIENTS (PTS) WITH TENOSYNOVIAL GIANT CELL TUMOR (TGCT) AND PRIOR COLONY-STIMULATING FACTOR 1 (CSF1) INHIBITOR THERAPY: A PHASE 2 CASE SERIES
Giulia Agnello
Favorite
Agolia, James

Stanford University
(P 37) DISSECTING THE TUMOR MICROENVIRONMENT OF UTERINE LEIOMYOSARCOMAS FOR TARGETED DRUG PREDICTIONS
James Agolia
Favorite
Agra, Carolina

Hospital General Universitario Gregorio Marañón
(P 356) DESMOID TUMORS: A RETROSPECTIVE ANALYSIS FROM A REFERRAL CENTER
Carolina Agra
Favorite
Aguado Sorolla, Maria

Hospital Santa Creu i Sant Pau
(P 218) THE IMPACT OF BROADENED GENETIC COUNSELLING REFERRAL CRITERIA IN SARCOMA PATIENTS: A REFERENCE CENTRE'S EXPERIENCE
Maria Aguado Sorolla
Favorite
(P 385) PROGNOSTIC IMPACT OF PERIPHERAL BLOOD CELL RATIO VALUES IN PATIENTS WITH ADVANCED LEIOMYOSARCOMA: A REFERENCE CENTER EXPERIENCE.
Maria Aguado Sorolla
Favorite
Aguiar Jr, Samuel

A.C.Camargo Cancer Center
(P 278) NEOADJUVANT HYPOFRACTIONATED RADIOTHERAPY AND CHEMOTHERAPY IN EXTREMITY SOFT TISSUE SARCOMAS
Samuel Aguiar Jr
Favorite
Agulnik, Mark

USC Norris Comprehensive Cancer Center, University of Southern California
(P 195) IMPACT OF EXPERT-LED EDUCATION PROGRAMS ON HEALTH CARE PROVIDER (HCP) KNOWLEDGE OF GASTROINTESTINAL STROMAL TUMOR (GIST)
Mark Agulnik
Favorite
Agulnik, Mark

Robert H Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL, USA
(P 416) A PHASE 2 MULTICENTER OPEN-LABEL BASKET STUDY OF TAZEMETOSTAT IN ADULT PATIENTS WITH INI1-NEGATIVE EPITHELIOID SARCOMA – FINAL ANALYSIS
Mark Agulnik
Favorite
Agulnik, Mark

USC Norris Comprehensive Cancer Center, University of Southern California
(P 423) ZIFTOMENIB IN COMBINATION WITH IMATINIB IN ADVANCED GASTROINTESTINAL STROMAL TUMORS (GIST) AFTER IMATINIB FAILURE: PHASE 1A/B STUDY OF SAFETY, PHARMACOKINETICS, AND ANTITUMOR ACTIVITY
Mark Agulnik
Favorite
Agyemang, Clement

MD Anderson Cancer Center
(P 47) EWSR1::WT1 FUSION ONCOPROTEIN ACTIVITY SHAPES LINEAGE HETEROGENEITY IN DESMOPLASTIC SMALL ROUND CELL TUMORS
Clement Agyemang
Favorite
Ahmed, Asmaa

MD Anderson Cancer Center
(P 47) EWSR1::WT1 FUSION ONCOPROTEIN ACTIVITY SHAPES LINEAGE HETEROGENEITY IN DESMOPLASTIC SMALL ROUND CELL TUMORS
Asmaa Ahmed
Favorite
Ahmed, Mahbubl

University College London Hospitals NHS Foundation Trust
(P 156) CHONDROSARCOMA INCIDENCE, SURVIVAL AND MANAGEMENT IN ENGLAND 2013-2022; AN ANALYSIS FROM THE NATIONAL DISEASE REGISTRATION SERVICE
Mahbubl Ahmed
Favorite
(P 281) LOCAL CONTROL WITH MODERATELY HYPOFRACTIONATED DEFINITIVE RADIOTHERAPY DELIVERED WITH A SIMULTANEOUS INTEGRATED BOOST TECHNIQUE TO NON-EXTREMITY SOFT TISSUE AND BONE SARCOMAS
Mahbubl Ahmed
Favorite
Ahmed, Shamim

All India Institute Of Medical Sciences
(P 435) A PHASE II STUDY OF HIGH DOSE IFOSFAMIDE IN METASTATIC/LOCALLY ADVANCED SYNOVIAL SARCOMA FROM A TERTIARY CARE CENTER IN INDIA
Shamim Ahmed
Favorite
Ahn, Diane

NCI/NIH
(P 181) THE DEVELOPMENT OF A NOVEL PDGFRA RESISTANCE MUTATION IN A RECURRENT KIT-MUTANT GASTROINTESTINAL STROMAL TUMOR (GIST)
Diane Ahn
Favorite
Ahrens, Will

Carolinas Pathology Group
(P 02) METHYLATION PROFILING AS A DIAGNOSTIC ADJUNCT FOR UNDIFFERENTIATED SARCOMAS: A REAL-WORLD EVALUATION
Will Ahrens
Favorite
Airoldi, Chiara

Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan
(P 277) THE ROLE OF RADIOTHERAPY IN THE MULTIDISCIPLINARY MANAGEMENT OF RADIATION-ASSOCIATED ANGIOSARCOMA OF THE BREAST: A REFERRAL CENTER EXPERIENCE
Chiara Airoldi
Favorite
Akella, Lalith

Parabilis Medicines
(P 415) A PHASE 1/2 TRIAL OF FOG-001, A FIRST-IN-CLASS DIRECT β-CATENIN:TCF4 INHIBITOR: SAFETY AND PRELIMINARY ANTITUMOR ACTIVITY IN PATIENTS WITH DESMOID TUMORS (DT)
Lalith Akella
Favorite
Akiko Nakagawa, Suely

A.C.Camargo Cancer Center
(P 132) MOLECULAR LANDSCAPE AND CLINICAL HETEROGENEITY OF BRAZILIAN CHONDROSARCOMAS: INSIGHTS FROM IDH, TERT, AND GENOME-WIDE ANALYSIS
Suely Akiko Nakagawa
Favorite
(P 137) GENOMIC ALTERATIONS IN RARE CARTILAGINOUS TUMOR SYNDROMES ASSOCIATED WITH CHONDROSARCOMA DEVELOPMENT
Suely Akiko Nakagawa
Favorite
(P 278) NEOADJUVANT HYPOFRACTIONATED RADIOTHERAPY AND CHEMOTHERAPY IN EXTREMITY SOFT TISSUE SARCOMAS
Suely Akiko Nakagawa
Favorite
Aksoy, Taha

Department of Orthopaedics, University of Miami
(P 89) PATELLAR HEIGHT AND ITS INFLUENCE ON FUNCTIONAL OUTCOMES FOR MEGAPROSTHESES AROUND THE KNEE PERFORMED FOR ONCOLOGICAL INDICATIONS
Taha Aksoy
Favorite
(P 90) MEGAPROSTHESIS CONVERSION FROM FAILED OSTEOARTICULAR ALLOGRAFT VERSUS PRIMARY RECONSTRUCTION FOR DISTAL FEMUR AND PROXIMAL TIBIA TUMORS: A PROPENSITY MATCHED-PAIR ANALYSIS
Taha Aksoy
Favorite
(P 99) LIMB SALVAGE FOR PROXIMAL TIBIA TUMORS: OUTCOMES OF ALLOGRAFT-PROSTHESIS COMPOSITE AND ENDOPROSTHETIC RECONSTRUCTION
Taha Aksoy
Favorite
Alamilla-Garcia, Gabriela

National Cancer Institute Mexico
(P 302) PREDICTORS AND OUTCOMES OF RECURRENT RETROPERITONEAL SARCOMA: A SINGLE-CENTER LATIN AMERICAN COHORT STUDY
Gabriela Alamilla-Garcia
Favorite
Albadi, Hanadi

Rush University School of Medicine
(P 138) A MULTI-INSTITUTIONAL ARCHIVE AND DEEP LEARNING PIPELINE FOR QUANTIFYING CHONDROSARCOMA COMPOSITION
Hanadi Albadi
Favorite
Alban, Gabriela

Grupo Oncoclinicas
(P 285) MULTICENTER STUDY OF SPATIALLY FRACTIONATED RADIOTHERAPY (LATTICE) FOR LARGE-VOLUME RADIORESISTANT SARCOMAS
Gabriela Alban
Favorite
Albergo, Jose Ignacio

Hospital Italiano De Buenos Aires
(P 151) SHOULD WE USE ADJUVANT CHEMOTHERAPY IN PATIENTS WITH LOCALIZED DEDIFFERENTIATED CHONDROSARCOMA (DDCS) OF THE PELVIS? AN ANALYSIS BY THE PELVIC DDCS STUDY GROUP
Jose Ignacio Albergo
Favorite
Albert, Catherine

Seattle Children's Hospital, University of Washington, Fred Hutchinson Cancer Center
(P 417) EFFICACY AND SAFETY OF LAROTRECTINIB (LARO) IN PATIENTS (PTS) WITH TRK FUSION SARCOMAS
Catherine Albert
Favorite
Albertsmeier, Markus

Department of General, Visceral and Transplantation Surgery, University Hospital, Ludwig-Maximilians-Universität Munich, Munich, Germany
(P 64) ATRX EXPRESSION CORRELATES WITH REDUCED IMMUNE CHECKPOINT EXPRESSION AND POOR SURVIVAL IN HIGH-RISK SOFT TISSUE SARCOMAS
Markus Albertsmeier
Favorite
(P 441) COLOSARC-Q: A PROSPECTIVE MULTICENTER STUDY FOR EVALUATING SURGICAL STRATEGIES FOR COLORECTAL RESECTIONS AND POSTOPERATIVE QUALITY OF LIFE IN RETROPERITONEAL SARCOMA PATIENTS
Markus Albertsmeier
Favorite
(P 443) FIRST-LINE PAZOPANIB IN PATIENTS WITH EPITHELIOID HEMANGIOENDOTHELIOMA: A RETROSPECTIVE SINGLE-CENTER ANALYSIS
Markus Albertsmeier
Favorite
Albieri, Benedetta

National Center for Cancer Immune Therapy, Department of Oncology, Copenhagen University Hospital, Herlev, Denmark
(P 249) IN VITRO EXPANSION OF TUMOR-INFILTRATING GAMMA-DELTA T-CELLS FROM PATIENTS WITH SOFT TISSUE SARCOMAS
Benedetta Albieri
Favorite
Alcindor, Thierry

Dana-Farber Cancer Institute
(P 235) AGNOSTIC INDICATION OF IMMUNE CHECKPOINT INHIBITORS (ICI): PATTERNS OF RESPONSE OF SARCOMAS
Thierry Alcindor
Favorite
Aldrich, Alison

The Ohio State University
(P 221) QUALITATIVE ANALYSIS OF THE PERIOPERATIVE EXPERIENCE OF YOUNG ADULT PATIENTS UNDERGOING EXTREMITY SARCOMA SURGERY
Alison Aldrich
Favorite
Alessandrino, Francesco

University of Miami Miller School of Medicine
(P 201) METASTATIC PATTERNS, TREATMENT MODALITIES, AND OVERALL SURVIVAL IN OLIGOMETASTATIC GIST: A SINGLE-CENTER RETROSPECTIVE STUDY
Francesco Alessandrino
Favorite
(P 333) METABOLIC SYNDROME CORRELATION WITH LIPOSARCOMA INCIDENCE AND OUTCOMES: A RETROSPECTIVE ANALYSIS.
Francesco Alessandrino
Favorite
Alexander, John

Ohio State University
(P 84) A MULTICENTER COMPARISON OF REVERSE TOTAL SHOULDER ARTHROPLASTY VERSUS HEMIARTHROPLASTY FOR ENDOPROSTHETIC RECONSTRUCTION FOLLOWING ONCOLOGIC RESECTION OF THE PROXIMAL HUMERUS
John Alexander
Favorite
Alexander, John

The Ohio State University
(P 161) CLINICAL CHARACTERISTICS, PATTERNS OF CARE, AND TREATMENT OUTCOMES OF CHONDROSARCOMA: A SINGLE-INSTITUTIONAL EXPERIENCE
John Alexander
Favorite
(P 221) QUALITATIVE ANALYSIS OF THE PERIOPERATIVE EXPERIENCE OF YOUNG ADULT PATIENTS UNDERGOING EXTREMITY SARCOMA SURGERY
John Alexander
Favorite
Alex, Nissy

University of Texas Southwestern Medical Center
(P 03) CONGRUENCE OF CIRCULATING TUMOR DNA & RADIOGRAPHIC RESPONSE IN BONE AND SOFT TISSUE SARCOMA
Nissy Alex
Favorite
Alfonsi, Samuel

Rush University Medical Center
(P 113) ASSESSING TREATMENT OUTCOMES OF CHONDROMYXOID FIBROMA: A CASE SERIES
Samuel Alfonsi
Favorite
Alfonso Ruiz, Rosa

Hospital Santa Creu i Sant Pau
(P 218) THE IMPACT OF BROADENED GENETIC COUNSELLING REFERRAL CRITERIA IN SARCOMA PATIENTS: A REFERENCE CENTRE'S EXPERIENCE
Rosa Alfonso Ruiz
Favorite
Aliberti, Sandra

Oncology Unit, Candiolo Cancer Institute, FPO-IRCCS
(P 231) INCREASED LIFETIME RISK (LTR) OF SOFT TISSUE SARCOMAS (STS) IN PATIENTS WITH LOW-RISK GASTROINTESTINAL STROMAL TUMORS (GIST): A RETROSPECTIVE ANALYSIS FROM THE ITALIAN SARCOMA GROUP (ISG)
Sandra Aliberti
Favorite
al-Ibraheemi, Alyaa

Dana Farber / Harvard Cancer Center
(P 168) LEVERAGING LARGE LANGUAGE MODELS FOR STRUCTURED INFORMATION EXTRACTION FROM EWING SARCOMA PATHOLOGY REPORTS
Alyaa al-Ibraheemi
Favorite
Ali, LeeAnn

Strand Therapeutics Inc.
(P 433) PHASE I DOSE ESCALATION TRIAL OF STX-001, AN LNP SELF-REPLICATING MRNA EXPRESSING IL-12, IN PATIENTS WITH REFRACTORY TUMORS INCLUDING SARCOMAS
LeeAnn Ali
Favorite
Allajbej, Albina

Fondazione IRCCS Istituto Nazionale Dei Tumori
(P 277) THE ROLE OF RADIOTHERAPY IN THE MULTIDISCIPLINARY MANAGEMENT OF RADIATION-ASSOCIATED ANGIOSARCOMA OF THE BREAST: A REFERRAL CENTER EXPERIENCE
Albina Allajbej
Favorite
Allajbej, Albina

Fondazione IRCCS Istituto Nazionale dei Tumori
(P 308) IMPACT OF PSOAS MUSCLE RESECTION ON OUTCOMES IN PRIMARY RETROPERITONEAL DEDIFFERENTIATED LIPOSARCOMA
Albina Allajbej
Favorite
Allison, Daniel Christopher

Cedars Sinai Medical Center
(P 230) CIRCULATING TUMOR DNA AS AN EARLY INDICATOR OF RESPONSE, PROGRESSION, AND RECURRENCE OF SARCOMAS
Daniel Christopher Allison
Favorite
(P 433) PHASE I DOSE ESCALATION TRIAL OF STX-001, AN LNP SELF-REPLICATING MRNA EXPRESSING IL-12, IN PATIENTS WITH REFRACTORY TUMORS INCLUDING SARCOMAS
Daniel Christopher Allison
Favorite
(P 440) CASE REPORT: COMPLETE CLINICAL AND MOLECULAR RESPONSE TO INTRATUMORAL STX-001, AN LNP-SELF REPLICATING MRNA EXPRESSING IL-12 IN A PATIENT WITH REFRACTORY ANGIOSARCOMA
Daniel Christopher Allison
Favorite
(P 471) COMBINATION CHEMOTHERAPY WITH GEMCITABINE AND PACLITAXEL: A HIGHLY EFFICACIOUS AND BETTER TOLERATED OPTION FOR ANGIOSARCOMA
Daniel Christopher Allison
Favorite
Almahdi, Yazan

University of Michigan
(P 50) A NEW MURINE MODEL OF DEDIFFERENTIATED LIPOSARCOMA DEFINED BY HIGH PROLIFERATION AND METABOLIC ADAPTABILITY
Yazan Almahdi
Favorite
Almalahi, Ateik

Indiana University School of Medicine
(P 82) DISPARITIES IN OSTEOSARCOMA BY SOCIOECONOMIC STATUS
Ateik Almalahi
Favorite
Alman, Benjamin

Duke University
(P 125) TARGETING LCP1-MEDIATED METASTASIS IN CHONDROSARCOMA WITH OROXYLIN A
Benjamin Alman
Favorite
(P 126) SINGLE-CELL RNA SEQUENCING AND PROTEOMIC SPATIAL PROFILING REVEAL COMPLEX TUMOR MICROENVIRONMENT AND NOVEL IMMUNE INTERACTIONS IN CHONDROSARCOMA
Benjamin Alman
Favorite
(P 130) INVESTIGATING LCP1-MEDIATED ONCOGENIC SIGNALING IN CHONDROSARCOMA METASTASIS
Benjamin Alman
Favorite
(P 380) INVESTIGATING THE ROLE OF HISTONE DEACETYLASE-3 IN METASTATIC UNDIFFERENTIATED PLEOMORPHIC SARCOMA
Benjamin Alman
Favorite
Almassalha, Luay

Northwestern University Feinberg School of Medicine
(P 252) NUCLEAR AND GENOMIC ORGANIZATION OF CHEMOTHERAPY RESISTANT RHABDOMYOSARCOMA CELLS
Luay Almassalha
Favorite
Almeida, Luiz

Universidade Federal Fluminense
(P 347) SURVIVAL ANALYSIS AND PROGNOSTIC FACTORS OF SOFT TISSUE SARCOMAS OF THE TRUNK AND EXTREMITIES TREATED BETWEEN 2010 AND 2015: EXPERIENCE OF THE BRAZILIAN NATIONAL CANCER INSTITUTE
Luiz Almeida
Favorite
Al-Sayegh, Hasan

Sultan Qaboos Comprehensive Cancer Care and Research Center - University Medical City
(P 56) COMPARISON OF PATHOGENIC AND LIKELY PATHOGENIC VARIANTS DISTINCT FROM SPECIFIC DRIVERS IN DIFFERENT SARCOMA GROUPS
Hasan Al-Sayegh
Favorite
alshammari, Raghad

University of British Columbia
(P 178) TREATMENT RESPONSE AND SURVIVAL OUTCOMES IN GASTROINTESTINAL STROMAL TUMORS FOLLOWING NEOADJUVANT THERAPY
Raghad alshammari
Favorite
Alsheimer, Hannah

Department of Radiation Oncology, Universitätsstraße 27, 91054 Erlangen, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Germany
(P 288) IDENTIFICATION OF A DNA REPAIR INHIBITOR FOR THE COMBINATION WITH LURBINECTEDIN AND RADIOTHERAPY IN SARCOMA CELL LINES
Hannah Alsheimer
Favorite
Altendorf-Hofmann, Annelore

Department of General, Visceral and Vascular Surgery, Friedrich-Schiller University Jena, Germany
(P 64) ATRX EXPRESSION CORRELATES WITH REDUCED IMMUNE CHECKPOINT EXPRESSION AND POOR SURVIVAL IN HIGH-RISK SOFT TISSUE SARCOMAS
Annelore Altendorf-Hofmann
Favorite
Alvarez, Elysia

University of California Davis School of Medicine
(P 77) BARRIERS TO GUIDELINE CONCORDANT CARE IN AYA PATIENTS WITH BONE SARCOMAS
Elysia Alvarez
Favorite
Alvarez, Jasmine

Thomas Jefferson University
(P 35) MECHANISTIC AND TRANSCRIPTOMIC ANALYSES REVEAL MUTATION-SPECIFIC THERAPEUTIC RESPONSES IN DESMOID TUMOR CELLS TREATED WITH SORAFENIB AND NIROGACESTAT
Jasmine Alvarez
Favorite
Alvarez-Perez, Jaime

Memorial Sloan Kettering Cancer Center
(P 26) DEVELOPING AN ORTHOTOPIC MODEL OF DESMOPLASTIC SMALL ROUND CELL TUMOR
Jaime Alvarez-Perez
Favorite
Alvarez, Rosa

Hospital General Universitario Gregorio Marañon. Instituto de Investigacion Sanitaria Gregorio Marañon
(P 71) GERMLINE POLYMORPHISMS IN THE VEGF PATHWAY AS PROGNOSTIC BIOMARKERS IN LOCALIZED HIGH-GRADE OSTEOSARCOMA: A STUDY BASED ON DATA FROM THE GEIS-33 PROTOCOL
Rosa Alvarez
Favorite
(P 356) DESMOID TUMORS: A RETROSPECTIVE ANALYSIS FROM A REFERRAL CENTER
Rosa Alvarez
Favorite
(P 389) UNRESECTABLE AND METASTATIC DEDIFFERENTIATED LIPOSARCOMA (DDLPS): INSIGHTS FROM A MULTICENTER REAL-WORLD COHORT (RWC)
Rosa Alvarez
Favorite
Ameline, Baptiste

University Hospital and University of Basel
(P 127) AN INTEGRATED CLINICAL GENOMIC AND TRANSCRIPTOMIC SUBGROUPING OF CENTRAL CHONDROSARCOMA
Baptiste Ameline
Favorite
Amendt, Christiane

Merck Healthcare KGaA
(P 42) PRECLINICAL VALIDATION OF M3554, A NOVEL ANTI-GD2 ANTIBODY-DRUG CONJUGATE, AND EPIGENETIC SENSITIZATION STRATEGIES IN SOFT TISSUE SARCOMAS
Christiane Amendt
Favorite
Amini, Behrang

The University of Texas MD Anderson Cancer Center
(P 311) A FOLLOW-UP STUDY ON THE NOVEL USE OF CONTRAST-ENHANCED SUSCEPTIBILITY-WEIGHTED IMAGING FOR EXTREMITY DESMOID FIBROMATOSIS RESPONSE ASSESSMENT
Behrang Amini
Favorite
(P 317) BUILDING A PRE-SURGICAL MULTIPARAMETRIC-MRI-BASED PREDICTIVE TREATMENT RESPONSE MODEL FOR UNDIFFERENTIATED PLEOMORPHIC SARCOMA TO REPLACE RECIST
Behrang Amini
Favorite
(P 334) MRI VOLUMETRIC AND MODIFIED CHOI-BASED ASSESSMENT OF TREATMENT RESPONSE IN EXTREMITY DESMOID TUMORS TREATED WITH NIROGACESTAT OR SORAFENIB
Behrang Amini
Favorite
(P 406) PILOT STUDY: CAN A MULTIPARAMETRIC MRI-DERIVED MODEL OUTPERFORM RECIST PREDICTING PATHOLOGY RESPONSE IN RHABDOMYOSARCOMA?
Behrang Amini
Favorite
(P 420) THE EFFECT OF CHEMOTHERAPY AND RADIOTHERAPY IN THE MULTIPARAMETRIC MRI-BASED ASSESSMENT OF TREATMENT RESPONSE IN EXTREMITY SOFT-TISSUE UNDIFFERENTIATED PLEOMORPHIC SARCOMA
Behrang Amini
Favorite
Amin, Shahla

Cencora, Inc.
(P 368) ASSESSMENT OF PAIN DIAGNOSIS AND PAIN MEDICATION USE IN ADULTS TREATED WITH NIROGACESTAT: A UNITED STATES REAL-WORLD ANALYSIS
Shahla Amin
Favorite
Amirkhanian, Hanah

Johns Hopkins University
(P 405) PAN-RAS INHIBITION AS A NOVEL THERAPEUTIC STRATEGY FOR RAS-DRIVEN RHABDOMYOSARCOMA
Hanah Amirkhanian
Favorite
An, Andrea

Cell Signaling Technology
(P 198) EXPLOITING METABOLIC DYSREGULATION IN SUCCINATE DEHYDROGENASE-DEFICIENT GASTROINTESTINAL STROMAL TUMOR
Andrea An
Favorite
Andelkovic, Vladimir

Princess Alexandra Hospital
(P 315) ANALYSIS OF CHANGES IN T2-WEIGHTED SIGNAL INTENSITY AND TUMOR VOLUME AND EXPOSURE-RESPONSE IN THE RINGSIDE PHASE 2 STUDY OF VAREGACESTAT FOR DESMOID TUMORS
Vladimir Andelkovic
Favorite
(P 410) SUBGROUP ANALYSIS OF THE PHASE 2 PART OF THE RINGSIDE PHASE 2/3 TRIAL OF VAREGACESTAT FOR TREATMENT OF DESMOID TUMORS
Vladimir Andelkovic
Favorite
Andersen, Flemming Littrup

Dept. of Clinical Physiology & Nuclear Medicine, Rigshospitalet - Copenhagen University Hospital
(P 322) DYNAMIC PET/MRI REVEALS METABOLIC-DIFFUSION INTERACTIONS IN SUSPECTED SOFT TISSUE SARCOMAS
Flemming Littrup Andersen
Favorite
Andersen, Kim Francis

Dept. of Clinical Physiology & Nuclear Medicine, Rigshospitalet - Copenhagen University Hospital
(P 322) DYNAMIC PET/MRI REVEALS METABOLIC-DIFFUSION INTERACTIONS IN SUSPECTED SOFT TISSUE SARCOMAS
Kim Francis Andersen
Favorite
Andersen, Thomas Lund

Dept. of Clinical Physiology & Nuclear Medicine, Rigshospitalet - Copenhagen University Hospital
(P 322) DYNAMIC PET/MRI REVEALS METABOLIC-DIFFUSION INTERACTIONS IN SUSPECTED SOFT TISSUE SARCOMAS
Thomas Lund Andersen
Favorite
Anderson, Colin

Allina Health Orthopedics and Allina Health Cancer Institute, Allina Health
(P 02) METHYLATION PROFILING AS A DIAGNOSTIC ADJUNCT FOR UNDIFFERENTIATED SARCOMAS: A REAL-WORLD EVALUATION
Colin Anderson
Favorite
Anderson, Iain

The Newcastle upon Tyne Hospitals NHS Foundation Trust
(P 314) AN INTERNATIONAL, MULTI-CENTRE STUDY OF SURGICAL MARGINS IN INTERMEDIATE TO HIGH GRADE SARCOMA
Iain Anderson
Favorite
Anderson, Megan

Boston Children's Hospital Department of Orthopaedic Surgery
(P 112) PEDIATRIC GIANT CELL TUMOR OF BONE
Megan Anderson
Favorite
Anderson, Peter

Cleveland Clinic
(P 284) THE IMPACT OF SARCOMA SBRT ON THE IMMUNE SYSTEM: EARLY RESULTS FROM A PROSPECTIVE TRIAL
Peter Anderson
Favorite
Andion, Maitane

Hospital Niño Jesus
(P 71) GERMLINE POLYMORPHISMS IN THE VEGF PATHWAY AS PROGNOSTIC BIOMARKERS IN LOCALIZED HIGH-GRADE OSTEOSARCOMA: A STUDY BASED ON DATA FROM THE GEIS-33 PROTOCOL
Maitane Andion
Favorite
Andre, Baptista

Hospital das Clínicas da Faculdade de Medicina FMUSP
(P 151) SHOULD WE USE ADJUVANT CHEMOTHERAPY IN PATIENTS WITH LOCALIZED DEDIFFERENTIATED CHONDROSARCOMA (DDCS) OF THE PELVIS? AN ANALYSIS BY THE PELVIC DDCS STUDY GROUP
Baptista Andre
Favorite
Andrulis, Irene

Mount Sinai Hospital
(P 55) THE EFFECT OF STAT1 Y701 PHOSPHORYLATION ON GENE EXPRESSION IN UPS
Irene Andrulis
Favorite
(P 323) EVALUATION OF COSMIC MUTATIONAL SIGNATURES IN SOFT TISSUE SARCOMA
Irene Andrulis
Favorite
Andryski, Allison

University of Miami School of Medicine
(P 362) SHOULD PAZOPANIB BE USED AS A MAINTENANCE THERAPY TO IMPROVE RECURRENCE-FREE SURVIVAL AND OVERALL SURVIVAL IN PATIENTS WHO RECEIVED MAI IN SOFT TISSUE SARCOMA?
Allison Andryski
Favorite
Angeles, Christina

University of Michigan
(P 50) A NEW MURINE MODEL OF DEDIFFERENTIATED LIPOSARCOMA DEFINED BY HIGH PROLIFERATION AND METABOLIC ADAPTABILITY
Christina Angeles
Favorite
(P 52) VALIDATION OF SYNGENEIC MURINE DEDIFFERENTIATED LIPOSARCOMA MODELS FOR PRECLINICAL EVALUATION OF THERAPEUTIC SENSITIVITY
Christina Angeles
Favorite
Angelini, Thomas

University of Florida
(P 248) AN EX VIVO ASSAY TO PREDICT IMMUNOTHERAPY RESPONSE IN SARCOMA
Thomas Angelini
Favorite
Annett, Alva

McGill university and RI-MUHC
(P 15) EZHIP: A NOVEL EPIGENETIC DRIVER OF OSTEOSARCOMA PATHOGENESIS
Alva Annett
Favorite
Antkowiak, Mark

Dept. of Surgery, Moores Cancer Center, University of California San Diego
(P 179) NEOADJUVANT AVAPRITINIB IN PDGFRA-MUTANT GIST: NEAR COMPLETE PATHOLOGICAL RESPONSES AT THE COST OF HIGH ADVERSE EVENT RATES
Mark Antkowiak
Favorite
(P 180) COMPARATIVE EFFICACY OF GENERIC AND BRAND-NAME IMATINIB IN NEOADJUVANT TREATMENT OF KIT EXON 11 MUTANT GIST
Mark Antkowiak
Favorite
(P 197) DIFFERENTIAL EFFECTS OF ANAGRELIDE IN GASTROINTESTINAL STROMAL TUMORS (GIST) IN VITRO
Mark Antkowiak
Favorite
Antonescu, Cristina

Memorial Sloan-Kettering Cancer Center, Weill-Cornell Medical College
(P 186) BRAF V600E-MUTATED GASTROINTESTINAL STROMAL TUMORS: A CASE SERIES AND ANALYSIS OF IMMUNE TUMOR INFILTRATE
Cristina Antonescu
Favorite
(P 187) THERAPEUTIC OUTCOMES IN NF1-ALTERED GIST TREATED WITH MEK INHIBITION: A SINGLE-CENTER EXPERIENCE
Cristina Antonescu
Favorite
Antony, Ramya

Kura Oncology, Inc.
(P 423) ZIFTOMENIB IN COMBINATION WITH IMATINIB IN ADVANCED GASTROINTESTINAL STROMAL TUMORS (GIST) AFTER IMATINIB FAILURE: PHASE 1A/B STUDY OF SAFETY, PHARMACOKINETICS, AND ANTITUMOR ACTIVITY
Ramya Antony
Favorite
Aoude, ahmed

McGill university and RI-MUHC
(P 15) EZHIP: A NOVEL EPIGENETIC DRIVER OF OSTEOSARCOMA PATHOGENESIS
ahmed Aoude
Favorite
Appana, Ojasvi

The Ohio State University
(P 161) CLINICAL CHARACTERISTICS, PATTERNS OF CARE, AND TREATMENT OUTCOMES OF CHONDROSARCOMA: A SINGLE-INSTITUTIONAL EXPERIENCE
Ojasvi Appana
Favorite
Appenzeller, Christina

Department of Medical Oncology and Hematology, Cantonal Hospital St. Gallen
(P 436) SAKK 57/24 FEASIBILITY OF TOTAL NEOADJUVANT TREATMENT WITH HYPERTHERMIA IN PATIENTS WITH HIGH-RISK EXTREMITY AND TRUNK SOFT TISSUE SARCOMA. A MULTICENTER, SINGLE ARM, OPEN LABEL, PHASE II TRIAL
Christina Appenzeller
Favorite
Appolloni, Viviana

Italian Sarcoma Group ISG ETS
(P 210) TOWARDS INTERNATIONALIZATION OF THE CLINICAL RESEARCH COORDINATOR ROLE: THE FIRST DROP OF THE NIAGARA FALLS PROJECT
Viviana Appolloni
Favorite
Aquino, Benigno

Princess Margaret Cancer Centre, UHN
(P 67) MULTIPLE MESENCHYMAL LINEAGES AS POTENTIAL CELL-OF-ORIGINS OF SMARCB1-DEFICIENT EPITHELIOID SARCOMA
Benigno Aquino
Favorite
ARAFAH, MOHAMMAD

King Faisal Specialist Hospital and Research Center - Riyadh, Saudi Arabia
(P 88) THE RAY CHALLENGE: HOW MANY RAY RESECTIONS CAN PATIENTS TOLERATE AND WHICH RAY RESECTIONS AFFECTS FUNCTIONAL OUTCOME THE MOST IN ORTHOPEDIC ONCOLOGY?
MOHAMMAD ARAFAH
Favorite
Arakawa, Ayumu

Department of Pediatric Oncology, National Cancer Center Hospital
(P 271) SAFETY AND EFFICACY OF CABOZANTINIB IN PEDIATRIC PATIENTS WITH MALIGNANT SOLID TUMORS (CAMEL TRIAL/NCCH2106): A SINGLE-CENTRE PHASE I TRIAL
Ayumu Arakawa
Favorite
(P 341) PROGNOSTIC RELEVANCE OF CYCLOPHOSPHAMIDE DOSE FOR HIGH-RISK RHABDOMYOSARCOMA IN ADULT PATIENTS TREATED WITH VAC THERAPY
Ayumu Arakawa
Favorite
Aramaki, Takeshi

Shizuoka Cancer Center
(P 291) INTRA-ARTERIAL CHEMOTHERAPY WITH CONCOMITANT RADIATION THERAPY FOR UNRESECTABLE SARCOMA
Takeshi Aramaki
Favorite
Araujo, Dejka

University of Texas MD Anderson Cancer Center
(P 83) OUTCOMES OF MULTIMODAL PERIOPERATIVE TREATMENT IN OSTEOSARCOMAS OF THE JAW
Dejka Araujo
Favorite
(P 451) TREATMENT OUTCOMES OF GEMCITABINE AND DOCETAXEL IN PATIENTS WITH CLEAR CELL SARCOMA (CCS) OR GASTROINTESTINAL NEUROECTODERMAL TUMOR (GNET): A CASE SERIES
Dejka Araujo
Favorite
(P 460) OUTCOMES OF LATER-LINES SYSTEMIC THERAPIES IN MALIGNANT PERIPHERAL NERVE SHEATH TUMORS (MPNST)
Dejka Araujo
Favorite
Araujo, Marcelo

Universidade Federal Fluminense
(P 347) SURVIVAL ANALYSIS AND PROGNOSTIC FACTORS OF SOFT TISSUE SARCOMAS OF THE TRUNK AND EXTREMITIES TREATED BETWEEN 2010 AND 2015: EXPERIENCE OF THE BRAZILIAN NATIONAL CANCER INSTITUTE
Marcelo Araujo
Favorite
Argraves, Kelley

Clear Cell Sarcoma Foundation
(P 450) OUTCOMES IN CLEAR CELL SARCOMA: UPDATED INSIGHTS FROM ELECTRONIC HEALTH RECORDS IN A PATIENT-LED REGISTRY
Kelley Argraves
Favorite
Ariyan, Charlotte

Memorial Sloan Kettering Cancer Center
(P 421) CHARACTERIZING THE IMMUNE RESPONSE TO INTRATUMORAL TIGILANOL TIGLATE (TT) IN PATIENTS WITH ADVANCED AND/OR METASTATIC SOFT TISSUE SARCOMA (STS) IN A PHASE IIA TRIAL (NCT05755113)
Charlotte Ariyan
Favorite
Armando, Nicholas

Nationwide Children’s Hospital
(P 264) RARE CASE OF INFLAMMATORY MYOFIBROBLASTIC TUMOR (IMT) IN NEWBORN
Nicholas Armando
Favorite
Arndt, Karin

Deutsche Sarkom-Stiftung (DSS) / German Sarcoma Foundation, patient support.
(P 454) TREATMENT PATTERNS AND OUTCOMES IN RADIATION-INDUCED SARCOMA: FIRST RESULTS OF THE TETRIS-PROJECT - A MULTIMODAL RETROSPECTIVE ANALYSIS FROM A TERTIARY CENTER
Karin Arndt
Favorite
Arranz, Maria Jesus

Mutua de Terrasa
(P 71) GERMLINE POLYMORPHISMS IN THE VEGF PATHWAY AS PROGNOSTIC BIOMARKERS IN LOCALIZED HIGH-GRADE OSTEOSARCOMA: A STUDY BASED ON DATA FROM THE GEIS-33 PROTOCOL
Maria Jesus Arranz
Favorite
Arregui, Marta

Hospital General Universitario Gregorio Marañón
(P 356) DESMOID TUMORS: A RETROSPECTIVE ANALYSIS FROM A REFERRAL CENTER
Marta Arregui
Favorite
Arseneault-Monette, Emerik

Arthur Child Cancer Center
(P 293) CRYOABLATION FOR EXTRA-ABDOMINAL DESMOID TUMORS: A RETROSPECTIVE STUDY OF RADIOLOGIC AND CLINICAL OUTCOMES
Emerik Arseneault-Monette
Favorite
Arslan, Emre

MD Anderson Cancer Center
(P 47) EWSR1::WT1 FUSION ONCOPROTEIN ACTIVITY SHAPES LINEAGE HETEROGENEITY IN DESMOPLASTIC SMALL ROUND CELL TUMORS
Emre Arslan
Favorite
Arteau, Annie

University of Laval
(P 143) IMPACT OF SURGICAL MARGINS IN CHEST WALL CHONDROSARCOMAS: A CANSARCC STUDY
Annie Arteau
Favorite
Arunkumar, Varshini

The University of Texas MD Anderson Cancer Center
(P 172) COMPARISON OF CELL SEGMENTATION METHODS IN SOFT TISSUE SARCOMA (STS) SPATIAL PROTEOMIC DATASETS
Varshini Arunkumar
Favorite
(P 242) IMMUNE PROFILING OF UNDIFFERENTIATED PLEOMORPHIC SARCOMAS REVEALS DISTINCT PROGNOSTIC SUBGROUPS
Varshini Arunkumar
Favorite
Asche, Carl

Department of Pharmacotherapy, College of Pharmacy, University of Utah
(P 357) DEVELOPMENT OF AN ALGORITHM TO IDENTIFY PATIENTS (PT) WITH DESMOID TUMORS (DT) IN A UNITED STATES (US) CLAIMS DATASET
Carl Asche
Favorite
Asero, Salvatore

Azienda Ospedaliera di Rilievo Nazionale e di Alta Specializzazione Garibaldi Catania
(P 328) INNOVATING SARCOMA EDUCATION: EARLY OUTCOMES OF THE ITALIAN SOCIETY OF SURGICAL ONCOLOGY (SICO) SARCOMA SOCIAL MULTI-PLATFORM JOURNAL CLUB INITIATIVE
Salvatore Asero
Favorite
Askehøj Rømer, Anne Mette

National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital—Herlev and Gentofte, Herlev, Denmark
(P 36) MODULATION OF THE SARCOMA MICROENVIRONMENT THROUGH β-ADRENERGIC BLOCKADE
Anne Mette Askehøj Rømer
Favorite
Asna, Noam

Shaare Zedek Medical Center
(P 326) GERMLINE POT1 MUTATIONS IN ANGIOSARCOMA DIFFER FROM SOMATIC MUTATIONS
Noam Asna
Favorite
Aso, Ayano

Massachusetts General Hospital
(P 91) A COMPARISON OF ACETABULAR AUGMENTATION AND PHOTODYNAMIC NAIL STABILIZATION FOR COMPLEX ONCOLOGIC TOTAL HIP ARTHROPLASTY
Ayano Aso
Favorite
Atkinson, Andrea

Newcastle University
(P 133) INVESTIGATION OF COMBINING MDM2 INHIBITORS WITH DR5 AGONISTS FOR BONE SARCOMA TREATMENT
Andrea Atkinson
Favorite
Attia, Steven

Mayo Clinic in Florida, Jacksonville, FL, USA
(P 404) OUTCOMES OF NEOADJUVANT THERAPY IN ANGIOSARCOMA PATIENTS: A KAPLAN-MEIER-RECONSTRUCTED INDIVIDUAL PATIENT-LEVEL META-ANALYSIS
Steven Attia
Favorite
(P 416) A PHASE 2 MULTICENTER OPEN-LABEL BASKET STUDY OF TAZEMETOSTAT IN ADULT PATIENTS WITH INI1-NEGATIVE EPITHELIOID SARCOMA – FINAL ANALYSIS
Steven Attia
Favorite
(P 424) AN OPEN-LABEL PHASE 1/2 STUDY OF DCC-3009 MONOTHERAPY IN PATIENTS (PTS) WITH ADVANCED GASTROINTESTINAL STROMAL TUMOR (GIST)
Steven Attia
Favorite
Aurelio, Claudia

Fondazione IRCCS Istituto Nazionale dei Tumori
(P 32) EFFECTIVENESS OF LURBINECTEDIN PLUS IRINOTECAN IN PRECLINICAL MODEL OF DESMOPLASTIC SMALL ROUND CELL TUMOR
Claudia Aurelio
Favorite
Avedian, Raffi

Stanford University
(P 93) INTERCALARY COMPRESSIVE OSSEOINTEGRATION OF DIAPHYSEAL TUMORS: A MULTI-INSTITUTIONAL CASE SERIES
Raffi Avedian
Favorite
(P 400) LONGITUDINAL EPIGENETIC AND TRANSCRIPTOMIC REMODELING ACROSS PRIMARY, IRRADIATED, AND LOCALLY RELAPSED SOFT TISSUE SARCOMAS
Raffi Avedian
Favorite
Aviles Marin, Pablo Manuel

PharmaMar
(P 33) THE NOVEL TRANSCRIPTIONAL INHIBITORS ECUBECTEDIN AND PM54 DEMONSTRATE ANTITUMOR ACTIVITY IN PATIENT-DERIVED XENOGRAFT MODELS OF SOFT TISSUE SARCOMA
Pablo Manuel Aviles Marin
Favorite
Avutu, Viswatej

Memorial Sloan Kettering Cancer Center
(P 186) BRAF V600E-MUTATED GASTROINTESTINAL STROMAL TUMORS: A CASE SERIES AND ANALYSIS OF IMMUNE TUMOR INFILTRATE
Viswatej Avutu
Favorite
(P 187) THERAPEUTIC OUTCOMES IN NF1-ALTERED GIST TREATED WITH MEK INHIBITION: A SINGLE-CENTER EXPERIENCE
Viswatej Avutu
Favorite
(P 409) RETROSPECTIVE ANALYSIS OF PROGNOSTIC FACTORS INCLUDING HLA GENOTYPE IN MYXOID LIPOSARCOMA
Viswatej Avutu
Favorite
(P 467) TREATMENT OUTCOMES IN AGGRESSIVE ANGIOMYXOMA: A SINGLE INSTITUTION EXPERIENCE
Viswatej Avutu
Favorite
Ayello, Janet

New York Medical College
(P 76) CD47 BLOCKADE SYNERGIZES WITH CHEMOTHERAPY IN ENHANCING MACROPHAGE PHAGOCYTOSIS OF EWING SARCOMA CELLS
Janet Ayello
Favorite
Aymerito, Fulvia

Royal Marsden Hospital NHS Foundation Trust
(P 298) RESECTION OF PARA-RENAL INFERIOR VENA CAVA LEIOMYOSARCOMA WITH RIGHT NEPHRECTOMY AND LEFT RENAL VEIN LIGATION WITHOUT VENOUS RECONSTRUCTION.
Fulvia Aymerito
Favorite
Ayx, Isabelle

Department of Radiology and Nuclear Medicine, University Medical Center Mannheim, Medical Faculty Mannheim, Heidelberg University
(P 367) ADHERENCE TO GERMAN SARCOMA GUIDELINE FOR MRI SEQUENCING IN SOFT TISSUE SARCOMA: EVALUATION OF IMAGING PRACTICES AND COMPLIANCE
Isabelle Ayx
Favorite
Azar, Patrick

IU
(P 256) THE SEAN KARL COHORT: A NATIONAL COLLABORATIVE SINGLE-CELL RNASEQ STUDY OF PAIRED PATIENT EWING SARCOMA SPECIMENS
Patrick Azar
Favorite
Azmani, Rihab

Institut Bergonié
(P 324) FULLY MATURE TERTIARY LYMHOID STRUCTURES AS PREDICTORS OF LOCAL RECURRENCE IN SOFT TISSUE SARCOMAS
Rihab Azmani
Favorite
B
Büttner, Sylvia

University of Heidelberg, Mannheim University Medical Center, Medical Statistics, Biomathematics and Information Processing, Mannheim, Germany.
(P 454) TREATMENT PATTERNS AND OUTCOMES IN RADIATION-INDUCED SARCOMA: FIRST RESULTS OF THE TETRIS-PROJECT - A MULTIMODAL RETROSPECTIVE ANALYSIS FROM A TERTIARY CENTER
Sylvia Büttner
Favorite
Babatunde, Olayode

Memorial Sloan Kettering Cancer Center
(P 187) THERAPEUTIC OUTCOMES IN NF1-ALTERED GIST TREATED WITH MEK INHIBITION: A SINGLE-CENTER EXPERIENCE
Olayode Babatunde
Favorite
(P 467) TREATMENT OUTCOMES IN AGGRESSIVE ANGIOMYXOMA: A SINGLE INSTITUTION EXPERIENCE
Olayode Babatunde
Favorite
Babich, John

Ratio Therapeutics
(P 430) A PH/2 STUDY OF THE RADIOPHARMACEUTICAL [AC-225]RTX-2358 IN THE TREATMENT OF RELAPSED / REFRACTORY (R/R) SOFT TISSUE SARCOMA (STS) THE ATLAS STUDY - ACTINIUM THERAPY FOR LATE-STAGE AGGRESSIVE SARCOMAS
John Babich
Favorite
Badalamenti, Giuseppe

University of Palermo
(P 231) INCREASED LIFETIME RISK (LTR) OF SOFT TISSUE SARCOMAS (STS) IN PATIENTS WITH LOW-RISK GASTROINTESTINAL STROMAL TUMORS (GIST): A RETROSPECTIVE ANALYSIS FROM THE ITALIAN SARCOMA GROUP (ISG)
Giuseppe Badalamenti
Favorite
(P 458) BETWEEN LYMPHOMAS AND SARCOMAS: A RETROSPECTIVE, MULTI-INSTITUTIONAL STUDY FROM THE ITALIAN SARCOMA GROUP (ISG) ON HISTIOCYTIC AND DENDRITIC CELL NEOPLASMS (HDCN)
Giuseppe Badalamenti
Favorite
Bae, Susie

Peter MacCallum Cancer Centre
(P 121) REAL-WORLD EXPERIENCE OF CABOZANTINIB MONOTHERAPY IN RELAPSED OR REFRACTORY OSTEOSARCOMA AND EWING SARCOMA: A SINGLE-CENTRE AUSTRALIAN STUDY
Susie Bae
Favorite
(P 344) REAL-WORLD EXPERIENCE OF SORAFENIB IN DESMOID TUMOURS: A SINGLE-CENTRE AUSTRALIAN STUDY
Susie Bae
Favorite
Baguidy, Marie Stephanie

MCW
(P 111) DOES DOSE MATTER? POSTOPERATIVE RADIATION DOSE AND OUTCOMES FOLLOWING FIXATION OF METASTATIC EXTREMITY BONE LESIONS
Marie Stephanie Baguidy
Favorite
Baheti, Akshay

Tata Memorial Hospital, Tata memorial Centre, Mumbai
(P 292) CRANIOVERTEBRAL EWINGS SARCOMA WITH MENINGEAL INFILTRATION - A CLINICAL OUTCOME ANALYSIS
Akshay Baheti
Favorite
Bähr, Katharina

Cancer Information Service, German Cancer Research Center (DKFZ)
(P 455) DEVELOPMENT OF PATIENT-CENTERED INFORMATION MATERIAL ON RADIATION-INDUCED SARCOMA: QUALITATIVE RESULTS FROM FOCUS GROUPS OF THE TETRIS-PROJECT
Katharina Bähr
Favorite
Baia, Marco

Fondazione IRCCS Istituto Nazionale dei Tumori
(P 308) IMPACT OF PSOAS MUSCLE RESECTION ON OUTCOMES IN PRIMARY RETROPERITONEAL DEDIFFERENTIATED LIPOSARCOMA
Marco Baia
Favorite
(P 328) INNOVATING SARCOMA EDUCATION: EARLY OUTCOMES OF THE ITALIAN SOCIETY OF SURGICAL ONCOLOGY (SICO) SARCOMA SOCIAL MULTI-PLATFORM JOURNAL CLUB INITIATIVE
Marco Baia
Favorite
Bailey, Kelly

University of Pittsburgh
(P 256) THE SEAN KARL COHORT: A NATIONAL COLLABORATIVE SINGLE-CELL RNASEQ STUDY OF PAIRED PATIENT EWING SARCOMA SPECIMENS
Kelly Bailey
Favorite
Baird, Lissa

Boston Children's Hospital
(P 290) CLINICAL OUTCOMES AFTER RADIOTHERAPY FOR PATIENTS WITH POORLY DIFFERENTIATED CHORDOMA
Lissa Baird
Favorite
Baker, Andrew

Johns Hopkins University
(P 405) PAN-RAS INHIBITION AS A NOVEL THERAPEUTIC STRATEGY FOR RAS-DRIVEN RHABDOMYOSARCOMA
Andrew Baker
Favorite
Bakke, Danika

Caris Life Sciences
(P 244) INTRATUMORAL TIGIT BLOCKADE AUGMENTS ANTI-TUMOR RESPONSES AND BYPASSES HYPERFUNCTIONALITY OF PERIPHERAL TIGIT+ NK CELLS IN MOUSE AND HUMAN MODELS OF BONE AND SOFT TISSUE SARCOMA
Danika Bakke
Favorite
Baldi, Giacomo Giulio

Department of Oncology, Hospital of Prato, Azienda USL Toscana Centro
(P 231) INCREASED LIFETIME RISK (LTR) OF SOFT TISSUE SARCOMAS (STS) IN PATIENTS WITH LOW-RISK GASTROINTESTINAL STROMAL TUMORS (GIST): A RETROSPECTIVE ANALYSIS FROM THE ITALIAN SARCOMA GROUP (ISG)
Giacomo Giulio Baldi
Favorite
(P 407) PIMICOTINIB IN TENOSYNOVIAL GIANT CELL TUMOR (TGCT): LONG-TERM EFFICACY, SAFETY, AND PATIENT-REPORTED OUTCOMES FROM THE PHASE 3 MANEUVER STUDY
Giacomo Giulio Baldi
Favorite
(P 458) BETWEEN LYMPHOMAS AND SARCOMAS: A RETROSPECTIVE, MULTI-INSTITUTIONAL STUDY FROM THE ITALIAN SARCOMA GROUP (ISG) ON HISTIOCYTIC AND DENDRITIC CELL NEOPLASMS (HDCN)
Giacomo Giulio Baldi
Favorite
Balis, Frank

Children's Hospital of Philadelphia
(P 427) PHASE 1/2 TRIAL TO EVALUATE THE SAFETY AND EFFICACY OF PEEL-224 IN COMBINATION WITH VINCRISTINE AND TEMOZOLOMIDE IN ADOLESCENTS AND YOUNG ADULTS WITH RELAPSED OR REFRACTORY SARCOMAS
Frank Balis
Favorite
Balkaran, Bridget

Genesis Research Group
(P 464) EFFICACY OUTCOMES AMONG PATIENTS WITH ADVANCED EPITHELIOID SARCOMAS OF PROXIMAL-TYPE AND DISTAL-TYPE TREATED WITH TAZ: POST HOC ANALYSIS OF STUDY EZH-202
Bridget Balkaran
Favorite
Balko, Jan

Department of Pathology and Molecular Medicine, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic
(P 243) CLINICAL SIGNIFICANCE OF TUMOR-INFILTRATING IMMUNE CELL SUBSETS IN THE RETROPERITONEAL DEDIFFERENTIATED LIPOSARCOMAS AND LEIOMYOSARCOMAS
Jan Balko
Favorite
Ballatori, Sarah

Yale
(P 402) LYMPH NODE METASTASES IN SOFT TISSUE SARCOMA: A DATABASE ANALYSIS
Sarah Ballatori
Favorite
Ballinger, Mandy

Centre for Molecular Oncology
(P 49) GENETIC INTERACTION BETWEEN SPRED3 AND SMARCB1 CAUSES EXPLOSIVE MULTIFOCAL MALIGNANT PERIPHERAL NERVE SHEATH TUMORS
Mandy Ballinger
Favorite
Ballon, Jason

Sarcoma Oncology Center
(P 388) TRIAL IN PROGRESS: A PHASE 2 STUDY OF METRONOMIC TRABECTEDIN, GEMCITIBAINE, AND DACARBAZINE IN PREVIOUSLY TREATED ADVANCED SOFT TISSUE SARCOMA (NCT04535271)
Jason Ballon
Favorite
(P 396) EVALUATING THE SAFETY AND EFFICACY OF METRONOMIC GEMCITABINE, DOXORUBICIN, AND DOCETAXEL PLUS NIVOLUMAB IN PREVIOUSLY TREATED ADVANCED LEIOMYOSARCOMA AND LIPOSARCOMA: A PHASE 2 STUDY (NCT04535713)
Jason Ballon
Favorite
(P 398) INVESTIGATING THE SAFETY AND EFFICACY OF LURBINECTEDIN WITH IPILIMUMAB AND NIVOLUMAB FOR ADVANCED SOFT TISSUE SARCOMA: LINNOVATE PHASE 1/2 STUDY (NCT05876715)
Jason Ballon
Favorite
(P 432) EXPANSION OF A PHASE 1 STUDY OF SON-1010 (IL12-FHAB) ADDING TRABECTEDIN IN SOFT TISSUE SARCOMA: TRIAL IN PROGRESS
Jason Ballon
Favorite
Balser, John

Veristat
(P 430) A PH/2 STUDY OF THE RADIOPHARMACEUTICAL [AC-225]RTX-2358 IN THE TREATMENT OF RELAPSED / REFRACTORY (R/R) SOFT TISSUE SARCOMA (STS) THE ATLAS STUDY - ACTINIUM THERAPY FOR LATE-STAGE AGGRESSIVE SARCOMAS
John Balser
Favorite
Banday, Shahid

UMass Chan Medical School
(P 198) EXPLOITING METABOLIC DYSREGULATION IN SUCCINATE DEHYDROGENASE-DEFICIENT GASTROINTESTINAL STROMAL TUMOR
Shahid Banday
Favorite
Ban, Joy

Duke University
(P 380) INVESTIGATING THE ROLE OF HISTONE DEACETYLASE-3 IN METASTATIC UNDIFFERENTIATED PLEOMORPHIC SARCOMA
Joy Ban
Favorite
Bankel, Lorenz

Department of Medical Oncology and Hematology, University Hospital Zurich
(P 436) SAKK 57/24 FEASIBILITY OF TOTAL NEOADJUVANT TREATMENT WITH HYPERTHERMIA IN PATIENTS WITH HIGH-RISK EXTREMITY AND TRUNK SOFT TISSUE SARCOMA. A MULTICENTER, SINGLE ARM, OPEN LABEL, PHASE II TRIAL
Lorenz Bankel
Favorite
Banks, Lauren

Memorial Sloan Kettering Cancer Center
(P 187) THERAPEUTIC OUTCOMES IN NF1-ALTERED GIST TREATED WITH MEK INHIBITION: A SINGLE-CENTER EXPERIENCE
Lauren Banks
Favorite
(P 409) RETROSPECTIVE ANALYSIS OF PROGNOSTIC FACTORS INCLUDING HLA GENOTYPE IN MYXOID LIPOSARCOMA
Lauren Banks
Favorite
(P 421) CHARACTERIZING THE IMMUNE RESPONSE TO INTRATUMORAL TIGILANOL TIGLATE (TT) IN PATIENTS WITH ADVANCED AND/OR METASTATIC SOFT TISSUE SARCOMA (STS) IN A PHASE IIA TRIAL (NCT05755113)
Lauren Banks
Favorite
(P 467) TREATMENT OUTCOMES IN AGGRESSIVE ANGIOMYXOMA: A SINGLE INSTITUTION EXPERIENCE
Lauren Banks
Favorite
Bannerji, Rajat

Ipsen, Cambridge, MA, USA
(P 416) A PHASE 2 MULTICENTER OPEN-LABEL BASKET STUDY OF TAZEMETOSTAT IN ADULT PATIENTS WITH INI1-NEGATIVE EPITHELIOID SARCOMA – FINAL ANALYSIS
Rajat Bannerji
Favorite
Bardia, Omav

Sarcoma Oncology Center
(P 388) TRIAL IN PROGRESS: A PHASE 2 STUDY OF METRONOMIC TRABECTEDIN, GEMCITIBAINE, AND DACARBAZINE IN PREVIOUSLY TREATED ADVANCED SOFT TISSUE SARCOMA (NCT04535271)
Omav Bardia
Favorite
(P 396) EVALUATING THE SAFETY AND EFFICACY OF METRONOMIC GEMCITABINE, DOXORUBICIN, AND DOCETAXEL PLUS NIVOLUMAB IN PREVIOUSLY TREATED ADVANCED LEIOMYOSARCOMA AND LIPOSARCOMA: A PHASE 2 STUDY (NCT04535713)
Omav Bardia
Favorite
Barger, Zara

Children's Cancer Institute
(P 11) ESTABLISHMENT, CHARACTERIZATION AND RESEARCH APPLICATION OF EIGHT NOVEL PATIENT-DERIVED OSTEOSARCOMA CELL LINES
Zara Barger
Favorite
Barisella, Marta

Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan
(P 452) EFFECTIVENESS OF ERIBULIN FOR MYXOID PLEOMORPHIC LIPOSARCOMA: INSIGHTS FROM A PATIENT-DERIVED MODEL AND CLINICAL TRANSLATION IN A PATIENT WITH ADVANCED DISEASE
Marta Barisella
Favorite
Barkauskas, Donald

Keck School of Medicine of the University of Southern California
(P 168) LEVERAGING LARGE LANGUAGE MODELS FOR STRUCTURED INFORMATION EXTRACTION FROM EWING SARCOMA PATHOLOGY REPORTS
Donald Barkauskas
Favorite
Barlebo Ahlborn, Lise

Center for Genomic Medicine, Copenhagen University Hospital, Rigshospitalet
(P 05) CONCORDANCE OF GENOMIC ALTERATIONS WITH CIRCULATING TUMOR DNA: INITIAL FINDINGS FROM A PILOT STUDY
Lise Barlebo Ahlborn
Favorite
Baroudi, Munther

Fred Hutchinson Cancer Center
(P 287) A PHASE 1 STUDY OF NEOADJUVANT CABOZANTINIB IN COMBINATION WITH RADIATION THERAPY FOR SARCOMAS OF THE EXTREMITIES
Munther Baroudi
Favorite
Barretta, Francesco

Fondazione IRCCS Istituto Nazionale dei Tumori
(P 308) IMPACT OF PSOAS MUSCLE RESECTION ON OUTCOMES IN PRIMARY RETROPERITONEAL DEDIFFERENTIATED LIPOSARCOMA
Francesco Barretta
Favorite
Barriga, Juan

University of Toronto
(P 88) THE RAY CHALLENGE: HOW MANY RAY RESECTIONS CAN PATIENTS TOLERATE AND WHICH RAY RESECTIONS AFFECTS FUNCTIONAL OUTCOME THE MOST IN ORTHOPEDIC ONCOLOGY?
Juan Barriga
Favorite
(P 332) MARGINAL EXCISION OF EXTREMITY DEDIFFERENTIATED LIPOSARCOMA WITHOUT RADIATION MAY BE SAFE IN SELECT PATIENTS
Juan Barriga
Favorite
Bartelstein, Meredith

Memorial Sloan-Kettering Cancer Center
(P 222) DO WE ALL SEE IT THE SAME: AN INTER-RATER RELIABILITY ANALYSIS OF THE MUSCULOSKELETAL TUMOR REGISTRY DATA ELEMENTS
Meredith Bartelstein
Favorite
Bartholomew, Alex

Duke University
(P 309) RETROPERITONEAL LIPOMAS: MULTICENTER CLINICAL EXPERIENCE WITH AN EXTREMELY RARE DISEASE ENTITY
Alex Bartholomew
Favorite
Bartlett, Edmund

Memorial Sloan Kettering Cancer Center
(P 186) BRAF V600E-MUTATED GASTROINTESTINAL STROMAL TUMORS: A CASE SERIES AND ANALYSIS OF IMMUNE TUMOR INFILTRATE
Edmund Bartlett
Favorite
(P 421) CHARACTERIZING THE IMMUNE RESPONSE TO INTRATUMORAL TIGILANOL TIGLATE (TT) IN PATIENTS WITH ADVANCED AND/OR METASTATIC SOFT TISSUE SARCOMA (STS) IN A PHASE IIA TRIAL (NCT05755113)
Edmund Bartlett
Favorite
Bartunkova, Jirina

Department of Immunology, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic
(P 243) CLINICAL SIGNIFICANCE OF TUMOR-INFILTRATING IMMUNE CELL SUBSETS IN THE RETROPERITONEAL DEDIFFERENTIATED LIPOSARCOMAS AND LEIOMYOSARCOMAS
Jirina Bartunkova
Favorite
Barwad, Adarsh

All India Institute of Medical Sciences, New Delhi
(P 276) RADIATION-INDUCED SARCOMA (RIS): CLINICAL SPECTRUM AND ONCOLOGIC OUTCOMES FROM A TERTIARY INDIAN SARCOMA CLINIC
Adarsh Barwad
Favorite
Barwad, Adarsh

All India Institute Of Medical Sciences
(P 435) A PHASE II STUDY OF HIGH DOSE IFOSFAMIDE IN METASTATIC/LOCALLY ADVANCED SYNOVIAL SARCOMA FROM A TERTIARY CARE CENTER IN INDIA
Adarsh Barwad
Favorite
Barwad, Adarsh

All India Institute of Medical Sciences, New Delhi
(P 468) CLINICAL UTILITY OF TARGETED NEXT-GENERATION SEQUENCING IN GUIDING SARCOMA DIAGNOSIS AND PERSONALIZED MANAGEMENT: A SINGLE-CENTER STUDY FROM INDIA
Adarsh Barwad
Favorite
Bary, Ashik

Cancer Institute (WIA), Adyar, Chennai
(P 110) DEFINITIVE RADIATION THERAPY IN "OPERABLE" EWING SARCOMA OF THE EXTREMITIES AND PELVIS
Ashik Bary
Favorite
Basi, Akshay

The University of Texas MD Anderson Cancer Center
(P 172) COMPARISON OF CELL SEGMENTATION METHODS IN SOFT TISSUE SARCOMA (STS) SPATIAL PROTEOMIC DATASETS
Akshay Basi
Favorite
Basile, George

Université de Montréal
(P 143) IMPACT OF SURGICAL MARGINS IN CHEST WALL CHONDROSARCOMAS: A CANSARCC STUDY
George Basile
Favorite
Bassil, Alex

Duke University
(P 84) A MULTICENTER COMPARISON OF REVERSE TOTAL SHOULDER ARTHROPLASTY VERSUS HEMIARTHROPLASTY FOR ENDOPROSTHETIC RECONSTRUCTION FOLLOWING ONCOLOGIC RESECTION OF THE PROXIMAL HUMERUS
Alex Bassil
Favorite
Bastianelli, Wynn

Children's Hospital of Philadelphia
(P 262) EVALUATING FRONT-LINE THERAPY ACCORDANCE WITH CURRENT SYNOVIAL SARCOMA GUIDELINES
Wynn Bastianelli
Favorite
(P 263) DESCRIBING THE CHARACTERISTICS AND TREATMENT OF SYNOVIAL SARCOMA IN THE RECURRENT SETTING
Wynn Bastianelli
Favorite
Basu Mallick, Atrayee

Thomas Jefferson University Hospital
(P 35) MECHANISTIC AND TRANSCRIPTOMIC ANALYSES REVEAL MUTATION-SPECIFIC THERAPEUTIC RESPONSES IN DESMOID TUMOR CELLS TREATED WITH SORAFENIB AND NIROGACESTAT
Atrayee Basu Mallick
Favorite
(P 315) ANALYSIS OF CHANGES IN T2-WEIGHTED SIGNAL INTENSITY AND TUMOR VOLUME AND EXPOSURE-RESPONSE IN THE RINGSIDE PHASE 2 STUDY OF VAREGACESTAT FOR DESMOID TUMORS
Atrayee Basu Mallick
Favorite
(P 410) SUBGROUP ANALYSIS OF THE PHASE 2 PART OF THE RINGSIDE PHASE 2/3 TRIAL OF VAREGACESTAT FOR TREATMENT OF DESMOID TUMORS
Atrayee Basu Mallick
Favorite
BATAILLON, Guillaume

Institut Universitaire du Cancer de Toulouse
(P 12) DNA REPLICATION STRESS AND DEFICIENT HOMOLOGOUS RECOMBINATION IN OSTEOSARCOMA RISK AND THERAPY
Guillaume BATAILLON
Favorite
Bath, Natalie

Adaptimmune
(P 247) SINGLE-CELL RNA SEQUENCING OF AFAMITRESGENE AUTOLEUCEL INDICATES MECHANISMS OF PERSISTENCE AND ANTI-TUMOR ACTIVITY
Natalie Bath
Favorite
Batra, Akshee

University of Miami
(P 224) PAN-SARCOMA DATABASE (PSDB): AN UPDATE ON MIAMI'S COLLABORATIVE MULTI-USER DATA PIPELINE OF SARCOMA DATA USING REDCAP AND R CODING
Akshee Batra
Favorite
(P 320) CLINICAL CHARACTERISTICS AND RECURRENCE PATTERNS IN HISPANIC VS. NON-HISPANIC PATIENTS WITH LEIOMYOSARCOMA: FINDINGS FROM A RETROSPECTIVE SINGLE-CENTER COHORT STUDY
Akshee Batra
Favorite
(P 327) INITIAL TREATMENT MODALITY AND RECURRENCE IN NON-METASTATIC LEIOMYOSARCOMA: A RETROSPECTIVE COHORT STUDY
Akshee Batra
Favorite
(P 333) METABOLIC SYNDROME CORRELATION WITH LIPOSARCOMA INCIDENCE AND OUTCOMES: A RETROSPECTIVE ANALYSIS.
Akshee Batra
Favorite
(P 362) SHOULD PAZOPANIB BE USED AS A MAINTENANCE THERAPY TO IMPROVE RECURRENCE-FREE SURVIVAL AND OVERALL SURVIVAL IN PATIENTS WHO RECEIVED MAI IN SOFT TISSUE SARCOMA?
Akshee Batra
Favorite
Baucco, Patricia

Cleveland Clinic
(P 284) THE IMPACT OF SARCOMA SBRT ON THE IMMUNE SYSTEM: EARLY RESULTS FROM A PROSPECTIVE TRIAL
Patricia Baucco
Favorite
Bauer, Fabian

University Hospital Cologne
(P 392) CLASSIFICATION AND DIFFERENTIATIONOF MYXOID LIPOSARCOMA AND MYXOMA WITH MACHINE LEARNING
Fabian Bauer
Favorite
(P 392) DIFFERENTIATION OF MYXOMA AND MYXOID LIPOSARCOMA BASED ON RADIOMICS PHENOTYPES
Fabian Bauer
Favorite
Bauer, Sebastian

Universitaetsklinikum Essen – Westdeutsches Tumorzentrum (WTZ) (West German Cancer Center)
(P 182) USING IN VITRO MODELS TO PREDICT IMATINIB RESPONSES OF PDGFRA EXON 18-MUTANT GIST
Sebastian Bauer
Favorite
(P 194) UPDATED RESULTS FROM STRATEGIST 1: A PHASE 1/1B STUDY OF IDRX-42 (GSK6042981A) IN PATIENTS (PTS) WITH ADVANCED GASTROINTESTINAL STROMAL TUMORS (GIST)
Sebastian Bauer
Favorite
Baumhoer, Daniel

University Hospital Basel
(P 127) AN INTEGRATED CLINICAL GENOMIC AND TRANSCRIPTOMIC SUBGROUPING OF CENTRAL CHONDROSARCOMA
Daniel Baumhoer
Favorite
Bazanjani, Soheil

Salford University
(P 392) CLASSIFICATION AND DIFFERENTIATIONOF MYXOID LIPOSARCOMA AND MYXOMA WITH MACHINE LEARNING
Soheil Bazanjani
Favorite
(P 392) DIFFERENTIATION OF MYXOMA AND MYXOID LIPOSARCOMA BASED ON RADIOMICS PHENOTYPES
Soheil Bazanjani
Favorite
Beadle, Erik

Vanderbilt University Medical Center
(P 51) OVEREXPRESSION OF GLI2 IN DEDIFFERENTIATED LIPOSARCOMA TUMORS INDUCES MICROENVIRONMENT REMODELING
Erik Beadle
Favorite
Beane, Joal

The Ohio State University
(P 161) CLINICAL CHARACTERISTICS, PATTERNS OF CARE, AND TREATMENT OUTCOMES OF CHONDROSARCOMA: A SINGLE-INSTITUTIONAL EXPERIENCE
Joal Beane
Favorite
Beato, Carlos

Hospital Amaral Carvalho
(P 128) ISOCITRATE DEHYDROGENASE 1 (IDH1) MUTATION TESTING IN THE PHASE 3 STUDY OF IVOSIDENIB VS PLACEBO IN IDH1-MUTANT CONVENTIONAL CHONDROSARCOMA (CHONQUER)
Carlos Beato
Favorite
Beausoleil, Sean

Cell Signaling Technology
(P 198) EXPLOITING METABOLIC DYSREGULATION IN SUCCINATE DEHYDROGENASE-DEFICIENT GASTROINTESTINAL STROMAL TUMOR
Sean Beausoleil
Favorite
Beckedorff, Felipe

University of Miami, Miller School of Medicine
(P 253) ELUCIDATING THE ROLE OF SIRT7 IN EWING SARCOMA
Felipe Beckedorff
Favorite
Becker, Svea

Tubulis, Gmbh
(P 34) EXPRESSION OF ONCOFETAL ANTIGEN 5T4 IN SARCOMA SUBTYPES AND PRECLINICAL ACTIVITY OF TUB-030, A NOVEL 5T4-TARGETING ANTIBODY-DRUG CONJUGATE (ADC)
Svea Becker
Favorite
Beckingsale, Thomas

The Newcastle upon Tyne Hospitals NHS Foundation Trust
(P 314) AN INTERNATIONAL, MULTI-CENTRE STUDY OF SURGICAL MARGINS IN INTERMEDIATE TO HIGH GRADE SARCOMA
Thomas Beckingsale
Favorite
Beck, Jessica

National Institutes of Health
(P 258) INVESTIGATING THE ROLE OF ALVEOLAR PNEUMOCYTES IN THE LUNG MICROENVIRONMENT OF OSTEOSARCOMA METASTASES
Jessica Beck
Favorite
Beck, Nikola

Bavarian Cancer Registry, Regional Center Würzburg, Bavarian Health and Food Safety Authority, Würzburg, Germany
(P 204) ANALYSIS OF QUALITY INDICATORS OF SOFT TISSUE SARCOMA TREATMENT WITH CANCER REGISTRY DATA IN GERMANY 2015-2021
Nikola Beck
Favorite
Becraft, Jacob

Strand Therapeutics Inc.
(P 433) PHASE I DOSE ESCALATION TRIAL OF STX-001, AN LNP SELF-REPLICATING MRNA EXPRESSING IL-12, IN PATIENTS WITH REFRACTORY TUMORS INCLUDING SARCOMAS
Jacob Becraft
Favorite
(P 440) CASE REPORT: COMPLETE CLINICAL AND MOLECULAR RESPONSE TO INTRATUMORAL STX-001, AN LNP-SELF REPLICATING MRNA EXPRESSING IL-12 IN A PATIENT WITH REFRACTORY ANGIOSARCOMA
Jacob Becraft
Favorite
Bedi, Meena

MCW
(P 111) DOES DOSE MATTER? POSTOPERATIVE RADIATION DOSE AND OUTCOMES FOLLOWING FIXATION OF METASTATIC EXTREMITY BONE LESIONS
Meena Bedi
Favorite
Behr, Gerald

Memorial Sloan Kettering Cancer Center
(P 273) RADIOMIC PREDICTORS OF SPONTANEOUS PNEUMOTHORAX DURING TYROSINE KINASE INHIBITOR THERAPY FOR LUNG METASTASES
Gerald Behr
Favorite
Beird, Hannah

MD Anderson Cancer Center
(P 47) EWSR1::WT1 FUSION ONCOPROTEIN ACTIVITY SHAPES LINEAGE HETEROGENEITY IN DESMOPLASTIC SMALL ROUND CELL TUMORS
Hannah Beird
Favorite
(P 54) PRECLINICAL MODELS REVEALING MDM2-P53 INTERACTION AND DEPENDENCY FOR TUMOR CELL SURVIVAL IN WELL-DIFFERENTIATED (WD) AND DEDIFFERENTIATED (DD) LIPOSARCOMA (LPS).
Hannah Beird
Favorite
Bell, Bryan

Providence Cancer Institute
(P 58) PLK1 AS A VULNERABLE TARGET OF BAP1-DRIVEN UNDIFFERENTIATED PLEOMORPHIC SARCOMAS
Bryan Bell
Favorite
Bellera, Carine

Institut Bergonié
(P 324) FULLY MATURE TERTIARY LYMHOID STRUCTURES AS PREDICTORS OF LOCAL RECURRENCE IN SOFT TISSUE SARCOMAS
Carine Bellera
Favorite
Bellotti, Chiara

IRCCS Rizzoli Orthopaedic Institute
(P 18) ESTABLISHMENT AND CHARACTERIZATION OF A NOVEL PRIMARY CELL LINE FROM A BONE METASTASIS OF OSTEOSARCOMA
Chiara Bellotti
Favorite
Bell, Timothy

Springworks Therapeutics, Inc.
(P 357) DEVELOPMENT OF AN ALGORITHM TO IDENTIFY PATIENTS (PT) WITH DESMOID TUMORS (DT) IN A UNITED STATES (US) CLAIMS DATASET
Timothy Bell
Favorite
(P 364) TRENDS IN SURGICAL MANAGEMENT OF DESMOID TUMOR IN THE VETERANS AFFAIRS (VA) NATIONAL DATABASE
Timothy Bell
Favorite
(P 368) ASSESSMENT OF PAIN DIAGNOSIS AND PAIN MEDICATION USE IN ADULTS TREATED WITH NIROGACESTAT: A UNITED STATES REAL-WORLD ANALYSIS
Timothy Bell
Favorite
(P 413) EFFICACY OF NIROGACESTAT IN PATIENTS WITH DESMOID TUMORS AND PRESENCE OR ABSENCE OF POOR PROGNOSTIC FACTORS: POST HOC ANALYSES OF THE PHASE 3 DEFI TRIAL
Timothy Bell
Favorite
Bell, Zoe

Newcastle University
(P 135) EXPLORING THE ROLE OF CLUSTER OF DIFFERENTIATION 44 IN CHONDROSARCOMA
Zoe Bell
Favorite
Benafif, Sarah

NIHR University College London Hospitals Clinical Research Facility
(P 431) INVOKE: A PHASE 1 STUDY OF OKN4395, A FIRST-IN-CLASS EP2/EP4/DP1 TRIPLE PROSTANOID RECEPTOR ANTAGONIST, IN PATIENTS WITH ADVANCED SOLID TUMORS, INCLUDING SARCOMAS
Sarah Benafif
Favorite
Benesova, Iva

Institute of Immunology, Second Faculty of Medicine, Charles University and University Hospital Motol
(P 243) CLINICAL SIGNIFICANCE OF TUMOR-INFILTRATING IMMUNE CELL SUBSETS IN THE RETROPERITONEAL DEDIFFERENTIATED LIPOSARCOMAS AND LEIOMYOSARCOMAS
Iva Benesova
Favorite
Benhaddou, Ataaillah

MAGIC GENOMIX
(P 28) ADVANCING PRECISION ONCOLOGY IN SOFT TISSUE SARCOMAS: THE ROLE OF ITRAC IN METASTATIC RISK STRATIFICATION AND TREATMENT PERSONALIZATION
Ataaillah Benhaddou
Favorite
Benini, Stefania

IRCCS Rizzoli Orthopaedic Institute
(P 18) ESTABLISHMENT AND CHARACTERIZATION OF A NOVEL PRIMARY CELL LINE FROM A BONE METASTASIS OF OSTEOSARCOMA
Stefania Benini
Favorite
Benjamin, Robert

The University of Texas MD Anderson Cancer Center
(P 83) OUTCOMES OF MULTIMODAL PERIOPERATIVE TREATMENT IN OSTEOSARCOMAS OF THE JAW
Robert Benjamin
Favorite
(P 451) TREATMENT OUTCOMES OF GEMCITABINE AND DOCETAXEL IN PATIENTS WITH CLEAR CELL SARCOMA (CCS) OR GASTROINTESTINAL NEUROECTODERMAL TUMOR (GNET): A CASE SERIES
Robert Benjamin
Favorite
(P 460) OUTCOMES OF LATER-LINES SYSTEMIC THERAPIES IN MALIGNANT PERIPHERAL NERVE SHEATH TUMORS (MPNST)
Robert Benjamin
Favorite
Ben-Kuzari, Boaz

Oncology Department, Sharett Institute for Oncology, Hadassah Medical Center & Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel
(P 06) RAPID, POINT-OF-CARE DNA METHYLATION & MOLECULAR LANDSCAPE BASED SARCOMA CLASSIFICATION
Boaz Ben-Kuzari
Favorite
Bennett, Natalie

Vanderbilt University Medical Center
(P 51) OVEREXPRESSION OF GLI2 IN DEDIFFERENTIATED LIPOSARCOMA TUMORS INDUCES MICROENVIRONMENT REMODELING
Natalie Bennett
Favorite
Benson, Charlotte

Royal Marsden Hospital
(P 413) EFFICACY OF NIROGACESTAT IN PATIENTS WITH DESMOID TUMORS AND PRESENCE OR ABSENCE OF POOR PROGNOSTIC FACTORS: POST HOC ANALYSES OF THE PHASE 3 DEFI TRIAL
Charlotte Benson
Favorite
(P 414) PATTERNS OF RELAPSE OF BORDERLINE AND MALIGNANT PHYLLODES TUMOUR- RESULTS FROM SARCOMA REFERENCE CENTRE (SRC)
Charlotte Benson
Favorite
Benyamini, Brian

Cleveland Clinic
(P 316) AREA DEPRIVATION INDEX (ADI) AND OUTCOMES IN LOCALIZED SOFT TISSUE SARCOMA: DO SOCIAL DETERMINANTS INFLUENCE SURVIVAL?
Brian Benyamini
Favorite
(P 355) CLASSIFYING WOUND HEALING COMPLICATIONS IN SURGICALLY TREATED EXTREMITY SOFT TISSUE SARCOMA
Brian Benyamini
Favorite
Berclaz, Luc

Department of Medicine III, LMU University Hospital, Munich, Germany
(P 64) ATRX EXPRESSION CORRELATES WITH REDUCED IMMUNE CHECKPOINT EXPRESSION AND POOR SURVIVAL IN HIGH-RISK SOFT TISSUE SARCOMAS
Luc Berclaz
Favorite
(P 437) CLINICAL DATA CONFIRM GALENIC PRINCIPLE AND DEMONSTRATE THERAPEUTIC POTENTIAL OF THE001 (DPPG2-TSL-DOX) PLUS REGIONAL HYPERTHERMIA IN SOFT TISSUE SARCOMA
Luc Berclaz
Favorite
(P 443) FIRST-LINE PAZOPANIB IN PATIENTS WITH EPITHELIOID HEMANGIOENDOTHELIOMA: A RETROSPECTIVE SINGLE-CENTER ANALYSIS
Luc Berclaz
Favorite
Beretta, Alessia

Fondazione IRCCS Istituto Nazionale dei Tumori
(P 446) GDF-15 AS A PROGNOSTIC FACTOR IN PATIENTS WITH EPITHELIOID HEMANGIOENDOTHELIOMA
Alessia Beretta
Favorite
Bergerot, Cristiane D

Psycho-Oncology Services, Oncoclinicas&Co - Medica Scientia Innovation Research (MEDSIR)
(P 444) HEALTH-RELATED QUALITY OF LIFE (HRQOL) CHALLENGES IN PATIENTS WITH EPITHELIOID HEMANGIOENDOTHELIOMA (EHE): ANALYSIS OF AN ULTRA-RARE SARCOMA GROUP
Cristiane D Bergerot
Favorite
Bergholtz, Sarah

Michigan Medicine
(P 24) THE SIRTUIN SIRT5 SUPPORTS EWING SARCOMA SURVIVAL VIA REGULATION OF EWS-FLI1 STABILITY AND ACTIVITY
Sarah Bergholtz
Favorite
Bernal, Jorge

Fundación Colombiana de Cancerología Clínica Vida
(P 219) RETROPERITONEAL SARCOMA: HEALTH SYSTEM BARRIERS AND THE RATIONALE FOR A SPECIALIZED SARCOMA UNIT
Jorge Bernal
Favorite
(P 301) RETROPERITONEAL SARCOMA: SINGLE CENTER EXPERIENCE IN LATIN AMERICA. DO WE HAVE DIFFERENT SARCOMAS WHEN COMPARED TO THE REST OF THE WORLD?
Jorge Bernal
Favorite
Bernard, Christopher

University of Kansas School of Medicine
(P 359) EVALUATION OF PREOPERATIVE MYXOFIBROSARCOMA GROWTH AND SURGICAL MORBIDITY AFTER NEOADJUVANT RADIATION USING SEMI-AUTOMATED VOLUMETRIC ANALYSIS
Christopher Bernard
Favorite
(P 382) METHOD FOR VOLUMETRIC ASSESMENT OF TUMOR RESPONSE FOLLOWING NEOADJUVANT RADIATION IN PRIMARY MYXOFIBROSARCOMA
Christopher Bernard
Favorite
Berndsen, Marta

Institute of Clinical Scinces/Sahlgrenska Academy
(P 124) ISOLATED LIMB PERFUSION AS LIMB SALVAGING TREATMENT; A SINGLE CENTRE RETROSPECTIVE STUDY
Marta Berndsen
Favorite
Bernthal, Nicholas

University of California Los Angeles
(P 16) MITOCHONDRIAL GENETIC VARIATION ORCHESTRATES COPZ1 TRANSCRIPT HETEROGENEITY AND REVEALS TELOMERE-MEDIATED VULNERABILITIES IN OSTEOSARCOMA
Nicholas Bernthal
Favorite
(P 72) COUNTY-LEVEL ASSOCIATIONS BETWEEN AIRBORNE TOXICANT EMISSIONS AND EWING SARCOMA DIAGNOSIS IN THE UNITED STATES
Nicholas Bernthal
Favorite
(P 81) ASSESSING PROGNOSTIC FACTORS OF CAUSE-SPECIFIC SURVIVAL IN PATIENTS WITH MALIGNANT GIANT CELL TUMORS: A POPULATION BASED STUDY FROM THE SEER DATABASE
Nicholas Bernthal
Favorite
(P 92) PRIMARY TUMOR SIZE AS AN INDEPENDENT PROGNOSTIC FACTOR IN OSTEOSARCOMA: PROPENSITY SCORE-MATCHED ANALYSIS DEMONSTRATES A CONTINUOUS DOSE-RESPONSE RELATIONSHIP
Nicholas Bernthal
Favorite
(P 100) THE ROLE OF CANCER TYPE IN THE DEVELOPMENT OF PERIPROSTHETIC JOINT INFECTION IN DISTAL FEMORAL REPLACEMENT
Nicholas Bernthal
Favorite
(P 106) REPAIR: A PRELIMINARY REPORT ON AN ONGOING MULTI-CENTER TRIAL FOR PATIENTS UNDERGOING SURGICAL STABILIZATION FOR METASTATIC BONE DISEASE OF THE FEMUR
Nicholas Bernthal
Favorite
(P 107) IS THERE A BETTER OPTION: INTRAMEDULLARY NAIL VERSUS PLATE OSTEOSYNTHESIS FOR PATHOLOGIC HUMERAL FRACTURES?
Nicholas Bernthal
Favorite
(P 108) DISTANCE WEIGHTED MATCHING IN THE QUANTIFICATION OF EXCESS MORBIDITY IN EXTERNAL HEMIPELVECTOMY AND HIP DISARTICULATION
Nicholas Bernthal
Favorite
(P 157) INCOME IMPACTS OVERALL BUT NOT CAUSE-SPECIFIC SURVIVAL IN PATIENTS WITH CHONDROSARCOMA: A POPULATION BASED STUDY FROM THE SEER DATABASE
Nicholas Bernthal
Favorite
(P 232) IS THERE A ROLE FOR POSITRON EMISSION TOMOGRAPHY IN THE STAGING OF LANGERHANS CELL HISTIOCYTOSIS?
Nicholas Bernthal
Favorite
(P 384) PELVIC LOCATION PREDICTS WORSE OUTCOMES IN ALVEOLAR RHABDOMYOSARCOMA: UNDERUSE OF RADIOTHERAPY AND MISSED SURVIVAL BENEFIT
Nicholas Bernthal
Favorite
Bertucci, François

Institut Paoli-Calmettes
(P 59) TARGETING ADORA2B TO HALT METASTASIS IN UNDIFFERENTIATED PLEOMORPHIC SARCOMA: FROM MULTI-OMICS TO THERAPEUTIC INHIBITION
François Bertucci
Favorite
Bertuzzi, Alexia

Medical Oncology, Humanitas Cancer Center
(P 231) INCREASED LIFETIME RISK (LTR) OF SOFT TISSUE SARCOMAS (STS) IN PATIENTS WITH LOW-RISK GASTROINTESTINAL STROMAL TUMORS (GIST): A RETROSPECTIVE ANALYSIS FROM THE ITALIAN SARCOMA GROUP (ISG)
Alexia Bertuzzi
Favorite
Berwitz, Kyra

University of Miami Miller School of Medicine
(P 397) EXPLORING REAL WORLD DATA OF RECURRENCE IN NON-METASTATIC MYXOFIBROSAROMA: AN UPDATED RETROSPECTIVE COHORT STUDY
Kyra Berwitz
Favorite
Beshah, Fireneh

University of Miami
(P 147) CONVENTIONAL AND DEDIFFERENTIATED CHONDROSARCOMA; IS ENCHONDROMA THE PRECURSOR LESION?
Fireneh Beshah
Favorite
(P 154) BCOR-MUTATED CONVENTIONAL AND DEDIFFERENTIATED CHONDROSARCOMA: A CLINICOPATHOLOGIC STUDY
Fireneh Beshah
Favorite
Betsch, Kevin

Duke University
(P 125) TARGETING LCP1-MEDIATED METASTASIS IN CHONDROSARCOMA WITH OROXYLIN A
Kevin Betsch
Favorite
(P 130) INVESTIGATING LCP1-MEDIATED ONCOGENIC SIGNALING IN CHONDROSARCOMA METASTASIS
Kevin Betsch
Favorite
Betts, Gareth

Adaptimmune
(P 247) SINGLE-CELL RNA SEQUENCING OF AFAMITRESGENE AUTOLEUCEL INDICATES MECHANISMS OF PERSISTENCE AND ANTI-TUMOR ACTIVITY
Gareth Betts
Favorite
Betzler, Alexander

Department of Surgery, University Medical Centre Mannheim, Medical Faculty Mannheim, Heidelberg University
(P 441) COLOSARC-Q: A PROSPECTIVE MULTICENTER STUDY FOR EVALUATING SURGICAL STRATEGIES FOR COLORECTAL RESECTIONS AND POSTOPERATIVE QUALITY OF LIFE IN RETROPERITONEAL SARCOMA PATIENTS
Alexander Betzler
Favorite
Bezzi, Federica

Humanitas University
(P 203) MINIMALLY INVASIVE RESECTION OF MULTIFOCAL DUODENO-JEJUNAL GISTS IN NEUROFIBROMATOSIS TYPE 1
Federica Bezzi
Favorite
Bhalla, Angela

MD Anderson Cancer Center
(P 351) THE ROLE OF SOCIOECONOMIC DISPARITIES ON SURVIVAL OUTCOMES IN MALIGNANT PERIPHERAL NERVE SHEATH TUMORS
Angela Bhalla
Favorite
Bhargava, Prabhat

Tata Memorial Hospital
(P 286) INTERSTITIAL BRACHYTHERAPY FOR ORGAN AND FUNCTION PRESERVATION IN SOFT TISSUE SARCOMAS: LONG TERM OUTCOMES
Prabhat Bhargava
Favorite
(P 292) CRANIOVERTEBRAL EWINGS SARCOMA WITH MENINGEAL INFILTRATION - A CLINICAL OUTCOME ANALYSIS
Prabhat Bhargava
Favorite
(P 304) MANAGEMENT OF RECURRENT RETROPERITONEAL SARCOMAS: A RETROSPECTIVE STUDY FROM A TERTIARY CANCER CENTER.
Prabhat Bhargava
Favorite
(P 338) POORLY DIFFERENTIATED SYNOVIAL SARCOMA: A HISTOLOGIC CHALLENGE OF AN AGGRESSIVE VARIANT
Prabhat Bhargava
Favorite
(P 387) TREATMENT PATTERNS AND PROGNOSTIC FACTORS IN LOCALISED SYNOVIAL SARCOMA: A RETROSPECTIVE STUDY FROM A TERTIARY CANCER CENTRE IN INDIA
Prabhat Bhargava
Favorite
(P 428) MAINTENANCE PEGYLATED LIPOSOMAL DOXORUBICIN VERSUS ACTIVE SURVEILLANCE FOR ADVANCED SOFT TISSUE SARCOMA PATIENTS WHO HAD CONTROLLED DISEASE AFTER STANDARD ANTHRACYCLINE-BASED TREATMENT (MELODY)
Prabhat Bhargava
Favorite
(P 438) RANDOMIZED, OPEN-LABEL, PHASE III TRIAL OF ADJUVANT CHEMOTHERAPY VERSUS OBSERVATION IN NON-METASTATIC, HIGH-RISK SOFT TISSUE SARCOMAS (ACO-SARC TRIAL)
Prabhat Bhargava
Favorite
(P 463) EXTRANODAL FOLLICULAR DENDRITIC CELL SARCOMAS AND THEIR OLIGORECURRENCES: TRIUMPHS, TRIALS AND LESSONS LEARNT AT A SINGLE TERTIARY CANCER REFERRAL CENTRE, INDIA.
Prabhat Bhargava
Favorite
Bhogal, Sumail

University of Pittsburgh Medical Center
(P 63) EVALUATING SURGICAL MARGINS IN SARCOMA RESECTION WITH INDOCYANINE GREEN FLUORESCENCE IMAGING
Sumail Bhogal
Favorite
Bhushan, Ketki

Dana-Farber Cancer Institute
(P 427) PHASE 1/2 TRIAL TO EVALUATE THE SAFETY AND EFFICACY OF PEEL-224 IN COMBINATION WITH VINCRISTINE AND TEMOZOLOMIDE IN ADOLESCENTS AND YOUNG ADULTS WITH RELAPSED OR REFRACTORY SARCOMAS
Ketki Bhushan
Favorite
Bialack, Steven

Sylvester Comprehensive Cancer Center
(P 224) PAN-SARCOMA DATABASE (PSDB): AN UPDATE ON MIAMI'S COLLABORATIVE MULTI-USER DATA PIPELINE OF SARCOMA DATA USING REDCAP AND R CODING
Steven Bialack
Favorite
Bialick, Steven

University of Miami Sylvester Comprehensive Cancer Center
(P 362) SHOULD PAZOPANIB BE USED AS A MAINTENANCE THERAPY TO IMPROVE RECURRENCE-FREE SURVIVAL AND OVERALL SURVIVAL IN PATIENTS WHO RECEIVED MAI IN SOFT TISSUE SARCOMA?
Steven Bialick
Favorite
Biau, David

The Hôpital Cochin
(P 151) SHOULD WE USE ADJUVANT CHEMOTHERAPY IN PATIENTS WITH LOCALIZED DEDIFFERENTIATED CHONDROSARCOMA (DDCS) OF THE PELVIS? AN ANALYSIS BY THE PELVIC DDCS STUDY GROUP
David Biau
Favorite
Biermann, Janet Sybil

University of Michigan Rogel Comprehensive Cancer Center
(P 227) TREATMENT PATTERNS IN PATIENTS WITH TENOSYNOVIAL GIANT CELL TUMORS: ADDRESSING COMMUNICATION IN A NEW THERAPEUTIC LANDSCAPE
Janet Sybil Biermann
Favorite
Bilani, Nadeem

Robert H. Lurie Comprehensive Cancer Center of Northwestern University
(P 183) ACTIONABLE GENOMICS IN GASTROINTESTINAL STROMAL TUMORS LACKING KIT OR PDGFRA MUTATIONS.
Nadeem Bilani
Favorite
(P 236) EXCEPTIONAL RESPONSE TO COMBINATION IMMUNOTHERAPY WITH YH001 AND ENVAFOLIMAB IN METASTATIC SARCOMA.
Nadeem Bilani
Favorite
(P 412) UNCOVERING HER2 OVEREXPRESSION IN SOFT TISSUE SARCOMAS (STS): INSIGHTS FROM THE CANCER GENOME ATLAS (TCGA)
Nadeem Bilani
Favorite
Bilani, Nadeem

Northwestern University Feinberg School of Medicine
(P 429) SINGLE-ARM, OPEN-LABEL PHASE II TRIAL OF XL092 (ZANZALINTINIB) IN PATIENTS WITH ADVANCED LEIOMYOSARCOMA: TRIAL IN PROGRESS
Nadeem Bilani
Favorite
Bilbao, Daniel

2.University of Miami Miller School of Medicine, Department of Pathology and Laboratory Medicine,3. Sylvester Comprehensive Cancer center
(P 31) TARGETING CANCER STEM CELLS BY TYROSINE PEPTIDE ANALOGUE IN REFRACTORY SARCOMA
Daniel Bilbao
Favorite
Binitie, Odion

H. Lee Moffitt Cancer Center
(P 84) A MULTICENTER COMPARISON OF REVERSE TOTAL SHOULDER ARTHROPLASTY VERSUS HEMIARTHROPLASTY FOR ENDOPROSTHETIC RECONSTRUCTION FOLLOWING ONCOLOGIC RESECTION OF THE PROXIMAL HUMERUS
Odion Binitie
Favorite
(P 102) FACTORS RELATED TO ASEPTIC LOOSENING IN ENDOPROSTHESIS RECONSTRUCTION OF THE PROXIMAL TIBIA
Odion Binitie
Favorite
(P 114) DENOSUMAB THERAPY AND MIRELS ADJUSTED ODDS OF PATHOLOGIC FRACTURE OR PROPHYLACTIC STABILIZATION IN APPENDICULAR SKELETAL METASTASES
Odion Binitie
Favorite
(P 140) REFINING PRE-SURGICAL ASSESSMENT OF LONG-BONE CHONDROSARCOMA THROUGH THE RADIOLOGIC AGGRESSIVENESS SCORE
Odion Binitie
Favorite
(P 141) A RETROSPECTIVE ANALYSIS OF THE BIRMINGHAM ATYPICAL CARTILAGE TUMOUR IMAGING PROTOCOL (BACTIP) IN MANAGING CENTRAL CARTILAGE TUMORS OF THE LONG BONES
Odion Binitie
Favorite
(P 142) ARE THERE INDEPENDENT PREDICTORS OF DEDIFFERENTIATED CHONDROSARCOMA ON MAGNETIC RESONANCE IMAGING? A MULTIVARIATE ANALYSIS
Odion Binitie
Favorite
(P 145) PATHOLOGIC FRACTURE IN CHONDROSARCOMA OF LONG BONES: A RETROSPECTIVE COHORT STUDY
Odion Binitie
Favorite
(P 160) A COMPARATIVE ANALYSIS OF DEDIFFERENTIATED AND CONVENTIONAL CHONDROSARCOMA OUTCOMES
Odion Binitie
Favorite
(P 163) CHONDROSARCOMA IN THE AYA POPULATION
Odion Binitie
Favorite
(P 375) DOES STAGED RESECTION WITH TEMPORIZING WOUND VACUUM INFLUENCE LOCAL RECURRENCE RISK? A MULTI-INSTITUTIONAL MATCHED COHORT ANALYSIS
Odion Binitie
Favorite
(P 453) OUTCOMES OF PLEOMORPHIC LIPOSARCOMA PATIENTS FOLLOWING MULTI-DISCIPLINARY MANAGEMENT WITHIN A TERTIARY CANCER CENTER
Odion Binitie
Favorite
Birger, Yehudit

Hemato-Oncology Laboratory, Schneider Children's Medical Center of Israel, Petach Tikva, Israel. Department of Human Molecular Genetics and Biochemistry, Faculty of Medicine, Tel Aviv University, Israel. Felsenstein Medical Research Center, Tel Aviv University, Israel
(P 06) RAPID, POINT-OF-CARE DNA METHYLATION & MOLECULAR LANDSCAPE BASED SARCOMA CLASSIFICATION
Yehudit Birger
Favorite
Birrenkott, Matthew

Immunome, Inc.
(P 315) ANALYSIS OF CHANGES IN T2-WEIGHTED SIGNAL INTENSITY AND TUMOR VOLUME AND EXPOSURE-RESPONSE IN THE RINGSIDE PHASE 2 STUDY OF VAREGACESTAT FOR DESMOID TUMORS
Matthew Birrenkott
Favorite
(P 410) SUBGROUP ANALYSIS OF THE PHASE 2 PART OF THE RINGSIDE PHASE 2/3 TRIAL OF VAREGACESTAT FOR TREATMENT OF DESMOID TUMORS
Matthew Birrenkott
Favorite
Bishop, Andrew

The University of Texas MD Anderson Cancer Center
(P 83) OUTCOMES OF MULTIMODAL PERIOPERATIVE TREATMENT IN OSTEOSARCOMAS OF THE JAW
Andrew Bishop
Favorite
Biskuspiak, Joseph

Department of Pharmacotherapy, College of Pharmacy, University of Utah
(P 357) DEVELOPMENT OF AN ALGORITHM TO IDENTIFY PATIENTS (PT) WITH DESMOID TUMORS (DT) IN A UNITED STATES (US) CLAIMS DATASET
Joseph Biskuspiak
Favorite
Bisogno, Gianni

University Hospital of Padua
(P 250) OUTCOME OF INFANTS WITH RHABDOMYOSARCOMA: A REPORT FROM THE INTERNATIONAL SOFT TISSUE SARCOMA CONSORTIUM
Gianni Bisogno
Favorite
Bitangacha, Mireille

The Ohio State University
(P 221) QUALITATIVE ANALYSIS OF THE PERIOPERATIVE EXPERIENCE OF YOUNG ADULT PATIENTS UNDERGOING EXTREMITY SARCOMA SURGERY
Mireille Bitangacha
Favorite
Black, Jennifer

Children's Hospital Colorado
(P 168) LEVERAGING LARGE LANGUAGE MODELS FOR STRUCTURED INFORMATION EXTRACTION FROM EWING SARCOMA PATHOLOGY REPORTS
Jennifer Black
Favorite
Black, Vandy

Deciphera Pharmaceuticals, LLC
(P 424) AN OPEN-LABEL PHASE 1/2 STUDY OF DCC-3009 MONOTHERAPY IN PATIENTS (PTS) WITH ADVANCED GASTROINTESTINAL STROMAL TUMOR (GIST)
Vandy Black
Favorite
Blair, Emily

Dana-Farber Cancer Institute
(P 427) PHASE 1/2 TRIAL TO EVALUATE THE SAFETY AND EFFICACY OF PEEL-224 IN COMBINATION WITH VINCRISTINE AND TEMOZOLOMIDE IN ADOLESCENTS AND YOUNG ADULTS WITH RELAPSED OR REFRACTORY SARCOMAS
Emily Blair
Favorite
Blakely, Andrew

NCI/NIH
(P 181) THE DEVELOPMENT OF A NOVEL PDGFRA RESISTANCE MUTATION IN A RECURRENT KIT-MUTANT GASTROINTESTINAL STROMAL TUMOR (GIST)
Andrew Blakely
Favorite
Blank, Alan

Rush University Medical Center
(P 104) 3D PRINTED CUTTING GUIDES FOR LONG BONE SARCOMA RESECTION AND INTERCALARY ALLOGRAFT RECONSTRUCTION: A CASE SERIES
Alan Blank
Favorite
(P 106) REPAIR: A PRELIMINARY REPORT ON AN ONGOING MULTI-CENTER TRIAL FOR PATIENTS UNDERGOING SURGICAL STABILIZATION FOR METASTATIC BONE DISEASE OF THE FEMUR
Alan Blank
Favorite
(P 113) ASSESSING TREATMENT OUTCOMES OF CHONDROMYXOID FIBROMA: A CASE SERIES
Alan Blank
Favorite
(P 138) A MULTI-INSTITUTIONAL ARCHIVE AND DEEP LEARNING PIPELINE FOR QUANTIFYING CHONDROSARCOMA COMPOSITION
Alan Blank
Favorite
(P 206) IMPACT OF PROXIMITY TO HEALTH CENTER ON ADHERENCE TO NATIONAL COMPREHENSIVE CANCER NETWORK GUIDELINES IN PATIENTS WITH SOFT TISSUE SARCOMAS
Alan Blank
Favorite
Blattmann, Claudia

Olgahospital
(P 417) EFFICACY AND SAFETY OF LAROTRECTINIB (LARO) IN PATIENTS (PTS) WITH TRK FUSION SARCOMAS
Claudia Blattmann
Favorite
Blay, Jean-Yves

Centre Léon Bérard
(P 128) ISOCITRATE DEHYDROGENASE 1 (IDH1) MUTATION TESTING IN THE PHASE 3 STUDY OF IVOSIDENIB VS PLACEBO IN IDH1-MUTANT CONVENTIONAL CHONDROSARCOMA (CHONQUER)
Jean-Yves Blay
Favorite
(P 139) IMMUNOGENOMIC PROFILING OF CHONDROSARCOMA REVEALS DISTINCT IMMUNE PHENOTYPES AND PROGNOSTIC MUTATIONS
Jean-Yves Blay
Favorite
(P 194) UPDATED RESULTS FROM STRATEGIST 1: A PHASE 1/1B STUDY OF IDRX-42 (GSK6042981A) IN PATIENTS (PTS) WITH ADVANCED GASTROINTESTINAL STROMAL TUMORS (GIST)
Jean-Yves Blay
Favorite
Blay, Pilar

Hospital Universitario Central de Asturias
(P 71) GERMLINE POLYMORPHISMS IN THE VEGF PATHWAY AS PROGNOSTIC BIOMARKERS IN LOCALIZED HIGH-GRADE OSTEOSARCOMA: A STUDY BASED ON DATA FROM THE GEIS-33 PROTOCOL
Pilar Blay
Favorite
Blazer, Dan

Duke University
(P 309) RETROPERITONEAL LIPOMAS: MULTICENTER CLINICAL EXPERIENCE WITH AN EXTREMELY RARE DISEASE ENTITY
Dan Blazer
Favorite
Blocker, Stephanie

Duke University School of Medicine
(P 177) DEEP LEARNING AND DIMENSIONALITY REDUCTION FOR SARCOMA SUBTYPING
Stephanie Blocker
Favorite
Blomain, Erik

Thomas Jefferson University
(P 35) MECHANISTIC AND TRANSCRIPTOMIC ANALYSES REVEAL MUTATION-SPECIFIC THERAPEUTIC RESPONSES IN DESMOID TUMOR CELLS TREATED WITH SORAFENIB AND NIROGACESTAT
Erik Blomain
Favorite
Blonski, Piotr

Maria Sklodowska-Curie National Research Institute of Oncology
(P 146) LOCALISED CHONDROSARCOMA PERIOPERATIVE TREATMENT: REAL-WORLD OUTCOMES AND CHALLENGES ACROSS HISTOLOGIC SUBTYPES
Piotr Blonski
Favorite
(P 149) SURGICAL TEXTBOOK OUTCOMES IN PATIENTS DIAGNOSED WITH CHONDROSARCOMA
Piotr Blonski
Favorite
(P 152) EFFICACY OF PALLIATIVE CHEMOTHERAPY AND LOCAL TREATMENTS IN ADVANCED CHONDROSARCOMA: A SUBTYPE-SPECIFIC RETROSPECTIVE ANALYSIS
Piotr Blonski
Favorite
(P 164) LONG TERM OUTCOMES IN PATIENTS DIAGNOSED WITH SECONDARY CHONDROSARCOMA
Piotr Blonski
Favorite
(P 313) SIGNIFICANCE OF LYMPH NODE PROCEDURES IN SOFT TISSUE SARCOMA PATIENTS
Piotr Blonski
Favorite
Bobak, Klaudia

Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie National Research Institute of Oncology
(P 27) MOLECULAR CHARACTERIZATION OF RESPONSE TO NEOADJUVANT CHEMORADIATION IN PATIENTS WITH LOCALLY ADVANCED SOFT TISSUE SARCOMAS
Klaudia Bobak
Favorite
Bodor, Orsolya

Department of Radiation Oncology, Universitätsstraße 27, 91054 Erlangen, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Germany
(P 288) IDENTIFICATION OF A DNA REPAIR INHIBITOR FOR THE COMBINATION WITH LURBINECTEDIN AND RADIOTHERAPY IN SARCOMA CELL LINES
Orsolya Bodor
Favorite
Boehm, Hans-Henning

Merck Healthcare KGaA
(P 42) PRECLINICAL VALIDATION OF M3554, A NOVEL ANTI-GD2 ANTIBODY-DRUG CONJUGATE, AND EPIGENETIC SENSITIZATION STRATEGIES IN SOFT TISSUE SARCOMAS
Hans-Henning Boehm
Favorite
Boglione, Antonella

Oncology Department, ASL Città di Torino
(P 231) INCREASED LIFETIME RISK (LTR) OF SOFT TISSUE SARCOMAS (STS) IN PATIENTS WITH LOW-RISK GASTROINTESTINAL STROMAL TUMORS (GIST): A RETROSPECTIVE ANALYSIS FROM THE ITALIAN SARCOMA GROUP (ISG)
Antonella Boglione
Favorite
Boguslawski, Elissa

University of Michigan
(P 256) THE SEAN KARL COHORT: A NATIONAL COLLABORATIVE SINGLE-CELL RNASEQ STUDY OF PAIRED PATIENT EWING SARCOMA SPECIMENS
Elissa Boguslawski
Favorite
Bonaccorsi, Bruna

Grupo Oncoclinicas
(P 285) MULTICENTER STUDY OF SPATIALLY FRACTIONATED RADIOTHERAPY (LATTICE) FOR LARGE-VOLUME RADIORESISTANT SARCOMAS
Bruna Bonaccorsi
Favorite
Bonomo, Iris

Institut Bergonié
(P 324) FULLY MATURE TERTIARY LYMHOID STRUCTURES AS PREDICTORS OF LOCAL RECURRENCE IN SOFT TISSUE SARCOMAS
Iris Bonomo
Favorite
Bontoux, Christophe

Toulouse University Cancer Institute
(P 20) IDENTIFICATION OF A PROGNOSTIC GENE SIGNATURE FOR OSTEOSARCOMA RELAPSE BASED ON RESIDUAL TUMOR DISEASE AND ITS MICROENVIRONMENT
Christophe Bontoux
Favorite
Borghi, Alessandra

Fondazione IRCCS Istituto Nazionale dei Tumori
(P 308) IMPACT OF PSOAS MUSCLE RESECTION ON OUTCOMES IN PRIMARY RETROPERITONEAL DEDIFFERENTIATED LIPOSARCOMA
Alessandra Borghi
Favorite
Borgia, Jeffery

Rush University School of Medicine
(P 138) A MULTI-INSTITUTIONAL ARCHIVE AND DEEP LEARNING PIPELINE FOR QUANTIFYING CHONDROSARCOMA COMPOSITION
Jeffery Borgia
Favorite
Boriwal, Sandeep

All India Institute of Medical Sciences
(P 276) RADIATION-INDUCED SARCOMA (RIS): CLINICAL SPECTRUM AND ONCOLOGIC OUTCOMES FROM A TERTIARY INDIAN SARCOMA CLINIC
Sandeep Boriwal
Favorite
Borkowska, Aneta

Maria Sklodowska-Curie National Research Institute of Oncology
(P 146) LOCALISED CHONDROSARCOMA PERIOPERATIVE TREATMENT: REAL-WORLD OUTCOMES AND CHALLENGES ACROSS HISTOLOGIC SUBTYPES
Aneta Borkowska
Favorite
(P 152) EFFICACY OF PALLIATIVE CHEMOTHERAPY AND LOCAL TREATMENTS IN ADVANCED CHONDROSARCOMA: A SUBTYPE-SPECIFIC RETROSPECTIVE ANALYSIS
Aneta Borkowska
Favorite
(P 216) VIRTUAL MULTIDISCIPLINARY MEETINGS IN THE CARE OF SARCOMA PATIENTS
Aneta Borkowska
Favorite
(P 470) OFF-LABEL TREATMENT AND ULTRARARE SARCOMAS - SINGLE INSTITUTION REPORT
Aneta Borkowska
Favorite
Borquez, Fernando

Instituto Traumatologico Teodoro Gebauer
(P 212) MISINFORMATION IN SARCOMA CONTENT ON SOCIAL MEDIA PLATFORMS
Fernando Borquez
Favorite
Bosma Ainaud, Freya

Hospital Santa Creu i Sant Pau
(P 218) THE IMPACT OF BROADENED GENETIC COUNSELLING REFERRAL CRITERIA IN SARCOMA PATIENTS: A REFERENCE CENTRE'S EXPERIENCE
Freya Bosma Ainaud
Favorite
(P 385) PROGNOSTIC IMPACT OF PERIPHERAL BLOOD CELL RATIO VALUES IN PATIENTS WITH ADVANCED LEIOMYOSARCOMA: A REFERENCE CENTER EXPERIENCE.
Freya Bosma Ainaud
Favorite
Bouchard-Fortier, Antoine

Arthur Child Cancer Center
(P 293) CRYOABLATION FOR EXTRA-ABDOMINAL DESMOID TUMORS: A RETROSPECTIVE STUDY OF RADIOLOGIC AND CLINICAL OUTCOMES
Antoine Bouchard-Fortier
Favorite
Boughey, Judy

Mayo Clinic
(P 246) CTLA4 PATHWAY ACTIVATION IN RADIATION-INDUCED ANGIOSARCOMA: A TRANSCRIPTOMIC RATIONALE FOR IMMUNE CHECKPOINT BLOCKADE
Judy Boughey
Favorite
Bouhana, Karyn

Cogent Biosciences
(P 425) BEZUCLASTINIB EXPANDED ACCESS PROGRAM (EAP) FOR PATIENTS WITH GASTROINTESTINAL STROMAL TUMORS (GIST)
Karyn Bouhana
Favorite
Boura, Vivi

SOTIO Biotech AG
(P 257) TARGETING LEUCINE-RICH REPEAT-CONTAINING PROTEIN 15 (LRRC15): SOT106 ANTIBODY-DRUG CONJUGATE FOR SOFT TISSUE SARCOMA AND OSTEOSARCOMA TREATMENT
Vivi Boura
Favorite
Bourdon, Aurélien

Institut Bergonié
(P 59) TARGETING ADORA2B TO HALT METASTASIS IN UNDIFFERENTIATED PLEOMORPHIC SARCOMA: FROM MULTI-OMICS TO THERAPEUTIC INHIBITION
Aurélien Bourdon
Favorite
(P 324) FULLY MATURE TERTIARY LYMHOID STRUCTURES AS PREDICTORS OF LOCAL RECURRENCE IN SOFT TISSUE SARCOMAS
Aurélien Bourdon
Favorite
Bovee, Judith V.M.G

Leiden University Medical Center
(P 127) AN INTEGRATED CLINICAL GENOMIC AND TRANSCRIPTOMIC SUBGROUPING OF CENTRAL CHONDROSARCOMA
Judith V.M.G Bovee
Favorite
(P 128) ISOCITRATE DEHYDROGENASE 1 (IDH1) MUTATION TESTING IN THE PHASE 3 STUDY OF IVOSIDENIB VS PLACEBO IN IDH1-MUTANT CONVENTIONAL CHONDROSARCOMA (CHONQUER)
Judith V.M.G Bovee
Favorite
(P 466) PATHOGENESIS AND THERAPEUTIC TARGETS IN KERATIN-POSITIVE GIANT CELL-RICH TUMOR
Judith V.M.G Bovee
Favorite
Bowers, Joshua

Massachusetts General Hospital
(P 17) EXTRASKELETAL OSTEOSARCOMA: MICRORNA PATTERNS PROVIDE INSIGHTS INTO SIMILARITIES AND CONTRASTS WITH OTHER SARCOMAS
Joshua Bowers
Favorite
Boye, Kjetil

Oslo University Hospital
(P 200) DISSECTING INTRATUMORAL HETEROGENEITY IN GIST USING SPATIAL TRANSCRIPTOMICS
Kjetil Boye
Favorite
Boyer, John

Ipsen
(P 464) EFFICACY OUTCOMES AMONG PATIENTS WITH ADVANCED EPITHELIOID SARCOMAS OF PROXIMAL-TYPE AND DISTAL-TYPE TREATED WITH TAZ: POST HOC ANALYSIS OF STUDY EZH-202
John Boyer
Favorite
Boyle, Gabe

Seattle Children's Research Institute
(P 260) MECHANISM AND EFFICACY OF ANTHRACYCLINE MEDIATED EPIGENETIC DISRUPTION IN BONE SARCOMAS.
Gabe Boyle
Favorite
Bozzo, Anthony

McGill University
(P 143) IMPACT OF SURGICAL MARGINS IN CHEST WALL CHONDROSARCOMAS: A CANSARCC STUDY
Anthony Bozzo
Favorite
Bradley, Julie

University of Florida Proton Therapy Institute
(P 250) OUTCOME OF INFANTS WITH RHABDOMYOSARCOMA: A REPORT FROM THE INTERNATIONAL SOFT TISSUE SARCOMA CONSORTIUM
Julie Bradley
Favorite
Brakha, Meni

Surgical Department, Sharett Institute for Oncology, Hadassah Medical Center & Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel
(P 06) RAPID, POINT-OF-CARE DNA METHYLATION & MOLECULAR LANDSCAPE BASED SARCOMA CLASSIFICATION
Meni Brakha
Favorite
Brega, Nicoletta

Bayer HealthCare Pharmaceuticals, Inc.
(P 417) EFFICACY AND SAFETY OF LAROTRECTINIB (LARO) IN PATIENTS (PTS) WITH TRK FUSION SARCOMAS
Nicoletta Brega
Favorite
Bretcanu, Oana

Newcastle University
(P 135) EXPLORING THE ROLE OF CLUSTER OF DIFFERENTIATION 44 IN CHONDROSARCOMA
Oana Bretcanu
Favorite
Briaire-de Bruijn, Inge

Leiden University Medical Center
(P 127) AN INTEGRATED CLINICAL GENOMIC AND TRANSCRIPTOMIC SUBGROUPING OF CENTRAL CHONDROSARCOMA
Inge Briaire-de Bruijn
Favorite
Brich, Silvia

Fondazione IRCCS Istituto Nazionale dei Tumori
(P 452) EFFECTIVENESS OF ERIBULIN FOR MYXOID PLEOMORPHIC LIPOSARCOMA: INSIGHTS FROM A PATIENT-DERIVED MODEL AND CLINICAL TRANSLATION IN A PATIENT WITH ADVANCED DISEASE
Silvia Brich
Favorite
Brien, Earl

Cedars Sinai Medical Center
(P 230) CIRCULATING TUMOR DNA AS AN EARLY INDICATOR OF RESPONSE, PROGRESSION, AND RECURRENCE OF SARCOMAS
Earl Brien
Favorite
(P 433) PHASE I DOSE ESCALATION TRIAL OF STX-001, AN LNP SELF-REPLICATING MRNA EXPRESSING IL-12, IN PATIENTS WITH REFRACTORY TUMORS INCLUDING SARCOMAS
Earl Brien
Favorite
(P 440) CASE REPORT: COMPLETE CLINICAL AND MOLECULAR RESPONSE TO INTRATUMORAL STX-001, AN LNP-SELF REPLICATING MRNA EXPRESSING IL-12 IN A PATIENT WITH REFRACTORY ANGIOSARCOMA
Earl Brien
Favorite
(P 471) COMBINATION CHEMOTHERAPY WITH GEMCITABINE AND PACLITAXEL: A HIGHLY EFFICACIOUS AND BETTER TOLERATED OPTION FOR ANGIOSARCOMA
Earl Brien
Favorite
Brigman, Brian

Duke University
(P 84) A MULTICENTER COMPARISON OF REVERSE TOTAL SHOULDER ARTHROPLASTY VERSUS HEMIARTHROPLASTY FOR ENDOPROSTHETIC RECONSTRUCTION FOLLOWING ONCOLOGIC RESECTION OF THE PROXIMAL HUMERUS
Brian Brigman
Favorite
(P 214) FINANCIAL TOXICITY IN PATIENTS WITH A HISTORY OF EXTREMITY AND PELVIC SARCOMA TREATMENT
Brian Brigman
Favorite
Brinkmann, Elyse

Fred Hutchinson Cancer Center
(P 287) A PHASE 1 STUDY OF NEOADJUVANT CABOZANTINIB IN COMBINATION WITH RADIATION THERAPY FOR SARCOMAS OF THE EXTREMITIES
Elyse Brinkmann
Favorite
Brixner, Diana

Department of Pharmacotherapy, College of Pharmacy, University of Utah
(P 357) DEVELOPMENT OF AN ALGORITHM TO IDENTIFY PATIENTS (PT) WITH DESMOID TUMORS (DT) IN A UNITED STATES (US) CLAIMS DATASET
Diana Brixner
Favorite
Brizendine, Richard

Cogent Biosciences
(P 425) BEZUCLASTINIB EXPANDED ACCESS PROGRAM (EAP) FOR PATIENTS WITH GASTROINTESTINAL STROMAL TUMORS (GIST)
Richard Brizendine
Favorite
Brochhausen, Christoph

Institute of Pathology, University Medical Center Mannheim, Medical Faculty Mannheim, University Heidelberg, Mannheim, Germany
(P 454) TREATMENT PATTERNS AND OUTCOMES IN RADIATION-INDUCED SARCOMA: FIRST RESULTS OF THE TETRIS-PROJECT - A MULTIMODAL RETROSPECTIVE ANALYSIS FROM A TERTIARY CENTER
Christoph Brochhausen
Favorite
Brockman, Qierra

University of Colorado School of Medicine
(P 234) DOXORUBICIN PLUS BOTENSILIMAB, A NEXT GENERATION CTLA4 INHIBITOR, WITH OR WITHOUT BALSTILIMAB, A PD1 INHIBITOR, IN PATIENTS WITH ADVANCED SOFT TISSUE SARCOMAS
Qierra Brockman
Favorite
Broekhuis, Demien

LUMC
(P 144) THE RISK OF PATHOLOGICAL FRACTURES AFTER INTRALESIONAL CURETTAGE IN ATYPICAL CARTILAGINOUS TUMOURS: A RETROSPECTIVE COHORT STUDY
Demien Broekhuis
Favorite
Brohl, Andrew

H. Lee Moffitt Cancer Center and Research Institute
(P 394) DUAL OR TRIMODALITY THERAPY VERSUS SURGERY ALONE IN RADIATION-ASSOCIATED ANGIOSARCOMA OF THE BREAST
Andrew Brohl
Favorite
(P 453) OUTCOMES OF PLEOMORPHIC LIPOSARCOMA PATIENTS FOLLOWING MULTI-DISCIPLINARY MANAGEMENT WITHIN A TERTIARY CANCER CENTER
Andrew Brohl
Favorite
Broida, Samuel

Mayo Clinic
(P 96) AMPUTATION FOLLOWING MEGAPROSTHESIS USE IN LIMB SALVAGE
Samuel Broida
Favorite
(P 150) LOCAL RECURRENCE OF CHONDROSARCOMA: IMPACT ON SURVIVAL AND RECURRENCE AT AN INCREASED GRADE
Samuel Broida
Favorite
(P 162) CHONDROSARCOMA OUTCOMES IN YOUNG VERSUS ADULT POPULATIONS
Samuel Broida
Favorite
(P 348) SYNOVIAL SARCOMA INVOLVING NERVES: HIGH RATE OF MISIDENTIFICATION AS BENIGN TUMORS
Samuel Broida
Favorite
Brookes, Marcus

The Newcastle upon Tyne Hospitals NHS Foundation Trust
(P 314) AN INTERNATIONAL, MULTI-CENTRE STUDY OF SURGICAL MARGINS IN INTERMEDIATE TO HIGH GRADE SARCOMA
Marcus Brookes
Favorite
Brooks, Branden

UC Davis School of Medicine
(P 95) COMPARATIVE OUTCOMES OF OPERATIVE AND NON-OPERATIVE TREATMENT FOR METASTATIC HUMERAL PATHOLOGIC FRACTURES
Branden Brooks
Favorite
Brosius, Samantha

Memorial Sloan Kettering Cancer Center
(P 08) BUILDING A MEDICAL DONATION NETWORK TO ENHANCE DEVELOPMENT OF PEDIATRIC TUMOR MODELS
Samantha Brosius
Favorite
(P 25) IDENTIFICATION AND VALIDATION OF NON-GENETICALLY ENCODED VULNERABILITIES IN EWING SARCOMA
Samantha Brosius
Favorite
(P 48) PRECLINICAL ACTIVITY OF MEK INHIBITION IN COMBINATION WITH CHEMOTHERAPY IN MALIGNANT PERIPHERAL NERVE SHEATH TUMOR
Samantha Brosius
Favorite
BROUSSET, Pierre

Institut Universitaire du Cancer de Toulouse
(P 12) DNA REPLICATION STRESS AND DEFICIENT HOMOLOGOUS RECOMBINATION IN OSTEOSARCOMA RISK AND THERAPY
Pierre BROUSSET
Favorite
Brown, Danielle

UC Davis Health
(P 95) COMPARATIVE OUTCOMES OF OPERATIVE AND NON-OPERATIVE TREATMENT FOR METASTATIC HUMERAL PATHOLOGIC FRACTURES
Danielle Brown
Favorite
(P 106) REPAIR: A PRELIMINARY REPORT ON AN ONGOING MULTI-CENTER TRIAL FOR PATIENTS UNDERGOING SURGICAL STABILIZATION FOR METASTATIC BONE DISEASE OF THE FEMUR
Danielle Brown
Favorite
(P 349) THE COST OF SURVEILLANCE IN CALIFORNIA: MRI UTILIZATION IN RECURRENT EXTREMITY SOFT TISSUE SARCOMA
Danielle Brown
Favorite
(P 360) MRI SURVEILLANCE PRACTICES AND RECURRENCE DETECTION IN EXTREMITY SOFT TISSUE SARCOMA: A RETROSPECTIVE STUDY
Danielle Brown
Favorite
Browne, MaKenna

Duke University
(P 43) OVERCOMING PROMISCUOUS TUMOR FORMATION: A CONTROLLED GENETICALLY ENGINEERED MOUSE MODEL OF CIC::DUX4 SARCOMA
MaKenna Browne
Favorite
Brown, Lauren

Children's Cancer Institute
(P 11) ESTABLISHMENT, CHARACTERIZATION AND RESEARCH APPLICATION OF EIGHT NOVEL PATIENT-DERIVED OSTEOSARCOMA CELL LINES
Lauren Brown
Favorite
Brown, Maia

University of Pittsburgh School of Medicine
(P 65) INVESTIGATING MACROPHAGE POPULATIONS IN PRIMARY AND METASTATIC SARCOMA SAMPLES
Maia Brown
Favorite
Brun Knudsen, Christina

Department of Oncology, Herlev University Hospital
(P 05) CONCORDANCE OF GENOMIC ALTERATIONS WITH CIRCULATING TUMOR DNA: INITIAL FINDINGS FROM A PILOT STUDY
Christina Brun Knudsen
Favorite
(P 319) CARDIOTOXICITY AND OVERALL SURVIVAL IN PATIENTS WITH SARCOMA TREATED WITH DOXORUBICIN, OLARATUMAB AND DEXRAZOXANE: A REAL-WORLD EXPERIENCE IN DENMARK
Christina Brun Knudsen
Favorite
Brunello, Antonella

Istituto Oncologico Veneto
(P 231) INCREASED LIFETIME RISK (LTR) OF SOFT TISSUE SARCOMAS (STS) IN PATIENTS WITH LOW-RISK GASTROINTESTINAL STROMAL TUMORS (GIST): A RETROSPECTIVE ANALYSIS FROM THE ITALIAN SARCOMA GROUP (ISG)
Antonella Brunello
Favorite
(P 458) BETWEEN LYMPHOMAS AND SARCOMAS: A RETROSPECTIVE, MULTI-INSTITUTIONAL STUDY FROM THE ITALIAN SARCOMA GROUP (ISG) ON HISTIOCYTIC AND DENDRITIC CELL NEOPLASMS (HDCN)
Antonella Brunello
Favorite
Bruno, Tullia

UPMC Department of Immunology and Hillman Cancer Center
(P 65) INVESTIGATING MACROPHAGE POPULATIONS IN PRIMARY AND METASTATIC SARCOMA SAMPLES
Tullia Bruno
Favorite
Budd, G. Thomas

Cleveland Clinic
(P 284) THE IMPACT OF SARCOMA SBRT ON THE IMMUNE SYSTEM: EARLY RESULTS FROM A PROSPECTIVE TRIAL
G. Thomas Budd
Favorite
Budhathoki, Yogesh

Nationwide Children's Hospital
(P 13) TRANSCRIPTIONAL DIVERSITY AND NICHE REMODELING AT THE METASTATIC BOTTLENECK IN OSTEOSARCOMA
Yogesh Budhathoki
Favorite
Buezas-Perez, Rafael

Hospital Universitario Virgen del Rocio
(P 115) SINGLE-CENTER EXPERIENCE WITH TYROSIN KINASA INHIBITORS IN ADVANCED BONE SARCOMA: EFFICACY AND SAFETY OUTCOMES
Rafael Buezas-Perez
Favorite
Buffi, Nicolò

Humanitas University
(P 365) UROLOGICAL RECONSTRUCTION DURING RETROPERITONEAL AND PELVIC SARCOMA SURGERY: EXPERIENCE FROM A HIGH-VOLUME SARCOMA CENTER
Nicolò Buffi
Favorite
Bui, Marilyn

Moffitt Cancer Center
(P 138) A MULTI-INSTITUTIONAL ARCHIVE AND DEEP LEARNING PIPELINE FOR QUANTIFYING CHONDROSARCOMA COMPOSITION
Marilyn Bui
Favorite
Bui, Nam

Stanford University
(P 37) DISSECTING THE TUMOR MICROENVIRONMENT OF UTERINE LEIOMYOSARCOMAS FOR TARGETED DRUG PREDICTIONS
Nam Bui
Favorite
(P 122) INTERVAL-COMPRESSED CHEMOTHERAPY FOR TREATMENT OF EWING SARCOMA IN ADULTS: A SINGLE INSTITUTION STUDY
Nam Bui
Favorite
(P 297) ANALYSIS OF CTDNA KINETICS IN PATIENTS WITH METASTATIC LEIOMYOSARCOMA UNDERGOING LOCOREGIONAL PROCEDURAL INTERVENTION
Nam Bui
Favorite
(P 315) ANALYSIS OF CHANGES IN T2-WEIGHTED SIGNAL INTENSITY AND TUMOR VOLUME AND EXPOSURE-RESPONSE IN THE RINGSIDE PHASE 2 STUDY OF VAREGACESTAT FOR DESMOID TUMORS
Nam Bui
Favorite
(P 410) SUBGROUP ANALYSIS OF THE PHASE 2 PART OF THE RINGSIDE PHASE 2/3 TRIAL OF VAREGACESTAT FOR TREATMENT OF DESMOID TUMORS
Nam Bui
Favorite
(P 413) EFFICACY OF NIROGACESTAT IN PATIENTS WITH DESMOID TUMORS AND PRESENCE OR ABSENCE OF POOR PROGNOSTIC FACTORS: POST HOC ANALYSES OF THE PHASE 3 DEFI TRIAL
Nam Bui
Favorite
Bult, Carol

PIVOT Coordinating Center
(P 267) THE RAF/MEK INHIBITOR VS-6766 SHOWS EFFICACY IN RAS-MUTANT PEDIATRIC PRECLINICAL XENOGRAFT MODELS- A REPORT FROM THE PEDIATRIC PRECLINICAL IN VIVO TESTING CONSORTIUM
Carol Bult
Favorite
Bunda, Severa

UHN
(P 465) JAK/STAT PATHWAY CO-OPERATES WITH CIC-FUSIONS TODRIVE CIC-REARRANGED SARCOMAS
Severa Bunda
Favorite
Buonadonna, Angela

Sarcoma and gastrointestinal tumors Unit, Centro di Riferimento Oncologico di Aviano
(P 231) INCREASED LIFETIME RISK (LTR) OF SOFT TISSUE SARCOMAS (STS) IN PATIENTS WITH LOW-RISK GASTROINTESTINAL STROMAL TUMORS (GIST): A RETROSPECTIVE ANALYSIS FROM THE ITALIAN SARCOMA GROUP (ISG)
Angela Buonadonna
Favorite
Burcoveanu, Domnita-Ileana

Bayer HealthCare Pharmaceuticals, Inc.
(P 417) EFFICACY AND SAFETY OF LAROTRECTINIB (LARO) IN PATIENTS (PTS) WITH TRK FUSION SARCOMAS
Domnita-Ileana Burcoveanu
Favorite
(P 419) PROSPECTIVE REAL-WORLD STUDY OF LAROTRECTINIB (LARO) IN PATIENTS (PTS) WITH TRK FUSION SOLID TUMORS: INTERIM ANALYSIS OF ON-TRK
Domnita-Ileana Burcoveanu
Favorite
Burdi, Allison

Mass General Cancer Center, Massachusetts General Hospital
(P 45) MONITORING EWSR1 FUSIONS IN SARCOMA PATIENTS USING PERSONALIZED LIQUID BIOPSY ASSAYS
Allison Burdi
Favorite
Burgoyne, Adam

University of California San Diego Moores Cancer Center
(P 179) NEOADJUVANT AVAPRITINIB IN PDGFRA-MUTANT GIST: NEAR COMPLETE PATHOLOGICAL RESPONSES AT THE COST OF HIGH ADVERSE EVENT RATES
Adam Burgoyne
Favorite
(P 180) COMPARATIVE EFFICACY OF GENERIC AND BRAND-NAME IMATINIB IN NEOADJUVANT TREATMENT OF KIT EXON 11 MUTANT GIST
Adam Burgoyne
Favorite
(P 424) AN OPEN-LABEL PHASE 1/2 STUDY OF DCC-3009 MONOTHERAPY IN PATIENTS (PTS) WITH ADVANCED GASTROINTESTINAL STROMAL TUMOR (GIST)
Adam Burgoyne
Favorite
Burke, Zachary

Cleveland Clinic Lerner College of Medicine
(P 10) COLLATERAL SENSITIVIES EMERGE DURING THE EVOLUTION OF CHEMORESISTANCE TO MAP CHEMOTHERAPY IN OSTEOSARCOMA
Zachary Burke
Favorite
Burke, Zachary D.

Cleveland Clinic
(P 84) A MULTICENTER COMPARISON OF REVERSE TOTAL SHOULDER ARTHROPLASTY VERSUS HEMIARTHROPLASTY FOR ENDOPROSTHETIC RECONSTRUCTION FOLLOWING ONCOLOGIC RESECTION OF THE PROXIMAL HUMERUS
Zachary D. Burke
Favorite
(P 220) THE IMPACT OF WOUND HEALING COMPLICATIONS ON PATIENT-REPORTED OUTCOMES FOLLOWING SOFT TISSUE SARCOMA SURGERY
Zachary D. Burke
Favorite
(P 284) THE IMPACT OF SARCOMA SBRT ON THE IMMUNE SYSTEM: EARLY RESULTS FROM A PROSPECTIVE TRIAL
Zachary D. Burke
Favorite
(P 316) AREA DEPRIVATION INDEX (ADI) AND OUTCOMES IN LOCALIZED SOFT TISSUE SARCOMA: DO SOCIAL DETERMINANTS INFLUENCE SURVIVAL?
Zachary D. Burke
Favorite
(P 355) CLASSIFYING WOUND HEALING COMPLICATIONS IN SURGICALLY TREATED EXTREMITY SOFT TISSUE SARCOMA
Zachary D. Burke
Favorite
(P 457) A RETROSPECTIVE REVIEW OF LOW-GRADE FIBROMYXOID SARCOMA: SURGICAL MANAGEMENT, RADIATION THERAPY, AND OUTCOMES
Zachary D. Burke
Favorite
Burkhard-Meier, Anton

Department of Medicine III, LMU University Hospital, Munich, Germany
(P 64) ATRX EXPRESSION CORRELATES WITH REDUCED IMMUNE CHECKPOINT EXPRESSION AND POOR SURVIVAL IN HIGH-RISK SOFT TISSUE SARCOMAS
Anton Burkhard-Meier
Favorite
(P 437) CLINICAL DATA CONFIRM GALENIC PRINCIPLE AND DEMONSTRATE THERAPEUTIC POTENTIAL OF THE001 (DPPG2-TSL-DOX) PLUS REGIONAL HYPERTHERMIA IN SOFT TISSUE SARCOMA
Anton Burkhard-Meier
Favorite
(P 443) FIRST-LINE PAZOPANIB IN PATIENTS WITH EPITHELIOID HEMANGIOENDOTHELIOMA: A RETROSPECTIVE SINGLE-CENTER ANALYSIS
Anton Burkhard-Meier
Favorite
Burks, Jared

The University of Texas MD Anderson Cancer Center
(P 172) COMPARISON OF CELL SEGMENTATION METHODS IN SOFT TISSUE SARCOMA (STS) SPATIAL PROTEOMIC DATASETS
Jared Burks
Favorite
Burns, ELIZABETH

University of Florida
(P 44) A SYSTEMATIC REVIEW OF FUSION-DRIVEN SARCOMAS
ELIZABETH Burns
Favorite
(P 325) FUSION GENES IN SARCOMAS: DIAGNOSTIC APPROACHES AND EMERGING TARGETED THERAPIES
ELIZABETH Burns
Favorite
(P 401) LONG-TERM OUTCOMES OF IMATINIB-TREATED DERMATOFIBROSARCOMA PROTUBERANS: INSIGHTS FROM A SINGLE-INSTITUTION CASE SERIES
ELIZABETH Burns
Favorite
Burns, Erin

Memorial Sloan Kettering Cancer Center
(P 237) DEVELOPMENT OF EPHA2 CAR T CELL THERAPY FOR OSTEOSARCOMA
Erin Burns
Favorite
Bus, Michael

Leiden University Medical Centre
(P 151) SHOULD WE USE ADJUVANT CHEMOTHERAPY IN PATIENTS WITH LOCALIZED DEDIFFERENTIATED CHONDROSARCOMA (DDCS) OF THE PELVIS? AN ANALYSIS BY THE PELVIC DDCS STUDY GROUP
Michael Bus
Favorite
Butler, Megan

Adaptimmune
(P 247) SINGLE-CELL RNA SEQUENCING OF AFAMITRESGENE AUTOLEUCEL INDICATES MECHANISMS OF PERSISTENCE AND ANTI-TUMOR ACTIVITY
Megan Butler
Favorite
Butler, Zachary

Rush University Medical Center
(P 104) 3D PRINTED CUTTING GUIDES FOR LONG BONE SARCOMA RESECTION AND INTERCALARY ALLOGRAFT RECONSTRUCTION: A CASE SERIES
Zachary Butler
Favorite
(P 113) ASSESSING TREATMENT OUTCOMES OF CHONDROMYXOID FIBROMA: A CASE SERIES
Zachary Butler
Favorite
Butler, Zachary

Rush University School of Medicine
(P 138) A MULTI-INSTITUTIONAL ARCHIVE AND DEEP LEARNING PIPELINE FOR QUANTIFYING CHONDROSARCOMA COMPOSITION
Zachary Butler
Favorite
Butler, Zachary

Rush University Medical Center
(P 206) IMPACT OF PROXIMITY TO HEALTH CENTER ON ADHERENCE TO NATIONAL COMPREHENSIVE CANCER NETWORK GUIDELINES IN PATIENTS WITH SOFT TISSUE SARCOMAS
Zachary Butler
Favorite
Byrne, Sean

The Ohio State University Wexner Medical Center
(P 153) DOES THE QUANTITY OF DEDIFFERENTIATION MATTER IN THE CLINICAL OUTCOMES OF DEDIFFERENTIATED CHONDROSARCOMA? A 10-YEAR SINGLE TERTIARY INSTITUTIONAL EXPERIENCE OF A SERIES.
Sean Byrne
Favorite
C
C P, Badira

Tata Memorial Hospital, Tata memorial Centre, Mumbai
(P 292) CRANIOVERTEBRAL EWINGS SARCOMA WITH MENINGEAL INFILTRATION - A CLINICAL OUTCOME ANALYSIS
Badira C P
Favorite
Cabanski, Christopher

Parker Institute for Cancer Immunotherapy
(P 350) THE PATTERN.ORG SARCOMA CONSORTIUM: BUILDING A MULTI-INSTITUTIONAL DATA RESOURCE FOR THE SARCOMA RESEARCH COMMUNITY
Christopher Cabanski
Favorite
Cable, LouAnn

Cogent Biosciences
(P 425) BEZUCLASTINIB EXPANDED ACCESS PROGRAM (EAP) FOR PATIENTS WITH GASTROINTESTINAL STROMAL TUMORS (GIST)
LouAnn Cable
Favorite
Cabrolier, Jorge

Clinica Alemana Santiago
(P 212) MISINFORMATION IN SARCOMA CONTENT ON SOCIAL MEDIA PLATFORMS
Jorge Cabrolier
Favorite
Caddeo, Elena

IRCCS Rizzoli Orthopaedic Institute
(P 18) ESTABLISHMENT AND CHARACTERIZATION OF A NOVEL PRIMARY CELL LINE FROM A BONE METASTASIS OF OSTEOSARCOMA
Elena Caddeo
Favorite
Cairo, Mitchell

New York Medical College
(P 76) CD47 BLOCKADE SYNERGIZES WITH CHEMOTHERAPY IN ENHANCING MACROPHAGE PHAGOCYTOSIS OF EWING SARCOMA CELLS
Mitchell Cairo
Favorite
Cai, Yiming

The University of Texas MD Anderson Cancer Center
(P 391) ATRX LOSS BLOCKS THE DIFFERENTIATION OF MESENCHYMAL STEM CELLS AND ADVANCES UNDIFFERENTIATED SARCOMA DEVELOPMENT
Yiming Cai
Favorite
Cai, Zhengdong

Department of Orthopaedics, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
(P 07) A LIVING MULTI-OMICS BIOBANK OF PATIENT-DERIVED XENOGRAFT MODELS FOR SARCOMA
Zhengdong Cai
Favorite
Cai, Zhenyu

Peking University People's Hospital
(P 75) CD248 AS A PROGNOSTIC MARKER IN OSTEOSARCOMA
Zhenyu Cai
Favorite
Calafiore, Eleonora

Humanitas University
(P 318) BURIED DE-EPITHELIALIZED FLAP RECONSTRUCTION AFTER WIDE EXCISION OF THIGH SARCOMAS: EARLY EXPERIENCE FROM A SPECIALIZED SARCOMA SURGERY UNIT
Eleonora Calafiore
Favorite
(P 339) POSTERIOR APPROACH FOR RADICAL RESECTION OF SACROCOCCYGEAL CHORDOMA: A SURGICAL PERSPECTIVE FROM A TERTIARY REFERRAL CENTER
Eleonora Calafiore
Favorite
Calagna, Silvia

Fondazione Policlinico Universitario Campus Bio-Medico
(P 61) HER2 TARGETING IN CHORDOMA: PRECLINICAL INSIGHTS ON TRASTUZUMAB DERUXTECAN
Silvia Calagna
Favorite
Calagna, Silvia

Università Campus Bio-Medico di Roma
(P 412) UNCOVERING HER2 OVEREXPRESSION IN SOFT TISSUE SARCOMAS (STS): INSIGHTS FROM THE CANCER GENOME ATLAS (TCGA)
Silvia Calagna
Favorite
Calderon Anyosa, Renzo

University of Toronto
(P 154) BCOR-MUTATED CONVENTIONAL AND DEDIFFERENTIATED CHONDROSARCOMA: A CLINICOPATHOLOGIC STUDY
Renzo Calderon Anyosa
Favorite
Calder, Paul

Memorial Sloan Kettering Cancer Center
(P 22) SINGLE CELL SEQUENCING ENABLES LINEAGE-INFORMED TARGETING OF OSTEOSARCOMA
Paul Calder
Favorite
Califano, Andrea

Columbia University Irving Medical Center
(P 25) IDENTIFICATION AND VALIDATION OF NON-GENETICALLY ENCODED VULNERABILITIES IN EWING SARCOMA
Andrea Califano
Favorite
Callan, Alexandra

UT Southwestern
(P 280) PERSONALIZED ULTRA-FRACTIONATED STEREOTACTIC ADAPTIVE RADIOTHERAPY (PULSAR) FOR ADULT AND PEDIATRIC SARCOMAS
Alexandra Callan
Favorite
Callegaro, Dario

Fondazione IRCCS IStituto Nazionale dei Tumori, Milan, Italy
(P 308) IMPACT OF PSOAS MUSCLE RESECTION ON OUTCOMES IN PRIMARY RETROPERITONEAL DEDIFFERENTIATED LIPOSARCOMA
Dario Callegaro
Favorite
Call, Jerry

The Life Raft Group
(P 188) A CALCULATOR TO ESTIMATE EFFECTIVE IMATINIB CONCENTRATIONS IN GIST AFTER ADJUSTING FOR PROTEIN BINDING
Jerry Call
Favorite
(P 189) AN ALGORITHM TO PERSONALIZE IMATINIB PLASMA TESTING AND DOSE DECISIONS IN GIST PATIENTS
Jerry Call
Favorite
(P 190) TEMPORAL DECLINE IN PROGRESSION-FREE SURVIVAL, TIME ON MEDICATION, AND OVERALL SURVIVAL IN ADVANCED GASTROINTESTINAL STROMAL TUMOR
Jerry Call
Favorite
Calvo Vergés, Núria

Hospital Santa Creu i Sant Pau
(P 218) THE IMPACT OF BROADENED GENETIC COUNSELLING REFERRAL CRITERIA IN SARCOMA PATIENTS: A REFERENCE CENTRE'S EXPERIENCE
Núria Calvo Vergés
Favorite
Cambeiro Cabré, Lorena

Hospital de la Santa Creu i Sant Pau
(P 383) MULTIDISCIPLINARY TREATMENT OF INGUINOSCROTAL SARCOMAS: ANALYSIS OF 39 CASES TREATED BY SURGICAL APPROACH
Lorena Cambeiro Cabré
Favorite
Campanacci, Domenico Andrea

AOU Careggi
(P 151) SHOULD WE USE ADJUVANT CHEMOTHERAPY IN PATIENTS WITH LOCALIZED DEDIFFERENTIATED CHONDROSARCOMA (DDCS) OF THE PELVIS? AN ANALYSIS BY THE PELVIC DDCS STUDY GROUP
Domenico Andrea Campanacci
Favorite
Campbell, Shauna

Cleveland Clinic
(P 284) THE IMPACT OF SARCOMA SBRT ON THE IMMUNE SYSTEM: EARLY RESULTS FROM A PROSPECTIVE TRIAL
Shauna Campbell
Favorite
Campos Gallego, Natalia

3.Sylvester comprehensive Cancer Center, Miami, FL, USA
(P 31) TARGETING CANCER STEM CELLS BY TYROSINE PEPTIDE ANALOGUE IN REFRACTORY SARCOMA
Natalia Campos Gallego
Favorite
Campos, Fernando

A.C.Camargo Cancer Center
(P 128) ISOCITRATE DEHYDROGENASE 1 (IDH1) MUTATION TESTING IN THE PHASE 3 STUDY OF IVOSIDENIB VS PLACEBO IN IDH1-MUTANT CONVENTIONAL CHONDROSARCOMA (CHONQUER)
Fernando Campos
Favorite
(P 132) MOLECULAR LANDSCAPE AND CLINICAL HETEROGENEITY OF BRAZILIAN CHONDROSARCOMAS: INSIGHTS FROM IDH, TERT, AND GENOME-WIDE ANALYSIS
Fernando Campos
Favorite
(P 137) GENOMIC ALTERATIONS IN RARE CARTILAGINOUS TUMOR SYNDROMES ASSOCIATED WITH CHONDROSARCOMA DEVELOPMENT
Fernando Campos
Favorite
(P 155) BRCA2-MUTATED CONVENTIONAL CHONDROSARCOMA RESPONDING TO PARP INHIBITION: A CASE REPORT
Fernando Campos
Favorite
(P 278) NEOADJUVANT HYPOFRACTIONATED RADIOTHERAPY AND CHEMOTHERAPY IN EXTREMITY SOFT TISSUE SARCOMAS
Fernando Campos
Favorite
(P 456) OUTCOMES OF FIRST-LINE CHEMOTHERAPY IN ADVANCED ADULT-TYPE RHABDOMYOSARCOMAS: POOLED ANALYSIS OF CLINICAL TRIALS FROM THE EORTC SOFT TISSUE AND BONE SARCOMA GROUP
Fernando Campos
Favorite
Canady, Stephanie

NCI/NIH
(P 181) THE DEVELOPMENT OF A NOVEL PDGFRA RESISTANCE MUTATION IN A RECURRENT KIT-MUTANT GASTROINTESTINAL STROMAL TUMOR (GIST)
Stephanie Canady
Favorite
Cananzi, Ferdinando Carlo Maria

Humanitas University
(P 203) MINIMALLY INVASIVE RESECTION OF MULTIFOCAL DUODENO-JEJUNAL GISTS IN NEUROFIBROMATOSIS TYPE 1
Ferdinando Carlo Maria Cananzi
Favorite
(P 318) BURIED DE-EPITHELIALIZED FLAP RECONSTRUCTION AFTER WIDE EXCISION OF THIGH SARCOMAS: EARLY EXPERIENCE FROM A SPECIALIZED SARCOMA SURGERY UNIT
Ferdinando Carlo Maria Cananzi
Favorite
(P 328) INNOVATING SARCOMA EDUCATION: EARLY OUTCOMES OF THE ITALIAN SOCIETY OF SURGICAL ONCOLOGY (SICO) SARCOMA SOCIAL MULTI-PLATFORM JOURNAL CLUB INITIATIVE
Ferdinando Carlo Maria Cananzi
Favorite
(P 339) POSTERIOR APPROACH FOR RADICAL RESECTION OF SACROCOCCYGEAL CHORDOMA: A SURGICAL PERSPECTIVE FROM A TERTIARY REFERRAL CENTER
Ferdinando Carlo Maria Cananzi
Favorite
(P 365) UROLOGICAL RECONSTRUCTION DURING RETROPERITONEAL AND PELVIC SARCOMA SURGERY: EXPERIENCE FROM A HIGH-VOLUME SARCOMA CENTER
Ferdinando Carlo Maria Cananzi
Favorite
Cancel, Chantelle

Texas Tech University Health Science Center El Paso
(P 78) MENTAL HEALTH DISORDERS FOLLOWING PATHOLOGICAL FRACTURE: A RETROSPECTIVE COHORT STUDY
Chantelle Cancel
Favorite
Canjirathinkal, Mathew A.

The University of Texas MD Anderson Cancer Center
(P 311) A FOLLOW-UP STUDY ON THE NOVEL USE OF CONTRAST-ENHANCED SUSCEPTIBILITY-WEIGHTED IMAGING FOR EXTREMITY DESMOID FIBROMATOSIS RESPONSE ASSESSMENT
Mathew A. Canjirathinkal
Favorite
(P 317) BUILDING A PRE-SURGICAL MULTIPARAMETRIC-MRI-BASED PREDICTIVE TREATMENT RESPONSE MODEL FOR UNDIFFERENTIATED PLEOMORPHIC SARCOMA TO REPLACE RECIST
Mathew A. Canjirathinkal
Favorite
(P 334) MRI VOLUMETRIC AND MODIFIED CHOI-BASED ASSESSMENT OF TREATMENT RESPONSE IN EXTREMITY DESMOID TUMORS TREATED WITH NIROGACESTAT OR SORAFENIB
Mathew A. Canjirathinkal
Favorite
(P 406) PILOT STUDY: CAN A MULTIPARAMETRIC MRI-DERIVED MODEL OUTPERFORM RECIST PREDICTING PATHOLOGY RESPONSE IN RHABDOMYOSARCOMA?
Mathew A. Canjirathinkal
Favorite
(P 420) THE EFFECT OF CHEMOTHERAPY AND RADIOTHERAPY IN THE MULTIPARAMETRIC MRI-BASED ASSESSMENT OF TREATMENT RESPONSE IN EXTREMITY SOFT-TISSUE UNDIFFERENTIATED PLEOMORPHIC SARCOMA
Mathew A. Canjirathinkal
Favorite
Cannon, Matthew

Nationwide Children's
(P 13) TRANSCRIPTIONAL DIVERSITY AND NICHE REMODELING AT THE METASTATIC BOTTLENECK IN OSTEOSARCOMA
Matthew Cannon
Favorite
Cano, Juana María

Hospital General Universitario Ciudad Real
(P 389) UNRESECTABLE AND METASTATIC DEDIFFERENTIATED LIPOSARCOMA (DDLPS): INSIGHTS FROM A MULTICENTER REAL-WORLD COHORT (RWC)
Juana María Cano
Favorite
Cantave, Kyle

UC Davis School of Medicine
(P 95) COMPARATIVE OUTCOMES OF OPERATIVE AND NON-OPERATIVE TREATMENT FOR METASTATIC HUMERAL PATHOLOGIC FRACTURES
Kyle Cantave
Favorite
(P 360) MRI SURVEILLANCE PRACTICES AND RECURRENCE DETECTION IN EXTREMITY SOFT TISSUE SARCOMA: A RETROSPECTIVE STUDY
Kyle Cantave
Favorite
Canter, Robert

Surgical Oncology, Department of Surgery, University of California, Davis
(P 244) INTRATUMORAL TIGIT BLOCKADE AUGMENTS ANTI-TUMOR RESPONSES AND BYPASSES HYPERFUNCTIONALITY OF PERIPHERAL TIGIT+ NK CELLS IN MOUSE AND HUMAN MODELS OF BONE AND SOFT TISSUE SARCOMA
Robert Canter
Favorite
(P 245) SUBTYPE SPECIFIC CHARACTERIZATION OF IMMUNE INFILTRATION IN SOFT TISSE SARCOMAS
Robert Canter
Favorite
Cantley, Lewis

Harvard Medical School
(P 198) EXPLOITING METABOLIC DYSREGULATION IN SUCCINATE DEHYDROGENASE-DEFICIENT GASTROINTESTINAL STROMAL TUMOR
Lewis Cantley
Favorite
Canton, Johnathan

Arnie Charbonneau Cancer Institute and McCaig Institute for Bone and Joint Health
(P 238) INVESTIGATING HOW MACROPHAGES INFILTRATE THE TUMOUR MICROENVIRONMENT AND INFLUENCE THE EFFICACY OF CAR T THERAPY IN A MURINE MODEL OF STS
Johnathan Canton
Favorite
(P 378) HIGH DOSE RADIATION THERAPY PROMOTES IMMUNE SUPPRESSIVE MACROPHAGE PHENOTYPES, WHEREAS LOW DOSE RADIATION THERAPY PROMOTES IMMUNOGENIC MACROPHAGE PHENOTYPES IN A MURINE MODEL OF SOFT TISSUE SARCOMA
Johnathan Canton
Favorite
Caracciolo, Jamie

Moffitt Cancer Center
(P 140) REFINING PRE-SURGICAL ASSESSMENT OF LONG-BONE CHONDROSARCOMA THROUGH THE RADIOLOGIC AGGRESSIVENESS SCORE
Jamie Caracciolo
Favorite
(P 141) A RETROSPECTIVE ANALYSIS OF THE BIRMINGHAM ATYPICAL CARTILAGE TUMOUR IMAGING PROTOCOL (BACTIP) IN MANAGING CENTRAL CARTILAGE TUMORS OF THE LONG BONES
Jamie Caracciolo
Favorite
(P 142) ARE THERE INDEPENDENT PREDICTORS OF DEDIFFERENTIATED CHONDROSARCOMA ON MAGNETIC RESONANCE IMAGING? A MULTIVARIATE ANALYSIS
Jamie Caracciolo
Favorite
Caradonio, Olivia

Children's Hospital of Philadelphia
(P 262) EVALUATING FRONT-LINE THERAPY ACCORDANCE WITH CURRENT SYNOVIAL SARCOMA GUIDELINES
Olivia Caradonio
Favorite
(P 263) DESCRIBING THE CHARACTERISTICS AND TREATMENT OF SYNOVIAL SARCOMA IN THE RECURRENT SETTING
Olivia Caradonio
Favorite
Carbo-Bague, Anna

ICO - Institut Català d’Oncologia-Girona
(P 389) UNRESECTABLE AND METASTATIC DEDIFFERENTIATED LIPOSARCOMA (DDLPS): INSIGHTS FROM A MULTICENTER REAL-WORLD COHORT (RWC)
Anna Carbo-Bague
Favorite
Cardenas Zuniga, Roberto

MD Anderson Cancer Center
(P 47) EWSR1::WT1 FUSION ONCOPROTEIN ACTIVITY SHAPES LINEAGE HETEROGENEITY IN DESMOPLASTIC SMALL ROUND CELL TUMORS
Roberto Cardenas Zuniga
Favorite
Cardoso, Sara

Leiden University Medical Center
(P 127) AN INTEGRATED CLINICAL GENOMIC AND TRANSCRIPTOMIC SUBGROUPING OF CENTRAL CHONDROSARCOMA
Sara Cardoso
Favorite
Carneiro, Wellington

Universidade de Fortaleza (UNIFOR)
(P 404) OUTCOMES OF NEOADJUVANT THERAPY IN ANGIOSARCOMA PATIENTS: A KAPLAN-MEIER-RECONSTRUCTED INDIVIDUAL PATIENT-LEVEL META-ANALYSIS
Wellington Carneiro
Favorite
Caro-Sanchez, Claudia

National Cancer Institute Mexico
(P 302) PREDICTORS AND OUTCOMES OF RECURRENT RETROPERITONEAL SARCOMA: A SINGLE-CENTER LATIN AMERICAN COHORT STUDY
Claudia Caro-Sanchez
Favorite
Carpano, Silvia

Division of Medical Oncology 2, IRCCS Regina Elena National Cancer Institute
(P 231) INCREASED LIFETIME RISK (LTR) OF SOFT TISSUE SARCOMAS (STS) IN PATIENTS WITH LOW-RISK GASTROINTESTINAL STROMAL TUMORS (GIST): A RETROSPECTIVE ANALYSIS FROM THE ITALIAN SARCOMA GROUP (ISG)
Silvia Carpano
Favorite
Carraro, Dirce

A.C.Camargo Cancer Center
(P 132) MOLECULAR LANDSCAPE AND CLINICAL HETEROGENEITY OF BRAZILIAN CHONDROSARCOMAS: INSIGHTS FROM IDH, TERT, AND GENOME-WIDE ANALYSIS
Dirce Carraro
Favorite
(P 137) GENOMIC ALTERATIONS IN RARE CARTILAGINOUS TUMOR SYNDROMES ASSOCIATED WITH CHONDROSARCOMA DEVELOPMENT
Dirce Carraro
Favorite
CARRASCO GARCIA, IRENE

HU VIRGEN DEL ROCIO
(P 115) SINGLE-CENTER EXPERIENCE WITH TYROSIN KINASA INHIBITORS IN ADVANCED BONE SARCOMA: EFFICACY AND SAFETY OUTCOMES
IRENE CARRASCO GARCIA
Favorite
(P 321) COMPARATIVE ANALYSIS OF FIRST-LINE DOXORUBICIN-BASED COMBINATION REGIMENS IN METASTATIC LEIOMYOSARCOMA: IMPACT ON SURVIVAL AND DISEASE CONTROL
IRENE CARRASCO GARCIA
Favorite
Carrasco, Carlos P.

Bayer HealthCare Pharmaceuticals, Inc.
(P 419) PROSPECTIVE REAL-WORLD STUDY OF LAROTRECTINIB (LARO) IN PATIENTS (PTS) WITH TRK FUSION SOLID TUMORS: INTERIM ANALYSIS OF ON-TRK
Carlos P. Carrasco
Favorite
Carroll, Hailey

St Vincent's University Hospital
(P 211) HEALTH-RELATED QUALITY OF LIFE IN IRISH SARCOMA PATIENTS
Hailey Carroll
Favorite
(P 213) FINANCIAL TOXICITY IN IRISH SARCOMA CARE: A SINGLE-CENTRE ANALYSIS
Hailey Carroll
Favorite
Carrozza, Susan

Dana-Farber Cancer Institute
(P 427) PHASE 1/2 TRIAL TO EVALUATE THE SAFETY AND EFFICACY OF PEEL-224 IN COMBINATION WITH VINCRISTINE AND TEMOZOLOMIDE IN ADOLESCENTS AND YOUNG ADULTS WITH RELAPSED OR REFRACTORY SARCOMAS
Susan Carrozza
Favorite
Carter, Claire

Center for Discovery and Innovation, Department of Pathology, Hackensack Meridian School of Medicine
(P 251) SPATIAL MULTI-OMIC ANALYSIS OF RHABDOMYOSARCOMA IDENTIFIES THERAPEUTIC VULNERABILITIES
Claire Carter
Favorite
Carter, Louise

The Division of Cancer Sciences, The University of Manchester and Department of Medical Oncology, The Christie NHS Foundation Trust
(P 431) INVOKE: A PHASE 1 STUDY OF OKN4395, A FIRST-IN-CLASS EP2/EP4/DP1 TRIPLE PROSTANOID RECEPTOR ANTAGONIST, IN PATIENTS WITH ADVANCED SOLID TUMORS, INCLUDING SARCOMAS
Louise Carter
Favorite
Carter, Rheanna

BostonGene
(P 233) DNG64-CAR-V+ REGIMEN SHOWS CLINICAL BENEFIT IN PATIENTS WITH ADVANCED CCNG1 ONCOGENE EXPRESSING SARCOMAS (NCT04091295)
Rheanna Carter
Favorite
Cartwright, Chelsey

University of Colorado Cancer Center
(P 234) DOXORUBICIN PLUS BOTENSILIMAB, A NEXT GENERATION CTLA4 INHIBITOR, WITH OR WITHOUT BALSTILIMAB, A PD1 INHIBITOR, IN PATIENTS WITH ADVANCED SOFT TISSUE SARCOMAS
Chelsey Cartwright
Favorite
Carvalho, Mariana

A.C.Camargo Cancer Center
(P 132) MOLECULAR LANDSCAPE AND CLINICAL HETEROGENEITY OF BRAZILIAN CHONDROSARCOMAS: INSIGHTS FROM IDH, TERT, AND GENOME-WIDE ANALYSIS
Mariana Carvalho
Favorite
Carvalho, Nathália

A.C.Camargo Cancer Center
(P 137) GENOMIC ALTERATIONS IN RARE CARTILAGINOUS TUMOR SYNDROMES ASSOCIATED WITH CHONDROSARCOMA DEVELOPMENT
Nathália Carvalho
Favorite
Casale, Paolo

IRCCS Humanitas Research Hospital
(P 365) UROLOGICAL RECONSTRUCTION DURING RETROPERITONEAL AND PELVIC SARCOMA SURGERY: EXPERIENCE FROM A HIGH-VOLUME SARCOMA CENTER
Paolo Casale
Favorite
Casali, Paolo G.

Fondazione IRCCS Istituto nazionale dei tumori
(P 32) EFFECTIVENESS OF LURBINECTEDIN PLUS IRINOTECAN IN PRECLINICAL MODEL OF DESMOPLASTIC SMALL ROUND CELL TUMOR
Paolo G. Casali
Favorite
(P 331) MAINTENANCE THERAPY (M-TP) WITH DACARBAZINE (DTIC) AFTER FIRST-LINE ANTHRACYCLINE-BASED DOUBLET IN ADVANCED LEIOMYOSARCOMA (LMS) PATIENTS (PTS): OUTCOMES OF A CASE SERIES IN A SINGLE REFERRAL CENTER
Paolo G. Casali
Favorite
(P 446) GDF-15 AS A PROGNOSTIC FACTOR IN PATIENTS WITH EPITHELIOID HEMANGIOENDOTHELIOMA
Paolo G. Casali
Favorite
(P 458) BETWEEN LYMPHOMAS AND SARCOMAS: A RETROSPECTIVE, MULTI-INSTITUTIONAL STUDY FROM THE ITALIAN SARCOMA GROUP (ISG) ON HISTIOCYTIC AND DENDRITIC CELL NEOPLASMS (HDCN)
Paolo G. Casali
Favorite
Casanova, Michela

Fondazione IRCCS Istituto Nazionale dei Tumori
(P 452) EFFECTIVENESS OF ERIBULIN FOR MYXOID PLEOMORPHIC LIPOSARCOMA: INSIGHTS FROM A PATIENT-DERIVED MODEL AND CLINICAL TRANSLATION IN A PATIENT WITH ADVANCED DISEASE
Michela Casanova
Favorite
Casey, Jessica

Cure 4 The Kids Foundation
(P 261) SUSTAINED RESPONSE WITH RIVOCERANIB AND DENOSUMAB IN RELASPED OSTEOSARCOMA
Jessica Casey
Favorite
Casiraghi, Marta

Humanitas University
(P 203) MINIMALLY INVASIVE RESECTION OF MULTIFOCAL DUODENO-JEJUNAL GISTS IN NEUROFIBROMATOSIS TYPE 1
Marta Casiraghi
Favorite
Casotti, Chiara

IRCCS Rizzoli Orthopaedic Institute
(P 18) ESTABLISHMENT AND CHARACTERIZATION OF A NOVEL PRIMARY CELL LINE FROM A BONE METASTASIS OF OSTEOSARCOMA
Chiara Casotti
Favorite
Castaneda-Wysocka, Patrycja

Maria Sklodowska-Curie National Research Institute of Oncology; Warsaw Poland
(P 216) VIRTUAL MULTIDISCIPLINARY MEETINGS IN THE CARE OF SARCOMA PATIENTS
Patrycja Castaneda-Wysocka
Favorite
Castilho, Marcus

Grupo Oncoclinicas
(P 285) MULTICENTER STUDY OF SPATIALLY FRACTIONATED RADIOTHERAPY (LATTICE) FOR LARGE-VOLUME RADIORESISTANT SARCOMAS
Marcus Castilho
Favorite
Castillo-Portellano, Lucia

Hospital Universitario Virgen de la Nieves
(P 389) UNRESECTABLE AND METASTATIC DEDIFFERENTIATED LIPOSARCOMA (DDLPS): INSIGHTS FROM A MULTICENTER REAL-WORLD COHORT (RWC)
Lucia Castillo-Portellano
Favorite
Catalano, Sabrina

The Ohio State University College of Medicine
(P 335) OUTCOMES OF TALIMOGENE LAHERPAREPVEC IN SOFT TISSUE SARCOMA
Sabrina Catalano
Favorite
Catin Kupper, Bruna Elisa

A.C.Camargo Cancer Center
(P 278) NEOADJUVANT HYPOFRACTIONATED RADIOTHERAPY AND CHEMOTHERAPY IN EXTREMITY SOFT TISSUE SARCOMAS
Bruna Elisa Catin Kupper
Favorite
Cattini, Luca

IRCCS Rizzoli Orthopaedic Institute
(P 18) ESTABLISHMENT AND CHARACTERIZATION OF A NOVEL PRIMARY CELL LINE FROM A BONE METASTASIS OF OSTEOSARCOMA
Luca Cattini
Favorite
Cavalcante, Ludimila

Division of Hematology and Oncology, University of Virginia Comprehensive Cancer Center, Charlottesville, Virginia, USA
(P 199) CHARACTERISTICS OF AN IMMUNOHISTOCHEMICAL AND MOLECULARLY DISCORDANT POPULATION OF GIST PATIENTS: A SINGLE CENTER RETROSPECTIVE REVIEW
Ludimila Cavalcante
Favorite
(P 404) OUTCOMES OF NEOADJUVANT THERAPY IN ANGIOSARCOMA PATIENTS: A KAPLAN-MEIER-RECONSTRUCTED INDIVIDUAL PATIENT-LEVEL META-ANALYSIS
Ludimila Cavalcante
Favorite
Cavaliere, Silvia

Fondazione Policlinico Universitario Campus Bio-Medico
(P 61) HER2 TARGETING IN CHORDOMA: PRECLINICAL INSIGHTS ON TRASTUZUMAB DERUXTECAN
Silvia Cavaliere
Favorite
Cavallo, Anna

Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan
(P 277) THE ROLE OF RADIOTHERAPY IN THE MULTIDISCIPLINARY MANAGEMENT OF RADIATION-ASSOCIATED ANGIOSARCOMA OF THE BREAST: A REFERRAL CENTER EXPERIENCE
Anna Cavallo
Favorite
Cavanaugh, Kerri

Dana-Farber Cancer Institute
(P 427) PHASE 1/2 TRIAL TO EVALUATE THE SAFETY AND EFFICACY OF PEEL-224 IN COMBINATION WITH VINCRISTINE AND TEMOZOLOMIDE IN ADOLESCENTS AND YOUNG ADULTS WITH RELAPSED OR REFRACTORY SARCOMAS
Kerri Cavanaugh
Favorite
Cazes, Romain

Institut Universitaire du Cancer de Toulouse
(P 12) DNA REPLICATION STRESS AND DEFICIENT HOMOLOGOUS RECOMBINATION IN OSTEOSARCOMA RISK AND THERAPY
Romain Cazes
Favorite
Cecchini, Michael

Yale University School of Medicine
(P 415) A PHASE 1/2 TRIAL OF FOG-001, A FIRST-IN-CLASS DIRECT β-CATENIN:TCF4 INHIBITOR: SAFETY AND PRELIMINARY ANTITUMOR ACTIVITY IN PATIENTS WITH DESMOID TUMORS (DT)
Michael Cecchini
Favorite
Chabot, Ashley

St. Jude Children's Research Hospital
(P 241) MACROPHAGE INHIBITION ENHANCES PERIPHERAL CAR T CELL EXPANSION AND TUMOR CONTROL IN A PATIENT-DERIVED HUMANIZED MODEL OF AUTOLOGOUS CAR T CELL EFFICACY IN PEDIATRIC OSTEOSARCOMA (OS)
Ashley Chabot
Favorite
Chainsukh Loya, Anand

Department of Pathology, Copenhagen University Hospital, Rigshospitalet
(P 05) CONCORDANCE OF GENOMIC ALTERATIONS WITH CIRCULATING TUMOR DNA: INITIAL FINDINGS FROM A PILOT STUDY
Anand Chainsukh Loya
Favorite
Chaire, Vanessa

Institut Bergonié
(P 59) TARGETING ADORA2B TO HALT METASTASIS IN UNDIFFERENTIATED PLEOMORPHIC SARCOMA: FROM MULTI-OMICS TO THERAPEUTIC INHIBITION
Vanessa Chaire
Favorite
Chakrabarty, Nivedita

Tata Memorial Hospital
(P 387) TREATMENT PATTERNS AND PROGNOSTIC FACTORS IN LOCALISED SYNOVIAL SARCOMA: A RETROSPECTIVE STUDY FROM A TERTIARY CANCER CENTRE IN INDIA
Nivedita Chakrabarty
Favorite
(P 438) RANDOMIZED, OPEN-LABEL, PHASE III TRIAL OF ADJUVANT CHEMOTHERAPY VERSUS OBSERVATION IN NON-METASTATIC, HIGH-RISK SOFT TISSUE SARCOMAS (ACO-SARC TRIAL)
Nivedita Chakrabarty
Favorite
Chalmers, Anna

Huntsman Cancer Institute
(P 357) DEVELOPMENT OF AN ALGORITHM TO IDENTIFY PATIENTS (PT) WITH DESMOID TUMORS (DT) IN A UNITED STATES (US) CLAIMS DATASET
Anna Chalmers
Favorite
Chamberlain, Victoria

Newcastle University
(P 133) INVESTIGATION OF COMBINING MDM2 INHIBITORS WITH DR5 AGONISTS FOR BONE SARCOMA TREATMENT
Victoria Chamberlain
Favorite
Champiat, Stephane

Department of Investigational Cancer Therapeutics, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center
(P 431) INVOKE: A PHASE 1 STUDY OF OKN4395, A FIRST-IN-CLASS EP2/EP4/DP1 TRIPLE PROSTANOID RECEPTOR ANTAGONIST, IN PATIENTS WITH ADVANCED SOLID TUMORS, INCLUDING SARCOMAS
Stephane Champiat
Favorite
Chan, Corey

Newcastle University Translational and Clinical Research Institute
(P 135) EXPLORING THE ROLE OF CLUSTER OF DIFFERENTIATION 44 IN CHONDROSARCOMA
Corey Chan
Favorite
Chan, Corey

Newcastle University Translational and Clinical Research Institute, United Kingdom
(P 314) AN INTERNATIONAL, MULTI-CENTRE STUDY OF SURGICAL MARGINS IN INTERMEDIATE TO HIGH GRADE SARCOMA
Corey Chan
Favorite
Chandana, Sreenivasa

START Midwest, The Cancer & Hematology Centers
(P 424) AN OPEN-LABEL PHASE 1/2 STUDY OF DCC-3009 MONOTHERAPY IN PATIENTS (PTS) WITH ADVANCED GASTROINTESTINAL STROMAL TUMOR (GIST)
Sreenivasa Chandana
Favorite
Chandra, Sanyogita

University of Iowa Health Care
(P 370) CLINICAL OUTCOMES OF CUTANEOUS UNDIFFERENTIATED PLEOMORPHIC SARCOMA AND SUBCUTANEOUS MYXOFIBROSARCOMA: A RETROSPECTIVE REVIEW
Sanyogita Chandra
Favorite
Chandrasekaran, Sanjay

University of Texas Southwestern Medical School
(P 280) PERSONALIZED ULTRA-FRACTIONATED STEREOTACTIC ADAPTIVE RADIOTHERAPY (PULSAR) FOR ADULT AND PEDIATRIC SARCOMAS
Sanjay Chandrasekaran
Favorite
Chandrashekaran, Sanjay

University of Texas Southwestern Medical Center
(P 03) CONGRUENCE OF CIRCULATING TUMOR DNA & RADIOGRAPHIC RESPONSE IN BONE AND SOFT TISSUE SARCOMA
Sanjay Chandrashekaran
Favorite
Chang, Connie Y.

Division of Musculoskeletal Radiology, Massachusetts General Hospital
(P 294) RISK FACTORS FOR RECURRENCE AND COMPLICATIONS OF CT-GUIDED RADIOFREQUENCY ABLATION FOR THE TREATMENT OF OSTEOID OSTEOMA: A MULTI-INSTITUTIONAL ANALYSIS.
Connie Y. Chang
Favorite
Chang, Yu-Cherng Channing

University of Miami Hospital, Department of Radiology
(P 201) METASTATIC PATTERNS, TREATMENT MODALITIES, AND OVERALL SURVIVAL IN OLIGOMETASTATIC GIST: A SINGLE-CENTER RETROSPECTIVE STUDY
Yu-Cherng Channing Chang
Favorite
Chan, Jason

Memorial Sloan-Kettering Cancer Center, Weill-Cornell Medical College
(P 187) THERAPEUTIC OUTCOMES IN NF1-ALTERED GIST TREATED WITH MEK INHIBITION: A SINGLE-CENTER EXPERIENCE
Jason Chan
Favorite
(P 467) TREATMENT OUTCOMES IN AGGRESSIVE ANGIOMYXOMA: A SINGLE INSTITUTION EXPERIENCE
Jason Chan
Favorite
Charles, Fadia

University of Miami/Sylvester Comprehensive Cancer Center
(P 225) GLOBAL REGISTRY OF SOLITARY FIBROUS TUMORS (SFT): INTEGRATING CLINICAL, MOLECULAR, AND ENVIRONMENTAL DATA- THE HOROWITZ SFT INITIATIVE (HSFTI)
Fadia Charles
Favorite
Charlson, John

Medical College of Wisconsin
(P 195) IMPACT OF EXPERT-LED EDUCATION PROGRAMS ON HEALTH CARE PROVIDER (HCP) KNOWLEDGE OF GASTROINTESTINAL STROMAL TUMOR (GIST)
John Charlson
Favorite
Charton, Connor

Vanderbilt University School of Medicine
(P 97) RISK FACTORS ASSOCIATED WITH AMPUTATION VERSUS CONTINUED LIMB SALVAGE IN LOWER EXTREMITY ENDOPROSTHETIC RECONSTRUCTION
Connor Charton
Favorite
Charville, Greg

Stanford University
(P 37) DISSECTING THE TUMOR MICROENVIRONMENT OF UTERINE LEIOMYOSARCOMAS FOR TARGETED DRUG PREDICTIONS
Greg Charville
Favorite
(P 400) LONGITUDINAL EPIGENETIC AND TRANSCRIPTOMIC REMODELING ACROSS PRIMARY, IRRADIATED, AND LOCALLY RELAPSED SOFT TISSUE SARCOMAS
Greg Charville
Favorite
(P 466) PATHOGENESIS AND THERAPEUTIC TARGETS IN KERATIN-POSITIVE GIANT CELL-RICH TUMOR
Greg Charville
Favorite
Chatfield, Jay

Cogent Biosciences
(P 425) BEZUCLASTINIB EXPANDED ACCESS PROGRAM (EAP) FOR PATIENTS WITH GASTROINTESTINAL STROMAL TUMORS (GIST)
Jay Chatfield
Favorite
Chattopadhyay, Priya

University of Miami/Jackson Health System
(P 217) PATIENT QUESTIONNAIRE EXPLORING THE PRE-SARCOMA DIAGNOSIS CHARACTERISTICS OF SARCOMA PATIENTS
Priya Chattopadhyay
Favorite
(P 224) PAN-SARCOMA DATABASE (PSDB): AN UPDATE ON MIAMI'S COLLABORATIVE MULTI-USER DATA PIPELINE OF SARCOMA DATA USING REDCAP AND R CODING
Priya Chattopadhyay
Favorite
Chattopadhyay, Priya

Jackson Memorial Hospital/University of Miami Internal Medicine Program
(P 320) CLINICAL CHARACTERISTICS AND RECURRENCE PATTERNS IN HISPANIC VS. NON-HISPANIC PATIENTS WITH LEIOMYOSARCOMA: FINDINGS FROM A RETROSPECTIVE SINGLE-CENTER COHORT STUDY
Priya Chattopadhyay
Favorite
Chattopadhyay, Priya

University of Miami/Jackson Health System
(P 327) INITIAL TREATMENT MODALITY AND RECURRENCE IN NON-METASTATIC LEIOMYOSARCOMA: A RETROSPECTIVE COHORT STUDY
Priya Chattopadhyay
Favorite
(P 333) METABOLIC SYNDROME CORRELATION WITH LIPOSARCOMA INCIDENCE AND OUTCOMES: A RETROSPECTIVE ANALYSIS.
Priya Chattopadhyay
Favorite
Chattopadhyay, Priya

Jackson Memorial Hospital/University of Miami Internal Medicine Program
(P 362) SHOULD PAZOPANIB BE USED AS A MAINTENANCE THERAPY TO IMPROVE RECURRENCE-FREE SURVIVAL AND OVERALL SURVIVAL IN PATIENTS WHO RECEIVED MAI IN SOFT TISSUE SARCOMA?
Priya Chattopadhyay
Favorite
Chattopadhyay, Priya

University of Miami/Jackson Health System
(P 397) EXPLORING REAL WORLD DATA OF RECURRENCE IN NON-METASTATIC MYXOFIBROSAROMA: AN UPDATED RETROSPECTIVE COHORT STUDY
Priya Chattopadhyay
Favorite
Chaudhary, Sahil

University of Virginia
(P 199) CHARACTERISTICS OF AN IMMUNOHISTOCHEMICAL AND MOLECULARLY DISCORDANT POPULATION OF GIST PATIENTS: A SINGLE CENTER RETROSPECTIVE REVIEW
Sahil Chaudhary
Favorite
Chaudhry, Sumra

University of Colorado School of Medicine
(P 234) DOXORUBICIN PLUS BOTENSILIMAB, A NEXT GENERATION CTLA4 INHIBITOR, WITH OR WITHOUT BALSTILIMAB, A PD1 INHIBITOR, IN PATIENTS WITH ADVANCED SOFT TISSUE SARCOMAS
Sumra Chaudhry
Favorite
Chaves, Roberta

Medical Faculty. Faculdade de Ciências Médicas de Minas Gerais (FCMMG)
(P 285) MULTICENTER STUDY OF SPATIALLY FRACTIONATED RADIOTHERAPY (LATTICE) FOR LARGE-VOLUME RADIORESISTANT SARCOMAS
Roberta Chaves
Favorite
Chawla, Neal

Sarcoma Oncology Center
(P 233) DNG64-CAR-V+ REGIMEN SHOWS CLINICAL BENEFIT IN PATIENTS WITH ADVANCED CCNG1 ONCOGENE EXPRESSING SARCOMAS (NCT04091295)
Neal Chawla
Favorite
(P 388) TRIAL IN PROGRESS: A PHASE 2 STUDY OF METRONOMIC TRABECTEDIN, GEMCITIBAINE, AND DACARBAZINE IN PREVIOUSLY TREATED ADVANCED SOFT TISSUE SARCOMA (NCT04535271)
Neal Chawla
Favorite
(P 396) EVALUATING THE SAFETY AND EFFICACY OF METRONOMIC GEMCITABINE, DOXORUBICIN, AND DOCETAXEL PLUS NIVOLUMAB IN PREVIOUSLY TREATED ADVANCED LEIOMYOSARCOMA AND LIPOSARCOMA: A PHASE 2 STUDY (NCT04535713)
Neal Chawla
Favorite
(P 398) INVESTIGATING THE SAFETY AND EFFICACY OF LURBINECTEDIN WITH IPILIMUMAB AND NIVOLUMAB FOR ADVANCED SOFT TISSUE SARCOMA: LINNOVATE PHASE 1/2 STUDY (NCT05876715)
Neal Chawla
Favorite
(P 431) INVOKE: A PHASE 1 STUDY OF OKN4395, A FIRST-IN-CLASS EP2/EP4/DP1 TRIPLE PROSTANOID RECEPTOR ANTAGONIST, IN PATIENTS WITH ADVANCED SOLID TUMORS, INCLUDING SARCOMAS
Neal Chawla
Favorite
(P 432) EXPANSION OF A PHASE 1 STUDY OF SON-1010 (IL12-FHAB) ADDING TRABECTEDIN IN SOFT TISSUE SARCOMA: TRIAL IN PROGRESS
Neal Chawla
Favorite
Chawla, Sant

Sarcoma Oncology Center
(P 233) DNG64-CAR-V+ REGIMEN SHOWS CLINICAL BENEFIT IN PATIENTS WITH ADVANCED CCNG1 ONCOGENE EXPRESSING SARCOMAS (NCT04091295)
Sant Chawla
Favorite
(P 388) TRIAL IN PROGRESS: A PHASE 2 STUDY OF METRONOMIC TRABECTEDIN, GEMCITIBAINE, AND DACARBAZINE IN PREVIOUSLY TREATED ADVANCED SOFT TISSUE SARCOMA (NCT04535271)
Sant Chawla
Favorite
(P 396) EVALUATING THE SAFETY AND EFFICACY OF METRONOMIC GEMCITABINE, DOXORUBICIN, AND DOCETAXEL PLUS NIVOLUMAB IN PREVIOUSLY TREATED ADVANCED LEIOMYOSARCOMA AND LIPOSARCOMA: A PHASE 2 STUDY (NCT04535713)
Sant Chawla
Favorite
(P 398) INVESTIGATING THE SAFETY AND EFFICACY OF LURBINECTEDIN WITH IPILIMUMAB AND NIVOLUMAB FOR ADVANCED SOFT TISSUE SARCOMA: LINNOVATE PHASE 1/2 STUDY (NCT05876715)
Sant Chawla
Favorite
(P 432) EXPANSION OF A PHASE 1 STUDY OF SON-1010 (IL12-FHAB) ADDING TRABECTEDIN IN SOFT TISSUE SARCOMA: TRIAL IN PROGRESS
Sant Chawla
Favorite
Chen, Abigail

MGH
(P 392) CLASSIFICATION AND DIFFERENTIATIONOF MYXOID LIPOSARCOMA AND MYXOMA WITH MACHINE LEARNING
Abigail Chen
Favorite
(P 392) DIFFERENTIATION OF MYXOMA AND MYXOID LIPOSARCOMA BASED ON RADIOMICS PHENOTYPES
Abigail Chen
Favorite
Chen, Anni

The First Affiliated Hospital of Sun Yat-sen University
(P 193) CLINICAL ANALYSIS OF RIPRETINIB DOSE ESCALATION IN ADVANCED GISTS AFTER STANDARD DOSE PROGRESSION
Anni Chen
Favorite
Chenard, Stephen

Vanderbilt University School of Medicine
(P 84) A MULTICENTER COMPARISON OF REVERSE TOTAL SHOULDER ARTHROPLASTY VERSUS HEMIARTHROPLASTY FOR ENDOPROSTHETIC RECONSTRUCTION FOLLOWING ONCOLOGIC RESECTION OF THE PROXIMAL HUMERUS
Stephen Chenard
Favorite
Chenard, Stephen

Vanderbilt University Medical Center
(P 85) MAKING NEGATIVE MARGIN MUSCULOSKELETAL TUMOR SURGERY A VIRTUAL REALITY USING 3D SPECIMEN SCANNING
Stephen Chenard
Favorite
Chenard, Stephen

Vanderbilt University School of Medicine
(P 97) RISK FACTORS ASSOCIATED WITH AMPUTATION VERSUS CONTINUED LIMB SALVAGE IN LOWER EXTREMITY ENDOPROSTHETIC RECONSTRUCTION
Stephen Chenard
Favorite
Chen, Benjamin Jieming

A*STAR Institute of Molecular and Cell Biology (A*STAR IMCB)
(P 53) ESTABLISHMENT AND CHARACTERISATION OF LIPOSARCOMA-DERIVED CELLS AS RELEVANT PRE-CLINICAL MODELS FOR TARGET DISCOVERY
Benjamin Jieming Chen
Favorite
Cheng, Edward

University of Minnesota
(P 418) INTEGRATING SARCULATOR AND PET RESPONSE TO GUIDE NEOADJUVANT TREATMENT DECISIONS IN HIGH-RISK SOFT TISSUE SARCOMA
Edward Cheng
Favorite
Cheng, Zhiwei

Department of Orthopaedics, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
(P 07) A LIVING MULTI-OMICS BIOBANK OF PATIENT-DERIVED XENOGRAFT MODELS FOR SARCOMA
Zhiwei Cheng
Favorite
Chen, James

The Ohio State University
(P 170) GEMSARC: AN AI BASED PREDICTIVE GENE SIGNATURE FOR GEMCITABINE EFFICACY IN ADVANCED SOFT-TISSUE SARCOMAS
James Chen
Favorite
(P 408) REAL-WORLD SINGLE-CENTER INSIGHTS INTO CT-DNA DYNAMICS ACROSS SOFT TISSUE SARCOMAS
James Chen
Favorite
Chen, Larry

Indiana University School of Medicine
(P 269) INCIDENCE OF MALIGNANCY IN BIOPSIED PEDIATRIC SOFT TISSUE MASSES
Larry Chen
Favorite
(P 272) THE HAZARDS OF BIOPSY IN PEDIATRIC SOFT TISSUE SARCOMAS
Larry Chen
Favorite
Chen, Nan

Boston Children's Hospital
(P 427) PHASE 1/2 TRIAL TO EVALUATE THE SAFETY AND EFFICACY OF PEEL-224 IN COMBINATION WITH VINCRISTINE AND TEMOZOLOMIDE IN ADOLESCENTS AND YOUNG ADULTS WITH RELAPSED OR REFRACTORY SARCOMAS
Nan Chen
Favorite
Chen, Ruohui

Northwestern University Feinberg School of Medicine
(P 183) ACTIONABLE GENOMICS IN GASTROINTESTINAL STROMAL TUMORS LACKING KIT OR PDGFRA MUTATIONS.
Ruohui Chen
Favorite
Chen, Tom Wei-Wu

National Taiwan University Cancer Center and National Taiwan University, Taipei, Taiwan
(P 416) A PHASE 2 MULTICENTER OPEN-LABEL BASKET STUDY OF TAZEMETOSTAT IN ADULT PATIENTS WITH INI1-NEGATIVE EPITHELIOID SARCOMA – FINAL ANALYSIS
Tom Wei-Wu Chen
Favorite
(P 428) MAINTENANCE PEGYLATED LIPOSOMAL DOXORUBICIN VERSUS ACTIVE SURVEILLANCE FOR ADVANCED SOFT TISSUE SARCOMA PATIENTS WHO HAD CONTROLLED DISEASE AFTER STANDARD ANTHRACYCLINE-BASED TREATMENT (MELODY)
Tom Wei-Wu Chen
Favorite
Chen, Yingxue

Ipsen, Cambridge, MA, USA
(P 416) A PHASE 2 MULTICENTER OPEN-LABEL BASKET STUDY OF TAZEMETOSTAT IN ADULT PATIENTS WITH INI1-NEGATIVE EPITHELIOID SARCOMA – FINAL ANALYSIS
Yingxue Chen
Favorite
Chen, Yung Hsin

Massachusetts General Hospital
(P 392) CLASSIFICATION AND DIFFERENTIATIONOF MYXOID LIPOSARCOMA AND MYXOMA WITH MACHINE LEARNING
Yung Hsin Chen
Favorite
(P 392) DIFFERENTIATION OF MYXOMA AND MYXOID LIPOSARCOMA BASED ON RADIOMICS PHENOTYPES
Yung Hsin Chen
Favorite
Cherlin, Svetlana

Newcastle University
(P 314) AN INTERNATIONAL, MULTI-CENTRE STUDY OF SURGICAL MARGINS IN INTERMEDIATE TO HIGH GRADE SARCOMA
Svetlana Cherlin
Favorite
Cheung, Alexander

UCSF Helen Diller Family Comprehensive Cancer Center
(P 439) AN OPEN LABEL MULTICENTER PHASE 2 STUDY WITH SAFETY LEAD IN OF INTRATUMORAL VUSOLIMOGENE ODERPAREPVEC IN COMBINATION WITH PEMBROLIZUMAB IN PATIENTS WITH ANGIOSARCOMA
Alexander Cheung
Favorite
Chia, Claramae Shulyn

National Cancer Center Singapore
(P 53) ESTABLISHMENT AND CHARACTERISATION OF LIPOSARCOMA-DERIVED CELLS AS RELEVANT PRE-CLINICAL MODELS FOR TARGET DISCOVERY
Claramae Shulyn Chia
Favorite
chibon, frederic

INSERM
(P 20) IDENTIFICATION OF A PROGNOSTIC GENE SIGNATURE FOR OSTEOSARCOMA RELAPSE BASED ON RESIDUAL TUMOR DISEASE AND ITS MICROENVIRONMENT
frederic chibon
Favorite
(P 28) ADVANCING PRECISION ONCOLOGY IN SOFT TISSUE SARCOMAS: THE ROLE OF ITRAC IN METASTATIC RISK STRATIFICATION AND TREATMENT PERSONALIZATION
frederic chibon
Favorite
Chilakapati, Lalitha

Clinical Safety & Pharmacovigilance, Daiichi Sankyo, Inc., Basking Ridge, NJ, USA
(P 336) PEXIDARTINIB RISK EVALUATION AND MITIGATION STRATEGY PROGRAM: 5-YEAR RETROSPECTIVE HEPATIC SAFETY ASSESSMENT
Lalitha Chilakapati
Favorite
Chinnaswammy, Girish

Tata Memorial Hospital
(P 292) CRANIOVERTEBRAL EWINGS SARCOMA WITH MENINGEAL INFILTRATION - A CLINICAL OUTCOME ANALYSIS
Girish Chinnaswammy
Favorite
(P 379) IMPACT OF EWSR1 GENE REARRANGEMENT TESTING ON DIAGNOSIS OF A WIDE RANGE OF SOLID TUMOURS
Girish Chinnaswammy
Favorite
Chi, Ping

Memorial Sloan Kettering Cancer Center and Weill Cornell Medicine
(P 186) BRAF V600E-MUTATED GASTROINTESTINAL STROMAL TUMORS: A CASE SERIES AND ANALYSIS OF IMMUNE TUMOR INFILTRATE
Ping Chi
Favorite
(P 187) THERAPEUTIC OUTCOMES IN NF1-ALTERED GIST TREATED WITH MEK INHIBITION: A SINGLE-CENTER EXPERIENCE
Ping Chi
Favorite
(P 409) RETROSPECTIVE ANALYSIS OF PROGNOSTIC FACTORS INCLUDING HLA GENOTYPE IN MYXOID LIPOSARCOMA
Ping Chi
Favorite
(P 424) AN OPEN-LABEL PHASE 1/2 STUDY OF DCC-3009 MONOTHERAPY IN PATIENTS (PTS) WITH ADVANCED GASTROINTESTINAL STROMAL TUMOR (GIST)
Ping Chi
Favorite
(P 467) TREATMENT OUTCOMES IN AGGRESSIVE ANGIOMYXOMA: A SINGLE INSTITUTION EXPERIENCE
Ping Chi
Favorite
Chitneedi, Sujani

Clinical Safety & Pharmacovigilance, Daiichi Sankyo, Inc., Basking Ridge, NJ, USA
(P 336) PEXIDARTINIB RISK EVALUATION AND MITIGATION STRATEGY PROGRAM: 5-YEAR RETROSPECTIVE HEPATIC SAFETY ASSESSMENT
Sujani Chitneedi
Favorite
Choi, Wonyoung

National Cancer Center
(P 419) PROSPECTIVE REAL-WORLD STUDY OF LAROTRECTINIB (LARO) IN PATIENTS (PTS) WITH TRK FUSION SOLID TUMORS: INTERIM ANALYSIS OF ON-TRK
Wonyoung Choi
Favorite
Cho, Jacqueline

Weill Cornell Medical College
(P 273) RADIOMIC PREDICTORS OF SPONTANEOUS PNEUMOTHORAX DURING TYROSINE KINASE INHIBITOR THERAPY FOR LUNG METASTASES
Jacqueline Cho
Favorite
Choo, Joan Rou-En

Memorial Sloan Kettering Cancer Center
(P 237) DEVELOPMENT OF EPHA2 CAR T CELL THERAPY FOR OSTEOSARCOMA
Joan Rou-En Choo
Favorite
Chose, Chloe

USF Morsani College of Medicine
(P 140) REFINING PRE-SURGICAL ASSESSMENT OF LONG-BONE CHONDROSARCOMA THROUGH THE RADIOLOGIC AGGRESSIVENESS SCORE
Chloe Chose
Favorite
(P 141) A RETROSPECTIVE ANALYSIS OF THE BIRMINGHAM ATYPICAL CARTILAGE TUMOUR IMAGING PROTOCOL (BACTIP) IN MANAGING CENTRAL CARTILAGE TUMORS OF THE LONG BONES
Chloe Chose
Favorite
(P 142) ARE THERE INDEPENDENT PREDICTORS OF DEDIFFERENTIATED CHONDROSARCOMA ON MAGNETIC RESONANCE IMAGING? A MULTIVARIATE ANALYSIS
Chloe Chose
Favorite
(P 145) PATHOLOGIC FRACTURE IN CHONDROSARCOMA OF LONG BONES: A RETROSPECTIVE COHORT STUDY
Chloe Chose
Favorite
(P 160) A COMPARATIVE ANALYSIS OF DEDIFFERENTIATED AND CONVENTIONAL CHONDROSARCOMA OUTCOMES
Chloe Chose
Favorite
(P 163) CHONDROSARCOMA IN THE AYA POPULATION
Chloe Chose
Favorite
Chose, Chloe

USF Health Morsani College of Medicine
(P 375) DOES STAGED RESECTION WITH TEMPORIZING WOUND VACUUM INFLUENCE LOCAL RECURRENCE RISK? A MULTI-INSTITUTIONAL MATCHED COHORT ANALYSIS
Chloe Chose
Favorite
Choudhari, Amit

Tata Memorial Hospital, Tata memorial Centre, Mumbai
(P 292) CRANIOVERTEBRAL EWINGS SARCOMA WITH MENINGEAL INFILTRATION - A CLINICAL OUTCOME ANALYSIS
Amit Choudhari
Favorite
Choudhary, Sania

The EHE Foundation
(P 449) UNDERSTANDING GAPS IN KNOWLEDGE AND PATIENT-REPORTED PAIN IN EPITHELIOID HEMANGIOENDOTHELIOMA: RESULTS FROM A GLOBAL PATIENT REGISTRY
Sania Choudhary
Favorite
Chowdhry, Varun

Roswell Park Comprehensive Cancer Center
(P 340) PREDICTORS OF LATE RECURRENCE AFTER SARCOMA SURGICAL RESECTION
Varun Chowdhry
Favorite
Choy, Edwin

Mass General Cancer Center, Massachusetts General Hospital
(P 45) MONITORING EWSR1 FUSIONS IN SARCOMA PATIENTS USING PERSONALIZED LIQUID BIOPSY ASSAYS
Edwin Choy
Favorite
(P 290) CLINICAL OUTCOMES AFTER RADIOTHERAPY FOR PATIENTS WITH POORLY DIFFERENTIATED CHORDOMA
Edwin Choy
Favorite
(P 315) ANALYSIS OF CHANGES IN T2-WEIGHTED SIGNAL INTENSITY AND TUMOR VOLUME AND EXPOSURE-RESPONSE IN THE RINGSIDE PHASE 2 STUDY OF VAREGACESTAT FOR DESMOID TUMORS
Edwin Choy
Favorite
(P 410) SUBGROUP ANALYSIS OF THE PHASE 2 PART OF THE RINGSIDE PHASE 2/3 TRIAL OF VAREGACESTAT FOR TREATMENT OF DESMOID TUMORS
Edwin Choy
Favorite
(P 461) A RETROSPECTIVE ANALYSIS OF PATIENTS WITH CONVENTIONAL CHORDOMA TREATED WITH SYSTEMIC THERAPY
Edwin Choy
Favorite
Cho, Yoon Joo

Department of Orthopedic Surgery, St. Vincent’s Hospital, College of Medicine, The Catholic University of Korea
(P 176) DEEP LEARNING MODEL FOR DIFFERENTIATING BETWEEN NEOPLASTIC PATHOLOGIC FRACTURE AND NONPATHOLOGIC FRACTURE FROM PLAIN HIP RADIOGRAPHS
Yoon Joo Cho
Favorite
Cho, Young-Eun

Korean Cell Line Bank, Laboratory of Cell Biology, Cancer Research Institute, Seoul National University
(P 09) ESTABLISHMENT AND CHARACTERIZATION OF 18 SARCOMA CELL LINES: UNRAVELING THE MOLECULAR MECHANISMS OF DOXORUBICIN RESISTANCE IN SARCOMA CELL LINES
Young-Eun Cho
Favorite
Chrisinger, John

Washington Universit
(P 466) PATHOGENESIS AND THERAPEUTIC TARGETS IN KERATIN-POSITIVE GIANT CELL-RICH TUMOR
John Chrisinger
Favorite
Christ, Alexander

Department of Orthopaedic Surgery, University of California Los Angeles
(P 16) MITOCHONDRIAL GENETIC VARIATION ORCHESTRATES COPZ1 TRANSCRIPT HETEROGENEITY AND REVEALS TELOMERE-MEDIATED VULNERABILITIES IN OSTEOSARCOMA
Alexander Christ
Favorite
(P 72) COUNTY-LEVEL ASSOCIATIONS BETWEEN AIRBORNE TOXICANT EMISSIONS AND EWING SARCOMA DIAGNOSIS IN THE UNITED STATES
Alexander Christ
Favorite
(P 81) ASSESSING PROGNOSTIC FACTORS OF CAUSE-SPECIFIC SURVIVAL IN PATIENTS WITH MALIGNANT GIANT CELL TUMORS: A POPULATION BASED STUDY FROM THE SEER DATABASE
Alexander Christ
Favorite
(P 92) PRIMARY TUMOR SIZE AS AN INDEPENDENT PROGNOSTIC FACTOR IN OSTEOSARCOMA: PROPENSITY SCORE-MATCHED ANALYSIS DEMONSTRATES A CONTINUOUS DOSE-RESPONSE RELATIONSHIP
Alexander Christ
Favorite
(P 100) THE ROLE OF CANCER TYPE IN THE DEVELOPMENT OF PERIPROSTHETIC JOINT INFECTION IN DISTAL FEMORAL REPLACEMENT
Alexander Christ
Favorite
(P 107) IS THERE A BETTER OPTION: INTRAMEDULLARY NAIL VERSUS PLATE OSTEOSYNTHESIS FOR PATHOLOGIC HUMERAL FRACTURES?
Alexander Christ
Favorite
(P 108) DISTANCE WEIGHTED MATCHING IN THE QUANTIFICATION OF EXCESS MORBIDITY IN EXTERNAL HEMIPELVECTOMY AND HIP DISARTICULATION
Alexander Christ
Favorite
(P 157) INCOME IMPACTS OVERALL BUT NOT CAUSE-SPECIFIC SURVIVAL IN PATIENTS WITH CHONDROSARCOMA: A POPULATION BASED STUDY FROM THE SEER DATABASE
Alexander Christ
Favorite
(P 232) IS THERE A ROLE FOR POSITRON EMISSION TOMOGRAPHY IN THE STAGING OF LANGERHANS CELL HISTIOCYTOSIS?
Alexander Christ
Favorite
(P 384) PELVIC LOCATION PREDICTS WORSE OUTCOMES IN ALVEOLAR RHABDOMYOSARCOMA: UNDERUSE OF RADIOTHERAPY AND MISSED SURVIVAL BENEFIT
Alexander Christ
Favorite
Christison-Lagay, Emily

Yale School of Medicine
(P 40) PRECLINICAL EFFICACY OF A PH-SENSITIVE EXATECAN PEPTIDE-DRUG-CONJUGATE IN RHABDOMYOSARCOMA
Emily Christison-Lagay
Favorite
Christo, Jessica

IDRx
(P 194) UPDATED RESULTS FROM STRATEGIST 1: A PHASE 1/1B STUDY OF IDRX-42 (GSK6042981A) IN PATIENTS (PTS) WITH ADVANCED GASTROINTESTINAL STROMAL TUMORS (GIST)
Jessica Christo
Favorite
Chuang, Jeffrey

PIVOT Coordinating Center
(P 267) THE RAF/MEK INHIBITOR VS-6766 SHOWS EFFICACY IN RAS-MUTANT PEDIATRIC PRECLINICAL XENOGRAFT MODELS- A REPORT FROM THE PEDIATRIC PRECLINICAL IN VIVO TESTING CONSORTIUM
Jeffrey Chuang
Favorite
Chua, Victoria

Sarcoma Oncology Center
(P 388) TRIAL IN PROGRESS: A PHASE 2 STUDY OF METRONOMIC TRABECTEDIN, GEMCITIBAINE, AND DACARBAZINE IN PREVIOUSLY TREATED ADVANCED SOFT TISSUE SARCOMA (NCT04535271)
Victoria Chua
Favorite
(P 396) EVALUATING THE SAFETY AND EFFICACY OF METRONOMIC GEMCITABINE, DOXORUBICIN, AND DOCETAXEL PLUS NIVOLUMAB IN PREVIOUSLY TREATED ADVANCED LEIOMYOSARCOMA AND LIPOSARCOMA: A PHASE 2 STUDY (NCT04535713)
Victoria Chua
Favorite
(P 398) INVESTIGATING THE SAFETY AND EFFICACY OF LURBINECTEDIN WITH IPILIMUMAB AND NIVOLUMAB FOR ADVANCED SOFT TISSUE SARCOMA: LINNOVATE PHASE 1/2 STUDY (NCT05876715)
Victoria Chua
Favorite
(P 432) EXPANSION OF A PHASE 1 STUDY OF SON-1010 (IL12-FHAB) ADDING TRABECTEDIN IN SOFT TISSUE SARCOMA: TRIAL IN PROGRESS
Victoria Chua
Favorite
Chugh, Rashmi

University of Michigan Rogel Comprehensive Cancer Center
(P 227) TREATMENT PATTERNS IN PATIENTS WITH TENOSYNOVIAL GIANT CELL TUMORS: ADDRESSING COMMUNICATION IN A NEW THERAPEUTIC LANDSCAPE
Rashmi Chugh
Favorite
(P 315) ANALYSIS OF CHANGES IN T2-WEIGHTED SIGNAL INTENSITY AND TUMOR VOLUME AND EXPOSURE-RESPONSE IN THE RINGSIDE PHASE 2 STUDY OF VAREGACESTAT FOR DESMOID TUMORS
Rashmi Chugh
Favorite
(P 410) SUBGROUP ANALYSIS OF THE PHASE 2 PART OF THE RINGSIDE PHASE 2/3 TRIAL OF VAREGACESTAT FOR TREATMENT OF DESMOID TUMORS
Rashmi Chugh
Favorite
(P 413) EFFICACY OF NIROGACESTAT IN PATIENTS WITH DESMOID TUMORS AND PRESENCE OR ABSENCE OF POOR PROGNOSTIC FACTORS: POST HOC ANALYSES OF THE PHASE 3 DEFI TRIAL
Rashmi Chugh
Favorite
(P 416) A PHASE 2 MULTICENTER OPEN-LABEL BASKET STUDY OF TAZEMETOSTAT IN ADULT PATIENTS WITH INI1-NEGATIVE EPITHELIOID SARCOMA – FINAL ANALYSIS
Rashmi Chugh
Favorite
(P 423) ZIFTOMENIB IN COMBINATION WITH IMATINIB IN ADVANCED GASTROINTESTINAL STROMAL TUMORS (GIST) AFTER IMATINIB FAILURE: PHASE 1A/B STUDY OF SAFETY, PHARMACOKINETICS, AND ANTITUMOR ACTIVITY
Rashmi Chugh
Favorite
Chung, Yang-Guk

Department of Orthopaedic Surgery, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea
(P 171) THREE-DIMENSIONAL DEEP LEARNING MODEL FOR PREDICTING PROXIMAL FEMORAL PATHOLOGIC FRACTURE USING OPPORTUNISTIC ABDOMINOPELVIC CT IN PATIENTS WITH ADVANCED CANCER: A PRELIMINARY REPORT
Yang-Guk Chung
Favorite
Chu, Yucheng

Sumptuous Data Sciences
(P 413) EFFICACY OF NIROGACESTAT IN PATIENTS WITH DESMOID TUMORS AND PRESENCE OR ABSENCE OF POOR PROGNOSTIC FACTORS: POST HOC ANALYSES OF THE PHASE 3 DEFI TRIAL
Yucheng Chu
Favorite
Cicala, Carlo Maria

Vall d'Hebron Institute of Oncology / Vall d'Hebron University Hospital
(P 389) UNRESECTABLE AND METASTATIC DEDIFFERENTIATED LIPOSARCOMA (DDLPS): INSIGHTS FROM A MULTICENTER REAL-WORLD COHORT (RWC)
Carlo Maria Cicala
Favorite
Ciećkiewicz, Anna Szumera

Narodowy Instytut Onkologii im. Marii Skłodowskiej-Curie
(P 134) INTEGRATIVE MICRORNA PROFILING IN CHONDROSARCOMA: TOWARD BIOMARKER DISCOVERY AND PROGNOSTIC SIGNATURE DEVELOPMENT
Anna Szumera Ciećkiewicz
Favorite
Cihan, Ali

Memorial Sloan Kettering Cancer Center
(P 237) DEVELOPMENT OF EPHA2 CAR T CELL THERAPY FOR OSTEOSARCOMA
Ali Cihan
Favorite
Cillo, Anthony

University of Pittsburgh
(P 256) THE SEAN KARL COHORT: A NATIONAL COLLABORATIVE SINGLE-CELL RNASEQ STUDY OF PAIRED PATIENT EWING SARCOMA SPECIMENS
Anthony Cillo
Favorite
Cini, John

Sonnet BioTherapeutics
(P 432) EXPANSION OF A PHASE 1 STUDY OF SON-1010 (IL12-FHAB) ADDING TRABECTEDIN IN SOFT TISSUE SARCOMA: TRIAL IN PROGRESS
John Cini
Favorite
Cipponi, Arcadi

Centre for Molecular Oncology
(P 49) GENETIC INTERACTION BETWEEN SPRED3 AND SMARCB1 CAUSES EXPLOSIVE MULTIFOCAL MALIGNANT PERIPHERAL NERVE SHEATH TUMORS
Arcadi Cipponi
Favorite
Clarke, Callisia

Medical College of Wisconsin
(P 329) LAPAROSCOPY-ASSISTED PERCUTANEOUS CRYOABLATION FOR THE TREATMENT OF ABDOMINAL WALL DESMOID TUMORS
Callisia Clarke
Favorite
Cleris, Loredana

Fondazione IRCCS Istituto Nazionale dei Tumori
(P 32) EFFECTIVENESS OF LURBINECTEDIN PLUS IRINOTECAN IN PRECLINICAL MODEL OF DESMOPLASTIC SMALL ROUND CELL TUMOR
Loredana Cleris
Favorite
Clinton, Catherine

Dana-Farber/Boston Children’s Cancer and Blood Disorders Center
(P 427) PHASE 1/2 TRIAL TO EVALUATE THE SAFETY AND EFFICACY OF PEEL-224 IN COMBINATION WITH VINCRISTINE AND TEMOZOLOMIDE IN ADOLESCENTS AND YOUNG ADULTS WITH RELAPSED OR REFRACTORY SARCOMAS
Catherine Clinton
Favorite
Codd, Elizabeth

Department of Pathology, Massachusetts General Hospital, Harvard Medical School
(P 45) MONITORING EWSR1 FUSIONS IN SARCOMA PATIENTS USING PERSONALIZED LIQUID BIOPSY ASSAYS
Elizabeth Codd
Favorite
Coe, Erykah

Vanderbilt University
(P 51) OVEREXPRESSION OF GLI2 IN DEDIFFERENTIATED LIPOSARCOMA TUMORS INDUCES MICROENVIRONMENT REMODELING
Erykah Coe
Favorite
Cogswell, Patty

The EHE Foundation
(P 448) OVERCOMING CHALLENGES IN ULTRA-RARE SARCOMAS: A CENTRALIZED BIOBANK FOR EPITHELIOID HEMANGIOENDOTHELIOMA AS A RESOURCE TO ACCELERATE DISCOVERY
Patty Cogswell
Favorite
Cohen, Rachel

SpringWorks Therapeutics
(P 413) EFFICACY OF NIROGACESTAT IN PATIENTS WITH DESMOID TUMORS AND PRESENCE OR ABSENCE OF POOR PROGNOSTIC FACTORS: POST HOC ANALYSES OF THE PHASE 3 DEFI TRIAL
Rachel Cohen
Favorite
(P 442) TRIAL IN PROGRESS: A SINGLE-ARM, OPEN-LABEL PHASE 4 TRIAL OF NIROGACESTAT IN ADULT PREMENOPAUSAL FEMALES WITH DESMOID TUMORS
Rachel Cohen
Favorite
Coil, Meredith

Northeast Ohio Medical University
(P 02) METHYLATION PROFILING AS A DIAGNOSTIC ADJUNCT FOR UNDIFFERENTIATED SARCOMAS: A REAL-WORLD EVALUATION
Meredith Coil
Favorite
Coindre, Jean-Michel

Institut Bergonié
(P 324) FULLY MATURE TERTIARY LYMHOID STRUCTURES AS PREDICTORS OF LOCAL RECURRENCE IN SOFT TISSUE SARCOMAS
Jean-Michel Coindre
Favorite
Colak, Gozde

IDRx
(P 194) UPDATED RESULTS FROM STRATEGIST 1: A PHASE 1/1B STUDY OF IDRX-42 (GSK6042981A) IN PATIENTS (PTS) WITH ADVANCED GASTROINTESTINAL STROMAL TUMORS (GIST)
Gozde Colak
Favorite
Colazo, Juan

School of Medicine, Vanderbilt University, Nashville, TN, USA
(P 85) MAKING NEGATIVE MARGIN MUSCULOSKELETAL TUMOR SURGERY A VIRTUAL REALITY USING 3D SPECIMEN SCANNING
Juan Colazo
Favorite
Collier, Christopher

Indiana University
(P 82) DISPARITIES IN OSTEOSARCOMA BY SOCIOECONOMIC STATUS
Christopher Collier
Favorite
(P 84) A MULTICENTER COMPARISON OF REVERSE TOTAL SHOULDER ARTHROPLASTY VERSUS HEMIARTHROPLASTY FOR ENDOPROSTHETIC RECONSTRUCTION FOLLOWING ONCOLOGIC RESECTION OF THE PROXIMAL HUMERUS
Christopher Collier
Favorite
(P 269) INCIDENCE OF MALIGNANCY IN BIOPSIED PEDIATRIC SOFT TISSUE MASSES
Christopher Collier
Favorite
(P 272) THE HAZARDS OF BIOPSY IN PEDIATRIC SOFT TISSUE SARCOMAS
Christopher Collier
Favorite
Collini, Paola

Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan
(P 32) EFFECTIVENESS OF LURBINECTEDIN PLUS IRINOTECAN IN PRECLINICAL MODEL OF DESMOPLASTIC SMALL ROUND CELL TUMOR
Paola Collini
Favorite
(P 277) THE ROLE OF RADIOTHERAPY IN THE MULTIDISCIPLINARY MANAGEMENT OF RADIATION-ASSOCIATED ANGIOSARCOMA OF THE BREAST: A REFERRAL CENTER EXPERIENCE
Paola Collini
Favorite
(P 331) MAINTENANCE THERAPY (M-TP) WITH DACARBAZINE (DTIC) AFTER FIRST-LINE ANTHRACYCLINE-BASED DOUBLET IN ADVANCED LEIOMYOSARCOMA (LMS) PATIENTS (PTS): OUTCOMES OF A CASE SERIES IN A SINGLE REFERRAL CENTER
Paola Collini
Favorite
(P 452) EFFECTIVENESS OF ERIBULIN FOR MYXOID PLEOMORPHIC LIPOSARCOMA: INSIGHTS FROM A PATIENT-DERIVED MODEL AND CLINICAL TRANSLATION IN A PATIENT WITH ADVANCED DISEASE
Paola Collini
Favorite
Collini, Paola

Fondazione IRCCS Istituto Nazionale Tumori
(P 458) BETWEEN LYMPHOMAS AND SARCOMAS: A RETROSPECTIVE, MULTI-INSTITUTIONAL STUDY FROM THE ITALIAN SARCOMA GROUP (ISG) ON HISTIOCYTIC AND DENDRITIC CELL NEOPLASMS (HDCN)
Paola Collini
Favorite
Colman, Matthew

Rush University School of Medicine
(P 138) A MULTI-INSTITUTIONAL ARCHIVE AND DEEP LEARNING PIPELINE FOR QUANTIFYING CHONDROSARCOMA COMPOSITION
Matthew Colman
Favorite
Colombo, Chiara

Fondazione IRCCS Istituto Nazionale dei Tumori
(P 308) IMPACT OF PSOAS MUSCLE RESECTION ON OUTCOMES IN PRIMARY RETROPERITONEAL DEDIFFERENTIATED LIPOSARCOMA
Chiara Colombo
Favorite
Colon, Alexander

University of Puerto Rico at Cayey
(P 130) INVESTIGATING LCP1-MEDIATED ONCOGENIC SIGNALING IN CHONDROSARCOMA METASTASIS
Alexander Colon
Favorite
Comandini, Danila

Medical Oncology 1, Ospedale Policlinico San Martino, University of Genova
(P 231) INCREASED LIFETIME RISK (LTR) OF SOFT TISSUE SARCOMAS (STS) IN PATIENTS WITH LOW-RISK GASTROINTESTINAL STROMAL TUMORS (GIST): A RETROSPECTIVE ANALYSIS FROM THE ITALIAN SARCOMA GROUP (ISG)
Danila Comandini
Favorite
Conces, Miriam

Department of Pathology and Laboratory Medicine, Nationwide Children’s Hospital; Department of Pathology, The Ohio State University College of Medicine
(P 264) RARE CASE OF INFLAMMATORY MYOFIBROBLASTIC TUMOR (IMT) IN NEWBORN
Miriam Conces
Favorite
Conley, Anthony

University of Texas MD Anderson Cancer Center
(P 83) OUTCOMES OF MULTIMODAL PERIOPERATIVE TREATMENT IN OSTEOSARCOMAS OF THE JAW
Anthony Conley
Favorite
(P 128) ISOCITRATE DEHYDROGENASE 1 (IDH1) MUTATION TESTING IN THE PHASE 3 STUDY OF IVOSIDENIB VS PLACEBO IN IDH1-MUTANT CONVENTIONAL CHONDROSARCOMA (CHONQUER)
Anthony Conley
Favorite
(P 411) TFCP2 FUSION-POSITVE RHABDOMYOSARCOMAS: A REPORT OF 10 CASES AND A REVIEW OF THE LITERATURE
Anthony Conley
Favorite
(P 451) TREATMENT OUTCOMES OF GEMCITABINE AND DOCETAXEL IN PATIENTS WITH CLEAR CELL SARCOMA (CCS) OR GASTROINTESTINAL NEUROECTODERMAL TUMOR (GNET): A CASE SERIES
Anthony Conley
Favorite
(P 460) OUTCOMES OF LATER-LINES SYSTEMIC THERAPIES IN MALIGNANT PERIPHERAL NERVE SHEATH TUMORS (MPNST)
Anthony Conley
Favorite
Connolly, Joseph

Massachusetts General Hospital
(P 17) EXTRASKELETAL OSTEOSARCOMA: MICRORNA PATTERNS PROVIDE INSIGHTS INTO SIMILARITIES AND CONTRASTS WITH OTHER SARCOMAS
Joseph Connolly
Favorite
(P 62) INTRAOPERATIVE BONE AND SOFT TISSUE TUMOR MARGIN IDENTIFICATION WITH FLUORESCENCE LIFETIME (FLT) IMAGING
Joseph Connolly
Favorite
(P 87) ACUTE PATHOLOGICAL LONG BONE FRACTURES: WEEKEND VERSUS WEEKDAY VARIATIONS AND THEIR CLINICAL IMPACT
Joseph Connolly
Favorite
(P 91) A COMPARISON OF ACETABULAR AUGMENTATION AND PHOTODYNAMIC NAIL STABILIZATION FOR COMPLEX ONCOLOGIC TOTAL HIP ARTHROPLASTY
Joseph Connolly
Favorite
(P 112) PEDIATRIC GIANT CELL TUMOR OF BONE
Joseph Connolly
Favorite
(P 118) IMPACT OF TYROSINE KINASE INHIBITOR THERAPY ON BONE PROGRESSION IN PATIENTS WITH DRIVER-MUTATED METASTATIC NON-SMALL CELL LUNG CANCER WITH DE NOVO BONE METASTASES
Joseph Connolly
Favorite
(P 205) CENTRALIZATION OF SARCOMA CARE IMPROVES OUTCOMES DESPITE POORER PRESENTATION: A SYSTEMATIC REVIEW AND META-ANALYSIS
Joseph Connolly
Favorite
(P 294) RISK FACTORS FOR RECURRENCE AND COMPLICATIONS OF CT-GUIDED RADIOFREQUENCY ABLATION FOR THE TREATMENT OF OSTEOID OSTEOMA: A MULTI-INSTITUTIONAL ANALYSIS.
Joseph Connolly
Favorite
(P 375) DOES STAGED RESECTION WITH TEMPORIZING WOUND VACUUM INFLUENCE LOCAL RECURRENCE RISK? A MULTI-INSTITUTIONAL MATCHED COHORT ANALYSIS
Joseph Connolly
Favorite
(P 392) CLASSIFICATION AND DIFFERENTIATIONOF MYXOID LIPOSARCOMA AND MYXOMA WITH MACHINE LEARNING
Joseph Connolly
Favorite
(P 392) DIFFERENTIATION OF MYXOMA AND MYXOID LIPOSARCOMA BASED ON RADIOMICS PHENOTYPES
Joseph Connolly
Favorite
Conway, Devin

Indiana University
(P 82) DISPARITIES IN OSTEOSARCOMA BY SOCIOECONOMIC STATUS
Devin Conway
Favorite
(P 84) A MULTICENTER COMPARISON OF REVERSE TOTAL SHOULDER ARTHROPLASTY VERSUS HEMIARTHROPLASTY FOR ENDOPROSTHETIC RECONSTRUCTION FOLLOWING ONCOLOGIC RESECTION OF THE PROXIMAL HUMERUS
Devin Conway
Favorite
(P 269) INCIDENCE OF MALIGNANCY IN BIOPSIED PEDIATRIC SOFT TISSUE MASSES
Devin Conway
Favorite
(P 272) THE HAZARDS OF BIOPSY IN PEDIATRIC SOFT TISSUE SARCOMAS
Devin Conway
Favorite
Cook, Chad

Duke University Department of Orthopaedic Surgery
(P 214) FINANCIAL TOXICITY IN PATIENTS WITH A HISTORY OF EXTREMITY AND PELVIC SARCOMA TREATMENT
Chad Cook
Favorite
Cooper, Samuel

Medical University of South Carolina
(P 279) IMPACT OF PREOPERATIVE 5-DAY HYPOFRACTIONATED RADIOTHERAPY (HFRT) FOR SOFT TISSUE SARCOMA (STS) ON BARRIERS TO TREATMENT AT A HIGH-VOLUME SARCOMA CENTER (HV-SC)
Samuel Cooper
Favorite
Cope, Brandon

Keesler Medical Center
(P 172) COMPARISON OF CELL SEGMENTATION METHODS IN SOFT TISSUE SARCOMA (STS) SPATIAL PROTEOMIC DATASETS
Brandon Cope
Favorite
Coppola, Sara

European Institute of Oncology IRCCS
(P 328) INNOVATING SARCOMA EDUCATION: EARLY OUTCOMES OF THE ITALIAN SOCIETY OF SURGICAL ONCOLOGY (SICO) SARCOMA SOCIAL MULTI-PLATFORM JOURNAL CLUB INITIATIVE
Sara Coppola
Favorite
Corn, Karsen

University of Florida
(P 129) HIJACKED FUEL: GLYCOGEN-DRIVEN METABOLIC SHIFTS IN IDH1-MUTANT CHONDROSARCOMA
Karsen Corn
Favorite
Corona, Francesco

IRCCS Regina Elena National Cancer Institute
(P 328) INNOVATING SARCOMA EDUCATION: EARLY OUTCOMES OF THE ITALIAN SOCIETY OF SURGICAL ONCOLOGY (SICO) SARCOMA SOCIAL MULTI-PLATFORM JOURNAL CLUB INITIATIVE
Francesco Corona
Favorite
Coronel Hernandez, Jossimar

Instituto Nacional de Cancerología
(P 39) BUB1 AN OVEREXPRESSED KINASE IN SARCOMA: FINDING NEW TARGET THERAPY FOR OSTEOSARCOMA, LIPOSARCOMA, SYNOVIAL SARCOMA AND LEIOMYOSARCOMA
Jossimar Coronel Hernandez
Favorite
Cortinovis, Umberto

Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan
(P 277) THE ROLE OF RADIOTHERAPY IN THE MULTIDISCIPLINARY MANAGEMENT OF RADIATION-ASSOCIATED ANGIOSARCOMA OF THE BREAST: A REFERRAL CENTER EXPERIENCE
Umberto Cortinovis
Favorite
Corum, Daniel

Kura Oncology, Inc.
(P 423) ZIFTOMENIB IN COMBINATION WITH IMATINIB IN ADVANCED GASTROINTESTINAL STROMAL TUMORS (GIST) AFTER IMATINIB FAILURE: PHASE 1A/B STUDY OF SAFETY, PHARMACOKINETICS, AND ANTITUMOR ACTIVITY
Daniel Corum
Favorite
Cosentini, Deborah

Spedali Civili di Brescia
(P 458) BETWEEN LYMPHOMAS AND SARCOMAS: A RETROSPECTIVE, MULTI-INSTITUTIONAL STUDY FROM THE ITALIAN SARCOMA GROUP (ISG) ON HISTIOCYTIC AND DENDRITIC CELL NEOPLASMS (HDCN)
Deborah Cosentini
Favorite
Costa, Felipe

A.C.Camargo Cancer Center
(P 132) MOLECULAR LANDSCAPE AND CLINICAL HETEROGENEITY OF BRAZILIAN CHONDROSARCOMAS: INSIGHTS FROM IDH, TERT, AND GENOME-WIDE ANALYSIS
Felipe Costa
Favorite
(P 137) GENOMIC ALTERATIONS IN RARE CARTILAGINOUS TUMOR SYNDROMES ASSOCIATED WITH CHONDROSARCOMA DEVELOPMENT
Felipe Costa
Favorite
Costelloe, Colleen M

The University of Texas MD Anderson Cancer Center
(P 311) A FOLLOW-UP STUDY ON THE NOVEL USE OF CONTRAST-ENHANCED SUSCEPTIBILITY-WEIGHTED IMAGING FOR EXTREMITY DESMOID FIBROMATOSIS RESPONSE ASSESSMENT
Colleen M Costelloe
Favorite
(P 317) BUILDING A PRE-SURGICAL MULTIPARAMETRIC-MRI-BASED PREDICTIVE TREATMENT RESPONSE MODEL FOR UNDIFFERENTIATED PLEOMORPHIC SARCOMA TO REPLACE RECIST
Colleen M Costelloe
Favorite
(P 334) MRI VOLUMETRIC AND MODIFIED CHOI-BASED ASSESSMENT OF TREATMENT RESPONSE IN EXTREMITY DESMOID TUMORS TREATED WITH NIROGACESTAT OR SORAFENIB
Colleen M Costelloe
Favorite
(P 406) PILOT STUDY: CAN A MULTIPARAMETRIC MRI-DERIVED MODEL OUTPERFORM RECIST PREDICTING PATHOLOGY RESPONSE IN RHABDOMYOSARCOMA?
Colleen M Costelloe
Favorite
(P 420) THE EFFECT OF CHEMOTHERAPY AND RADIOTHERAPY IN THE MULTIPARAMETRIC MRI-BASED ASSESSMENT OF TREATMENT RESPONSE IN EXTREMITY SOFT-TISSUE UNDIFFERENTIATED PLEOMORPHIC SARCOMA
Colleen M Costelloe
Favorite
Cote, Gregory

Mass General Cancer Center, Massachusetts General Hospital
(P 45) MONITORING EWSR1 FUSIONS IN SARCOMA PATIENTS USING PERSONALIZED LIQUID BIOPSY ASSAYS
Gregory Cote
Favorite
(P 290) CLINICAL OUTCOMES AFTER RADIOTHERAPY FOR PATIENTS WITH POORLY DIFFERENTIATED CHORDOMA
Gregory Cote
Favorite
(P 415) A PHASE 1/2 TRIAL OF FOG-001, A FIRST-IN-CLASS DIRECT β-CATENIN:TCF4 INHIBITOR: SAFETY AND PRELIMINARY ANTITUMOR ACTIVITY IN PATIENTS WITH DESMOID TUMORS (DT)
Gregory Cote
Favorite
(P 416) A PHASE 2 MULTICENTER OPEN-LABEL BASKET STUDY OF TAZEMETOSTAT IN ADULT PATIENTS WITH INI1-NEGATIVE EPITHELIOID SARCOMA – FINAL ANALYSIS
Gregory Cote
Favorite
(P 461) A RETROSPECTIVE ANALYSIS OF PATIENTS WITH CONVENTIONAL CHORDOMA TREATED WITH SYSTEMIC THERAPY
Gregory Cote
Favorite
Cottrell, Catherine

Institute for Genomic Medicine, Nationwide Children's Hospital
(P 377) GERMLINE RECQL4 VARIANT IN A PEDIATRIC PATIENT WITH EWING SARCOMA AND DESMOID FIBROMATOSIS
Catherine Cottrell
Favorite
Courington, Reese

Erlanger Health/University of Tennessee College of Medicine - Chattanooga
(P 84) A MULTICENTER COMPARISON OF REVERSE TOTAL SHOULDER ARTHROPLASTY VERSUS HEMIARTHROPLASTY FOR ENDOPROSTHETIC RECONSTRUCTION FOLLOWING ONCOLOGIC RESECTION OF THE PROXIMAL HUMERUS
Reese Courington
Favorite
Coward, Victoria

Mount Sinai Hospital
(P 55) THE EFFECT OF STAT1 Y701 PHOSPHORYLATION ON GENE EXPRESSION IN UPS
Victoria Coward
Favorite
(P 323) EVALUATION OF COSMIC MUTATIONAL SIGNATURES IN SOFT TISSUE SARCOMA
Victoria Coward
Favorite
Crago, Aimee

Memorial Sloan Kettering Cancer Center
(P 187) THERAPEUTIC OUTCOMES IN NF1-ALTERED GIST TREATED WITH MEK INHIBITION: A SINGLE-CENTER EXPERIENCE
Aimee Crago
Favorite
(P 467) TREATMENT OUTCOMES IN AGGRESSIVE ANGIOMYXOMA: A SINGLE INSTITUTION EXPERIENCE
Aimee Crago
Favorite
Crane, Jacquelyn

The Children’s Hospital of Philadelphia, University of Pennsylvania
(P 262) EVALUATING FRONT-LINE THERAPY ACCORDANCE WITH CURRENT SYNOVIAL SARCOMA GUIDELINES
Jacquelyn Crane
Favorite
(P 263) DESCRIBING THE CHARACTERISTICS AND TREATMENT OF SYNOVIAL SARCOMA IN THE RECURRENT SETTING
Jacquelyn Crane
Favorite
(P 427) PHASE 1/2 TRIAL TO EVALUATE THE SAFETY AND EFFICACY OF PEEL-224 IN COMBINATION WITH VINCRISTINE AND TEMOZOLOMIDE IN ADOLESCENTS AND YOUNG ADULTS WITH RELAPSED OR REFRACTORY SARCOMAS
Jacquelyn Crane
Favorite
Cranmer, Lee

City of Hope National Medical Center
(P 287) A PHASE 1 STUDY OF NEOADJUVANT CABOZANTINIB IN COMBINATION WITH RADIATION THERAPY FOR SARCOMAS OF THE EXTREMITIES
Lee Cranmer
Favorite
Crawford, Brooke

Department of Orthopaedics, University of Miami
(P 89) PATELLAR HEIGHT AND ITS INFLUENCE ON FUNCTIONAL OUTCOMES FOR MEGAPROSTHESES AROUND THE KNEE PERFORMED FOR ONCOLOGICAL INDICATIONS
Brooke Crawford
Favorite
(P 90) MEGAPROSTHESIS CONVERSION FROM FAILED OSTEOARTICULAR ALLOGRAFT VERSUS PRIMARY RECONSTRUCTION FOR DISTAL FEMUR AND PROXIMAL TIBIA TUMORS: A PROPENSITY MATCHED-PAIR ANALYSIS
Brooke Crawford
Favorite
(P 94) EFFECT OF POSTOPERATIVE PHYSICAL THERAPY ON FUNCTIONAL OUTCOMES FOLLOWING MUSCULOSKELETAL TUMOR RESECTION
Brooke Crawford
Favorite
(P 98) PERCUTANEOUS STABILIZATION OF METASTATIC BONE LESIONS WITH A PHOTODYNAMIC INTRAMEDULLARY SYSTEM: EXPERIENCE FROM A 15-PATIENT CASE SERIES
Brooke Crawford
Favorite
(P 99) LIMB SALVAGE FOR PROXIMAL TIBIA TUMORS: OUTCOMES OF ALLOGRAFT-PROSTHESIS COMPOSITE AND ENDOPROSTHETIC RECONSTRUCTION
Brooke Crawford
Favorite
Crenn, Vicent

Centre Hospitalier Universitaire de Nantes
(P 151) SHOULD WE USE ADJUVANT CHEMOTHERAPY IN PATIENTS WITH LOCALIZED DEDIFFERENTIATED CHONDROSARCOMA (DDCS) OF THE PELVIS? AN ANALYSIS BY THE PELVIC DDCS STUDY GROUP
Vicent Crenn
Favorite
Crimella, Jessica

Moffitt Cancer Center
(P 426) A PHASE I/II TRIAL USING RNA LIPID NANOPARTICLES FOR RECURRENT OSTEOSARCOMA: A REPORT FROM THE NATIONAL PEDIATRIC CANCER FOUNDATION
Jessica Crimella
Favorite
Crochiere, Marsha

Pyxis Oncology
(P 29) ANTI-TUMOR ACTIVITY OF MICVOTABART PELIDOTIN IS ASSOCIATED WITH ENZYME GENE EXPRESSION IN PATIENT-DERIVED XENOGRAFT SARCOMA MODELS
Marsha Crochiere
Favorite
Crommens, Barrett

Indiana University
(P 272) THE HAZARDS OF BIOPSY IN PEDIATRIC SOFT TISSUE SARCOMAS
Barrett Crommens
Favorite
Crompton, Brian

Dana-Farber/Boston Children’s Cancer and Blood Disorders Center
(P 08) BUILDING A MEDICAL DONATION NETWORK TO ENHANCE DEVELOPMENT OF PEDIATRIC TUMOR MODELS
Brian Crompton
Favorite
Crompton, Brian

Boston Children's
(P 256) THE SEAN KARL COHORT: A NATIONAL COLLABORATIVE SINGLE-CELL RNASEQ STUDY OF PAIRED PATIENT EWING SARCOMA SPECIMENS
Brian Crompton
Favorite
Crompton, Brian

Dana-Farber/Boston Children’s Cancer and Blood Disorders Center
(P 427) PHASE 1/2 TRIAL TO EVALUATE THE SAFETY AND EFFICACY OF PEEL-224 IN COMBINATION WITH VINCRISTINE AND TEMOZOLOMIDE IN ADOLESCENTS AND YOUNG ADULTS WITH RELAPSED OR REFRACTORY SARCOMAS
Brian Crompton
Favorite
Crosse, Matthew

Rush University Medical Center
(P 206) IMPACT OF PROXIMITY TO HEALTH CENTER ON ADHERENCE TO NATIONAL COMPREHENSIVE CANCER NETWORK GUIDELINES IN PATIENTS WITH SOFT TISSUE SARCOMAS
Matthew Crosse
Favorite
Crowley, Timothy

The Newcastle upon Tyne Hospitals NHS Foundation Trust
(P 314) AN INTERNATIONAL, MULTI-CENTRE STUDY OF SURGICAL MARGINS IN INTERMEDIATE TO HIGH GRADE SARCOMA
Timothy Crowley
Favorite
Crow, Michelle

Cogent Biosciences
(P 425) BEZUCLASTINIB EXPANDED ACCESS PROGRAM (EAP) FOR PATIENTS WITH GASTROINTESTINAL STROMAL TUMORS (GIST)
Michelle Crow
Favorite
Cruz, Emmanuel

University of Colorado School of Medicine
(P 268) QUALITY OF LIFE OUTCOMES IN PEDIATRIC PATIENTS UNDERGOING SURGICAL INTERVENTION FOR LOWER EXTREMITY BONE SARCOMAS
Emmanuel Cruz
Favorite
Cruz, Sylvia

Surgical Oncology, Department of Surgery, University of California, Davis
(P 244) INTRATUMORAL TIGIT BLOCKADE AUGMENTS ANTI-TUMOR RESPONSES AND BYPASSES HYPERFUNCTIONALITY OF PERIPHERAL TIGIT+ NK CELLS IN MOUSE AND HUMAN MODELS OF BONE AND SOFT TISSUE SARCOMA
Sylvia Cruz
Favorite
(P 245) SUBTYPE SPECIFIC CHARACTERIZATION OF IMMUNE INFILTRATION IN SOFT TISSE SARCOMAS
Sylvia Cruz
Favorite
Cucurull-Salamero, Marc

ICO - Institut Català d’Oncologia Badalona, Germans Trias i Pujol University Hospital
(P 389) UNRESECTABLE AND METASTATIC DEDIFFERENTIATED LIPOSARCOMA (DDLPS): INSIGHTS FROM A MULTICENTER REAL-WORLD COHORT (RWC)
Marc Cucurull-Salamero
Favorite
Cuevas Marchante, Maria del Carmen

PharmaMar
(P 33) THE NOVEL TRANSCRIPTIONAL INHIBITORS ECUBECTEDIN AND PM54 DEMONSTRATE ANTITUMOR ACTIVITY IN PATIENT-DERIVED XENOGRAFT MODELS OF SOFT TISSUE SARCOMA
Maria del Carmen Cuevas Marchante
Favorite
Cummings, Caleb

Moffitt Cancer Center
(P 102) FACTORS RELATED TO ASEPTIC LOOSENING IN ENDOPROSTHESIS RECONSTRUCTION OF THE PROXIMAL TIBIA
Caleb Cummings
Favorite
(P 138) A MULTI-INSTITUTIONAL ARCHIVE AND DEEP LEARNING PIPELINE FOR QUANTIFYING CHONDROSARCOMA COMPOSITION
Caleb Cummings
Favorite
Cummings, Caleb

USF Health Morsani College of Medicine
(P 140) REFINING PRE-SURGICAL ASSESSMENT OF LONG-BONE CHONDROSARCOMA THROUGH THE RADIOLOGIC AGGRESSIVENESS SCORE
Caleb Cummings
Favorite
(P 141) A RETROSPECTIVE ANALYSIS OF THE BIRMINGHAM ATYPICAL CARTILAGE TUMOUR IMAGING PROTOCOL (BACTIP) IN MANAGING CENTRAL CARTILAGE TUMORS OF THE LONG BONES
Caleb Cummings
Favorite
(P 142) ARE THERE INDEPENDENT PREDICTORS OF DEDIFFERENTIATED CHONDROSARCOMA ON MAGNETIC RESONANCE IMAGING? A MULTIVARIATE ANALYSIS
Caleb Cummings
Favorite
(P 145) PATHOLOGIC FRACTURE IN CHONDROSARCOMA OF LONG BONES: A RETROSPECTIVE COHORT STUDY
Caleb Cummings
Favorite
(P 160) A COMPARATIVE ANALYSIS OF DEDIFFERENTIATED AND CONVENTIONAL CHONDROSARCOMA OUTCOMES
Caleb Cummings
Favorite
(P 375) DOES STAGED RESECTION WITH TEMPORIZING WOUND VACUUM INFLUENCE LOCAL RECURRENCE RISK? A MULTI-INSTITUTIONAL MATCHED COHORT ANALYSIS
Caleb Cummings
Favorite
Cunningham, Danielle

University of Kansas Medical Center
(P 366) WOUND COMPLICATIONS AFTER ULTRA-HYPOFRACTIONATED NEOADJUVANT RADIATION FOR SOFT TISSUE SARCOMA: WHAT IS OPTIMAL SURGICAL TIMING?
Danielle Cunningham
Favorite
Curry, William

Massachusetts General Hospital
(P 290) CLINICAL OUTCOMES AFTER RADIOTHERAPY FOR PATIENTS WITH POORLY DIFFERENTIATED CHORDOMA
William Curry
Favorite
Cuscó Donadeu, Francesc

Hospital Santa Creu i Sant Pau
(P 218) THE IMPACT OF BROADENED GENETIC COUNSELLING REFERRAL CRITERIA IN SARCOMA PATIENTS: A REFERENCE CENTRE'S EXPERIENCE
Francesc Cuscó Donadeu
Favorite
Cypel, Marcelo

University Health Network, Toronto, Canada
(P 143) IMPACT OF SURGICAL MARGINS IN CHEST WALL CHONDROSARCOMAS: A CANSARCC STUDY
Marcelo Cypel
Favorite
Czarnecka, Anna

Maria Sklodowska-Curie National Research Institute of Oncology
(P 27) MOLECULAR CHARACTERIZATION OF RESPONSE TO NEOADJUVANT CHEMORADIATION IN PATIENTS WITH LOCALLY ADVANCED SOFT TISSUE SARCOMAS
Anna Czarnecka
Favorite
(P 134) INTEGRATIVE MICRORNA PROFILING IN CHONDROSARCOMA: TOWARD BIOMARKER DISCOVERY AND PROGNOSTIC SIGNATURE DEVELOPMENT
Anna Czarnecka
Favorite
(P 139) IMMUNOGENOMIC PROFILING OF CHONDROSARCOMA REVEALS DISTINCT IMMUNE PHENOTYPES AND PROGNOSTIC MUTATIONS
Anna Czarnecka
Favorite
(P 146) LOCALISED CHONDROSARCOMA PERIOPERATIVE TREATMENT: REAL-WORLD OUTCOMES AND CHALLENGES ACROSS HISTOLOGIC SUBTYPES
Anna Czarnecka
Favorite
(P 149) SURGICAL TEXTBOOK OUTCOMES IN PATIENTS DIAGNOSED WITH CHONDROSARCOMA
Anna Czarnecka
Favorite
(P 152) EFFICACY OF PALLIATIVE CHEMOTHERAPY AND LOCAL TREATMENTS IN ADVANCED CHONDROSARCOMA: A SUBTYPE-SPECIFIC RETROSPECTIVE ANALYSIS
Anna Czarnecka
Favorite
(P 164) LONG TERM OUTCOMES IN PATIENTS DIAGNOSED WITH SECONDARY CHONDROSARCOMA
Anna Czarnecka
Favorite
(P 313) SIGNIFICANCE OF LYMPH NODE PROCEDURES IN SOFT TISSUE SARCOMA PATIENTS
Anna Czarnecka
Favorite
Czerwiec, Jordan

University of Miami Miller School of Medicine
(P 217) PATIENT QUESTIONNAIRE EXPLORING THE PRE-SARCOMA DIAGNOSIS CHARACTERISTICS OF SARCOMA PATIENTS
Jordan Czerwiec
Favorite
D
Da Silva Moura, David

INSTITUTO DE INVESTIGACIÓN SANITARIA FUNDACIÓN JIMENEZ DIAZ (IIS-FJD)
(P 38) VALIDATION OF THE SIGNIOS SEVEN-GENE SIGNATURE FOR PREDICTING ANTI-PD-1 INHIBITOR EFFICACY IN SARCOMA
David Da Silva Moura
Favorite
(P 462) HDAC INHIBITORS AS POTENTIAL SFT THERAPIES
David Da Silva Moura
Favorite
Dürr, Hans Roland

Orthopaedic Oncology, Department of Orthopaedics and Trauma Surgery, LMU University Hospital, Munich, Germany
(P 64) ATRX EXPRESSION CORRELATES WITH REDUCED IMMUNE CHECKPOINT EXPRESSION AND POOR SURVIVAL IN HIGH-RISK SOFT TISSUE SARCOMAS
Hans Roland Dürr
Favorite
(P 443) FIRST-LINE PAZOPANIB IN PATIENTS WITH EPITHELIOID HEMANGIOENDOTHELIOMA: A RETROSPECTIVE SINGLE-CENTER ANALYSIS
Hans Roland Dürr
Favorite
Daffinoti, Anabella

Angel H Roffo Institute of Oncology
(P 386) RADIO-GUIDED SURGERY FOR NONPALPABLE SOFT-TISSUE SARCOMAS
Anabella Daffinoti
Favorite
Dagrada, Gianpaolo

Fondazione IRCCS Istituto Nazionale dei Tumori
(P 32) EFFECTIVENESS OF LURBINECTEDIN PLUS IRINOTECAN IN PRECLINICAL MODEL OF DESMOPLASTIC SMALL ROUND CELL TUMOR
Gianpaolo Dagrada
Favorite
Dai, Xiaoxian

Kura Oncology, Inc.
(P 423) ZIFTOMENIB IN COMBINATION WITH IMATINIB IN ADVANCED GASTROINTESTINAL STROMAL TUMORS (GIST) AFTER IMATINIB FAILURE: PHASE 1A/B STUDY OF SAFETY, PHARMACOKINETICS, AND ANTITUMOR ACTIVITY
Xiaoxian Dai
Favorite
Dalal, Shivani

Memorial Healthcare System
(P 330) LEIOMYOSARCOMA IN THE REAL WORLD: RETROSPECTIVE ANALYSIS OF CLINICAL CHARACTERISTICS AND TREATMENT PATTERNS IN PATIENTS AT A COMMUNITY ONCOLOGY CENTER IN SOUTH FLORIDA (MEMORIAL HEALTHCARE SYSTEM)
Shivani Dalal
Favorite
(P 459) EPIDEMIOLOGICAL TRENDS, TREATMENT PATTERNS, AND SURVIVAL DISPARITIES IN MALIGNANT PERIPHERAL NERVE SHEATH TUMORS: A SEER ANALYSIS, 2001-2020
Shivani Dalal
Favorite
Daley, Jessica

University of Pittsburgh
(P 256) THE SEAN KARL COHORT: A NATIONAL COLLABORATIVE SINGLE-CELL RNASEQ STUDY OF PAIRED PATIENT EWING SARCOMA SPECIMENS
Jessica Daley
Favorite
Dalrio, Caterina

IRCCS Rizzoli Orthopaedic Institute
(P 18) ESTABLISHMENT AND CHARACTERIZATION OF A NOVEL PRIMARY CELL LINE FROM A BONE METASTASIS OF OSTEOSARCOMA
Caterina Dalrio
Favorite
D'Amato, Gina

University of Miami Sylvester Comprehensive Cancer Center
(P 117) THERAPEUTIC POTENTIAL OF DOXORUBICIN AND DASATINIB COMBINATION IN OSTEOSARCOMA
Gina D'Amato
Favorite
(P 131) GLUCOSE TRANSPORTER 1 (GLUT1) INHIBITION DECREASES THE GROWTH AND PROLIFERATION OF CHONDROSARCOMA
Gina D'Amato
Favorite
(P 201) METASTATIC PATTERNS, TREATMENT MODALITIES, AND OVERALL SURVIVAL IN OLIGOMETASTATIC GIST: A SINGLE-CENTER RETROSPECTIVE STUDY
Gina D'Amato
Favorite
(P 217) PATIENT QUESTIONNAIRE EXPLORING THE PRE-SARCOMA DIAGNOSIS CHARACTERISTICS OF SARCOMA PATIENTS
Gina D'Amato
Favorite
(P 224) PAN-SARCOMA DATABASE (PSDB): AN UPDATE ON MIAMI'S COLLABORATIVE MULTI-USER DATA PIPELINE OF SARCOMA DATA USING REDCAP AND R CODING
Gina D'Amato
Favorite
(P 225) GLOBAL REGISTRY OF SOLITARY FIBROUS TUMORS (SFT): INTEGRATING CLINICAL, MOLECULAR, AND ENVIRONMENTAL DATA- THE HOROWITZ SFT INITIATIVE (HSFTI)
Gina D'Amato
Favorite
(P 320) CLINICAL CHARACTERISTICS AND RECURRENCE PATTERNS IN HISPANIC VS. NON-HISPANIC PATIENTS WITH LEIOMYOSARCOMA: FINDINGS FROM A RETROSPECTIVE SINGLE-CENTER COHORT STUDY
Gina D'Amato
Favorite
(P 327) INITIAL TREATMENT MODALITY AND RECURRENCE IN NON-METASTATIC LEIOMYOSARCOMA: A RETROSPECTIVE COHORT STUDY
Gina D'Amato
Favorite
(P 333) METABOLIC SYNDROME CORRELATION WITH LIPOSARCOMA INCIDENCE AND OUTCOMES: A RETROSPECTIVE ANALYSIS.
Gina D'Amato
Favorite
(P 362) SHOULD PAZOPANIB BE USED AS A MAINTENANCE THERAPY TO IMPROVE RECURRENCE-FREE SURVIVAL AND OVERALL SURVIVAL IN PATIENTS WHO RECEIVED MAI IN SOFT TISSUE SARCOMA?
Gina D'Amato
Favorite
(P 369) CLINICAL CHARACTERISTICS & TREATMENT OUTCOME PATTERNS OF SOLITARY FIBROUS TUMORS: A SINGLE-INSTITUTION RETROSPECTIVE ANALYSIS
Gina D'Amato
Favorite
(P 393) DISTINCT SECONDARY MUTATIONAL LANDSCAPES ARE ASSOCIATED WITH NAB2–STAT6 FUSION BREAKPOINTS IN SOLITARY FIBROUS TUMORS
Gina D'Amato
Favorite
(P 397) EXPLORING REAL WORLD DATA OF RECURRENCE IN NON-METASTATIC MYXOFIBROSAROMA: AN UPDATED RETROSPECTIVE COHORT STUDY
Gina D'Amato
Favorite
(P 422) EFFICACY WITH VIMSELTINIB IN PATIENTS (PTS) WITH TENOSYNOVIAL GIANT CELL TUMOR (TGCT) AND PRIOR COLONY-STIMULATING FACTOR 1 (CSF1) INHIBITOR THERAPY: A PHASE 2 CASE SERIES
Gina D'Amato
Favorite
D'Amato, Vittoria

IRCCS Humanitas Research Hospital
(P 203) MINIMALLY INVASIVE RESECTION OF MULTIFOCAL DUODENO-JEJUNAL GISTS IN NEUROFIBROMATOSIS TYPE 1
Vittoria D'Amato
Favorite
(P 318) BURIED DE-EPITHELIALIZED FLAP RECONSTRUCTION AFTER WIDE EXCISION OF THIGH SARCOMAS: EARLY EXPERIENCE FROM A SPECIALIZED SARCOMA SURGERY UNIT
Vittoria D'Amato
Favorite
D'Amato, Vittoria

IRCCS Humanitas Research Hospotal
(P 339) POSTERIOR APPROACH FOR RADICAL RESECTION OF SACROCOCCYGEAL CHORDOMA: A SURGICAL PERSPECTIVE FROM A TERTIARY REFERRAL CENTER
Vittoria D'Amato
Favorite
D'Amato, Vittoria

IRCCS Humanitas Research Hospital
(P 365) UROLOGICAL RECONSTRUCTION DURING RETROPERITONEAL AND PELVIC SARCOMA SURGERY: EXPERIENCE FROM A HIGH-VOLUME SARCOMA CENTER
Vittoria D'Amato
Favorite
D'Ambrosio, Lorenzo

University Hospital S. Luigi Gonzaga
(P 231) INCREASED LIFETIME RISK (LTR) OF SOFT TISSUE SARCOMAS (STS) IN PATIENTS WITH LOW-RISK GASTROINTESTINAL STROMAL TUMORS (GIST): A RETROSPECTIVE ANALYSIS FROM THE ITALIAN SARCOMA GROUP (ISG)
Lorenzo D'Ambrosio
Favorite
(P 458) BETWEEN LYMPHOMAS AND SARCOMAS: A RETROSPECTIVE, MULTI-INSTITUTIONAL STUDY FROM THE ITALIAN SARCOMA GROUP (ISG) ON HISTIOCYTIC AND DENDRITIC CELL NEOPLASMS (HDCN)
Lorenzo D'Ambrosio
Favorite
Dandwani, Mehndi

University of Iowa Hospitals and Clinics
(P 343) PROGRESSION FREE SURVIVAL OF IMMUNE CHECKPOINT INHIBITORS IN THE FIRST-LINE TREATMENT OF METASTATIC SARCOMA: A SINGLE CENTER RETROSPECTIVE ANALYSIS.
Mehndi Dandwani
Favorite
D'Angelo, Sandra

Memorial Sloan Kettering Cancer Center
(P 186) BRAF V600E-MUTATED GASTROINTESTINAL STROMAL TUMORS: A CASE SERIES AND ANALYSIS OF IMMUNE TUMOR INFILTRATE
Sandra D'Angelo
Favorite
(P 187) THERAPEUTIC OUTCOMES IN NF1-ALTERED GIST TREATED WITH MEK INHIBITION: A SINGLE-CENTER EXPERIENCE
Sandra D'Angelo
Favorite
(P 409) RETROSPECTIVE ANALYSIS OF PROGNOSTIC FACTORS INCLUDING HLA GENOTYPE IN MYXOID LIPOSARCOMA
Sandra D'Angelo
Favorite
(P 421) CHARACTERIZING THE IMMUNE RESPONSE TO INTRATUMORAL TIGILANOL TIGLATE (TT) IN PATIENTS WITH ADVANCED AND/OR METASTATIC SOFT TISSUE SARCOMA (STS) IN A PHASE IIA TRIAL (NCT05755113)
Sandra D'Angelo
Favorite
(P 430) A PH/2 STUDY OF THE RADIOPHARMACEUTICAL [AC-225]RTX-2358 IN THE TREATMENT OF RELAPSED / REFRACTORY (R/R) SOFT TISSUE SARCOMA (STS) THE ATLAS STUDY - ACTINIUM THERAPY FOR LATE-STAGE AGGRESSIVE SARCOMAS
Sandra D'Angelo
Favorite
(P 467) TREATMENT OUTCOMES IN AGGRESSIVE ANGIOMYXOMA: A SINGLE INSTITUTION EXPERIENCE
Sandra D'Angelo
Favorite
Danieau, Geoffroy

McGill university and RI-MUHC
(P 15) EZHIP: A NOVEL EPIGENETIC DRIVER OF OSTEOSARCOMA PATHOGENESIS
Geoffroy Danieau
Favorite
Daniel, Sara

Mayo Clinic
(P 300) FEATURES AND OUTCOMES OF PATIENTS WITH GASTROINTESTINAL LEIYOMYOSARCOMA
Sara Daniel
Favorite
Daniyan, Anthony

Memorial Sloan Kettering Cancer Center
(P 237) DEVELOPMENT OF EPHA2 CAR T CELL THERAPY FOR OSTEOSARCOMA
Anthony Daniyan
Favorite
Dann, Amanda

University of Texas Southwestern Medical Center
(P 03) CONGRUENCE OF CIRCULATING TUMOR DNA & RADIOGRAPHIC RESPONSE IN BONE AND SOFT TISSUE SARCOMA
Amanda Dann
Favorite
(P 280) PERSONALIZED ULTRA-FRACTIONATED STEREOTACTIC ADAPTIVE RADIOTHERAPY (PULSAR) FOR ADULT AND PEDIATRIC SARCOMAS
Amanda Dann
Favorite
Darrow, Morgan

Pathology and Laboratory Medicine, University of California, Davis
(P 244) INTRATUMORAL TIGIT BLOCKADE AUGMENTS ANTI-TUMOR RESPONSES AND BYPASSES HYPERFUNCTIONALITY OF PERIPHERAL TIGIT+ NK CELLS IN MOUSE AND HUMAN MODELS OF BONE AND SOFT TISSUE SARCOMA
Morgan Darrow
Favorite
(P 245) SUBTYPE SPECIFIC CHARACTERIZATION OF IMMUNE INFILTRATION IN SOFT TISSE SARCOMAS
Morgan Darrow
Favorite
Darwish, Alaa

Department of Genetics, The Hebrew University of Jerusalem, Jerusalem, Israel.
(P 06) RAPID, POINT-OF-CARE DNA METHYLATION & MOLECULAR LANDSCAPE BASED SARCOMA CLASSIFICATION
Alaa Darwish
Favorite
Das, Bidisha

Brigham and Women's Hospital
(P 309) RETROPERITONEAL LIPOMAS: MULTICENTER CLINICAL EXPERIENCE WITH AN EXTREMELY RARE DISEASE ENTITY
Bidisha Das
Favorite
David, Andre

UNIFESP
(P 347) SURVIVAL ANALYSIS AND PROGNOSTIC FACTORS OF SOFT TISSUE SARCOMAS OF THE TRUNK AND EXTREMITIES TREATED BETWEEN 2010 AND 2015: EXPERIENCE OF THE BRAZILIAN NATIONAL CANCER INSTITUTE
Andre David
Favorite
David, Bruna

Grupo Oncoclinicas / Brazilian National Cancer Institute
(P 285) MULTICENTER STUDY OF SPATIALLY FRACTIONATED RADIOTHERAPY (LATTICE) FOR LARGE-VOLUME RADIORESISTANT SARCOMAS
Bruna David
Favorite
David, Clare

University College London Hospitals
(P 281) LOCAL CONTROL WITH MODERATELY HYPOFRACTIONATED DEFINITIVE RADIOTHERAPY DELIVERED WITH A SIMULTANEOUS INTEGRATED BOOST TECHNIQUE TO NON-EXTREMITY SOFT TISSUE AND BONE SARCOMAS
Clare David
Favorite
Davidorf, Oliver

Sarcoma Oncology Center
(P 388) TRIAL IN PROGRESS: A PHASE 2 STUDY OF METRONOMIC TRABECTEDIN, GEMCITIBAINE, AND DACARBAZINE IN PREVIOUSLY TREATED ADVANCED SOFT TISSUE SARCOMA (NCT04535271)
Oliver Davidorf
Favorite
Davila, Eduardo

University of Colorado School of Medicine
(P 234) DOXORUBICIN PLUS BOTENSILIMAB, A NEXT GENERATION CTLA4 INHIBITOR, WITH OR WITHOUT BALSTILIMAB, A PD1 INHIBITOR, IN PATIENTS WITH ADVANCED SOFT TISSUE SARCOMAS
Eduardo Davila
Favorite
Davis, Jessica

Riley Hospital for Children
(P 168) LEVERAGING LARGE LANGUAGE MODELS FOR STRUCTURED INFORMATION EXTRACTION FROM EWING SARCOMA PATHOLOGY REPORTS
Jessica Davis
Favorite
(P 256) THE SEAN KARL COHORT: A NATIONAL COLLABORATIVE SINGLE-CELL RNASEQ STUDY OF PAIRED PATIENT EWING SARCOMA SPECIMENS
Jessica Davis
Favorite
Davis, Lara

Knight Cancer Institute, Oregon Health & Science University
(P 315) ANALYSIS OF CHANGES IN T2-WEIGHTED SIGNAL INTENSITY AND TUMOR VOLUME AND EXPOSURE-RESPONSE IN THE RINGSIDE PHASE 2 STUDY OF VAREGACESTAT FOR DESMOID TUMORS
Lara Davis
Favorite
(P 410) SUBGROUP ANALYSIS OF THE PHASE 2 PART OF THE RINGSIDE PHASE 2/3 TRIAL OF VAREGACESTAT FOR TREATMENT OF DESMOID TUMORS
Lara Davis
Favorite
(P 416) A PHASE 2 MULTICENTER OPEN-LABEL BASKET STUDY OF TAZEMETOSTAT IN ADULT PATIENTS WITH INI1-NEGATIVE EPITHELIOID SARCOMA – FINAL ANALYSIS
Lara Davis
Favorite
Davis, Olivia

Department of Internal Medicine, University of Michigan
(P 227) TREATMENT PATTERNS IN PATIENTS WITH TENOSYNOVIAL GIANT CELL TUMORS: ADDRESSING COMMUNICATION IN A NEW THERAPEUTIC LANDSCAPE
Olivia Davis
Favorite
Davison, Zoe

Bone Cancer Research Trust
(P 207) LONG-TERM FOLLOW-UP AND LATE EFECTS MONITORING FOR UK BONE SARCOMA PATIENTS: A SERVICE MAPPING EXCERCISE
Zoe Davison
Favorite
Davis, Sterenn

Adaptimmune
(P 247) SINGLE-CELL RNA SEQUENCING OF AFAMITRESGENE AUTOLEUCEL INDICATES MECHANISMS OF PERSISTENCE AND ANTI-TUMOR ACTIVITY
Sterenn Davis
Favorite
Davtyan, Ellen

Yerevan State Medical University
(P 158) GLOBAL INEQUITIES IN CHONDROSARCOMA CLINICAL TRIALS: A COMPREHENSIVE ANALYSIS ACROSS THREE DECADES
Ellen Davtyan
Favorite
Daw, Najat

MD Anderson Cancer Center
(P 47) EWSR1::WT1 FUSION ONCOPROTEIN ACTIVITY SHAPES LINEAGE HETEROGENEITY IN DESMOPLASTIC SMALL ROUND CELL TUMORS
Najat Daw
Favorite
(P 83) OUTCOMES OF MULTIMODAL PERIOPERATIVE TREATMENT IN OSTEOSARCOMAS OF THE JAW
Najat Daw
Favorite
De Bellis, Chelsea

McGill University
(P 68) MULTI-OMIC INTRA- AND INTER-TUMOR HETEROGENEITY OF BENIGN SMOOTH MUSCLE TUMORS
Chelsea De Bellis
Favorite
De Cian, Franco

IRCCS Ospedale Policlinico San Martino
(P 328) INNOVATING SARCOMA EDUCATION: EARLY OUTCOMES OF THE ITALIAN SOCIETY OF SURGICAL ONCOLOGY (SICO) SARCOMA SOCIAL MULTI-PLATFORM JOURNAL CLUB INITIATIVE
Franco De Cian
Favorite
De Cock, Lore

UZ Leuven
(P 33) THE NOVEL TRANSCRIPTIONAL INHIBITORS ECUBECTEDIN AND PM54 DEMONSTRATE ANTITUMOR ACTIVITY IN PATIENT-DERIVED XENOGRAFT MODELS OF SOFT TISSUE SARCOMA
Lore De Cock
Favorite
De La Cuesta, Esther

Bayer HealthCare Pharmaceuticals, Inc., Whippany, NJ, USA
(P 417) EFFICACY AND SAFETY OF LAROTRECTINIB (LARO) IN PATIENTS (PTS) WITH TRK FUSION SARCOMAS
Esther De La Cuesta
Favorite
De Luca, Ida

Azienda Ospedaliera di Cosenza
(P 458) BETWEEN LYMPHOMAS AND SARCOMAS: A RETROSPECTIVE, MULTI-INSTITUTIONAL STUDY FROM THE ITALIAN SARCOMA GROUP (ISG) ON HISTIOCYTIC AND DENDRITIC CELL NEOPLASMS (HDCN)
Ida De Luca
Favorite
de Miranda, Noel

Leiden University Medical Center
(P 127) AN INTEGRATED CLINICAL GENOMIC AND TRANSCRIPTOMIC SUBGROUPING OF CENTRAL CHONDROSARCOMA
Noel de Miranda
Favorite
de Moraes, Jose Carlos

Brazilian National Cancer Institute
(P 347) SURVIVAL ANALYSIS AND PROGNOSTIC FACTORS OF SOFT TISSUE SARCOMAS OF THE TRUNK AND EXTREMITIES TREATED BETWEEN 2010 AND 2015: EXPERIENCE OF THE BRAZILIAN NATIONAL CANCER INSTITUTE
Jose Carlos de Moraes
Favorite
De Pas, Tommaso Martino

Medical Oncology Division, Cliniche Humanitas Gavazzeni, Bergamo, Italy; previously at Unit of Sarcomas and Thymomas, European Institute of Oncology, Milan
(P 231) INCREASED LIFETIME RISK (LTR) OF SOFT TISSUE SARCOMAS (STS) IN PATIENTS WITH LOW-RISK GASTROINTESTINAL STROMAL TUMORS (GIST): A RETROSPECTIVE ANALYSIS FROM THE ITALIAN SARCOMA GROUP (ISG)
Tommaso Martino De Pas
Favorite
De Sutter, Luna

UZ Leuven
(P 33) THE NOVEL TRANSCRIPTIONAL INHIBITORS ECUBECTEDIN AND PM54 DEMONSTRATE ANTITUMOR ACTIVITY IN PATIENT-DERIVED XENOGRAFT MODELS OF SOFT TISSUE SARCOMA
Luna De Sutter
Favorite
Deasy, Joseph

Memorial Sloan Kettering Cancer Center
(P 22) SINGLE CELL SEQUENCING ENABLES LINEAGE-INFORMED TARGETING OF OSTEOSARCOMA
Joseph Deasy
Favorite
Debruyne, Channa

Servier
(P 128) ISOCITRATE DEHYDROGENASE 1 (IDH1) MUTATION TESTING IN THE PHASE 3 STUDY OF IVOSIDENIB VS PLACEBO IN IDH1-MUTANT CONVENTIONAL CHONDROSARCOMA (CHONQUER)
Channa Debruyne
Favorite
Degnim, Amy

Mayo Clinic
(P 246) CTLA4 PATHWAY ACTIVATION IN RADIATION-INDUCED ANGIOSARCOMA: A TRANSCRIPTOMIC RATIONALE FOR IMMUNE CHECKPOINT BLOCKADE
Amy Degnim
Favorite
Dehner, Carina

University of Pennsylvania
(P 466) PATHOGENESIS AND THERAPEUTIC TARGETS IN KERATIN-POSITIVE GIANT CELL-RICH TUMOR
Carina Dehner
Favorite
Dei Tos, Angelo Paolo

Azienda Ospedaliera di Padova
(P 231) INCREASED LIFETIME RISK (LTR) OF SOFT TISSUE SARCOMAS (STS) IN PATIENTS WITH LOW-RISK GASTROINTESTINAL STROMAL TUMORS (GIST): A RETROSPECTIVE ANALYSIS FROM THE ITALIAN SARCOMA GROUP (ISG)
Angelo Paolo Dei Tos
Favorite
(P 458) BETWEEN LYMPHOMAS AND SARCOMAS: A RETROSPECTIVE, MULTI-INSTITUTIONAL STUDY FROM THE ITALIAN SARCOMA GROUP (ISG) ON HISTIOCYTIC AND DENDRITIC CELL NEOPLASMS (HDCN)
Angelo Paolo Dei Tos
Favorite
Deinzer, Christoph K. W.

Department of Internal Medicine VIII - Medical Oncology and Pneumology, University Hospital Tübingen and Center for Soft Tissue Sarcomas, GIST and Bone Tumors (ZWS) of the University Hospital Tübingen and of the Comprehensive Cancer Center (CCC) Tübingen-Stuttgart, Tübingen, Germany
(P 204) ANALYSIS OF QUALITY INDICATORS OF SOFT TISSUE SARCOMA TREATMENT WITH CANCER REGISTRY DATA IN GERMANY 2015-2021
Christoph K. W. Deinzer
Favorite
Dela Cruz, Filemon

Memorial Sloan Kettering Cancer Center
(P 08) BUILDING A MEDICAL DONATION NETWORK TO ENHANCE DEVELOPMENT OF PEDIATRIC TUMOR MODELS
Filemon Dela Cruz
Favorite
(P 22) SINGLE CELL SEQUENCING ENABLES LINEAGE-INFORMED TARGETING OF OSTEOSARCOMA
Filemon Dela Cruz
Favorite
(P 25) IDENTIFICATION AND VALIDATION OF NON-GENETICALLY ENCODED VULNERABILITIES IN EWING SARCOMA
Filemon Dela Cruz
Favorite
(P 26) DEVELOPING AN ORTHOTOPIC MODEL OF DESMOPLASTIC SMALL ROUND CELL TUMOR
Filemon Dela Cruz
Favorite
(P 48) PRECLINICAL ACTIVITY OF MEK INHIBITION IN COMBINATION WITH CHEMOTHERAPY IN MALIGNANT PERIPHERAL NERVE SHEATH TUMOR
Filemon Dela Cruz
Favorite
(P 237) DEVELOPMENT OF EPHA2 CAR T CELL THERAPY FOR OSTEOSARCOMA
Filemon Dela Cruz
Favorite
(P 256) THE SEAN KARL COHORT: A NATIONAL COLLABORATIVE SINGLE-CELL RNASEQ STUDY OF PAIRED PATIENT EWING SARCOMA SPECIMENS
Filemon Dela Cruz
Favorite
(P 267) THE RAF/MEK INHIBITOR VS-6766 SHOWS EFFICACY IN RAS-MUTANT PEDIATRIC PRECLINICAL XENOGRAFT MODELS- A REPORT FROM THE PEDIATRIC PRECLINICAL IN VIVO TESTING CONSORTIUM
Filemon Dela Cruz
Favorite
Delclarro, Alessandro

Fondazione IRCCS Istituto Nazionale del Tumori
(P 309) RETROPERITONEAL LIPOMAS: MULTICENTER CLINICAL EXPERIENCE WITH AN EXTREMELY RARE DISEASE ENTITY
Alessandro Delclarro
Favorite
Delitto, Daniel

Stanford University
(P 37) DISSECTING THE TUMOR MICROENVIRONMENT OF UTERINE LEIOMYOSARCOMAS FOR TARGETED DRUG PREDICTIONS
Daniel Delitto
Favorite
DeMass, Reid

Medical University of South Carolina
(P 279) IMPACT OF PREOPERATIVE 5-DAY HYPOFRACTIONATED RADIOTHERAPY (HFRT) FOR SOFT TISSUE SARCOMA (STS) ON BARRIERS TO TREATMENT AT A HIGH-VOLUME SARCOMA CENTER (HV-SC)
Reid DeMass
Favorite
DeMatteo, Ronald

University of Pennsylvania
(P 185) CANCER TESTIS ANTIGENS AS TARGETS IN KIT11-MUTATED, IMATINIB-RESISTANT GIST
Ronald DeMatteo
Favorite
Demetri, George D.

Dana-Farber Cancer Institute
(P 194) UPDATED RESULTS FROM STRATEGIST 1: A PHASE 1/1B STUDY OF IDRX-42 (GSK6042981A) IN PATIENTS (PTS) WITH ADVANCED GASTROINTESTINAL STROMAL TUMORS (GIST)
George D. Demetri
Favorite
(P 416) A PHASE 2 MULTICENTER OPEN-LABEL BASKET STUDY OF TAZEMETOSTAT IN ADULT PATIENTS WITH INI1-NEGATIVE EPITHELIOID SARCOMA – FINAL ANALYSIS
George D. Demetri
Favorite
(P 434) A FIRST-IN-HUMAN PHASE 1, MULTICENTER, OPEN-LABEL STUDY OF M3554, A NOVEL ANTI-GD2 ANTIBODY-DRUG CONJUGATE, IN PATIENTS WITH ADVANCED SOLID TUMORS
George D. Demetri
Favorite
(P 464) EFFICACY OUTCOMES AMONG PATIENTS WITH ADVANCED EPITHELIOID SARCOMAS OF PROXIMAL-TYPE AND DISTAL-TYPE TREATED WITH TAZ: POST HOC ANALYSIS OF STUDY EZH-202
George D. Demetri
Favorite
Demicco, Elizabeth

Mount Sinai Hospital
(P 466) PATHOGENESIS AND THERAPEUTIC TARGETS IN KERATIN-POSITIVE GIANT CELL-RICH TUMOR
Elizabeth Demicco
Favorite
Demma, Jonathan Abraham

Surgical Department, Sharett Institute for Oncology, Hadassah Medical Center & Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel
(P 06) RAPID, POINT-OF-CARE DNA METHYLATION & MOLECULAR LANDSCAPE BASED SARCOMA CLASSIFICATION
Jonathan Abraham Demma
Favorite
Denny, Carina

1.University of Miami, Miller School of Medicine, Department of Orthopedic Surgery
(P 31) TARGETING CANCER STEM CELLS BY TYROSINE PEPTIDE ANALOGUE IN REFRACTORY SARCOMA
Carina Denny
Favorite
Denton, Zachary

University of Kansas School of Medicine
(P 359) EVALUATION OF PREOPERATIVE MYXOFIBROSARCOMA GROWTH AND SURGICAL MORBIDITY AFTER NEOADJUVANT RADIATION USING SEMI-AUTOMATED VOLUMETRIC ANALYSIS
Zachary Denton
Favorite
(P 382) METHOD FOR VOLUMETRIC ASSESMENT OF TUMOR RESPONSE FOLLOWING NEOADJUVANT RADIATION IN PRIMARY MYXOFIBROSARCOMA
Zachary Denton
Favorite
Denu, Ryan

MD Anderson Cancer Center
(P 184) MTAP IN GASTROINTESTINAL STROMAL TUMOR (GIST): RATE OF MTAP LOSS AND CONCORDANCE BETWEEN GENOMIC SEQUENCING AND IMMUNOHISTOCHEMISTRY
Ryan Denu
Favorite
(P 391) ATRX LOSS BLOCKS THE DIFFERENTIATION OF MESENCHYMAL STEM CELLS AND ADVANCES UNDIFFERENTIATED SARCOMA DEVELOPMENT
Ryan Denu
Favorite
(P 411) TFCP2 FUSION-POSITVE RHABDOMYOSARCOMAS: A REPORT OF 10 CASES AND A REVIEW OF THE LITERATURE
Ryan Denu
Favorite
DeRenzo, Chris

St. Jude Children's Research Hospital
(P 241) MACROPHAGE INHIBITION ENHANCES PERIPHERAL CAR T CELL EXPANSION AND TUMOR CONTROL IN A PATIENT-DERIVED HUMANIZED MODEL OF AUTOLOGOUS CAR T CELL EFFICACY IN PEDIATRIC OSTEOSARCOMA (OS)
Chris DeRenzo
Favorite
Dermawan, Josephine

Cleveland Clinic
(P 284) THE IMPACT OF SARCOMA SBRT ON THE IMMUNE SYSTEM: EARLY RESULTS FROM A PROSPECTIVE TRIAL
Josephine Dermawan
Favorite
Derrac Soria, Alicia

Adaptimmune
(P 247) SINGLE-CELL RNA SEQUENCING OF AFAMITRESGENE AUTOLEUCEL INDICATES MECHANISMS OF PERSISTENCE AND ANTI-TUMOR ACTIVITY
Alicia Derrac Soria
Favorite
Desai, Anant

Queen Elizabeth Hospital Birmingham
(P 307) STRATEGIES FOR DATA QUALITY IN TARPSWG RETROPERITONEAL SARCOMA REGISTRY (RESAR)
Anant Desai
Favorite
Deshpande, Hari

Yale School of Medicine
(P 128) ISOCITRATE DEHYDROGENASE 1 (IDH1) MUTATION TESTING IN THE PHASE 3 STUDY OF IVOSIDENIB VS PLACEBO IN IDH1-MUTANT CONVENTIONAL CHONDROSARCOMA (CHONQUER)
Hari Deshpande
Favorite
(P 423) ZIFTOMENIB IN COMBINATION WITH IMATINIB IN ADVANCED GASTROINTESTINAL STROMAL TUMORS (GIST) AFTER IMATINIB FAILURE: PHASE 1A/B STUDY OF SAFETY, PHARMACOKINETICS, AND ANTITUMOR ACTIVITY
Hari Deshpande
Favorite
Deshpande, Prashant

Sultan Qaboos Comprehensive Cancer Care and Research Center - University Medical City
(P 56) COMPARISON OF PATHOGENIC AND LIKELY PATHOGENIC VARIANTS DISTINCT FROM SPECIFIC DRIVERS IN DIFFERENT SARCOMA GROUPS
Prashant Deshpande
Favorite
Desir-Camille, Rheona

Memorial Sloan Kettering Cancer Center
(P 467) TREATMENT OUTCOMES IN AGGRESSIVE ANGIOMYXOMA: A SINGLE INSTITUTION EXPERIENCE
Rheona Desir-Camille
Favorite
Dessenberger, Joshua

University of Kansas Medical Center
(P 366) WOUND COMPLICATIONS AFTER ULTRA-HYPOFRACTIONATED NEOADJUVANT RADIATION FOR SOFT TISSUE SARCOMA: WHAT IS OPTIMAL SURGICAL TIMING?
Joshua Dessenberger
Favorite
Devaud, Nicolás A.

Clínica Universidad de Los Andes
(P 306) PROGNOSTIC NUTRITIONAL INDEX PREDICTS MAJOR POSTOPERATIVE COMPLICATIONS IN RETROPERITONEAL SARCOMA: RESULTS FROM THE LATAMSARC COHORT
Nicolás A. Devaud
Favorite
Dey, Mritunjoy

Maria Sklodowska-Curie National Research Institute of Oncology
(P 134) INTEGRATIVE MICRORNA PROFILING IN CHONDROSARCOMA: TOWARD BIOMARKER DISCOVERY AND PROGNOSTIC SIGNATURE DEVELOPMENT
Mritunjoy Dey
Favorite
Dhamija, Ekta

All India Institute of Medical Sciences, Delhi, India
(P 276) RADIATION-INDUCED SARCOMA (RIS): CLINICAL SPECTRUM AND ONCOLOGIC OUTCOMES FROM A TERTIARY INDIAN SARCOMA CLINIC
Ekta Dhamija
Favorite
(P 468) CLINICAL UTILITY OF TARGETED NEXT-GENERATION SEQUENCING IN GUIDING SARCOMA DIAGNOSIS AND PERSONALIZED MANAGEMENT: A SINGLE-CENTER STUDY FROM INDIA
Ekta Dhamija
Favorite
Dharmani, Charles

Daiichi Sankyo, Inc., Basking Ridge, NJ, USA
(P 336) PEXIDARTINIB RISK EVALUATION AND MITIGATION STRATEGY PROGRAM: 5-YEAR RETROSPECTIVE HEPATIC SAFETY ASSESSMENT
Charles Dharmani
Favorite
(P 381) KNOWLEDGE, ATTITUDES, AND BEHAVIOR OF HEALTHCARE PROVIDERS ENROLLED IN THE PEXIDARTINIB RISK MITIGATION AND EVALUATION PROGRAM
Charles Dharmani
Favorite
Dharmashaktu, Yamini

All India Institute of Medical Sciences, New Delhi
(P 276) RADIATION-INDUCED SARCOMA (RIS): CLINICAL SPECTRUM AND ONCOLOGIC OUTCOMES FROM A TERTIARY INDIAN SARCOMA CLINIC
Yamini Dharmashaktu
Favorite
Dhir, Aditi

University of Miami/Jackson Memorial Hospital
(P 224) PAN-SARCOMA DATABASE (PSDB): AN UPDATE ON MIAMI'S COLLABORATIVE MULTI-USER DATA PIPELINE OF SARCOMA DATA USING REDCAP AND R CODING
Aditi Dhir
Favorite
(P 254) EOSINOPHILIC FASCIITIS (EF) AS A COMPLICATION OF NATURAL KILLER (NK) CELL-BASED IMMUNOTHERAPY IN A YOUNG ADULT WITH RECURRENT METASTATIC EWING SARCOMA
Aditi Dhir
Favorite
Di Blasi, Elena

Fondazione IRCCS Istituto Nazionale Tumori
(P 308) IMPACT OF PSOAS MUSCLE RESECTION ON OUTCOMES IN PRIMARY RETROPERITONEAL DEDIFFERENTIATED LIPOSARCOMA
Elena Di Blasi
Favorite
(P 331) MAINTENANCE THERAPY (M-TP) WITH DACARBAZINE (DTIC) AFTER FIRST-LINE ANTHRACYCLINE-BASED DOUBLET IN ADVANCED LEIOMYOSARCOMA (LMS) PATIENTS (PTS): OUTCOMES OF A CASE SERIES IN A SINGLE REFERRAL CENTER
Elena Di Blasi
Favorite
Di Gioia, Dorit

Department of Medicine III, LMU University Hospital, Munich, Germany
(P 64) ATRX EXPRESSION CORRELATES WITH REDUCED IMMUNE CHECKPOINT EXPRESSION AND POOR SURVIVAL IN HIGH-RISK SOFT TISSUE SARCOMAS
Dorit Di Gioia
Favorite
(P 437) CLINICAL DATA CONFIRM GALENIC PRINCIPLE AND DEMONSTRATE THERAPEUTIC POTENTIAL OF THE001 (DPPG2-TSL-DOX) PLUS REGIONAL HYPERTHERMIA IN SOFT TISSUE SARCOMA
Dorit Di Gioia
Favorite
(P 443) FIRST-LINE PAZOPANIB IN PATIENTS WITH EPITHELIOID HEMANGIOENDOTHELIOMA: A RETROSPECTIVE SINGLE-CENTER ANALYSIS
Dorit Di Gioia
Favorite
Di Marzo, Massimiliano

Istituto Nazionale Tumori-IRCCS-Fondazione "G. Pascale"
(P 328) INNOVATING SARCOMA EDUCATION: EARLY OUTCOMES OF THE ITALIAN SOCIETY OF SURGICAL ONCOLOGY (SICO) SARCOMA SOCIAL MULTI-PLATFORM JOURNAL CLUB INITIATIVE
Massimiliano Di Marzo
Favorite
Di Mauro, Pierluigi

Fondazione IRCSS Istituto Nazionale Tumori
(P 458) BETWEEN LYMPHOMAS AND SARCOMAS: A RETROSPECTIVE, MULTI-INSTITUTIONAL STUDY FROM THE ITALIAN SARCOMA GROUP (ISG) ON HISTIOCYTIC AND DENDRITIC CELL NEOPLASMS (HDCN)
Pierluigi Di Mauro
Favorite
Diao, Yarui

Duke University
(P 126) SINGLE-CELL RNA SEQUENCING AND PROTEOMIC SPATIAL PROFILING REVEAL COMPLEX TUMOR MICROENVIRONMENT AND NOVEL IMMUNE INTERACTIONS IN CHONDROSARCOMA
Yarui Diao
Favorite
DIAZ LOPEZ, SEBASTIAN

HOSPITAL VIRGEN DE VALME
(P 321) COMPARATIVE ANALYSIS OF FIRST-LINE DOXORUBICIN-BASED COMBINATION REGIMENS IN METASTATIC LEIOMYOSARCOMA: IMPACT ON SURVIVAL AND DISEASE CONTROL
SEBASTIAN DIAZ LOPEZ
Favorite
Diaz-Montero, Claudia Marcela

Cleveland Clinic
(P 284) THE IMPACT OF SARCOMA SBRT ON THE IMMUNE SYSTEM: EARLY RESULTS FROM A PROSPECTIVE TRIAL
Claudia Marcela Diaz-Montero
Favorite
Dickson, Mark

Memorial Sloan Kettering Cancer Center
(P 187) THERAPEUTIC OUTCOMES IN NF1-ALTERED GIST TREATED WITH MEK INHIBITION: A SINGLE-CENTER EXPERIENCE
Mark Dickson
Favorite
(P 409) RETROSPECTIVE ANALYSIS OF PROGNOSTIC FACTORS INCLUDING HLA GENOTYPE IN MYXOID LIPOSARCOMA
Mark Dickson
Favorite
(P 467) TREATMENT OUTCOMES IN AGGRESSIVE ANGIOMYXOMA: A SINGLE INSTITUTION EXPERIENCE
Mark Dickson
Favorite
Diergaarde, Brenda

UPMC Hillman Cancer Center
(P 63) EVALUATING SURGICAL MARGINS IN SARCOMA RESECTION WITH INDOCYANINE GREEN FLUORESCENCE IMAGING
Brenda Diergaarde
Favorite
Dierselhuis, Miranda

Prinses Máxima Centrum
(P 417) EFFICACY AND SAFETY OF LAROTRECTINIB (LARO) IN PATIENTS (PTS) WITH TRK FUSION SARCOMAS
Miranda Dierselhuis
Favorite
Dietrich, Daniel

Swiss Group of Clinical Cancer Research
(P 436) SAKK 57/24 FEASIBILITY OF TOTAL NEOADJUVANT TREATMENT WITH HYPERTHERMIA IN PATIENTS WITH HIGH-RISK EXTREMITY AND TRUNK SOFT TISSUE SARCOMA. A MULTICENTER, SINGLE ARM, OPEN LABEL, PHASE II TRIAL
Daniel Dietrich
Favorite
Dijkstra, Sander

LUMC
(P 144) THE RISK OF PATHOLOGICAL FRACTURES AFTER INTRALESIONAL CURETTAGE IN ATYPICAL CARTILAGINOUS TUMOURS: A RETROSPECTIVE COHORT STUDY
Sander Dijkstra
Favorite
Dileo, Palma

IRCCS Istituto Ortopedico Rizzoli
(P 416) A PHASE 2 MULTICENTER OPEN-LABEL BASKET STUDY OF TAZEMETOSTAT IN ADULT PATIENTS WITH INI1-NEGATIVE EPITHELIOID SARCOMA – FINAL ANALYSIS
Palma Dileo
Favorite
Dilley, Julian

University of Florida
(P 269) INCIDENCE OF MALIGNANCY IN BIOPSIED PEDIATRIC SOFT TISSUE MASSES
Julian Dilley
Favorite
(P 272) THE HAZARDS OF BIOPSY IN PEDIATRIC SOFT TISSUE SARCOMAS
Julian Dilley
Favorite
Dinart, Derek

Institut Bergonié
(P 324) FULLY MATURE TERTIARY LYMHOID STRUCTURES AS PREDICTORS OF LOCAL RECURRENCE IN SOFT TISSUE SARCOMAS
Derek Dinart
Favorite
Dinerman, Aaron

NCI/NIH
(P 181) THE DEVELOPMENT OF A NOVEL PDGFRA RESISTANCE MUTATION IN A RECURRENT KIT-MUTANT GASTROINTESTINAL STROMAL TUMOR (GIST)
Aaron Dinerman
Favorite
Dingle, Ezekiel

David Geffen School of Medicine at University of California Los Angeles
(P 16) MITOCHONDRIAL GENETIC VARIATION ORCHESTRATES COPZ1 TRANSCRIPT HETEROGENEITY AND REVEALS TELOMERE-MEDIATED VULNERABILITIES IN OSTEOSARCOMA
Ezekiel Dingle
Favorite
(P 72) COUNTY-LEVEL ASSOCIATIONS BETWEEN AIRBORNE TOXICANT EMISSIONS AND EWING SARCOMA DIAGNOSIS IN THE UNITED STATES
Ezekiel Dingle
Favorite
(P 81) ASSESSING PROGNOSTIC FACTORS OF CAUSE-SPECIFIC SURVIVAL IN PATIENTS WITH MALIGNANT GIANT CELL TUMORS: A POPULATION BASED STUDY FROM THE SEER DATABASE
Ezekiel Dingle
Favorite
(P 92) PRIMARY TUMOR SIZE AS AN INDEPENDENT PROGNOSTIC FACTOR IN OSTEOSARCOMA: PROPENSITY SCORE-MATCHED ANALYSIS DEMONSTRATES A CONTINUOUS DOSE-RESPONSE RELATIONSHIP
Ezekiel Dingle
Favorite
(P 107) IS THERE A BETTER OPTION: INTRAMEDULLARY NAIL VERSUS PLATE OSTEOSYNTHESIS FOR PATHOLOGIC HUMERAL FRACTURES?
Ezekiel Dingle
Favorite
(P 108) DISTANCE WEIGHTED MATCHING IN THE QUANTIFICATION OF EXCESS MORBIDITY IN EXTERNAL HEMIPELVECTOMY AND HIP DISARTICULATION
Ezekiel Dingle
Favorite
(P 157) INCOME IMPACTS OVERALL BUT NOT CAUSE-SPECIFIC SURVIVAL IN PATIENTS WITH CHONDROSARCOMA: A POPULATION BASED STUDY FROM THE SEER DATABASE
Ezekiel Dingle
Favorite
(P 232) IS THERE A ROLE FOR POSITRON EMISSION TOMOGRAPHY IN THE STAGING OF LANGERHANS CELL HISTIOCYTOSIS?
Ezekiel Dingle
Favorite
(P 384) PELVIC LOCATION PREDICTS WORSE OUTCOMES IN ALVEOLAR RHABDOMYOSARCOMA: UNDERUSE OF RADIOTHERAPY AND MISSED SURVIVAL BENEFIT
Ezekiel Dingle
Favorite
Diniz, Paulo

Hospital das Clínicas da Universidade Federal de Minas Gerais
(P 128) ISOCITRATE DEHYDROGENASE 1 (IDH1) MUTATION TESTING IN THE PHASE 3 STUDY OF IVOSIDENIB VS PLACEBO IN IDH1-MUTANT CONVENTIONAL CHONDROSARCOMA (CHONQUER)
Paulo Diniz
Favorite
Distel, Luitpold

Department of Radiation Oncology, Universitätsstraße 27, 91054 Erlangen, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Germany
(P 288) IDENTIFICATION OF A DNA REPAIR INHIBITOR FOR THE COMBINATION WITH LURBINECTEDIN AND RADIOTHERAPY IN SARCOMA CELL LINES
Luitpold Distel
Favorite
Divirgilio, Rebecca

Dana-Farber Cancer Institute
(P 427) PHASE 1/2 TRIAL TO EVALUATE THE SAFETY AND EFFICACY OF PEEL-224 IN COMBINATION WITH VINCRISTINE AND TEMOZOLOMIDE IN ADOLESCENTS AND YOUNG ADULTS WITH RELAPSED OR REFRACTORY SARCOMAS
Rebecca Divirgilio
Favorite
Doherty, Mark

St. Vincent's UCD Cancer Centre
(P 211) HEALTH-RELATED QUALITY OF LIFE IN IRISH SARCOMA PATIENTS
Mark Doherty
Favorite
(P 213) FINANCIAL TOXICITY IN IRISH SARCOMA CARE: A SINGLE-CENTRE ANALYSIS
Mark Doherty
Favorite
Doherty, Terence

Dept. of Surgery, Moores Cancer Center, University of California San Diego
(P 197) DIFFERENTIAL EFFECTS OF ANAGRELIDE IN GASTROINTESTINAL STROMAL TUMORS (GIST) IN VITRO
Terence Doherty
Favorite
Doldi, Valentina

Fondazione IRCCS Istituto Nazionale dei Tumori
(P 32) EFFECTIVENESS OF LURBINECTEDIN PLUS IRINOTECAN IN PRECLINICAL MODEL OF DESMOPLASTIC SMALL ROUND CELL TUMOR
Valentina Doldi
Favorite
Dolman, Emmy

Children's Cancer Institute
(P 266) TARGETING THE DNA DAMAGE RESPONSE TO ADVANCE PRECISION THERAPIES IN PAEDIATRIC SARCOMA
Emmy Dolman
Favorite
Donaldson, Ian

Adaptimmune
(P 247) SINGLE-CELL RNA SEQUENCING OF AFAMITRESGENE AUTOLEUCEL INDICATES MECHANISMS OF PERSISTENCE AND ANTI-TUMOR ACTIVITY
Ian Donaldson
Favorite
Donaldson, Nathan

University of Colorado Department of Orthopedics
(P 268) QUALITY OF LIFE OUTCOMES IN PEDIATRIC PATIENTS UNDERGOING SURGICAL INTERVENTION FOR LOWER EXTREMITY BONE SARCOMAS
Nathan Donaldson
Favorite
Dona, Margo

Institute of Biology Leiden, Leiden University
(P 197) DIFFERENTIAL EFFECTS OF ANAGRELIDE IN GASTROINTESTINAL STROMAL TUMORS (GIST) IN VITRO
Margo Dona
Favorite
Donati, Davide Maria

IRCCS Rizzoli Orthopaedic Institute
(P 18) ESTABLISHMENT AND CHARACTERIZATION OF A NOVEL PRIMARY CELL LINE FROM A BONE METASTASIS OF OSTEOSARCOMA
Davide Maria Donati
Favorite
Dong, Haoyao

Department of Anesthesiology, Peking University International Hospital
(P 305) COMPARISON OF GOAL-DIRECTED VERSUS EMPIRICAL TRANSFUSION MANAGEMENT IN PATIENTS WITH SEVERE HEMORRHAGE DURING RETROPERITONEAL TUMOR SURGERY
Haoyao Dong
Favorite
(P 469) THE IMPACT OF PREOPERATIVE ANEMIA ON POSTOPERATIVE COMPLICATIONS AND SHORT-TERM PROGNOSIS IN RETROPERITONEAL TUMOR SURGERY PATIENTS.
Haoyao Dong
Favorite
dongyang, ma

The Second Hospital of HeBei Medical University
(P 469) THE IMPACT OF PREOPERATIVE ANEMIA ON POSTOPERATIVE COMPLICATIONS AND SHORT-TERM PROGNOSIS IN RETROPERITONEAL TUMOR SURGERY PATIENTS.
ma dongyang
Favorite
Donoghue, Mark

Memorial Sloan Kettering Cancer Center
(P 409) RETROSPECTIVE ANALYSIS OF PROGNOSTIC FACTORS INCLUDING HLA GENOTYPE IN MYXOID LIPOSARCOMA
Mark Donoghue
Favorite
Dorleijn, Desirée

Uz Ghent
(P 144) THE RISK OF PATHOLOGICAL FRACTURES AFTER INTRALESIONAL CURETTAGE IN ATYPICAL CARTILAGINOUS TUMOURS: A RETROSPECTIVE COHORT STUDY
Desirée Dorleijn
Favorite
Doshi, Dipam

Springworks Therapeutics, Inc.
(P 357) DEVELOPMENT OF AN ALGORITHM TO IDENTIFY PATIENTS (PT) WITH DESMOID TUMORS (DT) IN A UNITED STATES (US) CLAIMS DATASET
Dipam Doshi
Favorite
(P 364) TRENDS IN SURGICAL MANAGEMENT OF DESMOID TUMOR IN THE VETERANS AFFAIRS (VA) NATIONAL DATABASE
Dipam Doshi
Favorite
Dotterweich, Julia

Merck Healthcare KGaA
(P 42) PRECLINICAL VALIDATION OF M3554, A NOVEL ANTI-GD2 ANTIBODY-DRUG CONJUGATE, AND EPIGENETIC SENSITIZATION STRATEGIES IN SOFT TISSUE SARCOMAS
Julia Dotterweich
Favorite
Dou, Juan

Emory University
(P 21) EXAMINING THE THERAPEUTIC EFFECT OF TBL1/ β-CATENIN TARGETED COMBINATION THERAPIES ON METASTATIC OSTEOSARCOMA
Juan Dou
Favorite
Doung, Yee-Cheen

Oregon Health & Science University
(P 93) INTERCALARY COMPRESSIVE OSSEOINTEGRATION OF DIAPHYSEAL TUMORS: A MULTI-INSTITUTIONAL CASE SERIES
Yee-Cheen Doung
Favorite
(P 364) TRENDS IN SURGICAL MANAGEMENT OF DESMOID TUMOR IN THE VETERANS AFFAIRS (VA) NATIONAL DATABASE
Yee-Cheen Doung
Favorite
Dreher, Rachel

Nationwide Children's Hospital
(P 23) DEFINING THE NONENZYMATIC FUNCTIONS OF LSD1 IN EWING SARCOMA
Rachel Dreher
Favorite
Drilon, Alexander

Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College
(P 417) EFFICACY AND SAFETY OF LAROTRECTINIB (LARO) IN PATIENTS (PTS) WITH TRK FUSION SARCOMAS
Alexander Drilon
Favorite
Druta, Mihaela

Moffitt Cancer Center
(P 247) SINGLE-CELL RNA SEQUENCING OF AFAMITRESGENE AUTOLEUCEL INDICATES MECHANISMS OF PERSISTENCE AND ANTI-TUMOR ACTIVITY
Mihaela Druta
Favorite
(P 394) DUAL OR TRIMODALITY THERAPY VERSUS SURGERY ALONE IN RADIATION-ASSOCIATED ANGIOSARCOMA OF THE BREAST
Mihaela Druta
Favorite
(P 453) OUTCOMES OF PLEOMORPHIC LIPOSARCOMA PATIENTS FOLLOWING MULTI-DISCIPLINARY MANAGEMENT WITHIN A TERTIARY CANCER CENTER
Mihaela Druta
Favorite
DUAN, ZHENFENG

University of Miami
(P 117) THERAPEUTIC POTENTIAL OF DOXORUBICIN AND DASATINIB COMBINATION IN OSTEOSARCOMA
ZHENFENG DUAN
Favorite
(P 131) GLUCOSE TRANSPORTER 1 (GLUT1) INHIBITION DECREASES THE GROWTH AND PROLIFERATION OF CHONDROSARCOMA
ZHENFENG DUAN
Favorite
(P 225) GLOBAL REGISTRY OF SOLITARY FIBROUS TUMORS (SFT): INTEGRATING CLINICAL, MOLECULAR, AND ENVIRONMENTAL DATA- THE HOROWITZ SFT INITIATIVE (HSFTI)
ZHENFENG DUAN
Favorite
DuBois, Steven

Dana-Farber/Boston Children’s Cancer and Blood Disorders Center
(P 168) LEVERAGING LARGE LANGUAGE MODELS FOR STRUCTURED INFORMATION EXTRACTION FROM EWING SARCOMA PATHOLOGY REPORTS
Steven DuBois
Favorite
(P 417) EFFICACY AND SAFETY OF LAROTRECTINIB (LARO) IN PATIENTS (PTS) WITH TRK FUSION SARCOMAS
Steven DuBois
Favorite
(P 427) PHASE 1/2 TRIAL TO EVALUATE THE SAFETY AND EFFICACY OF PEEL-224 IN COMBINATION WITH VINCRISTINE AND TEMOZOLOMIDE IN ADOLESCENTS AND YOUNG ADULTS WITH RELAPSED OR REFRACTORY SARCOMAS
Steven DuBois
Favorite
Dufour, Antoine

Arnie Charbonneau Cancer Institute and McCaig Institute for Bone and Joint Health
(P 238) INVESTIGATING HOW MACROPHAGES INFILTRATE THE TUMOUR MICROENVIRONMENT AND INFLUENCE THE EFFICACY OF CAR T THERAPY IN A MURINE MODEL OF STS
Antoine Dufour
Favorite
(P 378) HIGH DOSE RADIATION THERAPY PROMOTES IMMUNE SUPPRESSIVE MACROPHAGE PHENOTYPES, WHEREAS LOW DOSE RADIATION THERAPY PROMOTES IMMUNOGENIC MACROPHAGE PHENOTYPES IN A MURINE MODEL OF SOFT TISSUE SARCOMA
Antoine Dufour
Favorite
Dunphy, Mallory

Meharry Medical College
(P 310) ATYPICAL SPINDLE CELL PLEOMORPHIC LIPOMATOUS TUMORS OF THE RETROPERITONEUM ARE HETEROGENOUS: A REPORT OF FOUR DISPARATE CASES
Mallory Dunphy
Favorite
Dupont, Christopher

Adaptimmune
(P 247) SINGLE-CELL RNA SEQUENCING OF AFAMITRESGENE AUTOLEUCEL INDICATES MECHANISMS OF PERSISTENCE AND ANTI-TUMOR ACTIVITY
Christopher Dupont
Favorite
Duprée, Anna

Department of General, Visceral and Thoracic Surgery, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
(P 441) COLOSARC-Q: A PROSPECTIVE MULTICENTER STUDY FOR EVALUATING SURGICAL STRATEGIES FOR COLORECTAL RESECTIONS AND POSTOPERATIVE QUALITY OF LIFE IN RETROPERITONEAL SARCOMA PATIENTS
Anna Duprée
Favorite
Duran Sierra, Elvis de Jesus

The University of Texas MD Anderson Cancer Center
(P 311) A FOLLOW-UP STUDY ON THE NOVEL USE OF CONTRAST-ENHANCED SUSCEPTIBILITY-WEIGHTED IMAGING FOR EXTREMITY DESMOID FIBROMATOSIS RESPONSE ASSESSMENT
Elvis de Jesus Duran Sierra
Favorite
(P 317) BUILDING A PRE-SURGICAL MULTIPARAMETRIC-MRI-BASED PREDICTIVE TREATMENT RESPONSE MODEL FOR UNDIFFERENTIATED PLEOMORPHIC SARCOMA TO REPLACE RECIST
Elvis de Jesus Duran Sierra
Favorite
(P 334) MRI VOLUMETRIC AND MODIFIED CHOI-BASED ASSESSMENT OF TREATMENT RESPONSE IN EXTREMITY DESMOID TUMORS TREATED WITH NIROGACESTAT OR SORAFENIB
Elvis de Jesus Duran Sierra
Favorite
(P 406) PILOT STUDY: CAN A MULTIPARAMETRIC MRI-DERIVED MODEL OUTPERFORM RECIST PREDICTING PATHOLOGY RESPONSE IN RHABDOMYOSARCOMA?
Elvis de Jesus Duran Sierra
Favorite
(P 420) THE EFFECT OF CHEMOTHERAPY AND RADIOTHERAPY IN THE MULTIPARAMETRIC MRI-BASED ASSESSMENT OF TREATMENT RESPONSE IN EXTREMITY SOFT-TISSUE UNDIFFERENTIATED PLEOMORPHIC SARCOMA
Elvis de Jesus Duran Sierra
Favorite
Durmaz, Arda

Cleveland Clinic
(P 10) COLLATERAL SENSITIVIES EMERGE DURING THE EVOLUTION OF CHEMORESISTANCE TO MAP CHEMOTHERAPY IN OSTEOSARCOMA
Arda Durmaz
Favorite
Dusch, Martin

Pain Centre, Department of Anesthesiology and Intensive Care, University Medical Centre Mannheim, Medical Faculty Mannheim, Heidelberg University
(P 312) APOSST: A PROSPECTIVE TRIAL TO EVALUATE ACUPUNCTURE AFTER SURGERY OF EXTREMITY SOFT TISSUE TUMORS
Martin Dusch
Favorite
Dutour, Aurelie

Léon Bérard Centre
(P 139) IMMUNOGENOMIC PROFILING OF CHONDROSARCOMA REVEALS DISTINCT IMMUNE PHENOTYPES AND PROGNOSTIC MUTATIONS
Aurelie Dutour
Favorite
Dutta, Ananya

Duke University’
(P 125) TARGETING LCP1-MEDIATED METASTASIS IN CHONDROSARCOMA WITH OROXYLIN A
Ananya Dutta
Favorite
Dybel, Stacey

Department of Pathology, Center for Integrated Diagnostics, Massachusetts General Hospital and Harvard Medical School
(P 45) MONITORING EWSR1 FUSIONS IN SARCOMA PATIENTS USING PERSONALIZED LIQUID BIOPSY ASSAYS
Stacey Dybel
Favorite
Dyer, Michael

St. Jude Children's Research Hospital
(P 267) THE RAF/MEK INHIBITOR VS-6766 SHOWS EFFICACY IN RAS-MUTANT PEDIATRIC PRECLINICAL XENOGRAFT MODELS- A REPORT FROM THE PEDIATRIC PRECLINICAL IN VIVO TESTING CONSORTIUM
Michael Dyer
Favorite
E
Easton, Rachael

Cogent Biosciences
(P 425) BEZUCLASTINIB EXPANDED ACCESS PROGRAM (EAP) FOR PATIENTS WITH GASTROINTESTINAL STROMAL TUMORS (GIST)
Rachael Easton
Favorite
Ebb, David

Massachusetts General Hospital
(P 290) CLINICAL OUTCOMES AFTER RADIOTHERAPY FOR PATIENTS WITH POORLY DIFFERENTIATED CHORDOMA
David Ebb
Favorite
Echebarria-Barona, Aizpea

Hospital Universitario Cruces
(P 71) GERMLINE POLYMORPHISMS IN THE VEGF PATHWAY AS PROGNOSTIC BIOMARKERS IN LOCALIZED HIGH-GRADE OSTEOSARCOMA: A STUDY BASED ON DATA FROM THE GEIS-33 PROTOCOL
Aizpea Echebarria-Barona
Favorite
Echeverri, Claudia

Fundación Colombiana de Cancerología Clínica Vida
(P 219) RETROPERITONEAL SARCOMA: HEALTH SYSTEM BARRIERS AND THE RATIONALE FOR A SPECIALIZED SARCOMA UNIT
Claudia Echeverri
Favorite
(P 301) RETROPERITONEAL SARCOMA: SINGLE CENTER EXPERIENCE IN LATIN AMERICA. DO WE HAVE DIFFERENT SARCOMAS WHEN COMPARED TO THE REST OF THE WORLD?
Claudia Echeverri
Favorite
Eckhoff, Michael

Texas Tech University
(P 84) A MULTICENTER COMPARISON OF REVERSE TOTAL SHOULDER ARTHROPLASTY VERSUS HEMIARTHROPLASTY FOR ENDOPROSTHETIC RECONSTRUCTION FOLLOWING ONCOLOGIC RESECTION OF THE PROXIMAL HUMERUS
Michael Eckhoff
Favorite
Eden, Amir

Department of Genetics, The Hebrew University of Jerusalem, Jerusalem, Israel.
(P 06) RAPID, POINT-OF-CARE DNA METHYLATION & MOLECULAR LANDSCAPE BASED SARCOMA CLASSIFICATION
Amir Eden
Favorite
Ednie, Alexander

Nova Scotia Health Authority
(P 143) IMPACT OF SURGICAL MARGINS IN CHEST WALL CHONDROSARCOMAS: A CANSARCC STUDY
Alexander Ednie
Favorite
Eeles, Christopher

Princess Margaret Cancer Centre, University Health Network
(P 68) MULTI-OMIC INTRA- AND INTER-TUMOR HETEROGENEITY OF BENIGN SMOOTH MUSCLE TUMORS
Christopher Eeles
Favorite
Eghtedari, Cyrus

Case Western Reserve University School of Medicine
(P 457) A RETROSPECTIVE REVIEW OF LOW-GRADE FIBROMYXOID SARCOMA: SURGICAL MANAGEMENT, RADIATION THERAPY, AND OUTCOMES
Cyrus Eghtedari
Favorite
Eguchi, Shiori

New York Medical College
(P 76) CD47 BLOCKADE SYNERGIZES WITH CHEMOTHERAPY IN ENHANCING MACROPHAGE PHAGOCYTOSIS OF EWING SARCOMA CELLS
Shiori Eguchi
Favorite
Eich, Anna

Sarcoma Unit, Department of Surgery, University Medical Centre Mannheim, Medical Faculty Mannheim, Heidelberg University
(P 441) COLOSARC-Q: A PROSPECTIVE MULTICENTER STUDY FOR EVALUATING SURGICAL STRATEGIES FOR COLORECTAL RESECTIONS AND POSTOPERATIVE QUALITY OF LIFE IN RETROPERITONEAL SARCOMA PATIENTS
Anna Eich
Favorite
Ekert, Paul

Children's Cancer Institute
(P 11) ESTABLISHMENT, CHARACTERIZATION AND RESEARCH APPLICATION OF EIGHT NOVEL PATIENT-DERIVED OSTEOSARCOMA CELL LINES
Paul Ekert
Favorite
(P 266) TARGETING THE DNA DAMAGE RESPONSE TO ADVANCE PRECISION THERAPIES IN PAEDIATRIC SARCOMA
Paul Ekert
Favorite
Eldershaw, Ruth

Department of Work and Pensions
(P 207) LONG-TERM FOLLOW-UP AND LATE EFECTS MONITORING FOR UK BONE SARCOMA PATIENTS: A SERVICE MAPPING EXCERCISE
Ruth Eldershaw
Favorite
Elias, Anthony

University of Colorado School of Medicine
(P 234) DOXORUBICIN PLUS BOTENSILIMAB, A NEXT GENERATION CTLA4 INHIBITOR, WITH OR WITHOUT BALSTILIMAB, A PD1 INHIBITOR, IN PATIENTS WITH ADVANCED SOFT TISSUE SARCOMAS
Anthony Elias
Favorite
Elliott, Andrew

Caris Life Sciences
(P 154) BCOR-MUTATED CONVENTIONAL AND DEDIFFERENTIATED CHONDROSARCOMA: A CLINICOPATHOLOGIC STUDY
Andrew Elliott
Favorite
Elliott, Leighton

University of Florida
(P 44) A SYSTEMATIC REVIEW OF FUSION-DRIVEN SARCOMAS
Leighton Elliott
Favorite
(P 129) HIJACKED FUEL: GLYCOGEN-DRIVEN METABOLIC SHIFTS IN IDH1-MUTANT CHONDROSARCOMA
Leighton Elliott
Favorite
(P 248) AN EX VIVO ASSAY TO PREDICT IMMUNOTHERAPY RESPONSE IN SARCOMA
Leighton Elliott
Favorite
(P 275) NEXT GENERATION SEQUENCING IN ADOLESCENT AND YOUNG ADULT (AYA) SARCOMAS: CLINICAL IMPACT, DIAGNOSTIC UTILITY, AND IMPLICATIONS
Leighton Elliott
Favorite
(P 325) FUSION GENES IN SARCOMAS: DIAGNOSTIC APPROACHES AND EMERGING TARGETED THERAPIES
Leighton Elliott
Favorite
(P 401) LONG-TERM OUTCOMES OF IMATINIB-TREATED DERMATOFIBROSARCOMA PROTUBERANS: INSIGHTS FROM A SINGLE-INSTITUTION CASE SERIES
Leighton Elliott
Favorite
ElSenduny, Fardous

Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL, USA
(P 462) HDAC INHIBITORS AS POTENTIAL SFT THERAPIES
Fardous ElSenduny
Favorite
Emanuela, Palmerini

University of Miami
(P 117) THERAPEUTIC POTENTIAL OF DOXORUBICIN AND DASATINIB COMBINATION IN OSTEOSARCOMA
Palmerini Emanuela
Favorite
(P 131) GLUCOSE TRANSPORTER 1 (GLUT1) INHIBITION DECREASES THE GROWTH AND PROLIFERATION OF CHONDROSARCOMA
Palmerini Emanuela
Favorite
(P 225) GLOBAL REGISTRY OF SOLITARY FIBROUS TUMORS (SFT): INTEGRATING CLINICAL, MOLECULAR, AND ENVIRONMENTAL DATA- THE HOROWITZ SFT INITIATIVE (HSFTI)
Palmerini Emanuela
Favorite
(P 369) CLINICAL CHARACTERISTICS & TREATMENT OUTCOME PATTERNS OF SOLITARY FIBROUS TUMORS: A SINGLE-INSTITUTION RETROSPECTIVE ANALYSIS
Palmerini Emanuela
Favorite
Endo, Makoto

Kyushu University
(P 128) ISOCITRATE DEHYDROGENASE 1 (IDH1) MUTATION TESTING IN THE PHASE 3 STUDY OF IVOSIDENIB VS PLACEBO IN IDH1-MUTANT CONVENTIONAL CHONDROSARCOMA (CHONQUER)
Makoto Endo
Favorite
(P 472) LANDSCAPE OF ULTRA-RARE SARCOMAS: A NATIONWIDE STUDY FOR EPIDEMIOLOGY AND PROGNOSIS
Makoto Endo
Favorite
Engelholm, Lars Henning

Finsen Laboratory, Biotech Research and Innovation Centre, University of Copenhagen
(P 36) MODULATION OF THE SARCOMA MICROENVIRONMENT THROUGH β-ADRENERGIC BLOCKADE
Lars Henning Engelholm
Favorite
Engelmann, Bodil Elisabeth

Department of Oncology, Herlev University Hospital
(P 05) CONCORDANCE OF GENOMIC ALTERATIONS WITH CIRCULATING TUMOR DNA: INITIAL FINDINGS FROM A PILOT STUDY
Bodil Elisabeth Engelmann
Favorite
(P 319) CARDIOTOXICITY AND OVERALL SURVIVAL IN PATIENTS WITH SARCOMA TREATED WITH DOXORUBICIN, OLARATUMAB AND DEXRAZOXANE: A REAL-WORLD EXPERIENCE IN DENMARK
Bodil Elisabeth Engelmann
Favorite
Erbasi, Neslihan

Oregon Health & Science University
(P 93) INTERCALARY COMPRESSIVE OSSEOINTEGRATION OF DIAPHYSEAL TUMORS: A MULTI-INSTITUTIONAL CASE SERIES
Neslihan Erbasi
Favorite
Erdem, Zeynep

Leiden University Medical Center
(P 127) AN INTEGRATED CLINICAL GENOMIC AND TRANSCRIPTOMIC SUBGROUPING OF CENTRAL CHONDROSARCOMA
Zeynep Erdem
Favorite
ESCUDIE, Frederic

Institut Universitaire du Cancer de Toulouse
(P 12) DNA REPLICATION STRESS AND DEFICIENT HOMOLOGOUS RECOMBINATION IN OSTEOSARCOMA RISK AND THERAPY
Frederic ESCUDIE
Favorite
Espejo Freire, Andrea

University of Minnesota
(P 418) INTEGRATING SARCULATOR AND PET RESPONSE TO GUIDE NEOADJUVANT TREATMENT DECISIONS IN HIGH-RISK SOFT TISSUE SARCOMA
Andrea Espejo Freire
Favorite
Espinoza, Jossue

The University of Texas MD Anderson Cancer Center
(P 311) A FOLLOW-UP STUDY ON THE NOVEL USE OF CONTRAST-ENHANCED SUSCEPTIBILITY-WEIGHTED IMAGING FOR EXTREMITY DESMOID FIBROMATOSIS RESPONSE ASSESSMENT
Jossue Espinoza
Favorite
(P 317) BUILDING A PRE-SURGICAL MULTIPARAMETRIC-MRI-BASED PREDICTIVE TREATMENT RESPONSE MODEL FOR UNDIFFERENTIATED PLEOMORPHIC SARCOMA TO REPLACE RECIST
Jossue Espinoza
Favorite
(P 334) MRI VOLUMETRIC AND MODIFIED CHOI-BASED ASSESSMENT OF TREATMENT RESPONSE IN EXTREMITY DESMOID TUMORS TREATED WITH NIROGACESTAT OR SORAFENIB
Jossue Espinoza
Favorite
(P 406) PILOT STUDY: CAN A MULTIPARAMETRIC MRI-DERIVED MODEL OUTPERFORM RECIST PREDICTING PATHOLOGY RESPONSE IN RHABDOMYOSARCOMA?
Jossue Espinoza
Favorite
(P 420) THE EFFECT OF CHEMOTHERAPY AND RADIOTHERAPY IN THE MULTIPARAMETRIC MRI-BASED ASSESSMENT OF TREATMENT RESPONSE IN EXTREMITY SOFT-TISSUE UNDIFFERENTIATED PLEOMORPHIC SARCOMA
Jossue Espinoza
Favorite
Esposito, Salvatore

Humanitas University
(P 339) POSTERIOR APPROACH FOR RADICAL RESECTION OF SACROCOCCYGEAL CHORDOMA: A SURGICAL PERSPECTIVE FROM A TERTIARY REFERRAL CENTER
Salvatore Esposito
Favorite
Eubank, Michael

Memorial Sloan Kettering Cancer Center
(P 409) RETROSPECTIVE ANALYSIS OF PROGNOSTIC FACTORS INCLUDING HLA GENOTYPE IN MYXOID LIPOSARCOMA
Michael Eubank
Favorite
Evans, Denisse

Life Raft Group
(P 190) TEMPORAL DECLINE IN PROGRESSION-FREE SURVIVAL, TIME ON MEDICATION, AND OVERALL SURVIVAL IN ADVANCED GASTROINTESTINAL STROMAL TUMOR
Denisse Evans
Favorite
Evans, Elizabeth

Adaptimmune
(P 247) SINGLE-CELL RNA SEQUENCING OF AFAMITRESGENE AUTOLEUCEL INDICATES MECHANISMS OF PERSISTENCE AND ANTI-TUMOR ACTIVITY
Elizabeth Evans
Favorite
Evans, Jeffry

Beatson West of Scotland Cancer Centre, University of Glasgow
(P 431) INVOKE: A PHASE 1 STUDY OF OKN4395, A FIRST-IN-CLASS EP2/EP4/DP1 TRIPLE PROSTANOID RECEPTOR ANTAGONIST, IN PATIENTS WITH ADVANCED SOLID TUMORS, INCLUDING SARCOMAS
Jeffry Evans
Favorite
Evans, Kathryn

Children's Cancer Institute Australia
(P 267) THE RAF/MEK INHIBITOR VS-6766 SHOWS EFFICACY IN RAS-MUTANT PEDIATRIC PRECLINICAL XENOGRAFT MODELS- A REPORT FROM THE PEDIATRIC PRECLINICAL IN VIVO TESTING CONSORTIUM
Kathryn Evans
Favorite
Evans, Mark

Caris Life Sciences
(P 154) BCOR-MUTATED CONVENTIONAL AND DEDIFFERENTIATED CHONDROSARCOMA: A CLINICOPATHOLOGIC STUDY
Mark Evans
Favorite
Evseev, Danyel

Arnie Charbonneau Cancer Institute and McCaig Institute for Bone and Joint Health
(P 238) INVESTIGATING HOW MACROPHAGES INFILTRATE THE TUMOUR MICROENVIRONMENT AND INFLUENCE THE EFFICACY OF CAR T THERAPY IN A MURINE MODEL OF STS
Danyel Evseev
Favorite
(P 378) HIGH DOSE RADIATION THERAPY PROMOTES IMMUNE SUPPRESSIVE MACROPHAGE PHENOTYPES, WHEREAS LOW DOSE RADIATION THERAPY PROMOTES IMMUNOGENIC MACROPHAGE PHENOTYPES IN A MURINE MODEL OF SOFT TISSUE SARCOMA
Danyel Evseev
Favorite
Eward, William

Duke University
(P 19) SERUM EXOSOMES IDENTIFY AN ABERRANT PROTEOMIC SIGNATURE IN CANINE OSTEOSARCOMA PRECEDING METASTATIC PROGRESSION
William Eward
Favorite
(P 84) A MULTICENTER COMPARISON OF REVERSE TOTAL SHOULDER ARTHROPLASTY VERSUS HEMIARTHROPLASTY FOR ENDOPROSTHETIC RECONSTRUCTION FOLLOWING ONCOLOGIC RESECTION OF THE PROXIMAL HUMERUS
William Eward
Favorite
(P 119) DEVELOPMENT OF AN EXTINCTION THERAPY APPROACH FOR OSTEOSARCOMA USING ECO-EVOLUTIONARY PRINCIPLES
William Eward
Favorite
(P 214) FINANCIAL TOXICITY IN PATIENTS WITH A HISTORY OF EXTREMITY AND PELVIC SARCOMA TREATMENT
William Eward
Favorite
(P 259) PRECLINICAL MODELING OF CHEMOTHERAPY RELEASE IDENTIFIES MITOCHONDRIAL ADAPTATIONS IN DOXORUBICIN TREATED OSTEOSARCOMA
William Eward
Favorite
Exter, Ben

Cogent Biosciences
(P 425) BEZUCLASTINIB EXPANDED ACCESS PROGRAM (EAP) FOR PATIENTS WITH GASTROINTESTINAL STROMAL TUMORS (GIST)
Ben Exter
Favorite
F
Fabbroni, Chiara

Fondazione IRCCS Istituto nazionale dei tumori
(P 308) IMPACT OF PSOAS MUSCLE RESECTION ON OUTCOMES IN PRIMARY RETROPERITONEAL DEDIFFERENTIATED LIPOSARCOMA
Chiara Fabbroni
Favorite
(P 331) MAINTENANCE THERAPY (M-TP) WITH DACARBAZINE (DTIC) AFTER FIRST-LINE ANTHRACYCLINE-BASED DOUBLET IN ADVANCED LEIOMYOSARCOMA (LMS) PATIENTS (PTS): OUTCOMES OF A CASE SERIES IN A SINGLE REFERRAL CENTER
Chiara Fabbroni
Favorite
Facchetti, Fabio

Spedali Civili di Brescia
(P 458) BETWEEN LYMPHOMAS AND SARCOMAS: A RETROSPECTIVE, MULTI-INSTITUTIONAL STUDY FROM THE ITALIAN SARCOMA GROUP (ISG) ON HISTIOCYTIC AND DENDRITIC CELL NEOPLASMS (HDCN)
Fabio Facchetti
Favorite
Facklam, Amanda

Pyxis Oncology
(P 29) ANTI-TUMOR ACTIVITY OF MICVOTABART PELIDOTIN IS ASSOCIATED WITH ENZYME GENE EXPRESSION IN PATIENT-DERIVED XENOGRAFT SARCOMA MODELS
Amanda Facklam
Favorite
Faco, Alexandre

MUHC - McGill University Health Center
(P 120) SURVIVAL OUTCOMES AND ROLE OF CHEMOTHERAPY IN PATIENTS OLDER THAN 40 YEARS WITH OSTEOSARCOMA (OLD-SARC STUDY).
Alexandre Faco
Favorite
Fagundes, Djalma

UNIFESP
(P 347) SURVIVAL ANALYSIS AND PROGNOSTIC FACTORS OF SOFT TISSUE SARCOMAS OF THE TRUNK AND EXTREMITIES TREATED BETWEEN 2010 AND 2015: EXPERIENCE OF THE BRAZILIAN NATIONAL CANCER INSTITUTE
Djalma Fagundes
Favorite
Fairweather, Mark

Brigham and Women's Hospital
(P 228) FREQUENCY AND CLARITY OF SURGICAL GOALS FOR TUMOR RESECTION IN ADVANCED SARCOMA
Mark Fairweather
Favorite
Falkenhorst, Johanna

West German Cancer Center, University Duisburg-Essen
(P 182) USING IN VITRO MODELS TO PREDICT IMATINIB RESPONSES OF PDGFRA EXON 18-MUTANT GIST
Johanna Falkenhorst
Favorite
Falkowski, Slawomir

Maria Sklodowska-Curie National Research Institute of Oncology
(P 146) LOCALISED CHONDROSARCOMA PERIOPERATIVE TREATMENT: REAL-WORLD OUTCOMES AND CHALLENGES ACROSS HISTOLOGIC SUBTYPES
Slawomir Falkowski
Favorite
(P 152) EFFICACY OF PALLIATIVE CHEMOTHERAPY AND LOCAL TREATMENTS IN ADVANCED CHONDROSARCOMA: A SUBTYPE-SPECIFIC RETROSPECTIVE ANALYSIS
Slawomir Falkowski
Favorite
Fanburg-Smith, Julie

University of Virginia
(P 199) CHARACTERISTICS OF AN IMMUNOHISTOCHEMICAL AND MOLECULARLY DISCORDANT POPULATION OF GIST PATIENTS: A SINGLE CENTER RETROSPECTIVE REVIEW
Julie Fanburg-Smith
Favorite
Fan, Jiaqian

MD Anderson Cancer Center
(P 47) EWSR1::WT1 FUSION ONCOPROTEIN ACTIVITY SHAPES LINEAGE HETEROGENEITY IN DESMOPLASTIC SMALL ROUND CELL TUMORS
Jiaqian Fan
Favorite
Fanta, Paul T.

University of California San Diego
(P 179) NEOADJUVANT AVAPRITINIB IN PDGFRA-MUTANT GIST: NEAR COMPLETE PATHOLOGICAL RESPONSES AT THE COST OF HIGH ADVERSE EVENT RATES
Paul T. Fanta
Favorite
(P 180) COMPARATIVE EFFICACY OF GENERIC AND BRAND-NAME IMATINIB IN NEOADJUVANT TREATMENT OF KIT EXON 11 MUTANT GIST
Paul T. Fanta
Favorite
Fantoni, Leonardo

IRCCS Rizzoli Orthopaedic Institute
(P 18) ESTABLISHMENT AND CHARACTERIZATION OF A NOVEL PRIMARY CELL LINE FROM A BONE METASTASIS OF OSTEOSARCOMA
Leonardo Fantoni
Favorite
Fan, Wenyi

Moffitt Cancer Center
(P 394) DUAL OR TRIMODALITY THERAPY VERSUS SURGERY ALONE IN RADIATION-ASSOCIATED ANGIOSARCOMA OF THE BREAST
Wenyi Fan
Favorite
Fan, Zhengfu

Department of Bone and Soft Tissue Tumour, Peking University Cancer Hospital, Beijing, China
(P 361) PEXIDARTINIB FOR THE TREATMENT OF TENOSYNOVIAL GIANT CELL TUMORS: CLINICAL EXPERIENCE FROM FIVE CHINESE PATIENTS
Zhengfu Fan
Favorite
Farley, Lauren

Surgical Oncology, Department of Surgery, University of California, Davis
(P 244) INTRATUMORAL TIGIT BLOCKADE AUGMENTS ANTI-TUMOR RESPONSES AND BYPASSES HYPERFUNCTIONALITY OF PERIPHERAL TIGIT+ NK CELLS IN MOUSE AND HUMAN MODELS OF BONE AND SOFT TISSUE SARCOMA
Lauren Farley
Favorite
Farmer, Rebecca

University of Kansas Medical Center
(P 366) WOUND COMPLICATIONS AFTER ULTRA-HYPOFRACTIONATED NEOADJUVANT RADIATION FOR SOFT TISSUE SARCOMA: WHAT IS OPTIMAL SURGICAL TIMING?
Rebecca Farmer
Favorite
Farmer, Trevor

West Virginia University Department of Surgery
(P 30) MYELOPEROXIDASE AS A POTENTIAL THERAPEUTIC TARGET IN SOFT TISSUE SARCOMA
Trevor Farmer
Favorite
Faron, Matthieu

Gustave Roussy Cancer Campus
(P 299) RECURRENCES AFTER PRIMARY RPS SURGERY IN A HIGH-VOLUME SARCOMA CENTER: A RETROSPECTIVE ANALYSIS ON 402 PATIENTS
Matthieu Faron
Favorite
Farooqi, Ahsan

MD Anderson Cancer Center
(P 242) IMMUNE PROFILING OF UNDIFFERENTIATED PLEOMORPHIC SARCOMAS REVEALS DISTINCT PROGNOSTIC SUBGROUPS
Ahsan Farooqi
Favorite
Farrelly, Eileen

Cencora, Inc.
(P 368) ASSESSMENT OF PAIN DIAGNOSIS AND PAIN MEDICATION USE IN ADULTS TREATED WITH NIROGACESTAT: A UNITED STATES REAL-WORLD ANALYSIS
Eileen Farrelly
Favorite
Faulkner, Lisa

Clear Cell Sarcoma Foundation
(P 450) OUTCOMES IN CLEAR CELL SARCOMA: UPDATED INSIGHTS FROM ELECTRONIC HEALTH RECORDS IN A PATIENT-LED REGISTRY
Lisa Faulkner
Favorite
FAU, Magali

Institut Bergonié
(P 390) USE OF DERMAL TEMPLATE FOR NERVE PROTECTION IN LIMB-SPARING SURGERY FOR SOFT TISSUE SARCOMAS: PRELIMINARY EXPERIENCE FROM INSTITUT BERGONIE
Magali FAU
Favorite
Faust, Caitlin

Huntsman Cancer Institute
(P 01) FEASIBILITY OF A QUANTITATIVE METHYLATION-BASED CTDNA ASSAY IN PATIENTS WITH ADVANCED SARCOMAS
Caitlin Faust
Favorite
Favini, Enrica

Fondazione IRCCS Istituto Nazionale dei Tumori
(P 452) EFFECTIVENESS OF ERIBULIN FOR MYXOID PLEOMORPHIC LIPOSARCOMA: INSIGHTS FROM A PATIENT-DERIVED MODEL AND CLINICAL TRANSLATION IN A PATIENT WITH ADVANCED DISEASE
Enrica Favini
Favorite
Fazelzad, Rouhi

Princess Margaret Cancer Centre
(P 346) SURROGATE ENDPOINTS FOR OVERALL SURVIVAL IN ADVANCED SOFT TISSUE SARCOMA TRIALS: A SYSTEMATIC REVIEW AND META-ANALYSIS
Rouhi Fazelzad
Favorite
Federation, Alex

TalusBio
(P 260) MECHANISM AND EFFICACY OF ANTHRACYCLINE MEDIATED EPIGENETIC DISRUPTION IN BONE SARCOMAS.
Alex Federation
Favorite
Federman, Noah

University of California, Los Angeles
(P 413) EFFICACY OF NIROGACESTAT IN PATIENTS WITH DESMOID TUMORS AND PRESENCE OR ABSENCE OF POOR PROGNOSTIC FACTORS: POST HOC ANALYSES OF THE PHASE 3 DEFI TRIAL
Noah Federman
Favorite
(P 417) EFFICACY AND SAFETY OF LAROTRECTINIB (LARO) IN PATIENTS (PTS) WITH TRK FUSION SARCOMAS
Noah Federman
Favorite
Fehnel, Katie

Boston Children's Hospital
(P 290) CLINICAL OUTCOMES AFTER RADIOTHERAPY FOR PATIENTS WITH POORLY DIFFERENTIATED CHORDOMA
Katie Fehnel
Favorite
Feinberg, Galina

Hemato-Oncology Laboratory, Schneider Children's Medical Center of Israel, Petach Tikva, Israel.
(P 06) RAPID, POINT-OF-CARE DNA METHYLATION & MOLECULAR LANDSCAPE BASED SARCOMA CLASSIFICATION
Galina Feinberg
Favorite
Feinberg, Tamar

Memorial Sloan Kettering Cancer Center
(P 26) DEVELOPING AN ORTHOTOPIC MODEL OF DESMOPLASTIC SMALL ROUND CELL TUMOR
Tamar Feinberg
Favorite
(P 237) DEVELOPMENT OF EPHA2 CAR T CELL THERAPY FOR OSTEOSARCOMA
Tamar Feinberg
Favorite
Felser, Brandi

Sarcoma Foundation of America
(P 209) SARCOMA PATIENT COMMUNITY DATA COLLABORATION TO ADVANCE RESEARCH
Brandi Felser
Favorite
Feng, Wei-Lien

National Health Research Institute
(P 428) MAINTENANCE PEGYLATED LIPOSOMAL DOXORUBICIN VERSUS ACTIVE SURVEILLANCE FOR ADVANCED SOFT TISSUE SARCOMA PATIENTS WHO HAD CONTROLLED DISEASE AFTER STANDARD ANTHRACYCLINE-BASED TREATMENT (MELODY)
Wei-Lien Feng
Favorite
Feng, Xiaolan

Tom Baker Cancer Center
(P 128) ISOCITRATE DEHYDROGENASE 1 (IDH1) MUTATION TESTING IN THE PHASE 3 STUDY OF IVOSIDENIB VS PLACEBO IN IDH1-MUTANT CONVENTIONAL CHONDROSARCOMA (CHONQUER)
Xiaolan Feng
Favorite
Feng, Xiaolan

University of Calgary
(P 395) ERIBULIN IN RECURRENT PRETREATED METASTATIC SOFT TISSUE SARCOMA. A CANADIAN SARCOMA RESEARCH AND CLINICAL COLLABORATION (CANSARCC) REAL WORLD ANALYSIS
Xiaolan Feng
Favorite
Feng, Yi

The Second Hospital of Shanxi Medical University
(P 407) PIMICOTINIB IN TENOSYNOVIAL GIANT CELL TUMOR (TGCT): LONG-TERM EFFICACY, SAFETY, AND PATIENT-REPORTED OUTCOMES FROM THE PHASE 3 MANEUVER STUDY
Yi Feng
Favorite
Fenner, Elizabeth

Johns Hopkins University
(P 405) PAN-RAS INHIBITION AS A NOVEL THERAPEUTIC STRATEGY FOR RAS-DRIVEN RHABDOMYOSARCOMA
Elizabeth Fenner
Favorite
Ferguson, Peter

Department of Surgery, Sinai Health
(P 88) THE RAY CHALLENGE: HOW MANY RAY RESECTIONS CAN PATIENTS TOLERATE AND WHICH RAY RESECTIONS AFFECTS FUNCTIONAL OUTCOME THE MOST IN ORTHOPEDIC ONCOLOGY?
Peter Ferguson
Favorite
(P 143) IMPACT OF SURGICAL MARGINS IN CHEST WALL CHONDROSARCOMAS: A CANSARCC STUDY
Peter Ferguson
Favorite
(P 332) MARGINAL EXCISION OF EXTREMITY DEDIFFERENTIATED LIPOSARCOMA WITHOUT RADIATION MAY BE SAFE IN SELECT PATIENTS
Peter Ferguson
Favorite
(P 374) DISTINCT PATTERNS OF METASTATIC SPREAD IN LEIOMYOSARCOMA: A COMPARATIVE ANALYSIS OF TRUNCAL AND EXTREMITY TUMOURS
Peter Ferguson
Favorite
(P 375) DOES STAGED RESECTION WITH TEMPORIZING WOUND VACUUM INFLUENCE LOCAL RECURRENCE RISK? A MULTI-INSTITUTIONAL MATCHED COHORT ANALYSIS
Peter Ferguson
Favorite
Feric Bojic, Elma

Deciphera Pharmaceuticals, LLC
(P 424) AN OPEN-LABEL PHASE 1/2 STUDY OF DCC-3009 MONOTHERAPY IN PATIENTS (PTS) WITH ADVANCED GASTROINTESTINAL STROMAL TUMOR (GIST)
Elma Feric Bojic
Favorite
Fernandez Garrido, Manuel

Hospital Clínic Barcelona
(P 383) MULTIDISCIPLINARY TREATMENT OF INGUINOSCROTAL SARCOMAS: ANALYSIS OF 39 CASES TREATED BY SURGICAL APPROACH
Manuel Fernandez Garrido
Favorite
FERNANDEZ MADRIGAL, LAURA

HOSPITAL JUAN RAMÓN JIMENEZ
(P 321) COMPARATIVE ANALYSIS OF FIRST-LINE DOXORUBICIN-BASED COMBINATION REGIMENS IN METASTATIC LEIOMYOSARCOMA: IMPACT ON SURVIVAL AND DISEASE CONTROL
LAURA FERNANDEZ MADRIGAL
Favorite
Ferrari, Andrea

Fondazione IRCCS Istituto Nazionale dei Tumori
(P 452) EFFECTIVENESS OF ERIBULIN FOR MYXOID PLEOMORPHIC LIPOSARCOMA: INSIGHTS FROM A PATIENT-DERIVED MODEL AND CLINICAL TRANSLATION IN A PATIENT WITH ADVANCED DISEASE
Andrea Ferrari
Favorite
Ferron, Gwenael

OCR
(P 28) ADVANCING PRECISION ONCOLOGY IN SOFT TISSUE SARCOMAS: THE ROLE OF ITRAC IN METASTATIC RISK STRATIFICATION AND TREATMENT PERSONALIZATION
Gwenael Ferron
Favorite
Fetterly, Gerald

Immunome, Inc.
(P 315) ANALYSIS OF CHANGES IN T2-WEIGHTED SIGNAL INTENSITY AND TUMOR VOLUME AND EXPOSURE-RESPONSE IN THE RINGSIDE PHASE 2 STUDY OF VAREGACESTAT FOR DESMOID TUMORS
Gerald Fetterly
Favorite
Fetzer, Erin

The Ohio State University
(P 170) GEMSARC: AN AI BASED PREDICTIVE GENE SIGNATURE FOR GEMCITABINE EFFICACY IN ADVANCED SOFT-TISSUE SARCOMAS
Erin Fetzer
Favorite
(P 408) REAL-WORLD SINGLE-CENTER INSIGHTS INTO CT-DNA DYNAMICS ACROSS SOFT TISSUE SARCOMAS
Erin Fetzer
Favorite
Fice, Michael

Department of Orthopaedic Surgery, University of California Los Angeles
(P 16) MITOCHONDRIAL GENETIC VARIATION ORCHESTRATES COPZ1 TRANSCRIPT HETEROGENEITY AND REVEALS TELOMERE-MEDIATED VULNERABILITIES IN OSTEOSARCOMA
Michael Fice
Favorite
(P 72) COUNTY-LEVEL ASSOCIATIONS BETWEEN AIRBORNE TOXICANT EMISSIONS AND EWING SARCOMA DIAGNOSIS IN THE UNITED STATES
Michael Fice
Favorite
(P 81) ASSESSING PROGNOSTIC FACTORS OF CAUSE-SPECIFIC SURVIVAL IN PATIENTS WITH MALIGNANT GIANT CELL TUMORS: A POPULATION BASED STUDY FROM THE SEER DATABASE
Michael Fice
Favorite
(P 92) PRIMARY TUMOR SIZE AS AN INDEPENDENT PROGNOSTIC FACTOR IN OSTEOSARCOMA: PROPENSITY SCORE-MATCHED ANALYSIS DEMONSTRATES A CONTINUOUS DOSE-RESPONSE RELATIONSHIP
Michael Fice
Favorite
(P 100) THE ROLE OF CANCER TYPE IN THE DEVELOPMENT OF PERIPROSTHETIC JOINT INFECTION IN DISTAL FEMORAL REPLACEMENT
Michael Fice
Favorite
(P 107) IS THERE A BETTER OPTION: INTRAMEDULLARY NAIL VERSUS PLATE OSTEOSYNTHESIS FOR PATHOLOGIC HUMERAL FRACTURES?
Michael Fice
Favorite
(P 108) DISTANCE WEIGHTED MATCHING IN THE QUANTIFICATION OF EXCESS MORBIDITY IN EXTERNAL HEMIPELVECTOMY AND HIP DISARTICULATION
Michael Fice
Favorite
(P 157) INCOME IMPACTS OVERALL BUT NOT CAUSE-SPECIFIC SURVIVAL IN PATIENTS WITH CHONDROSARCOMA: A POPULATION BASED STUDY FROM THE SEER DATABASE
Michael Fice
Favorite
(P 232) IS THERE A ROLE FOR POSITRON EMISSION TOMOGRAPHY IN THE STAGING OF LANGERHANS CELL HISTIOCYTOSIS?
Michael Fice
Favorite
(P 384) PELVIC LOCATION PREDICTS WORSE OUTCOMES IN ALVEOLAR RHABDOMYOSARCOMA: UNDERUSE OF RADIOTHERAPY AND MISSED SURVIVAL BENEFIT
Michael Fice
Favorite
Field, Julie

Dana-Farber Cancer Institute
(P 427) PHASE 1/2 TRIAL TO EVALUATE THE SAFETY AND EFFICACY OF PEEL-224 IN COMBINATION WITH VINCRISTINE AND TEMOZOLOMIDE IN ADOLESCENTS AND YOUNG ADULTS WITH RELAPSED OR REFRACTORY SARCOMAS
Julie Field
Favorite
Fietkau, Rainer

Department of Radiation Oncology, Universitätsstraße 27, 91054 Erlangen, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Germany
(P 288) IDENTIFICATION OF A DNA REPAIR INHIBITOR FOR THE COMBINATION WITH LURBINECTEDIN AND RADIOTHERAPY IN SARCOMA CELL LINES
Rainer Fietkau
Favorite
Fiksen, Lars

Department of Oncology, Herlev University Hospital
(P 319) CARDIOTOXICITY AND OVERALL SURVIVAL IN PATIENTS WITH SARCOMA TREATED WITH DOXORUBICIN, OLARATUMAB AND DEXRAZOXANE: A REAL-WORLD EXPERIENCE IN DENMARK
Lars Fiksen
Favorite
Finetti, pascal

Institut Paoli-Calmettes
(P 59) TARGETING ADORA2B TO HALT METASTASIS IN UNDIFFERENTIATED PLEOMORPHIC SARCOMA: FROM MULTI-OMICS TO THERAPEUTIC INHIBITION
pascal Finetti
Favorite
Fingerle-Rowson, Günter

Tubulis, Inc
(P 34) EXPRESSION OF ONCOFETAL ANTIGEN 5T4 IN SARCOMA SUBTYPES AND PRECLINICAL ACTIVITY OF TUB-030, A NOVEL 5T4-TARGETING ANTIBODY-DRUG CONJUGATE (ADC)
Günter Fingerle-Rowson
Favorite
Fiocco, Marta

Mathematical institute
(P 144) THE RISK OF PATHOLOGICAL FRACTURES AFTER INTRALESIONAL CURETTAGE IN ATYPICAL CARTILAGINOUS TUMOURS: A RETROSPECTIVE COHORT STUDY
Marta Fiocco
Favorite
(P 295) FROM HISTORICAL REFERENCE TO MODERN PRACTICE: WOUND COMPLICATION RATES IN SOFT TISSUE SARCOMA TREATED WITH RADIOTHERAPY ACROSS ERAS
Marta Fiocco
Favorite
Fiore, Marco

Fondazione IRCCS Istituto Nazionale dei Tumori
(P 231) INCREASED LIFETIME RISK (LTR) OF SOFT TISSUE SARCOMAS (STS) IN PATIENTS WITH LOW-RISK GASTROINTESTINAL STROMAL TUMORS (GIST): A RETROSPECTIVE ANALYSIS FROM THE ITALIAN SARCOMA GROUP (ISG)
Marco Fiore
Favorite
(P 307) STRATEGIES FOR DATA QUALITY IN TARPSWG RETROPERITONEAL SARCOMA REGISTRY (RESAR)
Marco Fiore
Favorite
(P 308) IMPACT OF PSOAS MUSCLE RESECTION ON OUTCOMES IN PRIMARY RETROPERITONEAL DEDIFFERENTIATED LIPOSARCOMA
Marco Fiore
Favorite
(P 309) RETROPERITONEAL LIPOMAS: MULTICENTER CLINICAL EXPERIENCE WITH AN EXTREMELY RARE DISEASE ENTITY
Marco Fiore
Favorite
(P 328) INNOVATING SARCOMA EDUCATION: EARLY OUTCOMES OF THE ITALIAN SOCIETY OF SURGICAL ONCOLOGY (SICO) SARCOMA SOCIAL MULTI-PLATFORM JOURNAL CLUB INITIATIVE
Marco Fiore
Favorite
Fischer, Hannah

Sarcoma Unit, Department of Surgery, University Medical Centre Mannheim, Medical Faculty Mannheim, Heidelberg University
(P 312) APOSST: A PROSPECTIVE TRIAL TO EVALUATE ACUPUNCTURE AFTER SURGERY OF EXTREMITY SOFT TISSUE TUMORS
Hannah Fischer
Favorite
Fisher-Wellman, Kelsey

Wake Forest University
(P 259) PRECLINICAL MODELING OF CHEMOTHERAPY RELEASE IDENTIFIES MITOCHONDRIAL ADAPTATIONS IN DOXORUBICIN TREATED OSTEOSARCOMA
Kelsey Fisher-Wellman
Favorite
Fitzgibbon, Gillian

St Vincent's University Hospital
(P 211) HEALTH-RELATED QUALITY OF LIFE IN IRISH SARCOMA PATIENTS
Gillian Fitzgibbon
Favorite
(P 213) FINANCIAL TOXICITY IN IRISH SARCOMA CARE: A SINGLE-CENTRE ANALYSIS
Gillian Fitzgibbon
Favorite
Fjaestad, Klaire Yixin

Herlev and Gentofte Hospital
(P 36) MODULATION OF THE SARCOMA MICROENVIRONMENT THROUGH β-ADRENERGIC BLOCKADE
Klaire Yixin Fjaestad
Favorite
Fleuren, Emmy

Children's Cancer Institute
(P 11) ESTABLISHMENT, CHARACTERIZATION AND RESEARCH APPLICATION OF EIGHT NOVEL PATIENT-DERIVED OSTEOSARCOMA CELL LINES
Emmy Fleuren
Favorite
(P 266) TARGETING THE DNA DAMAGE RESPONSE TO ADVANCE PRECISION THERAPIES IN PAEDIATRIC SARCOMA
Emmy Fleuren
Favorite
Flojo, Renceh

Stanford University
(P 37) DISSECTING THE TUMOR MICROENVIRONMENT OF UTERINE LEIOMYOSARCOMAS FOR TARGETED DRUG PREDICTIONS
Renceh Flojo
Favorite
FLOR ONCALA, MARIA JOSE

HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO
(P 115) SINGLE-CENTER EXPERIENCE WITH TYROSIN KINASA INHIBITORS IN ADVANCED BONE SARCOMA: EFFICACY AND SAFETY OUTCOMES
MARIA JOSE FLOR ONCALA
Favorite
(P 321) COMPARATIVE ANALYSIS OF FIRST-LINE DOXORUBICIN-BASED COMBINATION REGIMENS IN METASTATIC LEIOMYOSARCOMA: IMPACT ON SURVIVAL AND DISEASE CONTROL
MARIA JOSE FLOR ONCALA
Favorite
Flor, Lior

University of British Columbia
(P 178) TREATMENT RESPONSE AND SURVIVAL OUTCOMES IN GASTROINTESTINAL STROMAL TUMORS FOLLOWING NEOADJUVANT THERAPY
Lior Flor
Favorite
Florou, Vaia

Huntsman Cancer Institute
(P 01) FEASIBILITY OF A QUANTITATIVE METHYLATION-BASED CTDNA ASSAY IN PATIENTS WITH ADVANCED SARCOMAS
Vaia Florou
Favorite
Floyd, Warren

M.D. Anderson Cancer Center, University of Texas
(P 58) PLK1 AS A VULNERABLE TARGET OF BAP1-DRIVEN UNDIFFERENTIATED PLEOMORPHIC SARCOMAS
Warren Floyd
Favorite
Flynn, Samantha

Department of Pathology, Massachusetts General Hospital, Harvard Medical School
(P 45) MONITORING EWSR1 FUSIONS IN SARCOMA PATIENTS USING PERSONALIZED LIQUID BIOPSY ASSAYS
Samantha Flynn
Favorite
Fofah, Oluwatosin

Epidemiology, Clinical Safety and Pharmacovigilance, Daiichi Sankyo, Inc., Basking Ridge, NJ, USA
(P 336) PEXIDARTINIB RISK EVALUATION AND MITIGATION STRATEGY PROGRAM: 5-YEAR RETROSPECTIVE HEPATIC SAFETY ASSESSMENT
Oluwatosin Fofah
Favorite
(P 381) KNOWLEDGE, ATTITUDES, AND BEHAVIOR OF HEALTHCARE PROVIDERS ENROLLED IN THE PEXIDARTINIB RISK MITIGATION AND EVALUATION PROGRAM
Oluwatosin Fofah
Favorite
Fojtů, Michaela

SOTIO Biotech a.s.
(P 257) TARGETING LEUCINE-RICH REPEAT-CONTAINING PROTEIN 15 (LRRC15): SOT106 ANTIBODY-DRUG CONJUGATE FOR SOFT TISSUE SARCOMA AND OSTEOSARCOMA TREATMENT
Michaela Fojtů
Favorite
Foppele, Geraldien Florine

Netherlands Cancer Institute
(P 295) FROM HISTORICAL REFERENCE TO MODERN PRACTICE: WOUND COMPLICATION RATES IN SOFT TISSUE SARCOMA TREATED WITH RADIOTHERAPY ACROSS ERAS
Geraldien Florine Foppele
Favorite
Fordham, Ashleigh

Children's Cancer Institute
(P 11) ESTABLISHMENT, CHARACTERIZATION AND RESEARCH APPLICATION OF EIGHT NOVEL PATIENT-DERIVED OSTEOSARCOMA CELL LINES
Ashleigh Fordham
Favorite
Ford, Marvella

Medical University of South Carolina
(P 279) IMPACT OF PREOPERATIVE 5-DAY HYPOFRACTIONATED RADIOTHERAPY (HFRT) FOR SOFT TISSUE SARCOMA (STS) ON BARRIERS TO TREATMENT AT A HIGH-VOLUME SARCOMA CENTER (HV-SC)
Marvella Ford
Favorite
Formiga, Maria N. C.

AC Camargo Cancer Center
(P 155) BRCA2-MUTATED CONVENTIONAL CHONDROSARCOMA RESPONDING TO PARP INHIBITION: A CASE REPORT
Maria N. C. Formiga
Favorite
Fröhling, Stefan

German Cancer Research Center
(P 454) TREATMENT PATTERNS AND OUTCOMES IN RADIATION-INDUCED SARCOMA: FIRST RESULTS OF THE TETRIS-PROJECT - A MULTIMODAL RETROSPECTIVE ANALYSIS FROM A TERTIARY CENTER
Stefan Fröhling
Favorite
(P 455) DEVELOPMENT OF PATIENT-CENTERED INFORMATION MATERIAL ON RADIATION-INDUCED SARCOMA: QUALITATIVE RESULTS FROM FOCUS GROUPS OF THE TETRIS-PROJECT
Stefan Fröhling
Favorite
Frölich, Matthias

Department of Radiology and Nuclear Medicine, University Medical Center Mannheim, Medical Faculty Mannheim, Heidelberg University
(P 367) ADHERENCE TO GERMAN SARCOMA GUIDELINE FOR MRI SEQUENCING IN SOFT TISSUE SARCOMA: EVALUATION OF IMAGING PRACTICES AND COMPLIANCE
Matthias Frölich
Favorite
Franca, Guilherme

Grupo Oncoclinicas
(P 285) MULTICENTER STUDY OF SPATIALLY FRACTIONATED RADIOTHERAPY (LATTICE) FOR LARGE-VOLUME RADIORESISTANT SARCOMAS
Guilherme Franca
Favorite
Franca, Monique

Grupo Oncoclinicas
(P 285) MULTICENTER STUDY OF SPATIALLY FRACTIONATED RADIOTHERAPY (LATTICE) FOR LARGE-VOLUME RADIORESISTANT SARCOMAS
Monique Franca
Favorite
Franceschi, Dido

University of Miami Hospital, Department of Surgical Oncology
(P 201) METASTATIC PATTERNS, TREATMENT MODALITIES, AND OVERALL SURVIVAL IN OLIGOMETASTATIC GIST: A SINGLE-CENTER RETROSPECTIVE STUDY
Dido Franceschi
Favorite
Franchini, Melania

Columbia University Irving Medical Center
(P 25) IDENTIFICATION AND VALIDATION OF NON-GENETICALLY ENCODED VULNERABILITIES IN EWING SARCOMA
Melania Franchini
Favorite
Franke, Bianca

Association of German Tumor Centers, ADT
(P 204) ANALYSIS OF QUALITY INDICATORS OF SOFT TISSUE SARCOMA TREATMENT WITH CANCER REGISTRY DATA IN GERMANY 2015-2021
Bianca Franke
Favorite
Frankel, Daniel

Colorfix
(P 135) EXPLORING THE ROLE OF CLUSTER OF DIFFERENTIATION 44 IN CHONDROSARCOMA
Daniel Frankel
Favorite
Franza, Andrea

ASST Lariana - Ospedale Sant'Anna
(P 331) MAINTENANCE THERAPY (M-TP) WITH DACARBAZINE (DTIC) AFTER FIRST-LINE ANTHRACYCLINE-BASED DOUBLET IN ADVANCED LEIOMYOSARCOMA (LMS) PATIENTS (PTS): OUTCOMES OF A CASE SERIES IN A SINGLE REFERRAL CENTER
Andrea Franza
Favorite
Frazee, Katherine

Mass Eye and Ear
(P 62) INTRAOPERATIVE BONE AND SOFT TISSUE TUMOR MARGIN IDENTIFICATION WITH FLUORESCENCE LIFETIME (FLT) IMAGING
Katherine Frazee
Favorite
Frega, Giorgio

IRCCS Rizzoli Orthopaedic Institute
(P 18) ESTABLISHMENT AND CHARACTERIZATION OF A NOVEL PRIMARY CELL LINE FROM A BONE METASTASIS OF OSTEOSARCOMA
Giorgio Frega
Favorite
(P 139) IMMUNOGENOMIC PROFILING OF CHONDROSARCOMA REVEALS DISTINCT IMMUNE PHENOTYPES AND PROGNOSTIC MUTATIONS
Giorgio Frega
Favorite
FRENOIS, Francois-Xavier

Institut Universitaire du Cancer de Toulouse
(P 12) DNA REPLICATION STRESS AND DEFICIENT HOMOLOGOUS RECOMBINATION IN OSTEOSARCOMA RISK AND THERAPY
Francois-Xavier FRENOIS
Favorite
Frezza, Anna Maria

Fondazione IRCCS Istituto Nazionale Tumori
(P 446) GDF-15 AS A PROGNOSTIC FACTOR IN PATIENTS WITH EPITHELIOID HEMANGIOENDOTHELIOMA
Anna Maria Frezza
Favorite
(P 447) PAIN ASSESSMENT CRITERIA (PAC) ANTICIPATE RECIST PROGRESSION AND CORRELATE WITH BLOOD LEVELS OF GROWTH DIFFERENTIATION FACTOR 15 (GDF15) IN EPITHELIOID HEMANGIOENDOTHELIOMA (EHE)
Anna Maria Frezza
Favorite
(P 458) BETWEEN LYMPHOMAS AND SARCOMAS: A RETROSPECTIVE, MULTI-INSTITUTIONAL STUDY FROM THE ITALIAN SARCOMA GROUP (ISG) ON HISTIOCYTIC AND DENDRITIC CELL NEOPLASMS (HDCN)
Anna Maria Frezza
Favorite
Friedman, Elizabeth

University of Kansas Medical Center
(P 366) WOUND COMPLICATIONS AFTER ULTRA-HYPOFRACTIONATED NEOADJUVANT RADIATION FOR SOFT TISSUE SARCOMA: WHAT IS OPTIMAL SURGICAL TIMING?
Elizabeth Friedman
Favorite
Fritchie, Karen

Cleveland Clinic
(P 284) THE IMPACT OF SARCOMA SBRT ON THE IMMUNE SYSTEM: EARLY RESULTS FROM A PROSPECTIVE TRIAL
Karen Fritchie
Favorite
Frohlich, Dean

Sarcoma Foundation of America
(P 209) SARCOMA PATIENT COMMUNITY DATA COLLABORATION TO ADVANCE RESEARCH
Dean Frohlich
Favorite
Fuchs, Bruno

LUKS University Hospital, Swiss Sarcoma Netowrk
(P 215) SHAPEHUB: A MULTICENTRE REAL-WORLD-TIME DATA PLATFORM WITH DIGITAL TWIN ENGINE FOR A LEARNING HEALTH SYSTEM IN SARCOMA
Bruno Fuchs
Favorite
(P 282) LOCAL FAILURE ANALYSIS OF SOFT TISSUE SARCOMA TREATED WITH PREOPERATIVE ULTRA-HYPOFRACTIONATED RADIATION: UPDATE
Bruno Fuchs
Favorite
(P 283) PALLIATIVE LATTICE RADIATION THERAPY IN SOFT TISSUE SARCOMA VERSUS CARCINOMA AND MELANOMA: OUTCOME COMPARISON
Bruno Fuchs
Favorite
(P 285) MULTICENTER STUDY OF SPATIALLY FRACTIONATED RADIOTHERAPY (LATTICE) FOR LARGE-VOLUME RADIORESISTANT SARCOMAS
Bruno Fuchs
Favorite
Fuchs, Jörg

University Children's Hospital
(P 250) OUTCOME OF INFANTS WITH RHABDOMYOSARCOMA: A REPORT FROM THE INTERNATIONAL SOFT TISSUE SARCOMA CONSORTIUM
Jörg Fuchs
Favorite
Fuchs, Joseph

McGaw Medical Center of Northwestern University
(P 353) TREATMENT OF ADVANCED EPITHELIOID SARCOMA WITH COMBINATION TAZEMETOSTAT AND PEMBROLIZUMAB
Joseph Fuchs
Favorite
(P 429) SINGLE-ARM, OPEN-LABEL PHASE II TRIAL OF XL092 (ZANZALINTINIB) IN PATIENTS WITH ADVANCED LEIOMYOSARCOMA: TRIAL IN PROGRESS
Joseph Fuchs
Favorite
Fujiwara, Tomohiro

Okayama University Hospital
(P 79) AGE-BASED TREATMENT PATTERNS AND OUTCOMES OF LOCALIZED HIGH-GRADE OSTEOSARCOMA FROM A NATIONWIDE DATABASE: WHAT IS THE OPTIMAL STRATEGY FOR PATIENTS OLDER THAN 40 YEARS?
Tomohiro Fujiwara
Favorite
Fujiwara, Toshifumi

Kyushu University
(P 472) LANDSCAPE OF ULTRA-RARE SARCOMAS: A NATIONWIDE STUDY FOR EPIDEMIOLOGY AND PROGNOSIS
Toshifumi Fujiwara
Favorite
Fumagalli, Elena

Medical Oncology Unit 2, Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano
(P 231) INCREASED LIFETIME RISK (LTR) OF SOFT TISSUE SARCOMAS (STS) IN PATIENTS WITH LOW-RISK GASTROINTESTINAL STROMAL TUMORS (GIST): A RETROSPECTIVE ANALYSIS FROM THE ITALIAN SARCOMA GROUP (ISG)
Elena Fumagalli
Favorite
Fumagalli, Elena

Fondazione IRCCS Istituto nazionale dei tumori
(P 331) MAINTENANCE THERAPY (M-TP) WITH DACARBAZINE (DTIC) AFTER FIRST-LINE ANTHRACYCLINE-BASED DOUBLET IN ADVANCED LEIOMYOSARCOMA (LMS) PATIENTS (PTS): OUTCOMES OF A CASE SERIES IN A SINGLE REFERRAL CENTER
Elena Fumagalli
Favorite
Funovics, Philipp

Medical University of Vienna
(P 86) CARBON FIBRE-REINFORCED PEEK IMPLANTS FOR TUMORS OF THE SPINE
Philipp Funovics
Favorite
Funovics, Philipp

University Hospital Vienna
(P 151) SHOULD WE USE ADJUVANT CHEMOTHERAPY IN PATIENTS WITH LOCALIZED DEDIFFERENTIATED CHONDROSARCOMA (DDCS) OF THE PELVIS? AN ANALYSIS BY THE PELVIC DDCS STUDY GROUP
Philipp Funovics
Favorite
Fura, Samuel

University of Miami School of Medicine
(P 362) SHOULD PAZOPANIB BE USED AS A MAINTENANCE THERAPY TO IMPROVE RECURRENCE-FREE SURVIVAL AND OVERALL SURVIVAL IN PATIENTS WHO RECEIVED MAI IN SOFT TISSUE SARCOMA?
Samuel Fura
Favorite
Futreal, P Andrew

MD Anderson Cancer Center
(P 47) EWSR1::WT1 FUSION ONCOPROTEIN ACTIVITY SHAPES LINEAGE HETEROGENEITY IN DESMOPLASTIC SMALL ROUND CELL TUMORS
P Andrew Futreal
Favorite
G
Güler, Sinan E.

Department of Medicine III, LMU University Hospital, Munich, Germany
(P 64) ATRX EXPRESSION CORRELATES WITH REDUCED IMMUNE CHECKPOINT EXPRESSION AND POOR SURVIVAL IN HIGH-RISK SOFT TISSUE SARCOMAS
Sinan E. Güler
Favorite
(P 437) CLINICAL DATA CONFIRM GALENIC PRINCIPLE AND DEMONSTRATE THERAPEUTIC POTENTIAL OF THE001 (DPPG2-TSL-DOX) PLUS REGIONAL HYPERTHERMIA IN SOFT TISSUE SARCOMA
Sinan E. Güler
Favorite
Gündisch, Charlotte

Sarcoma Unit, Department of Surgery, University Medical Centre Mannheim, Medical Faculty Mannheim, Heidelberg University
(P 303) MULTIVISCERAL RESECTIONS AND URINARY TRACT RECONSTRUCTION TECHNIQUES IN THE SURGERY OF RETROPERITONEAL SARCOMAS: A CASE SERIES.
Charlotte Gündisch
Favorite
Gala, Kunal

Tata Memorial Hospital
(P 304) MANAGEMENT OF RECURRENT RETROPERITONEAL SARCOMAS: A RETROSPECTIVE STUDY FROM A TERTIARY CANCER CENTER.
Kunal Gala
Favorite
(P 463) EXTRANODAL FOLLICULAR DENDRITIC CELL SARCOMAS AND THEIR OLIGORECURRENCES: TRIUMPHS, TRIALS AND LESSONS LEARNT AT A SINGLE TERTIARY CANCER REFERRAL CENTRE, INDIA.
Kunal Gala
Favorite
Galanou, Sofia

INSERM
(P 20) IDENTIFICATION OF A PROGNOSTIC GENE SIGNATURE FOR OSTEOSARCOMA RELAPSE BASED ON RESIDUAL TUMOR DISEASE AND ITS MICROENVIRONMENT
Sofia Galanou
Favorite
Galoaa, Bishoy

Massachusetts General Hospital
(P 17) EXTRASKELETAL OSTEOSARCOMA: MICRORNA PATTERNS PROVIDE INSIGHTS INTO SIMILARITIES AND CONTRASTS WITH OTHER SARCOMAS
Bishoy Galoaa
Favorite
(P 173) DEVELOPMENT AND EXTERNAL VALIDATION OF A MACHINE LEARNING ALGORITHM TO PREDICT OVERALL SURVIVAL IN PATIENTS WITH PELVIC OR APPENDICULAR LIPOSARCOMA
Bishoy Galoaa
Favorite
(P 174) BIAS OR BEST FIT? A COMPARATIVE ANALYSIS OF SEER AND NCDB DATASETS IN SINGLE MODEL MACHINE LEARNING FOR PREDICTING OSTEOSARCOMA SURVIVAL OUTCOMES
Bishoy Galoaa
Favorite
Galoian, Karina

1.University of Miami ,Miller School of Medicine, Department of Orthopedic Surgery
(P 31) TARGETING CANCER STEM CELLS BY TYROSINE PEPTIDE ANALOGUE IN REFRACTORY SARCOMA
Karina Galoian
Favorite
Gamanagatti, Shivanand

AIIMS Delhi
(P 276) RADIATION-INDUCED SARCOMA (RIS): CLINICAL SPECTRUM AND ONCOLOGIC OUTCOMES FROM A TERTIARY INDIAN SARCOMA CLINIC
Shivanand Gamanagatti
Favorite
(P 468) CLINICAL UTILITY OF TARGETED NEXT-GENERATION SEQUENCING IN GUIDING SARCOMA DIAGNOSIS AND PERSONALIZED MANAGEMENT: A SINGLE-CENTER STUDY FROM INDIA
Shivanand Gamanagatti
Favorite
Gamanaghatti, Shivanand

All Inidia Institute Of Medical Sciences
(P 435) A PHASE II STUDY OF HIGH DOSE IFOSFAMIDE IN METASTATIC/LOCALLY ADVANCED SYNOVIAL SARCOMA FROM A TERTIARY CARE CENTER IN INDIA
Shivanand Gamanaghatti
Favorite
Gambarotti, Marco

IRCCS Rizzoli Orthopaedic Institute
(P 18) ESTABLISHMENT AND CHARACTERIZATION OF A NOVEL PRIMARY CELL LINE FROM A BONE METASTASIS OF OSTEOSARCOMA
Marco Gambarotti
Favorite
(P 139) IMMUNOGENOMIC PROFILING OF CHONDROSARCOMA REVEALS DISTINCT IMMUNE PHENOTYPES AND PROGNOSTIC MUTATIONS
Marco Gambarotti
Favorite
Gamie, Zakareya

Newcastle Hospitals NHS Trust and Newcastle University
(P 133) INVESTIGATION OF COMBINING MDM2 INHIBITORS WITH DR5 AGONISTS FOR BONE SARCOMA TREATMENT
Zakareya Gamie
Favorite
Ganapathi, Shireen

Seattle Children's Research Institute
(P 256) THE SEAN KARL COHORT: A NATIONAL COLLABORATIVE SINGLE-CELL RNASEQ STUDY OF PAIRED PATIENT EWING SARCOMA SPECIMENS
Shireen Ganapathi
Favorite
(P 260) MECHANISM AND EFFICACY OF ANTHRACYCLINE MEDIATED EPIGENETIC DISRUPTION IN BONE SARCOMAS.
Shireen Ganapathi
Favorite
Gangi, Alex

Cedars Sinai Medical Center
(P 230) CIRCULATING TUMOR DNA AS AN EARLY INDICATOR OF RESPONSE, PROGRESSION, AND RECURRENCE OF SARCOMAS
Alex Gangi
Favorite
(P 433) PHASE I DOSE ESCALATION TRIAL OF STX-001, AN LNP SELF-REPLICATING MRNA EXPRESSING IL-12, IN PATIENTS WITH REFRACTORY TUMORS INCLUDING SARCOMAS
Alex Gangi
Favorite
(P 440) CASE REPORT: COMPLETE CLINICAL AND MOLECULAR RESPONSE TO INTRATUMORAL STX-001, AN LNP-SELF REPLICATING MRNA EXPRESSING IL-12 IN A PATIENT WITH REFRACTORY ANGIOSARCOMA
Alex Gangi
Favorite
(P 471) COMBINATION CHEMOTHERAPY WITH GEMCITABINE AND PACLITAXEL: A HIGHLY EFFICACIOUS AND BETTER TOLERATED OPTION FOR ANGIOSARCOMA
Alex Gangi
Favorite
Ganjoo, Kristen

Stanford Comprehensive Cancer Center
(P 37) DISSECTING THE TUMOR MICROENVIRONMENT OF UTERINE LEIOMYOSARCOMAS FOR TARGETED DRUG PREDICTIONS
Kristen Ganjoo
Favorite
(P 297) ANALYSIS OF CTDNA KINETICS IN PATIENTS WITH METASTATIC LEIOMYOSARCOMA UNDERGOING LOCOREGIONAL PROCEDURAL INTERVENTION
Kristen Ganjoo
Favorite
(P 422) EFFICACY WITH VIMSELTINIB IN PATIENTS (PTS) WITH TENOSYNOVIAL GIANT CELL TUMOR (TGCT) AND PRIOR COLONY-STIMULATING FACTOR 1 (CSF1) INHIBITOR THERAPY: A PHASE 2 CASE SERIES
Kristen Ganjoo
Favorite
Gannamedi, Durga Prasad

University of Miami
(P 24) THE SIRTUIN SIRT5 SUPPORTS EWING SARCOMA SURVIVAL VIA REGULATION OF EWS-FLI1 STABILITY AND ACTIVITY
Durga Prasad Gannamedi
Favorite
(P 60) EXPLORING METABOLIC REWIRING IN CHORDOMA
Durga Prasad Gannamedi
Favorite
(P 253) ELUCIDATING THE ROLE OF SIRT7 IN EWING SARCOMA
Durga Prasad Gannamedi
Favorite
(P 462) HDAC INHIBITORS AS POTENTIAL SFT THERAPIES
Durga Prasad Gannamedi
Favorite
Gao, Dexiang

University of Colorado Cancer Center
(P 234) DOXORUBICIN PLUS BOTENSILIMAB, A NEXT GENERATION CTLA4 INHIBITOR, WITH OR WITHOUT BALSTILIMAB, A PD1 INHIBITOR, IN PATIENTS WITH ADVANCED SOFT TISSUE SARCOMAS
Dexiang Gao
Favorite
Gao, Zhengya

COG Data Center
(P 250) OUTCOME OF INFANTS WITH RHABDOMYOSARCOMA: A REPORT FROM THE INTERNATIONAL SOFT TISSUE SARCOMA CONSORTIUM
Zhengya Gao
Favorite
Garcia, Nicolas

Seattle Children's Research Institute
(P 260) MECHANISM AND EFFICACY OF ANTHRACYCLINE MEDIATED EPIGENETIC DISRUPTION IN BONE SARCOMAS.
Nicolas Garcia
Favorite
Garcia-Ortega, Dorian

National Cancer Institute (Mexico)
(P 302) PREDICTORS AND OUTCOMES OF RECURRENT RETROPERITONEAL SARCOMA: A SINGLE-CENTER LATIN AMERICAN COHORT STUDY
Dorian Garcia-Ortega
Favorite
(P 306) PROGNOSTIC NUTRITIONAL INDEX PREDICTS MAJOR POSTOPERATIVE COMPLICATIONS IN RETROPERITONEAL SARCOMA: RESULTS FROM THE LATAMSARC COHORT
Dorian Garcia-Ortega
Favorite
Garcia, Sarah

Dana-Farber Cancer Institute
(P 427) PHASE 1/2 TRIAL TO EVALUATE THE SAFETY AND EFFICACY OF PEEL-224 IN COMBINATION WITH VINCRISTINE AND TEMOZOLOMIDE IN ADOLESCENTS AND YOUNG ADULTS WITH RELAPSED OR REFRACTORY SARCOMAS
Sarah Garcia
Favorite
Gardner, Paul

University of Pittsburgh
(P 290) CLINICAL OUTCOMES AFTER RADIOTHERAPY FOR PATIENTS WITH POORLY DIFFERENTIATED CHORDOMA
Paul Gardner
Favorite
Garg, Anjali

National Institutes of Health
(P 258) INVESTIGATING THE ROLE OF ALVEOLAR PNEUMOCYTES IN THE LUNG MICROENVIRONMENT OF OSTEOSARCOMA METASTASES
Anjali Garg
Favorite
Garland, Julia

Dana-Farber Cancer Institute
(P 427) PHASE 1/2 TRIAL TO EVALUATE THE SAFETY AND EFFICACY OF PEEL-224 IN COMBINATION WITH VINCRISTINE AND TEMOZOLOMIDE IN ADOLESCENTS AND YOUNG ADULTS WITH RELAPSED OR REFRACTORY SARCOMAS
Julia Garland
Favorite
Garland-Kledzik, Mary

West Virginia University Department of Surgery
(P 30) MYELOPEROXIDASE AS A POTENTIAL THERAPEUTIC TARGET IN SOFT TISSUE SARCOMA
Mary Garland-Kledzik
Favorite
Garofalo, Amanda

Parabilis Medicines
(P 415) A PHASE 1/2 TRIAL OF FOG-001, A FIRST-IN-CLASS DIRECT β-CATENIN:TCF4 INHIBITOR: SAFETY AND PRELIMINARY ANTITUMOR ACTIVITY IN PATIENTS WITH DESMOID TUMORS (DT)
Amanda Garofalo
Favorite
Garofalo, Serena

Università Campus Bio-Medico di Roma
(P 412) UNCOVERING HER2 OVEREXPRESSION IN SOFT TISSUE SARCOMAS (STS): INSIGHTS FROM THE CANCER GENOME ATLAS (TCGA)
Serena Garofalo
Favorite
Garratt, CHris

ORION PHARMA
(P 445) TEADES PH1/2 STUDY WITH ODM-212: PRELIMINARY RESULTS IN EHE PATIENTS
CHris Garratt
Favorite
Gartland, Alison

The University of Sheffield
(P 136) ESTROGEN HAS A PROTECTIVE EFFECT ON CHONDROSARCOMA GROWTH IN VITRO AND IN VIVO
Alison Gartland
Favorite
Garvin II, Lawrence
(P 63) EVALUATING SURGICAL MARGINS IN SARCOMA RESECTION WITH INDOCYANINE GREEN FLUORESCENCE IMAGING
Lawrence Garvin II
Favorite
(P 80) UTILIZATION OF THE MUSCULOSKELETAL ONCOLOGY TUMOR REGISTRY AND TISSUE BANK (MOTOR) FOR THE ACCELERATION OF SARCOMA RESEARCH
Lawrence Garvin II
Favorite
Garzia, Livia

McGill University
(P 15) EZHIP: A NOVEL EPIGENETIC DRIVER OF OSTEOSARCOMA PATHOGENESIS
Livia Garzia
Favorite
(P 73) TARGETABLE GENE DEPENDENCIES IN EWING SARCOMA SUBTYPES
Livia Garzia
Favorite
Gasparini, Patrizia

Fondazione IRCCS Istituto Nazionale dei Tumori
(P 452) EFFECTIVENESS OF ERIBULIN FOR MYXOID PLEOMORPHIC LIPOSARCOMA: INSIGHTS FROM A PATIENT-DERIVED MODEL AND CLINICAL TRANSLATION IN A PATIENT WITH ADVANCED DISEASE
Patrizia Gasparini
Favorite
Gasperoni, Silvia

Clinical Oncology Unit, Oncology Department and Robotic Surgery, AOU Careggi
(P 231) INCREASED LIFETIME RISK (LTR) OF SOFT TISSUE SARCOMAS (STS) IN PATIENTS WITH LOW-RISK GASTROINTESTINAL STROMAL TUMORS (GIST): A RETROSPECTIVE ANALYSIS FROM THE ITALIAN SARCOMA GROUP (ISG)
Silvia Gasperoni
Favorite
Gayle, Sophia

Cybrexa Therapeutics
(P 40) PRECLINICAL EFFICACY OF A PH-SENSITIVE EXATECAN PEPTIDE-DRUG-CONJUGATE IN RHABDOMYOSARCOMA
Sophia Gayle
Favorite
Gazendam, Aaron

Department of Surgery, Sinai Health
(P 143) IMPACT OF SURGICAL MARGINS IN CHEST WALL CHONDROSARCOMAS: A CANSARCC STUDY
Aaron Gazendam
Favorite
(P 374) DISTINCT PATTERNS OF METASTATIC SPREAD IN LEIOMYOSARCOMA: A COMPARATIVE ANALYSIS OF TRUNCAL AND EXTREMITY TUMOURS
Aaron Gazendam
Favorite
Gazzoni, Gabriela

Institute of Medical Assistance to the State Public Servant (IAMSPE), São Paulo, Brazil
(P 404) OUTCOMES OF NEOADJUVANT THERAPY IN ANGIOSARCOMA PATIENTS: A KAPLAN-MEIER-RECONSTRUCTED INDIVIDUAL PATIENT-LEVEL META-ANALYSIS
Gabriela Gazzoni
Favorite
Gebhardt, Mark

Boston Children's Hospital Department of Orthopaedic Surgery
(P 112) PEDIATRIC GIANT CELL TUMOR OF BONE
Mark Gebhardt
Favorite
Geiger, Erik

Department of Orthopaedics, University of Miami
(P 89) PATELLAR HEIGHT AND ITS INFLUENCE ON FUNCTIONAL OUTCOMES FOR MEGAPROSTHESES AROUND THE KNEE PERFORMED FOR ONCOLOGICAL INDICATIONS
Erik Geiger
Favorite
(P 90) MEGAPROSTHESIS CONVERSION FROM FAILED OSTEOARTICULAR ALLOGRAFT VERSUS PRIMARY RECONSTRUCTION FOR DISTAL FEMUR AND PROXIMAL TIBIA TUMORS: A PROPENSITY MATCHED-PAIR ANALYSIS
Erik Geiger
Favorite
Geiger, Erik

University of Miami
(P 99) LIMB SALVAGE FOR PROXIMAL TIBIA TUMORS: OUTCOMES OF ALLOGRAFT-PROSTHESIS COMPOSITE AND ENDOPROSTHETIC RECONSTRUCTION
Erik Geiger
Favorite
Gelderblom, Hans

Leiden University Medical Center
(P 407) PIMICOTINIB IN TENOSYNOVIAL GIANT CELL TUMOR (TGCT): LONG-TERM EFFICACY, SAFETY, AND PATIENT-REPORTED OUTCOMES FROM THE PHASE 3 MANEUVER STUDY
Hans Gelderblom
Favorite
(P 422) EFFICACY WITH VIMSELTINIB IN PATIENTS (PTS) WITH TENOSYNOVIAL GIANT CELL TUMOR (TGCT) AND PRIOR COLONY-STIMULATING FACTOR 1 (CSF1) INHIBITOR THERAPY: A PHASE 2 CASE SERIES
Hans Gelderblom
Favorite
Gelsomini, Andrew

University of Miami
(P 60) EXPLORING METABOLIC REWIRING IN CHORDOMA
Andrew Gelsomini
Favorite
Gennaro, Massimiliano

Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan
(P 277) THE ROLE OF RADIOTHERAPY IN THE MULTIDISCIPLINARY MANAGEMENT OF RADIATION-ASSOCIATED ANGIOSARCOMA OF THE BREAST: A REFERRAL CENTER EXPERIENCE
Massimiliano Gennaro
Favorite
Geoerger, Birgit

Gustave Roussy Cancer Center, Université Paris-Saclay, INSERM U1015
(P 417) EFFICACY AND SAFETY OF LAROTRECTINIB (LARO) IN PATIENTS (PTS) WITH TRK FUSION SARCOMAS
Birgit Geoerger
Favorite
George, Amanda

St. Jude Children's Research Hospital
(P 241) MACROPHAGE INHIBITION ENHANCES PERIPHERAL CAR T CELL EXPANSION AND TUMOR CONTROL IN A PATIENT-DERIVED HUMANIZED MODEL OF AUTOLOGOUS CAR T CELL EFFICACY IN PEDIATRIC OSTEOSARCOMA (OS)
Amanda George
Favorite
George, Suzanne

Division of Sarcoma, Dana-Farber Cancer Institute – Sarcoma Center
(P 184) MTAP IN GASTROINTESTINAL STROMAL TUMOR (GIST): RATE OF MTAP LOSS AND CONCORDANCE BETWEEN GENOMIC SEQUENCING AND IMMUNOHISTOCHEMISTRY
Suzanne George
Favorite
(P 194) UPDATED RESULTS FROM STRATEGIST 1: A PHASE 1/1B STUDY OF IDRX-42 (GSK6042981A) IN PATIENTS (PTS) WITH ADVANCED GASTROINTESTINAL STROMAL TUMORS (GIST)
Suzanne George
Favorite
(P 235) AGNOSTIC INDICATION OF IMMUNE CHECKPOINT INHIBITORS (ICI): PATTERNS OF RESPONSE OF SARCOMAS
Suzanne George
Favorite
(P 423) ZIFTOMENIB IN COMBINATION WITH IMATINIB IN ADVANCED GASTROINTESTINAL STROMAL TUMORS (GIST) AFTER IMATINIB FAILURE: PHASE 1A/B STUDY OF SAFETY, PHARMACOKINETICS, AND ANTITUMOR ACTIVITY
Suzanne George
Favorite
(P 424) AN OPEN-LABEL PHASE 1/2 STUDY OF DCC-3009 MONOTHERAPY IN PATIENTS (PTS) WITH ADVANCED GASTROINTESTINAL STROMAL TUMOR (GIST)
Suzanne George
Favorite
Gerrand, Craig

Royal National Orthopaedic Hospital
(P 156) CHONDROSARCOMA INCIDENCE, SURVIVAL AND MANAGEMENT IN ENGLAND 2013-2022; AN ANALYSIS FROM THE NATIONAL DISEASE REGISTRATION SERVICE
Craig Gerrand
Favorite
Gerstle, Justin

Memorial Sloan Kettering Cancer Center
(P 265) MULTI-SITE SINGLE CELL TRANSCRIPTOMICS REVEAL DISTINCT IMMUNE INFILTRATIVE PATTERNS IN DESMOPLASTIC SMALL ROUND CELL TUMOR
Justin Gerstle
Favorite
(P 273) RADIOMIC PREDICTORS OF SPONTANEOUS PNEUMOTHORAX DURING TYROSINE KINASE INHIBITOR THERAPY FOR LUNG METASTASES
Justin Gerstle
Favorite
Gettleman, Brandon

Department of Orthopaedic Surgery, University of California Los Angeles
(P 16) MITOCHONDRIAL GENETIC VARIATION ORCHESTRATES COPZ1 TRANSCRIPT HETEROGENEITY AND REVEALS TELOMERE-MEDIATED VULNERABILITIES IN OSTEOSARCOMA
Brandon Gettleman
Favorite
(P 72) COUNTY-LEVEL ASSOCIATIONS BETWEEN AIRBORNE TOXICANT EMISSIONS AND EWING SARCOMA DIAGNOSIS IN THE UNITED STATES
Brandon Gettleman
Favorite
(P 81) ASSESSING PROGNOSTIC FACTORS OF CAUSE-SPECIFIC SURVIVAL IN PATIENTS WITH MALIGNANT GIANT CELL TUMORS: A POPULATION BASED STUDY FROM THE SEER DATABASE
Brandon Gettleman
Favorite
(P 92) PRIMARY TUMOR SIZE AS AN INDEPENDENT PROGNOSTIC FACTOR IN OSTEOSARCOMA: PROPENSITY SCORE-MATCHED ANALYSIS DEMONSTRATES A CONTINUOUS DOSE-RESPONSE RELATIONSHIP
Brandon Gettleman
Favorite
(P 107) IS THERE A BETTER OPTION: INTRAMEDULLARY NAIL VERSUS PLATE OSTEOSYNTHESIS FOR PATHOLOGIC HUMERAL FRACTURES?
Brandon Gettleman
Favorite
(P 108) DISTANCE WEIGHTED MATCHING IN THE QUANTIFICATION OF EXCESS MORBIDITY IN EXTERNAL HEMIPELVECTOMY AND HIP DISARTICULATION
Brandon Gettleman
Favorite
(P 157) INCOME IMPACTS OVERALL BUT NOT CAUSE-SPECIFIC SURVIVAL IN PATIENTS WITH CHONDROSARCOMA: A POPULATION BASED STUDY FROM THE SEER DATABASE
Brandon Gettleman
Favorite
(P 232) IS THERE A ROLE FOR POSITRON EMISSION TOMOGRAPHY IN THE STAGING OF LANGERHANS CELL HISTIOCYTOSIS?
Brandon Gettleman
Favorite
(P 384) PELVIC LOCATION PREDICTS WORSE OUTCOMES IN ALVEOLAR RHABDOMYOSARCOMA: UNDERUSE OF RADIOTHERAPY AND MISSED SURVIVAL BENEFIT
Brandon Gettleman
Favorite
Geulen, Julia

Cancer Information Service, German Cancer Research Center (DKFZ)
(P 455) DEVELOPMENT OF PATIENT-CENTERED INFORMATION MATERIAL ON RADIATION-INDUCED SARCOMA: QUALITATIVE RESULTS FROM FOCUS GROUPS OF THE TETRIS-PROJECT
Julia Geulen
Favorite
Ghanad, Erfan

Pain Centre, Department of Anesthesiology and Intensive Care, University Medical Centre Mannheim, Medical Faculty Mannheim, Heidelberg University
(P 312) APOSST: A PROSPECTIVE TRIAL TO EVALUATE ACUPUNCTURE AFTER SURGERY OF EXTREMITY SOFT TISSUE TUMORS
Erfan Ghanad
Favorite
Ghani, Saeed

Helios Klinikum Berlin-Buch and Medical School Berlin, Berlin, Germany
(P 437) CLINICAL DATA CONFIRM GALENIC PRINCIPLE AND DEMONSTRATE THERAPEUTIC POTENTIAL OF THE001 (DPPG2-TSL-DOX) PLUS REGIONAL HYPERTHERMIA IN SOFT TISSUE SARCOMA
Saeed Ghani
Favorite
Ghosh, Kanishka

The Newcastle upon Tyne Hospitals NHS Foundation Trust
(P 314) AN INTERNATIONAL, MULTI-CENTRE STUDY OF SURGICAL MARGINS IN INTERMEDIATE TO HIGH GRADE SARCOMA
Kanishka Ghosh
Favorite
Ghosh, Sujan

Tata Memorial Hospital, Mumbai
(P 286) INTERSTITIAL BRACHYTHERAPY FOR ORGAN AND FUNCTION PRESERVATION IN SOFT TISSUE SARCOMAS: LONG TERM OUTCOMES
Sujan Ghosh
Favorite
Ghos, Kanishka

Hospitals NHS Foundation Trust
(P 151) SHOULD WE USE ADJUVANT CHEMOTHERAPY IN PATIENTS WITH LOCALIZED DEDIFFERENTIATED CHONDROSARCOMA (DDCS) OF THE PELVIS? AN ANALYSIS BY THE PELVIC DDCS STUDY GROUP
Kanishka Ghos
Favorite
Ghuman, Nicole

Univeresity of British Columbia
(P 196) SURVEILLANCE STRATEGIES AND LONG-TERM OUTCOMES IN LOW-RISK GASTRIC GASTROINTESTINAL STROMAL TUMORS (GGISTS)
Nicole Ghuman
Favorite
Giani, Claudia

Fondazione IRCCS Istituto Nazionale Tumori
(P 32) EFFECTIVENESS OF LURBINECTEDIN PLUS IRINOTECAN IN PRECLINICAL MODEL OF DESMOPLASTIC SMALL ROUND CELL TUMOR
Claudia Giani
Favorite
(P 446) GDF-15 AS A PROGNOSTIC FACTOR IN PATIENTS WITH EPITHELIOID HEMANGIOENDOTHELIOMA
Claudia Giani
Favorite
(P 447) PAIN ASSESSMENT CRITERIA (PAC) ANTICIPATE RECIST PROGRESSION AND CORRELATE WITH BLOOD LEVELS OF GROWTH DIFFERENTIATION FACTOR 15 (GDF15) IN EPITHELIOID HEMANGIOENDOTHELIOMA (EHE)
Claudia Giani
Favorite
(P 458) BETWEEN LYMPHOMAS AND SARCOMAS: A RETROSPECTIVE, MULTI-INSTITUTIONAL STUDY FROM THE ITALIAN SARCOMA GROUP (ISG) ON HISTIOCYTIC AND DENDRITIC CELL NEOPLASMS (HDCN)
Claudia Giani
Favorite
Giap, Fantine

Massachusetts General Hospital
(P 461) A RETROSPECTIVE ANALYSIS OF PATIENTS WITH CONVENTIONAL CHORDOMA TREATED WITH SYSTEMIC THERAPY
Fantine Giap
Favorite
Gibbs, C. Parker

University of Florida
(P 129) HIJACKED FUEL: GLYCOGEN-DRIVEN METABOLIC SHIFTS IN IDH1-MUTANT CHONDROSARCOMA
C. Parker Gibbs
Favorite
Giblin, William

University of Michigan
(P 24) THE SIRTUIN SIRT5 SUPPORTS EWING SARCOMA SURVIVAL VIA REGULATION OF EWS-FLI1 STABILITY AND ACTIVITY
William Giblin
Favorite
Giese, alban

Institut Bergonié
(P 59) TARGETING ADORA2B TO HALT METASTASIS IN UNDIFFERENTIATED PLEOMORPHIC SARCOMA: FROM MULTI-OMICS TO THERAPEUTIC INHIBITION
alban Giese
Favorite
Gifford, Andrew

Children's Cancer Institute
(P 11) ESTABLISHMENT, CHARACTERIZATION AND RESEARCH APPLICATION OF EIGHT NOVEL PATIENT-DERIVED OSTEOSARCOMA CELL LINES
Andrew Gifford
Favorite
Gilbertson, Riley

School of Medicine, Vanderbilt University, Nashville, TN, USA
(P 85) MAKING NEGATIVE MARGIN MUSCULOSKELETAL TUMOR SURGERY A VIRTUAL REALITY USING 3D SPECIMEN SCANNING
Riley Gilbertson
Favorite
Gilbertson, Riley

Vanderbilt University School of Medicine
(P 97) RISK FACTORS ASSOCIATED WITH AMPUTATION VERSUS CONTINUED LIMB SALVAGE IN LOWER EXTREMITY ENDOPROSTHETIC RECONSTRUCTION
Riley Gilbertson
Favorite
Gillani, Riaz

Boston Children's
(P 256) THE SEAN KARL COHORT: A NATIONAL COLLABORATIVE SINGLE-CELL RNASEQ STUDY OF PAIRED PATIENT EWING SARCOMA SPECIMENS
Riaz Gillani
Favorite
Gillis, Amy

Tallaght University Hospital
(P 211) HEALTH-RELATED QUALITY OF LIFE IN IRISH SARCOMA PATIENTS
Amy Gillis
Favorite
(P 213) FINANCIAL TOXICITY IN IRISH SARCOMA CARE: A SINGLE-CENTRE ANALYSIS
Amy Gillis
Favorite
Gillis, Roni

Shaare Zedek Medical Center
(P 326) GERMLINE POT1 MUTATIONS IN ANGIOSARCOMA DIFFER FROM SOMATIC MUTATIONS
Roni Gillis
Favorite
Gill, Jonathan

MD Anderson Cancer Center
(P 427) PHASE 1/2 TRIAL TO EVALUATE THE SAFETY AND EFFICACY OF PEEL-224 IN COMBINATION WITH VINCRISTINE AND TEMOZOLOMIDE IN ADOLESCENTS AND YOUNG ADULTS WITH RELAPSED OR REFRACTORY SARCOMAS
Jonathan Gill
Favorite
Ginn, Madison

University of Texas Health Sciences Center at Houston
(P 411) TFCP2 FUSION-POSITVE RHABDOMYOSARCOMAS: A REPORT OF 10 CASES AND A REVIEW OF THE LITERATURE
Madison Ginn
Favorite
Girgis, Andrew

Massachusetts General Hospital
(P 173) DEVELOPMENT AND EXTERNAL VALIDATION OF A MACHINE LEARNING ALGORITHM TO PREDICT OVERALL SURVIVAL IN PATIENTS WITH PELVIC OR APPENDICULAR LIPOSARCOMA
Andrew Girgis
Favorite
(P 174) BIAS OR BEST FIT? A COMPARATIVE ANALYSIS OF SEER AND NCDB DATASETS IN SINGLE MODEL MACHINE LEARNING FOR PREDICTING OSTEOSARCOMA SURVIVAL OUTCOMES
Andrew Girgis
Favorite
(P 402) LYMPH NODE METASTASES IN SOFT TISSUE SARCOMA: A DATABASE ANALYSIS
Andrew Girgis
Favorite
Girod, Miguel

Mayo Clinic, Rochester
(P 166) LARGE LANGUAGE MODEL EXTRACTION OF STRUCTURED DATA IN UNSTRUCTURED SARCOMA PATHOLOGY NOTES: A PILOT STUDY
Miguel Girod
Favorite
(P 167) LARGE LANGUAGE MODEL EXTRACTION OF STRUCTURED DATA FROM UNSTRUCTURED RADIATION ONCOLOGY NOTES: A PILOT STUDY
Miguel Girod
Favorite
Gitelis, Steven

Rush University Medical Center
(P 104) 3D PRINTED CUTTING GUIDES FOR LONG BONE SARCOMA RESECTION AND INTERCALARY ALLOGRAFT RECONSTRUCTION: A CASE SERIES
Steven Gitelis
Favorite
(P 113) ASSESSING TREATMENT OUTCOMES OF CHONDROMYXOID FIBROMA: A CASE SERIES
Steven Gitelis
Favorite
(P 206) IMPACT OF PROXIMITY TO HEALTH CENTER ON ADHERENCE TO NATIONAL COMPREHENSIVE CANCER NETWORK GUIDELINES IN PATIENTS WITH SOFT TISSUE SARCOMAS
Steven Gitelis
Favorite
Giusti, Veronica

IRCCS Rizzoli Orthopaedic Institute
(P 18) ESTABLISHMENT AND CHARACTERIZATION OF A NOVEL PRIMARY CELL LINE FROM A BONE METASTASIS OF OSTEOSARCOMA
Veronica Giusti
Favorite
Gladdy, Rebecca

Mount Sinai Hospital
(P 210) TOWARDS INTERNATIONALIZATION OF THE CLINICAL RESEARCH COORDINATOR ROLE: THE FIRST DROP OF THE NIAGARA FALLS PROJECT
Rebecca Gladdy
Favorite
(P 323) EVALUATION OF COSMIC MUTATIONAL SIGNATURES IN SOFT TISSUE SARCOMA
Rebecca Gladdy
Favorite
(P 465) JAK/STAT PATHWAY CO-OPERATES WITH CIC-FUSIONS TODRIVE CIC-REARRANGED SARCOMAS
Rebecca Gladdy
Favorite
Glade Bender, Julia

Memorial Sloan Kettering Cancer Center
(P 419) PROSPECTIVE REAL-WORLD STUDY OF LAROTRECTINIB (LARO) IN PATIENTS (PTS) WITH TRK FUSION SOLID TUMORS: INTERIM ANALYSIS OF ON-TRK
Julia Glade Bender
Favorite
GLANZMANN, Christoph

LUKS
(P 282) LOCAL FAILURE ANALYSIS OF SOFT TISSUE SARCOMA TREATED WITH PREOPERATIVE ULTRA-HYPOFRACTIONATED RADIATION: UPDATE
Christoph GLANZMANN
Favorite
(P 283) PALLIATIVE LATTICE RADIATION THERAPY IN SOFT TISSUE SARCOMA VERSUS CARCINOMA AND MELANOMA: OUTCOME COMPARISON
Christoph GLANZMANN
Favorite
Glanzmann, Christoph

Luzerner Kantonsspital, Klinik für Radio-Onkologie
(P 285) MULTICENTER STUDY OF SPATIALLY FRACTIONATED RADIOTHERAPY (LATTICE) FOR LARGE-VOLUME RADIORESISTANT SARCOMAS
Christoph Glanzmann
Favorite
Goßmann, Frank

Bavarian Cancer Registry, Regional Center Würzburg, Bavarian Health and Food Safety Authority, Würzburg, Germany
(P 204) ANALYSIS OF QUALITY INDICATORS OF SOFT TISSUE SARCOMA TREATMENT WITH CANCER REGISTRY DATA IN GERMANY 2015-2021
Frank Goßmann
Favorite
Gobo Silva, Maria Leticia

A.C.Camargo Cancer Center
(P 278) NEOADJUVANT HYPOFRACTIONATED RADIOTHERAPY AND CHEMOTHERAPY IN EXTREMITY SOFT TISSUE SARCOMAS
Maria Leticia Gobo Silva
Favorite
Godin, Rebecca

Precision NextGen Oncology
(P 230) CIRCULATING TUMOR DNA AS AN EARLY INDICATOR OF RESPONSE, PROGRESSION, AND RECURRENCE OF SARCOMAS
Rebecca Godin
Favorite
(P 433) PHASE I DOSE ESCALATION TRIAL OF STX-001, AN LNP SELF-REPLICATING MRNA EXPRESSING IL-12, IN PATIENTS WITH REFRACTORY TUMORS INCLUDING SARCOMAS
Rebecca Godin
Favorite
(P 440) CASE REPORT: COMPLETE CLINICAL AND MOLECULAR RESPONSE TO INTRATUMORAL STX-001, AN LNP-SELF REPLICATING MRNA EXPRESSING IL-12 IN A PATIENT WITH REFRACTORY ANGIOSARCOMA
Rebecca Godin
Favorite
(P 471) COMBINATION CHEMOTHERAPY WITH GEMCITABINE AND PACLITAXEL: A HIGHLY EFFICACIOUS AND BETTER TOLERATED OPTION FOR ANGIOSARCOMA
Rebecca Godin
Favorite
Godoy Almeida, Gustavo

University of Iowa Health Care
(P 343) PROGRESSION FREE SURVIVAL OF IMMUNE CHECKPOINT INHIBITORS IN THE FIRST-LINE TREATMENT OF METASTATIC SARCOMA: A SINGLE CENTER RETROSPECTIVE ANALYSIS.
Gustavo Godoy Almeida
Favorite
(P 370) CLINICAL OUTCOMES OF CUTANEOUS UNDIFFERENTIATED PLEOMORPHIC SARCOMA AND SUBCUTANEOUS MYXOFIBROSARCOMA: A RETROSPECTIVE REVIEW
Gustavo Godoy Almeida
Favorite
(P 371) CLINICAL PROFILE AND TREATMENT PATTERNS OF ANGIOSARCOMA IN THE REAL- WORLD SETTING: A SINGLE CENTER EXPERIENCE FROM 1991-2024.
Gustavo Godoy Almeida
Favorite
Goel, Mahesh

Tata Memorial Hospital
(P 304) MANAGEMENT OF RECURRENT RETROPERITONEAL SARCOMAS: A RETROSPECTIVE STUDY FROM A TERTIARY CANCER CENTER.
Mahesh Goel
Favorite
(P 463) EXTRANODAL FOLLICULAR DENDRITIC CELL SARCOMAS AND THEIR OLIGORECURRENCES: TRIUMPHS, TRIALS AND LESSONS LEARNT AT A SINGLE TERTIARY CANCER REFERRAL CENTRE, INDIA.
Mahesh Goel
Favorite
Goepfert, Ryan

University of Texas MD Anderson Cancer Center
(P 83) OUTCOMES OF MULTIMODAL PERIOPERATIVE TREATMENT IN OSTEOSARCOMAS OF THE JAW
Ryan Goepfert
Favorite
Goh, Megan

Massachusetts General Hospital
(P 87) ACUTE PATHOLOGICAL LONG BONE FRACTURES: WEEKEND VERSUS WEEKDAY VARIATIONS AND THEIR CLINICAL IMPACT
Megan Goh
Favorite
(P 91) A COMPARISON OF ACETABULAR AUGMENTATION AND PHOTODYNAMIC NAIL STABILIZATION FOR COMPLEX ONCOLOGIC TOTAL HIP ARTHROPLASTY
Megan Goh
Favorite
(P 174) BIAS OR BEST FIT? A COMPARATIVE ANALYSIS OF SEER AND NCDB DATASETS IN SINGLE MODEL MACHINE LEARNING FOR PREDICTING OSTEOSARCOMA SURVIVAL OUTCOMES
Megan Goh
Favorite
(P 402) LYMPH NODE METASTASES IN SOFT TISSUE SARCOMA: A DATABASE ANALYSIS
Megan Goh
Favorite
Gokgoz, Nalan

The Lunenfeld-Tanenbaum Research Institute
(P 55) THE EFFECT OF STAT1 Y701 PHOSPHORYLATION ON GENE EXPRESSION IN UPS
Nalan Gokgoz
Favorite
Gokgoz, Nalan

Mount Sinai Hospital
(P 323) EVALUATION OF COSMIC MUTATIONAL SIGNATURES IN SOFT TISSUE SARCOMA
Nalan Gokgoz
Favorite
Golden, Lexi

University of Michigan Medical School
(P 50) A NEW MURINE MODEL OF DEDIFFERENTIATED LIPOSARCOMA DEFINED BY HIGH PROLIFERATION AND METABOLIC ADAPTABILITY
Lexi Golden
Favorite
(P 52) VALIDATION OF SYNGENEIC MURINE DEDIFFERENTIATED LIPOSARCOMA MODELS FOR PRECLINICAL EVALUATION OF THERAPEUTIC SENSITIVITY
Lexi Golden
Favorite
Golik, Paweł

Institute of Genetics and Biotechnology, Faculty of Biology, University of Warsaw
(P 27) MOLECULAR CHARACTERIZATION OF RESPONSE TO NEOADJUVANT CHEMORADIATION IN PATIENTS WITH LOCALLY ADVANCED SOFT TISSUE SARCOMAS
Paweł Golik
Favorite
Golik, Paweł

University of Warsaw
(P 134) INTEGRATIVE MICRORNA PROFILING IN CHONDROSARCOMA: TOWARD BIOMARKER DISCOVERY AND PROGNOSTIC SIGNATURE DEVELOPMENT
Paweł Golik
Favorite
(P 139) IMMUNOGENOMIC PROFILING OF CHONDROSARCOMA REVEALS DISTINCT IMMUNE PHENOTYPES AND PROGNOSTIC MUTATIONS
Paweł Golik
Favorite
Gomez-Mascard, Anne

Institut Universitaire du Cancer de Toulouse
(P 12) DNA REPLICATION STRESS AND DEFICIENT HOMOLOGOUS RECOMBINATION IN OSTEOSARCOMA RISK AND THERAPY
Anne Gomez-Mascard
Favorite
(P 20) IDENTIFICATION OF A PROGNOSTIC GENE SIGNATURE FOR OSTEOSARCOMA RELAPSE BASED ON RESIDUAL TUMOR DISEASE AND ITS MICROENVIRONMENT
Anne Gomez-Mascard
Favorite
Gomez-Puerto, Diego

Vall d'Hebron Institute of Oncology / Vall d'Hebron University Hospital
(P 389) UNRESECTABLE AND METASTATIC DEDIFFERENTIATED LIPOSARCOMA (DDLPS): INSIGHTS FROM A MULTICENTER REAL-WORLD COHORT (RWC)
Diego Gomez-Puerto
Favorite
Gonçalves, Amanda

Stanford University
(P 37) DISSECTING THE TUMOR MICROENVIRONMENT OF UTERINE LEIOMYOSARCOMAS FOR TARGETED DRUG PREDICTIONS
Amanda Gonçalves
Favorite
Gonda, Bianca

Department of Pathology, Massachusetts General Hospital, Harvard Medical School
(P 45) MONITORING EWSR1 FUSIONS IN SARCOMA PATIENTS USING PERSONALIZED LIQUID BIOPSY ASSAYS
Bianca Gonda
Favorite
Gong, Matthew

University of Pittsburgh Medical Center
(P 63) EVALUATING SURGICAL MARGINS IN SARCOMA RESECTION WITH INDOCYANINE GREEN FLUORESCENCE IMAGING
Matthew Gong
Favorite
González López, Jose Antonio

Hospital de la Santa Creu i Sant Pau
(P 383) MULTIDISCIPLINARY TREATMENT OF INGUINOSCROTAL SARCOMAS: ANALYSIS OF 39 CASES TREATED BY SURGICAL APPROACH
Jose Antonio González López
Favorite
González Abós, Sandra

Hospital Universitari Mútua de Terrassa
(P 383) MULTIDISCIPLINARY TREATMENT OF INGUINOSCROTAL SARCOMAS: ANALYSIS OF 39 CASES TREATED BY SURGICAL APPROACH
Sandra González Abós
Favorite
Gonzalez, Marcos R.

Massachusetts General Hospital Department of Orthopaedic Surgery
(P 91) A COMPARISON OF ACETABULAR AUGMENTATION AND PHOTODYNAMIC NAIL STABILIZATION FOR COMPLEX ONCOLOGIC TOTAL HIP ARTHROPLASTY
Marcos R. Gonzalez
Favorite
(P 105) TREATMENT SUCCESS RATE AFTER SURGICAL MANAGEMENT OF PERIPROSTHETIC JOINT INFECTIONS IN ONCOLOGIC PROXIMAL TIBIA RECONSTRUCTION
Marcos R. Gonzalez
Favorite
(P 112) PEDIATRIC GIANT CELL TUMOR OF BONE
Marcos R. Gonzalez
Favorite
(P 118) IMPACT OF TYROSINE KINASE INHIBITOR THERAPY ON BONE PROGRESSION IN PATIENTS WITH DRIVER-MUTATED METASTATIC NON-SMALL CELL LUNG CANCER WITH DE NOVO BONE METASTASES
Marcos R. Gonzalez
Favorite
(P 173) DEVELOPMENT AND EXTERNAL VALIDATION OF A MACHINE LEARNING ALGORITHM TO PREDICT OVERALL SURVIVAL IN PATIENTS WITH PELVIC OR APPENDICULAR LIPOSARCOMA
Marcos R. Gonzalez
Favorite
(P 174) BIAS OR BEST FIT? A COMPARATIVE ANALYSIS OF SEER AND NCDB DATASETS IN SINGLE MODEL MACHINE LEARNING FOR PREDICTING OSTEOSARCOMA SURVIVAL OUTCOMES
Marcos R. Gonzalez
Favorite
(P 205) CENTRALIZATION OF SARCOMA CARE IMPROVES OUTCOMES DESPITE POORER PRESENTATION: A SYSTEMATIC REVIEW AND META-ANALYSIS
Marcos R. Gonzalez
Favorite
(P 294) RISK FACTORS FOR RECURRENCE AND COMPLICATIONS OF CT-GUIDED RADIOFREQUENCY ABLATION FOR THE TREATMENT OF OSTEOID OSTEOMA: A MULTI-INSTITUTIONAL ANALYSIS.
Marcos R. Gonzalez
Favorite
(P 392) CLASSIFICATION AND DIFFERENTIATIONOF MYXOID LIPOSARCOMA AND MYXOMA WITH MACHINE LEARNING
Marcos R. Gonzalez
Favorite
(P 392) DIFFERENTIATION OF MYXOMA AND MYXOID LIPOSARCOMA BASED ON RADIOMICS PHENOTYPES
Marcos R. Gonzalez
Favorite
(P 402) LYMPH NODE METASTASES IN SOFT TISSUE SARCOMA: A DATABASE ANALYSIS
Marcos R. Gonzalez
Favorite
Gonzalez, Ricardo

Moffitt Cancer Center
(P 394) DUAL OR TRIMODALITY THERAPY VERSUS SURGERY ALONE IN RADIATION-ASSOCIATED ANGIOSARCOMA OF THE BREAST
Ricardo Gonzalez
Favorite
(P 453) OUTCOMES OF PLEOMORPHIC LIPOSARCOMA PATIENTS FOLLOWING MULTI-DISCIPLINARY MANAGEMENT WITHIN A TERTIARY CANCER CENTER
Ricardo Gonzalez
Favorite
Gordon, Erlinda

Sarcoma Oncology Center
(P 233) DNG64-CAR-V+ REGIMEN SHOWS CLINICAL BENEFIT IN PATIENTS WITH ADVANCED CCNG1 ONCOGENE EXPRESSING SARCOMAS (NCT04091295)
Erlinda Gordon
Favorite
(P 388) TRIAL IN PROGRESS: A PHASE 2 STUDY OF METRONOMIC TRABECTEDIN, GEMCITIBAINE, AND DACARBAZINE IN PREVIOUSLY TREATED ADVANCED SOFT TISSUE SARCOMA (NCT04535271)
Erlinda Gordon
Favorite
(P 396) EVALUATING THE SAFETY AND EFFICACY OF METRONOMIC GEMCITABINE, DOXORUBICIN, AND DOCETAXEL PLUS NIVOLUMAB IN PREVIOUSLY TREATED ADVANCED LEIOMYOSARCOMA AND LIPOSARCOMA: A PHASE 2 STUDY (NCT04535713)
Erlinda Gordon
Favorite
(P 398) INVESTIGATING THE SAFETY AND EFFICACY OF LURBINECTEDIN WITH IPILIMUMAB AND NIVOLUMAB FOR ADVANCED SOFT TISSUE SARCOMA: LINNOVATE PHASE 1/2 STUDY (NCT05876715)
Erlinda Gordon
Favorite
(P 432) EXPANSION OF A PHASE 1 STUDY OF SON-1010 (IL12-FHAB) ADDING TRABECTEDIN IN SOFT TISSUE SARCOMA: TRIAL IN PROGRESS
Erlinda Gordon
Favorite
Gordon, Michael

HonorHealth Research Institute
(P 424) AN OPEN-LABEL PHASE 1/2 STUDY OF DCC-3009 MONOTHERAPY IN PATIENTS (PTS) WITH ADVANCED GASTROINTESTINAL STROMAL TUMOR (GIST)
Michael Gordon
Favorite
Gorgels, Daniël

KU Leuven
(P 33) THE NOVEL TRANSCRIPTIONAL INHIBITORS ECUBECTEDIN AND PM54 DEMONSTRATE ANTITUMOR ACTIVITY IN PATIENT-DERIVED XENOGRAFT MODELS OF SOFT TISSUE SARCOMA
Daniël Gorgels
Favorite
(P 70) EPIDEMIOLOGY AND POTENTIAL CLINICAL RELEVANCE OF CONTACTIN-4 EXPRESSION IN SOFT TISSUE SARCOMA
Daniël Gorgels
Favorite
Gorgone, Pierangelo

Università Campus Bio-Medico di Roma
(P 412) UNCOVERING HER2 OVEREXPRESSION IN SOFT TISSUE SARCOMAS (STS): INSIGHTS FROM THE CANCER GENOME ATLAS (TCGA)
Pierangelo Gorgone
Favorite
Gorlick, Richard

UT MD Anderson Cancer Center
(P 83) OUTCOMES OF MULTIMODAL PERIOPERATIVE TREATMENT IN OSTEOSARCOMAS OF THE JAW
Richard Gorlick
Favorite
Gottschalk, Stephen

St. Jude Children's Research Hospital
(P 241) MACROPHAGE INHIBITION ENHANCES PERIPHERAL CAR T CELL EXPANSION AND TUMOR CONTROL IN A PATIENT-DERIVED HUMANIZED MODEL OF AUTOLOGOUS CAR T CELL EFFICACY IN PEDIATRIC OSTEOSARCOMA (OS)
Stephen Gottschalk
Favorite
Gouin, Francois

Centre Léon Bérard
(P 151) SHOULD WE USE ADJUVANT CHEMOTHERAPY IN PATIENTS WITH LOCALIZED DEDIFFERENTIATED CHONDROSARCOMA (DDCS) OF THE PELVIS? AN ANALYSIS BY THE PELVIC DDCS STUDY GROUP
Francois Gouin
Favorite
Goulett, Natlie

Sylvester Comprehensive Cancer Center
(P 224) PAN-SARCOMA DATABASE (PSDB): AN UPDATE ON MIAMI'S COLLABORATIVE MULTI-USER DATA PIPELINE OF SARCOMA DATA USING REDCAP AND R CODING
Natlie Goulett
Favorite
Gounder, Mrinal

Memorial Sloan Kettering Cancer Center, and Weill Cornell Medical College
(P 187) THERAPEUTIC OUTCOMES IN NF1-ALTERED GIST TREATED WITH MEK INHIBITION: A SINGLE-CENTER EXPERIENCE
Mrinal Gounder
Favorite
(P 315) ANALYSIS OF CHANGES IN T2-WEIGHTED SIGNAL INTENSITY AND TUMOR VOLUME AND EXPOSURE-RESPONSE IN THE RINGSIDE PHASE 2 STUDY OF VAREGACESTAT FOR DESMOID TUMORS
Mrinal Gounder
Favorite
(P 409) RETROSPECTIVE ANALYSIS OF PROGNOSTIC FACTORS INCLUDING HLA GENOTYPE IN MYXOID LIPOSARCOMA
Mrinal Gounder
Favorite
(P 410) SUBGROUP ANALYSIS OF THE PHASE 2 PART OF THE RINGSIDE PHASE 2/3 TRIAL OF VAREGACESTAT FOR TREATMENT OF DESMOID TUMORS
Mrinal Gounder
Favorite
(P 416) A PHASE 2 MULTICENTER OPEN-LABEL BASKET STUDY OF TAZEMETOSTAT IN ADULT PATIENTS WITH INI1-NEGATIVE EPITHELIOID SARCOMA – FINAL ANALYSIS
Mrinal Gounder
Favorite
(P 423) ZIFTOMENIB IN COMBINATION WITH IMATINIB IN ADVANCED GASTROINTESTINAL STROMAL TUMORS (GIST) AFTER IMATINIB FAILURE: PHASE 1A/B STUDY OF SAFETY, PHARMACOKINETICS, AND ANTITUMOR ACTIVITY
Mrinal Gounder
Favorite
(P 464) EFFICACY OUTCOMES AMONG PATIENTS WITH ADVANCED EPITHELIOID SARCOMAS OF PROXIMAL-TYPE AND DISTAL-TYPE TREATED WITH TAZ: POST HOC ANALYSIS OF STUDY EZH-202
Mrinal Gounder
Favorite
(P 467) TREATMENT OUTCOMES IN AGGRESSIVE ANGIOMYXOMA: A SINGLE INSTITUTION EXPERIENCE
Mrinal Gounder
Favorite
Gouveia, Emanuel

Instituto Português de Oncologia de Lisboa Francisco Gentil
(P 372) CLINICOPATHOLOGICAL FEATURES AND OUTCOMES OF PATIENTS WITH KAPOSI SARCOMA: A SINGLE CENTER RETROSPECTIVE REAL WORLD ANALYSIS
Emanuel Gouveia
Favorite
Grabenbauer, Felix

Department of Radiation Oncology, Universitätsstraße 27, 91054 Erlangen, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Germany
(P 288) IDENTIFICATION OF A DNA REPAIR INHIBITOR FOR THE COMBINATION WITH LURBINECTEDIN AND RADIOTHERAPY IN SARCOMA CELL LINES
Felix Grabenbauer
Favorite
Gracia Alegria, Isidro

Hospital de la Santa Creu i Sant Pau
(P 383) MULTIDISCIPLINARY TREATMENT OF INGUINOSCROTAL SARCOMAS: ANALYSIS OF 39 CASES TREATED BY SURGICAL APPROACH
Isidro Gracia Alegria
Favorite
GRAND, David

Institut Universitaire du Cancer de Toulouse
(P 12) DNA REPLICATION STRESS AND DEFICIENT HOMOLOGOUS RECOMBINATION IN OSTEOSARCOMA RISK AND THERAPY
David GRAND
Favorite
Grant, Kyle

Vancouver General Hospital
(P 143) IMPACT OF SURGICAL MARGINS IN CHEST WALL CHONDROSARCOMAS: A CANSARCC STUDY
Kyle Grant
Favorite
Gratny, Hanna

University of Colorado Department of Orthopedics
(P 268) QUALITY OF LIFE OUTCOMES IN PEDIATRIC PATIENTS UNDERGOING SURGICAL INTERVENTION FOR LOWER EXTREMITY BONE SARCOMAS
Hanna Gratny
Favorite
Graves, Laurie

Duke University
(P 19) SERUM EXOSOMES IDENTIFY AN ABERRANT PROTEOMIC SIGNATURE IN CANINE OSTEOSARCOMA PRECEDING METASTATIC PROGRESSION
Laurie Graves
Favorite
(P 119) DEVELOPMENT OF AN EXTINCTION THERAPY APPROACH FOR OSTEOSARCOMA USING ECO-EVOLUTIONARY PRINCIPLES
Laurie Graves
Favorite
(P 259) PRECLINICAL MODELING OF CHEMOTHERAPY RELEASE IDENTIFIES MITOCHONDRIAL ADAPTATIONS IN DOXORUBICIN TREATED OSTEOSARCOMA
Laurie Graves
Favorite
Greco, Francesca Gabriella

Fondazione IRCCS Istituto Nazionale Tumori
(P 331) MAINTENANCE THERAPY (M-TP) WITH DACARBAZINE (DTIC) AFTER FIRST-LINE ANTHRACYCLINE-BASED DOUBLET IN ADVANCED LEIOMYOSARCOMA (LMS) PATIENTS (PTS): OUTCOMES OF A CASE SERIES IN A SINGLE REFERRAL CENTER
Francesca Gabriella Greco
Favorite
Greco, Gabriella

Fondazione IRCCS Istituto nazionale dei tumori
(P 446) GDF-15 AS A PROGNOSTIC FACTOR IN PATIENTS WITH EPITHELIOID HEMANGIOENDOTHELIOMA
Gabriella Greco
Favorite
Griffin, Anthony

Orthopaedic Surgery, Sinai Health
(P 88) THE RAY CHALLENGE: HOW MANY RAY RESECTIONS CAN PATIENTS TOLERATE AND WHICH RAY RESECTIONS AFFECTS FUNCTIONAL OUTCOME THE MOST IN ORTHOPEDIC ONCOLOGY?
Anthony Griffin
Favorite
(P 143) IMPACT OF SURGICAL MARGINS IN CHEST WALL CHONDROSARCOMAS: A CANSARCC STUDY
Anthony Griffin
Favorite
(P 151) SHOULD WE USE ADJUVANT CHEMOTHERAPY IN PATIENTS WITH LOCALIZED DEDIFFERENTIATED CHONDROSARCOMA (DDCS) OF THE PELVIS? AN ANALYSIS BY THE PELVIC DDCS STUDY GROUP
Anthony Griffin
Favorite
(P 332) MARGINAL EXCISION OF EXTREMITY DEDIFFERENTIATED LIPOSARCOMA WITHOUT RADIATION MAY BE SAFE IN SELECT PATIENTS
Anthony Griffin
Favorite
(P 374) DISTINCT PATTERNS OF METASTATIC SPREAD IN LEIOMYOSARCOMA: A COMPARATIVE ANALYSIS OF TRUNCAL AND EXTREMITY TUMOURS
Anthony Griffin
Favorite
(P 375) DOES STAGED RESECTION WITH TEMPORIZING WOUND VACUUM INFLUENCE LOCAL RECURRENCE RISK? A MULTI-INSTITUTIONAL MATCHED COHORT ANALYSIS
Anthony Griffin
Favorite
Grignani, Giovanni

Candiolo Cancer Institute, FPO-IRCCS
(P 231) INCREASED LIFETIME RISK (LTR) OF SOFT TISSUE SARCOMAS (STS) IN PATIENTS WITH LOW-RISK GASTROINTESTINAL STROMAL TUMORS (GIST): A RETROSPECTIVE ANALYSIS FROM THE ITALIAN SARCOMA GROUP (ISG)
Giovanni Grignani
Favorite
Grignol, Valerie

The Ohio State University Medical Center
(P 161) CLINICAL CHARACTERISTICS, PATTERNS OF CARE, AND TREATMENT OUTCOMES OF CHONDROSARCOMA: A SINGLE-INSTITUTIONAL EXPERIENCE
Valerie Grignol
Favorite
(P 307) STRATEGIES FOR DATA QUALITY IN TARPSWG RETROPERITONEAL SARCOMA REGISTRY (RESAR)
Valerie Grignol
Favorite
(P 309) RETROPERITONEAL LIPOMAS: MULTICENTER CLINICAL EXPERIENCE WITH AN EXTREMELY RARE DISEASE ENTITY
Valerie Grignol
Favorite
(P 335) OUTCOMES OF TALIMOGENE LAHERPAREPVEC IN SOFT TISSUE SARCOMA
Valerie Grignol
Favorite
Grigoryan, Vahe

Yerevan State Medical University
(P 158) GLOBAL INEQUITIES IN CHONDROSARCOMA CLINICAL TRIALS: A COMPREHENSIVE ANALYSIS ACROSS THREE DECADES
Vahe Grigoryan
Favorite
Grimaldi, Alexandre

Owkin
(P 431) INVOKE: A PHASE 1 STUDY OF OKN4395, A FIRST-IN-CLASS EP2/EP4/DP1 TRIPLE PROSTANOID RECEPTOR ANTAGONIST, IN PATIENTS WITH ADVANCED SOLID TUMORS, INCLUDING SARCOMAS
Alexandre Grimaldi
Favorite
Grimes, Helen

University College London Hospitals
(P 281) LOCAL CONTROL WITH MODERATELY HYPOFRACTIONATED DEFINITIVE RADIOTHERAPY DELIVERED WITH A SIMULTANEOUS INTEGRATED BOOST TECHNIQUE TO NON-EXTREMITY SOFT TISSUE AND BONE SARCOMAS
Helen Grimes
Favorite
Grohar, Patrick

CS Mott Children's Hospital
(P 168) LEVERAGING LARGE LANGUAGE MODELS FOR STRUCTURED INFORMATION EXTRACTION FROM EWING SARCOMA PATHOLOGY REPORTS
Patrick Grohar
Favorite
(P 256) THE SEAN KARL COHORT: A NATIONAL COLLABORATIVE SINGLE-CELL RNASEQ STUDY OF PAIRED PATIENT EWING SARCOMA SPECIMENS
Patrick Grohar
Favorite
Gronchi, Alessandro

Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan
(P 32) EFFECTIVENESS OF LURBINECTEDIN PLUS IRINOTECAN IN PRECLINICAL MODEL OF DESMOPLASTIC SMALL ROUND CELL TUMOR
Alessandro Gronchi
Favorite
(P 210) TOWARDS INTERNATIONALIZATION OF THE CLINICAL RESEARCH COORDINATOR ROLE: THE FIRST DROP OF THE NIAGARA FALLS PROJECT
Alessandro Gronchi
Favorite
(P 231) INCREASED LIFETIME RISK (LTR) OF SOFT TISSUE SARCOMAS (STS) IN PATIENTS WITH LOW-RISK GASTROINTESTINAL STROMAL TUMORS (GIST): A RETROSPECTIVE ANALYSIS FROM THE ITALIAN SARCOMA GROUP (ISG)
Alessandro Gronchi
Favorite
(P 277) THE ROLE OF RADIOTHERAPY IN THE MULTIDISCIPLINARY MANAGEMENT OF RADIATION-ASSOCIATED ANGIOSARCOMA OF THE BREAST: A REFERRAL CENTER EXPERIENCE
Alessandro Gronchi
Favorite
(P 307) STRATEGIES FOR DATA QUALITY IN TARPSWG RETROPERITONEAL SARCOMA REGISTRY (RESAR)
Alessandro Gronchi
Favorite
(P 308) IMPACT OF PSOAS MUSCLE RESECTION ON OUTCOMES IN PRIMARY RETROPERITONEAL DEDIFFERENTIATED LIPOSARCOMA
Alessandro Gronchi
Favorite
(P 309) RETROPERITONEAL LIPOMAS: MULTICENTER CLINICAL EXPERIENCE WITH AN EXTREMELY RARE DISEASE ENTITY
Alessandro Gronchi
Favorite
(P 442) TRIAL IN PROGRESS: A SINGLE-ARM, OPEN-LABEL PHASE 4 TRIAL OF NIROGACESTAT IN ADULT PREMENOPAUSAL FEMALES WITH DESMOID TUMORS
Alessandro Gronchi
Favorite
(P 446) GDF-15 AS A PROGNOSTIC FACTOR IN PATIENTS WITH EPITHELIOID HEMANGIOENDOTHELIOMA
Alessandro Gronchi
Favorite
Gronchi, Alessandro

Fondazione IRCCS Istituto Nazionale dei Tumori
(P 452) EFFECTIVENESS OF ERIBULIN FOR MYXOID PLEOMORPHIC LIPOSARCOMA: INSIGHTS FROM A PATIENT-DERIVED MODEL AND CLINICAL TRANSLATION IN A PATIENT WITH ADVANCED DISEASE
Alessandro Gronchi
Favorite
Gronchi, Alessandro

Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan
(P 458) BETWEEN LYMPHOMAS AND SARCOMAS: A RETROSPECTIVE, MULTI-INSTITUTIONAL STUDY FROM THE ITALIAN SARCOMA GROUP (ISG) ON HISTIOCYTIC AND DENDRITIC CELL NEOPLASMS (HDCN)
Alessandro Gronchi
Favorite
Gross, Amy

Nationwide Children's Hospital
(P 08) BUILDING A MEDICAL DONATION NETWORK TO ENHANCE DEVELOPMENT OF PEDIATRIC TUMOR MODELS
Amy Gross
Favorite
(P 13) TRANSCRIPTIONAL DIVERSITY AND NICHE REMODELING AT THE METASTATIC BOTTLENECK IN OSTEOSARCOMA
Amy Gross
Favorite
Grossman, Julie

University of Miami Hospital, Department of Surgical Oncology
(P 201) METASTATIC PATTERNS, TREATMENT MODALITIES, AND OVERALL SURVIVAL IN OLIGOMETASTATIC GIST: A SINGLE-CENTER RETROSPECTIVE STUDY
Julie Grossman
Favorite
(P 289) SIX YEAR FOLLOW-UP ON CIVASHEET® USE FOR SOFT TISSUE SARCOMA: A SINGLE INSTITUTION EXPERIENCE
Julie Grossman
Favorite
(P 333) METABOLIC SYNDROME CORRELATION WITH LIPOSARCOMA INCIDENCE AND OUTCOMES: A RETROSPECTIVE ANALYSIS.
Julie Grossman
Favorite
Grunhagen, D.J.

Erasmus Medical Center
(P 444) HEALTH-RELATED QUALITY OF LIFE (HRQOL) CHALLENGES IN PATIENTS WITH EPITHELIOID HEMANGIOENDOTHELIOMA (EHE): ANALYSIS OF AN ULTRA-RARE SARCOMA GROUP
D.J. Grunhagen
Favorite
Grunn, Adina

Columbia University Irving Medical Center
(P 25) IDENTIFICATION AND VALIDATION OF NON-GENETICALLY ENCODED VULNERABILITIES IN EWING SARCOMA
Adina Grunn
Favorite
Grunwald, Assaf

Felsenstein Medical Research Center, Tel Aviv University, Israel. Department of Physical Chemistry, School of Chemistry, Tel Aviv University, Tel Aviv, Israel
(P 06) RAPID, POINT-OF-CARE DNA METHYLATION & MOLECULAR LANDSCAPE BASED SARCOMA CLASSIFICATION
Assaf Grunwald
Favorite
Guadagnolo, B

UT MD Anderson Cancer Center
(P 83) OUTCOMES OF MULTIMODAL PERIOPERATIVE TREATMENT IN OSTEOSARCOMAS OF THE JAW
B Guadagnolo
Favorite
Guardino, Nicholas

Duke University
(P 125) TARGETING LCP1-MEDIATED METASTASIS IN CHONDROSARCOMA WITH OROXYLIN A
Nicholas Guardino
Favorite
(P 126) SINGLE-CELL RNA SEQUENCING AND PROTEOMIC SPATIAL PROFILING REVEAL COMPLEX TUMOR MICROENVIRONMENT AND NOVEL IMMUNE INTERACTIONS IN CHONDROSARCOMA
Nicholas Guardino
Favorite
Guardino, Nicholas

Stanford University
(P 130) INVESTIGATING LCP1-MEDIATED ONCOGENIC SIGNALING IN CHONDROSARCOMA METASTASIS
Nicholas Guardino
Favorite
Guegan, Jean Philippe

Explicyte
(P 59) TARGETING ADORA2B TO HALT METASTASIS IN UNDIFFERENTIATED PLEOMORPHIC SARCOMA: FROM MULTI-OMICS TO THERAPEUTIC INHIBITION
Jean Philippe Guegan
Favorite
Guerrieri, Ania Naila

IRCCS Rizzoli Orthopaedic Institute
(P 18) ESTABLISHMENT AND CHARACTERIZATION OF A NOVEL PRIMARY CELL LINE FROM A BONE METASTASIS OF OSTEOSARCOMA
Ania Naila Guerrieri
Favorite
Guido, Valentina

Fondazione IRCCS Istituto Nazionale dei Tumori
(P 446) GDF-15 AS A PROGNOSTIC FACTOR IN PATIENTS WITH EPITHELIOID HEMANGIOENDOTHELIOMA
Valentina Guido
Favorite
(P 447) PAIN ASSESSMENT CRITERIA (PAC) ANTICIPATE RECIST PROGRESSION AND CORRELATE WITH BLOOD LEVELS OF GROWTH DIFFERENTIATION FACTOR 15 (GDF15) IN EPITHELIOID HEMANGIOENDOTHELIOMA (EHE)
Valentina Guido
Favorite
Guillan, Kristina

Memorial Sloan Kettering Cancer Center
(P 237) DEVELOPMENT OF EPHA2 CAR T CELL THERAPY FOR OSTEOSARCOMA
Kristina Guillan
Favorite
Guillen Navarro, Maria Jose

PharmaMar
(P 33) THE NOVEL TRANSCRIPTIONAL INHIBITORS ECUBECTEDIN AND PM54 DEMONSTRATE ANTITUMOR ACTIVITY IN PATIENT-DERIVED XENOGRAFT MODELS OF SOFT TISSUE SARCOMA
Maria Jose Guillen Navarro
Favorite
Gularte-Merida, Rodrigo

Memorial Sloan Kettering Cancer Center
(P 421) CHARACTERIZING THE IMMUNE RESPONSE TO INTRATUMORAL TIGILANOL TIGLATE (TT) IN PATIENTS WITH ADVANCED AND/OR METASTATIC SOFT TISSUE SARCOMA (STS) IN A PHASE IIA TRIAL (NCT05755113)
Rodrigo Gularte-Merida
Favorite
Gulia, Ashish

HBCH&RC
(P 103) EARLY OUTCOMES OF BONE PROSTHESIS COMPOSITE FOR RECONSTRUCTION IN LOWER LIMB TUMORS. A SINGLE INSTITUTION STUDY
Ashish Gulia
Favorite
Gulia, Ashish

HBCH New Chandigarh
(P 286) INTERSTITIAL BRACHYTHERAPY FOR ORGAN AND FUNCTION PRESERVATION IN SOFT TISSUE SARCOMAS: LONG TERM OUTCOMES
Ashish Gulia
Favorite
Gundle, Kenneth

Oregon Heatlh & Science University | Portland VA Medical Center
(P 93) INTERCALARY COMPRESSIVE OSSEOINTEGRATION OF DIAPHYSEAL TUMORS: A MULTI-INSTITUTIONAL CASE SERIES
Kenneth Gundle
Favorite
(P 364) TRENDS IN SURGICAL MANAGEMENT OF DESMOID TUMOR IN THE VETERANS AFFAIRS (VA) NATIONAL DATABASE
Kenneth Gundle
Favorite
Gunn, Alasdair

Adaptimmune
(P 247) SINGLE-CELL RNA SEQUENCING OF AFAMITRESGENE AUTOLEUCEL INDICATES MECHANISMS OF PERSISTENCE AND ANTI-TUMOR ACTIVITY
Alasdair Gunn
Favorite
Gunther, Kate

Children's Cancer Institute
(P 11) ESTABLISHMENT, CHARACTERIZATION AND RESEARCH APPLICATION OF EIGHT NOVEL PATIENT-DERIVED OSTEOSARCOMA CELL LINES
Kate Gunther
Favorite
Guo, Hanjia

University of Michigan Ann Arbor
(P 24) THE SIRTUIN SIRT5 SUPPORTS EWING SARCOMA SURVIVAL VIA REGULATION OF EWS-FLI1 STABILITY AND ACTIVITY
Hanjia Guo
Favorite
Gupta, Abha

The Hospital for Sick Children and Princess Margaret Cancer Center, Toronto, ON, Canada
(P 143) IMPACT OF SURGICAL MARGINS IN CHEST WALL CHONDROSARCOMAS: A CANSARCC STUDY
Abha Gupta
Favorite
(P 416) A PHASE 2 MULTICENTER OPEN-LABEL BASKET STUDY OF TAZEMETOSTAT IN ADULT PATIENTS WITH INI1-NEGATIVE EPITHELIOID SARCOMA – FINAL ANALYSIS
Abha Gupta
Favorite
Gupta, Abha A

Division of Medical Oncology, Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada and Division of Hematology/Oncology, Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada
(P 395) ERIBULIN IN RECURRENT PRETREATED METASTATIC SOFT TISSUE SARCOMA. A CANADIAN SARCOMA RESEARCH AND CLINICAL COLLABORATION (CANSARCC) REAL WORLD ANALYSIS
Abha A Gupta
Favorite
Gupta, Ajay

Roswell Park Comprehensive Cancer Center
(P 340) PREDICTORS OF LATE RECURRENCE AFTER SARCOMA SURGICAL RESECTION
Ajay Gupta
Favorite
Gupta, Rajul

Vanderbilt University Medical Center
(P 97) RISK FACTORS ASSOCIATED WITH AMPUTATION VERSUS CONTINUED LIMB SALVAGE IN LOWER EXTREMITY ENDOPROSTHETIC RECONSTRUCTION
Rajul Gupta
Favorite
Guragain, Diwakar

Dept. of Surgery, Moores Cancer Center, University of California San Diego
(P 197) DIFFERENTIAL EFFECTS OF ANAGRELIDE IN GASTROINTESTINAL STROMAL TUMORS (GIST) IN VITRO
Diwakar Guragain
Favorite
gurav, mamta

Tata Memorial Hospital
(P 379) IMPACT OF EWSR1 GENE REARRANGEMENT TESTING ON DIAGNOSIS OF A WIDE RANGE OF SOLID TUMOURS
mamta gurav
Favorite
Gutiérrez, Natalia

Hospital General Universitario Gregorio Marañón
(P 356) DESMOID TUMORS: A RETROSPECTIVE ANALYSIS FROM A REFERRAL CENTER
Natalia Gutiérrez
Favorite
Gutierrez, Ana

Hospital General Universitario Gregorio Marañón
(P 356) DESMOID TUMORS: A RETROSPECTIVE ANALYSIS FROM A REFERRAL CENTER
Ana Gutierrez
Favorite
Gutierrez, Guiomar

Hospital Regional Universitario de Málaga
(P 71) GERMLINE POLYMORPHISMS IN THE VEGF PATHWAY AS PROGNOSTIC BIOMARKERS IN LOCALIZED HIGH-GRADE OSTEOSARCOMA: A STUDY BASED ON DATA FROM THE GEIS-33 PROTOCOL
Guiomar Gutierrez
Favorite
Gutierrez, Natalia

Hospital General Universitario Gregorio Marañon. Instituto de Investigacion Sanitaria Gregorio Marañon
(P 389) UNRESECTABLE AND METASTATIC DEDIFFERENTIATED LIPOSARCOMA (DDLPS): INSIGHTS FROM A MULTICENTER REAL-WORLD COHORT (RWC)
Natalia Gutierrez
Favorite
Gutpell, Kelly

Nationwide Children's Hospital
(P 13) TRANSCRIPTIONAL DIVERSITY AND NICHE REMODELING AT THE METASTATIC BOTTLENECK IN OSTEOSARCOMA
Kelly Gutpell
Favorite
Gutstein, Lauren

Children's Hospital of Philadelphia
(P 256) THE SEAN KARL COHORT: A NATIONAL COLLABORATIVE SINGLE-CELL RNASEQ STUDY OF PAIRED PATIENT EWING SARCOMA SPECIMENS
Lauren Gutstein
Favorite
(P 262) EVALUATING FRONT-LINE THERAPY ACCORDANCE WITH CURRENT SYNOVIAL SARCOMA GUIDELINES
Lauren Gutstein
Favorite
(P 263) DESCRIBING THE CHARACTERISTICS AND TREATMENT OF SYNOVIAL SARCOMA IN THE RECURRENT SETTING
Lauren Gutstein
Favorite
Guzmán Gomez, Daniel

Universidad Veracruzana
(P 39) BUB1 AN OVEREXPRESSED KINASE IN SARCOMA: FINDING NEW TARGET THERAPY FOR OSTEOSARCOMA, LIPOSARCOMA, SYNOVIAL SARCOMA AND LEIOMYOSARCOMA
Daniel Guzmán Gomez
Favorite
Gyorki, David

Peter MacCallum Cancer Centre
(P 307) STRATEGIES FOR DATA QUALITY IN TARPSWG RETROPERITONEAL SARCOMA REGISTRY (RESAR)
David Gyorki
Favorite
H
Haaren, Mareike

Cleveland Clinic
(P 316) AREA DEPRIVATION INDEX (ADI) AND OUTCOMES IN LOCALIZED SOFT TISSUE SARCOMA: DO SOCIAL DETERMINANTS INFLUENCE SURVIVAL?
Mareike Haaren
Favorite
Haas, Rick

The Netherlands Cancer Institute
(P 41) THE IMPACT OF PAZOPANIB AND EXTREMITY RADIOTHERAPY ON TRANSAMINASES
Rick Haas
Favorite
(P 295) FROM HISTORICAL REFERENCE TO MODERN PRACTICE: WOUND COMPLICATION RATES IN SOFT TISSUE SARCOMA TREATED WITH RADIOTHERAPY ACROSS ERAS
Rick Haas
Favorite
Habermehl, Christina

the healthcare business of Merck KGaA, Darmstadt, Germany
(P 434) A FIRST-IN-HUMAN PHASE 1, MULTICENTER, OPEN-LABEL STUDY OF M3554, A NOVEL ANTI-GD2 ANTIBODY-DRUG CONJUGATE, IN PATIENTS WITH ADVANCED SOLID TUMORS
Christina Habermehl
Favorite
Haddix, Seth

The EHE Foundation
(P 448) OVERCOMING CHALLENGES IN ULTRA-RARE SARCOMAS: A CENTRALIZED BIOBANK FOR EPITHELIOID HEMANGIOENDOTHELIOMA AS A RESOURCE TO ACCELERATE DISCOVERY
Seth Haddix
Favorite
Haddox, Candace

Dana Farber Cancer Institute
(P 34) EXPRESSION OF ONCOFETAL ANTIGEN 5T4 IN SARCOMA SUBTYPES AND PRECLINICAL ACTIVITY OF TUB-030, A NOVEL 5T4-TARGETING ANTIBODY-DRUG CONJUGATE (ADC)
Candace Haddox
Favorite
(P 184) MTAP IN GASTROINTESTINAL STROMAL TUMOR (GIST): RATE OF MTAP LOSS AND CONCORDANCE BETWEEN GENOMIC SEQUENCING AND IMMUNOHISTOCHEMISTRY
Candace Haddox
Favorite
(P 235) AGNOSTIC INDICATION OF IMMUNE CHECKPOINT INHIBITORS (ICI): PATTERNS OF RESPONSE OF SARCOMAS
Candace Haddox
Favorite
(P 434) A FIRST-IN-HUMAN PHASE 1, MULTICENTER, OPEN-LABEL STUDY OF M3554, A NOVEL ANTI-GD2 ANTIBODY-DRUG CONJUGATE, IN PATIENTS WITH ADVANCED SOLID TUMORS
Candace Haddox
Favorite
Haglund, Karl

The Ohio State University
(P 161) CLINICAL CHARACTERISTICS, PATTERNS OF CARE, AND TREATMENT OUTCOMES OF CHONDROSARCOMA: A SINGLE-INSTITUTIONAL EXPERIENCE
Karl Haglund
Favorite
Haibe-Kains, Benjamin

Princess Margaret Cancer Centre, University Health Network
(P 68) MULTI-OMIC INTRA- AND INTER-TUMOR HETEROGENEITY OF BENIGN SMOOTH MUSCLE TUMORS
Benjamin Haibe-Kains
Favorite
Hajiannasab, Rasam

Moffitt Cancer Center
(P 138) A MULTI-INSTITUTIONAL ARCHIVE AND DEEP LEARNING PIPELINE FOR QUANTIFYING CHONDROSARCOMA COMPOSITION
Rasam Hajiannasab
Favorite
HAJITOU, Amin

Imperial College London
(P 116) A DUAL-TARGETED SYSTEMIC THERAPEUTIC APPROACH FOR THE SELECTIVE ELIMINATION OF TUMOR CELLS IN PRIMARY AND METASTATIC SARCOMA.
Amin HAJITOU
Favorite
Hakem Zadeh, Farigol

UCF/HCA NF Hospital
(P 44) A SYSTEMATIC REVIEW OF FUSION-DRIVEN SARCOMAS
Farigol Hakem Zadeh
Favorite
(P 325) FUSION GENES IN SARCOMAS: DIAGNOSTIC APPROACHES AND EMERGING TARGETED THERAPIES
Farigol Hakem Zadeh
Favorite
Hakim, Abraham

NCI/NIH
(P 181) THE DEVELOPMENT OF A NOVEL PDGFRA RESISTANCE MUTATION IN A RECURRENT KIT-MUTANT GASTROINTESTINAL STROMAL TUMOR (GIST)
Abraham Hakim
Favorite
Hakkesteegt, Stefanie

Erasmus Medical Center
(P 444) HEALTH-RELATED QUALITY OF LIFE (HRQOL) CHALLENGES IN PATIENTS WITH EPITHELIOID HEMANGIOENDOTHELIOMA (EHE): ANALYSIS OF AN ULTRA-RARE SARCOMA GROUP
Stefanie Hakkesteegt
Favorite
Haldar, Malay

University of Pennsylvania
(P 240) NEW INSIGHTS FROM SPATIOTEMPORALLY DEFINED TUMOR INDUCTIONS IN A NOVEL MOUSE MODEL OF SYNOVIAL SARCOMA
Malay Haldar
Favorite
Hale, Martina

Cleveland Clinic
(P 355) CLASSIFYING WOUND HEALING COMPLICATIONS IN SURGICALLY TREATED EXTREMITY SOFT TISSUE SARCOMA
Martina Hale
Favorite
Hall, Frederick

Delta Next-Gene
(P 233) DNG64-CAR-V+ REGIMEN SHOWS CLINICAL BENEFIT IN PATIENTS WITH ADVANCED CCNG1 ONCOGENE EXPRESSING SARCOMAS (NCT04091295)
Frederick Hall
Favorite
Hall, Lisa

Nationwide Children's Hospital; Center for Childhood Cancer Research, The Abigail Wexner Research Institute, Nationwide Children’s Hospital
(P 264) RARE CASE OF INFLAMMATORY MYOFIBROBLASTIC TUMOR (IMT) IN NEWBORN
Lisa Hall
Favorite
Halpern, Jennifer

Vanderbilt University Medical Center
(P 84) A MULTICENTER COMPARISON OF REVERSE TOTAL SHOULDER ARTHROPLASTY VERSUS HEMIARTHROPLASTY FOR ENDOPROSTHETIC RECONSTRUCTION FOLLOWING ONCOLOGIC RESECTION OF THE PROXIMAL HUMERUS
Jennifer Halpern
Favorite
(P 85) MAKING NEGATIVE MARGIN MUSCULOSKELETAL TUMOR SURGERY A VIRTUAL REALITY USING 3D SPECIMEN SCANNING
Jennifer Halpern
Favorite
(P 97) RISK FACTORS ASSOCIATED WITH AMPUTATION VERSUS CONTINUED LIMB SALVAGE IN LOWER EXTREMITY ENDOPROSTHETIC RECONSTRUCTION
Jennifer Halpern
Favorite
(P 226) REAL-WORLD MANAGEMENT OF SYMPTOMATIC VS ASYMPTOMATIC TGCT FROM AN OBSERVATIONAL REGISTRY
Jennifer Halpern
Favorite
Halur, Shreya

Massachusetts General Hospital
(P 91) A COMPARISON OF ACETABULAR AUGMENTATION AND PHOTODYNAMIC NAIL STABILIZATION FOR COMPLEX ONCOLOGIC TOTAL HIP ARTHROPLASTY
Shreya Halur
Favorite
(P 392) CLASSIFICATION AND DIFFERENTIATIONOF MYXOID LIPOSARCOMA AND MYXOMA WITH MACHINE LEARNING
Shreya Halur
Favorite
Hamad, Christopher

Department of Orthopaedic Surgery, University of California Los Angeles
(P 16) MITOCHONDRIAL GENETIC VARIATION ORCHESTRATES COPZ1 TRANSCRIPT HETEROGENEITY AND REVEALS TELOMERE-MEDIATED VULNERABILITIES IN OSTEOSARCOMA
Christopher Hamad
Favorite
(P 72) COUNTY-LEVEL ASSOCIATIONS BETWEEN AIRBORNE TOXICANT EMISSIONS AND EWING SARCOMA DIAGNOSIS IN THE UNITED STATES
Christopher Hamad
Favorite
(P 81) ASSESSING PROGNOSTIC FACTORS OF CAUSE-SPECIFIC SURVIVAL IN PATIENTS WITH MALIGNANT GIANT CELL TUMORS: A POPULATION BASED STUDY FROM THE SEER DATABASE
Christopher Hamad
Favorite
(P 92) PRIMARY TUMOR SIZE AS AN INDEPENDENT PROGNOSTIC FACTOR IN OSTEOSARCOMA: PROPENSITY SCORE-MATCHED ANALYSIS DEMONSTRATES A CONTINUOUS DOSE-RESPONSE RELATIONSHIP
Christopher Hamad
Favorite
(P 100) THE ROLE OF CANCER TYPE IN THE DEVELOPMENT OF PERIPROSTHETIC JOINT INFECTION IN DISTAL FEMORAL REPLACEMENT
Christopher Hamad
Favorite
(P 107) IS THERE A BETTER OPTION: INTRAMEDULLARY NAIL VERSUS PLATE OSTEOSYNTHESIS FOR PATHOLOGIC HUMERAL FRACTURES?
Christopher Hamad
Favorite
(P 108) DISTANCE WEIGHTED MATCHING IN THE QUANTIFICATION OF EXCESS MORBIDITY IN EXTERNAL HEMIPELVECTOMY AND HIP DISARTICULATION
Christopher Hamad
Favorite
(P 157) INCOME IMPACTS OVERALL BUT NOT CAUSE-SPECIFIC SURVIVAL IN PATIENTS WITH CHONDROSARCOMA: A POPULATION BASED STUDY FROM THE SEER DATABASE
Christopher Hamad
Favorite
(P 232) IS THERE A ROLE FOR POSITRON EMISSION TOMOGRAPHY IN THE STAGING OF LANGERHANS CELL HISTIOCYTOSIS?
Christopher Hamad
Favorite
(P 384) PELVIC LOCATION PREDICTS WORSE OUTCOMES IN ALVEOLAR RHABDOMYOSARCOMA: UNDERUSE OF RADIOTHERAPY AND MISSED SURVIVAL BENEFIT
Christopher Hamad
Favorite
Hamilton, Anne

Peter MacCallum Cancer Centre
(P 121) REAL-WORLD EXPERIENCE OF CABOZANTINIB MONOTHERAPY IN RELAPSED OR REFRACTORY OSTEOSARCOMA AND EWING SARCOMA: A SINGLE-CENTRE AUSTRALIAN STUDY
Anne Hamilton
Favorite
Hamilton, Trevor D

University of British Columbia
(P 178) TREATMENT RESPONSE AND SURVIVAL OUTCOMES IN GASTROINTESTINAL STROMAL TUMORS FOLLOWING NEOADJUVANT THERAPY
Trevor D Hamilton
Favorite
(P 196) SURVEILLANCE STRATEGIES AND LONG-TERM OUTCOMES IN LOW-RISK GASTRIC GASTROINTESTINAL STROMAL TUMORS (GGISTS)
Trevor D Hamilton
Favorite
Hamlin, Julie

The University of Kansas Health System
(P 354) UNEXPECTED RESPONSE TO ERIBULIN IN A REFRACTORY LEIOMYOSARCOMA PATIENT WITH HEREDITARY P53 MUTATION
Julie Hamlin
Favorite
Handoklow, Lyla

Rush University School of Medicine
(P 138) A MULTI-INSTITUTIONAL ARCHIVE AND DEEP LEARNING PIPELINE FOR QUANTIFYING CHONDROSARCOMA COMPOSITION
Lyla Handoklow
Favorite
Han, Ilkyu

Department of Orthopaedic surgery, Seoul National University Hospital
(P 09) ESTABLISHMENT AND CHARACTERIZATION OF 18 SARCOMA CELL LINES: UNRAVELING THE MOLECULAR MECHANISMS OF DOXORUBICIN RESISTANCE IN SARCOMA CELL LINES
Ilkyu Han
Favorite
(P 66) ARHGEF4 EXPRESSION IN SOFT TISSUE SARCOMA CORRELATES WITH LOCAL GROWTH PATTERN: WHOLE TRANSCRIPTOME SEQUENCING ON SPATIALLY SEPARATED REGIONS, PATIENT-DERIVED MODELS, AND ORTHOTOPIC IN VIVO ANALYSIS
Ilkyu Han
Favorite
Han, Ilkyu

Department of Orthopaedic Surgery, Seoul National University Hospital
(P 171) THREE-DIMENSIONAL DEEP LEARNING MODEL FOR PREDICTING PROXIMAL FEMORAL PATHOLOGIC FRACTURE USING OPPORTUNISTIC ABDOMINOPELVIC CT IN PATIENTS WITH ADVANCED CANCER: A PRELIMINARY REPORT
Ilkyu Han
Favorite
Han, Ilkyu

Department of Orthopaedic surgery, Seoul National University Hospital
(P 175) INTERPRETABLE DEEP LEARNING BASED CLASSIFICATION OF SARCOMA IMMUNE SUBTYPES FROM H&E SLIDES FOR IMMUNOTHERAPY STRATIFICATION
Ilkyu Han
Favorite
(P 176) DEEP LEARNING MODEL FOR DIFFERENTIATING BETWEEN NEOPLASTIC PATHOLOGIC FRACTURE AND NONPATHOLOGIC FRACTURE FROM PLAIN HIP RADIOGRAPHS
Ilkyu Han
Favorite
(P 342) PROGNOSTIC RELEVANCE OF TUMOR LOCATION IN MYXOID LIPOSARCOMA
Ilkyu Han
Favorite
(P 399) LATE LOCAL RECURRENCE (>5YEARS) OF SOFT TISSUE SARCOMA OF THE EXTREMITIES AND TRUNK WALL: PREDICTIVE FACTORS AND ONCOLOGIC OUTCOMES
Ilkyu Han
Favorite
Hanna, Markus

Medical University of Vienna
(P 86) CARBON FIBRE-REINFORCED PEEK IMPLANTS FOR TUMORS OF THE SPINE
Markus Hanna
Favorite
Han, Xinwei

Parabilis Medicines
(P 415) A PHASE 1/2 TRIAL OF FOG-001, A FIRST-IN-CLASS DIRECT β-CATENIN:TCF4 INHIBITOR: SAFETY AND PRELIMINARY ANTITUMOR ACTIVITY IN PATIENTS WITH DESMOID TUMORS (DT)
Xinwei Han
Favorite
Han, Yiqun

Mayo Clinic
(P 223) OUTCOMES OF GERIATRIC PATIENTS WITH DE NOVO SARCOMA AND LUNG METASTASES: ROLE OF TUMOR CHARACTERISTICS AND TREATMENT STRATEGY
Yiqun Han
Favorite
(P 246) CTLA4 PATHWAY ACTIVATION IN RADIATION-INDUCED ANGIOSARCOMA: A TRANSCRIPTOMIC RATIONALE FOR IMMUNE CHECKPOINT BLOCKADE
Yiqun Han
Favorite
Haque, Farah

UHN
(P 465) JAK/STAT PATHWAY CO-OPERATES WITH CIC-FUSIONS TODRIVE CIC-REARRANGED SARCOMAS
Farah Haque
Favorite
Harada, Hideyuki

Shizuoka Cancer Center
(P 291) INTRA-ARTERIAL CHEMOTHERAPY WITH CONCOMITANT RADIATION THERAPY FOR UNRESECTABLE SARCOMA
Hideyuki Harada
Favorite
Haramiova, Zuzana

Thermosome GmbH, Martinsried, Germany
(P 437) CLINICAL DATA CONFIRM GALENIC PRINCIPLE AND DEMONSTRATE THERAPEUTIC POTENTIAL OF THE001 (DPPG2-TSL-DOX) PLUS REGIONAL HYPERTHERMIA IN SOFT TISSUE SARCOMA
Zuzana Haramiova
Favorite
Harbrücker, Melissa

Sarcoma Unit, Department of Surgery, University Medical Centre Mannheim, Medical Faculty Mannheim, Heidelberg University
(P 165) EVALUATING LARGE LANGUAGE MODELS AS DECISION SUPPORT TOOLS IN MULTIDISCIPLINARY TUMOR BOARDS FOR GASTROINTESTINAL STROMAL TUMORS
Melissa Harbrücker
Favorite
(P 303) MULTIVISCERAL RESECTIONS AND URINARY TRACT RECONSTRUCTION TECHNIQUES IN THE SURGERY OF RETROPERITONEAL SARCOMAS: A CASE SERIES.
Melissa Harbrücker
Favorite
(P 367) ADHERENCE TO GERMAN SARCOMA GUIDELINE FOR MRI SEQUENCING IN SOFT TISSUE SARCOMA: EVALUATION OF IMAGING PRACTICES AND COMPLIANCE
Melissa Harbrücker
Favorite
(P 441) COLOSARC-Q: A PROSPECTIVE MULTICENTER STUDY FOR EVALUATING SURGICAL STRATEGIES FOR COLORECTAL RESECTIONS AND POSTOPERATIVE QUALITY OF LIFE IN RETROPERITONEAL SARCOMA PATIENTS
Melissa Harbrücker
Favorite
(P 454) TREATMENT PATTERNS AND OUTCOMES IN RADIATION-INDUCED SARCOMA: FIRST RESULTS OF THE TETRIS-PROJECT - A MULTIMODAL RETROSPECTIVE ANALYSIS FROM A TERTIARY CENTER
Melissa Harbrücker
Favorite
(P 455) DEVELOPMENT OF PATIENT-CENTERED INFORMATION MATERIAL ON RADIATION-INDUCED SARCOMA: QUALITATIVE RESULTS FROM FOCUS GROUPS OF THE TETRIS-PROJECT
Melissa Harbrücker
Favorite
Hargbøl Madsen, Daniel

National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital—Herlev and Gentofte, Herlev
(P 36) MODULATION OF THE SARCOMA MICROENVIRONMENT THROUGH β-ADRENERGIC BLOCKADE
Daniel Hargbøl Madsen
Favorite
Harman, Joshua D.

University of Florida
(P 129) HIJACKED FUEL: GLYCOGEN-DRIVEN METABOLIC SHIFTS IN IDH1-MUTANT CHONDROSARCOMA
Joshua D. Harman
Favorite
Harper, Jennifer

Medical University of South Carolina
(P 279) IMPACT OF PREOPERATIVE 5-DAY HYPOFRACTIONATED RADIOTHERAPY (HFRT) FOR SOFT TISSUE SARCOMA (STS) ON BARRIERS TO TREATMENT AT A HIGH-VOLUME SARCOMA CENTER (HV-SC)
Jennifer Harper
Favorite
Harrison, Douglas

Division of Pediatrics, University of Texas MD Anderson Cancer Center
(P 411) TFCP2 FUSION-POSITVE RHABDOMYOSARCOMAS: A REPORT OF 10 CASES AND A REVIEW OF THE LITERATURE
Douglas Harrison
Favorite
Hastings, Reuben

NHS England, UCL Cancer Institute
(P 156) CHONDROSARCOMA INCIDENCE, SURVIVAL AND MANAGEMENT IN ENGLAND 2013-2022; AN ANALYSIS FROM THE NATIONAL DISEASE REGISTRATION SERVICE
Reuben Hastings
Favorite
Hattinger, Claudia

IRCCS Rizzoli Orthopaedic Institute
(P 18) ESTABLISHMENT AND CHARACTERIZATION OF A NOVEL PRIMARY CELL LINE FROM A BONE METASTASIS OF OSTEOSARCOMA
Claudia Hattinger
Favorite
Haugh, William

Providence Cancer Institute
(P 58) PLK1 AS A VULNERABLE TARGET OF BAP1-DRIVEN UNDIFFERENTIATED PLEOMORPHIC SARCOMAS
William Haugh
Favorite
Hawkey, Nathan

Tubulis, Inc
(P 34) EXPRESSION OF ONCOFETAL ANTIGEN 5T4 IN SARCOMA SUBTYPES AND PRECLINICAL ACTIVITY OF TUB-030, A NOVEL 5T4-TARGETING ANTIBODY-DRUG CONJUGATE (ADC)
Nathan Hawkey
Favorite
Hawkins, Allegra

Alex's CC Data Lab
(P 256) THE SEAN KARL COHORT: A NATIONAL COLLABORATIVE SINGLE-CELL RNASEQ STUDY OF PAIRED PATIENT EWING SARCOMA SPECIMENS
Allegra Hawkins
Favorite
Hawthorn, Rachael

The Ohio State University
(P 221) QUALITATIVE ANALYSIS OF THE PERIOPERATIVE EXPERIENCE OF YOUNG ADULT PATIENTS UNDERGOING EXTREMITY SARCOMA SURGERY
Rachael Hawthorn
Favorite
Hayenga, Heather

University of Texas at Dallas
(P 462) HDAC INHIBITORS AS POTENTIAL SFT THERAPIES
Heather Hayenga
Favorite
Hayes, Andrew

Royal Marsden Hospital NHS Foundation Trust
(P 298) RESECTION OF PARA-RENAL INFERIOR VENA CAVA LEIOMYOSARCOMA WITH RIGHT NEPHRECTOMY AND LEFT RENAL VEIN LIGATION WITHOUT VENOUS RECONSTRUCTION.
Andrew Hayes
Favorite
(P 414) PATTERNS OF RELAPSE OF BORDERLINE AND MALIGNANT PHYLLODES TUMOUR- RESULTS FROM SARCOMA REFERENCE CENTRE (SRC)
Andrew Hayes
Favorite
Hayes, Colin

Nationwide Children's Hospital
(P 377) GERMLINE RECQL4 VARIANT IN A PEDIATRIC PATIENT WITH EWING SARCOMA AND DESMOID FIBROMATOSIS
Colin Hayes
Favorite
Hayes-Dixon, Andrea

Howard University
(P 47) EWSR1::WT1 FUSION ONCOPROTEIN ACTIVITY SHAPES LINEAGE HETEROGENEITY IN DESMOPLASTIC SMALL ROUND CELL TUMORS
Andrea Hayes-Dixon
Favorite
Hayward, Colin

Ratio Therapeutics
(P 430) A PH/2 STUDY OF THE RADIOPHARMACEUTICAL [AC-225]RTX-2358 IN THE TREATMENT OF RELAPSED / REFRACTORY (R/R) SOFT TISSUE SARCOMA (STS) THE ATLAS STUDY - ACTINIUM THERAPY FOR LATE-STAGE AGGRESSIVE SARCOMAS
Colin Hayward
Favorite
Heaviside, Brianna

Precision NextGen Oncology and Research Center
(P 230) CIRCULATING TUMOR DNA AS AN EARLY INDICATOR OF RESPONSE, PROGRESSION, AND RECURRENCE OF SARCOMAS
Brianna Heaviside
Favorite
(P 433) PHASE I DOSE ESCALATION TRIAL OF STX-001, AN LNP SELF-REPLICATING MRNA EXPRESSING IL-12, IN PATIENTS WITH REFRACTORY TUMORS INCLUDING SARCOMAS
Brianna Heaviside
Favorite
(P 440) CASE REPORT: COMPLETE CLINICAL AND MOLECULAR RESPONSE TO INTRATUMORAL STX-001, AN LNP-SELF REPLICATING MRNA EXPRESSING IL-12 IN A PATIENT WITH REFRACTORY ANGIOSARCOMA
Brianna Heaviside
Favorite
(P 471) COMBINATION CHEMOTHERAPY WITH GEMCITABINE AND PACLITAXEL: A HIGHLY EFFICACIOUS AND BETTER TOLERATED OPTION FOR ANGIOSARCOMA
Brianna Heaviside
Favorite
He, Chen

St. Jude Children's Research Hospital
(P 267) THE RAF/MEK INHIBITOR VS-6766 SHOWS EFFICACY IN RAS-MUTANT PEDIATRIC PRECLINICAL XENOGRAFT MODELS- A REPORT FROM THE PEDIATRIC PRECLINICAL IN VIVO TESTING CONSORTIUM
Chen He
Favorite
Hederick, Lucy

MGH
(P 62) INTRAOPERATIVE BONE AND SOFT TISSUE TUMOR MARGIN IDENTIFICATION WITH FLUORESCENCE LIFETIME (FLT) IMAGING
Lucy Hederick
Favorite
(P 91) A COMPARISON OF ACETABULAR AUGMENTATION AND PHOTODYNAMIC NAIL STABILIZATION FOR COMPLEX ONCOLOGIC TOTAL HIP ARTHROPLASTY
Lucy Hederick
Favorite
(P 105) TREATMENT SUCCESS RATE AFTER SURGICAL MANAGEMENT OF PERIPROSTHETIC JOINT INFECTIONS IN ONCOLOGIC PROXIMAL TIBIA RECONSTRUCTION
Lucy Hederick
Favorite
(P 294) RISK FACTORS FOR RECURRENCE AND COMPLICATIONS OF CT-GUIDED RADIOFREQUENCY ABLATION FOR THE TREATMENT OF OSTEOID OSTEOMA: A MULTI-INSTITUTIONAL ANALYSIS.
Lucy Hederick
Favorite
(P 375) DOES STAGED RESECTION WITH TEMPORIZING WOUND VACUUM INFLUENCE LOCAL RECURRENCE RISK? A MULTI-INSTITUTIONAL MATCHED COHORT ANALYSIS
Lucy Hederick
Favorite
(P 392) CLASSIFICATION AND DIFFERENTIATIONOF MYXOID LIPOSARCOMA AND MYXOMA WITH MACHINE LEARNING
Lucy Hederick
Favorite
(P 392) DIFFERENTIATION OF MYXOMA AND MYXOID LIPOSARCOMA BASED ON RADIOMICS PHENOTYPES
Lucy Hederick
Favorite
Heesen, Philip

Swiss Sarcoma Network
(P 215) SHAPEHUB: A MULTICENTRE REAL-WORLD-TIME DATA PLATFORM WITH DIGITAL TWIN ENGINE FOR A LEARNING HEALTH SYSTEM IN SARCOMA
Philip Heesen
Favorite
Hefley, William

Vanderbilt University Medical Center
(P 97) RISK FACTORS ASSOCIATED WITH AMPUTATION VERSUS CONTINUED LIMB SALVAGE IN LOWER EXTREMITY ENDOPROSTHETIC RECONSTRUCTION
William Hefley
Favorite
Hegde, Prateek

TMH
(P 208) TRANSLATION, CROSS CULTURAL ADAPTATION AND VALIDATION OF TESS IN REGIONAL INDIAN LANGUAGES WITH ~500 MILLION GLOBAL DIASPORA
Prateek Hegde
Favorite
Heidkamp, Mackenize

Massachusetts General Hospital Department of Orthopaedic Surgery
(P 112) PEDIATRIC GIANT CELL TUMOR OF BONE
Mackenize Heidkamp
Favorite
Heim, Tanya

University of Pittsburgh
(P 14) EVALUATING THE COMBINATION OF DISULFIRAM AND ENZALUTAMIDE IN OSTEOSARCOMA
Tanya Heim
Favorite
Heim, Tanya

University of Pittsburgh Medical Center
(P 65) INVESTIGATING MACROPHAGE POPULATIONS IN PRIMARY AND METASTATIC SARCOMA SAMPLES
Tanya Heim
Favorite
(P 80) UTILIZATION OF THE MUSCULOSKELETAL ONCOLOGY TUMOR REGISTRY AND TISSUE BANK (MOTOR) FOR THE ACCELERATION OF SARCOMA RESEARCH
Tanya Heim
Favorite
Heinrich, Michael

Department of Medicine, Oregon Health & Science University
(P 181) THE DEVELOPMENT OF A NOVEL PDGFRA RESISTANCE MUTATION IN A RECURRENT KIT-MUTANT GASTROINTESTINAL STROMAL TUMOR (GIST)
Michael Heinrich
Favorite
(P 182) USING IN VITRO MODELS TO PREDICT IMATINIB RESPONSES OF PDGFRA EXON 18-MUTANT GIST
Michael Heinrich
Favorite
(P 194) UPDATED RESULTS FROM STRATEGIST 1: A PHASE 1/1B STUDY OF IDRX-42 (GSK6042981A) IN PATIENTS (PTS) WITH ADVANCED GASTROINTESTINAL STROMAL TUMORS (GIST)
Michael Heinrich
Favorite
(P 423) ZIFTOMENIB IN COMBINATION WITH IMATINIB IN ADVANCED GASTROINTESTINAL STROMAL TUMORS (GIST) AFTER IMATINIB FAILURE: PHASE 1A/B STUDY OF SAFETY, PHARMACOKINETICS, AND ANTITUMOR ACTIVITY
Michael Heinrich
Favorite
Heinzelmann, Katharina

Tubulis Gmbh
(P 34) EXPRESSION OF ONCOFETAL ANTIGEN 5T4 IN SARCOMA SUBTYPES AND PRECLINICAL ACTIVITY OF TUB-030, A NOVEL 5T4-TARGETING ANTIBODY-DRUG CONJUGATE (ADC)
Katharina Heinzelmann
Favorite
Hemke, Robert

Department of Radiology, Amsterdam University Medical Center
(P 294) RISK FACTORS FOR RECURRENCE AND COMPLICATIONS OF CT-GUIDED RADIOFREQUENCY ABLATION FOR THE TREATMENT OF OSTEOID OSTEOMA: A MULTI-INSTITUTIONAL ANALYSIS.
Robert Hemke
Favorite
Hemming, Matthew

UMass Chan Medical School
(P 198) EXPLOITING METABOLIC DYSREGULATION IN SUCCINATE DEHYDROGENASE-DEFICIENT GASTROINTESTINAL STROMAL TUMOR
Matthew Hemming
Favorite
Henderson, Eric

Dartmouth-Hitchcock Medical Center
(P 222) DO WE ALL SEE IT THE SAME: AN INTER-RATER RELIABILITY ANALYSIS OF THE MUSCULOSKELETAL TUMOR REGISTRY DATA ELEMENTS
Eric Henderson
Favorite
Hendrick, Leah

Moffitt Cancer Center
(P 394) DUAL OR TRIMODALITY THERAPY VERSUS SURGERY ALONE IN RADIATION-ASSOCIATED ANGIOSARCOMA OF THE BREAST
Leah Hendrick
Favorite
(P 453) OUTCOMES OF PLEOMORPHIC LIPOSARCOMA PATIENTS FOLLOWING MULTI-DISCIPLINARY MANAGEMENT WITHIN A TERTIARY CANCER CENTER
Leah Hendrick
Favorite
Hendricks, Anne

Sarcoma Center Würzburg,University Hospital of Würzburg
(P 204) ANALYSIS OF QUALITY INDICATORS OF SOFT TISSUE SARCOMA TREATMENT WITH CANCER REGISTRY DATA IN GERMANY 2015-2021
Anne Hendricks
Favorite
Hendrickson, Peter

Duke University
(P 43) OVERCOMING PROMISCUOUS TUMOR FORMATION: A CONTROLLED GENETICALLY ENGINEERED MOUSE MODEL OF CIC::DUX4 SARCOMA
Peter Hendrickson
Favorite
Henning, Evonne

McGill University
(P 143) IMPACT OF SURGICAL MARGINS IN CHEST WALL CHONDROSARCOMAS: A CANSARCC STUDY
Evonne Henning
Favorite
henon, Clémence

Gustave Roussy
(P 299) RECURRENCES AFTER PRIMARY RPS SURGERY IN A HIGH-VOLUME SARCOMA CENTER: A RETROSPECTIVE ANALYSIS ON 402 PATIENTS
Clémence henon
Favorite
Hermann, Frank

Thermosome GmbH, Martinsried, Germany
(P 437) CLINICAL DATA CONFIRM GALENIC PRINCIPLE AND DEMONSTRATE THERAPEUTIC POTENTIAL OF THE001 (DPPG2-TSL-DOX) PLUS REGIONAL HYPERTHERMIA IN SOFT TISSUE SARCOMA
Frank Hermann
Favorite
Hermida De Viveiros, Pedro

Robert H. Lurie Comprehensive Cancer Center of Northwestern University
(P 128) ISOCITRATE DEHYDROGENASE 1 (IDH1) MUTATION TESTING IN THE PHASE 3 STUDY OF IVOSIDENIB VS PLACEBO IN IDH1-MUTANT CONVENTIONAL CHONDROSARCOMA (CHONQUER)
Pedro Hermida De Viveiros
Favorite
(P 183) ACTIONABLE GENOMICS IN GASTROINTESTINAL STROMAL TUMORS LACKING KIT OR PDGFRA MUTATIONS.
Pedro Hermida De Viveiros
Favorite
(P 236) EXCEPTIONAL RESPONSE TO COMBINATION IMMUNOTHERAPY WITH YH001 AND ENVAFOLIMAB IN METASTATIC SARCOMA.
Pedro Hermida De Viveiros
Favorite
(P 353) TREATMENT OF ADVANCED EPITHELIOID SARCOMA WITH COMBINATION TAZEMETOSTAT AND PEMBROLIZUMAB
Pedro Hermida De Viveiros
Favorite
(P 373) COMPLETE RESPONSE TO FRONT-LINE PEXIDARTINIB IN SYMPTOMATIC TEMPOROMANDIBULAR JOINT TENOSYNOVIAL GIANT CELL TUMOR
Pedro Hermida De Viveiros
Favorite
(P 412) UNCOVERING HER2 OVEREXPRESSION IN SOFT TISSUE SARCOMAS (STS): INSIGHTS FROM THE CANCER GENOME ATLAS (TCGA)
Pedro Hermida De Viveiros
Favorite
(P 429) SINGLE-ARM, OPEN-LABEL PHASE II TRIAL OF XL092 (ZANZALINTINIB) IN PATIENTS WITH ADVANCED LEIOMYOSARCOMA: TRIAL IN PROGRESS
Pedro Hermida De Viveiros
Favorite
Hernández-Torrado, Guillermo

Hospital General Universitario Gregorio Marañón
(P 356) DESMOID TUMORS: A RETROSPECTIVE ANALYSIS FROM A REFERRAL CENTER
Guillermo Hernández-Torrado
Favorite
Herrera, Laura

Fundación Colombiana de Cancerología Clínica Vida
(P 219) RETROPERITONEAL SARCOMA: HEALTH SYSTEM BARRIERS AND THE RATIONALE FOR A SPECIALIZED SARCOMA UNIT
Laura Herrera
Favorite
Hester, Caitlin

University of Miami Hospital, Department of Surgical Oncology
(P 201) METASTATIC PATTERNS, TREATMENT MODALITIES, AND OVERALL SURVIVAL IN OLIGOMETASTATIC GIST: A SINGLE-CENTER RETROSPECTIVE STUDY
Caitlin Hester
Favorite
Hesterman, Jacob

Ratio Therapeutics
(P 430) A PH/2 STUDY OF THE RADIOPHARMACEUTICAL [AC-225]RTX-2358 IN THE TREATMENT OF RELAPSED / REFRACTORY (R/R) SOFT TISSUE SARCOMA (STS) THE ATLAS STUDY - ACTINIUM THERAPY FOR LATE-STAGE AGGRESSIVE SARCOMAS
Jacob Hesterman
Favorite
Hetjens, Svetlana

Department of Medical Statistics and Biomathematics, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany
(P 441) COLOSARC-Q: A PROSPECTIVE MULTICENTER STUDY FOR EVALUATING SURGICAL STRATEGIES FOR COLORECTAL RESECTIONS AND POSTOPERATIVE QUALITY OF LIFE IN RETROPERITONEAL SARCOMA PATIENTS
Svetlana Hetjens
Favorite
Hettler, Madelaine

Sarcoma unit, Department of Surgery, University Medical Center and Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.
(P 165) EVALUATING LARGE LANGUAGE MODELS AS DECISION SUPPORT TOOLS IN MULTIDISCIPLINARY TUMOR BOARDS FOR GASTROINTESTINAL STROMAL TUMORS
Madelaine Hettler
Favorite
Hettler, Madelaine

Sarcoma Unit, Department of Surgery, University Medical Centre Mannheim, Medical Faculty Mannheim, Heidelberg University
(P 303) MULTIVISCERAL RESECTIONS AND URINARY TRACT RECONSTRUCTION TECHNIQUES IN THE SURGERY OF RETROPERITONEAL SARCOMAS: A CASE SERIES.
Madelaine Hettler
Favorite
(P 367) ADHERENCE TO GERMAN SARCOMA GUIDELINE FOR MRI SEQUENCING IN SOFT TISSUE SARCOMA: EVALUATION OF IMAGING PRACTICES AND COMPLIANCE
Madelaine Hettler
Favorite
(P 441) COLOSARC-Q: A PROSPECTIVE MULTICENTER STUDY FOR EVALUATING SURGICAL STRATEGIES FOR COLORECTAL RESECTIONS AND POSTOPERATIVE QUALITY OF LIFE IN RETROPERITONEAL SARCOMA PATIENTS
Madelaine Hettler
Favorite
Hettler, Madelaine

Sarcoma unit, Department of Surgery, University Medical Center and Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.
(P 454) TREATMENT PATTERNS AND OUTCOMES IN RADIATION-INDUCED SARCOMA: FIRST RESULTS OF THE TETRIS-PROJECT - A MULTIMODAL RETROSPECTIVE ANALYSIS FROM A TERTIARY CENTER
Madelaine Hettler
Favorite
(P 455) DEVELOPMENT OF PATIENT-CENTERED INFORMATION MATERIAL ON RADIATION-INDUCED SARCOMA: QUALITATIVE RESULTS FROM FOCUS GROUPS OF THE TETRIS-PROJECT
Madelaine Hettler
Favorite
Hickey, John

Duke University
(P 126) SINGLE-CELL RNA SEQUENCING AND PROTEOMIC SPATIAL PROFILING REVEAL COMPLEX TUMOR MICROENVIRONMENT AND NOVEL IMMUNE INTERACTIONS IN CHONDROSARCOMA
John Hickey
Favorite
Higashi, Takahiro

National Cancer Center Hospital
(P 159) CHONDROSARCOMA IN JAPAN: A POPULATION-BASED ANALYSIS USING NATIONAL CANCER REGISTRY
Takahiro Higashi
Favorite
Higazy, Randa

University Health Network
(P 57) STUDYING HYPOXIA-INDUCED METASTASIS IN GENETICALLY ENGINEERED MOUSE MODELS OF UPS
Randa Higazy
Favorite
Hildebrand, Karys

University of Calgary
(P 238) INVESTIGATING HOW MACROPHAGES INFILTRATE THE TUMOUR MICROENVIRONMENT AND INFLUENCE THE EFFICACY OF CAR T THERAPY IN A MURINE MODEL OF STS
Karys Hildebrand
Favorite
(P 239) CHARACTERIZING THE ROLES OF T-CELLS IN THE CONTEXT OF TUMOR CLEARANCE AND MEMORY IN THE KP MODEL OF SARCOMA FOLLOWING STING THERAPY
Karys Hildebrand
Favorite
(P 378) HIGH DOSE RADIATION THERAPY PROMOTES IMMUNE SUPPRESSIVE MACROPHAGE PHENOTYPES, WHEREAS LOW DOSE RADIATION THERAPY PROMOTES IMMUNOGENIC MACROPHAGE PHENOTYPES IN A MURINE MODEL OF SOFT TISSUE SARCOMA
Karys Hildebrand
Favorite
Hildebrand, Kurt

university of calgary
(P 238) INVESTIGATING HOW MACROPHAGES INFILTRATE THE TUMOUR MICROENVIRONMENT AND INFLUENCE THE EFFICACY OF CAR T THERAPY IN A MURINE MODEL OF STS
Kurt Hildebrand
Favorite
(P 239) CHARACTERIZING THE ROLES OF T-CELLS IN THE CONTEXT OF TUMOR CLEARANCE AND MEMORY IN THE KP MODEL OF SARCOMA FOLLOWING STING THERAPY
Kurt Hildebrand
Favorite
(P 378) HIGH DOSE RADIATION THERAPY PROMOTES IMMUNE SUPPRESSIVE MACROPHAGE PHENOTYPES, WHEREAS LOW DOSE RADIATION THERAPY PROMOTES IMMUNOGENIC MACROPHAGE PHENOTYPES IN A MURINE MODEL OF SOFT TISSUE SARCOMA
Kurt Hildebrand
Favorite
Hildebrand, Laura

Department of Radiation Oncology, Universitätsstraße 27, 91054 Erlangen, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Germany
(P 288) IDENTIFICATION OF A DNA REPAIR INHIBITOR FOR THE COMBINATION WITH LURBINECTEDIN AND RADIOTHERAPY IN SARCOMA CELL LINES
Laura Hildebrand
Favorite
Hill, Elizabeth

Medical University of South Carolina
(P 279) IMPACT OF PREOPERATIVE 5-DAY HYPOFRACTIONATED RADIOTHERAPY (HFRT) FOR SOFT TISSUE SARCOMA (STS) ON BARRIERS TO TREATMENT AT A HIGH-VOLUME SARCOMA CENTER (HV-SC)
Elizabeth Hill
Favorite
Hincapie, Nicolas

University of Florida
(P 248) AN EX VIVO ASSAY TO PREDICT IMMUNOTHERAPY RESPONSE IN SARCOMA
Nicolas Hincapie
Favorite
HINDI, NADIA

Instituto de Investigacion Sanitaria Fundacion Jimenez Diaz (IIS/FJD)
(P 38) VALIDATION OF THE SIGNIOS SEVEN-GENE SIGNATURE FOR PREDICTING ANTI-PD-1 INHIBITOR EFFICACY IN SARCOMA
NADIA HINDI
Favorite
Hines, Elaine

Cleveland Clinic
(P 316) AREA DEPRIVATION INDEX (ADI) AND OUTCOMES IN LOCALIZED SOFT TISSUE SARCOMA: DO SOCIAL DETERMINANTS INFLUENCE SURVIVAL?
Elaine Hines
Favorite
Hiraga, Hiroaki

Hokkaido Cancer Center
(P 128) ISOCITRATE DEHYDROGENASE 1 (IDH1) MUTATION TESTING IN THE PHASE 3 STUDY OF IVOSIDENIB VS PLACEBO IN IDH1-MUTANT CONVENTIONAL CHONDROSARCOMA (CHONQUER)
Hiroaki Hiraga
Favorite
Hirapara, Het

University of Miami
(P 333) METABOLIC SYNDROME CORRELATION WITH LIPOSARCOMA INCIDENCE AND OUTCOMES: A RETROSPECTIVE ANALYSIS.
Het Hirapara
Favorite
Hitomi, Masahiro

Cleveland Clinic
(P 10) COLLATERAL SENSITIVIES EMERGE DURING THE EVOLUTION OF CHEMORESISTANCE TO MAP CHEMOTHERAPY IN OSTEOSARCOMA
Masahiro Hitomi
Favorite
Hoberger, Michael

Department of Medicine III, LMU University Hospital, Munich, Germany
(P 64) ATRX EXPRESSION CORRELATES WITH REDUCED IMMUNE CHECKPOINT EXPRESSION AND POOR SURVIVAL IN HIGH-RISK SOFT TISSUE SARCOMAS
Michael Hoberger
Favorite
(P 443) FIRST-LINE PAZOPANIB IN PATIENTS WITH EPITHELIOID HEMANGIOENDOTHELIOMA: A RETROSPECTIVE SINGLE-CENTER ANALYSIS
Michael Hoberger
Favorite
Hoch, Lucy

Adaptimmune
(P 337) POOLED ANALYSIS OF TRABECTEDIN EFFICACY IN MYXOID/ROUND CELL LIPOSARCOMA FROM THREE PROSPECTIVE CLINICAL TRIALS
Lucy Hoch
Favorite
Hock, Björn

Tubulis, SarL
(P 34) EXPRESSION OF ONCOFETAL ANTIGEN 5T4 IN SARCOMA SUBTYPES AND PRECLINICAL ACTIVITY OF TUB-030, A NOVEL 5T4-TARGETING ANTIBODY-DRUG CONJUGATE (ADC)
Björn Hock
Favorite
Ho, Dean

National University of Singapore
(P 53) ESTABLISHMENT AND CHARACTERISATION OF LIPOSARCOMA-DERIVED CELLS AS RELEVANT PRE-CLINICAL MODELS FOR TARGET DISCOVERY
Dean Ho
Favorite
Hodik, Marcia

University of Florida
(P 426) A PHASE I/II TRIAL USING RNA LIPID NANOPARTICLES FOR RECURRENT OSTEOSARCOMA: A REPORT FROM THE NATIONAL PEDIATRIC CANCER FOUNDATION
Marcia Hodik
Favorite
Hoey, Maggie

Duke University Department of Orthopaedic Surgery
(P 119) DEVELOPMENT OF AN EXTINCTION THERAPY APPROACH FOR OSTEOSARCOMA USING ECO-EVOLUTIONARY PRINCIPLES
Maggie Hoey
Favorite
(P 259) PRECLINICAL MODELING OF CHEMOTHERAPY RELEASE IDENTIFIES MITOCHONDRIAL ADAPTATIONS IN DOXORUBICIN TREATED OSTEOSARCOMA
Maggie Hoey
Favorite
Hoffman, Alexander

University of Pittsburgh Medical Center
(P 14) EVALUATING THE COMBINATION OF DISULFIRAM AND ENZALUTAMIDE IN OSTEOSARCOMA
Alexander Hoffman
Favorite
(P 63) EVALUATING SURGICAL MARGINS IN SARCOMA RESECTION WITH INDOCYANINE GREEN FLUORESCENCE IMAGING
Alexander Hoffman
Favorite
Hoffmann, Caroline

Owkin
(P 431) INVOKE: A PHASE 1 STUDY OF OKN4395, A FIRST-IN-CLASS EP2/EP4/DP1 TRIPLE PROSTANOID RECEPTOR ANTAGONIST, IN PATIENTS WITH ADVANCED SOLID TUMORS, INCLUDING SARCOMAS
Caroline Hoffmann
Favorite
HOFFMANN, Jean-Sebastien

Institut Universitaire du Cancer de Toulouse
(P 12) DNA REPLICATION STRESS AND DEFICIENT HOMOLOGOUS RECOMBINATION IN OSTEOSARCOMA RISK AND THERAPY
Jean-Sebastien HOFFMANN
Favorite
Hohenberger, Peter

Sarcoma Unit, Department of Surgery, University Medical Centre Mannheim, Medical Faculty Mannheim, Heidelberg University
(P 165) EVALUATING LARGE LANGUAGE MODELS AS DECISION SUPPORT TOOLS IN MULTIDISCIPLINARY TUMOR BOARDS FOR GASTROINTESTINAL STROMAL TUMORS
Peter Hohenberger
Favorite
Hohenberger, Peter

Mannheim University Medical Center
(P 204) ANALYSIS OF QUALITY INDICATORS OF SOFT TISSUE SARCOMA TREATMENT WITH CANCER REGISTRY DATA IN GERMANY 2015-2021
Peter Hohenberger
Favorite
Hohenberger, Peter

Sarcoma Unit, Department of Surgery, University Medical Centre Mannheim, Medical Faculty Mannheim, Heidelberg University
(P 441) COLOSARC-Q: A PROSPECTIVE MULTICENTER STUDY FOR EVALUATING SURGICAL STRATEGIES FOR COLORECTAL RESECTIONS AND POSTOPERATIVE QUALITY OF LIFE IN RETROPERITONEAL SARCOMA PATIENTS
Peter Hohenberger
Favorite
(P 454) TREATMENT PATTERNS AND OUTCOMES IN RADIATION-INDUCED SARCOMA: FIRST RESULTS OF THE TETRIS-PROJECT - A MULTIMODAL RETROSPECTIVE ANALYSIS FROM A TERTIARY CENTER
Peter Hohenberger
Favorite
Hohos, Melissa

Dana-Farber Cancer Institute
(P 427) PHASE 1/2 TRIAL TO EVALUATE THE SAFETY AND EFFICACY OF PEEL-224 IN COMBINATION WITH VINCRISTINE AND TEMOZOLOMIDE IN ADOLESCENTS AND YOUNG ADULTS WITH RELAPSED OR REFRACTORY SARCOMAS
Melissa Hohos
Favorite
Holloway, Caroline

BC Cancer
(P 143) IMPACT OF SURGICAL MARGINS IN CHEST WALL CHONDROSARCOMAS: A CANSARCC STUDY
Caroline Holloway
Favorite
Holt, Ginger

TriStar Medical Group
(P 84) A MULTICENTER COMPARISON OF REVERSE TOTAL SHOULDER ARTHROPLASTY VERSUS HEMIARTHROPLASTY FOR ENDOPROSTHETIC RECONSTRUCTION FOLLOWING ONCOLOGIC RESECTION OF THE PROXIMAL HUMERUS
Ginger Holt
Favorite
Holthuis, Emily I.

The Netherlands Cancer Institute
(P 444) HEALTH-RELATED QUALITY OF LIFE (HRQOL) CHALLENGES IN PATIENTS WITH EPITHELIOID HEMANGIOENDOTHELIOMA (EHE): ANALYSIS OF AN ULTRA-RARE SARCOMA GROUP
Emily I. Holthuis
Favorite
Homs samsó, Roger

Hospital de la Santa Creu i Sant Pau
(P 383) MULTIDISCIPLINARY TREATMENT OF INGUINOSCROTAL SARCOMAS: ANALYSIS OF 39 CASES TREATED BY SURGICAL APPROACH
Roger Homs samsó
Favorite
Honeyman, Joshua

Memorial Sloan Kettering Cancer Center
(P 273) RADIOMIC PREDICTORS OF SPONTANEOUS PNEUMOTHORAX DURING TYROSINE KINASE INHIBITOR THERAPY FOR LUNG METASTASES
Joshua Honeyman
Favorite
Hong, David S.

The University of Texas MD Anderson Cancer Center
(P 419) PROSPECTIVE REAL-WORLD STUDY OF LAROTRECTINIB (LARO) IN PATIENTS (PTS) WITH TRK FUSION SOLID TUMORS: INTERIM ANALYSIS OF ON-TRK
David S. Hong
Favorite
Honoré, Charles

Gustave Roussy
(P 299) RECURRENCES AFTER PRIMARY RPS SURGERY IN A HIGH-VOLUME SARCOMA CENTER: A RETROSPECTIVE ANALYSIS ON 402 PATIENTS
Charles Honoré
Favorite
Hoogstoel, Fanny

European Organisation for Research and Treatment of Cancer
(P 456) OUTCOMES OF FIRST-LINE CHEMOTHERAPY IN ADVANCED ADULT-TYPE RHABDOMYOSARCOMAS: POOLED ANALYSIS OF CLINICAL TRIALS FROM THE EORTC SOFT TISSUE AND BONE SARCOMA GROUP
Fanny Hoogstoel
Favorite
Hopman, Alon G. M.

Amsterdam University Medical Center Amsterdam
(P 294) RISK FACTORS FOR RECURRENCE AND COMPLICATIONS OF CT-GUIDED RADIOFREQUENCY ABLATION FOR THE TREATMENT OF OSTEOID OSTEOMA: A MULTI-INSTITUTIONAL ANALYSIS.
Alon G. M. Hopman
Favorite
Hornicek, Francis

Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA; Miller School of Medicine, University of Miami, Miami, FL, USA
(P 60) EXPLORING METABOLIC REWIRING IN CHORDOMA
Francis Hornicek
Favorite
(P 89) PATELLAR HEIGHT AND ITS INFLUENCE ON FUNCTIONAL OUTCOMES FOR MEGAPROSTHESES AROUND THE KNEE PERFORMED FOR ONCOLOGICAL INDICATIONS
Francis Hornicek
Favorite
(P 90) MEGAPROSTHESIS CONVERSION FROM FAILED OSTEOARTICULAR ALLOGRAFT VERSUS PRIMARY RECONSTRUCTION FOR DISTAL FEMUR AND PROXIMAL TIBIA TUMORS: A PROPENSITY MATCHED-PAIR ANALYSIS
Francis Hornicek
Favorite
(P 99) LIMB SALVAGE FOR PROXIMAL TIBIA TUMORS: OUTCOMES OF ALLOGRAFT-PROSTHESIS COMPOSITE AND ENDOPROSTHETIC RECONSTRUCTION
Francis Hornicek
Favorite
(P 117) THERAPEUTIC POTENTIAL OF DOXORUBICIN AND DASATINIB COMBINATION IN OSTEOSARCOMA
Francis Hornicek
Favorite
(P 131) GLUCOSE TRANSPORTER 1 (GLUT1) INHIBITION DECREASES THE GROWTH AND PROLIFERATION OF CHONDROSARCOMA
Francis Hornicek
Favorite
(P 225) GLOBAL REGISTRY OF SOLITARY FIBROUS TUMORS (SFT): INTEGRATING CLINICAL, MOLECULAR, AND ENVIRONMENTAL DATA- THE HOROWITZ SFT INITIATIVE (HSFTI)
Francis Hornicek
Favorite
(P 369) CLINICAL CHARACTERISTICS & TREATMENT OUTCOME PATTERNS OF SOLITARY FIBROUS TUMORS: A SINGLE-INSTITUTION RETROSPECTIVE ANALYSIS
Francis Hornicek
Favorite
(P 403) MEDICAL MANAGEMENT OF TENOSYNOVIAL GIANT CELL TUMOR
Francis Hornicek
Favorite
Hornick, Jason

Brigham and Women's Hospital
(P 184) MTAP IN GASTROINTESTINAL STROMAL TUMOR (GIST): RATE OF MTAP LOSS AND CONCORDANCE BETWEEN GENOMIC SEQUENCING AND IMMUNOHISTOCHEMISTRY
Jason Hornick
Favorite
Hosszu, Kinga

Memorial Sloan Kettering Cancer Center
(P 421) CHARACTERIZING THE IMMUNE RESPONSE TO INTRATUMORAL TIGILANOL TIGLATE (TT) IN PATIENTS WITH ADVANCED AND/OR METASTATIC SOFT TISSUE SARCOMA (STS) IN A PHASE IIA TRIAL (NCT05755113)
Kinga Hosszu
Favorite
HOTEIT, Bassel

Institut Bergonié
(P 390) USE OF DERMAL TEMPLATE FOR NERVE PROTECTION IN LIMB-SPARING SURGERY FOR SOFT TISSUE SARCOMAS: PRELIMINARY EXPERIENCE FROM INSTITUT BERGONIE
Bassel HOTEIT
Favorite
Ho, Thanh

Mayo Clinic
(P 223) OUTCOMES OF GERIATRIC PATIENTS WITH DE NOVO SARCOMA AND LUNG METASTASES: ROLE OF TUMOR CHARACTERISTICS AND TREATMENT STRATEGY
Thanh Ho
Favorite
(P 246) CTLA4 PATHWAY ACTIVATION IN RADIATION-INDUCED ANGIOSARCOMA: A TRANSCRIPTOMIC RATIONALE FOR IMMUNE CHECKPOINT BLOCKADE
Thanh Ho
Favorite
(P 300) FEATURES AND OUTCOMES OF PATIENTS WITH GASTROINTESTINAL LEIYOMYOSARCOMA
Thanh Ho
Favorite
Houdek, Matthew

Mayo Clinic
(P 96) AMPUTATION FOLLOWING MEGAPROSTHESIS USE IN LIMB SALVAGE
Matthew Houdek
Favorite
(P 150) LOCAL RECURRENCE OF CHONDROSARCOMA: IMPACT ON SURVIVAL AND RECURRENCE AT AN INCREASED GRADE
Matthew Houdek
Favorite
(P 151) SHOULD WE USE ADJUVANT CHEMOTHERAPY IN PATIENTS WITH LOCALIZED DEDIFFERENTIATED CHONDROSARCOMA (DDCS) OF THE PELVIS? AN ANALYSIS BY THE PELVIC DDCS STUDY GROUP
Matthew Houdek
Favorite
(P 162) CHONDROSARCOMA OUTCOMES IN YOUNG VERSUS ADULT POPULATIONS
Matthew Houdek
Favorite
(P 166) LARGE LANGUAGE MODEL EXTRACTION OF STRUCTURED DATA IN UNSTRUCTURED SARCOMA PATHOLOGY NOTES: A PILOT STUDY
Matthew Houdek
Favorite
(P 167) LARGE LANGUAGE MODEL EXTRACTION OF STRUCTURED DATA FROM UNSTRUCTURED RADIATION ONCOLOGY NOTES: A PILOT STUDY
Matthew Houdek
Favorite
(P 246) CTLA4 PATHWAY ACTIVATION IN RADIATION-INDUCED ANGIOSARCOMA: A TRANSCRIPTOMIC RATIONALE FOR IMMUNE CHECKPOINT BLOCKADE
Matthew Houdek
Favorite
(P 348) SYNOVIAL SARCOMA INVOLVING NERVES: HIGH RATE OF MISIDENTIFICATION AS BENIGN TUMORS
Matthew Houdek
Favorite
Houvras, Yariv

Tubulis, Inc
(P 34) EXPRESSION OF ONCOFETAL ANTIGEN 5T4 IN SARCOMA SUBTYPES AND PRECLINICAL ACTIVITY OF TUB-030, A NOVEL 5T4-TARGETING ANTIBODY-DRUG CONJUGATE (ADC)
Yariv Houvras
Favorite
Hovsepyan, Shushan

Immune Oncology Research Institute
(P 158) GLOBAL INEQUITIES IN CHONDROSARCOMA CLINICAL TRIALS: A COMPREHENSIVE ANALYSIS ACROSS THREE DECADES
Shushan Hovsepyan
Favorite
Howarth, Rachel

Newcastle University
(P 135) EXPLORING THE ROLE OF CLUSTER OF DIFFERENTIATION 44 IN CHONDROSARCOMA
Rachel Howarth
Favorite
Hsiao, Chin-Fu

National Health Research Institute
(P 428) MAINTENANCE PEGYLATED LIPOSOMAL DOXORUBICIN VERSUS ACTIVE SURVEILLANCE FOR ADVANCED SOFT TISSUE SARCOMA PATIENTS WHO HAD CONTROLLED DISEASE AFTER STANDARD ANTHRACYCLINE-BASED TREATMENT (MELODY)
Chin-Fu Hsiao
Favorite
Hsu, Johann

Atrium Health Levine Cancer Institute
(P 02) METHYLATION PROFILING AS A DIAGNOSTIC ADJUNCT FOR UNDIFFERENTIATED SARCOMAS: A REAL-WORLD EVALUATION
Johann Hsu
Favorite
Huang, Chiung-Yu

UCSF Helen Diller Family Comprehensive Cancer Center
(P 439) AN OPEN LABEL MULTICENTER PHASE 2 STUDY WITH SAFETY LEAD IN OF INTRATUMORAL VUSOLIMOGENE ODERPAREPVEC IN COMBINATION WITH PEMBROLIZUMAB IN PATIENTS WITH ANGIOSARCOMA
Chiung-Yu Huang
Favorite
Huang, Jianguo

Providence Cancer Institute
(P 58) PLK1 AS A VULNERABLE TARGET OF BAP1-DRIVEN UNDIFFERENTIATED PLEOMORPHIC SARCOMAS
Jianguo Huang
Favorite
Huang, Jingwei

UT Southwestern Medical Center
(P 168) LEVERAGING LARGE LANGUAGE MODELS FOR STRUCTURED INFORMATION EXTRACTION FROM EWING SARCOMA PATHOLOGY REPORTS
Jingwei Huang
Favorite
Huang, Karen

Children's Hospital of Philadelphia
(P 262) EVALUATING FRONT-LINE THERAPY ACCORDANCE WITH CURRENT SYNOVIAL SARCOMA GUIDELINES
Karen Huang
Favorite
(P 263) DESCRIBING THE CHARACTERISTICS AND TREATMENT OF SYNOVIAL SARCOMA IN THE RECURRENT SETTING
Karen Huang
Favorite
Huang, Paul

Institute of Cancer Research London
(P 446) GDF-15 AS A PROGNOSTIC FACTOR IN PATIENTS WITH EPITHELIOID HEMANGIOENDOTHELIOMA
Paul Huang
Favorite
Huang, Shaoqing

Sun Yat-sen University
(P 193) CLINICAL ANALYSIS OF RIPRETINIB DOSE ESCALATION IN ADVANCED GISTS AFTER STANDARD DOSE PROGRESSION
Shaoqing Huang
Favorite
Hua, Yingqi

Department of Orthopedic Oncology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
(P 07) A LIVING MULTI-OMICS BIOBANK OF PATIENT-DERIVED XENOGRAFT MODELS FOR SARCOMA
Yingqi Hua
Favorite
(P 407) PIMICOTINIB IN TENOSYNOVIAL GIANT CELL TUMOR (TGCT): LONG-TERM EFFICACY, SAFETY, AND PATIENT-REPORTED OUTCOMES FROM THE PHASE 3 MANEUVER STUDY
Yingqi Hua
Favorite
Huda, Md Nazmul

Thomas Jefferson University
(P 35) MECHANISTIC AND TRANSCRIPTOMIC ANALYSES REVEAL MUTATION-SPECIFIC THERAPEUTIC RESPONSES IN DESMOID TUMOR CELLS TREATED WITH SORAFENIB AND NIROGACESTAT
Md Nazmul Huda
Favorite
Huebner, Dirk

Radiation Oncology LUKS
(P 282) LOCAL FAILURE ANALYSIS OF SOFT TISSUE SARCOMA TREATED WITH PREOPERATIVE ULTRA-HYPOFRACTIONATED RADIATION: UPDATE
Dirk Huebner
Favorite
(P 283) PALLIATIVE LATTICE RADIATION THERAPY IN SOFT TISSUE SARCOMA VERSUS CARCINOMA AND MELANOMA: OUTCOME COMPARISON
Dirk Huebner
Favorite
Huguet, Romain

Bordeaux university Hospital, INSERM BRIC U1312
(P 42) PRECLINICAL VALIDATION OF M3554, A NOVEL ANTI-GD2 ANTIBODY-DRUG CONJUGATE, AND EPIGENETIC SENSITIZATION STRATEGIES IN SOFT TISSUE SARCOMAS
Romain Huguet
Favorite
Huibers, Anne

Institute of Clinical Scinces/Sahlgrenska Academy
(P 124) ISOLATED LIMB PERFUSION AS LIMB SALVAGING TREATMENT; A SINGLE CENTRE RETROSPECTIVE STUDY
Anne Huibers
Favorite
Hummedah, Kamal

Department of Surgery, Medical Faculty Mannheim, Mannheim School of Medicine, Heidelberg University
(P 169) BENCHMARKING LARGE LANGUAGE MODELS VS MULTIDISCIPLINARY TUMOR BOARDS OF 21 SARCOMA CENTERS
Kamal Hummedah
Favorite
Humphries, Timothy

Linear Clinical Research Ltd
(P 431) INVOKE: A PHASE 1 STUDY OF OKN4395, A FIRST-IN-CLASS EP2/EP4/DP1 TRIPLE PROSTANOID RECEPTOR ANTAGONIST, IN PATIENTS WITH ADVANCED SOLID TUMORS, INCLUDING SARCOMAS
Timothy Humphries
Favorite
Hung, Yin

MGH
(P 62) INTRAOPERATIVE BONE AND SOFT TISSUE TUMOR MARGIN IDENTIFICATION WITH FLUORESCENCE LIFETIME (FLT) IMAGING
Yin Hung
Favorite
(P 290) CLINICAL OUTCOMES AFTER RADIOTHERAPY FOR PATIENTS WITH POORLY DIFFERENTIATED CHORDOMA
Yin Hung
Favorite
(P 392) CLASSIFICATION AND DIFFERENTIATIONOF MYXOID LIPOSARCOMA AND MYXOMA WITH MACHINE LEARNING
Yin Hung
Favorite
(P 392) DIFFERENTIATION OF MYXOMA AND MYXOID LIPOSARCOMA BASED ON RADIOMICS PHENOTYPES
Yin Hung
Favorite
Hunt, Kelly

MD Anderson Cancer Center
(P 351) THE ROLE OF SOCIOECONOMIC DISPARITIES ON SURVIVAL OUTCOMES IN MALIGNANT PERIPHERAL NERVE SHEATH TUMORS
Kelly Hunt
Favorite
Huntsman, Emily

Weill Cornell Medicine
(P 198) EXPLOITING METABOLIC DYSREGULATION IN SUCCINATE DEHYDROGENASE-DEFICIENT GASTROINTESTINAL STROMAL TUMOR
Emily Huntsman
Favorite
Hurley, Rachel

The Children’s Hospital of Philadelphia, University of Pennsylvania
(P 262) EVALUATING FRONT-LINE THERAPY ACCORDANCE WITH CURRENT SYNOVIAL SARCOMA GUIDELINES
Rachel Hurley
Favorite
(P 263) DESCRIBING THE CHARACTERISTICS AND TREATMENT OF SYNOVIAL SARCOMA IN THE RECURRENT SETTING
Rachel Hurley
Favorite
Husain, Marium

The Ohio State University
(P 161) CLINICAL CHARACTERISTICS, PATTERNS OF CARE, AND TREATMENT OUTCOMES OF CHONDROSARCOMA: A SINGLE-INSTITUTIONAL EXPERIENCE
Marium Husain
Favorite
(P 170) GEMSARC: AN AI BASED PREDICTIVE GENE SIGNATURE FOR GEMCITABINE EFFICACY IN ADVANCED SOFT-TISSUE SARCOMAS
Marium Husain
Favorite
(P 408) REAL-WORLD SINGLE-CENTER INSIGHTS INTO CT-DNA DYNAMICS ACROSS SOFT TISSUE SARCOMAS
Marium Husain
Favorite
Hussein, Atif

Memorial Healthcare System
(P 330) LEIOMYOSARCOMA IN THE REAL WORLD: RETROSPECTIVE ANALYSIS OF CLINICAL CHARACTERISTICS AND TREATMENT PATTERNS IN PATIENTS AT A COMMUNITY ONCOLOGY CENTER IN SOUTH FLORIDA (MEMORIAL HEALTHCARE SYSTEM)
Atif Hussein
Favorite
(P 459) EPIDEMIOLOGICAL TRENDS, TREATMENT PATTERNS, AND SURVIVAL DISPARITIES IN MALIGNANT PERIPHERAL NERVE SHEATH TUMORS: A SEER ANALYSIS, 2001-2020
Atif Hussein
Favorite
Husson, Olga

The Netherlands Cancer Institute
(P 444) HEALTH-RELATED QUALITY OF LIFE (HRQOL) CHALLENGES IN PATIENTS WITH EPITHELIOID HEMANGIOENDOTHELIOMA (EHE): ANALYSIS OF AN ULTRA-RARE SARCOMA GROUP
Olga Husson
Favorite
Hutchison, Ruby

Medical University of South Carolina
(P 279) IMPACT OF PREOPERATIVE 5-DAY HYPOFRACTIONATED RADIOTHERAPY (HFRT) FOR SOFT TISSUE SARCOMA (STS) ON BARRIERS TO TREATMENT AT A HIGH-VOLUME SARCOMA CENTER (HV-SC)
Ruby Hutchison
Favorite
Hu, Tu

Fudan University Shanghai Cancer Center, Shanghai, China
(P 361) PEXIDARTINIB FOR THE TREATMENT OF TENOSYNOVIAL GIANT CELL TUMORS: CLINICAL EXPERIENCE FROM FIVE CHINESE PATIENTS
Tu Hu
Favorite
Hwang, Eugene

Children's National Hospital
(P 426) A PHASE I/II TRIAL USING RNA LIPID NANOPARTICLES FOR RECURRENT OSTEOSARCOMA: A REPORT FROM THE NATIONAL PEDIATRIC CANCER FOUNDATION
Eugene Hwang
Favorite
I
Iafrate, A John

Department of Pathology, Massachusetts General Hospital, Harvard Medical School
(P 45) MONITORING EWSR1 FUSIONS IN SARCOMA PATIENTS USING PERSONALIZED LIQUID BIOPSY ASSAYS
A John Iafrate
Favorite
Ibanez Sanchez, Glorife

Memorial Sloan Kettering Cancer Center
(P 25) IDENTIFICATION AND VALIDATION OF NON-GENETICALLY ENCODED VULNERABILITIES IN EWING SARCOMA
Glorife Ibanez Sanchez
Favorite
Ibanez Sanchez, Glorymar

Memorial Sloan Kettering Cancer Center
(P 22) SINGLE CELL SEQUENCING ENABLES LINEAGE-INFORMED TARGETING OF OSTEOSARCOMA
Glorymar Ibanez Sanchez
Favorite
(P 25) IDENTIFICATION AND VALIDATION OF NON-GENETICALLY ENCODED VULNERABILITIES IN EWING SARCOMA
Glorymar Ibanez Sanchez
Favorite
Ibrahim, Minas

Medical University of Vienna
(P 86) CARBON FIBRE-REINFORCED PEEK IMPLANTS FOR TUMORS OF THE SPINE
Minas Ibrahim
Favorite
Ibrahim, Toni

IRCCS Istituto Ortopedico Rizzoli
(P 18) ESTABLISHMENT AND CHARACTERIZATION OF A NOVEL PRIMARY CELL LINE FROM A BONE METASTASIS OF OSTEOSARCOMA
Toni Ibrahim
Favorite
(P 139) IMMUNOGENOMIC PROFILING OF CHONDROSARCOMA REVEALS DISTINCT IMMUNE PHENOTYPES AND PROGNOSTIC MUTATIONS
Toni Ibrahim
Favorite
Iglesias, Antía

Hospital La Princesa
(P 356) DESMOID TUMORS: A RETROSPECTIVE ANALYSIS FROM A REFERRAL CENTER
Antía Iglesias
Favorite
Ignazzi, Gianluca

Italian Sarcoma Group ISG ETS
(P 210) TOWARDS INTERNATIONALIZATION OF THE CLINICAL RESEARCH COORDINATOR ROLE: THE FIRST DROP OF THE NIAGARA FALLS PROJECT
Gianluca Ignazzi
Favorite
Ikeuchi, Kyoko

Hyogo Cancer Center
(P 192) OPTIMAL DOSING SCHEDULE OF SUNITINIB BASED ON PLATELET COUNT IN AN OLDER PATIENT WITH GASTROINTESTINAL STROMAL TUMOR
Kyoko Ikeuchi
Favorite
Imamura, Jarrell

Cleveland Clinic Research
(P 10) COLLATERAL SENSITIVIES EMERGE DURING THE EVOLUTION OF CHEMORESISTANCE TO MAP CHEMOTHERAPY IN OSTEOSARCOMA
Jarrell Imamura
Favorite
Ingram, Davis

MD Anderson Cancer Center
(P 38) VALIDATION OF THE SIGNIOS SEVEN-GENE SIGNATURE FOR PREDICTING ANTI-PD-1 INHIBITOR EFFICACY IN SARCOMA
Davis Ingram
Favorite
(P 47) EWSR1::WT1 FUSION ONCOPROTEIN ACTIVITY SHAPES LINEAGE HETEROGENEITY IN DESMOPLASTIC SMALL ROUND CELL TUMORS
Davis Ingram
Favorite
(P 172) COMPARISON OF CELL SEGMENTATION METHODS IN SOFT TISSUE SARCOMA (STS) SPATIAL PROTEOMIC DATASETS
Davis Ingram
Favorite
(P 184) MTAP IN GASTROINTESTINAL STROMAL TUMOR (GIST): RATE OF MTAP LOSS AND CONCORDANCE BETWEEN GENOMIC SEQUENCING AND IMMUNOHISTOCHEMISTRY
Davis Ingram
Favorite
(P 242) IMMUNE PROFILING OF UNDIFFERENTIATED PLEOMORPHIC SARCOMAS REVEALS DISTINCT PROGNOSTIC SUBGROUPS
Davis Ingram
Favorite
(P 411) TFCP2 FUSION-POSITVE RHABDOMYOSARCOMAS: A REPORT OF 10 CASES AND A REVIEW OF THE LITERATURE
Davis Ingram
Favorite
Ioakeim-Ioannidou, Myrsini

Massachusetts General Hospital
(P 290) CLINICAL OUTCOMES AFTER RADIOTHERAPY FOR PATIENTS WITH POORLY DIFFERENTIATED CHORDOMA
Myrsini Ioakeim-Ioannidou
Favorite
(P 461) A RETROSPECTIVE ANALYSIS OF PATIENTS WITH CONVENTIONAL CHORDOMA TREATED WITH SYSTEMIC THERAPY
Myrsini Ioakeim-Ioannidou
Favorite
Iranpur, Khurshid

Surgical Oncology, Department of Surgery, University of California, Davis
(P 244) INTRATUMORAL TIGIT BLOCKADE AUGMENTS ANTI-TUMOR RESPONSES AND BYPASSES HYPERFUNCTIONALITY OF PERIPHERAL TIGIT+ NK CELLS IN MOUSE AND HUMAN MODELS OF BONE AND SOFT TISSUE SARCOMA
Khurshid Iranpur
Favorite
Ireland, Beth

Adaptimmune
(P 337) POOLED ANALYSIS OF TRABECTEDIN EFFICACY IN MYXOID/ROUND CELL LIPOSARCOMA FROM THREE PROSPECTIVE CLINICAL TRIALS
Beth Ireland
Favorite
Irvin, Boston

University of Miami School of Medicine
(P 320) CLINICAL CHARACTERISTICS AND RECURRENCE PATTERNS IN HISPANIC VS. NON-HISPANIC PATIENTS WITH LEIOMYOSARCOMA: FINDINGS FROM A RETROSPECTIVE SINGLE-CENTER COHORT STUDY
Boston Irvin
Favorite
(P 327) INITIAL TREATMENT MODALITY AND RECURRENCE IN NON-METASTATIC LEIOMYOSARCOMA: A RETROSPECTIVE COHORT STUDY
Boston Irvin
Favorite
Isaacson, Alexandra

University of Iowa Health Care
(P 370) CLINICAL OUTCOMES OF CUTANEOUS UNDIFFERENTIATED PLEOMORPHIC SARCOMA AND SUBCUTANEOUS MYXOFIBROSARCOMA: A RETROSPECTIVE REVIEW
Alexandra Isaacson
Favorite
Isakoff, MIchael

Connecticut Childrens
(P 426) A PHASE I/II TRIAL USING RNA LIPID NANOPARTICLES FOR RECURRENT OSTEOSARCOMA: A REPORT FROM THE NATIONAL PEDIATRIC CANCER FOUNDATION
MIchael Isakoff
Favorite
Ismail, Nur Nadiah

National University of Singapore
(P 53) ESTABLISHMENT AND CHARACTERISATION OF LIPOSARCOMA-DERIVED CELLS AS RELEVANT PRE-CLINICAL MODELS FOR TARGET DISCOVERY
Nur Nadiah Ismail
Favorite
Isobe, Kiyotaka

Department of Pediatric Oncology, National Cancer Center Hospital
(P 271) SAFETY AND EFFICACY OF CABOZANTINIB IN PEDIATRIC PATIENTS WITH MALIGNANT SOLID TUMORS (CAMEL TRIAL/NCCH2106): A SINGLE-CENTRE PHASE I TRIAL
Kiyotaka Isobe
Favorite
Istl, Alexandra

Medical College of Wisconsin
(P 329) LAPAROSCOPY-ASSISTED PERCUTANEOUS CRYOABLATION FOR THE TREATMENT OF ABDOMINAL WALL DESMOID TUMORS
Alexandra Istl
Favorite
Italiano, Antoine

Department of Medicine, Institut Bergonié
(P 42) PRECLINICAL VALIDATION OF M3554, A NOVEL ANTI-GD2 ANTIBODY-DRUG CONJUGATE, AND EPIGENETIC SENSITIZATION STRATEGIES IN SOFT TISSUE SARCOMAS
Antoine Italiano
Favorite
(P 59) TARGETING ADORA2B TO HALT METASTASIS IN UNDIFFERENTIATED PLEOMORPHIC SARCOMA: FROM MULTI-OMICS TO THERAPEUTIC INHIBITION
Antoine Italiano
Favorite
(P 194) UPDATED RESULTS FROM STRATEGIST 1: A PHASE 1/1B STUDY OF IDRX-42 (GSK6042981A) IN PATIENTS (PTS) WITH ADVANCED GASTROINTESTINAL STROMAL TUMORS (GIST)
Antoine Italiano
Favorite
(P 416) A PHASE 2 MULTICENTER OPEN-LABEL BASKET STUDY OF TAZEMETOSTAT IN ADULT PATIENTS WITH INI1-NEGATIVE EPITHELIOID SARCOMA – FINAL ANALYSIS
Antoine Italiano
Favorite
(P 434) A FIRST-IN-HUMAN PHASE 1, MULTICENTER, OPEN-LABEL STUDY OF M3554, A NOVEL ANTI-GD2 ANTIBODY-DRUG CONJUGATE, IN PATIENTS WITH ADVANCED SOLID TUMORS
Antoine Italiano
Favorite
(P 445) TEADES PH1/2 STUDY WITH ODM-212: PRELIMINARY RESULTS IN EHE PATIENTS
Antoine Italiano
Favorite
Itkin, Boris

SQCCCRC
(P 56) COMPARISON OF PATHOGENIC AND LIKELY PATHOGENIC VARIANTS DISTINCT FROM SPECIFIC DRIVERS IN DIFFERENT SARCOMA GROUPS
Boris Itkin
Favorite
Ito, Kan

Shizuoka Cancer Center
(P 291) INTRA-ARTERIAL CHEMOTHERAPY WITH CONCOMITANT RADIATION THERAPY FOR UNRESECTABLE SARCOMA
Kan Ito
Favorite
Iuliani, Michele

Fondazione Policlinico Universitario Campus Bio-Medico
(P 61) HER2 TARGETING IN CHORDOMA: PRECLINICAL INSIGHTS ON TRASTUZUMAB DERUXTECAN
Michele Iuliani
Favorite
Iwata, Shintaro

National Cancer Center Hospital Japan
(P 79) AGE-BASED TREATMENT PATTERNS AND OUTCOMES OF LOCALIZED HIGH-GRADE OSTEOSARCOMA FROM A NATIONWIDE DATABASE: WHAT IS THE OPTIMAL STRATEGY FOR PATIENTS OLDER THAN 40 YEARS?
Shintaro Iwata
Favorite
(P 151) SHOULD WE USE ADJUVANT CHEMOTHERAPY IN PATIENTS WITH LOCALIZED DEDIFFERENTIATED CHONDROSARCOMA (DDCS) OF THE PELVIS? AN ANALYSIS BY THE PELVIC DDCS STUDY GROUP
Shintaro Iwata
Favorite
(P 159) CHONDROSARCOMA IN JAPAN: A POPULATION-BASED ANALYSIS USING NATIONAL CANCER REGISTRY
Shintaro Iwata
Favorite
(P 309) RETROPERITONEAL LIPOMAS: MULTICENTER CLINICAL EXPERIENCE WITH AN EXTREMELY RARE DISEASE ENTITY
Shintaro Iwata
Favorite
Iwenofu, O. Hans

The Ohio State University Wexner Medical Center
(P 153) DOES THE QUANTITY OF DEDIFFERENTIATION MATTER IN THE CLINICAL OUTCOMES OF DEDIFFERENTIATED CHONDROSARCOMA? A 10-YEAR SINGLE TERTIARY INSTITUTIONAL EXPERIENCE OF A SERIES.
O. Hans Iwenofu
Favorite
Iyer, Aditya Venkat

Green hope high school
(P 460) OUTCOMES OF LATER-LINES SYSTEMIC THERAPIES IN MALIGNANT PERIPHERAL NERVE SHEATH TUMORS (MPNST)
Aditya Venkat Iyer
Favorite
Iyer, Sowmya

Broad Institute
(P 24) THE SIRTUIN SIRT5 SUPPORTS EWING SARCOMA SURVIVAL VIA REGULATION OF EWS-FLI1 STABILITY AND ACTIVITY
Sowmya Iyer
Favorite
J
Jabado, Nada

McGill university and RI-MUHC
(P 15) EZHIP: A NOVEL EPIGENETIC DRIVER OF OSTEOSARCOMA PATHOGENESIS
Nada Jabado
Favorite
Jaburek, Filip

SOTIO Biotech a.s.
(P 257) TARGETING LEUCINE-RICH REPEAT-CONTAINING PROTEIN 15 (LRRC15): SOT106 ANTIBODY-DRUG CONJUGATE FOR SOFT TISSUE SARCOMA AND OSTEOSARCOMA TREATMENT
Filip Jaburek
Favorite
Jacob, Gustavo

Oncoclinicas & Co
(P 285) MULTICENTER STUDY OF SPATIALLY FRACTIONATED RADIOTHERAPY (LATTICE) FOR LARGE-VOLUME RADIORESISTANT SARCOMAS
Gustavo Jacob
Favorite
Jagodzinska-Mucha, Paulina

Maria Sklodowska-Curie National Research Institute of Oncology
(P 146) LOCALISED CHONDROSARCOMA PERIOPERATIVE TREATMENT: REAL-WORLD OUTCOMES AND CHALLENGES ACROSS HISTOLOGIC SUBTYPES
Paulina Jagodzinska-Mucha
Favorite
(P 152) EFFICACY OF PALLIATIVE CHEMOTHERAPY AND LOCAL TREATMENTS IN ADVANCED CHONDROSARCOMA: A SUBTYPE-SPECIFIC RETROSPECTIVE ANALYSIS
Paulina Jagodzinska-Mucha
Favorite
(P 470) OFF-LABEL TREATMENT AND ULTRARARE SARCOMAS - SINGLE INSTITUTION REPORT
Paulina Jagodzinska-Mucha
Favorite
Jagosky, Megan

Levine Cancer Institute
(P 02) METHYLATION PROFILING AS A DIAGNOSTIC ADJUNCT FOR UNDIFFERENTIATED SARCOMAS: A REAL-WORLD EVALUATION
Megan Jagosky
Favorite
Jahan, Thierry

University of California San Francisco, San Francisco, CA, USA
(P 416) A PHASE 2 MULTICENTER OPEN-LABEL BASKET STUDY OF TAZEMETOSTAT IN ADULT PATIENTS WITH INI1-NEGATIVE EPITHELIOID SARCOMA – FINAL ANALYSIS
Thierry Jahan
Favorite
Jain, Akhil

University of Iowa Hospitals and Clinics
(P 343) PROGRESSION FREE SURVIVAL OF IMMUNE CHECKPOINT INHIBITORS IN THE FIRST-LINE TREATMENT OF METASTATIC SARCOMA: A SINGLE CENTER RETROSPECTIVE ANALYSIS.
Akhil Jain
Favorite
(P 371) CLINICAL PROFILE AND TREATMENT PATTERNS OF ANGIOSARCOMA IN THE REAL- WORLD SETTING: A SINGLE CENTER EXPERIENCE FROM 1991-2024.
Akhil Jain
Favorite
Jain, Rahul

USF Morsani College of Medicine
(P 114) DENOSUMAB THERAPY AND MIRELS ADJUSTED ODDS OF PATHOLOGIC FRACTURE OR PROPHYLACTIC STABILIZATION IN APPENDICULAR SKELETAL METASTASES
Rahul Jain
Favorite
Jakob, Jens

Sarcoma Unit, Department of Surgery, University Medical Centre Mannheim, Medical Faculty Mannheim, Heidelberg University
(P 165) EVALUATING LARGE LANGUAGE MODELS AS DECISION SUPPORT TOOLS IN MULTIDISCIPLINARY TUMOR BOARDS FOR GASTROINTESTINAL STROMAL TUMORS
Jens Jakob
Favorite
(P 169) BENCHMARKING LARGE LANGUAGE MODELS VS MULTIDISCIPLINARY TUMOR BOARDS OF 21 SARCOMA CENTERS
Jens Jakob
Favorite
(P 204) ANALYSIS OF QUALITY INDICATORS OF SOFT TISSUE SARCOMA TREATMENT WITH CANCER REGISTRY DATA IN GERMANY 2015-2021
Jens Jakob
Favorite
(P 303) MULTIVISCERAL RESECTIONS AND URINARY TRACT RECONSTRUCTION TECHNIQUES IN THE SURGERY OF RETROPERITONEAL SARCOMAS: A CASE SERIES.
Jens Jakob
Favorite
(P 312) APOSST: A PROSPECTIVE TRIAL TO EVALUATE ACUPUNCTURE AFTER SURGERY OF EXTREMITY SOFT TISSUE TUMORS
Jens Jakob
Favorite
(P 367) ADHERENCE TO GERMAN SARCOMA GUIDELINE FOR MRI SEQUENCING IN SOFT TISSUE SARCOMA: EVALUATION OF IMAGING PRACTICES AND COMPLIANCE
Jens Jakob
Favorite
(P 441) COLOSARC-Q: A PROSPECTIVE MULTICENTER STUDY FOR EVALUATING SURGICAL STRATEGIES FOR COLORECTAL RESECTIONS AND POSTOPERATIVE QUALITY OF LIFE IN RETROPERITONEAL SARCOMA PATIENTS
Jens Jakob
Favorite
(P 454) TREATMENT PATTERNS AND OUTCOMES IN RADIATION-INDUCED SARCOMA: FIRST RESULTS OF THE TETRIS-PROJECT - A MULTIMODAL RETROSPECTIVE ANALYSIS FROM A TERTIARY CENTER
Jens Jakob
Favorite
(P 455) DEVELOPMENT OF PATIENT-CENTERED INFORMATION MATERIAL ON RADIATION-INDUCED SARCOMA: QUALITATIVE RESULTS FROM FOCUS GROUPS OF THE TETRIS-PROJECT
Jens Jakob
Favorite
Jalluri, Ravi

Cogent Biosciences
(P 425) BEZUCLASTINIB EXPANDED ACCESS PROGRAM (EAP) FOR PATIENTS WITH GASTROINTESTINAL STROMAL TUMORS (GIST)
Ravi Jalluri
Favorite
Jambhekar, Ashwini

Dana-Farber Cancer Institute
(P 235) AGNOSTIC INDICATION OF IMMUNE CHECKPOINT INHIBITORS (ICI): PATTERNS OF RESPONSE OF SARCOMAS
Ashwini Jambhekar
Favorite
Janeway, Katherine

Boston Children's
(P 256) THE SEAN KARL COHORT: A NATIONAL COLLABORATIVE SINGLE-CELL RNASEQ STUDY OF PAIRED PATIENT EWING SARCOMA SPECIMENS
Katherine Janeway
Favorite
Janu, Amit

ACTREC, Tata Meorial Centre, Mumbai
(P 286) INTERSTITIAL BRACHYTHERAPY FOR ORGAN AND FUNCTION PRESERVATION IN SOFT TISSUE SARCOMAS: LONG TERM OUTCOMES
Amit Janu
Favorite
(P 292) CRANIOVERTEBRAL EWINGS SARCOMA WITH MENINGEAL INFILTRATION - A CLINICAL OUTCOME ANALYSIS
Amit Janu
Favorite
(P 387) TREATMENT PATTERNS AND PROGNOSTIC FACTORS IN LOCALISED SYNOVIAL SARCOMA: A RETROSPECTIVE STUDY FROM A TERTIARY CANCER CENTRE IN INDIA
Amit Janu
Favorite
(P 438) RANDOMIZED, OPEN-LABEL, PHASE III TRIAL OF ADJUVANT CHEMOTHERAPY VERSUS OBSERVATION IN NON-METASTATIC, HIGH-RISK SOFT TISSUE SARCOMAS (ACO-SARC TRIAL)
Amit Janu
Favorite
Jasnani, Simran

Memorial Sloan Kettering Cancer Center
(P 409) RETROSPECTIVE ANALYSIS OF PROGNOSTIC FACTORS INCLUDING HLA GENOTYPE IN MYXOID LIPOSARCOMA
Simran Jasnani
Favorite
jawhar, wajih

McGill university and RI-MUHC
(P 15) EZHIP: A NOVEL EPIGENETIC DRIVER OF OSTEOSARCOMA PATHOGENESIS
wajih jawhar
Favorite
Jean-Denis, Myriam

Léon Bérard Centre
(P 139) IMMUNOGENOMIC PROFILING OF CHONDROSARCOMA REVEALS DISTINCT IMMUNE PHENOTYPES AND PROGNOSTIC MUTATIONS
Myriam Jean-Denis
Favorite
Jebastin Thangaiah, Judith

Mayo Clinic
(P 223) OUTCOMES OF GERIATRIC PATIENTS WITH DE NOVO SARCOMA AND LUNG METASTASES: ROLE OF TUMOR CHARACTERISTICS AND TREATMENT STRATEGY
Judith Jebastin Thangaiah
Favorite
(P 246) CTLA4 PATHWAY ACTIVATION IN RADIATION-INDUCED ANGIOSARCOMA: A TRANSCRIPTOMIC RATIONALE FOR IMMUNE CHECKPOINT BLOCKADE
Judith Jebastin Thangaiah
Favorite
Jeck, William

Duke University School of Medicine
(P 138) A MULTI-INSTITUTIONAL ARCHIVE AND DEEP LEARNING PIPELINE FOR QUANTIFYING CHONDROSARCOMA COMPOSITION
William Jeck
Favorite
(P 177) DEEP LEARNING AND DIMENSIONALITY REDUCTION FOR SARCOMA SUBTYPING
William Jeck
Favorite
Jeffrey, Samantha

Sarcoma Oncology Center
(P 233) DNG64-CAR-V+ REGIMEN SHOWS CLINICAL BENEFIT IN PATIENTS WITH ADVANCED CCNG1 ONCOGENE EXPRESSING SARCOMAS (NCT04091295)
Samantha Jeffrey
Favorite
(P 388) TRIAL IN PROGRESS: A PHASE 2 STUDY OF METRONOMIC TRABECTEDIN, GEMCITIBAINE, AND DACARBAZINE IN PREVIOUSLY TREATED ADVANCED SOFT TISSUE SARCOMA (NCT04535271)
Samantha Jeffrey
Favorite
(P 396) EVALUATING THE SAFETY AND EFFICACY OF METRONOMIC GEMCITABINE, DOXORUBICIN, AND DOCETAXEL PLUS NIVOLUMAB IN PREVIOUSLY TREATED ADVANCED LEIOMYOSARCOMA AND LIPOSARCOMA: A PHASE 2 STUDY (NCT04535713)
Samantha Jeffrey
Favorite
(P 398) INVESTIGATING THE SAFETY AND EFFICACY OF LURBINECTEDIN WITH IPILIMUMAB AND NIVOLUMAB FOR ADVANCED SOFT TISSUE SARCOMA: LINNOVATE PHASE 1/2 STUDY (NCT05876715)
Samantha Jeffrey
Favorite
Jeller, David

Radiation Oncology LUKS
(P 282) LOCAL FAILURE ANALYSIS OF SOFT TISSUE SARCOMA TREATED WITH PREOPERATIVE ULTRA-HYPOFRACTIONATED RADIATION: UPDATE
David Jeller
Favorite
(P 283) PALLIATIVE LATTICE RADIATION THERAPY IN SOFT TISSUE SARCOMA VERSUS CARCINOMA AND MELANOMA: OUTCOME COMPARISON
David Jeller
Favorite
Jen, Jeremy

Memorial Sloan Kettering Cancer Center
(P 273) RADIOMIC PREDICTORS OF SPONTANEOUS PNEUMOTHORAX DURING TYROSINE KINASE INHIBITOR THERAPY FOR LUNG METASTASES
Jeremy Jen
Favorite
Jensen-Smith, Amy

SOTIO Biotech Inc.
(P 257) TARGETING LEUCINE-RICH REPEAT-CONTAINING PROTEIN 15 (LRRC15): SOT106 ANTIBODY-DRUG CONJUGATE FOR SOFT TISSUE SARCOMA AND OSTEOSARCOMA TREATMENT
Amy Jensen-Smith
Favorite
Jeong, Sumin

David Geffen School of Medicine at University of California Los Angeles
(P 16) MITOCHONDRIAL GENETIC VARIATION ORCHESTRATES COPZ1 TRANSCRIPT HETEROGENEITY AND REVEALS TELOMERE-MEDIATED VULNERABILITIES IN OSTEOSARCOMA
Sumin Jeong
Favorite
(P 72) COUNTY-LEVEL ASSOCIATIONS BETWEEN AIRBORNE TOXICANT EMISSIONS AND EWING SARCOMA DIAGNOSIS IN THE UNITED STATES
Sumin Jeong
Favorite
(P 81) ASSESSING PROGNOSTIC FACTORS OF CAUSE-SPECIFIC SURVIVAL IN PATIENTS WITH MALIGNANT GIANT CELL TUMORS: A POPULATION BASED STUDY FROM THE SEER DATABASE
Sumin Jeong
Favorite
(P 92) PRIMARY TUMOR SIZE AS AN INDEPENDENT PROGNOSTIC FACTOR IN OSTEOSARCOMA: PROPENSITY SCORE-MATCHED ANALYSIS DEMONSTRATES A CONTINUOUS DOSE-RESPONSE RELATIONSHIP
Sumin Jeong
Favorite
(P 100) THE ROLE OF CANCER TYPE IN THE DEVELOPMENT OF PERIPROSTHETIC JOINT INFECTION IN DISTAL FEMORAL REPLACEMENT
Sumin Jeong
Favorite
(P 107) IS THERE A BETTER OPTION: INTRAMEDULLARY NAIL VERSUS PLATE OSTEOSYNTHESIS FOR PATHOLOGIC HUMERAL FRACTURES?
Sumin Jeong
Favorite
(P 108) DISTANCE WEIGHTED MATCHING IN THE QUANTIFICATION OF EXCESS MORBIDITY IN EXTERNAL HEMIPELVECTOMY AND HIP DISARTICULATION
Sumin Jeong
Favorite
(P 157) INCOME IMPACTS OVERALL BUT NOT CAUSE-SPECIFIC SURVIVAL IN PATIENTS WITH CHONDROSARCOMA: A POPULATION BASED STUDY FROM THE SEER DATABASE
Sumin Jeong
Favorite
(P 232) IS THERE A ROLE FOR POSITRON EMISSION TOMOGRAPHY IN THE STAGING OF LANGERHANS CELL HISTIOCYTOSIS?
Sumin Jeong
Favorite
(P 384) PELVIC LOCATION PREDICTS WORSE OUTCOMES IN ALVEOLAR RHABDOMYOSARCOMA: UNDERUSE OF RADIOTHERAPY AND MISSED SURVIVAL BENEFIT
Sumin Jeong
Favorite
Jeys, Lee

The Royal Orthopaedic Hospital NHS Foundation Trust
(P 136) ESTROGEN HAS A PROTECTIVE EFFECT ON CHONDROSARCOMA GROWTH IN VITRO AND IN VIVO
Lee Jeys
Favorite
(P 151) SHOULD WE USE ADJUVANT CHEMOTHERAPY IN PATIENTS WITH LOCALIZED DEDIFFERENTIATED CHONDROSARCOMA (DDCS) OF THE PELVIS? AN ANALYSIS BY THE PELVIC DDCS STUDY GROUP
Lee Jeys
Favorite
JIANG, JIE

Peking University People's Hospital
(P 74) TERTIARY LYMPHOID STRUCTURES PREDICT PROGNOSIS AND IMMUNE LANDSCAPE IN OSTEOSARCOMA: A MACHINE LEARNING-BASED TRANSCRIPTOMIC STUDY
JIE JIANG
Favorite
Jiang, Yafei

Department of Orthopaedics, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
(P 07) A LIVING MULTI-OMICS BIOBANK OF PATIENT-DERIVED XENOGRAFT MODELS FOR SARCOMA
Yafei Jiang
Favorite
Jiminez Garcia, Leyre

Nationwide Children's
(P 13) TRANSCRIPTIONAL DIVERSITY AND NICHE REMODELING AT THE METASTATIC BOTTLENECK IN OSTEOSARCOMA
Leyre Jiminez Garcia
Favorite
Jin, Ruyun

University of Virginia School of Medicine, Department of Public Health Sciences, Charlottesville, VA, USA
(P 404) OUTCOMES OF NEOADJUVANT THERAPY IN ANGIOSARCOMA PATIENTS: A KAPLAN-MEIER-RECONSTRUCTED INDIVIDUAL PATIENT-LEVEL META-ANALYSIS
Ruyun Jin
Favorite
Jin, Whitney

Department of Otolaryngology-Head and Neck Surgery, Vanderbilt University Medical Center
(P 85) MAKING NEGATIVE MARGIN MUSCULOSKELETAL TUMOR SURGERY A VIRTUAL REALITY USING 3D SPECIMEN SCANNING
Whitney Jin
Favorite
Jin, Yanqing

The University of Texas MD Anderson Cancer Center
(P 391) ATRX LOSS BLOCKS THE DIFFERENTIATION OF MESENCHYMAL STEM CELLS AND ADVANCES UNDIFFERENTIATED SARCOMA DEVELOPMENT
Yanqing Jin
Favorite
Joachim, Kole

David Geffen School of Medicine at University of California Los Angeles
(P 16) MITOCHONDRIAL GENETIC VARIATION ORCHESTRATES COPZ1 TRANSCRIPT HETEROGENEITY AND REVEALS TELOMERE-MEDIATED VULNERABILITIES IN OSTEOSARCOMA
Kole Joachim
Favorite
(P 72) COUNTY-LEVEL ASSOCIATIONS BETWEEN AIRBORNE TOXICANT EMISSIONS AND EWING SARCOMA DIAGNOSIS IN THE UNITED STATES
Kole Joachim
Favorite
(P 81) ASSESSING PROGNOSTIC FACTORS OF CAUSE-SPECIFIC SURVIVAL IN PATIENTS WITH MALIGNANT GIANT CELL TUMORS: A POPULATION BASED STUDY FROM THE SEER DATABASE
Kole Joachim
Favorite
(P 92) PRIMARY TUMOR SIZE AS AN INDEPENDENT PROGNOSTIC FACTOR IN OSTEOSARCOMA: PROPENSITY SCORE-MATCHED ANALYSIS DEMONSTRATES A CONTINUOUS DOSE-RESPONSE RELATIONSHIP
Kole Joachim
Favorite
(P 100) THE ROLE OF CANCER TYPE IN THE DEVELOPMENT OF PERIPROSTHETIC JOINT INFECTION IN DISTAL FEMORAL REPLACEMENT
Kole Joachim
Favorite
(P 107) IS THERE A BETTER OPTION: INTRAMEDULLARY NAIL VERSUS PLATE OSTEOSYNTHESIS FOR PATHOLOGIC HUMERAL FRACTURES?
Kole Joachim
Favorite
(P 108) DISTANCE WEIGHTED MATCHING IN THE QUANTIFICATION OF EXCESS MORBIDITY IN EXTERNAL HEMIPELVECTOMY AND HIP DISARTICULATION
Kole Joachim
Favorite
(P 157) INCOME IMPACTS OVERALL BUT NOT CAUSE-SPECIFIC SURVIVAL IN PATIENTS WITH CHONDROSARCOMA: A POPULATION BASED STUDY FROM THE SEER DATABASE
Kole Joachim
Favorite
(P 232) IS THERE A ROLE FOR POSITRON EMISSION TOMOGRAPHY IN THE STAGING OF LANGERHANS CELL HISTIOCYTOSIS?
Kole Joachim
Favorite
(P 384) PELVIC LOCATION PREDICTS WORSE OUTCOMES IN ALVEOLAR RHABDOMYOSARCOMA: UNDERUSE OF RADIOTHERAPY AND MISSED SURVIVAL BENEFIT
Kole Joachim
Favorite
Jocoy, Emily

PIVOT Coordinating Center
(P 267) THE RAF/MEK INHIBITOR VS-6766 SHOWS EFFICACY IN RAS-MUTANT PEDIATRIC PRECLINICAL XENOGRAFT MODELS- A REPORT FROM THE PEDIATRIC PRECLINICAL IN VIVO TESTING CONSORTIUM
Emily Jocoy
Favorite
John, Ivy

University of Pittsburgh
(P 256) THE SEAN KARL COHORT: A NATIONAL COLLABORATIVE SINGLE-CELL RNASEQ STUDY OF PAIRED PATIENT EWING SARCOMA SPECIMENS
Ivy John
Favorite
Johnson, Ben

University of South Florida
(P 82) DISPARITIES IN OSTEOSARCOMA BY SOCIOECONOMIC STATUS
Ben Johnson
Favorite
Johnson, Debbie

Clinical Operations, IDRx
(P 194) UPDATED RESULTS FROM STRATEGIST 1: A PHASE 1/1B STUDY OF IDRX-42 (GSK6042981A) IN PATIENTS (PTS) WITH ADVANCED GASTROINTESTINAL STROMAL TUMORS (GIST)
Debbie Johnson
Favorite
Johnson, Jared

Dana-Farber Cancer Institute
(P 198) EXPLOITING METABOLIC DYSREGULATION IN SUCCINATE DEHYDROGENASE-DEFICIENT GASTROINTESTINAL STROMAL TUMOR
Jared Johnson
Favorite
Johnson, Rylee

Fred Hutchinson Cancer Center
(P 287) A PHASE 1 STUDY OF NEOADJUVANT CABOZANTINIB IN COMBINATION WITH RADIATION THERAPY FOR SARCOMAS OF THE EXTREMITIES
Rylee Johnson
Favorite
johnston, Wendy

Princess Margaret Cancer Centre, University Health Network and Mount Sinai Hospital
(P 210) TOWARDS INTERNATIONALIZATION OF THE CLINICAL RESEARCH COORDINATOR ROLE: THE FIRST DROP OF THE NIAGARA FALLS PROJECT
Wendy johnston
Favorite
(P 307) STRATEGIES FOR DATA QUALITY IN TARPSWG RETROPERITONEAL SARCOMA REGISTRY (RESAR)
Wendy johnston
Favorite
Jolin, Hina

Cogent Biosciences
(P 425) BEZUCLASTINIB EXPANDED ACCESS PROGRAM (EAP) FOR PATIENTS WITH GASTROINTESTINAL STROMAL TUMORS (GIST)
Hina Jolin
Favorite
Jolivet, Philippe

The Research Institute of the McGill University Health Centre
(P 68) MULTI-OMIC INTRA- AND INTER-TUMOR HETEROGENEITY OF BENIGN SMOOTH MUSCLE TUMORS
Philippe Jolivet
Favorite
Jonczak, Emily

Sylvester Comprehensive Cancer Center
(P 201) METASTATIC PATTERNS, TREATMENT MODALITIES, AND OVERALL SURVIVAL IN OLIGOMETASTATIC GIST: A SINGLE-CENTER RETROSPECTIVE STUDY
Emily Jonczak
Favorite
(P 217) PATIENT QUESTIONNAIRE EXPLORING THE PRE-SARCOMA DIAGNOSIS CHARACTERISTICS OF SARCOMA PATIENTS
Emily Jonczak
Favorite
(P 224) PAN-SARCOMA DATABASE (PSDB): AN UPDATE ON MIAMI'S COLLABORATIVE MULTI-USER DATA PIPELINE OF SARCOMA DATA USING REDCAP AND R CODING
Emily Jonczak
Favorite
(P 225) GLOBAL REGISTRY OF SOLITARY FIBROUS TUMORS (SFT): INTEGRATING CLINICAL, MOLECULAR, AND ENVIRONMENTAL DATA- THE HOROWITZ SFT INITIATIVE (HSFTI)
Emily Jonczak
Favorite
(P 320) CLINICAL CHARACTERISTICS AND RECURRENCE PATTERNS IN HISPANIC VS. NON-HISPANIC PATIENTS WITH LEIOMYOSARCOMA: FINDINGS FROM A RETROSPECTIVE SINGLE-CENTER COHORT STUDY
Emily Jonczak
Favorite
(P 327) INITIAL TREATMENT MODALITY AND RECURRENCE IN NON-METASTATIC LEIOMYOSARCOMA: A RETROSPECTIVE COHORT STUDY
Emily Jonczak
Favorite
(P 333) METABOLIC SYNDROME CORRELATION WITH LIPOSARCOMA INCIDENCE AND OUTCOMES: A RETROSPECTIVE ANALYSIS.
Emily Jonczak
Favorite
(P 362) SHOULD PAZOPANIB BE USED AS A MAINTENANCE THERAPY TO IMPROVE RECURRENCE-FREE SURVIVAL AND OVERALL SURVIVAL IN PATIENTS WHO RECEIVED MAI IN SOFT TISSUE SARCOMA?
Emily Jonczak
Favorite
(P 369) CLINICAL CHARACTERISTICS & TREATMENT OUTCOME PATTERNS OF SOLITARY FIBROUS TUMORS: A SINGLE-INSTITUTION RETROSPECTIVE ANALYSIS
Emily Jonczak
Favorite
(P 397) EXPLORING REAL WORLD DATA OF RECURRENCE IN NON-METASTATIC MYXOFIBROSAROMA: AN UPDATED RETROSPECTIVE COHORT STUDY
Emily Jonczak
Favorite
Jones, Amy

University of Texas Southwestern Medical School
(P 280) PERSONALIZED ULTRA-FRACTIONATED STEREOTACTIC ADAPTIVE RADIOTHERAPY (PULSAR) FOR ADULT AND PEDIATRIC SARCOMAS
Amy Jones
Favorite
Jones, Robin

Medical Oncology, The Royal Marsden and Institute of Cancer Research
(P 194) UPDATED RESULTS FROM STRATEGIST 1: A PHASE 1/1B STUDY OF IDRX-42 (GSK6042981A) IN PATIENTS (PTS) WITH ADVANCED GASTROINTESTINAL STROMAL TUMORS (GIST)
Robin Jones
Favorite
(P 226) REAL-WORLD MANAGEMENT OF SYMPTOMATIC VS ASYMPTOMATIC TGCT FROM AN OBSERVATIONAL REGISTRY
Robin Jones
Favorite
(P 233) DNG64-CAR-V+ REGIMEN SHOWS CLINICAL BENEFIT IN PATIENTS WITH ADVANCED CCNG1 ONCOGENE EXPRESSING SARCOMAS (NCT04091295)
Robin Jones
Favorite
(P 416) A PHASE 2 MULTICENTER OPEN-LABEL BASKET STUDY OF TAZEMETOSTAT IN ADULT PATIENTS WITH INI1-NEGATIVE EPITHELIOID SARCOMA – FINAL ANALYSIS
Robin Jones
Favorite
(P 446) GDF-15 AS A PROGNOSTIC FACTOR IN PATIENTS WITH EPITHELIOID HEMANGIOENDOTHELIOMA
Robin Jones
Favorite
(P 447) PAIN ASSESSMENT CRITERIA (PAC) ANTICIPATE RECIST PROGRESSION AND CORRELATE WITH BLOOD LEVELS OF GROWTH DIFFERENTIATION FACTOR 15 (GDF15) IN EPITHELIOID HEMANGIOENDOTHELIOMA (EHE)
Robin Jones
Favorite
Jones, Robin L.

Sarcoma Unit, Royal Marsden Hospital and Institute of Cancer Research
(P 315) ANALYSIS OF CHANGES IN T2-WEIGHTED SIGNAL INTENSITY AND TUMOR VOLUME AND EXPOSURE-RESPONSE IN THE RINGSIDE PHASE 2 STUDY OF VAREGACESTAT FOR DESMOID TUMORS
Robin L. Jones
Favorite
(P 410) SUBGROUP ANALYSIS OF THE PHASE 2 PART OF THE RINGSIDE PHASE 2/3 TRIAL OF VAREGACESTAT FOR TREATMENT OF DESMOID TUMORS
Robin L. Jones
Favorite
(P 414) PATTERNS OF RELAPSE OF BORDERLINE AND MALIGNANT PHYLLODES TUMOUR- RESULTS FROM SARCOMA REFERENCE CENTRE (SRC)
Robin L. Jones
Favorite
Joo, Min Wook

Department of Orthopedic Surgery, St. Vincent’s Hospital, College of Medicine, The Catholic University of Korea
(P 171) THREE-DIMENSIONAL DEEP LEARNING MODEL FOR PREDICTING PROXIMAL FEMORAL PATHOLOGIC FRACTURE USING OPPORTUNISTIC ABDOMINOPELVIC CT IN PATIENTS WITH ADVANCED CANCER: A PRELIMINARY REPORT
Min Wook Joo
Favorite
(P 176) DEEP LEARNING MODEL FOR DIFFERENTIATING BETWEEN NEOPLASTIC PATHOLOGIC FRACTURE AND NONPATHOLOGIC FRACTURE FROM PLAIN HIP RADIOGRAPHS
Min Wook Joo
Favorite
Joseph, Cissimol

MD Anderson Cancer Center
(P 351) THE ROLE OF SOCIOECONOMIC DISPARITIES ON SURVIVAL OUTCOMES IN MALIGNANT PERIPHERAL NERVE SHEATH TUMORS
Cissimol Joseph
Favorite
(P 460) OUTCOMES OF LATER-LINES SYSTEMIC THERAPIES IN MALIGNANT PERIPHERAL NERVE SHEATH TUMORS (MPNST)
Cissimol Joseph
Favorite
Joyce, David

Moffitt Cancer Center
(P 84) A MULTICENTER COMPARISON OF REVERSE TOTAL SHOULDER ARTHROPLASTY VERSUS HEMIARTHROPLASTY FOR ENDOPROSTHETIC RECONSTRUCTION FOLLOWING ONCOLOGIC RESECTION OF THE PROXIMAL HUMERUS
David Joyce
Favorite
(P 102) FACTORS RELATED TO ASEPTIC LOOSENING IN ENDOPROSTHESIS RECONSTRUCTION OF THE PROXIMAL TIBIA
David Joyce
Favorite
(P 114) DENOSUMAB THERAPY AND MIRELS ADJUSTED ODDS OF PATHOLOGIC FRACTURE OR PROPHYLACTIC STABILIZATION IN APPENDICULAR SKELETAL METASTASES
David Joyce
Favorite
(P 140) REFINING PRE-SURGICAL ASSESSMENT OF LONG-BONE CHONDROSARCOMA THROUGH THE RADIOLOGIC AGGRESSIVENESS SCORE
David Joyce
Favorite
(P 141) A RETROSPECTIVE ANALYSIS OF THE BIRMINGHAM ATYPICAL CARTILAGE TUMOUR IMAGING PROTOCOL (BACTIP) IN MANAGING CENTRAL CARTILAGE TUMORS OF THE LONG BONES
David Joyce
Favorite
(P 142) ARE THERE INDEPENDENT PREDICTORS OF DEDIFFERENTIATED CHONDROSARCOMA ON MAGNETIC RESONANCE IMAGING? A MULTIVARIATE ANALYSIS
David Joyce
Favorite
(P 145) PATHOLOGIC FRACTURE IN CHONDROSARCOMA OF LONG BONES: A RETROSPECTIVE COHORT STUDY
David Joyce
Favorite
(P 160) A COMPARATIVE ANALYSIS OF DEDIFFERENTIATED AND CONVENTIONAL CHONDROSARCOMA OUTCOMES
David Joyce
Favorite
(P 163) CHONDROSARCOMA IN THE AYA POPULATION
David Joyce
Favorite
(P 375) DOES STAGED RESECTION WITH TEMPORIZING WOUND VACUUM INFLUENCE LOCAL RECURRENCE RISK? A MULTI-INSTITUTIONAL MATCHED COHORT ANALYSIS
David Joyce
Favorite
(P 453) OUTCOMES OF PLEOMORPHIC LIPOSARCOMA PATIENTS FOLLOWING MULTI-DISCIPLINARY MANAGEMENT WITHIN A TERTIARY CANCER CENTER
David Joyce
Favorite
Juan Ribelles, Antonio

Hospital Universitario y Politécnico La Fe
(P 71) GERMLINE POLYMORPHISMS IN THE VEGF PATHWAY AS PROGNOSTIC BIOMARKERS IN LOCALIZED HIGH-GRADE OSTEOSARCOMA: A STUDY BASED ON DATA FROM THE GEIS-33 PROTOCOL
Antonio Juan Ribelles
Favorite
Juarez Reyes, Joselyn

Universidad Veracruzana
(P 39) BUB1 AN OVEREXPRESSED KINASE IN SARCOMA: FINDING NEW TARGET THERAPY FOR OSTEOSARCOMA, LIPOSARCOMA, SYNOVIAL SARCOMA AND LEIOMYOSARCOMA
Joselyn Juarez Reyes
Favorite
Jude Michael, Michelle

University Health Network, Toronto, Canada
(P 143) IMPACT OF SURGICAL MARGINS IN CHEST WALL CHONDROSARCOMAS: A CANSARCC STUDY
Michelle Jude Michael
Favorite
(P 395) ERIBULIN IN RECURRENT PRETREATED METASTATIC SOFT TISSUE SARCOMA. A CANADIAN SARCOMA RESEARCH AND CLINICAL COLLABORATION (CANSARCC) REAL WORLD ANALYSIS
Michelle Jude Michael
Favorite
Judge, Charlotte

National Disease Registration Service, NHS England
(P 156) CHONDROSARCOMA INCIDENCE, SURVIVAL AND MANAGEMENT IN ENGLAND 2013-2022; AN ANALYSIS FROM THE NATIONAL DISEASE REGISTRATION SERVICE
Charlotte Judge
Favorite
Judge, Sean

Surgical Oncology, Department of Surgery, University of California, Davis
(P 244) INTRATUMORAL TIGIT BLOCKADE AUGMENTS ANTI-TUMOR RESPONSES AND BYPASSES HYPERFUNCTIONALITY OF PERIPHERAL TIGIT+ NK CELLS IN MOUSE AND HUMAN MODELS OF BONE AND SOFT TISSUE SARCOMA
Sean Judge
Favorite
(P 245) SUBTYPE SPECIFIC CHARACTERIZATION OF IMMUNE INFILTRATION IN SOFT TISSE SARCOMAS
Sean Judge
Favorite
Jung, Im Doo

Department of Mechanical Engineering,Ulsan National Institute of Science and Technology (UNIST)
(P 109) FINITE ELEMENT ANALYSIS FOR FIXATION EVALUATION OF PATIENT-SPECIFIC ORTHOPEDIC IMPLANTS
Im Doo Jung
Favorite
jung, sungmi

McGill university and RI-MUHC
(P 15) EZHIP: A NOVEL EPIGENETIC DRIVER OF OSTEOSARCOMA PATHOGENESIS
sungmi jung
Favorite
Junker, Niels

Department of Oncology, Herlev University Hospital
(P 05) CONCORDANCE OF GENOMIC ALTERATIONS WITH CIRCULATING TUMOR DNA: INITIAL FINDINGS FROM A PILOT STUDY
Niels Junker
Favorite
(P 36) MODULATION OF THE SARCOMA MICROENVIRONMENT THROUGH β-ADRENERGIC BLOCKADE
Niels Junker
Favorite
(P 249) IN VITRO EXPANSION OF TUMOR-INFILTRATING GAMMA-DELTA T-CELLS FROM PATIENTS WITH SOFT TISSUE SARCOMAS
Niels Junker
Favorite
(P 319) CARDIOTOXICITY AND OVERALL SURVIVAL IN PATIENTS WITH SARCOMA TREATED WITH DOXORUBICIN, OLARATUMAB AND DEXRAZOXANE: A REAL-WORLD EXPERIENCE IN DENMARK
Niels Junker
Favorite
(P 352) TIME TOXICITY AND EFFECT OF CHEMOTHERAPY FOR PATIENTS WITH METASTATIC SOFT TISSUE SARCOMA - A RETROSPECTIVE REAL-WORLD STUDY OF 244 PATIENTS
Niels Junker
Favorite
Jurinovic, Vindi

LMU Munich
(P 443) FIRST-LINE PAZOPANIB IN PATIENTS WITH EPITHELIOID HEMANGIOENDOTHELIOMA: A RETROSPECTIVE SINGLE-CENTER ANALYSIS
Vindi Jurinovic
Favorite
Jutte, Paul

Universitair Medisch Centrum Groningen
(P 151) SHOULD WE USE ADJUVANT CHEMOTHERAPY IN PATIENTS WITH LOCALIZED DEDIFFERENTIATED CHONDROSARCOMA (DDCS) OF THE PELVIS? AN ANALYSIS BY THE PELVIC DDCS STUDY GROUP
Paul Jutte
Favorite
K
Kümler, Thomas

Department of Cardiology, Herlev University Hospital
(P 319) CARDIOTOXICITY AND OVERALL SURVIVAL IN PATIENTS WITH SARCOMA TREATED WITH DOXORUBICIN, OLARATUMAB AND DEXRAZOXANE: A REAL-WORLD EXPERIENCE IN DENMARK
Thomas Kümler
Favorite
Kacena, Katherine

Strand Therapeutics Inc
(P 433) PHASE I DOSE ESCALATION TRIAL OF STX-001, AN LNP SELF-REPLICATING MRNA EXPRESSING IL-12, IN PATIENTS WITH REFRACTORY TUMORS INCLUDING SARCOMAS
Katherine Kacena
Favorite
Kaczkofsky, Brynn

University of Michigan
(P 50) A NEW MURINE MODEL OF DEDIFFERENTIATED LIPOSARCOMA DEFINED BY HIGH PROLIFERATION AND METABOLIC ADAPTABILITY
Brynn Kaczkofsky
Favorite
(P 52) VALIDATION OF SYNGENEIC MURINE DEDIFFERENTIATED LIPOSARCOMA MODELS FOR PRECLINICAL EVALUATION OF THERAPEUTIC SENSITIVITY
Brynn Kaczkofsky
Favorite
Kaderi, Saif

Tata Memorial Hospital
(P 304) MANAGEMENT OF RECURRENT RETROPERITONEAL SARCOMAS: A RETROSPECTIVE STUDY FROM A TERTIARY CANCER CENTER.
Saif Kaderi
Favorite
(P 463) EXTRANODAL FOLLICULAR DENDRITIC CELL SARCOMAS AND THEIR OLIGORECURRENCES: TRIUMPHS, TRIALS AND LESSONS LEARNT AT A SINGLE TERTIARY CANCER REFERRAL CENTRE, INDIA.
Saif Kaderi
Favorite
Kalbasi, Anusha

Stanford University
(P 37) DISSECTING THE TUMOR MICROENVIRONMENT OF UTERINE LEIOMYOSARCOMAS FOR TARGETED DRUG PREDICTIONS
Anusha Kalbasi
Favorite
(P 400) LONGITUDINAL EPIGENETIC AND TRANSCRIPTOMIC REMODELING ACROSS PRIMARY, IRRADIATED, AND LOCALLY RELAPSED SOFT TISSUE SARCOMAS
Anusha Kalbasi
Favorite
Kalinowska, Iwona

Maria Sklodowska-Curie National Research Institute of Oncology
(P 313) SIGNIFICANCE OF LYMPH NODE PROCEDURES IN SOFT TISSUE SARCOMA PATIENTS
Iwona Kalinowska
Favorite
Kalisa, Aimé Terence

Department of Surgery, Medical Faculty Mannheim, Mannheim School of Medicine, Heidelberg University
(P 169) BENCHMARKING LARGE LANGUAGE MODELS VS MULTIDISCIPLINARY TUMOR BOARDS OF 21 SARCOMA CENTERS
Aimé Terence Kalisa
Favorite
Kaloti, Ramneet

UHN
(P 465) JAK/STAT PATHWAY CO-OPERATES WITH CIC-FUSIONS TODRIVE CIC-REARRANGED SARCOMAS
Ramneet Kaloti
Favorite
Kaltoft, Nicolai Stefan

Dept. of Radiology, Rigshospitalet - Copenhagen University HospitalRigshospitalet, Copenhagen University Hospital
(P 322) DYNAMIC PET/MRI REVEALS METABOLIC-DIFFUSION INTERACTIONS IN SUSPECTED SOFT TISSUE SARCOMAS
Nicolai Stefan Kaltoft
Favorite
Kaluziak, Stefan

Department of Pathology, Massachusetts General Hospital, Harvard Medical School
(P 45) MONITORING EWSR1 FUSIONS IN SARCOMA PATIENTS USING PERSONALIZED LIQUID BIOPSY ASSAYS
Stefan Kaluziak
Favorite
Kalyan, Prinjali

Department of Pathology, Massachusetts General Hospital, Harvard Medical School
(P 45) MONITORING EWSR1 FUSIONS IN SARCOMA PATIENTS USING PERSONALIZED LIQUID BIOPSY ASSAYS
Prinjali Kalyan
Favorite
Kamal, Caroline

Memorial Healthcare System
(P 217) PATIENT QUESTIONNAIRE EXPLORING THE PRE-SARCOMA DIAGNOSIS CHARACTERISTICS OF SARCOMA PATIENTS
Caroline Kamal
Favorite
Kanarek, Naama

Children's Hospital Boston
(P 198) EXPLOITING METABOLIC DYSREGULATION IN SUCCINATE DEHYDROGENASE-DEFICIENT GASTROINTESTINAL STROMAL TUMOR
Naama Kanarek
Favorite
Kane, Kathleen

Bone Cancer Research Trust
(P 207) LONG-TERM FOLLOW-UP AND LATE EFECTS MONITORING FOR UK BONE SARCOMA PATIENTS: A SERVICE MAPPING EXCERCISE
Kathleen Kane
Favorite
Kaneko, Taryn

Stanford Medicine
(P 400) LONGITUDINAL EPIGENETIC AND TRANSCRIPTOMIC REMODELING ACROSS PRIMARY, IRRADIATED, AND LOCALLY RELAPSED SOFT TISSUE SARCOMAS
Taryn Kaneko
Favorite
Kang, Alina

University of Miami Miller School of Medicine
(P 217) PATIENT QUESTIONNAIRE EXPLORING THE PRE-SARCOMA DIAGNOSIS CHARACTERISTICS OF SARCOMA PATIENTS
Alina Kang
Favorite
Kang, Grace

University of Tennessee Health Science Center
(P 275) NEXT GENERATION SEQUENCING IN ADOLESCENT AND YOUNG ADULT (AYA) SARCOMAS: CLINICAL IMPACT, DIAGNOSTIC UTILITY, AND IMPLICATIONS
Grace Kang
Favorite
Kang, Hakmook

Vanderbilt University Medical Center
(P 84) A MULTICENTER COMPARISON OF REVERSE TOTAL SHOULDER ARTHROPLASTY VERSUS HEMIARTHROPLASTY FOR ENDOPROSTHETIC RECONSTRUCTION FOLLOWING ONCOLOGIC RESECTION OF THE PROXIMAL HUMERUS
Hakmook Kang
Favorite
Kang, Hyun Guy

National Cancer Center
(P 101) METAL ION MONITORING AFTER CUSTOM 3D-PRINTED IMPLANTS IN BONE TUMOR SURGERY: COMPARISON WITH MODULAR SYSTEMS AND EARLY OBSERVATIONS
Hyun Guy Kang
Favorite
(P 109) FINITE ELEMENT ANALYSIS FOR FIXATION EVALUATION OF PATIENT-SPECIFIC ORTHOPEDIC IMPLANTS
Hyun Guy Kang
Favorite
(P 296) PULMONARY CEMENT EMBOLISM ASSOCIATED WITH PERCUTANEOUS CEMENTOPLASTY FOR BONE METASTASIS: MECHANISMS AND PROTECTIVE FACTORS
Hyun Guy Kang
Favorite
Kang, Hyun-Cheol

Department of Radiation Oncology, Seoul National University Hospital
(P 342) PROGNOSTIC RELEVANCE OF TUMOR LOCATION IN MYXOID LIPOSARCOMA
Hyun-Cheol Kang
Favorite
Kao, Steven

Department of Medical Oncology, Chris O'Brien Lifehouse
(P 431) INVOKE: A PHASE 1 STUDY OF OKN4395, A FIRST-IN-CLASS EP2/EP4/DP1 TRIPLE PROSTANOID RECEPTOR ANTAGONIST, IN PATIENTS WITH ADVANCED SOLID TUMORS, INCLUDING SARCOMAS
Steven Kao
Favorite
Karabajakian, Andy

Owkin
(P 431) INVOKE: A PHASE 1 STUDY OF OKN4395, A FIRST-IN-CLASS EP2/EP4/DP1 TRIPLE PROSTANOID RECEPTOR ANTAGONIST, IN PATIENTS WITH ADVANCED SOLID TUMORS, INCLUDING SARCOMAS
Andy Karabajakian
Favorite
Karadimas, Thomas

USF Health Morsani College of Medicine
(P 114) DENOSUMAB THERAPY AND MIRELS ADJUSTED ODDS OF PATHOLOGIC FRACTURE OR PROPHYLACTIC STABILIZATION IN APPENDICULAR SKELETAL METASTASES
Thomas Karadimas
Favorite
(P 375) DOES STAGED RESECTION WITH TEMPORIZING WOUND VACUUM INFLUENCE LOCAL RECURRENCE RISK? A MULTI-INSTITUTIONAL MATCHED COHORT ANALYSIS
Thomas Karadimas
Favorite
Kasenda, Benjamin

Universitätsspital Basel (USB)
(P 419) PROSPECTIVE REAL-WORLD STUDY OF LAROTRECTINIB (LARO) IN PATIENTS (PTS) WITH TRK FUSION SOLID TUMORS: INTERIM ANALYSIS OF ON-TRK
Benjamin Kasenda
Favorite
Kashyap, Saarang

Precision NextGen Oncology and Research Center
(P 230) CIRCULATING TUMOR DNA AS AN EARLY INDICATOR OF RESPONSE, PROGRESSION, AND RECURRENCE OF SARCOMAS
Saarang Kashyap
Favorite
Kasper, Bernd

Mannheim University Medical Center, University of Heidelberg
(P 204) ANALYSIS OF QUALITY INDICATORS OF SOFT TISSUE SARCOMA TREATMENT WITH CANCER REGISTRY DATA IN GERMANY 2015-2021
Bernd Kasper
Favorite
(P 229) DETERMINANTS OF DIAGNOSTIC INTERVAL IN EPITHELIOID HEMANGIOENDOTHELIOMA: A LINEAR AND QUANTILE REGRESSION ANALYSIS OF PATIENT-REPORTED DATA FROM THE SPAGN GLOBAL SARCOMA DIAGNOSIS PATHWAY SURVEY
Bernd Kasper
Favorite
(P 315) ANALYSIS OF CHANGES IN T2-WEIGHTED SIGNAL INTENSITY AND TUMOR VOLUME AND EXPOSURE-RESPONSE IN THE RINGSIDE PHASE 2 STUDY OF VAREGACESTAT FOR DESMOID TUMORS
Bernd Kasper
Favorite
(P 410) SUBGROUP ANALYSIS OF THE PHASE 2 PART OF THE RINGSIDE PHASE 2/3 TRIAL OF VAREGACESTAT FOR TREATMENT OF DESMOID TUMORS
Bernd Kasper
Favorite
(P 413) EFFICACY OF NIROGACESTAT IN PATIENTS WITH DESMOID TUMORS AND PRESENCE OR ABSENCE OF POOR PROGNOSTIC FACTORS: POST HOC ANALYSES OF THE PHASE 3 DEFI TRIAL
Bernd Kasper
Favorite
(P 442) TRIAL IN PROGRESS: A SINGLE-ARM, OPEN-LABEL PHASE 4 TRIAL OF NIROGACESTAT IN ADULT PREMENOPAUSAL FEMALES WITH DESMOID TUMORS
Bernd Kasper
Favorite
(P 454) TREATMENT PATTERNS AND OUTCOMES IN RADIATION-INDUCED SARCOMA: FIRST RESULTS OF THE TETRIS-PROJECT - A MULTIMODAL RETROSPECTIVE ANALYSIS FROM A TERTIARY CENTER
Bernd Kasper
Favorite
(P 456) OUTCOMES OF FIRST-LINE CHEMOTHERAPY IN ADVANCED ADULT-TYPE RHABDOMYOSARCOMAS: POOLED ANALYSIS OF CLINICAL TRIALS FROM THE EORTC SOFT TISSUE AND BONE SARCOMA GROUP
Bernd Kasper
Favorite
kasraoui, Ines

Gustave Roussy
(P 299) RECURRENCES AFTER PRIMARY RPS SURGERY IN A HIGH-VOLUME SARCOMA CENTER: A RETROSPECTIVE ANALYSIS ON 402 PATIENTS
Ines kasraoui
Favorite
Kassim, Yusra

Department of Medical Oncology, The Ottawa Hospital, Ottawa, ON, Canada.
(P 395) ERIBULIN IN RECURRENT PRETREATED METASTATIC SOFT TISSUE SARCOMA. A CANADIAN SARCOMA RESEARCH AND CLINICAL COLLABORATION (CANSARCC) REAL WORLD ANALYSIS
Yusra Kassim
Favorite
Kass, Jonathan

University of Florida
(P 129) HIJACKED FUEL: GLYCOGEN-DRIVEN METABOLIC SHIFTS IN IDH1-MUTANT CHONDROSARCOMA
Jonathan Kass
Favorite
Katagiri, Hirohisa

Shizuoka Cancer Center
(P 291) INTRA-ARTERIAL CHEMOTHERAPY WITH CONCOMITANT RADIATION THERAPY FOR UNRESECTABLE SARCOMA
Hirohisa Katagiri
Favorite
Kato, Shumei

University of California San Diego
(P 179) NEOADJUVANT AVAPRITINIB IN PDGFRA-MUTANT GIST: NEAR COMPLETE PATHOLOGICAL RESPONSES AT THE COST OF HIGH ADVERSE EVENT RATES
Shumei Kato
Favorite
(P 180) COMPARATIVE EFFICACY OF GENERIC AND BRAND-NAME IMATINIB IN NEOADJUVANT TREATMENT OF KIT EXON 11 MUTANT GIST
Shumei Kato
Favorite
Katwala, Ajay

Medical College of Wisconsin
(P 329) LAPAROSCOPY-ASSISTED PERCUTANEOUS CRYOABLATION FOR THE TREATMENT OF ABDOMINAL WALL DESMOID TUMORS
Ajay Katwala
Favorite
Katz, Daniela

Shaare Zedek Medical Center
(P 326) GERMLINE POT1 MUTATIONS IN ANGIOSARCOMA DIFFER FROM SOMATIC MUTATIONS
Daniela Katz
Favorite
Kawai, Akira

National Cancer Center Hospital
(P 79) AGE-BASED TREATMENT PATTERNS AND OUTCOMES OF LOCALIZED HIGH-GRADE OSTEOSARCOMA FROM A NATIONWIDE DATABASE: WHAT IS THE OPTIMAL STRATEGY FOR PATIENTS OLDER THAN 40 YEARS?
Akira Kawai
Favorite
(P 159) CHONDROSARCOMA IN JAPAN: A POPULATION-BASED ANALYSIS USING NATIONAL CANCER REGISTRY
Akira Kawai
Favorite
(P 341) PROGNOSTIC RELEVANCE OF CYCLOPHOSPHAMIDE DOSE FOR HIGH-RISK RHABDOMYOSARCOMA IN ADULT PATIENTS TREATED WITH VAC THERAPY
Akira Kawai
Favorite
(P 472) LANDSCAPE OF ULTRA-RARE SARCOMAS: A NATIONWIDE STUDY FOR EPIDEMIOLOGY AND PROGNOSIS
Akira Kawai
Favorite
Kawamura, Miyuki

Hyogo Cancer Center
(P 192) OPTIMAL DOSING SCHEDULE OF SUNITINIB BASED ON PLATELET COUNT IN AN OLDER PATIENT WITH GASTROINTESTINAL STROMAL TUMOR
Miyuki Kawamura
Favorite
Keedy, Vicki Leigh

Division of Hematology/Oncology, Vanderbilt University Medical Center
(P 310) ATYPICAL SPINDLE CELL PLEOMORPHIC LIPOMATOUS TUMORS OF THE RETROPERITONEUM ARE HETEROGENOUS: A REPORT OF FOUR DISPARATE CASES
Vicki Leigh Keedy
Favorite
(P 424) AN OPEN-LABEL PHASE 1/2 STUDY OF DCC-3009 MONOTHERAPY IN PATIENTS (PTS) WITH ADVANCED GASTROINTESTINAL STROMAL TUMOR (GIST)
Vicki Leigh Keedy
Favorite
Keen, Judy

Judy Keen Constulting
(P 209) SARCOMA PATIENT COMMUNITY DATA COLLABORATION TO ADVANCE RESEARCH
Judy Keen
Favorite
Keeter, Carson

University of Colorado Department of Orthopedics
(P 268) QUALITY OF LIFE OUTCOMES IN PEDIATRIC PATIENTS UNDERGOING SURGICAL INTERVENTION FOR LOWER EXTREMITY BONE SARCOMAS
Carson Keeter
Favorite
Kelaney, Mohamed R

Ain Shams University
(P 444) HEALTH-RELATED QUALITY OF LIFE (HRQOL) CHALLENGES IN PATIENTS WITH EPITHELIOID HEMANGIOENDOTHELIOMA (EHE): ANALYSIS OF AN ULTRA-RARE SARCOMA GROUP
Mohamed R Kelaney
Favorite
Kelly, Ciara

Sarcoma Medical Oncology Service, Memorial Sloan Kettering
(P 186) BRAF V600E-MUTATED GASTROINTESTINAL STROMAL TUMORS: A CASE SERIES AND ANALYSIS OF IMMUNE TUMOR INFILTRATE
Ciara Kelly
Favorite
(P 187) THERAPEUTIC OUTCOMES IN NF1-ALTERED GIST TREATED WITH MEK INHIBITION: A SINGLE-CENTER EXPERIENCE
Ciara Kelly
Favorite
(P 194) UPDATED RESULTS FROM STRATEGIST 1: A PHASE 1/1B STUDY OF IDRX-42 (GSK6042981A) IN PATIENTS (PTS) WITH ADVANCED GASTROINTESTINAL STROMAL TUMORS (GIST)
Ciara Kelly
Favorite
(P 195) IMPACT OF EXPERT-LED EDUCATION PROGRAMS ON HEALTH CARE PROVIDER (HCP) KNOWLEDGE OF GASTROINTESTINAL STROMAL TUMOR (GIST)
Ciara Kelly
Favorite
(P 409) RETROSPECTIVE ANALYSIS OF PROGNOSTIC FACTORS INCLUDING HLA GENOTYPE IN MYXOID LIPOSARCOMA
Ciara Kelly
Favorite
(P 421) CHARACTERIZING THE IMMUNE RESPONSE TO INTRATUMORAL TIGILANOL TIGLATE (TT) IN PATIENTS WITH ADVANCED AND/OR METASTATIC SOFT TISSUE SARCOMA (STS) IN A PHASE IIA TRIAL (NCT05755113)
Ciara Kelly
Favorite
(P 467) TREATMENT OUTCOMES IN AGGRESSIVE ANGIOMYXOMA: A SINGLE INSTITUTION EXPERIENCE
Ciara Kelly
Favorite
Kelly, Hillary

Massachusetts General Hospital and Massachusetts Eye and Ear
(P 290) CLINICAL OUTCOMES AFTER RADIOTHERAPY FOR PATIENTS WITH POORLY DIFFERENTIATED CHORDOMA
Hillary Kelly
Favorite
Kendal, Joseph

University of Calgary
(P 106) REPAIR: A PRELIMINARY REPORT ON AN ONGOING MULTI-CENTER TRIAL FOR PATIENTS UNDERGOING SURGICAL STABILIZATION FOR METASTATIC BONE DISEASE OF THE FEMUR
Joseph Kendal
Favorite
Kenna, Emma

University of Michigan
(P 50) A NEW MURINE MODEL OF DEDIFFERENTIATED LIPOSARCOMA DEFINED BY HIGH PROLIFERATION AND METABOLIC ADAPTABILITY
Emma Kenna
Favorite
(P 52) VALIDATION OF SYNGENEIC MURINE DEDIFFERENTIATED LIPOSARCOMA MODELS FOR PRECLINICAL EVALUATION OF THERAPEUTIC SENSITIVITY
Emma Kenna
Favorite
Kenney, Deborah

Stanford University
(P 400) LONGITUDINAL EPIGENETIC AND TRANSCRIPTOMIC REMODELING ACROSS PRIMARY, IRRADIATED, AND LOCALLY RELAPSED SOFT TISSUE SARCOMAS
Deborah Kenney
Favorite
Kenney, Richard

Sonnet BioTherapeutics
(P 432) EXPANSION OF A PHASE 1 STUDY OF SON-1010 (IL12-FHAB) ADDING TRABECTEDIN IN SOFT TISSUE SARCOMA: TRIAL IN PROGRESS
Richard Kenney
Favorite
Keohan, Mary

Memorial Sloan Kettering Cancer Center
(P 186) BRAF V600E-MUTATED GASTROINTESTINAL STROMAL TUMORS: A CASE SERIES AND ANALYSIS OF IMMUNE TUMOR INFILTRATE
Mary Keohan
Favorite
(P 187) THERAPEUTIC OUTCOMES IN NF1-ALTERED GIST TREATED WITH MEK INHIBITION: A SINGLE-CENTER EXPERIENCE
Mary Keohan
Favorite
(P 409) RETROSPECTIVE ANALYSIS OF PROGNOSTIC FACTORS INCLUDING HLA GENOTYPE IN MYXOID LIPOSARCOMA
Mary Keohan
Favorite
(P 467) TREATMENT OUTCOMES IN AGGRESSIVE ANGIOMYXOMA: A SINGLE INSTITUTION EXPERIENCE
Mary Keohan
Favorite
Kerfoot, Joseph

Dana-Farber Cancer Institute
(P 198) EXPLOITING METABOLIC DYSREGULATION IN SUCCINATE DEHYDROGENASE-DEFICIENT GASTROINTESTINAL STROMAL TUMOR
Joseph Kerfoot
Favorite
Kerimo, Emma Rose

Massachusetts General Hospital
(P 392) CLASSIFICATION AND DIFFERENTIATIONOF MYXOID LIPOSARCOMA AND MYXOMA WITH MACHINE LEARNING
Emma Rose Kerimo
Favorite
Kerstein, David

IDRx
(P 194) UPDATED RESULTS FROM STRATEGIST 1: A PHASE 1/1B STUDY OF IDRX-42 (GSK6042981A) IN PATIENTS (PTS) WITH ADVANCED GASTROINTESTINAL STROMAL TUMORS (GIST)
David Kerstein
Favorite
Keung, Emily

MD Anderson Cancer Center
(P 38) VALIDATION OF THE SIGNIOS SEVEN-GENE SIGNATURE FOR PREDICTING ANTI-PD-1 INHIBITOR EFFICACY IN SARCOMA
Emily Keung
Favorite
(P 172) COMPARISON OF CELL SEGMENTATION METHODS IN SOFT TISSUE SARCOMA (STS) SPATIAL PROTEOMIC DATASETS
Emily Keung
Favorite
(P 242) IMMUNE PROFILING OF UNDIFFERENTIATED PLEOMORPHIC SARCOMAS REVEALS DISTINCT PROGNOSTIC SUBGROUPS
Emily Keung
Favorite
(P 351) THE ROLE OF SOCIOECONOMIC DISPARITIES ON SURVIVAL OUTCOMES IN MALIGNANT PERIPHERAL NERVE SHEATH TUMORS
Emily Keung
Favorite
Key, Brandon

Medical College of Wisconsin
(P 111) DOES DOSE MATTER? POSTOPERATIVE RADIATION DOSE AND OUTCOMES FOLLOWING FIXATION OF METASTATIC EXTREMITY BONE LESIONS
Brandon Key
Favorite
(P 329) LAPAROSCOPY-ASSISTED PERCUTANEOUS CRYOABLATION FOR THE TREATMENT OF ABDOMINAL WALL DESMOID TUMORS
Brandon Key
Favorite
Khalil, Moustafa

Centre de recherche Maisonneuve-Rosemont
(P 46) INVESTIGATING THE IMPACT OF SARCOMA FUSION PROTEINS ON EPIGENETIC AND DNA-DEPENDENT PROCESSES THROUGH INTERACTOME PROFILING
Moustafa Khalil
Favorite
Khan, Faaris

University of Miami Miller School of Medicine, Department of Orthopaedic Surgery
(P 94) EFFECT OF POSTOPERATIVE PHYSICAL THERAPY ON FUNCTIONAL OUTCOMES FOLLOWING MUSCULOSKELETAL TUMOR RESECTION
Faaris Khan
Favorite
Khanna, Nehal

Tata Memorial Hospital
(P 286) INTERSTITIAL BRACHYTHERAPY FOR ORGAN AND FUNCTION PRESERVATION IN SOFT TISSUE SARCOMAS: LONG TERM OUTCOMES
Nehal Khanna
Favorite
(P 292) CRANIOVERTEBRAL EWINGS SARCOMA WITH MENINGEAL INFILTRATION - A CLINICAL OUTCOME ANALYSIS
Nehal Khanna
Favorite
(P 338) POORLY DIFFERENTIATED SYNOVIAL SARCOMA: A HISTOLOGIC CHALLENGE OF AN AGGRESSIVE VARIANT
Nehal Khanna
Favorite
(P 387) TREATMENT PATTERNS AND PROGNOSTIC FACTORS IN LOCALISED SYNOVIAL SARCOMA: A RETROSPECTIVE STUDY FROM A TERTIARY CANCER CENTRE IN INDIA
Nehal Khanna
Favorite
(P 438) RANDOMIZED, OPEN-LABEL, PHASE III TRIAL OF ADJUVANT CHEMOTHERAPY VERSUS OBSERVATION IN NON-METASTATIC, HIGH-RISK SOFT TISSUE SARCOMAS (ACO-SARC TRIAL)
Nehal Khanna
Favorite
Khela, Monty

Mayo Clinic, Rochester
(P 166) LARGE LANGUAGE MODEL EXTRACTION OF STRUCTURED DATA IN UNSTRUCTURED SARCOMA PATHOLOGY NOTES: A PILOT STUDY
Monty Khela
Favorite
(P 167) LARGE LANGUAGE MODEL EXTRACTION OF STRUCTURED DATA FROM UNSTRUCTURED RADIATION ONCOLOGY NOTES: A PILOT STUDY
Monty Khela
Favorite
Khosravi, Amirali

Mayo Clinic, Rochester
(P 166) LARGE LANGUAGE MODEL EXTRACTION OF STRUCTURED DATA IN UNSTRUCTURED SARCOMA PATHOLOGY NOTES: A PILOT STUDY
Amirali Khosravi
Favorite
(P 167) LARGE LANGUAGE MODEL EXTRACTION OF STRUCTURED DATA FROM UNSTRUCTURED RADIATION ONCOLOGY NOTES: A PILOT STUDY
Amirali Khosravi
Favorite
Khosroyani, Homma

OHSU Knight Cancer Institute
(P 181) THE DEVELOPMENT OF A NOVEL PDGFRA RESISTANCE MUTATION IN A RECURRENT KIT-MUTANT GASTROINTESTINAL STROMAL TUMOR (GIST)
Homma Khosroyani
Favorite
(P 182) USING IN VITRO MODELS TO PREDICT IMATINIB RESPONSES OF PDGFRA EXON 18-MUTANT GIST
Homma Khosroyani
Favorite
Khushman, Moh’d

Washington University School of Medicine
(P 415) A PHASE 1/2 TRIAL OF FOG-001, A FIRST-IN-CLASS DIRECT β-CATENIN:TCF4 INHIBITOR: SAFETY AND PRELIMINARY ANTITUMOR ACTIVITY IN PATIENTS WITH DESMOID TUMORS (DT)
Moh’d Khushman
Favorite
Kichenadasse, Ganessan

Flinders Medical Centre
(P 128) ISOCITRATE DEHYDROGENASE 1 (IDH1) MUTATION TESTING IN THE PHASE 3 STUDY OF IVOSIDENIB VS PLACEBO IN IDH1-MUTANT CONVENTIONAL CHONDROSARCOMA (CHONQUER)
Ganessan Kichenadasse
Favorite
Kilpatrick, Scott

Cleveland Clinic
(P 284) THE IMPACT OF SARCOMA SBRT ON THE IMMUNE SYSTEM: EARLY RESULTS FROM A PROSPECTIVE TRIAL
Scott Kilpatrick
Favorite
Kim, Angela

Yale School of Medicine
(P 40) PRECLINICAL EFFICACY OF A PH-SENSITIVE EXATECAN PEPTIDE-DRUG-CONJUGATE IN RHABDOMYOSARCOMA
Angela Kim
Favorite
Kim, Carl

University of Pittsburgh
(P 14) EVALUATING THE COMBINATION OF DISULFIRAM AND ENZALUTAMIDE IN OSTEOSARCOMA
Carl Kim
Favorite
Kim, Edward

Fred Hutchinson Cancer Center
(P 287) A PHASE 1 STUDY OF NEOADJUVANT CABOZANTINIB IN COMBINATION WITH RADIATION THERAPY FOR SARCOMAS OF THE EXTREMITIES
Edward Kim
Favorite
Kim, Ha Jeong

Department of Orthopaedic surgery, Seoul National University Hospital
(P 09) ESTABLISHMENT AND CHARACTERIZATION OF 18 SARCOMA CELL LINES: UNRAVELING THE MOLECULAR MECHANISMS OF DOXORUBICIN RESISTANCE IN SARCOMA CELL LINES
Ha Jeong Kim
Favorite
Kim, Hangil

The Ohio State University
(P 161) CLINICAL CHARACTERISTICS, PATTERNS OF CARE, AND TREATMENT OUTCOMES OF CHONDROSARCOMA: A SINGLE-INSTITUTIONAL EXPERIENCE
Hangil Kim
Favorite
Kim, Han-Soo

Department of Orthopaedic surgery, Seoul National University Hospital
(P 09) ESTABLISHMENT AND CHARACTERIZATION OF 18 SARCOMA CELL LINES: UNRAVELING THE MOLECULAR MECHANISMS OF DOXORUBICIN RESISTANCE IN SARCOMA CELL LINES
Han-Soo Kim
Favorite
(P 66) ARHGEF4 EXPRESSION IN SOFT TISSUE SARCOMA CORRELATES WITH LOCAL GROWTH PATTERN: WHOLE TRANSCRIPTOME SEQUENCING ON SPATIALLY SEPARATED REGIONS, PATIENT-DERIVED MODELS, AND ORTHOTOPIC IN VIVO ANALYSIS
Han-Soo Kim
Favorite
(P 101) METAL ION MONITORING AFTER CUSTOM 3D-PRINTED IMPLANTS IN BONE TUMOR SURGERY: COMPARISON WITH MODULAR SYSTEMS AND EARLY OBSERVATIONS
Han-Soo Kim
Favorite
(P 175) INTERPRETABLE DEEP LEARNING BASED CLASSIFICATION OF SARCOMA IMMUNE SUBTYPES FROM H&E SLIDES FOR IMMUNOTHERAPY STRATIFICATION
Han-Soo Kim
Favorite
(P 176) DEEP LEARNING MODEL FOR DIFFERENTIATING BETWEEN NEOPLASTIC PATHOLOGIC FRACTURE AND NONPATHOLOGIC FRACTURE FROM PLAIN HIP RADIOGRAPHS
Han-Soo Kim
Favorite
(P 342) PROGNOSTIC RELEVANCE OF TUMOR LOCATION IN MYXOID LIPOSARCOMA
Han-Soo Kim
Favorite
(P 399) LATE LOCAL RECURRENCE (>5YEARS) OF SOFT TISSUE SARCOMA OF THE EXTREMITIES AND TRUNK WALL: PREDICTIVE FACTORS AND ONCOLOGIC OUTCOMES
Han-Soo Kim
Favorite
Kim, Hayun

Memorial Sloan Kettering Cancer Center
(P 273) RADIOMIC PREDICTORS OF SPONTANEOUS PNEUMOTHORAX DURING TYROSINE KINASE INHIBITOR THERAPY FOR LUNG METASTASES
Hayun Kim
Favorite
Kim, HyoSong

Yonsei University College of Medicine
(P 315) ANALYSIS OF CHANGES IN T2-WEIGHTED SIGNAL INTENSITY AND TUMOR VOLUME AND EXPOSURE-RESPONSE IN THE RINGSIDE PHASE 2 STUDY OF VAREGACESTAT FOR DESMOID TUMORS
HyoSong Kim
Favorite
(P 410) SUBGROUP ANALYSIS OF THE PHASE 2 PART OF THE RINGSIDE PHASE 2/3 TRIAL OF VAREGACESTAT FOR TREATMENT OF DESMOID TUMORS
HyoSong Kim
Favorite
Kim, Jinhwan

Biomedical Engineering, University of California, Davis
(P 244) INTRATUMORAL TIGIT BLOCKADE AUGMENTS ANTI-TUMOR RESPONSES AND BYPASSES HYPERFUNCTIONALITY OF PERIPHERAL TIGIT+ NK CELLS IN MOUSE AND HUMAN MODELS OF BONE AND SOFT TISSUE SARCOMA
Jinhwan Kim
Favorite
Kim, June Hyuk

National Cancer Center
(P 101) METAL ION MONITORING AFTER CUSTOM 3D-PRINTED IMPLANTS IN BONE TUMOR SURGERY: COMPARISON WITH MODULAR SYSTEMS AND EARLY OBSERVATIONS
June Hyuk Kim
Favorite
(P 109) FINITE ELEMENT ANALYSIS FOR FIXATION EVALUATION OF PATIENT-SPECIFIC ORTHOPEDIC IMPLANTS
June Hyuk Kim
Favorite
(P 176) DEEP LEARNING MODEL FOR DIFFERENTIATING BETWEEN NEOPLASTIC PATHOLOGIC FRACTURE AND NONPATHOLOGIC FRACTURE FROM PLAIN HIP RADIOGRAPHS
June Hyuk Kim
Favorite
(P 296) PULMONARY CEMENT EMBOLISM ASSOCIATED WITH PERCUTANEOUS CEMENTOPLASTY FOR BONE METASTASIS: MECHANISMS AND PROTECTIVE FACTORS
June Hyuk Kim
Favorite
Kim, Minsu

Seoul National University
(P 176) DEEP LEARNING MODEL FOR DIFFERENTIATING BETWEEN NEOPLASTIC PATHOLOGIC FRACTURE AND NONPATHOLOGIC FRACTURE FROM PLAIN HIP RADIOGRAPHS
Minsu Kim
Favorite
Kim, Shinn

Seoul National University
(P 175) INTERPRETABLE DEEP LEARNING BASED CLASSIFICATION OF SARCOMA IMMUNE SUBTYPES FROM H&E SLIDES FOR IMMUNOTHERAPY STRATIFICATION
Shinn Kim
Favorite
(P 176) DEEP LEARNING MODEL FOR DIFFERENTIATING BETWEEN NEOPLASTIC PATHOLOGIC FRACTURE AND NONPATHOLOGIC FRACTURE FROM PLAIN HIP RADIOGRAPHS
Shinn Kim
Favorite
(P 342) PROGNOSTIC RELEVANCE OF TUMOR LOCATION IN MYXOID LIPOSARCOMA
Shinn Kim
Favorite
Kim, So Young

Duke University Medical Center
(P 58) PLK1 AS A VULNERABLE TARGET OF BAP1-DRIVEN UNDIFFERENTIATED PLEOMORPHIC SARCOMAS
So Young Kim
Favorite
Kim, Soon-Chan

Korean Cell Line Bank, Laboratory of Cell Biology, Cancer Research Institute, Seoul National University
(P 09) ESTABLISHMENT AND CHARACTERIZATION OF 18 SARCOMA CELL LINES: UNRAVELING THE MOLECULAR MECHANISMS OF DOXORUBICIN RESISTANCE IN SARCOMA CELL LINES
Soon-Chan Kim
Favorite
Kimura, Toshimi

Department of Pharmacy, Juntendo University
(P 271) SAFETY AND EFFICACY OF CABOZANTINIB IN PEDIATRIC PATIENTS WITH MALIGNANT SOLID TUMORS (CAMEL TRIAL/NCCH2106): A SINGLE-CENTRE PHASE I TRIAL
Toshimi Kimura
Favorite
Kim, Wanlim

Department of Orthopaedic Surgery, Asan Medical Center, University of Ulsan College of Medicine
(P 176) DEEP LEARNING MODEL FOR DIFFERENTIATING BETWEEN NEOPLASTIC PATHOLOGIC FRACTURE AND NONPATHOLOGIC FRACTURE FROM PLAIN HIP RADIOGRAPHS
Wanlim Kim
Favorite
Kim, Yongsung

Department of Orthopaedic surgery, Seoul National University Bundang Hospital
(P 09) ESTABLISHMENT AND CHARACTERIZATION OF 18 SARCOMA CELL LINES: UNRAVELING THE MOLECULAR MECHANISMS OF DOXORUBICIN RESISTANCE IN SARCOMA CELL LINES
Yongsung Kim
Favorite
(P 66) ARHGEF4 EXPRESSION IN SOFT TISSUE SARCOMA CORRELATES WITH LOCAL GROWTH PATTERN: WHOLE TRANSCRIPTOME SEQUENCING ON SPATIALLY SEPARATED REGIONS, PATIENT-DERIVED MODELS, AND ORTHOTOPIC IN VIVO ANALYSIS
Yongsung Kim
Favorite
(P 175) INTERPRETABLE DEEP LEARNING BASED CLASSIFICATION OF SARCOMA IMMUNE SUBTYPES FROM H&E SLIDES FOR IMMUNOTHERAPY STRATIFICATION
Yongsung Kim
Favorite
(P 176) DEEP LEARNING MODEL FOR DIFFERENTIATING BETWEEN NEOPLASTIC PATHOLOGIC FRACTURE AND NONPATHOLOGIC FRACTURE FROM PLAIN HIP RADIOGRAPHS
Yongsung Kim
Favorite
(P 342) PROGNOSTIC RELEVANCE OF TUMOR LOCATION IN MYXOID LIPOSARCOMA
Yongsung Kim
Favorite
King, Bo

Deciphera Pharmaceuticals, LLC
(P 424) AN OPEN-LABEL PHASE 1/2 STUDY OF DCC-3009 MONOTHERAPY IN PATIENTS (PTS) WITH ADVANCED GASTROINTESTINAL STROMAL TUMOR (GIST)
Bo King
Favorite
King, David

MCW
(P 111) DOES DOSE MATTER? POSTOPERATIVE RADIATION DOSE AND OUTCOMES FOLLOWING FIXATION OF METASTATIC EXTREMITY BONE LESIONS
David King
Favorite
Kirsch, David

Princess Margaret Cancer Centre
(P 43) OVERCOMING PROMISCUOUS TUMOR FORMATION: A CONTROLLED GENETICALLY ENGINEERED MOUSE MODEL OF CIC::DUX4 SARCOMA
David Kirsch
Favorite
(P 57) STUDYING HYPOXIA-INDUCED METASTASIS IN GENETICALLY ENGINEERED MOUSE MODELS OF UPS
David Kirsch
Favorite
(P 58) PLK1 AS A VULNERABLE TARGET OF BAP1-DRIVEN UNDIFFERENTIATED PLEOMORPHIC SARCOMAS
David Kirsch
Favorite
(P 67) MULTIPLE MESENCHYMAL LINEAGES AS POTENTIAL CELL-OF-ORIGINS OF SMARCB1-DEFICIENT EPITHELIOID SARCOMA
David Kirsch
Favorite
(P 380) INVESTIGATING THE ROLE OF HISTONE DEACETYLASE-3 IN METASTATIC UNDIFFERENTIATED PLEOMORPHIC SARCOMA
David Kirsch
Favorite
Kirschstein, Josephine

Sarcoma Unit, Department of Surgery, University Medical Centre Mannheim, Medical Faculty Mannheim, Heidelberg University
(P 367) ADHERENCE TO GERMAN SARCOMA GUIDELINE FOR MRI SEQUENCING IN SOFT TISSUE SARCOMA: EVALUATION OF IMAGING PRACTICES AND COMPLIANCE
Josephine Kirschstein
Favorite
Kirsner, Robert

Jackson Memorial Hospital/University of Miami Health System
(P 254) EOSINOPHILIC FASCIITIS (EF) AS A COMPLICATION OF NATURAL KILLER (NK) CELL-BASED IMMUNOTHERAPY IN A YOUNG ADULT WITH RECURRENT METASTATIC EWING SARCOMA
Robert Kirsner
Favorite
Kisielewska, Katarzyna

Maria Sklodowska-Curie National Research Institute of Oncology
(P 191) EFFICACY OF SYSTEMIC PALLIATIVE THERAPIES IN PATIENTS WITH ADVANCED GASTROINTESTINAL STROMAL TUMORS (GIST) PREVIOUSLY TREATED WITH ADJUVANT IMATINIB - REAL-WORLD CLINICAL PRACTICE DATA
Katarzyna Kisielewska
Favorite
Kistner-Griffin, Emily

Medical University of South Carolina
(P 279) IMPACT OF PREOPERATIVE 5-DAY HYPOFRACTIONATED RADIOTHERAPY (HFRT) FOR SOFT TISSUE SARCOMA (STS) ON BARRIERS TO TREATMENT AT A HIGH-VOLUME SARCOMA CENTER (HV-SC)
Emily Kistner-Griffin
Favorite
Kitada, Tasuku

Strand Therapeutics Inc.
(P 433) PHASE I DOSE ESCALATION TRIAL OF STX-001, AN LNP SELF-REPLICATING MRNA EXPRESSING IL-12, IN PATIENTS WITH REFRACTORY TUMORS INCLUDING SARCOMAS
Tasuku Kitada
Favorite
(P 440) CASE REPORT: COMPLETE CLINICAL AND MOLECULAR RESPONSE TO INTRATUMORAL STX-001, AN LNP-SELF REPLICATING MRNA EXPRESSING IL-12 IN A PATIENT WITH REFRACTORY ANGIOSARCOMA
Tasuku Kitada
Favorite
Klauber-DeMore, Nancy

Medical University of South Carolina
(P 279) IMPACT OF PREOPERATIVE 5-DAY HYPOFRACTIONATED RADIOTHERAPY (HFRT) FOR SOFT TISSUE SARCOMA (STS) ON BARRIERS TO TREATMENT AT A HIGH-VOLUME SARCOMA CENTER (HV-SC)
Nancy Klauber-DeMore
Favorite
Klauschen, Frederick

Institute of Pathology, Ludwig-Maximilians-University (LMU) Munich, Germany
(P 64) ATRX EXPRESSION CORRELATES WITH REDUCED IMMUNE CHECKPOINT EXPRESSION AND POOR SURVIVAL IN HIGH-RISK SOFT TISSUE SARCOMAS
Frederick Klauschen
Favorite
Klega, Kelly

Dana-Farber/Boston Children’s Cancer and Blood Disorders Center
(P 427) PHASE 1/2 TRIAL TO EVALUATE THE SAFETY AND EFFICACY OF PEEL-224 IN COMBINATION WITH VINCRISTINE AND TEMOZOLOMIDE IN ADOLESCENTS AND YOUNG ADULTS WITH RELAPSED OR REFRACTORY SARCOMAS
Kelly Klega
Favorite
Klein Schwengber, Wallace

Department of Internal Medicine, Mayo Clinic, Phoenix, Arizona
(P 404) OUTCOMES OF NEOADJUVANT THERAPY IN ANGIOSARCOMA PATIENTS: A KAPLAN-MEIER-RECONSTRUCTED INDIVIDUAL PATIENT-LEVEL META-ANALYSIS
Wallace Klein Schwengber
Favorite
Klein, Alexander

Orthopaedic Oncology, Department of Orthopaedics and Trauma Surgery, LMU University Hospital, Munich, Germany
(P 64) ATRX EXPRESSION CORRELATES WITH REDUCED IMMUNE CHECKPOINT EXPRESSION AND POOR SURVIVAL IN HIGH-RISK SOFT TISSUE SARCOMAS
Alexander Klein
Favorite
(P 443) FIRST-LINE PAZOPANIB IN PATIENTS WITH EPITHELIOID HEMANGIOENDOTHELIOMA: A RETROSPECTIVE SINGLE-CENTER ANALYSIS
Alexander Klein
Favorite
kleinman, Claudia

McGill university and RI-MUHC
(P 15) EZHIP: A NOVEL EPIGENETIC DRIVER OF OSTEOSARCOMA PATHOGENESIS
Claudia kleinman
Favorite
Klempner, Samuel J.

Massachusetts General Hospital
(P 415) A PHASE 1/2 TRIAL OF FOG-001, A FIRST-IN-CLASS DIRECT β-CATENIN:TCF4 INHIBITOR: SAFETY AND PRELIMINARY ANTITUMOR ACTIVITY IN PATIENTS WITH DESMOID TUMORS (DT)
Samuel J. Klempner
Favorite
Klimczak, Anna

Maria Sklodowska-Curie National Research Institute of Oncology
(P 191) EFFICACY OF SYSTEMIC PALLIATIVE THERAPIES IN PATIENTS WITH ADVANCED GASTROINTESTINAL STROMAL TUMORS (GIST) PREVIOUSLY TREATED WITH ADJUVANT IMATINIB - REAL-WORLD CLINICAL PRACTICE DATA
Anna Klimczak
Favorite
(P 470) OFF-LABEL TREATMENT AND ULTRARARE SARCOMAS - SINGLE INSTITUTION REPORT
Anna Klimczak
Favorite
Klinkhammer-Schalke, Monika

aBavarian Cancer Registry, Regional Center Würzburg, Bavarian Health and Food Safety Authority
(P 204) ANALYSIS OF QUALITY INDICATORS OF SOFT TISSUE SARCOMA TREATMENT WITH CANCER REGISTRY DATA IN GERMANY 2015-2021
Monika Klinkhammer-Schalke
Favorite
Knösel, Thomas

Institute of Pathology, Ludwig-Maximilians-University (LMU) Munich, Germany
(P 64) ATRX EXPRESSION CORRELATES WITH REDUCED IMMUNE CHECKPOINT EXPRESSION AND POOR SURVIVAL IN HIGH-RISK SOFT TISSUE SARCOMAS
Thomas Knösel
Favorite
(P 443) FIRST-LINE PAZOPANIB IN PATIENTS WITH EPITHELIOID HEMANGIOENDOTHELIOMA: A RETROSPECTIVE SINGLE-CENTER ANALYSIS
Thomas Knösel
Favorite
Kneser, Ulrich

Department of Hand, Plastic and Reconstructive Surgery, Microsurgery, Burn Trauma Center, BG Trauma Center Ludwigshafen, University of Heidelberg, Ludwigshafen, 67071 Germany.
(P 454) TREATMENT PATTERNS AND OUTCOMES IN RADIATION-INDUCED SARCOMA: FIRST RESULTS OF THE TETRIS-PROJECT - A MULTIMODAL RETROSPECTIVE ANALYSIS FROM A TERTIARY CENTER
Ulrich Kneser
Favorite
Knops, Rutger

Princess Máxima Center for Pediatric Oncology
(P 250) OUTCOME OF INFANTS WITH RHABDOMYOSARCOMA: A REPORT FROM THE INTERNATIONAL SOFT TISSUE SARCOMA CONSORTIUM
Rutger Knops
Favorite
Kobald, Samantha

University of New England College of Osteopathic Medicine
(P 118) IMPACT OF TYROSINE KINASE INHIBITOR THERAPY ON BONE PROGRESSION IN PATIENTS WITH DRIVER-MUTATED METASTATIC NON-SMALL CELL LUNG CANCER WITH DE NOVO BONE METASTASES
Samantha Kobald
Favorite
Kobayashi, Eisuke

National Cancer Center Hospital
(P 159) CHONDROSARCOMA IN JAPAN: A POPULATION-BASED ANALYSIS USING NATIONAL CANCER REGISTRY
Eisuke Kobayashi
Favorite
Kochat, Veena

MD Anderson Cancer Center
(P 47) EWSR1::WT1 FUSION ONCOPROTEIN ACTIVITY SHAPES LINEAGE HETEROGENEITY IN DESMOPLASTIC SMALL ROUND CELL TUMORS
Veena Kochat
Favorite
Koch, Keith

Cogent Biosciences
(P 425) BEZUCLASTINIB EXPANDED ACCESS PROGRAM (EAP) FOR PATIENTS WITH GASTROINTESTINAL STROMAL TUMORS (GIST)
Keith Koch
Favorite
Kojima, Yuki

Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan
(P 341) PROGNOSTIC RELEVANCE OF CYCLOPHOSPHAMIDE DOSE FOR HIGH-RISK RHABDOMYOSARCOMA IN ADULT PATIENTS TREATED WITH VAC THERAPY
Yuki Kojima
Favorite
Kollár, Attila

Department of Medical Oncology, University Hospital Bern, Inselspital
(P 436) SAKK 57/24 FEASIBILITY OF TOTAL NEOADJUVANT TREATMENT WITH HYPERTHERMIA IN PATIENTS WITH HIGH-RISK EXTREMITY AND TRUNK SOFT TISSUE SARCOMA. A MULTICENTER, SINGLE ARM, OPEN LABEL, PHASE II TRIAL
Attila Kollár
Favorite
Kondo, Hiroya

Okayama University Hospital
(P 79) AGE-BASED TREATMENT PATTERNS AND OUTCOMES OF LOCALIZED HIGH-GRADE OSTEOSARCOMA FROM A NATIONWIDE DATABASE: WHAT IS THE OPTIMAL STRATEGY FOR PATIENTS OLDER THAN 40 YEARS?
Hiroya Kondo
Favorite
Kondo, Hiroya

National Cancer Center Hospital
(P 159) CHONDROSARCOMA IN JAPAN: A POPULATION-BASED ANALYSIS USING NATIONAL CANCER REGISTRY
Hiroya Kondo
Favorite
Kong, Chang-Bae

Korea Cancer Center Hospital
(P 342) PROGNOSTIC RELEVANCE OF TUMOR LOCATION IN MYXOID LIPOSARCOMA
Chang-Bae Kong
Favorite
Konieczkowski, David

The Ohio State University
(P 161) CLINICAL CHARACTERISTICS, PATTERNS OF CARE, AND TREATMENT OUTCOMES OF CHONDROSARCOMA: A SINGLE-INSTITUTIONAL EXPERIENCE
David Konieczkowski
Favorite
Koo, Younghyun

Department of Artificial Intelligence and Data Science, Sejong University, Seoul, Korea
(P 171) THREE-DIMENSIONAL DEEP LEARNING MODEL FOR PREDICTING PROXIMAL FEMORAL PATHOLOGIC FRACTURE USING OPPORTUNISTIC ABDOMINOPELVIC CT IN PATIENTS WITH ADVANCED CANCER: A PRELIMINARY REPORT
Younghyun Koo
Favorite
Kopec, Sylwia

Maria Sklodowska-Curie National Research Institute of Oncology
(P 470) OFF-LABEL TREATMENT AND ULTRARARE SARCOMAS - SINGLE INSTITUTION REPORT
Sylwia Kopec
Favorite
Korah, Maria

Stanford University
(P 37) DISSECTING THE TUMOR MICROENVIRONMENT OF UTERINE LEIOMYOSARCOMAS FOR TARGETED DRUG PREDICTIONS
Maria Korah
Favorite
Korfhage, Justin

Yale University
(P 24) THE SIRTUIN SIRT5 SUPPORTS EWING SARCOMA SURVIVAL VIA REGULATION OF EWS-FLI1 STABILITY AND ACTIVITY
Justin Korfhage
Favorite
Koseła-Paterczyk, Hanna

Maria Sklodowska-Curie National Research Institute of Oncology; Warsaw Poland
(P 216) VIRTUAL MULTIDISCIPLINARY MEETINGS IN THE CARE OF SARCOMA PATIENTS
Hanna Koseła-Paterczyk
Favorite
Kosela-Paterczyk, Hanna

Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie National Research Institute of Oncology
(P 27) MOLECULAR CHARACTERIZATION OF RESPONSE TO NEOADJUVANT CHEMORADIATION IN PATIENTS WITH LOCALLY ADVANCED SOFT TISSUE SARCOMAS
Hanna Kosela-Paterczyk
Favorite
(P 470) OFF-LABEL TREATMENT AND ULTRARARE SARCOMAS - SINGLE INSTITUTION REPORT
Hanna Kosela-Paterczyk
Favorite
Ko, Somang

Seoul National University
(P 175) INTERPRETABLE DEEP LEARNING BASED CLASSIFICATION OF SARCOMA IMMUNE SUBTYPES FROM H&E SLIDES FOR IMMUNOTHERAPY STRATIFICATION
Somang Ko
Favorite
Kotamraju, Tushar

Surgical Oncology, Department of Surgery, University of California, Davis
(P 244) INTRATUMORAL TIGIT BLOCKADE AUGMENTS ANTI-TUMOR RESPONSES AND BYPASSES HYPERFUNCTIONALITY OF PERIPHERAL TIGIT+ NK CELLS IN MOUSE AND HUMAN MODELS OF BONE AND SOFT TISSUE SARCOMA
Tushar Kotamraju
Favorite
Kotzur, Travis

University of Texas San Antonio Health
(P 78) MENTAL HEALTH DISORDERS FOLLOWING PATHOLOGICAL FRACTURE: A RETROSPECTIVE COHORT STUDY
Travis Kotzur
Favorite
Kozak, Katarzyna

Maria Sklodowska-Curie National Research Institute of Oncology
(P 470) OFF-LABEL TREATMENT AND ULTRARARE SARCOMAS - SINGLE INSTITUTION REPORT
Katarzyna Kozak
Favorite
Kozak, Margaret

University of Texas Southwestern Medical School
(P 280) PERSONALIZED ULTRA-FRACTIONATED STEREOTACTIC ADAPTIVE RADIOTHERAPY (PULSAR) FOR ADULT AND PEDIATRIC SARCOMAS
Margaret Kozak
Favorite
Kozlek, Tom

Kura Oncology, Inc.
(P 423) ZIFTOMENIB IN COMBINATION WITH IMATINIB IN ADVANCED GASTROINTESTINAL STROMAL TUMORS (GIST) AFTER IMATINIB FAILURE: PHASE 1A/B STUDY OF SAFETY, PHARMACOKINETICS, AND ANTITUMOR ACTIVITY
Tom Kozlek
Favorite
Krabbe, Ellen

Institute of Clinical Scinces/Sahlgrenska Academy
(P 124) ISOLATED LIMB PERFUSION AS LIMB SALVAGING TREATMENT; A SINGLE CENTRE RETROSPECTIVE STUDY
Ellen Krabbe
Favorite
Kram, David

University of North Carolina
(P 426) A PHASE I/II TRIAL USING RNA LIPID NANOPARTICLES FOR RECURRENT OSTEOSARCOMA: A REPORT FROM THE NATIONAL PEDIATRIC CANCER FOUNDATION
David Kram
Favorite
Krarup-Hansen, Anders

Department of Oncology, Herlev University Hospital
(P 05) CONCORDANCE OF GENOMIC ALTERATIONS WITH CIRCULATING TUMOR DNA: INITIAL FINDINGS FROM A PILOT STUDY
Anders Krarup-Hansen
Favorite
(P 249) IN VITRO EXPANSION OF TUMOR-INFILTRATING GAMMA-DELTA T-CELLS FROM PATIENTS WITH SOFT TISSUE SARCOMAS
Anders Krarup-Hansen
Favorite
(P 319) CARDIOTOXICITY AND OVERALL SURVIVAL IN PATIENTS WITH SARCOMA TREATED WITH DOXORUBICIN, OLARATUMAB AND DEXRAZOXANE: A REAL-WORLD EXPERIENCE IN DENMARK
Anders Krarup-Hansen
Favorite
Krasniqi, Fatime

Department of Oncology, University Hospital Basel
(P 436) SAKK 57/24 FEASIBILITY OF TOTAL NEOADJUVANT TREATMENT WITH HYPERTHERMIA IN PATIENTS WITH HIGH-RISK EXTREMITY AND TRUNK SOFT TISSUE SARCOMA. A MULTICENTER, SINGLE ARM, OPEN LABEL, PHASE II TRIAL
Fatime Krasniqi
Favorite
Krawetz, Roman

Arnie Charbonneau Cancer Institute and McCaig Institute for Bone and Joint Health
(P 238) INVESTIGATING HOW MACROPHAGES INFILTRATE THE TUMOUR MICROENVIRONMENT AND INFLUENCE THE EFFICACY OF CAR T THERAPY IN A MURINE MODEL OF STS
Roman Krawetz
Favorite
(P 378) HIGH DOSE RADIATION THERAPY PROMOTES IMMUNE SUPPRESSIVE MACROPHAGE PHENOTYPES, WHEREAS LOW DOSE RADIATION THERAPY PROMOTES IMMUNOGENIC MACROPHAGE PHENOTYPES IN A MURINE MODEL OF SOFT TISSUE SARCOMA
Roman Krawetz
Favorite
Krishnamoorthy, Murali

Msas Eye and Ear
(P 62) INTRAOPERATIVE BONE AND SOFT TISSUE TUMOR MARGIN IDENTIFICATION WITH FLUORESCENCE LIFETIME (FLT) IMAGING
Murali Krishnamoorthy
Favorite
Krishnan, Chandra Kumar

Cancer Institute (WIA), Adyar, Chennai
(P 110) DEFINITIVE RADIATION THERAPY IN "OPERABLE" EWING SARCOMA OF THE EXTREMITIES AND PELVIS
Chandra Kumar Krishnan
Favorite
Krishna, Sakshi

Vanderbilt University School of Medicine
(P 85) MAKING NEGATIVE MARGIN MUSCULOSKELETAL TUMOR SURGERY A VIRTUAL REALITY USING 3D SPECIMEN SCANNING
Sakshi Krishna
Favorite
Krotewicz, Maria

Maria Sklodowska-Curie National Research Institute of Oncology
(P 313) SIGNIFICANCE OF LYMPH NODE PROCEDURES IN SOFT TISSUE SARCOMA PATIENTS
Maria Krotewicz
Favorite
Kubik, William

McGill University
(P 143) IMPACT OF SURGICAL MARGINS IN CHEST WALL CHONDROSARCOMAS: A CANSARCC STUDY
William Kubik
Favorite
Kucharik, Michael

University of South Florida
(P 84) A MULTICENTER COMPARISON OF REVERSE TOTAL SHOULDER ARTHROPLASTY VERSUS HEMIARTHROPLASTY FOR ENDOPROSTHETIC RECONSTRUCTION FOLLOWING ONCOLOGIC RESECTION OF THE PROXIMAL HUMERUS
Michael Kucharik
Favorite
Kuijjer, Marieke

Centre for Molecular Medicine Norway
(P 127) AN INTEGRATED CLINICAL GENOMIC AND TRANSCRIPTOMIC SUBGROUPING OF CENTRAL CHONDROSARCOMA
Marieke Kuijjer
Favorite
Ku, Ja-Lok

Korean Cell Line Bank, Laboratory of Cell Biology, Cancer Research Institute, Seoul National University
(P 09) ESTABLISHMENT AND CHARACTERIZATION OF 18 SARCOMA CELL LINES: UNRAVELING THE MOLECULAR MECHANISMS OF DOXORUBICIN RESISTANCE IN SARCOMA CELL LINES
Ja-Lok Ku
Favorite
Kuleshov, Nikol

Service d'hémato-oncologie, CHU de Québec - Université Laval, Québec, Canada
(P 395) ERIBULIN IN RECURRENT PRETREATED METASTATIC SOFT TISSUE SARCOMA. A CANADIAN SARCOMA RESEARCH AND CLINICAL COLLABORATION (CANSARCC) REAL WORLD ANALYSIS
Nikol Kuleshov
Favorite
Kulkarni, Nichita

Memorial Sloan Kettering Cancer Center
(P 421) CHARACTERIZING THE IMMUNE RESPONSE TO INTRATUMORAL TIGILANOL TIGLATE (TT) IN PATIENTS WITH ADVANCED AND/OR METASTATIC SOFT TISSUE SARCOMA (STS) IN A PHASE IIA TRIAL (NCT05755113)
Nichita Kulkarni
Favorite
Kumar, Anand

Harvard Medical School, Mass Eye and Ear
(P 62) INTRAOPERATIVE BONE AND SOFT TISSUE TUMOR MARGIN IDENTIFICATION WITH FLUORESCENCE LIFETIME (FLT) IMAGING
Anand Kumar
Favorite
Kumar, Kiran

University of Texas Southwestern Medical School
(P 280) PERSONALIZED ULTRA-FRACTIONATED STEREOTACTIC ADAPTIVE RADIOTHERAPY (PULSAR) FOR ADULT AND PEDIATRIC SARCOMAS
Kiran Kumar
Favorite
Kumar, Sonia

Humanitas University
(P 318) BURIED DE-EPITHELIALIZED FLAP RECONSTRUCTION AFTER WIDE EXCISION OF THIGH SARCOMAS: EARLY EXPERIENCE FROM A SPECIALIZED SARCOMA SURGERY UNIT
Sonia Kumar
Favorite
(P 339) POSTERIOR APPROACH FOR RADICAL RESECTION OF SACROCOCCYGEAL CHORDOMA: A SURGICAL PERSPECTIVE FROM A TERTIARY REFERRAL CENTER
Sonia Kumar
Favorite
(P 365) UROLOGICAL RECONSTRUCTION DURING RETROPERITONEAL AND PELVIC SARCOMA SURGERY: EXPERIENCE FROM A HIGH-VOLUME SARCOMA CENTER
Sonia Kumar
Favorite
Kumar, Surinder

University of Miami
(P 24) THE SIRTUIN SIRT5 SUPPORTS EWING SARCOMA SURVIVAL VIA REGULATION OF EWS-FLI1 STABILITY AND ACTIVITY
Surinder Kumar
Favorite
(P 253) ELUCIDATING THE ROLE OF SIRT7 IN EWING SARCOMA
Surinder Kumar
Favorite
Kummar, Shivaani

Oregon Health and Science University
(P 415) A PHASE 1/2 TRIAL OF FOG-001, A FIRST-IN-CLASS DIRECT β-CATENIN:TCF4 INHIBITOR: SAFETY AND PRELIMINARY ANTITUMOR ACTIVITY IN PATIENTS WITH DESMOID TUMORS (DT)
Shivaani Kummar
Favorite
Kung, Andrew

Memorial Sloan Kettering Cancer Center
(P 08) BUILDING A MEDICAL DONATION NETWORK TO ENHANCE DEVELOPMENT OF PEDIATRIC TUMOR MODELS
Andrew Kung
Favorite
(P 25) IDENTIFICATION AND VALIDATION OF NON-GENETICALLY ENCODED VULNERABILITIES IN EWING SARCOMA
Andrew Kung
Favorite
(P 26) DEVELOPING AN ORTHOTOPIC MODEL OF DESMOPLASTIC SMALL ROUND CELL TUMOR
Andrew Kung
Favorite
(P 48) PRECLINICAL ACTIVITY OF MEK INHIBITION IN COMBINATION WITH CHEMOTHERAPY IN MALIGNANT PERIPHERAL NERVE SHEATH TUMOR
Andrew Kung
Favorite
(P 237) DEVELOPMENT OF EPHA2 CAR T CELL THERAPY FOR OSTEOSARCOMA
Andrew Kung
Favorite
(P 267) THE RAF/MEK INHIBITOR VS-6766 SHOWS EFFICACY IN RAS-MUTANT PEDIATRIC PRECLINICAL XENOGRAFT MODELS- A REPORT FROM THE PEDIATRIC PRECLINICAL IN VIVO TESTING CONSORTIUM
Andrew Kung
Favorite
Kunisada, Toshiyuki

Okayama University Hospital
(P 79) AGE-BASED TREATMENT PATTERNS AND OUTCOMES OF LOCALIZED HIGH-GRADE OSTEOSARCOMA FROM A NATIONWIDE DATABASE: WHAT IS THE OPTIMAL STRATEGY FOR PATIENTS OLDER THAN 40 YEARS?
Toshiyuki Kunisada
Favorite
Kunning, Sheryl

UPMC Department of Immunology and Hillman Cancer Center
(P 65) INVESTIGATING MACROPHAGE POPULATIONS IN PRIMARY AND METASTATIC SARCOMA SAMPLES
Sheryl Kunning
Favorite
Kunz, Wolfgang G.

Department of Radiology, LMU University Hospital, Munich, Germany
(P 64) ATRX EXPRESSION CORRELATES WITH REDUCED IMMUNE CHECKPOINT EXPRESSION AND POOR SURVIVAL IN HIGH-RISK SOFT TISSUE SARCOMAS
Wolfgang G. Kunz
Favorite
(P 437) CLINICAL DATA CONFIRM GALENIC PRINCIPLE AND DEMONSTRATE THERAPEUTIC POTENTIAL OF THE001 (DPPG2-TSL-DOX) PLUS REGIONAL HYPERTHERMIA IN SOFT TISSUE SARCOMA
Wolfgang G. Kunz
Favorite
(P 443) FIRST-LINE PAZOPANIB IN PATIENTS WITH EPITHELIOID HEMANGIOENDOTHELIOMA: A RETROSPECTIVE SINGLE-CENTER ANALYSIS
Wolfgang G. Kunz
Favorite
Kuo, Fengshen

Memorial Sloan Kettering Cancer Center
(P 265) MULTI-SITE SINGLE CELL TRANSCRIPTOMICS REVEAL DISTINCT IMMUNE INFILTRATIVE PATTERNS IN DESMOPLASTIC SMALL ROUND CELL TUMOR
Fengshen Kuo
Favorite
Kuttschreuter, Luke

Owkin
(P 431) INVOKE: A PHASE 1 STUDY OF OKN4395, A FIRST-IN-CLASS EP2/EP4/DP1 TRIPLE PROSTANOID RECEPTOR ANTAGONIST, IN PATIENTS WITH ADVANCED SOLID TUMORS, INCLUDING SARCOMAS
Luke Kuttschreuter
Favorite
Kwon, Daeheon

Seoul National University
(P 175) INTERPRETABLE DEEP LEARNING BASED CLASSIFICATION OF SARCOMA IMMUNE SUBTYPES FROM H&E SLIDES FOR IMMUNOTHERAPY STRATIFICATION
Daeheon Kwon
Favorite
Kwon, Jee Young

PIVOT Coordinating Center
(P 267) THE RAF/MEK INHIBITOR VS-6766 SHOWS EFFICACY IN RAS-MUTANT PEDIATRIC PRECLINICAL XENOGRAFT MODELS- A REPORT FROM THE PEDIATRIC PRECLINICAL IN VIVO TESTING CONSORTIUM
Jee Young Kwon
Favorite
Kwon, Sunghoon

Seoul National University
(P 175) INTERPRETABLE DEEP LEARNING BASED CLASSIFICATION OF SARCOMA IMMUNE SUBTYPES FROM H&E SLIDES FOR IMMUNOTHERAPY STRATIFICATION
Sunghoon Kwon
Favorite
(P 176) DEEP LEARNING MODEL FOR DIFFERENTIATING BETWEEN NEOPLASTIC PATHOLOGIC FRACTURE AND NONPATHOLOGIC FRACTURE FROM PLAIN HIP RADIOGRAPHS
Sunghoon Kwon
Favorite
L
La Greca, Francesca

Università Campus Biomedico di Roma
(P 70) EPIDEMIOLOGY AND POTENTIAL CLINICAL RELEVANCE OF CONTACTIN-4 EXPRESSION IN SOFT TISSUE SARCOMA
Francesca La Greca
Favorite
López Sanmartín, Consol

Hospital Santa Creu i Sant Pau
(P 218) THE IMPACT OF BROADENED GENETIC COUNSELLING REFERRAL CRITERIA IN SARCOMA PATIENTS: A REFERENCE CENTRE'S EXPERIENCE
Consol López Sanmartín
Favorite
Labib, Ramy

University of Miami Miller School of Medicine, Department of Orthopaedic Surgery
(P 94) EFFECT OF POSTOPERATIVE PHYSICAL THERAPY ON FUNCTIONAL OUTCOMES FOLLOWING MUSCULOSKELETAL TUMOR RESECTION
Ramy Labib
Favorite
Laetsch, Theodore

The Children’s Hospital of Philadelphia, University of Pennsylvania
(P 256) THE SEAN KARL COHORT: A NATIONAL COLLABORATIVE SINGLE-CELL RNASEQ STUDY OF PAIRED PATIENT EWING SARCOMA SPECIMENS
Theodore Laetsch
Favorite
(P 262) EVALUATING FRONT-LINE THERAPY ACCORDANCE WITH CURRENT SYNOVIAL SARCOMA GUIDELINES
Theodore Laetsch
Favorite
(P 263) DESCRIBING THE CHARACTERISTICS AND TREATMENT OF SYNOVIAL SARCOMA IN THE RECURRENT SETTING
Theodore Laetsch
Favorite
Laetsch, Theodore

The Children’s Hospital of Philadelphia, University of Pennsylvania Philadelphia
(P 417) EFFICACY AND SAFETY OF LAROTRECTINIB (LARO) IN PATIENTS (PTS) WITH TRK FUSION SARCOMAS
Theodore Laetsch
Favorite
(P 419) PROSPECTIVE REAL-WORLD STUDY OF LAROTRECTINIB (LARO) IN PATIENTS (PTS) WITH TRK FUSION SOLID TUMORS: INTERIM ANALYSIS OF ON-TRK
Theodore Laetsch
Favorite
Laetsch, Theodore

The Children’s Hospital of Philadelphia, University of Pennsylvania
(P 427) PHASE 1/2 TRIAL TO EVALUATE THE SAFETY AND EFFICACY OF PEEL-224 IN COMBINATION WITH VINCRISTINE AND TEMOZOLOMIDE IN ADOLESCENTS AND YOUNG ADULTS WITH RELAPSED OR REFRACTORY SARCOMAS
Theodore Laetsch
Favorite
Lagmay, Joanne

University of Florida
(P 426) A PHASE I/II TRIAL USING RNA LIPID NANOPARTICLES FOR RECURRENT OSTEOSARCOMA: A REPORT FROM THE NATIONAL PEDIATRIC CANCER FOUNDATION
Joanne Lagmay
Favorite
Laitinen, Minna

Helsinki University Hospital
(P 151) SHOULD WE USE ADJUVANT CHEMOTHERAPY IN PATIENTS WITH LOCALIZED DEDIFFERENTIATED CHONDROSARCOMA (DDCS) OF THE PELVIS? AN ANALYSIS BY THE PELVIC DDCS STUDY GROUP
Minna Laitinen
Favorite
Lalli, Narinder

University College London Hospitals
(P 281) LOCAL CONTROL WITH MODERATELY HYPOFRACTIONATED DEFINITIVE RADIOTHERAPY DELIVERED WITH A SIMULTANEOUS INTEGRATED BOOST TECHNIQUE TO NON-EXTREMITY SOFT TISSUE AND BONE SARCOMAS
Narinder Lalli
Favorite
Lam, Alexander

University of California, San Francisco
(P 439) AN OPEN LABEL MULTICENTER PHASE 2 STUDY WITH SAFETY LEAD IN OF INTRATUMORAL VUSOLIMOGENE ODERPAREPVEC IN COMBINATION WITH PEMBROLIZUMAB IN PATIENTS WITH ANGIOSARCOMA
Alexander Lam
Favorite
Lammers, Marshall

Surgical Oncology, Department of Surgery, University of California, Davis
(P 244) INTRATUMORAL TIGIT BLOCKADE AUGMENTS ANTI-TUMOR RESPONSES AND BYPASSES HYPERFUNCTIONALITY OF PERIPHERAL TIGIT+ NK CELLS IN MOUSE AND HUMAN MODELS OF BONE AND SOFT TISSUE SARCOMA
Marshall Lammers
Favorite
Lammers, Marshall

mlammers@ucdavis.edu
(P 245) SUBTYPE SPECIFIC CHARACTERIZATION OF IMMUNE INFILTRATION IN SOFT TISSE SARCOMAS
Marshall Lammers
Favorite
Landers, Sharon

MD Anderson Cancer Center
(P 351) THE ROLE OF SOCIOECONOMIC DISPARITIES ON SURVIVAL OUTCOMES IN MALIGNANT PERIPHERAL NERVE SHEATH TUMORS
Sharon Landers
Favorite
Landreth, Kaitlyn

West Virginia University School of Medicine, Department of Microbiology, Immunology, and Cell Biology
(P 30) MYELOPEROXIDASE AS A POTENTIAL THERAPEUTIC TARGET IN SOFT TISSUE SARCOMA
Kaitlyn Landreth
Favorite
Langfitt, Deanna

St. Jude Children's Research Hospital
(P 241) MACROPHAGE INHIBITION ENHANCES PERIPHERAL CAR T CELL EXPANSION AND TUMOR CONTROL IN A PATIENT-DERIVED HUMANIZED MODEL OF AUTOLOGOUS CAR T CELL EFFICACY IN PEDIATRIC OSTEOSARCOMA (OS)
Deanna Langfitt
Favorite
Lansu, Jules

Haga Hospital, The Hague, The Netherlands
(P 295) FROM HISTORICAL REFERENCE TO MODERN PRACTICE: WOUND COMPLICATION RATES IN SOFT TISSUE SARCOMA TREATED WITH RADIOTHERAPY ACROSS ERAS
Jules Lansu
Favorite
LaQuaglia, Michael

Memorial Sloan Kettering Cancer Center
(P 265) MULTI-SITE SINGLE CELL TRANSCRIPTOMICS REVEAL DISTINCT IMMUNE INFILTRATIVE PATTERNS IN DESMOPLASTIC SMALL ROUND CELL TUMOR
Michael LaQuaglia
Favorite
Lara, Daniela

Fundación Colombiana de Cancerología Clínica Vida
(P 219) RETROPERITONEAL SARCOMA: HEALTH SYSTEM BARRIERS AND THE RATIONALE FOR A SPECIALIZED SARCOMA UNIT
Daniela Lara
Favorite
Larson, Aubriannah

University of Iowa Health Care
(P 370) CLINICAL OUTCOMES OF CUTANEOUS UNDIFFERENTIATED PLEOMORPHIC SARCOMA AND SUBCUTANEOUS MYXOFIBROSARCOMA: A RETROSPECTIVE REVIEW
Aubriannah Larson
Favorite
Larson, Reece C.

University of Florida
(P 129) HIJACKED FUEL: GLYCOGEN-DRIVEN METABOLIC SHIFTS IN IDH1-MUTANT CHONDROSARCOMA
Reece C. Larson
Favorite
Lasa Laborda, Adriana

Hospital Santa Creu i Sant Pau
(P 218) THE IMPACT OF BROADENED GENETIC COUNSELLING REFERRAL CRITERIA IN SARCOMA PATIENTS: A REFERENCE CENTRE'S EXPERIENCE
Adriana Lasa Laborda
Favorite
Laskar, Siddhartha

Tata Memorial Hospital, Mumbai
(P 286) INTERSTITIAL BRACHYTHERAPY FOR ORGAN AND FUNCTION PRESERVATION IN SOFT TISSUE SARCOMAS: LONG TERM OUTCOMES
Siddhartha Laskar
Favorite
(P 292) CRANIOVERTEBRAL EWINGS SARCOMA WITH MENINGEAL INFILTRATION - A CLINICAL OUTCOME ANALYSIS
Siddhartha Laskar
Favorite
(P 387) TREATMENT PATTERNS AND PROGNOSTIC FACTORS IN LOCALISED SYNOVIAL SARCOMA: A RETROSPECTIVE STUDY FROM A TERTIARY CANCER CENTRE IN INDIA
Siddhartha Laskar
Favorite
(P 438) RANDOMIZED, OPEN-LABEL, PHASE III TRIAL OF ADJUVANT CHEMOTHERAPY VERSUS OBSERVATION IN NON-METASTATIC, HIGH-RISK SOFT TISSUE SARCOMAS (ACO-SARC TRIAL)
Siddhartha Laskar
Favorite
Lasky, Joseph

Cure 4 The Kids Foundation
(P 261) SUSTAINED RESPONSE WITH RIVOCERANIB AND DENOSUMAB IN RELASPED OSTEOSARCOMA
Joseph Lasky
Favorite
Lau, Chelsea

Northwestern Medicine
(P 373) COMPLETE RESPONSE TO FRONT-LINE PEXIDARTINIB IN SYMPTOMATIC TEMPOROMANDIBULAR JOINT TENOSYNOVIAL GIANT CELL TUMOR
Chelsea Lau
Favorite
Lau, Chelsea

Northwestern University Feinberg School of Medicine
(P 429) SINGLE-ARM, OPEN-LABEL PHASE II TRIAL OF XL092 (ZANZALINTINIB) IN PATIENTS WITH ADVANCED LEIOMYOSARCOMA: TRIAL IN PROGRESS
Chelsea Lau
Favorite
Lauretta, Andrea

Centro di Riferimento Oncologico di Aviano (CRO), IRCCS
(P 328) INNOVATING SARCOMA EDUCATION: EARLY OUTCOMES OF THE ITALIAN SOCIETY OF SURGICAL ONCOLOGY (SICO) SARCOMA SOCIAL MULTI-PLATFORM JOURNAL CLUB INITIATIVE
Andrea Lauretta
Favorite
Lawlor, Elizabeth

Seattle Children's Research Institute
(P 24) THE SIRTUIN SIRT5 SUPPORTS EWING SARCOMA SURVIVAL VIA REGULATION OF EWS-FLI1 STABILITY AND ACTIVITY
Elizabeth Lawlor
Favorite
(P 256) THE SEAN KARL COHORT: A NATIONAL COLLABORATIVE SINGLE-CELL RNASEQ STUDY OF PAIRED PATIENT EWING SARCOMA SPECIMENS
Elizabeth Lawlor
Favorite
(P 260) MECHANISM AND EFFICACY OF ANTHRACYCLINE MEDIATED EPIGENETIC DISRUPTION IN BONE SARCOMAS.
Elizabeth Lawlor
Favorite
Lawrenz, Joshua

Vanderbilt University Medical Center
(P 84) A MULTICENTER COMPARISON OF REVERSE TOTAL SHOULDER ARTHROPLASTY VERSUS HEMIARTHROPLASTY FOR ENDOPROSTHETIC RECONSTRUCTION FOLLOWING ONCOLOGIC RESECTION OF THE PROXIMAL HUMERUS
Joshua Lawrenz
Favorite
Lawrenz, Joshua

Division of Musculoskeletal Oncology, Department of Orthopaedic Surgery, Vanderbilt University Medical Center
(P 85) MAKING NEGATIVE MARGIN MUSCULOSKELETAL TUMOR SURGERY A VIRTUAL REALITY USING 3D SPECIMEN SCANNING
Joshua Lawrenz
Favorite
Lawrenz, Joshua

Vanderbilt University Medical Center
(P 97) RISK FACTORS ASSOCIATED WITH AMPUTATION VERSUS CONTINUED LIMB SALVAGE IN LOWER EXTREMITY ENDOPROSTHETIC RECONSTRUCTION
Joshua Lawrenz
Favorite
Lazar, Alexander

MD Anderson Cancer Center
(P 38) VALIDATION OF THE SIGNIOS SEVEN-GENE SIGNATURE FOR PREDICTING ANTI-PD-1 INHIBITOR EFFICACY IN SARCOMA
Alexander Lazar
Favorite
(P 47) EWSR1::WT1 FUSION ONCOPROTEIN ACTIVITY SHAPES LINEAGE HETEROGENEITY IN DESMOPLASTIC SMALL ROUND CELL TUMORS
Alexander Lazar
Favorite
(P 54) PRECLINICAL MODELS REVEALING MDM2-P53 INTERACTION AND DEPENDENCY FOR TUMOR CELL SURVIVAL IN WELL-DIFFERENTIATED (WD) AND DEDIFFERENTIATED (DD) LIPOSARCOMA (LPS).
Alexander Lazar
Favorite
(P 172) COMPARISON OF CELL SEGMENTATION METHODS IN SOFT TISSUE SARCOMA (STS) SPATIAL PROTEOMIC DATASETS
Alexander Lazar
Favorite
(P 184) MTAP IN GASTROINTESTINAL STROMAL TUMOR (GIST): RATE OF MTAP LOSS AND CONCORDANCE BETWEEN GENOMIC SEQUENCING AND IMMUNOHISTOCHEMISTRY
Alexander Lazar
Favorite
(P 242) IMMUNE PROFILING OF UNDIFFERENTIATED PLEOMORPHIC SARCOMAS REVEALS DISTINCT PROGNOSTIC SUBGROUPS
Alexander Lazar
Favorite
(P 411) TFCP2 FUSION-POSITVE RHABDOMYOSARCOMAS: A REPORT OF 10 CASES AND A REVIEW OF THE LITERATURE
Alexander Lazar
Favorite
Lazarides, Alexander

Moffitt Cancer Center
(P 84) A MULTICENTER COMPARISON OF REVERSE TOTAL SHOULDER ARTHROPLASTY VERSUS HEMIARTHROPLASTY FOR ENDOPROSTHETIC RECONSTRUCTION FOLLOWING ONCOLOGIC RESECTION OF THE PROXIMAL HUMERUS
Alexander Lazarides
Favorite
(P 102) FACTORS RELATED TO ASEPTIC LOOSENING IN ENDOPROSTHESIS RECONSTRUCTION OF THE PROXIMAL TIBIA
Alexander Lazarides
Favorite
(P 114) DENOSUMAB THERAPY AND MIRELS ADJUSTED ODDS OF PATHOLOGIC FRACTURE OR PROPHYLACTIC STABILIZATION IN APPENDICULAR SKELETAL METASTASES
Alexander Lazarides
Favorite
(P 138) A MULTI-INSTITUTIONAL ARCHIVE AND DEEP LEARNING PIPELINE FOR QUANTIFYING CHONDROSARCOMA COMPOSITION
Alexander Lazarides
Favorite
(P 140) REFINING PRE-SURGICAL ASSESSMENT OF LONG-BONE CHONDROSARCOMA THROUGH THE RADIOLOGIC AGGRESSIVENESS SCORE
Alexander Lazarides
Favorite
(P 141) A RETROSPECTIVE ANALYSIS OF THE BIRMINGHAM ATYPICAL CARTILAGE TUMOUR IMAGING PROTOCOL (BACTIP) IN MANAGING CENTRAL CARTILAGE TUMORS OF THE LONG BONES
Alexander Lazarides
Favorite
(P 142) ARE THERE INDEPENDENT PREDICTORS OF DEDIFFERENTIATED CHONDROSARCOMA ON MAGNETIC RESONANCE IMAGING? A MULTIVARIATE ANALYSIS
Alexander Lazarides
Favorite
(P 145) PATHOLOGIC FRACTURE IN CHONDROSARCOMA OF LONG BONES: A RETROSPECTIVE COHORT STUDY
Alexander Lazarides
Favorite
(P 160) A COMPARATIVE ANALYSIS OF DEDIFFERENTIATED AND CONVENTIONAL CHONDROSARCOMA OUTCOMES
Alexander Lazarides
Favorite
(P 163) CHONDROSARCOMA IN THE AYA POPULATION
Alexander Lazarides
Favorite
(P 375) DOES STAGED RESECTION WITH TEMPORIZING WOUND VACUUM INFLUENCE LOCAL RECURRENCE RISK? A MULTI-INSTITUTIONAL MATCHED COHORT ANALYSIS
Alexander Lazarides
Favorite
(P 453) OUTCOMES OF PLEOMORPHIC LIPOSARCOMA PATIENTS FOLLOWING MULTI-DISCIPLINARY MANAGEMENT WITHIN A TERTIARY CANCER CENTER
Alexander Lazarides
Favorite
Le Cesne, Axel

International Department, Gustave Roussy Institute
(P 194) UPDATED RESULTS FROM STRATEGIST 1: A PHASE 1/1B STUDY OF IDRX-42 (GSK6042981A) IN PATIENTS (PTS) WITH ADVANCED GASTROINTESTINAL STROMAL TUMORS (GIST)
Axel Le Cesne
Favorite
(P 299) RECURRENCES AFTER PRIMARY RPS SURGERY IN A HIGH-VOLUME SARCOMA CENTER: A RETROSPECTIVE ANALYSIS ON 402 PATIENTS
Axel Le Cesne
Favorite
(P 422) EFFICACY WITH VIMSELTINIB IN PATIENTS (PTS) WITH TENOSYNOVIAL GIANT CELL TUMOR (TGCT) AND PRIOR COLONY-STIMULATING FACTOR 1 (CSF1) INHIBITOR THERAPY: A PHASE 2 CASE SERIES
Axel Le Cesne
Favorite
Le Grange, Franel

University College London Hospitals
(P 281) LOCAL CONTROL WITH MODERATELY HYPOFRACTIONATED DEFINITIVE RADIOTHERAPY DELIVERED WITH A SIMULTANEOUS INTEGRATED BOOST TECHNIQUE TO NON-EXTREMITY SOFT TISSUE AND BONE SARCOMAS
Franel Le Grange
Favorite
Le loarer, François

Institut Bergonié
(P 324) FULLY MATURE TERTIARY LYMHOID STRUCTURES AS PREDICTORS OF LOCAL RECURRENCE IN SOFT TISSUE SARCOMAS
François Le loarer
Favorite
le Pechoux, Cecile

Gustave Roussy
(P 299) RECURRENCES AFTER PRIMARY RPS SURGERY IN A HIGH-VOLUME SARCOMA CENTER: A RETROSPECTIVE ANALYSIS ON 402 PATIENTS
Cecile le Pechoux
Favorite
Leavey, Patrick

UT Southwestern Medical Center
(P 168) LEVERAGING LARGE LANGUAGE MODELS FOR STRUCTURED INFORMATION EXTRACTION FROM EWING SARCOMA PATHOLOGY REPORTS
Patrick Leavey
Favorite
LeBlanc, Amy

National Institutes of Health
(P 258) INVESTIGATING THE ROLE OF ALVEOLAR PNEUMOCYTES IN THE LUNG MICROENVIRONMENT OF OSTEOSARCOMA METASTASES
Amy LeBlanc
Favorite
Leddy, Lee

Medical University of South Carolina
(P 279) IMPACT OF PREOPERATIVE 5-DAY HYPOFRACTIONATED RADIOTHERAPY (HFRT) FOR SOFT TISSUE SARCOMA (STS) ON BARRIERS TO TREATMENT AT A HIGH-VOLUME SARCOMA CENTER (HV-SC)
Lee Leddy
Favorite
Ledo Hopgood, Paula

University of Miami, Miller School of Medicine
(P 253) ELUCIDATING THE ROLE OF SIRT7 IN EWING SARCOMA
Paula Ledo Hopgood
Favorite
Lee, Bohae

University of Iowa Hospitals and Clinics
(P 343) PROGRESSION FREE SURVIVAL OF IMMUNE CHECKPOINT INHIBITORS IN THE FIRST-LINE TREATMENT OF METASTATIC SARCOMA: A SINGLE CENTER RETROSPECTIVE ANALYSIS.
Bohae Lee
Favorite
Lee, Byrne

Stanford University
(P 37) DISSECTING THE TUMOR MICROENVIRONMENT OF UTERINE LEIOMYOSARCOMAS FOR TARGETED DRUG PREDICTIONS
Byrne Lee
Favorite
Lee, Chao-Tung

National Health Research Institute
(P 428) MAINTENANCE PEGYLATED LIPOSOMAL DOXORUBICIN VERSUS ACTIVE SURVEILLANCE FOR ADVANCED SOFT TISSUE SARCOMA PATIENTS WHO HAD CONTROLLED DISEASE AFTER STANDARD ANTHRACYCLINE-BASED TREATMENT (MELODY)
Chao-Tung Lee
Favorite
Lee, Dean

Nationwide Children's Hospital
(P 254) EOSINOPHILIC FASCIITIS (EF) AS A COMPLICATION OF NATURAL KILLER (NK) CELL-BASED IMMUNOTHERAPY IN A YOUNG ADULT WITH RECURRENT METASTATIC EWING SARCOMA
Dean Lee
Favorite
Lee, Grace

University of Michigan
(P 52) VALIDATION OF SYNGENEIC MURINE DEDIFFERENTIATED LIPOSARCOMA MODELS FOR PRECLINICAL EVALUATION OF THERAPEUTIC SENSITIVITY
Grace Lee
Favorite
Lee, Jewoo

Department of Orthopaedic Surgery, St. Vincent’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea
(P 171) THREE-DIMENSIONAL DEEP LEARNING MODEL FOR PREDICTING PROXIMAL FEMORAL PATHOLOGIC FRACTURE USING OPPORTUNISTIC ABDOMINOPELVIC CT IN PATIENTS WITH ADVANCED CANCER: A PRELIMINARY REPORT
Jewoo Lee
Favorite
lee, JISOO

Department of Orthopaedic Surgery, Seoul National University Bundang Hospital
(P 66) ARHGEF4 EXPRESSION IN SOFT TISSUE SARCOMA CORRELATES WITH LOCAL GROWTH PATTERN: WHOLE TRANSCRIPTOME SEQUENCING ON SPATIALLY SEPARATED REGIONS, PATIENT-DERIVED MODELS, AND ORTHOTOPIC IN VIVO ANALYSIS
JISOO lee
Favorite
Lee, Ming-Jing

National Taiwan University Hospital Hsin-Chu Branch
(P 428) MAINTENANCE PEGYLATED LIPOSOMAL DOXORUBICIN VERSUS ACTIVE SURVEILLANCE FOR ADVANCED SOFT TISSUE SARCOMA PATIENTS WHO HAD CONTROLLED DISEASE AFTER STANDARD ANTHRACYCLINE-BASED TREATMENT (MELODY)
Ming-Jing Lee
Favorite
Lee, Minpyo

Department of Orthopaedic Surgery, St. Vincent’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea
(P 171) THREE-DIMENSIONAL DEEP LEARNING MODEL FOR PREDICTING PROXIMAL FEMORAL PATHOLOGIC FRACTURE USING OPPORTUNISTIC ABDOMINOPELVIC CT IN PATIENTS WITH ADVANCED CANCER: A PRELIMINARY REPORT
Minpyo Lee
Favorite
Leeper, Haley

Oregon State University
(P 19) SERUM EXOSOMES IDENTIFY AN ABERRANT PROTEOMIC SIGNATURE IN CANINE OSTEOSARCOMA PRECEDING METASTATIC PROGRESSION
Haley Leeper
Favorite
Lee, Sean

Tulane University
(P 47) EWSR1::WT1 FUSION ONCOPROTEIN ACTIVITY SHAPES LINEAGE HETEROGENEITY IN DESMOPLASTIC SMALL ROUND CELL TUMORS
Sean Lee
Favorite
Lee, Seungjun

Boston University Chobanian and Avedisian School of Medicine
(P 205) CENTRALIZATION OF SARCOMA CARE IMPROVES OUTCOMES DESPITE POORER PRESENTATION: A SYSTEMATIC REVIEW AND META-ANALYSIS
Seungjun Lee
Favorite
Lee, Soobin

Seoul National University
(P 175) INTERPRETABLE DEEP LEARNING BASED CLASSIFICATION OF SARCOMA IMMUNE SUBTYPES FROM H&E SLIDES FOR IMMUNOTHERAPY STRATIFICATION
Soobin Lee
Favorite
Lee, Stella

University of Pittsburgh Medical Center
(P 63) EVALUATING SURGICAL MARGINS IN SARCOMA RESECTION WITH INDOCYANINE GREEN FLUORESCENCE IMAGING
Stella Lee
Favorite
Lee, Suyeon

National Cancer Center
(P 109) FINITE ELEMENT ANALYSIS FOR FIXATION EVALUATION OF PATIENT-SPECIFIC ORTHOPEDIC IMPLANTS
Suyeon Lee
Favorite
Lee, Yeh Chen

Prince of Wales Hospital
(P 428) MAINTENANCE PEGYLATED LIPOSOMAL DOXORUBICIN VERSUS ACTIVE SURVEILLANCE FOR ADVANCED SOFT TISSUE SARCOMA PATIENTS WHO HAD CONTROLLED DISEASE AFTER STANDARD ANTHRACYCLINE-BASED TREATMENT (MELODY)
Yeh Chen Lee
Favorite
Lee, Yong-Suk

Incheon St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea
(P 171) THREE-DIMENSIONAL DEEP LEARNING MODEL FOR PREDICTING PROXIMAL FEMORAL PATHOLOGIC FRACTURE USING OPPORTUNISTIC ABDOMINOPELVIC CT IN PATIENTS WITH ADVANCED CANCER: A PRELIMINARY REPORT
Yong-Suk Lee
Favorite
Lee, Yu Na

National Cancer Center
(P 296) PULMONARY CEMENT EMBOLISM ASSOCIATED WITH PERCUTANEOUS CEMENTOPLASTY FOR BONE METASTASIS: MECHANISMS AND PROTECTIVE FACTORS
Yu Na Lee
Favorite
Lefler, Daniel

University of Pennsylvania
(P 185) CANCER TESTIS ANTIGENS AS TARGETS IN KIT11-MUTATED, IMATINIB-RESISTANT GIST
Daniel Lefler
Favorite
Leite, Luis

Universidade Federal Fluminense
(P 347) SURVIVAL ANALYSIS AND PROGNOSTIC FACTORS OF SOFT TISSUE SARCOMAS OF THE TRUNK AND EXTREMITIES TREATED BETWEEN 2010 AND 2015: EXPERIENCE OF THE BRAZILIAN NATIONAL CANCER INSTITUTE
Luis Leite
Favorite
Leithner, Andreas

Medical University of GrazDept of Orthopaedics and Trauma, Medical University of Graz
(P 151) SHOULD WE USE ADJUVANT CHEMOTHERAPY IN PATIENTS WITH LOCALIZED DEDIFFERENTIATED CHONDROSARCOMA (DDCS) OF THE PELVIS? AN ANALYSIS BY THE PELVIC DDCS STUDY GROUP
Andreas Leithner
Favorite
Lekberg, Tobias

Karolinska Hospital and Institute
(P 270) FEASIBILITY OF FERTILITY PRESERVATION IN CHILDREN, ADOLESCENTS AND YOUNG ADULTS WITH SARCOMAS - A PROSPECTIVE COHORT STUDY WITH LONG-TERM FOLLOW-UP
Tobias Lekberg
Favorite
Lemieux, Christopher

Service d'Hémato-oncologie, CHU de Québec-Université Laval, Québec, Canada
(P 395) ERIBULIN IN RECURRENT PRETREATED METASTATIC SOFT TISSUE SARCOMA. A CANADIAN SARCOMA RESEARCH AND CLINICAL COLLABORATION (CANSARCC) REAL WORLD ANALYSIS
Christopher Lemieux
Favorite
Lemos Ballester, Pedro

The Hospital for Sick Children
(P 73) TARGETABLE GENE DEPENDENCIES IN EWING SARCOMA SUBTYPES
Pedro Lemos Ballester
Favorite
Le, Ngan

UNC
(P 350) THE PATTERN.ORG SARCOMA CONSORTIUM: BUILDING A MULTI-INSTITUTIONAL DATA RESOURCE FOR THE SARCOMA RESEARCH COMMUNITY
Ngan Le
Favorite
Lennerz, Jochen

Department of Pathology, Center for Integrated Diagnostics, Massachusetts General Hospital and Harvard Medical School
(P 45) MONITORING EWSR1 FUSIONS IN SARCOMA PATIENTS USING PERSONALIZED LIQUID BIOPSY ASSAYS
Jochen Lennerz
Favorite
Leonard, Hugh

EHE Rare Cancer Charity (UK)
(P 446) GDF-15 AS A PROGNOSTIC FACTOR IN PATIENTS WITH EPITHELIOID HEMANGIOENDOTHELIOMA
Hugh Leonard
Favorite
(P 447) PAIN ASSESSMENT CRITERIA (PAC) ANTICIPATE RECIST PROGRESSION AND CORRELATE WITH BLOOD LEVELS OF GROWTH DIFFERENTIATION FACTOR 15 (GDF15) IN EPITHELIOID HEMANGIOENDOTHELIOMA (EHE)
Hugh Leonard
Favorite
Leoni, Mollie

Kura Oncology, Inc.
(P 423) ZIFTOMENIB IN COMBINATION WITH IMATINIB IN ADVANCED GASTROINTESTINAL STROMAL TUMORS (GIST) AFTER IMATINIB FAILURE: PHASE 1A/B STUDY OF SAFETY, PHARMACOKINETICS, AND ANTITUMOR ACTIVITY
Mollie Leoni
Favorite
Lerman, Daniel

St. Luke's Medical Center
(P 106) REPAIR: A PRELIMINARY REPORT ON AN ONGOING MULTI-CENTER TRIAL FOR PATIENTS UNDERGOING SURGICAL STABILIZATION FOR METASTATIC BONE DISEASE OF THE FEMUR
Daniel Lerman
Favorite
Letson, Doug

Moffitt Cancer Center
(P 84) A MULTICENTER COMPARISON OF REVERSE TOTAL SHOULDER ARTHROPLASTY VERSUS HEMIARTHROPLASTY FOR ENDOPROSTHETIC RECONSTRUCTION FOLLOWING ONCOLOGIC RESECTION OF THE PROXIMAL HUMERUS
Doug Letson
Favorite
(P 102) FACTORS RELATED TO ASEPTIC LOOSENING IN ENDOPROSTHESIS RECONSTRUCTION OF THE PROXIMAL TIBIA
Doug Letson
Favorite
(P 114) DENOSUMAB THERAPY AND MIRELS ADJUSTED ODDS OF PATHOLOGIC FRACTURE OR PROPHYLACTIC STABILIZATION IN APPENDICULAR SKELETAL METASTASES
Doug Letson
Favorite
(P 163) CHONDROSARCOMA IN THE AYA POPULATION
Doug Letson
Favorite
Levin, Adam

Johns Hopkins University
(P 222) DO WE ALL SEE IT THE SAME: AN INTER-RATER RELIABILITY ANALYSIS OF THE MUSCULOSKELETAL TUMOR REGISTRY DATA ELEMENTS
Adam Levin
Favorite
(P 345) SARCOMA BIOPSY COMPARISON BETWEEN REFERRAL CENTERS AND TREATING CENTERS: THE MUSCULOSKELETAL TUMOR REGISTRY (MSTR) EXPERIENCE
Adam Levin
Favorite
levy, Antonin

Gustave Roussy
(P 299) RECURRENCES AFTER PRIMARY RPS SURGERY IN A HIGH-VOLUME SARCOMA CENTER: A RETROSPECTIVE ANALYSIS ON 402 PATIENTS
Antonin levy
Favorite
Levy, Tyler

Cell Signaling Technology
(P 198) EXPLOITING METABOLIC DYSREGULATION IN SUCCINATE DEHYDROGENASE-DEFICIENT GASTROINTESTINAL STROMAL TUMOR
Tyler Levy
Favorite
Lewandowski, Sara

Pyxis Oncology
(P 29) ANTI-TUMOR ACTIVITY OF MICVOTABART PELIDOTIN IS ASSOCIATED WITH ENZYME GENE EXPRESSION IN PATIENT-DERIVED XENOGRAFT SARCOMA MODELS
Sara Lewandowski
Favorite
Lewin, Jeremy

Peter MacCallum Cancer Centre
(P 121) REAL-WORLD EXPERIENCE OF CABOZANTINIB MONOTHERAPY IN RELAPSED OR REFRACTORY OSTEOSARCOMA AND EWING SARCOMA: A SINGLE-CENTRE AUSTRALIAN STUDY
Jeremy Lewin
Favorite
(P 315) ANALYSIS OF CHANGES IN T2-WEIGHTED SIGNAL INTENSITY AND TUMOR VOLUME AND EXPOSURE-RESPONSE IN THE RINGSIDE PHASE 2 STUDY OF VAREGACESTAT FOR DESMOID TUMORS
Jeremy Lewin
Favorite
(P 344) REAL-WORLD EXPERIENCE OF SORAFENIB IN DESMOID TUMOURS: A SINGLE-CENTRE AUSTRALIAN STUDY
Jeremy Lewin
Favorite
(P 410) SUBGROUP ANALYSIS OF THE PHASE 2 PART OF THE RINGSIDE PHASE 2/3 TRIAL OF VAREGACESTAT FOR TREATMENT OF DESMOID TUMORS
Jeremy Lewin
Favorite
Liang, Jiahao

University of Miami
(P 253) ELUCIDATING THE ROLE OF SIRT7 IN EWING SARCOMA
Jiahao Liang
Favorite
Li, Annie

Department of Pathology, Massachusetts General Hospital, Harvard Medical School
(P 45) MONITORING EWSR1 FUSIONS IN SARCOMA PATIENTS USING PERSONALIZED LIQUID BIOPSY ASSAYS
Annie Li
Favorite
Liapis, Evangelos

Center for Discovery and Innovation, Hackensack Meridian Health
(P 251) SPATIAL MULTI-OMIC ANALYSIS OF RHABDOMYOSARCOMA IDENTIFIES THERAPEUTIC VULNERABILITIES
Evangelos Liapis
Favorite
Li, Cheng-Peng

Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing); Sarcoma Center
(P 165) EVALUATING LARGE LANGUAGE MODELS AS DECISION SUPPORT TOOLS IN MULTIDISCIPLINARY TUMOR BOARDS FOR GASTROINTESTINAL STROMAL TUMORS
Cheng-Peng Li
Favorite
(P 169) BENCHMARKING LARGE LANGUAGE MODELS VS MULTIDISCIPLINARY TUMOR BOARDS OF 21 SARCOMA CENTERS
Cheng-Peng Li
Favorite
Lid, Ana

Oslo University Hospital
(P 200) DISSECTING INTRATUMORAL HETEROGENEITY IN GIST USING SPATIAL TRANSCRIPTOMICS
Ana Lid
Favorite
Li, Duan

Memorial Sloan Kettering Cancer Center
(P 421) CHARACTERIZING THE IMMUNE RESPONSE TO INTRATUMORAL TIGILANOL TIGLATE (TT) IN PATIENTS WITH ADVANCED AND/OR METASTATIC SOFT TISSUE SARCOMA (STS) IN A PHASE IIA TRIAL (NCT05755113)
Duan Li
Favorite
Lieb, Camryn

Genesis Research Group
(P 464) EFFICACY OUTCOMES AMONG PATIENTS WITH ADVANCED EPITHELIOID SARCOMAS OF PROXIMAL-TYPE AND DISTAL-TYPE TREATED WITH TAZ: POST HOC ANALYSIS OF STUDY EZH-202
Camryn Lieb
Favorite
Liebner, David

The Ohio State University Comprehensive Cancer Center
(P 161) CLINICAL CHARACTERISTICS, PATTERNS OF CARE, AND TREATMENT OUTCOMES OF CHONDROSARCOMA: A SINGLE-INSTITUTIONAL EXPERIENCE
David Liebner
Favorite
(P 170) GEMSARC: AN AI BASED PREDICTIVE GENE SIGNATURE FOR GEMCITABINE EFFICACY IN ADVANCED SOFT-TISSUE SARCOMAS
David Liebner
Favorite
(P 335) OUTCOMES OF TALIMOGENE LAHERPAREPVEC IN SOFT TISSUE SARCOMA
David Liebner
Favorite
(P 408) REAL-WORLD SINGLE-CENTER INSIGHTS INTO CT-DNA DYNAMICS ACROSS SOFT TISSUE SARCOMAS
David Liebner
Favorite
Lietz, Christopher

Massachusetts General Hospital
(P 17) EXTRASKELETAL OSTEOSARCOMA: MICRORNA PATTERNS PROVIDE INSIGHTS INTO SIMILARITIES AND CONTRASTS WITH OTHER SARCOMAS
Christopher Lietz
Favorite
Li, Evelyn

Tom Baker Cancer Center, University of Calgary, Calgary, Alberta, Canada
(P 395) ERIBULIN IN RECURRENT PRETREATED METASTATIC SOFT TISSUE SARCOMA. A CANADIAN SARCOMA RESEARCH AND CLINICAL COLLABORATION (CANSARCC) REAL WORLD ANALYSIS
Evelyn Li
Favorite
Li, George

Memorial Sloan Kettering Cancer Center
(P 409) RETROSPECTIVE ANALYSIS OF PROGNOSTIC FACTORS INCLUDING HLA GENOTYPE IN MYXOID LIPOSARCOMA
George Li
Favorite
Ligon, John

University of Florida
(P 248) AN EX VIVO ASSAY TO PREDICT IMMUNOTHERAPY RESPONSE IN SARCOMA
John Ligon
Favorite
(P 426) A PHASE I/II TRIAL USING RNA LIPID NANOPARTICLES FOR RECURRENT OSTEOSARCOMA: A REPORT FROM THE NATIONAL PEDIATRIC CANCER FOUNDATION
John Ligon
Favorite
Li, Jia

Ipsen, Cambridge, MA, USA
(P 416) A PHASE 2 MULTICENTER OPEN-LABEL BASKET STUDY OF TAZEMETOSTAT IN ADULT PATIENTS WITH INI1-NEGATIVE EPITHELIOID SARCOMA – FINAL ANALYSIS
Jia Li
Favorite
Li, Jian

Department of Gastrointestinal Oncology, Beijing Cancer Hospital
(P 194) UPDATED RESULTS FROM STRATEGIST 1: A PHASE 1/1B STUDY OF IDRX-42 (GSK6042981A) IN PATIENTS (PTS) WITH ADVANCED GASTROINTESTINAL STROMAL TUMORS (GIST)
Jian Li
Favorite
Lillemoe, Heather

MD Anderson Cancer Center
(P 351) THE ROLE OF SOCIOECONOMIC DISPARITIES ON SURVIVAL OUTCOMES IN MALIGNANT PERIPHERAL NERVE SHEATH TUMORS
Heather Lillemoe
Favorite
Lilley, Elizabeth

Brigham and Women's Hospital
(P 228) FREQUENCY AND CLARITY OF SURGICAL GOALS FOR TUMOR RESECTION IN ADVANCED SARCOMA
Elizabeth Lilley
Favorite
Li, Luyuan

North Alabama Medical Center
(P 117) THERAPEUTIC POTENTIAL OF DOXORUBICIN AND DASATINIB COMBINATION IN OSTEOSARCOMA
Luyuan Li
Favorite
(P 148) CHARACTERISTICS AND OUTCOMES OF CHONDROSARCOMA PATIENTS TREATED WITH PROTON THERAPY: A SYSTEMATIC REVIEW OF PUBLISHED SERIES
Luyuan Li
Favorite
Lim, Hyun-ju

National Cancer Center
(P 296) PULMONARY CEMENT EMBOLISM ASSOCIATED WITH PERCUTANEOUS CEMENTOPLASTY FOR BONE METASTASIS: MECHANISMS AND PROTECTIVE FACTORS
Hyun-ju Lim
Favorite
Lim, Tse Hui

Singapore General Hospital
(P 53) ESTABLISHMENT AND CHARACTERISATION OF LIPOSARCOMA-DERIVED CELLS AS RELEVANT PRE-CLINICAL MODELS FOR TARGET DISCOVERY
Tse Hui Lim
Favorite
Lim, Vivian Yujing

A*STAR Institute of Molecular and Cell Biology (A*STAR IMCB)
(P 53) ESTABLISHMENT AND CHARACTERISATION OF LIPOSARCOMA-DERIVED CELLS AS RELEVANT PRE-CLINICAL MODELS FOR TARGET DISCOVERY
Vivian Yujing Lim
Favorite
Lin, Adrian

David Geffen School of Medicine at University of California Los Angeles
(P 16) MITOCHONDRIAL GENETIC VARIATION ORCHESTRATES COPZ1 TRANSCRIPT HETEROGENEITY AND REVEALS TELOMERE-MEDIATED VULNERABILITIES IN OSTEOSARCOMA
Adrian Lin
Favorite
(P 72) COUNTY-LEVEL ASSOCIATIONS BETWEEN AIRBORNE TOXICANT EMISSIONS AND EWING SARCOMA DIAGNOSIS IN THE UNITED STATES
Adrian Lin
Favorite
(P 81) ASSESSING PROGNOSTIC FACTORS OF CAUSE-SPECIFIC SURVIVAL IN PATIENTS WITH MALIGNANT GIANT CELL TUMORS: A POPULATION BASED STUDY FROM THE SEER DATABASE
Adrian Lin
Favorite
(P 92) PRIMARY TUMOR SIZE AS AN INDEPENDENT PROGNOSTIC FACTOR IN OSTEOSARCOMA: PROPENSITY SCORE-MATCHED ANALYSIS DEMONSTRATES A CONTINUOUS DOSE-RESPONSE RELATIONSHIP
Adrian Lin
Favorite
(P 100) THE ROLE OF CANCER TYPE IN THE DEVELOPMENT OF PERIPROSTHETIC JOINT INFECTION IN DISTAL FEMORAL REPLACEMENT
Adrian Lin
Favorite
(P 107) IS THERE A BETTER OPTION: INTRAMEDULLARY NAIL VERSUS PLATE OSTEOSYNTHESIS FOR PATHOLOGIC HUMERAL FRACTURES?
Adrian Lin
Favorite
(P 108) DISTANCE WEIGHTED MATCHING IN THE QUANTIFICATION OF EXCESS MORBIDITY IN EXTERNAL HEMIPELVECTOMY AND HIP DISARTICULATION
Adrian Lin
Favorite
(P 157) INCOME IMPACTS OVERALL BUT NOT CAUSE-SPECIFIC SURVIVAL IN PATIENTS WITH CHONDROSARCOMA: A POPULATION BASED STUDY FROM THE SEER DATABASE
Adrian Lin
Favorite
(P 232) IS THERE A ROLE FOR POSITRON EMISSION TOMOGRAPHY IN THE STAGING OF LANGERHANS CELL HISTIOCYTOSIS?
Adrian Lin
Favorite
(P 384) PELVIC LOCATION PREDICTS WORSE OUTCOMES IN ALVEOLAR RHABDOMYOSARCOMA: UNDERUSE OF RADIOTHERAPY AND MISSED SURVIVAL BENEFIT
Adrian Lin
Favorite
Linder-Stragliotto, Christina

Karolinska Hospital and Institute
(P 270) FEASIBILITY OF FERTILITY PRESERVATION IN CHILDREN, ADOLESCENTS AND YOUNG ADULTS WITH SARCOMAS - A PROSPECTIVE COHORT STUDY WITH LONG-TERM FOLLOW-UP
Christina Linder-Stragliotto
Favorite
Lind, Meredith

Department of Otolaryngology, Nationwide Children's Hospital; Department of Otolaryngology, The Ohio State University College of Medicine
(P 264) RARE CASE OF INFLAMMATORY MYOFIBROBLASTIC TUMOR (IMT) IN NEWBORN
Meredith Lind
Favorite
Lindner, Lars H.

Department of Medicine III, LMU University Hospital, Munich, Germany
(P 64) ATRX EXPRESSION CORRELATES WITH REDUCED IMMUNE CHECKPOINT EXPRESSION AND POOR SURVIVAL IN HIGH-RISK SOFT TISSUE SARCOMAS
Lars H. Lindner
Favorite
(P 436) SAKK 57/24 FEASIBILITY OF TOTAL NEOADJUVANT TREATMENT WITH HYPERTHERMIA IN PATIENTS WITH HIGH-RISK EXTREMITY AND TRUNK SOFT TISSUE SARCOMA. A MULTICENTER, SINGLE ARM, OPEN LABEL, PHASE II TRIAL
Lars H. Lindner
Favorite
(P 437) CLINICAL DATA CONFIRM GALENIC PRINCIPLE AND DEMONSTRATE THERAPEUTIC POTENTIAL OF THE001 (DPPG2-TSL-DOX) PLUS REGIONAL HYPERTHERMIA IN SOFT TISSUE SARCOMA
Lars H. Lindner
Favorite
(P 443) FIRST-LINE PAZOPANIB IN PATIENTS WITH EPITHELIOID HEMANGIOENDOTHELIOMA: A RETROSPECTIVE SINGLE-CENTER ANALYSIS
Lars H. Lindner
Favorite
Lindsay, Sarah

Mount Sinai Hospital
(P 93) INTERCALARY COMPRESSIVE OSSEOINTEGRATION OF DIAPHYSEAL TUMORS: A MULTI-INSTITUTIONAL CASE SERIES
Sarah Lindsay
Favorite
(P 364) TRENDS IN SURGICAL MANAGEMENT OF DESMOID TUMOR IN THE VETERANS AFFAIRS (VA) NATIONAL DATABASE
Sarah Lindsay
Favorite
Lingad, Allyssa

Sarcoma Oncology Center
(P 233) DNG64-CAR-V+ REGIMEN SHOWS CLINICAL BENEFIT IN PATIENTS WITH ADVANCED CCNG1 ONCOGENE EXPRESSING SARCOMAS (NCT04091295)
Allyssa Lingad
Favorite
(P 388) TRIAL IN PROGRESS: A PHASE 2 STUDY OF METRONOMIC TRABECTEDIN, GEMCITIBAINE, AND DACARBAZINE IN PREVIOUSLY TREATED ADVANCED SOFT TISSUE SARCOMA (NCT04535271)
Allyssa Lingad
Favorite
(P 396) EVALUATING THE SAFETY AND EFFICACY OF METRONOMIC GEMCITABINE, DOXORUBICIN, AND DOCETAXEL PLUS NIVOLUMAB IN PREVIOUSLY TREATED ADVANCED LEIOMYOSARCOMA AND LIPOSARCOMA: A PHASE 2 STUDY (NCT04535713)
Allyssa Lingad
Favorite
Lin, Heather

MD Anderson Cancer Center
(P 460) OUTCOMES OF LATER-LINES SYSTEMIC THERAPIES IN MALIGNANT PERIPHERAL NERVE SHEATH TUMORS (MPNST)
Heather Lin
Favorite
Lin, Jessica

Massachusetts General Hospital
(P 118) IMPACT OF TYROSINE KINASE INHIBITOR THERAPY ON BONE PROGRESSION IN PATIENTS WITH DRIVER-MUTATED METASTATIC NON-SMALL CELL LUNG CANCER WITH DE NOVO BONE METASTASES
Jessica Lin
Favorite
Lin, Jiahui

Sun Yat-sen University
(P 193) CLINICAL ANALYSIS OF RIPRETINIB DOSE ESCALATION IN ADVANCED GISTS AFTER STANDARD DOSE PROGRESSION
Jiahui Lin
Favorite
Lin, Miranda

Mayo Clinic
(P 300) FEATURES AND OUTCOMES OF PATIENTS WITH GASTROINTESTINAL LEIYOMYOSARCOMA
Miranda Lin
Favorite
Lin, Xin

Duke University
(P 126) SINGLE-CELL RNA SEQUENCING AND PROTEOMIC SPATIAL PROFILING REVEAL COMPLEX TUMOR MICROENVIRONMENT AND NOVEL IMMUNE INTERACTIONS IN CHONDROSARCOMA
Xin Lin
Favorite
Lischke, Robert

Third Department of Surgery, 1st Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic
(P 243) CLINICAL SIGNIFICANCE OF TUMOR-INFILTRATING IMMUNE CELL SUBSETS IN THE RETROPERITONEAL DEDIFFERENTIATED LIPOSARCOMAS AND LEIOMYOSARCOMAS
Robert Lischke
Favorite
Li, Shu

Department of Bone and Soft Tissue Tumour, Peking University Cancer Hospital, Beijing, China
(P 361) PEXIDARTINIB FOR THE TREATMENT OF TENOSYNOVIAL GIANT CELL TUMORS: CLINICAL EXPERIENCE FROM FIVE CHINESE PATIENTS
Shu Li
Favorite
Li, Tao

Zhejiang Cancer Hospital
(P 407) PIMICOTINIB IN TENOSYNOVIAL GIANT CELL TUMOR (TGCT): LONG-TERM EFFICACY, SAFETY, AND PATIENT-REPORTED OUTCOMES FROM THE PHASE 3 MANEUVER STUDY
Tao Li
Favorite
Litière, Saskia

European Organisation for Research and Treatment of Cancer
(P 456) OUTCOMES OF FIRST-LINE CHEMOTHERAPY IN ADVANCED ADULT-TYPE RHABDOMYOSARCOMAS: POOLED ANALYSIS OF CLINICAL TRIALS FROM THE EORTC SOFT TISSUE AND BONE SARCOMA GROUP
Saskia Litière
Favorite
Littleford, Hana

Rare Cancer Research Foundation
(P 350) THE PATTERN.ORG SARCOMA CONSORTIUM: BUILDING A MULTI-INSTITUTIONAL DATA RESOURCE FOR THE SARCOMA RESEARCH COMMUNITY
Hana Littleford
Favorite
Liu, Kevin

Massachusetts General Hospital
(P 290) CLINICAL OUTCOMES AFTER RADIOTHERAPY FOR PATIENTS WITH POORLY DIFFERENTIATED CHORDOMA
Kevin Liu
Favorite
(P 461) A RETROSPECTIVE ANALYSIS OF PATIENTS WITH CONVENTIONAL CHORDOMA TREATED WITH SYSTEMIC THERAPY
Kevin Liu
Favorite
Liu, Kunpeng

Department of Anesthesiology, Peking University International Hospital
(P 305) COMPARISON OF GOAL-DIRECTED VERSUS EMPIRICAL TRANSFUSION MANAGEMENT IN PATIENTS WITH SEVERE HEMORRHAGE DURING RETROPERITONEAL TUMOR SURGERY
Kunpeng Liu
Favorite
(P 469) THE IMPACT OF PREOPERATIVE ANEMIA ON POSTOPERATIVE COMPLICATIONS AND SHORT-TERM PROGNOSIS IN RETROPERITONEAL TUMOR SURGERY PATIENTS.
Kunpeng Liu
Favorite
Liu, Marion

Memorial Sloan Kettering Cancer Center
(P 186) BRAF V600E-MUTATED GASTROINTESTINAL STROMAL TUMORS: A CASE SERIES AND ANALYSIS OF IMMUNE TUMOR INFILTRATE
Marion Liu
Favorite
(P 187) THERAPEUTIC OUTCOMES IN NF1-ALTERED GIST TREATED WITH MEK INHIBITION: A SINGLE-CENTER EXPERIENCE
Marion Liu
Favorite
Liu, Minetta

Natera
(P 04) EARLY ON-TREATMENT CIRCULATING TUMOR DNA DYNAMICS TO PREDICT RESPONSE IN PATIENTS WITH SARCOMA
Minetta Liu
Favorite
Liu, Natalie

Surgical Oncology, Department of Surgery, University of California, Davis
(P 244) INTRATUMORAL TIGIT BLOCKADE AUGMENTS ANTI-TUMOR RESPONSES AND BYPASSES HYPERFUNCTIONALITY OF PERIPHERAL TIGIT+ NK CELLS IN MOUSE AND HUMAN MODELS OF BONE AND SOFT TISSUE SARCOMA
Natalie Liu
Favorite
Liu, Tang

The Second Xiangya Hospital of Central South University
(P 407) PIMICOTINIB IN TENOSYNOVIAL GIANT CELL TUMOR (TGCT): LONG-TERM EFFICACY, SAFETY, AND PATIENT-REPORTED OUTCOMES FROM THE PHASE 3 MANEUVER STUDY
Tang Liu
Favorite
Liu, Tracy

West Virginia University School of Medicine, Department of Microbiology, Immunology, and Cell Biology
(P 30) MYELOPEROXIDASE AS A POTENTIAL THERAPEUTIC TARGET IN SOFT TISSUE SARCOMA
Tracy Liu
Favorite
Liu, Xingliang

Providence Cancer Institute
(P 58) PLK1 AS A VULNERABLE TARGET OF BAP1-DRIVEN UNDIFFERENTIATED PLEOMORPHIC SARCOMAS
Xingliang Liu
Favorite
Liu, Yanghan

University of Michigan
(P 24) THE SIRTUIN SIRT5 SUPPORTS EWING SARCOMA SURVIVAL VIA REGULATION OF EWS-FLI1 STABILITY AND ACTIVITY
Yanghan Liu
Favorite
Livergant, Rachel

University of British Columbia
(P 196) SURVEILLANCE STRATEGIES AND LONG-TERM OUTCOMES IN LOW-RISK GASTRIC GASTROINTESTINAL STROMAL TUMORS (GGISTS)
Rachel Livergant
Favorite
Livingston, Andrew

Departments of Sarcoma Medical Oncology and Paediatrics, the University of Texas MD Anderson Cancer Center, Houston, TX, USA
(P 83) OUTCOMES OF MULTIMODAL PERIOPERATIVE TREATMENT IN OSTEOSARCOMAS OF THE JAW
Andrew Livingston
Favorite
(P 411) TFCP2 FUSION-POSITVE RHABDOMYOSARCOMAS: A REPORT OF 10 CASES AND A REVIEW OF THE LITERATURE
Andrew Livingston
Favorite
(P 427) PHASE 1/2 TRIAL TO EVALUATE THE SAFETY AND EFFICACY OF PEEL-224 IN COMBINATION WITH VINCRISTINE AND TEMOZOLOMIDE IN ADOLESCENTS AND YOUNG ADULTS WITH RELAPSED OR REFRACTORY SARCOMAS
Andrew Livingston
Favorite
(P 451) TREATMENT OUTCOMES OF GEMCITABINE AND DOCETAXEL IN PATIENTS WITH CLEAR CELL SARCOMA (CCS) OR GASTROINTESTINAL NEUROECTODERMAL TUMOR (GNET): A CASE SERIES
Andrew Livingston
Favorite
(P 460) OUTCOMES OF LATER-LINES SYSTEMIC THERAPIES IN MALIGNANT PERIPHERAL NERVE SHEATH TUMORS (MPNST)
Andrew Livingston
Favorite
Livingstone, Alan

University of Miami Hospital, Department of Surgical Oncology
(P 201) METASTATIC PATTERNS, TREATMENT MODALITIES, AND OVERALL SURVIVAL IN OLIGOMETASTATIC GIST: A SINGLE-CENTER RETROSPECTIVE STUDY
Alan Livingstone
Favorite
Li, William

University of Pittsburgh Medical Center
(P 63) EVALUATING SURGICAL MARGINS IN SARCOMA RESECTION WITH INDOCYANINE GREEN FLUORESCENCE IMAGING
William Li
Favorite
Li, Yi

University of Texas at Dallas
(P 462) HDAC INHIBITORS AS POTENTIAL SFT THERAPIES
Yi Li
Favorite
Li, Zola Chia-Chen

National Taiwan University Cancer Center
(P 428) MAINTENANCE PEGYLATED LIPOSOMAL DOXORUBICIN VERSUS ACTIVE SURVEILLANCE FOR ADVANCED SOFT TISSUE SARCOMA PATIENTS WHO HAD CONTROLLED DISEASE AFTER STANDARD ANTHRACYCLINE-BASED TREATMENT (MELODY)
Zola Chia-Chen Li
Favorite
Ljungberg, Emil

University of Florida
(P 275) NEXT GENERATION SEQUENCING IN ADOLESCENT AND YOUNG ADULT (AYA) SARCOMAS: CLINICAL IMPACT, DIAGNOSTIC UTILITY, AND IMPLICATIONS
Emil Ljungberg
Favorite
Lobmaier, Ingvild Victoria Koren

Oslo University Hospital
(P 200) DISSECTING INTRATUMORAL HETEROGENEITY IN GIST USING SPATIAL TRANSCRIPTOMICS
Ingvild Victoria Koren Lobmaier
Favorite
Locker, Amanda

University of Pittsburgh
(P 14) EVALUATING THE COMBINATION OF DISULFIRAM AND ENZALUTAMIDE IN OSTEOSARCOMA
Amanda Locker
Favorite
(P 63) EVALUATING SURGICAL MARGINS IN SARCOMA RESECTION WITH INDOCYANINE GREEN FLUORESCENCE IMAGING
Amanda Locker
Favorite
(P 80) UTILIZATION OF THE MUSCULOSKELETAL ONCOLOGY TUMOR REGISTRY AND TISSUE BANK (MOTOR) FOR THE ACCELERATION OF SARCOMA RESEARCH
Amanda Locker
Favorite
Lock, Richard

Children's Cancer Institute Australia
(P 267) THE RAF/MEK INHIBITOR VS-6766 SHOWS EFFICACY IN RAS-MUTANT PEDIATRIC PRECLINICAL XENOGRAFT MODELS- A REPORT FROM THE PEDIATRIC PRECLINICAL IN VIVO TESTING CONSORTIUM
Richard Lock
Favorite
Loggers, Elizabeth

Fred Hutchinson Cancer Center
(P 287) A PHASE 1 STUDY OF NEOADJUVANT CABOZANTINIB IN COMBINATION WITH RADIATION THERAPY FOR SARCOMAS OF THE EXTREMITIES
Elizabeth Loggers
Favorite
(P 315) ANALYSIS OF CHANGES IN T2-WEIGHTED SIGNAL INTENSITY AND TUMOR VOLUME AND EXPOSURE-RESPONSE IN THE RINGSIDE PHASE 2 STUDY OF VAREGACESTAT FOR DESMOID TUMORS
Elizabeth Loggers
Favorite
(P 410) SUBGROUP ANALYSIS OF THE PHASE 2 PART OF THE RINGSIDE PHASE 2/3 TRIAL OF VAREGACESTAT FOR TREATMENT OF DESMOID TUMORS
Elizabeth Loggers
Favorite
(P 416) A PHASE 2 MULTICENTER OPEN-LABEL BASKET STUDY OF TAZEMETOSTAT IN ADULT PATIENTS WITH INI1-NEGATIVE EPITHELIOID SARCOMA – FINAL ANALYSIS
Elizabeth Loggers
Favorite
Lohse, Ines

University of Pittsburgh
(P 14) EVALUATING THE COMBINATION OF DISULFIRAM AND ENZALUTAMIDE IN OSTEOSARCOMA
Ines Lohse
Favorite
(P 65) INVESTIGATING MACROPHAGE POPULATIONS IN PRIMARY AND METASTATIC SARCOMA SAMPLES
Ines Lohse
Favorite
(P 80) UTILIZATION OF THE MUSCULOSKELETAL ONCOLOGY TUMOR REGISTRY AND TISSUE BANK (MOTOR) FOR THE ACCELERATION OF SARCOMA RESEARCH
Ines Lohse
Favorite
Loidl, Verena

Sarcoma Patient Advocacy Global Network e.V.
(P 229) DETERMINANTS OF DIAGNOSTIC INTERVAL IN EPITHELIOID HEMANGIOENDOTHELIOMA: A LINEAR AND QUANTILE REGRESSION ANALYSIS OF PATIENT-REPORTED DATA FROM THE SPAGN GLOBAL SARCOMA DIAGNOSIS PATHWAY SURVEY
Verena Loidl
Favorite
Loidl, Verena

The EHE Foundation
(P 449) UNDERSTANDING GAPS IN KNOWLEDGE AND PATIENT-REPORTED PAIN IN EPITHELIOID HEMANGIOENDOTHELIOMA: RESULTS FROM A GLOBAL PATIENT REGISTRY
Verena Loidl
Favorite
Lombard, David

University of Miami Department of Pathology & Laboratory Medicine
(P 24) THE SIRTUIN SIRT5 SUPPORTS EWING SARCOMA SURVIVAL VIA REGULATION OF EWS-FLI1 STABILITY AND ACTIVITY
David Lombard
Favorite
(P 60) EXPLORING METABOLIC REWIRING IN CHORDOMA
David Lombard
Favorite
(P 225) GLOBAL REGISTRY OF SOLITARY FIBROUS TUMORS (SFT): INTEGRATING CLINICAL, MOLECULAR, AND ENVIRONMENTAL DATA- THE HOROWITZ SFT INITIATIVE (HSFTI)
David Lombard
Favorite
(P 253) ELUCIDATING THE ROLE OF SIRT7 IN EWING SARCOMA
David Lombard
Favorite
(P 369) CLINICAL CHARACTERISTICS & TREATMENT OUTCOME PATTERNS OF SOLITARY FIBROUS TUMORS: A SINGLE-INSTITUTION RETROSPECTIVE ANALYSIS
David Lombard
Favorite
(P 393) DISTINCT SECONDARY MUTATIONAL LANDSCAPES ARE ASSOCIATED WITH NAB2–STAT6 FUSION BREAKPOINTS IN SOLITARY FIBROUS TUMORS
David Lombard
Favorite
(P 462) HDAC INHIBITORS AS POTENTIAL SFT THERAPIES
David Lombard
Favorite
London, Wendy

Boston Children's Hospital / Dana-Farber Cancer Institute
(P 427) PHASE 1/2 TRIAL TO EVALUATE THE SAFETY AND EFFICACY OF PEEL-224 IN COMBINATION WITH VINCRISTINE AND TEMOZOLOMIDE IN ADOLESCENTS AND YOUNG ADULTS WITH RELAPSED OR REFRACTORY SARCOMAS
Wendy London
Favorite
Longaker, Michael

Stanford University
(P 37) DISSECTING THE TUMOR MICROENVIRONMENT OF UTERINE LEIOMYOSARCOMAS FOR TARGETED DRUG PREDICTIONS
Michael Longaker
Favorite
Long, Georgina

Melanoma Institute Australia, Faculty of Medicine and Health, The University of Sydney, and Mater and Royal North Shore Hospitals
(P 433) PHASE I DOSE ESCALATION TRIAL OF STX-001, AN LNP SELF-REPLICATING MRNA EXPRESSING IL-12, IN PATIENTS WITH REFRACTORY TUMORS INCLUDING SARCOMAS
Georgina Long
Favorite
Lopes, Ademar

A.C.Camargo Cancer Center
(P 278) NEOADJUVANT HYPOFRACTIONATED RADIOTHERAPY AND CHEMOTHERAPY IN EXTREMITY SOFT TISSUE SARCOMAS
Ademar Lopes
Favorite
Lopes, Carlos

Princess Margaret Cancer Centre, Mount Sinai Hospital, University of Toronto
(P 395) ERIBULIN IN RECURRENT PRETREATED METASTATIC SOFT TISSUE SARCOMA. A CANADIAN SARCOMA RESEARCH AND CLINICAL COLLABORATION (CANSARCC) REAL WORLD ANALYSIS
Carlos Lopes
Favorite
Lopez Saavedra, Alejandro

Instituto Nacional de Cancerología
(P 39) BUB1 AN OVEREXPRESSED KINASE IN SARCOMA: FINDING NEW TARGET THERAPY FOR OSTEOSARCOMA, LIPOSARCOMA, SYNOVIAL SARCOMA AND LEIOMYOSARCOMA
Alejandro Lopez Saavedra
Favorite
Lopez, Ann

Clear Cell Sarcoma Foundation
(P 450) OUTCOMES IN CLEAR CELL SARCOMA: UPDATED INSIGHTS FROM ELECTRONIC HEALTH RECORDS IN A PATIENT-LED REGISTRY
Ann Lopez
Favorite
López-Jiménez, Carlos

Hospital Universitario Fundación Jiménez Díaz. Instituto de Investigación Sanitaria FJD-UAM.
(P 356) DESMOID TUMORS: A RETROSPECTIVE ANALYSIS FROM A REFERRAL CENTER
Carlos López-Jiménez
Favorite
(P 389) UNRESECTABLE AND METASTATIC DEDIFFERENTIATED LIPOSARCOMA (DDLPS): INSIGHTS FROM A MULTICENTER REAL-WORLD COHORT (RWC)
Carlos López-Jiménez
Favorite
Lopez-Marti, Jesus

Instituto de Investigacion Sanitaria Fundacion Jimenez Diaz
(P 38) VALIDATION OF THE SIGNIOS SEVEN-GENE SIGNATURE FOR PREDICTING ANTI-PD-1 INHIBITOR EFFICACY IN SARCOMA
Jesus Lopez-Marti
Favorite
Lorenzi, Luisa

University of Brescia and ASST Spedali Civili di Brescia
(P 458) BETWEEN LYMPHOMAS AND SARCOMAS: A RETROSPECTIVE, MULTI-INSTITUTIONAL STUDY FROM THE ITALIAN SARCOMA GROUP (ISG) ON HISTIOCYTIC AND DENDRITIC CELL NEOPLASMS (HDCN)
Luisa Lorenzi
Favorite
Lorenz, Susanne

Oslo University Hospital
(P 200) DISSECTING INTRATUMORAL HETEROGENEITY IN GIST USING SPATIAL TRANSCRIPTOMICS
Susanne Lorenz
Favorite
Louka, Jean

Department of Orthopaedics, University of Miami
(P 90) MEGAPROSTHESIS CONVERSION FROM FAILED OSTEOARTICULAR ALLOGRAFT VERSUS PRIMARY RECONSTRUCTION FOR DISTAL FEMUR AND PROXIMAL TIBIA TUMORS: A PROPENSITY MATCHED-PAIR ANALYSIS
Jean Louka
Favorite
Louka, Jean G.

Department of Orthopaedics, University of Miami
(P 89) PATELLAR HEIGHT AND ITS INFLUENCE ON FUNCTIONAL OUTCOMES FOR MEGAPROSTHESES AROUND THE KNEE PERFORMED FOR ONCOLOGICAL INDICATIONS
Jean G. Louka
Favorite
Lovell, Timothy

Peter MacCallum Cancer Centre
(P 344) REAL-WORLD EXPERIENCE OF SORAFENIB IN DESMOID TUMOURS: A SINGLE-CENTRE AUSTRALIAN STUDY
Timothy Lovell
Favorite
Low, Gill

Precision for Medicine
(P 431) INVOKE: A PHASE 1 STUDY OF OKN4395, A FIRST-IN-CLASS EP2/EP4/DP1 TRIPLE PROSTANOID RECEPTOR ANTAGONIST, IN PATIENTS WITH ADVANCED SOLID TUMORS, INCLUDING SARCOMAS
Gill Low
Favorite
Lowney, Rachael

NCI/NIH
(P 181) THE DEVELOPMENT OF A NOVEL PDGFRA RESISTANCE MUTATION IN A RECURRENT KIT-MUTANT GASTROINTESTINAL STROMAL TUMOR (GIST)
Rachael Lowney
Favorite
Lozano Calderon, Santiago

Massachusetts General Hospital Department of Orthopaedic Surgery
(P 17) EXTRASKELETAL OSTEOSARCOMA: MICRORNA PATTERNS PROVIDE INSIGHTS INTO SIMILARITIES AND CONTRASTS WITH OTHER SARCOMAS
Santiago Lozano Calderon
Favorite
(P 62) INTRAOPERATIVE BONE AND SOFT TISSUE TUMOR MARGIN IDENTIFICATION WITH FLUORESCENCE LIFETIME (FLT) IMAGING
Santiago Lozano Calderon
Favorite
(P 87) ACUTE PATHOLOGICAL LONG BONE FRACTURES: WEEKEND VERSUS WEEKDAY VARIATIONS AND THEIR CLINICAL IMPACT
Santiago Lozano Calderon
Favorite
(P 91) A COMPARISON OF ACETABULAR AUGMENTATION AND PHOTODYNAMIC NAIL STABILIZATION FOR COMPLEX ONCOLOGIC TOTAL HIP ARTHROPLASTY
Santiago Lozano Calderon
Favorite
(P 98) PERCUTANEOUS STABILIZATION OF METASTATIC BONE LESIONS WITH A PHOTODYNAMIC INTRAMEDULLARY SYSTEM: EXPERIENCE FROM A 15-PATIENT CASE SERIES
Santiago Lozano Calderon
Favorite
(P 105) TREATMENT SUCCESS RATE AFTER SURGICAL MANAGEMENT OF PERIPROSTHETIC JOINT INFECTIONS IN ONCOLOGIC PROXIMAL TIBIA RECONSTRUCTION
Santiago Lozano Calderon
Favorite
(P 112) PEDIATRIC GIANT CELL TUMOR OF BONE
Santiago Lozano Calderon
Favorite
(P 118) IMPACT OF TYROSINE KINASE INHIBITOR THERAPY ON BONE PROGRESSION IN PATIENTS WITH DRIVER-MUTATED METASTATIC NON-SMALL CELL LUNG CANCER WITH DE NOVO BONE METASTASES
Santiago Lozano Calderon
Favorite
(P 151) SHOULD WE USE ADJUVANT CHEMOTHERAPY IN PATIENTS WITH LOCALIZED DEDIFFERENTIATED CHONDROSARCOMA (DDCS) OF THE PELVIS? AN ANALYSIS BY THE PELVIC DDCS STUDY GROUP
Santiago Lozano Calderon
Favorite
(P 173) DEVELOPMENT AND EXTERNAL VALIDATION OF A MACHINE LEARNING ALGORITHM TO PREDICT OVERALL SURVIVAL IN PATIENTS WITH PELVIC OR APPENDICULAR LIPOSARCOMA
Santiago Lozano Calderon
Favorite
(P 174) BIAS OR BEST FIT? A COMPARATIVE ANALYSIS OF SEER AND NCDB DATASETS IN SINGLE MODEL MACHINE LEARNING FOR PREDICTING OSTEOSARCOMA SURVIVAL OUTCOMES
Santiago Lozano Calderon
Favorite
(P 205) CENTRALIZATION OF SARCOMA CARE IMPROVES OUTCOMES DESPITE POORER PRESENTATION: A SYSTEMATIC REVIEW AND META-ANALYSIS
Santiago Lozano Calderon
Favorite
(P 294) RISK FACTORS FOR RECURRENCE AND COMPLICATIONS OF CT-GUIDED RADIOFREQUENCY ABLATION FOR THE TREATMENT OF OSTEOID OSTEOMA: A MULTI-INSTITUTIONAL ANALYSIS.
Santiago Lozano Calderon
Favorite
(P 375) DOES STAGED RESECTION WITH TEMPORIZING WOUND VACUUM INFLUENCE LOCAL RECURRENCE RISK? A MULTI-INSTITUTIONAL MATCHED COHORT ANALYSIS
Santiago Lozano Calderon
Favorite
(P 392) CLASSIFICATION AND DIFFERENTIATIONOF MYXOID LIPOSARCOMA AND MYXOMA WITH MACHINE LEARNING
Santiago Lozano Calderon
Favorite
(P 392) DIFFERENTIATION OF MYXOMA AND MYXOID LIPOSARCOMA BASED ON RADIOMICS PHENOTYPES
Santiago Lozano Calderon
Favorite
(P 402) LYMPH NODE METASTASES IN SOFT TISSUE SARCOMA: A DATABASE ANALYSIS
Santiago Lozano Calderon
Favorite
Lozza, Laura

Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan
(P 277) THE ROLE OF RADIOTHERAPY IN THE MULTIDISCIPLINARY MANAGEMENT OF RADIATION-ASSOCIATED ANGIOSARCOMA OF THE BREAST: A REFERRAL CENTER EXPERIENCE
Laura Lozza
Favorite
Lucarelli, Enrico

IRCCS Rizzoli Orthopaedic Institute
(P 18) ESTABLISHMENT AND CHARACTERIZATION OF A NOVEL PRIMARY CELL LINE FROM A BONE METASTASIS OF OSTEOSARCOMA
Enrico Lucarelli
Favorite
Ludwig, Joseph

MD Anderson Cancer Center
(P 22) SINGLE CELL SEQUENCING ENABLES LINEAGE-INFORMED TARGETING OF OSTEOSARCOMA
Joseph Ludwig
Favorite
(P 47) EWSR1::WT1 FUSION ONCOPROTEIN ACTIVITY SHAPES LINEAGE HETEROGENEITY IN DESMOPLASTIC SMALL ROUND CELL TUMORS
Joseph Ludwig
Favorite
(P 451) TREATMENT OUTCOMES OF GEMCITABINE AND DOCETAXEL IN PATIENTS WITH CLEAR CELL SARCOMA (CCS) OR GASTROINTESTINAL NEUROECTODERMAL TUMOR (GNET): A CASE SERIES
Joseph Ludwig
Favorite
(P 460) OUTCOMES OF LATER-LINES SYSTEMIC THERAPIES IN MALIGNANT PERIPHERAL NERVE SHEATH TUMORS (MPNST)
Joseph Ludwig
Favorite
Luen, Stephen

Peter MacCallum Cancer Centre
(P 121) REAL-WORLD EXPERIENCE OF CABOZANTINIB MONOTHERAPY IN RELAPSED OR REFRACTORY OSTEOSARCOMA AND EWING SARCOMA: A SINGLE-CENTRE AUSTRALIAN STUDY
Stephen Luen
Favorite
Lu, Hui

Department of Bioinformatics and Biostatistics, School of Life Sciences and Biotechnology, Shanghai Jiao Tong University
(P 07) A LIVING MULTI-OMICS BIOBANK OF PATIENT-DERIVED XENOGRAFT MODELS FOR SARCOMA
Hui Lu
Favorite
Luke, Jason

Strand Therapeutics Inc.
(P 433) PHASE I DOSE ESCALATION TRIAL OF STX-001, AN LNP SELF-REPLICATING MRNA EXPRESSING IL-12, IN PATIENTS WITH REFRACTORY TUMORS INCLUDING SARCOMAS
Jason Luke
Favorite
(P 440) CASE REPORT: COMPLETE CLINICAL AND MOLECULAR RESPONSE TO INTRATUMORAL STX-001, AN LNP-SELF REPLICATING MRNA EXPRESSING IL-12 IN A PATIENT WITH REFRACTORY ANGIOSARCOMA
Jason Luke
Favorite
Lu, Lin

Memorial Sloan Kettering Cancer Center
(P 273) RADIOMIC PREDICTORS OF SPONTANEOUS PNEUMOTHORAX DURING TYROSINE KINASE INHIBITOR THERAPY FOR LUNG METASTASES
Lin Lu
Favorite
Lum, Deirdre

Stanford University
(P 68) MULTI-OMIC INTRA- AND INTER-TUMOR HETEROGENEITY OF BENIGN SMOOTH MUSCLE TUMORS
Deirdre Lum
Favorite
Luna Hurtado, Hernán Camilo

Fundación Colombiana de Cancerología Clínica Vida
(P 219) RETROPERITONEAL SARCOMA: HEALTH SYSTEM BARRIERS AND THE RATIONALE FOR A SPECIALIZED SARCOMA UNIT
Hernán Camilo Luna Hurtado
Favorite
(P 301) RETROPERITONEAL SARCOMA: SINGLE CENTER EXPERIENCE IN LATIN AMERICA. DO WE HAVE DIFFERENT SARCOMAS WHEN COMPARED TO THE REST OF THE WORLD?
Hernán Camilo Luna Hurtado
Favorite
Luna-Ortiz, Kuauhyama

National Cancer Institute Mexico
(P 302) PREDICTORS AND OUTCOMES OF RECURRENT RETROPERITONEAL SARCOMA: A SINGLE-CENTER LATIN AMERICAN COHORT STUDY
Kuauhyama Luna-Ortiz
Favorite
Luna, Pablo

Hospital Universitari Son Espases
(P 71) GERMLINE POLYMORPHISMS IN THE VEGF PATHWAY AS PROGNOSTIC BIOMARKERS IN LOCALIZED HIGH-GRADE OSTEOSARCOMA: A STUDY BASED ON DATA FROM THE GEIS-33 PROTOCOL
Pablo Luna
Favorite
Lundin, Mia

University of Colorado Department of Orthopedics
(P 268) QUALITY OF LIFE OUTCOMES IN PEDIATRIC PATIENTS UNDERGOING SURGICAL INTERVENTION FOR LOWER EXTREMITY BONE SARCOMAS
Mia Lundin
Favorite
Lunec, John

Newcastle University
(P 133) INVESTIGATION OF COMBINING MDM2 INHIBITORS WITH DR5 AGONISTS FOR BONE SARCOMA TREATMENT
John Lunec
Favorite
Luo, Lixia

Duke University Medical Center
(P 58) PLK1 AS A VULNERABLE TARGET OF BAP1-DRIVEN UNDIFFERENTIATED PLEOMORPHIC SARCOMAS
Lixia Luo
Favorite
Luo, Tim

University of Calgary
(P 293) CRYOABLATION FOR EXTRA-ABDOMINAL DESMOID TUMORS: A RETROSPECTIVE STUDY OF RADIOLOGIC AND CLINICAL OUTCOMES
Tim Luo
Favorite
Luo, Wen

New York Medical College
(P 76) CD47 BLOCKADE SYNERGIZES WITH CHEMOTHERAPY IN ENHANCING MACROPHAGE PHAGOCYTOSIS OF EWING SARCOMA CELLS
Wen Luo
Favorite
Lu, Qiang

Deciphera Pharmaceuticals, LLC
(P 358) EFFECT OF A HIGH-FAT MEAL ON THE PHARMACOKINETICS (PK) OF VIMSELTINIB, AN ORAL INHIBITOR OF THE COLONY-STIMULATING FACTOR 1 RECEPTOR (CSF1R), IN HEALTHY PARTICIPANTS
Qiang Lu
Favorite
(P 376) EFFECT OF ITRACONAZOLE (ITZ) AND RABEPRAZOLE (RBP) ON THE PHARMACOKINETICS (PK) OF VIMSELTINIB, AN ORAL INHIBITOR OF THE COLONY-STIMULATING FACTOR 1 RECEPTOR, IN HEALTHY PARTICIPANTS
Qiang Lu
Favorite
Lurie, Eugene

Pyxis Oncology
(P 29) ANTI-TUMOR ACTIVITY OF MICVOTABART PELIDOTIN IS ASSOCIATED WITH ENZYME GENE EXPRESSION IN PATIENT-DERIVED XENOGRAFT SARCOMA MODELS
Eugene Lurie
Favorite
Lu, Sally

University of Florida
(P 401) LONG-TERM OUTCOMES OF IMATINIB-TREATED DERMATOFIBROSARCOMA PROTUBERANS: INSIGHTS FROM A SINGLE-INSTITUTION CASE SERIES
Sally Lu
Favorite
Luu, Thao

Deciphera Pharmaceuticals, LLC
(P 195) IMPACT OF EXPERT-LED EDUCATION PROGRAMS ON HEALTH CARE PROVIDER (HCP) KNOWLEDGE OF GASTROINTESTINAL STROMAL TUMOR (GIST)
Thao Luu
Favorite
Lv, Yu

Department of Orthopaedics, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
(P 07) A LIVING MULTI-OMICS BIOBANK OF PATIENT-DERIVED XENOGRAFT MODELS FOR SARCOMA
Yu Lv
Favorite
Lydon, Nicholas

IDRx
(P 194) UPDATED RESULTS FROM STRATEGIST 1: A PHASE 1/1B STUDY OF IDRX-42 (GSK6042981A) IN PATIENTS (PTS) WITH ADVANCED GASTROINTESTINAL STROMAL TUMORS (GIST)
Nicholas Lydon
Favorite
Lyssiotis, Costas

University of Michigan
(P 24) THE SIRTUIN SIRT5 SUPPORTS EWING SARCOMA SURVIVAL VIA REGULATION OF EWS-FLI1 STABILITY AND ACTIVITY
Costas Lyssiotis
Favorite
Lyu, Heather

MD Anderson Cancer Center
(P 351) THE ROLE OF SOCIOECONOMIC DISPARITIES ON SURVIVAL OUTCOMES IN MALIGNANT PERIPHERAL NERVE SHEATH TUMORS
Heather Lyu
Favorite
M
M. Pereira, Patricia

Instituto Português de Oncologia de Lisboa Francisco Gentil
(P 372) CLINICOPATHOLOGICAL FEATURES AND OUTCOMES OF PATIENTS WITH KAPOSI SARCOMA: A SINGLE CENTER RETROSPECTIVE REAL WORLD ANALYSIS
Patricia M. Pereira
Favorite
Mørk Petersen, Michael

Department of orthopedic surgery, Copenhagen University Hospital, Denmark
(P 246) CTLA4 PATHWAY ACTIVATION IN RADIATION-INDUCED ANGIOSARCOMA: A TRANSCRIPTOMIC RATIONALE FOR IMMUNE CHECKPOINT BLOCKADE
Michael Mørk Petersen
Favorite
(P 249) IN VITRO EXPANSION OF TUMOR-INFILTRATING GAMMA-DELTA T-CELLS FROM PATIENTS WITH SOFT TISSUE SARCOMAS
Michael Mørk Petersen
Favorite
Maccaroni, Elena

Department of Oncology, Azienda Ospedaliero-Universitaria delle Marche
(P 231) INCREASED LIFETIME RISK (LTR) OF SOFT TISSUE SARCOMAS (STS) IN PATIENTS WITH LOW-RISK GASTROINTESTINAL STROMAL TUMORS (GIST): A RETROSPECTIVE ANALYSIS FROM THE ITALIAN SARCOMA GROUP (ISG)
Elena Maccaroni
Favorite
MacDonald, Shannon

Southwest Florida Proton
(P 290) CLINICAL OUTCOMES AFTER RADIOTHERAPY FOR PATIENTS WITH POORLY DIFFERENTIATED CHORDOMA
Shannon MacDonald
Favorite
(P 461) A RETROSPECTIVE ANALYSIS OF PATIENTS WITH CONVENTIONAL CHORDOMA TREATED WITH SYSTEMIC THERAPY
Shannon MacDonald
Favorite
MacGregor, Peter

Huntsman Cancer Institute
(P 01) FEASIBILITY OF A QUANTITATIVE METHYLATION-BASED CTDNA ASSAY IN PATIENTS WITH ADVANCED SARCOMAS
Peter MacGregor
Favorite
Macierzynski, Agnieszka

Children's Cancer Institute
(P 11) ESTABLISHMENT, CHARACTERIZATION AND RESEARCH APPLICATION OF EIGHT NOVEL PATIENT-DERIVED OSTEOSARCOMA CELL LINES
Agnieszka Macierzynski
Favorite
Mackert, Gina

Department of Hand, Plastic and Reconstructive Surgery, Microsurgery, Burn Trauma Center, BG Trauma Center Ludwigshafen, University of Heidelberg, Ludwigshafen, 67071 Germany.
(P 454) TREATMENT PATTERNS AND OUTCOMES IN RADIATION-INDUCED SARCOMA: FIRST RESULTS OF THE TETRIS-PROJECT - A MULTIMODAL RETROSPECTIVE ANALYSIS FROM A TERTIARY CENTER
Gina Mackert
Favorite
Mack, Jennifer

Dana-Farber Cancer Institute
(P 228) FREQUENCY AND CLARITY OF SURGICAL GOALS FOR TUMOR RESECTION IN ADVANCED SARCOMA
Jennifer Mack
Favorite
Mack, Lloyd

Arthur Child Cancer Center/ University of Calgary
(P 293) CRYOABLATION FOR EXTRA-ABDOMINAL DESMOID TUMORS: A RETROSPECTIVE STUDY OF RADIOLOGIC AND CLINICAL OUTCOMES
Lloyd Mack
Favorite
MacQuarrie, Kyle

Northwestern University Feinberg School of Medicine/Ann & Robert H Lurie Children's Hospital of Chicago
(P 252) NUCLEAR AND GENOMIC ORGANIZATION OF CHEMOTHERAPY RESISTANT RHABDOMYOSARCOMA CELLS
Kyle MacQuarrie
Favorite
Madewell, John E.

The University of Texas MD Anderson Cancer Center
(P 311) A FOLLOW-UP STUDY ON THE NOVEL USE OF CONTRAST-ENHANCED SUSCEPTIBILITY-WEIGHTED IMAGING FOR EXTREMITY DESMOID FIBROMATOSIS RESPONSE ASSESSMENT
John E. Madewell
Favorite
(P 317) BUILDING A PRE-SURGICAL MULTIPARAMETRIC-MRI-BASED PREDICTIVE TREATMENT RESPONSE MODEL FOR UNDIFFERENTIATED PLEOMORPHIC SARCOMA TO REPLACE RECIST
John E. Madewell
Favorite
(P 334) MRI VOLUMETRIC AND MODIFIED CHOI-BASED ASSESSMENT OF TREATMENT RESPONSE IN EXTREMITY DESMOID TUMORS TREATED WITH NIROGACESTAT OR SORAFENIB
John E. Madewell
Favorite
(P 406) PILOT STUDY: CAN A MULTIPARAMETRIC MRI-DERIVED MODEL OUTPERFORM RECIST PREDICTING PATHOLOGY RESPONSE IN RHABDOMYOSARCOMA?
John E. Madewell
Favorite
(P 420) THE EFFECT OF CHEMOTHERAPY AND RADIOTHERAPY IN THE MULTIPARAMETRIC MRI-BASED ASSESSMENT OF TREATMENT RESPONSE IN EXTREMITY SOFT-TISSUE UNDIFFERENTIATED PLEOMORPHIC SARCOMA
John E. Madewell
Favorite
Madison, Cecelia

VA Informatics and Computing Infrastructure, VA Salt Lake City Health Care System
(P 364) TRENDS IN SURGICAL MANAGEMENT OF DESMOID TUMOR IN THE VETERANS AFFAIRS (VA) NATIONAL DATABASE
Cecelia Madison
Favorite
Ma, dongyang

Department of Anesthesiology, Peking University International Hospital
(P 305) COMPARISON OF GOAL-DIRECTED VERSUS EMPIRICAL TRANSFUSION MANAGEMENT IN PATIENTS WITH SEVERE HEMORRHAGE DURING RETROPERITONEAL TUMOR SURGERY
dongyang Ma
Favorite
Magagnoli, Giovanna

IRCCS Istituto Ortopedico Rizzoli
(P 139) IMMUNOGENOMIC PROFILING OF CHONDROSARCOMA REVEALS DISTINCT IMMUNE PHENOTYPES AND PROGNOSTIC MUTATIONS
Giovanna Magagnoli
Favorite
(P 151) SHOULD WE USE ADJUVANT CHEMOTHERAPY IN PATIENTS WITH LOCALIZED DEDIFFERENTIATED CHONDROSARCOMA (DDCS) OF THE PELVIS? AN ANALYSIS BY THE PELVIC DDCS STUDY GROUP
Giovanna Magagnoli
Favorite
Maganti, Manjula

Princess Margaret Cancer Centre
(P 346) SURROGATE ENDPOINTS FOR OVERALL SURVIVAL IN ADVANCED SOFT TISSUE SARCOMA TRIALS: A SYSTEMATIC REVIEW AND META-ANALYSIS
Manjula Maganti
Favorite
MAGNAN, MARIE CLAUDE

University of Toronto
(P 88) THE RAY CHALLENGE: HOW MANY RAY RESECTIONS CAN PATIENTS TOLERATE AND WHICH RAY RESECTIONS AFFECTS FUNCTIONAL OUTCOME THE MOST IN ORTHOPEDIC ONCOLOGY?
MARIE CLAUDE MAGNAN
Favorite
Magnelli, Anthony

Cleveland Clinic
(P 284) THE IMPACT OF SARCOMA SBRT ON THE IMMUNE SYSTEM: EARLY RESULTS FROM A PROSPECTIVE TRIAL
Anthony Magnelli
Favorite
Magrath, Justin

Tulane University
(P 47) EWSR1::WT1 FUSION ONCOPROTEIN ACTIVITY SHAPES LINEAGE HETEROGENEITY IN DESMOPLASTIC SMALL ROUND CELL TUMORS
Justin Magrath
Favorite
Maheshwari, Aryan

All India Institute of Medical Sciences, New Delhi
(P 276) RADIATION-INDUCED SARCOMA (RIS): CLINICAL SPECTRUM AND ONCOLOGIC OUTCOMES FROM A TERTIARY INDIAN SARCOMA CLINIC
Aryan Maheshwari
Favorite
Mahoney, Douglas

Arnie Charbonneau Cancer Institute and McCaig Institute for Bone and Joint Health
(P 238) INVESTIGATING HOW MACROPHAGES INFILTRATE THE TUMOUR MICROENVIRONMENT AND INFLUENCE THE EFFICACY OF CAR T THERAPY IN A MURINE MODEL OF STS
Douglas Mahoney
Favorite
(P 378) HIGH DOSE RADIATION THERAPY PROMOTES IMMUNE SUPPRESSIVE MACROPHAGE PHENOTYPES, WHEREAS LOW DOSE RADIATION THERAPY PROMOTES IMMUNOGENIC MACROPHAGE PHENOTYPES IN A MURINE MODEL OF SOFT TISSUE SARCOMA
Douglas Mahoney
Favorite
Mai Nørbak, Malene

Center for Genomic Medicine, Copenhagen University Hospital, Rigshospitalet
(P 05) CONCORDANCE OF GENOMIC ALTERATIONS WITH CIRCULATING TUMOR DNA: INITIAL FINDINGS FROM A PILOT STUDY
Malene Mai Nørbak
Favorite
Mailhot, Anne

University of Colorado School of Medicine
(P 234) DOXORUBICIN PLUS BOTENSILIMAB, A NEXT GENERATION CTLA4 INHIBITOR, WITH OR WITHOUT BALSTILIMAB, A PD1 INHIBITOR, IN PATIENTS WITH ADVANCED SOFT TISSUE SARCOMAS
Anne Mailhot
Favorite
Maioli, Margherita

IRCCS Rizzoli Orthopaedic Institute
(P 18) ESTABLISHMENT AND CHARACTERIZATION OF A NOVEL PRIMARY CELL LINE FROM A BONE METASTASIS OF OSTEOSARCOMA
Margherita Maioli
Favorite
Majercakova, Katarina

Hospital de la Santa Creu i Sant Pau
(P 383) MULTIDISCIPLINARY TREATMENT OF INGUINOSCROTAL SARCOMAS: ANALYSIS OF 39 CASES TREATED BY SURGICAL APPROACH
Katarina Majercakova
Favorite
MAKI, Robert

Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College
(P 187) THERAPEUTIC OUTCOMES IN NF1-ALTERED GIST TREATED WITH MEK INHIBITION: A SINGLE-CENTER EXPERIENCE
Robert MAKI
Favorite
(P 409) RETROSPECTIVE ANALYSIS OF PROGNOSTIC FACTORS INCLUDING HLA GENOTYPE IN MYXOID LIPOSARCOMA
Robert MAKI
Favorite
(P 467) TREATMENT OUTCOMES IN AGGRESSIVE ANGIOMYXOMA: A SINGLE INSTITUTION EXPERIENCE
Robert MAKI
Favorite
Makuła, Donata

Maria Sklodowska-Curie National Research Institute of Oncology; Warsaw Poland
(P 216) VIRTUAL MULTIDISCIPLINARY MEETINGS IN THE CARE OF SARCOMA PATIENTS
Donata Makuła
Favorite
Malchau, Erik

Institute of Clinical Scinces/Sahlgrenska Academy
(P 124) ISOLATED LIMB PERFUSION AS LIMB SALVAGING TREATMENT; A SINGLE CENTRE RETROSPECTIVE STUDY
Erik Malchau
Favorite
Maleddu, Alessandra

Department of Medicine, University of Colorado School of Medicine
(P 234) DOXORUBICIN PLUS BOTENSILIMAB, A NEXT GENERATION CTLA4 INHIBITOR, WITH OR WITHOUT BALSTILIMAB, A PD1 INHIBITOR, IN PATIENTS WITH ADVANCED SOFT TISSUE SARCOMAS
Alessandra Maleddu
Favorite
(P 424) AN OPEN-LABEL PHASE 1/2 STUDY OF DCC-3009 MONOTHERAPY IN PATIENTS (PTS) WITH ADVANCED GASTROINTESTINAL STROMAL TUMOR (GIST)
Alessandra Maleddu
Favorite
Malinowska, Natalia

Maria Sklodowska-Curie National Research Institute of Oncology
(P 164) LONG TERM OUTCOMES IN PATIENTS DIAGNOSED WITH SECONDARY CHONDROSARCOMA
Natalia Malinowska
Favorite
Malinowski, Alexandra

Cogent Biosciences
(P 425) BEZUCLASTINIB EXPANDED ACCESS PROGRAM (EAP) FOR PATIENTS WITH GASTROINTESTINAL STROMAL TUMORS (GIST)
Alexandra Malinowski
Favorite
Malkin, David

The Hospital for Sick Children
(P 73) TARGETABLE GENE DEPENDENCIES IN EWING SARCOMA SUBTYPES
David Malkin
Favorite
Malli, Shashwath Kalladi

Dept. of Surgery, Moores Cancer Center, University of California San Diego
(P 197) DIFFERENTIAL EFFECTS OF ANAGRELIDE IN GASTROINTESTINAL STROMAL TUMORS (GIST) IN VITRO
Shashwath Kalladi Malli
Favorite
Malogolowkin, Marcio

University of California, Davis
(P 77) BARRIERS TO GUIDELINE CONCORDANT CARE IN AYA PATIENTS WITH BONE SARCOMAS
Marcio Malogolowkin
Favorite
Mamede, Isadora

Federal University of São João del Rei, Divinópolis, Brazil
(P 404) OUTCOMES OF NEOADJUVANT THERAPY IN ANGIOSARCOMA PATIENTS: A KAPLAN-MEIER-RECONSTRUCTED INDIVIDUAL PATIENT-LEVEL META-ANALYSIS
Isadora Mamede
Favorite
Manalo, Zoe

University of Miami
(P 462) HDAC INHIBITORS AS POTENTIAL SFT THERAPIES
Zoe Manalo
Favorite
Mandel, Gabriel

Cleveland Clinic
(P 10) COLLATERAL SENSITIVIES EMERGE DURING THE EVOLUTION OF CHEMORESISTANCE TO MAP CHEMOTHERAPY IN OSTEOSARCOMA
Gabriel Mandel
Favorite
Mangla, Ankit

Case Comprehensive Cancer Center
(P 430) A PH/2 STUDY OF THE RADIOPHARMACEUTICAL [AC-225]RTX-2358 IN THE TREATMENT OF RELAPSED / REFRACTORY (R/R) SOFT TISSUE SARCOMA (STS) THE ATLAS STUDY - ACTINIUM THERAPY FOR LATE-STAGE AGGRESSIVE SARCOMAS
Ankit Mangla
Favorite
Mangray, Shamlal

Nationwide Children's Hospital
(P 377) GERMLINE RECQL4 VARIANT IN A PEDIATRIC PATIENT WITH EWING SARCOMA AND DESMOID FIBROMATOSIS
Shamlal Mangray
Favorite
Manion, Elizabeth

University of Kansas Medical Center
(P 366) WOUND COMPLICATIONS AFTER ULTRA-HYPOFRACTIONATED NEOADJUVANT RADIATION FOR SOFT TISSUE SARCOMA: WHAT IS OPTIMAL SURGICAL TIMING?
Elizabeth Manion
Favorite
Manish, Agarwal

Nanavati Max Super Speciality Hospital / Hinduja Hospital
(P 151) SHOULD WE USE ADJUVANT CHEMOTHERAPY IN PATIENTS WITH LOCALIZED DEDIFFERENTIATED CHONDROSARCOMA (DDCS) OF THE PELVIS? AN ANALYSIS BY THE PELVIC DDCS STUDY GROUP
Agarwal Manish
Favorite
Manjali, Jifmi

Tata Memorial Hospital
(P 286) INTERSTITIAL BRACHYTHERAPY FOR ORGAN AND FUNCTION PRESERVATION IN SOFT TISSUE SARCOMAS: LONG TERM OUTCOMES
Jifmi Manjali
Favorite
(P 292) CRANIOVERTEBRAL EWINGS SARCOMA WITH MENINGEAL INFILTRATION - A CLINICAL OUTCOME ANALYSIS
Jifmi Manjali
Favorite
(P 304) MANAGEMENT OF RECURRENT RETROPERITONEAL SARCOMAS: A RETROSPECTIVE STUDY FROM A TERTIARY CANCER CENTER.
Jifmi Manjali
Favorite
(P 387) TREATMENT PATTERNS AND PROGNOSTIC FACTORS IN LOCALISED SYNOVIAL SARCOMA: A RETROSPECTIVE STUDY FROM A TERTIARY CANCER CENTRE IN INDIA
Jifmi Manjali
Favorite
(P 438) RANDOMIZED, OPEN-LABEL, PHASE III TRIAL OF ADJUVANT CHEMOTHERAPY VERSUS OBSERVATION IN NON-METASTATIC, HIGH-RISK SOFT TISSUE SARCOMAS (ACO-SARC TRIAL)
Jifmi Manjali
Favorite
Mann, Gary

Roswell Park Comprehensive Cancer Center
(P 340) PREDICTORS OF LATE RECURRENCE AFTER SARCOMA SURGICAL RESECTION
Gary Mann
Favorite
Manzano, Aranzazu

HOSPITAL CLINIO SAN CARLOS
(P 445) TEADES PH1/2 STUDY WITH ODM-212: PRELIMINARY RESULTS IN EHE PATIENTS
Aranzazu Manzano
Favorite
Mao, Jie

Children's Cancer Institute
(P 11) ESTABLISHMENT, CHARACTERIZATION AND RESEARCH APPLICATION OF EIGHT NOVEL PATIENT-DERIVED OSTEOSARCOMA CELL LINES
Jie Mao
Favorite
Maoz, Myriam

Oncology Department, Sharett Institute for Oncology, Hadassah Medical Center & Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel
(P 06) RAPID, POINT-OF-CARE DNA METHYLATION & MOLECULAR LANDSCAPE BASED SARCOMA CLASSIFICATION
Myriam Maoz
Favorite
Maple, Ellen

Children's Hospital of Philadelphia
(P 262) EVALUATING FRONT-LINE THERAPY ACCORDANCE WITH CURRENT SYNOVIAL SARCOMA GUIDELINES
Ellen Maple
Favorite
(P 263) DESCRIBING THE CHARACTERISTICS AND TREATMENT OF SYNOVIAL SARCOMA IN THE RECURRENT SETTING
Ellen Maple
Favorite
Mar, Damon

University of Kansas School of Medicine
(P 359) EVALUATION OF PREOPERATIVE MYXOFIBROSARCOMA GROWTH AND SURGICAL MORBIDITY AFTER NEOADJUVANT RADIATION USING SEMI-AUTOMATED VOLUMETRIC ANALYSIS
Damon Mar
Favorite
(P 382) METHOD FOR VOLUMETRIC ASSESMENT OF TUMOR RESPONSE FOLLOWING NEOADJUVANT RADIATION IN PRIMARY MYXOFIBROSARCOMA
Damon Mar
Favorite
Mariuk-Jarema, Ann

Maria Sklodowska-Curie National Research Institute of Oncology
(P 470) OFF-LABEL TREATMENT AND ULTRARARE SARCOMAS - SINGLE INSTITUTION REPORT
Ann Mariuk-Jarema
Favorite
Marquez-Gaffaro, Gloria

Hospital Universitario Fundación Jiménez Díaz
(P 389) UNRESECTABLE AND METASTATIC DEDIFFERENTIATED LIPOSARCOMA (DDLPS): INSIGHTS FROM A MULTICENTER REAL-WORLD COHORT (RWC)
Gloria Marquez-Gaffaro
Favorite
Marquez, John Patrick

Department of Orthopaedic surgery, Seoul National University Hospital
(P 09) ESTABLISHMENT AND CHARACTERIZATION OF 18 SARCOMA CELL LINES: UNRAVELING THE MOLECULAR MECHANISMS OF DOXORUBICIN RESISTANCE IN SARCOMA CELL LINES
John Patrick Marquez
Favorite
(P 399) LATE LOCAL RECURRENCE (>5YEARS) OF SOFT TISSUE SARCOMA OF THE EXTREMITIES AND TRUNK WALL: PREDICTIVE FACTORS AND ONCOLOGIC OUTCOMES
John Patrick Marquez
Favorite
Marquina-Ospina, Gloria

Hospital Clinico San Carlos. Department of Medical Oncology
(P 389) UNRESECTABLE AND METASTATIC DEDIFFERENTIATED LIPOSARCOMA (DDLPS): INSIGHTS FROM A MULTICENTER REAL-WORLD COHORT (RWC)
Gloria Marquina-Ospina
Favorite
Marritt, Kayla

University of Saskatchewan
(P 395) ERIBULIN IN RECURRENT PRETREATED METASTATIC SOFT TISSUE SARCOMA. A CANADIAN SARCOMA RESEARCH AND CLINICAL COLLABORATION (CANSARCC) REAL WORLD ANALYSIS
Kayla Marritt
Favorite
Martín-Broto, Javier

Fundación Jiménez Díaz University Hospital
(P 38) VALIDATION OF THE SIGNIOS SEVEN-GENE SIGNATURE FOR PREDICTING ANTI-PD-1 INHIBITOR EFFICACY IN SARCOMA
Javier Martín-Broto
Favorite
(P 71) GERMLINE POLYMORPHISMS IN THE VEGF PATHWAY AS PROGNOSTIC BIOMARKERS IN LOCALIZED HIGH-GRADE OSTEOSARCOMA: A STUDY BASED ON DATA FROM THE GEIS-33 PROTOCOL
Javier Martín-Broto
Favorite
(P 315) ANALYSIS OF CHANGES IN T2-WEIGHTED SIGNAL INTENSITY AND TUMOR VOLUME AND EXPOSURE-RESPONSE IN THE RINGSIDE PHASE 2 STUDY OF VAREGACESTAT FOR DESMOID TUMORS
Javier Martín-Broto
Favorite
(P 407) PIMICOTINIB IN TENOSYNOVIAL GIANT CELL TUMOR (TGCT): LONG-TERM EFFICACY, SAFETY, AND PATIENT-REPORTED OUTCOMES FROM THE PHASE 3 MANEUVER STUDY
Javier Martín-Broto
Favorite
(P 410) SUBGROUP ANALYSIS OF THE PHASE 2 PART OF THE RINGSIDE PHASE 2/3 TRIAL OF VAREGACESTAT FOR TREATMENT OF DESMOID TUMORS
Javier Martín-Broto
Favorite
Martin, Camino Ruano San

A*STAR Bioinformatics Institute (BII)
(P 53) ESTABLISHMENT AND CHARACTERISATION OF LIPOSARCOMA-DERIVED CELLS AS RELEVANT PRE-CLINICAL MODELS FOR TARGET DISCOVERY
Camino Ruano San Martin
Favorite
Martin, Dana

Cogent Biosciences
(P 425) BEZUCLASTINIB EXPANDED ACCESS PROGRAM (EAP) FOR PATIENTS WITH GASTROINTESTINAL STROMAL TUMORS (GIST)
Dana Martin
Favorite
Martínez-Bernal, Gala

Hospital Universitario Virgen del Rocio
(P 115) SINGLE-CENTER EXPERIENCE WITH TYROSIN KINASA INHIBITORS IN ADVANCED BONE SARCOMA: EFFICACY AND SAFETY OUTCOMES
Gala Martínez-Bernal
Favorite
(P 321) COMPARATIVE ANALYSIS OF FIRST-LINE DOXORUBICIN-BASED COMBINATION REGIMENS IN METASTATIC LEIOMYOSARCOMA: IMPACT ON SURVIVAL AND DISEASE CONTROL
Gala Martínez-Bernal
Favorite
(P 389) UNRESECTABLE AND METASTATIC DEDIFFERENTIATED LIPOSARCOMA (DDLPS): INSIGHTS FROM A MULTICENTER REAL-WORLD COHORT (RWC)
Gala Martínez-Bernal
Favorite
Martinez, Daniel

1.University of Miami , Miller School of Medicine, Department of Orthopedic Surgery
(P 31) TARGETING CANCER STEM CELLS BY TYROSINE PEPTIDE ANALOGUE IN REFRACTORY SARCOMA
Daniel Martinez
Favorite
Martinez-Garcia, Jeronimo

Hospital Universitario Virgen de la Arrixaca
(P 71) GERMLINE POLYMORPHISMS IN THE VEGF PATHWAY AS PROGNOSTIC BIOMARKERS IN LOCALIZED HIGH-GRADE OSTEOSARCOMA: A STUDY BASED ON DATA FROM THE GEIS-33 PROTOCOL
Jeronimo Martinez-Garcia
Favorite
Martinez, Jeronimo

Hospital Universitario Virgen de la Arrixaca
(P 389) UNRESECTABLE AND METASTATIC DEDIFFERENTIATED LIPOSARCOMA (DDLPS): INSIGHTS FROM A MULTICENTER REAL-WORLD COHORT (RWC)
Jeronimo Martinez
Favorite
Martinez-Trufero, Javier

Hospital Universitario Miguel Servet
(P 71) GERMLINE POLYMORPHISMS IN THE VEGF PATHWAY AS PROGNOSTIC BIOMARKERS IN LOCALIZED HIGH-GRADE OSTEOSARCOMA: A STUDY BASED ON DATA FROM THE GEIS-33 PROTOCOL
Javier Martinez-Trufero
Favorite
(P 389) UNRESECTABLE AND METASTATIC DEDIFFERENTIATED LIPOSARCOMA (DDLPS): INSIGHTS FROM A MULTICENTER REAL-WORLD COHORT (RWC)
Javier Martinez-Trufero
Favorite
Martin, John

Rush University School of Medicine
(P 138) A MULTI-INSTITUTIONAL ARCHIVE AND DEEP LEARNING PIPELINE FOR QUANTIFYING CHONDROSARCOMA COMPOSITION
John Martin
Favorite
(P 177) DEEP LEARNING AND DIMENSIONALITY REDUCTION FOR SARCOMA SUBTYPING
John Martin
Favorite
Martin, Olivia

Roswell Park Comprehensive Cancer Center
(P 340) PREDICTORS OF LATE RECURRENCE AFTER SARCOMA SURGICAL RESECTION
Olivia Martin
Favorite
Martinuzzi, Arianna

IRCCS Rizzoli Orthopaedic Institute
(P 18) ESTABLISHMENT AND CHARACTERIZATION OF A NOVEL PRIMARY CELL LINE FROM A BONE METASTASIS OF OSTEOSARCOMA
Arianna Martinuzzi
Favorite
Marwa, Billal

Division of Medical Oncology, Saskatchewan Cancer Agency, Saskatoon, Saskatchewan, Canada
(P 395) ERIBULIN IN RECURRENT PRETREATED METASTATIC SOFT TISSUE SARCOMA. A CANADIAN SARCOMA RESEARCH AND CLINICAL COLLABORATION (CANSARCC) REAL WORLD ANALYSIS
Billal Marwa
Favorite
Mascarenhas, Leo

Cedars-Sinai Medical Center
(P 417) EFFICACY AND SAFETY OF LAROTRECTINIB (LARO) IN PATIENTS (PTS) WITH TRK FUSION SARCOMAS
Leo Mascarenhas
Favorite
Mascherini, Matteo

IRCCS Ospedale Policlinico San Martino
(P 328) INNOVATING SARCOMA EDUCATION: EARLY OUTCOMES OF THE ITALIAN SOCIETY OF SURGICAL ONCOLOGY (SICO) SARCOMA SOCIAL MULTI-PLATFORM JOURNAL CLUB INITIATIVE
Matteo Mascherini
Favorite
Massa, Giacomo

Fondazione IRCCS Istituto Nazionale dei Tumori di Milano
(P 447) PAIN ASSESSMENT CRITERIA (PAC) ANTICIPATE RECIST PROGRESSION AND CORRELATE WITH BLOOD LEVELS OF GROWTH DIFFERENTIATION FACTOR 15 (GDF15) IN EPITHELIOID HEMANGIOENDOTHELIOMA (EHE)
Giacomo Massa
Favorite
Matarangas, Ariana

Duke University
(P 125) TARGETING LCP1-MEDIATED METASTASIS IN CHONDROSARCOMA WITH OROXYLIN A
Ariana Matarangas
Favorite
(P 130) INVESTIGATING LCP1-MEDIATED ONCOGENIC SIGNALING IN CHONDROSARCOMA METASTASIS
Ariana Matarangas
Favorite
(P 214) FINANCIAL TOXICITY IN PATIENTS WITH A HISTORY OF EXTREMITY AND PELVIC SARCOMA TREATMENT
Ariana Matarangas
Favorite
Matin, Bahar

Clinical Pharmacology, IDRx
(P 194) UPDATED RESULTS FROM STRATEGIST 1: A PHASE 1/1B STUDY OF IDRX-42 (GSK6042981A) IN PATIENTS (PTS) WITH ADVANCED GASTROINTESTINAL STROMAL TUMORS (GIST)
Bahar Matin
Favorite
Matsumoto, Koji

Hyogo Cancer Center
(P 192) OPTIMAL DOSING SCHEDULE OF SUNITINIB BASED ON PLATELET COUNT IN AN OLDER PATIENT WITH GASTROINTESTINAL STROMAL TUMOR
Koji Matsumoto
Favorite
Mattei, Jean Camille

APHM and Hôpital Européen Marseille
(P 151) SHOULD WE USE ADJUVANT CHEMOTHERAPY IN PATIENTS WITH LOCALIZED DEDIFFERENTIATED CHONDROSARCOMA (DDCS) OF THE PELVIS? AN ANALYSIS BY THE PELVIC DDCS STUDY GROUP
Jean Camille Mattei
Favorite
Matyas, John

Arnie Charbonneau Cancer Institute and McCaig Institute for Bone and Joint Health
(P 238) INVESTIGATING HOW MACROPHAGES INFILTRATE THE TUMOUR MICROENVIRONMENT AND INFLUENCE THE EFFICACY OF CAR T THERAPY IN A MURINE MODEL OF STS
John Matyas
Favorite
(P 378) HIGH DOSE RADIATION THERAPY PROMOTES IMMUNE SUPPRESSIVE MACROPHAGE PHENOTYPES, WHEREAS LOW DOSE RADIATION THERAPY PROMOTES IMMUNOGENIC MACROPHAGE PHENOTYPES IN A MURINE MODEL OF SOFT TISSUE SARCOMA
John Matyas
Favorite
Mauguen, Audrey

Memorial Sloan Kettering Cancer Center
(P 273) RADIOMIC PREDICTORS OF SPONTANEOUS PNEUMOTHORAX DURING TYROSINE KINASE INHIBITOR THERAPY FOR LUNG METASTASES
Audrey Mauguen
Favorite
Ma, Xinyi

Duke University
(P 126) SINGLE-CELL RNA SEQUENCING AND PROTEOMIC SPATIAL PROFILING REVEAL COMPLEX TUMOR MICROENVIRONMENT AND NOVEL IMMUNE INTERACTIONS IN CHONDROSARCOMA
Xinyi Ma
Favorite
Ma, Yan

Duke University Medical Center
(P 58) PLK1 AS A VULNERABLE TARGET OF BAP1-DRIVEN UNDIFFERENTIATED PLEOMORPHIC SARCOMAS
Yan Ma
Favorite
May, Dalit

Shaare Zedek Medical Center
(P 326) GERMLINE POT1 MUTATIONS IN ANGIOSARCOMA DIFFER FROM SOMATIC MUTATIONS
Dalit May
Favorite
Mayerson, Joel

Ohio State University
(P 84) A MULTICENTER COMPARISON OF REVERSE TOTAL SHOULDER ARTHROPLASTY VERSUS HEMIARTHROPLASTY FOR ENDOPROSTHETIC RECONSTRUCTION FOLLOWING ONCOLOGIC RESECTION OF THE PROXIMAL HUMERUS
Joel Mayerson
Favorite
(P 153) DOES THE QUANTITY OF DEDIFFERENTIATION MATTER IN THE CLINICAL OUTCOMES OF DEDIFFERENTIATED CHONDROSARCOMA? A 10-YEAR SINGLE TERTIARY INSTITUTIONAL EXPERIENCE OF A SERIES.
Joel Mayerson
Favorite
(P 161) CLINICAL CHARACTERISTICS, PATTERNS OF CARE, AND TREATMENT OUTCOMES OF CHONDROSARCOMA: A SINGLE-INSTITUTIONAL EXPERIENCE
Joel Mayerson
Favorite
(P 221) QUALITATIVE ANALYSIS OF THE PERIOPERATIVE EXPERIENCE OF YOUNG ADULT PATIENTS UNDERGOING EXTREMITY SARCOMA SURGERY
Joel Mayerson
Favorite
Mazcko, Christina

National Institutes of Health
(P 258) INVESTIGATING THE ROLE OF ALVEOLAR PNEUMOCYTES IN THE LUNG MICROENVIRONMENT OF OSTEOSARCOMA METASTASES
Christina Mazcko
Favorite
Mazzocca, Alessandro

Fondazione Policlinico Universitario Campus Bio-Medico
(P 61) HER2 TARGETING IN CHORDOMA: PRECLINICAL INSIGHTS ON TRASTUZUMAB DERUXTECAN
Alessandro Mazzocca
Favorite
Mazzocca, Alessandro

UNIVERSITA' CAMPUS BIO-MEDICO ROMA
(P 412) UNCOVERING HER2 OVEREXPRESSION IN SOFT TISSUE SARCOMAS (STS): INSIGHTS FROM THE CANCER GENOME ATLAS (TCGA)
Alessandro Mazzocca
Favorite
Mazzocca, Alessandro

Fondazione Policlinico Universitario Campus Bio-Medico
(P 458) BETWEEN LYMPHOMAS AND SARCOMAS: A RETROSPECTIVE, MULTI-INSTITUTIONAL STUDY FROM THE ITALIAN SARCOMA GROUP (ISG) ON HISTIOCYTIC AND DENDRITIC CELL NEOPLASMS (HDCN)
Alessandro Mazzocca
Favorite
McAlearney, Ann

The Ohio State University
(P 221) QUALITATIVE ANALYSIS OF THE PERIOPERATIVE EXPERIENCE OF YOUNG ADULT PATIENTS UNDERGOING EXTREMITY SARCOMA SURGERY
Ann McAlearney
Favorite
McAlpine, Cheryl

Adaptimmune
(P 247) SINGLE-CELL RNA SEQUENCING OF AFAMITRESGENE AUTOLEUCEL INDICATES MECHANISMS OF PERSISTENCE AND ANTI-TUMOR ACTIVITY
Cheryl McAlpine
Favorite
Mcavoy, Devin

Memorial Sloan Kettering Cancer Center
(P 421) CHARACTERIZING THE IMMUNE RESPONSE TO INTRATUMORAL TIGILANOL TIGLATE (TT) IN PATIENTS WITH ADVANCED AND/OR METASTATIC SOFT TISSUE SARCOMA (STS) IN A PHASE IIA TRIAL (NCT05755113)
Devin Mcavoy
Favorite
McCaw, Nicole

University of Colorado School of Medicine
(P 268) QUALITY OF LIFE OUTCOMES IN PEDIATRIC PATIENTS UNDERGOING SURGICAL INTERVENTION FOR LOWER EXTREMITY BONE SARCOMAS
Nicole McCaw
Favorite
McCutcheon, Ian

MD Anderson Cancer Center
(P 351) THE ROLE OF SOCIOECONOMIC DISPARITIES ON SURVIVAL OUTCOMES IN MALIGNANT PERIPHERAL NERVE SHEATH TUMORS
Ian McCutcheon
Favorite
McEachron, Troy

National Institutes of Health
(P 258) INVESTIGATING THE ROLE OF ALVEOLAR PNEUMOCYTES IN THE LUNG MICROENVIRONMENT OF OSTEOSARCOMA METASTASES
Troy McEachron
Favorite
McFadden, Andrew

University of British Columbia
(P 178) TREATMENT RESPONSE AND SURVIVAL OUTCOMES IN GASTROINTESTINAL STROMAL TUMORS FOLLOWING NEOADJUVANT THERAPY
Andrew McFadden
Favorite
McGee, Lauren

National Institutes of Health
(P 258) INVESTIGATING THE ROLE OF ALVEOLAR PNEUMOCYTES IN THE LUNG MICROENVIRONMENT OF OSTEOSARCOMA METASTASES
Lauren McGee
Favorite
McGough, Richard

University of Pittsburgh Medical Center
(P 63) EVALUATING SURGICAL MARGINS IN SARCOMA RESECTION WITH INDOCYANINE GREEN FLUORESCENCE IMAGING
Richard McGough
Favorite
McKenzie, Laurie

University of Texas MD Anderson Cancer Center
(P 442) TRIAL IN PROGRESS: A SINGLE-ARM, OPEN-LABEL PHASE 4 TRIAL OF NIROGACESTAT IN ADULT PREMENOPAUSAL FEMALES WITH DESMOID TUMORS
Laurie McKenzie
Favorite
McKinney, Caleb

University of Virginia
(P 199) CHARACTERISTICS OF AN IMMUNOHISTOCHEMICAL AND MOLECULARLY DISCORDANT POPULATION OF GIST PATIENTS: A SINGLE CENTER RETROSPECTIVE REVIEW
Caleb McKinney
Favorite
McManus, Jeanine

Dana-Farber Cancer Institute
(P 427) PHASE 1/2 TRIAL TO EVALUATE THE SAFETY AND EFFICACY OF PEEL-224 IN COMBINATION WITH VINCRISTINE AND TEMOZOLOMIDE IN ADOLESCENTS AND YOUNG ADULTS WITH RELAPSED OR REFRACTORY SARCOMAS
Jeanine McManus
Favorite
Meade, Julia

UPMC Children’s Hospital of Pittsburgh
(P 48) PRECLINICAL ACTIVITY OF MEK INHIBITION IN COMBINATION WITH CHEMOTHERAPY IN MALIGNANT PERIPHERAL NERVE SHEATH TUMOR
Julia Meade
Favorite
Mebrahtu, Aron

Duke University School of Medicine
(P 125) TARGETING LCP1-MEDIATED METASTASIS IN CHONDROSARCOMA WITH OROXYLIN A
Aron Mebrahtu
Favorite
(P 126) SINGLE-CELL RNA SEQUENCING AND PROTEOMIC SPATIAL PROFILING REVEAL COMPLEX TUMOR MICROENVIRONMENT AND NOVEL IMMUNE INTERACTIONS IN CHONDROSARCOMA
Aron Mebrahtu
Favorite
(P 130) INVESTIGATING LCP1-MEDIATED ONCOGENIC SIGNALING IN CHONDROSARCOMA METASTASIS
Aron Mebrahtu
Favorite
Meijer, Debora

Leiden University Medical Center
(P 127) AN INTEGRATED CLINICAL GENOMIC AND TRANSCRIPTOMIC SUBGROUPING OF CENTRAL CHONDROSARCOMA
Debora Meijer
Favorite
Melendez-Fernandez, Ana

National Cancer Institute Mexico
(P 302) PREDICTORS AND OUTCOMES OF RECURRENT RETROPERITONEAL SARCOMA: A SINGLE-CENTER LATIN AMERICAN COHORT STUDY
Ana Melendez-Fernandez
Favorite
Melissa, Gosdin

University of California Davis School of Medicine
(P 77) BARRIERS TO GUIDELINE CONCORDANT CARE IN AYA PATIENTS WITH BONE SARCOMAS
Gosdin Melissa
Favorite
Mendez-Gomez, Hector

University of Florida
(P 248) AN EX VIVO ASSAY TO PREDICT IMMUNOTHERAPY RESPONSE IN SARCOMA
Hector Mendez-Gomez
Favorite
(P 426) A PHASE I/II TRIAL USING RNA LIPID NANOPARTICLES FOR RECURRENT OSTEOSARCOMA: A REPORT FROM THE NATIONAL PEDIATRIC CANCER FOUNDATION
Hector Mendez-Gomez
Favorite
Mendez-Pino, Eduardo

Mass General Brigham
(P 87) ACUTE PATHOLOGICAL LONG BONE FRACTURES: WEEKEND VERSUS WEEKDAY VARIATIONS AND THEIR CLINICAL IMPACT
Eduardo Mendez-Pino
Favorite
Menge, Franka

Sarcoma Unit, Department of Surgery, University Medical Centre Mannheim, Medical Faculty Mannheim, Heidelberg University
(P 165) EVALUATING LARGE LANGUAGE MODELS AS DECISION SUPPORT TOOLS IN MULTIDISCIPLINARY TUMOR BOARDS FOR GASTROINTESTINAL STROMAL TUMORS
Franka Menge
Favorite
(P 204) ANALYSIS OF QUALITY INDICATORS OF SOFT TISSUE SARCOMA TREATMENT WITH CANCER REGISTRY DATA IN GERMANY 2015-2021
Franka Menge
Favorite
(P 303) MULTIVISCERAL RESECTIONS AND URINARY TRACT RECONSTRUCTION TECHNIQUES IN THE SURGERY OF RETROPERITONEAL SARCOMAS: A CASE SERIES.
Franka Menge
Favorite
(P 312) APOSST: A PROSPECTIVE TRIAL TO EVALUATE ACUPUNCTURE AFTER SURGERY OF EXTREMITY SOFT TISSUE TUMORS
Franka Menge
Favorite
(P 367) ADHERENCE TO GERMAN SARCOMA GUIDELINE FOR MRI SEQUENCING IN SOFT TISSUE SARCOMA: EVALUATION OF IMAGING PRACTICES AND COMPLIANCE
Franka Menge
Favorite
(P 441) COLOSARC-Q: A PROSPECTIVE MULTICENTER STUDY FOR EVALUATING SURGICAL STRATEGIES FOR COLORECTAL RESECTIONS AND POSTOPERATIVE QUALITY OF LIFE IN RETROPERITONEAL SARCOMA PATIENTS
Franka Menge
Favorite
(P 454) TREATMENT PATTERNS AND OUTCOMES IN RADIATION-INDUCED SARCOMA: FIRST RESULTS OF THE TETRIS-PROJECT - A MULTIMODAL RETROSPECTIVE ANALYSIS FROM A TERTIARY CENTER
Franka Menge
Favorite
Menzies, Alexander

Melanoma Institute Australia, The University of Sydney
(P 433) PHASE I DOSE ESCALATION TRIAL OF STX-001, AN LNP SELF-REPLICATING MRNA EXPRESSING IL-12, IN PATIENTS WITH REFRACTORY TUMORS INCLUDING SARCOMAS
Alexander Menzies
Favorite
Mercatali, Laura

IRCCS Rizzoli Orthopaedic Institute
(P 18) ESTABLISHMENT AND CHARACTERIZATION OF A NOVEL PRIMARY CELL LINE FROM A BONE METASTASIS OF OSTEOSARCOMA
Laura Mercatali
Favorite
Merchant, Nipun

University of Miami Hospital, Department of Surgical Oncology
(P 201) METASTATIC PATTERNS, TREATMENT MODALITIES, AND OVERALL SURVIVAL IN OLIGOMETASTATIC GIST: A SINGLE-CENTER RETROSPECTIVE STUDY
Nipun Merchant
Favorite
Merks, Johannes

University Medical Center Utrecht
(P 250) OUTCOME OF INFANTS WITH RHABDOMYOSARCOMA: A REPORT FROM THE INTERNATIONAL SOFT TISSUE SARCOMA CONSORTIUM
Johannes Merks
Favorite
Merlini, Alessandra

University Hospital S. Luigi Gonzaga
(P 231) INCREASED LIFETIME RISK (LTR) OF SOFT TISSUE SARCOMAS (STS) IN PATIENTS WITH LOW-RISK GASTROINTESTINAL STROMAL TUMORS (GIST): A RETROSPECTIVE ANALYSIS FROM THE ITALIAN SARCOMA GROUP (ISG)
Alessandra Merlini
Favorite
(P 458) BETWEEN LYMPHOMAS AND SARCOMAS: A RETROSPECTIVE, MULTI-INSTITUTIONAL STUDY FROM THE ITALIAN SARCOMA GROUP (ISG) ON HISTIOCYTIC AND DENDRITIC CELL NEOPLASMS (HDCN)
Alessandra Merlini
Favorite
Merriam, Priscilla

Dana-Farber Cancer Institute
(P 235) AGNOSTIC INDICATION OF IMMUNE CHECKPOINT INHIBITORS (ICI): PATTERNS OF RESPONSE OF SARCOMAS
Priscilla Merriam
Favorite
Merrill, Morgan

Seattle Children's Research Institute
(P 260) MECHANISM AND EFFICACY OF ANTHRACYCLINE MEDIATED EPIGENETIC DISRUPTION IN BONE SARCOMAS.
Morgan Merrill
Favorite
Merritt, Ainsley

University of Texas Southwestern Medical School
(P 280) PERSONALIZED ULTRA-FRACTIONATED STEREOTACTIC ADAPTIVE RADIOTHERAPY (PULSAR) FOR ADULT AND PEDIATRIC SARCOMAS
Ainsley Merritt
Favorite
Mesko, Nathan

Cleveland Clinic
(P 84) A MULTICENTER COMPARISON OF REVERSE TOTAL SHOULDER ARTHROPLASTY VERSUS HEMIARTHROPLASTY FOR ENDOPROSTHETIC RECONSTRUCTION FOLLOWING ONCOLOGIC RESECTION OF THE PROXIMAL HUMERUS
Nathan Mesko
Favorite
(P 220) THE IMPACT OF WOUND HEALING COMPLICATIONS ON PATIENT-REPORTED OUTCOMES FOLLOWING SOFT TISSUE SARCOMA SURGERY
Nathan Mesko
Favorite
(P 222) DO WE ALL SEE IT THE SAME: AN INTER-RATER RELIABILITY ANALYSIS OF THE MUSCULOSKELETAL TUMOR REGISTRY DATA ELEMENTS
Nathan Mesko
Favorite
(P 284) THE IMPACT OF SARCOMA SBRT ON THE IMMUNE SYSTEM: EARLY RESULTS FROM A PROSPECTIVE TRIAL
Nathan Mesko
Favorite
(P 316) AREA DEPRIVATION INDEX (ADI) AND OUTCOMES IN LOCALIZED SOFT TISSUE SARCOMA: DO SOCIAL DETERMINANTS INFLUENCE SURVIVAL?
Nathan Mesko
Favorite
(P 345) SARCOMA BIOPSY COMPARISON BETWEEN REFERRAL CENTERS AND TREATING CENTERS: THE MUSCULOSKELETAL TUMOR REGISTRY (MSTR) EXPERIENCE
Nathan Mesko
Favorite
(P 355) CLASSIFYING WOUND HEALING COMPLICATIONS IN SURGICALLY TREATED EXTREMITY SOFT TISSUE SARCOMA
Nathan Mesko
Favorite
MESQUIDA LUQUE, NEUS

HOSPITAL SON LLATZER
(P 321) COMPARATIVE ANALYSIS OF FIRST-LINE DOXORUBICIN-BASED COMBINATION REGIMENS IN METASTATIC LEIOMYOSARCOMA: IMPACT ON SURVIVAL AND DISEASE CONTROL
NEUS MESQUIDA LUQUE
Favorite
Messina, Maiya-Mari

University of Miami Miller School of Medicine
(P 201) METASTATIC PATTERNS, TREATMENT MODALITIES, AND OVERALL SURVIVAL IN OLIGOMETASTATIC GIST: A SINGLE-CENTER RETROSPECTIVE STUDY
Maiya-Mari Messina
Favorite
Metts, Jonathan

Moffitt Cancer Center
(P 163) CHONDROSARCOMA IN THE AYA POPULATION
Jonathan Metts
Favorite
(P 426) A PHASE I/II TRIAL USING RNA LIPID NANOPARTICLES FOR RECURRENT OSTEOSARCOMA: A REPORT FROM THE NATIONAL PEDIATRIC CANCER FOUNDATION
Jonathan Metts
Favorite
(P 453) OUTCOMES OF PLEOMORPHIC LIPOSARCOMA PATIENTS FOLLOWING MULTI-DISCIPLINARY MANAGEMENT WITHIN A TERTIARY CANCER CENTER
Jonathan Metts
Favorite
Meyer, Anders

University of Kansas Medical Center
(P 366) WOUND COMPLICATIONS AFTER ULTRA-HYPOFRACTIONATED NEOADJUVANT RADIATION FOR SOFT TISSUE SARCOMA: WHAT IS OPTIMAL SURGICAL TIMING?
Anders Meyer
Favorite
Meza-Zepeda, Leonardo

Oslo University Hospital
(P 38) VALIDATION OF THE SIGNIOS SEVEN-GENE SIGNATURE FOR PREDICTING ANTI-PD-1 INHIBITOR EFFICACY IN SARCOMA
Leonardo Meza-Zepeda
Favorite
(P 200) DISSECTING INTRATUMORAL HETEROGENEITY IN GIST USING SPATIAL TRANSCRIPTOMICS
Leonardo Meza-Zepeda
Favorite
Miah, Aisha

The Royal Marsden Hospital
(P 414) PATTERNS OF RELAPSE OF BORDERLINE AND MALIGNANT PHYLLODES TUMOUR- RESULTS FROM SARCOMA REFERENCE CENTRE (SRC)
Aisha Miah
Favorite
Miceli, Rosalba

Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan
(P 277) THE ROLE OF RADIOTHERAPY IN THE MULTIDISCIPLINARY MANAGEMENT OF RADIATION-ASSOCIATED ANGIOSARCOMA OF THE BREAST: A REFERRAL CENTER EXPERIENCE
Rosalba Miceli
Favorite
(P 446) GDF-15 AS A PROGNOSTIC FACTOR IN PATIENTS WITH EPITHELIOID HEMANGIOENDOTHELIOMA
Rosalba Miceli
Favorite
(P 447) PAIN ASSESSMENT CRITERIA (PAC) ANTICIPATE RECIST PROGRESSION AND CORRELATE WITH BLOOD LEVELS OF GROWTH DIFFERENTIATION FACTOR 15 (GDF15) IN EPITHELIOID HEMANGIOENDOTHELIOMA (EHE)
Rosalba Miceli
Favorite
(P 458) BETWEEN LYMPHOMAS AND SARCOMAS: A RETROSPECTIVE, MULTI-INSTITUTIONAL STUDY FROM THE ITALIAN SARCOMA GROUP (ISG) ON HISTIOCYTIC AND DENDRITIC CELL NEOPLASMS (HDCN)
Rosalba Miceli
Favorite
Michaeli, Orly

Hemato-Oncology Laboratory, Schneider Children's Medical Center of Israel, Petach Tikva, Israel
(P 06) RAPID, POINT-OF-CARE DNA METHYLATION & MOLECULAR LANDSCAPE BASED SARCOMA CLASSIFICATION
Orly Michaeli
Favorite
Michael, Samer

Memorial Sloan Kettering Cancer Center
(P 273) RADIOMIC PREDICTORS OF SPONTANEOUS PNEUMOTHORAX DURING TYROSINE KINASE INHIBITOR THERAPY FOR LUNG METASTASES
Samer Michael
Favorite
Michel, Marius

Department of Radiation Oncology, Universitätsstraße 27, 91054 Erlangen, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Germany
(P 288) IDENTIFICATION OF A DNA REPAIR INHIBITOR FOR THE COMBINATION WITH LURBINECTEDIN AND RADIOTHERAPY IN SARCOMA CELL LINES
Marius Michel
Favorite
Michel, Maurice Stephan

Department of Urology and Urosurgery, University Medical Center Mannheim, Medical Faculty Mannheim, Heidelberg University
(P 303) MULTIVISCERAL RESECTIONS AND URINARY TRACT RECONSTRUCTION TECHNIQUES IN THE SURGERY OF RETROPERITONEAL SARCOMAS: A CASE SERIES.
Maurice Stephan Michel
Favorite
Michelon, Isabella

Department of Medicine, Catholic University of Pelotas, Brazil
(P 404) OUTCOMES OF NEOADJUVANT THERAPY IN ANGIOSARCOMA PATIENTS: A KAPLAN-MEIER-RECONSTRUCTED INDIVIDUAL PATIENT-LEVEL META-ANALYSIS
Isabella Michelon
Favorite
Michlitsch, Jennifer

UCSF Benioff Children's Hospital
(P 427) PHASE 1/2 TRIAL TO EVALUATE THE SAFETY AND EFFICACY OF PEEL-224 IN COMBINATION WITH VINCRISTINE AND TEMOZOLOMIDE IN ADOLESCENTS AND YOUNG ADULTS WITH RELAPSED OR REFRACTORY SARCOMAS
Jennifer Michlitsch
Favorite
MICHOT, audrey

Institut Bergonié
(P 324) FULLY MATURE TERTIARY LYMHOID STRUCTURES AS PREDICTORS OF LOCAL RECURRENCE IN SOFT TISSUE SARCOMAS
audrey MICHOT
Favorite
(P 390) USE OF DERMAL TEMPLATE FOR NERVE PROTECTION IN LIMB-SPARING SURGERY FOR SOFT TISSUE SARCOMAS: PRELIMINARY EXPERIENCE FROM INSTITUT BERGONIE
audrey MICHOT
Favorite
Midboe, Amanda

US Department of Veteran Affairs
(P 77) BARRIERS TO GUIDELINE CONCORDANT CARE IN AYA PATIENTS WITH BONE SARCOMAS
Amanda Midboe
Favorite
Milhem, Mohammed

University of Iowa
(P 343) PROGRESSION FREE SURVIVAL OF IMMUNE CHECKPOINT INHIBITORS IN THE FIRST-LINE TREATMENT OF METASTATIC SARCOMA: A SINGLE CENTER RETROSPECTIVE ANALYSIS.
Mohammed Milhem
Favorite
(P 370) CLINICAL OUTCOMES OF CUTANEOUS UNDIFFERENTIATED PLEOMORPHIC SARCOMA AND SUBCUTANEOUS MYXOFIBROSARCOMA: A RETROSPECTIVE REVIEW
Mohammed Milhem
Favorite
(P 371) CLINICAL PROFILE AND TREATMENT PATTERNS OF ANGIOSARCOMA IN THE REAL- WORLD SETTING: A SINGLE CENTER EXPERIENCE FROM 1991-2024.
Mohammed Milhem
Favorite
(P 439) AN OPEN LABEL MULTICENTER PHASE 2 STUDY WITH SAFETY LEAD IN OF INTRATUMORAL VUSOLIMOGENE ODERPAREPVEC IN COMBINATION WITH PEMBROLIZUMAB IN PATIENTS WITH ANGIOSARCOMA
Mohammed Milhem
Favorite
Millan Catalan, Oliver

Instituto Nacional de Cancerologia
(P 39) BUB1 AN OVEREXPRESSED KINASE IN SARCOMA: FINDING NEW TARGET THERAPY FOR OSTEOSARCOMA, LIPOSARCOMA, SYNOVIAL SARCOMA AND LEIOMYOSARCOMA
Oliver Millan Catalan
Favorite
Miller, Benjamin

University of Iowa
(P 220) THE IMPACT OF WOUND HEALING COMPLICATIONS ON PATIENT-REPORTED OUTCOMES FOLLOWING SOFT TISSUE SARCOMA SURGERY
Benjamin Miller
Favorite
(P 222) DO WE ALL SEE IT THE SAME: AN INTER-RATER RELIABILITY ANALYSIS OF THE MUSCULOSKELETAL TUMOR REGISTRY DATA ELEMENTS
Benjamin Miller
Favorite
(P 345) SARCOMA BIOPSY COMPARISON BETWEEN REFERRAL CENTERS AND TREATING CENTERS: THE MUSCULOSKELETAL TUMOR REGISTRY (MSTR) EXPERIENCE
Benjamin Miller
Favorite
Miller, Ira

Nationwide Children's Hospital
(P 23) DEFINING THE NONENZYMATIC FUNCTIONS OF LSD1 IN EWING SARCOMA
Ira Miller
Favorite
Miller, Jade

Vanderbilt University
(P 51) OVEREXPRESSION OF GLI2 IN DEDIFFERENTIATED LIPOSARCOMA TUMORS INDUCES MICROENVIRONMENT REMODELING
Jade Miller
Favorite
Miloh, Roy
(P 217) PATIENT QUESTIONNAIRE EXPLORING THE PRE-SARCOMA DIAGNOSIS CHARACTERISTICS OF SARCOMA PATIENTS
Roy Miloh
Favorite
Minard-Colin, Veronique

Gustave Roussy
(P 250) OUTCOME OF INFANTS WITH RHABDOMYOSARCOMA: A REPORT FROM THE INTERNATIONAL SOFT TISSUE SARCOMA CONSORTIUM
Veronique Minard-Colin
Favorite
Miranda, Hernan

Instituto Traumatologico Teodoro Gebauer
(P 212) MISINFORMATION IN SARCOMA CONTENT ON SOCIAL MEDIA PLATFORMS
Hernan Miranda
Favorite
MIRAS RODRIGUEZ, ISABEL

HOSPITAL UNIVERSITARIO VIRGEN DEL ROCIO
(P 115) SINGLE-CENTER EXPERIENCE WITH TYROSIN KINASA INHIBITORS IN ADVANCED BONE SARCOMA: EFFICACY AND SAFETY OUTCOMES
ISABEL MIRAS RODRIGUEZ
Favorite
(P 321) COMPARATIVE ANALYSIS OF FIRST-LINE DOXORUBICIN-BASED COMBINATION REGIMENS IN METASTATIC LEIOMYOSARCOMA: IMPACT ON SURVIVAL AND DISEASE CONTROL
ISABEL MIRAS RODRIGUEZ
Favorite
Mir, Olivier

Institut Gustave-Roussy, Villejuif, France
(P 416) A PHASE 2 MULTICENTER OPEN-LABEL BASKET STUDY OF TAZEMETOSTAT IN ADULT PATIENTS WITH INI1-NEGATIVE EPITHELIOID SARCOMA – FINAL ANALYSIS
Olivier Mir
Favorite
Mitchell, Duane

University of Florida
(P 426) A PHASE I/II TRIAL USING RNA LIPID NANOPARTICLES FOR RECURRENT OSTEOSARCOMA: A REPORT FROM THE NATIONAL PEDIATRIC CANCER FOUNDATION
Duane Mitchell
Favorite
Mitra, Amitava

Kura Oncology, Inc.
(P 423) ZIFTOMENIB IN COMBINATION WITH IMATINIB IN ADVANCED GASTROINTESTINAL STROMAL TUMORS (GIST) AFTER IMATINIB FAILURE: PHASE 1A/B STUDY OF SAFETY, PHARMACOKINETICS, AND ANTITUMOR ACTIVITY
Amitava Mitra
Favorite
Mitra, Ramkrishna

Thomas Jefferson University
(P 35) MECHANISTIC AND TRANSCRIPTOMIC ANALYSES REVEAL MUTATION-SPECIFIC THERAPEUTIC RESPONSES IN DESMOID TUMOR CELLS TREATED WITH SORAFENIB AND NIROGACESTAT
Ramkrishna Mitra
Favorite
Miyamoto, Ryo

Princess Margaret Cancer Centre, UHN
(P 67) MULTIPLE MESENCHYMAL LINEAGES AS POTENTIAL CELL-OF-ORIGINS OF SMARCB1-DEFICIENT EPITHELIOID SARCOMA
Ryo Miyamoto
Favorite
Miyazaki, Bunpei

Department of Pediatric Oncology, National Cancer Center Hospital
(P 271) SAFETY AND EFFICACY OF CABOZANTINIB IN PEDIATRIC PATIENTS WITH MALIGNANT SOLID TUMORS (CAMEL TRIAL/NCCH2106): A SINGLE-CENTRE PHASE I TRIAL
Bunpei Miyazaki
Favorite
(P 341) PROGNOSTIC RELEVANCE OF CYCLOPHOSPHAMIDE DOSE FOR HIGH-RISK RHABDOMYOSARCOMA IN ADULT PATIENTS TREATED WITH VAC THERAPY
Bunpei Miyazaki
Favorite
Mizusawa, Junki

Clinical Research Support Office, National Cancer Center Hospital
(P 271) SAFETY AND EFFICACY OF CABOZANTINIB IN PEDIATRIC PATIENTS WITH MALIGNANT SOLID TUMORS (CAMEL TRIAL/NCCH2106): A SINGLE-CENTRE PHASE I TRIAL
Junki Mizusawa
Favorite
Mock, Andreas

LMU Munich
(P 443) FIRST-LINE PAZOPANIB IN PATIENTS WITH EPITHELIOID HEMANGIOENDOTHELIOMA: A RETROSPECTIVE SINGLE-CENTER ANALYSIS
Andreas Mock
Favorite
Moding, Everett

Stanford University
(P 37) DISSECTING THE TUMOR MICROENVIRONMENT OF UTERINE LEIOMYOSARCOMAS FOR TARGETED DRUG PREDICTIONS
Everett Moding
Favorite
(P 400) LONGITUDINAL EPIGENETIC AND TRANSCRIPTOMIC REMODELING ACROSS PRIMARY, IRRADIATED, AND LOCALLY RELAPSED SOFT TISSUE SARCOMAS
Everett Moding
Favorite
Modi, Shivani

Jefferson Einstein Healthcare Network
(P 330) LEIOMYOSARCOMA IN THE REAL WORLD: RETROSPECTIVE ANALYSIS OF CLINICAL CHARACTERISTICS AND TREATMENT PATTERNS IN PATIENTS AT A COMMUNITY ONCOLOGY CENTER IN SOUTH FLORIDA (MEMORIAL HEALTHCARE SYSTEM)
Shivani Modi
Favorite
(P 459) EPIDEMIOLOGICAL TRENDS, TREATMENT PATTERNS, AND SURVIVAL DISPARITIES IN MALIGNANT PERIPHERAL NERVE SHEATH TUMORS: A SEER ANALYSIS, 2001-2020
Shivani Modi
Favorite
Mody, Rajen

University of Michigan
(P 256) THE SEAN KARL COHORT: A NATIONAL COLLABORATIVE SINGLE-CELL RNASEQ STUDY OF PAIRED PATIENT EWING SARCOMA SPECIMENS
Rajen Mody
Favorite
Moebius, Ulrich

SOTIO Biotech a.s.
(P 257) TARGETING LEUCINE-RICH REPEAT-CONTAINING PROTEIN 15 (LRRC15): SOT106 ANTIBODY-DRUG CONJUGATE FOR SOFT TISSUE SARCOMA AND OSTEOSARCOMA TREATMENT
Ulrich Moebius
Favorite
Mogavero, Andrea

University Hospital S. Luigi Gonzaga
(P 231) INCREASED LIFETIME RISK (LTR) OF SOFT TISSUE SARCOMAS (STS) IN PATIENTS WITH LOW-RISK GASTROINTESTINAL STROMAL TUMORS (GIST): A RETROSPECTIVE ANALYSIS FROM THE ITALIAN SARCOMA GROUP (ISG)
Andrea Mogavero
Favorite
Mohamed Noor, Nur Fazlin

National Cancer Center Singapore
(P 53) ESTABLISHMENT AND CHARACTERISATION OF LIPOSARCOMA-DERIVED CELLS AS RELEVANT PRE-CLINICAL MODELS FOR TARGET DISCOVERY
Nur Fazlin Mohamed Noor
Favorite
Mohan Gollamudi, Venkata Rama

ACTREC, Tata Memorial Centre, Mumbai
(P 292) CRANIOVERTEBRAL EWINGS SARCOMA WITH MENINGEAL INFILTRATION - A CLINICAL OUTCOME ANALYSIS
Venkata Rama Mohan Gollamudi
Favorite
Mohei, Hesham

University of Pennsylvania
(P 240) NEW INSIGHTS FROM SPATIOTEMPORALLY DEFINED TUMOR INDUCTIONS IN A NOVEL MOUSE MODEL OF SYNOVIAL SARCOMA
Hesham Mohei
Favorite
Mohler, David

Stanford University
(P 93) INTERCALARY COMPRESSIVE OSSEOINTEGRATION OF DIAPHYSEAL TUMORS: A MULTI-INSTITUTIONAL CASE SERIES
David Mohler
Favorite
(P 400) LONGITUDINAL EPIGENETIC AND TRANSCRIPTOMIC REMODELING ACROSS PRIMARY, IRRADIATED, AND LOCALLY RELAPSED SOFT TISSUE SARCOMAS
David Mohler
Favorite
Molloy, Alan

St Vincent's University Hospital
(P 211) HEALTH-RELATED QUALITY OF LIFE IN IRISH SARCOMA PATIENTS
Alan Molloy
Favorite
(P 213) FINANCIAL TOXICITY IN IRISH SARCOMA CARE: A SINGLE-CENTRE ANALYSIS
Alan Molloy
Favorite
Moncho, Juliet

Massachusetts General Hospital
(P 62) INTRAOPERATIVE BONE AND SOFT TISSUE TUMOR MARGIN IDENTIFICATION WITH FLUORESCENCE LIFETIME (FLT) IMAGING
Juliet Moncho
Favorite
(P 392) CLASSIFICATION AND DIFFERENTIATIONOF MYXOID LIPOSARCOMA AND MYXOMA WITH MACHINE LEARNING
Juliet Moncho
Favorite
Mondaza-Hernandez, Jose

Instituto de Investigacion Sanitaria Fundacion Jimenez Diaz
(P 38) VALIDATION OF THE SIGNIOS SEVEN-GENE SIGNATURE FOR PREDICTING ANTI-PD-1 INHIBITOR EFFICACY IN SARCOMA
Jose Mondaza-Hernandez
Favorite
(P 462) HDAC INHIBITORS AS POTENTIAL SFT THERAPIES
Jose Mondaza-Hernandez
Favorite
Monga, Varun

UCSF Helen Diller Family Comprehensive Cancer Center
(P 439) AN OPEN LABEL MULTICENTER PHASE 2 STUDY WITH SAFETY LEAD IN OF INTRATUMORAL VUSOLIMOGENE ODERPAREPVEC IN COMBINATION WITH PEMBROLIZUMAB IN PATIENTS WITH ANGIOSARCOMA
Varun Monga
Favorite
Monjazeb, Arta

Radiation Oncology, University of California, Davis
(P 244) INTRATUMORAL TIGIT BLOCKADE AUGMENTS ANTI-TUMOR RESPONSES AND BYPASSES HYPERFUNCTIONALITY OF PERIPHERAL TIGIT+ NK CELLS IN MOUSE AND HUMAN MODELS OF BONE AND SOFT TISSUE SARCOMA
Arta Monjazeb
Favorite
(P 245) SUBTYPE SPECIFIC CHARACTERIZATION OF IMMUNE INFILTRATION IN SOFT TISSE SARCOMAS
Arta Monjazeb
Favorite
Monjure, Tia

University of Florida
(P 248) AN EX VIVO ASSAY TO PREDICT IMMUNOTHERAPY RESPONSE IN SARCOMA
Tia Monjure
Favorite
Monteleone, Laura

Fondazione IRCCS Istituto Nazionale dei Tumori
(P 446) GDF-15 AS A PROGNOSTIC FACTOR IN PATIENTS WITH EPITHELIOID HEMANGIOENDOTHELIOMA
Laura Monteleone
Favorite
Montgomery, Elizabeth Anne

University of Miami Miller School of Medicine
(P 147) CONVENTIONAL AND DEDIFFERENTIATED CHONDROSARCOMA; IS ENCHONDROMA THE PRECURSOR LESION?
Elizabeth Anne Montgomery
Favorite
(P 154) BCOR-MUTATED CONVENTIONAL AND DEDIFFERENTIATED CHONDROSARCOMA: A CLINICOPATHOLOGIC STUDY
Elizabeth Anne Montgomery
Favorite
Montiel, Eduarda M. S.

AC Camargo Cancer Center
(P 155) BRCA2-MUTATED CONVENTIONAL CHONDROSARCOMA RESPONDING TO PARP INHIBITION: A CASE REPORT
Eduarda M. S. Montiel
Favorite
Montoya-Cerrillo, Diego

University of Miami
(P 147) CONVENTIONAL AND DEDIFFERENTIATED CHONDROSARCOMA; IS ENCHONDROMA THE PRECURSOR LESION?
Diego Montoya-Cerrillo
Favorite
(P 154) BCOR-MUTATED CONVENTIONAL AND DEDIFFERENTIATED CHONDROSARCOMA: A CLINICOPATHOLOGIC STUDY
Diego Montoya-Cerrillo
Favorite
Monument, Michael

University of Calgary
(P 143) IMPACT OF SURGICAL MARGINS IN CHEST WALL CHONDROSARCOMAS: A CANSARCC STUDY
Michael Monument
Favorite
(P 238) INVESTIGATING HOW MACROPHAGES INFILTRATE THE TUMOUR MICROENVIRONMENT AND INFLUENCE THE EFFICACY OF CAR T THERAPY IN A MURINE MODEL OF STS
Michael Monument
Favorite
(P 239) CHARACTERIZING THE ROLES OF T-CELLS IN THE CONTEXT OF TUMOR CLEARANCE AND MEMORY IN THE KP MODEL OF SARCOMA FOLLOWING STING THERAPY
Michael Monument
Favorite
(P 378) HIGH DOSE RADIATION THERAPY PROMOTES IMMUNE SUPPRESSIVE MACROPHAGE PHENOTYPES, WHEREAS LOW DOSE RADIATION THERAPY PROMOTES IMMUNOGENIC MACROPHAGE PHENOTYPES IN A MURINE MODEL OF SOFT TISSUE SARCOMA
Michael Monument
Favorite
Moon, Matthew

University of Iowa Hospitals and Clinics
(P 343) PROGRESSION FREE SURVIVAL OF IMMUNE CHECKPOINT INHIBITORS IN THE FIRST-LINE TREATMENT OF METASTATIC SARCOMA: A SINGLE CENTER RETROSPECTIVE ANALYSIS.
Matthew Moon
Favorite
Moore, Roxanne

Fred Hutchinson Cancer Center
(P 287) A PHASE 1 STUDY OF NEOADJUVANT CABOZANTINIB IN COMBINATION WITH RADIATION THERAPY FOR SARCOMAS OF THE EXTREMITIES
Roxanne Moore
Favorite
Moradkhani, Ania

Sarcoma Oncology Center
(P 388) TRIAL IN PROGRESS: A PHASE 2 STUDY OF METRONOMIC TRABECTEDIN, GEMCITIBAINE, AND DACARBAZINE IN PREVIOUSLY TREATED ADVANCED SOFT TISSUE SARCOMA (NCT04535271)
Ania Moradkhani
Favorite
(P 396) EVALUATING THE SAFETY AND EFFICACY OF METRONOMIC GEMCITABINE, DOXORUBICIN, AND DOCETAXEL PLUS NIVOLUMAB IN PREVIOUSLY TREATED ADVANCED LEIOMYOSARCOMA AND LIPOSARCOMA: A PHASE 2 STUDY (NCT04535713)
Ania Moradkhani
Favorite
(P 398) INVESTIGATING THE SAFETY AND EFFICACY OF LURBINECTEDIN WITH IPILIMUMAB AND NIVOLUMAB FOR ADVANCED SOFT TISSUE SARCOMA: LINNOVATE PHASE 1/2 STUDY (NCT05876715)
Ania Moradkhani
Favorite
Morais, Alice

Instituto do Câncer do Estado de São Paulo
(P 128) ISOCITRATE DEHYDROGENASE 1 (IDH1) MUTATION TESTING IN THE PHASE 3 STUDY OF IVOSIDENIB VS PLACEBO IN IDH1-MUTANT CONVENTIONAL CHONDROSARCOMA (CHONQUER)
Alice Morais
Favorite
Moral Duarte, Antonio

Hospital de la Santa Creu i Sant Pau
(P 383) MULTIDISCIPLINARY TREATMENT OF INGUINOSCROTAL SARCOMAS: ANALYSIS OF 39 CASES TREATED BY SURGICAL APPROACH
Antonio Moral Duarte
Favorite
Morales, Samantha

University of South Carolina School of Medicine Greenville
(P 19) SERUM EXOSOMES IDENTIFY AN ABERRANT PROTEOMIC SIGNATURE IN CANINE OSTEOSARCOMA PRECEDING METASTATIC PROGRESSION
Samantha Morales
Favorite
(P 119) DEVELOPMENT OF AN EXTINCTION THERAPY APPROACH FOR OSTEOSARCOMA USING ECO-EVOLUTIONARY PRINCIPLES
Samantha Morales
Favorite
Morelli, Daniele

Fondazione IRCCS Istituto Nazionale dei Tumori
(P 446) GDF-15 AS A PROGNOSTIC FACTOR IN PATIENTS WITH EPITHELIOID HEMANGIOENDOTHELIOMA
Daniele Morelli
Favorite
(P 447) PAIN ASSESSMENT CRITERIA (PAC) ANTICIPATE RECIST PROGRESSION AND CORRELATE WITH BLOOD LEVELS OF GROWTH DIFFERENTIATION FACTOR 15 (GDF15) IN EPITHELIOID HEMANGIOENDOTHELIOMA (EHE)
Daniele Morelli
Favorite
MORENO VEGA, ALBERTO

HOSPITAL UNIVERSITARIO VIRGEN DEL ROCIO
(P 115) SINGLE-CENTER EXPERIENCE WITH TYROSIN KINASA INHIBITORS IN ADVANCED BONE SARCOMA: EFFICACY AND SAFETY OUTCOMES
ALBERTO MORENO VEGA
Favorite
(P 321) COMPARATIVE ANALYSIS OF FIRST-LINE DOXORUBICIN-BASED COMBINATION REGIMENS IN METASTATIC LEIOMYOSARCOMA: IMPACT ON SURVIVAL AND DISEASE CONTROL
ALBERTO MORENO VEGA
Favorite
Morey, Rohini

The University of Texas MD Anderson Cancer Center
(P 172) COMPARISON OF CELL SEGMENTATION METHODS IN SOFT TISSUE SARCOMA (STS) SPATIAL PROTEOMIC DATASETS
Rohini Morey
Favorite
Moria, Feras

MUHC
(P 120) SURVIVAL OUTCOMES AND ROLE OF CHEMOTHERAPY IN PATIENTS OLDER THAN 40 YEARS WITH OSTEOSARCOMA (OLD-SARC STUDY).
Feras Moria
Favorite
Morin, Niall

Fred Hutchinson Cancer Center
(P 287) A PHASE 1 STUDY OF NEOADJUVANT CABOZANTINIB IN COMBINATION WITH RADIATION THERAPY FOR SARCOMAS OF THE EXTREMITIES
Niall Morin
Favorite
Morita, Mitsunori

Hyogo Cancer Center
(P 192) OPTIMAL DOSING SCHEDULE OF SUNITINIB BASED ON PLATELET COUNT IN AN OLDER PATIENT WITH GASTROINTESTINAL STROMAL TUMOR
Mitsunori Morita
Favorite
Morizane, Chigusa

National Cancer Center Hospital
(P 159) CHONDROSARCOMA IN JAPAN: A POPULATION-BASED ANALYSIS USING NATIONAL CANCER REGISTRY
Chigusa Morizane
Favorite
Morosi, Carlo

Fondazione IRCCS Istituto nazionale dei tumori
(P 308) IMPACT OF PSOAS MUSCLE RESECTION ON OUTCOMES IN PRIMARY RETROPERITONEAL DEDIFFERENTIATED LIPOSARCOMA
Carlo Morosi
Favorite
(P 331) MAINTENANCE THERAPY (M-TP) WITH DACARBAZINE (DTIC) AFTER FIRST-LINE ANTHRACYCLINE-BASED DOUBLET IN ADVANCED LEIOMYOSARCOMA (LMS) PATIENTS (PTS): OUTCOMES OF A CASE SERIES IN A SINGLE REFERRAL CENTER
Carlo Morosi
Favorite
(P 447) PAIN ASSESSMENT CRITERIA (PAC) ANTICIPATE RECIST PROGRESSION AND CORRELATE WITH BLOOD LEVELS OF GROWTH DIFFERENTIATION FACTOR 15 (GDF15) IN EPITHELIOID HEMANGIOENDOTHELIOMA (EHE)
Carlo Morosi
Favorite
(P 458) BETWEEN LYMPHOMAS AND SARCOMAS: A RETROSPECTIVE, MULTI-INSTITUTIONAL STUDY FROM THE ITALIAN SARCOMA GROUP (ISG) ON HISTIOCYTIC AND DENDRITIC CELL NEOPLASMS (HDCN)
Carlo Morosi
Favorite
Morris, Ashlyn

Indiana University
(P 84) A MULTICENTER COMPARISON OF REVERSE TOTAL SHOULDER ARTHROPLASTY VERSUS HEMIARTHROPLASTY FOR ENDOPROSTHETIC RECONSTRUCTION FOLLOWING ONCOLOGIC RESECTION OF THE PROXIMAL HUMERUS
Ashlyn Morris
Favorite
Morris, Carol

Memorial Sloan Kettering Cancer Center
(P 151) SHOULD WE USE ADJUVANT CHEMOTHERAPY IN PATIENTS WITH LOCALIZED DEDIFFERENTIATED CHONDROSARCOMA (DDCS) OF THE PELVIS? AN ANALYSIS BY THE PELVIC DDCS STUDY GROUP
Carol Morris
Favorite
Morris, Luc

Memorial Sloan Kettering Cancer Center
(P 265) MULTI-SITE SINGLE CELL TRANSCRIPTOMICS REVEAL DISTINCT IMMUNE INFILTRATIVE PATTERNS IN DESMOPLASTIC SMALL ROUND CELL TUMOR
Luc Morris
Favorite
Morrissy, Sorana

Arnie Charbonneau Cancer Institute and McCaig Institute for Bone and Joint Health
(P 238) INVESTIGATING HOW MACROPHAGES INFILTRATE THE TUMOUR MICROENVIRONMENT AND INFLUENCE THE EFFICACY OF CAR T THERAPY IN A MURINE MODEL OF STS
Sorana Morrissy
Favorite
(P 378) HIGH DOSE RADIATION THERAPY PROMOTES IMMUNE SUPPRESSIVE MACROPHAGE PHENOTYPES, WHEREAS LOW DOSE RADIATION THERAPY PROMOTES IMMUNOGENIC MACROPHAGE PHENOTYPES IN A MURINE MODEL OF SOFT TISSUE SARCOMA
Sorana Morrissy
Favorite
Moschetta, Ileana

Fondazione IRCCS Istituto Nazionale dei Tumori
(P 446) GDF-15 AS A PROGNOSTIC FACTOR IN PATIENTS WITH EPITHELIOID HEMANGIOENDOTHELIOMA
Ileana Moschetta
Favorite
Mosher, Hannah

University of Miami Miller School of Medicine
(P 90) MEGAPROSTHESIS CONVERSION FROM FAILED OSTEOARTICULAR ALLOGRAFT VERSUS PRIMARY RECONSTRUCTION FOR DISTAL FEMUR AND PROXIMAL TIBIA TUMORS: A PROPENSITY MATCHED-PAIR ANALYSIS
Hannah Mosher
Favorite
(P 397) EXPLORING REAL WORLD DATA OF RECURRENCE IN NON-METASTATIC MYXOFIBROSAROMA: AN UPDATED RETROSPECTIVE COHORT STUDY
Hannah Mosher
Favorite
Moskaluk, Christopher

University of Virginia
(P 199) CHARACTERISTICS OF AN IMMUNOHISTOCHEMICAL AND MOLECULARLY DISCORDANT POPULATION OF GIST PATIENTS: A SINGLE CENTER RETROSPECTIVE REVIEW
Christopher Moskaluk
Favorite
Mosu, Alexis

Visgauss Lab — Duke Orthopedic Oncology
(P 130) INVESTIGATING LCP1-MEDIATED ONCOGENIC SIGNALING IN CHONDROSARCOMA METASTASIS
Alexis Mosu
Favorite
Mottard, Sophie

Maisonneuve-Rosemont Hospital
(P 46) INVESTIGATING THE IMPACT OF SARCOMA FUSION PROTEINS ON EPIGENETIC AND DNA-DEPENDENT PROCESSES THROUGH INTERACTOME PROFILING
Sophie Mottard
Favorite
Movva, Sujana

Memorial Sloan Kettering Cancer Center
(P 187) THERAPEUTIC OUTCOMES IN NF1-ALTERED GIST TREATED WITH MEK INHIBITION: A SINGLE-CENTER EXPERIENCE
Sujana Movva
Favorite
(P 409) RETROSPECTIVE ANALYSIS OF PROGNOSTIC FACTORS INCLUDING HLA GENOTYPE IN MYXOID LIPOSARCOMA
Sujana Movva
Favorite
(P 467) TREATMENT OUTCOMES IN AGGRESSIVE ANGIOMYXOMA: A SINGLE INSTITUTION EXPERIENCE
Sujana Movva
Favorite
Mridha, Asit

AIIMS Delhi
(P 468) CLINICAL UTILITY OF TARGETED NEXT-GENERATION SEQUENCING IN GUIDING SARCOMA DIAGNOSIS AND PERSONALIZED MANAGEMENT: A SINGLE-CENTER STUDY FROM INDIA
Asit Mridha
Favorite
Mukarrama, Trasneem

Biomedical Engineering, University of California, Davis
(P 244) INTRATUMORAL TIGIT BLOCKADE AUGMENTS ANTI-TUMOR RESPONSES AND BYPASSES HYPERFUNCTIONALITY OF PERIPHERAL TIGIT+ NK CELLS IN MOUSE AND HUMAN MODELS OF BONE AND SOFT TISSUE SARCOMA
Trasneem Mukarrama
Favorite
Mukherjee, Elina

University of Pittsburgh
(P 256) THE SEAN KARL COHORT: A NATIONAL COLLABORATIVE SINGLE-CELL RNASEQ STUDY OF PAIRED PATIENT EWING SARCOMA SPECIMENS
Elina Mukherjee
Favorite
Mullinax, John

Moffitt Cancer Center
(P 394) DUAL OR TRIMODALITY THERAPY VERSUS SURGERY ALONE IN RADIATION-ASSOCIATED ANGIOSARCOMA OF THE BREAST
John Mullinax
Favorite
(P 453) OUTCOMES OF PLEOMORPHIC LIPOSARCOMA PATIENTS FOLLOWING MULTI-DISCIPLINARY MANAGEMENT WITHIN A TERTIARY CANCER CENTER
John Mullinax
Favorite
Mundra, Piyush

Children's Cancer Institute of Australia
(P 49) GENETIC INTERACTION BETWEEN SPRED3 AND SMARCB1 CAUSES EXPLOSIVE MULTIFOCAL MALIGNANT PERIPHERAL NERVE SHEATH TUMORS
Piyush Mundra
Favorite
Munnangi, Pujita

University of California, San Francisco
(P 351) THE ROLE OF SOCIOECONOMIC DISPARITIES ON SURVIVAL OUTCOMES IN MALIGNANT PERIPHERAL NERVE SHEATH TUMORS
Pujita Munnangi
Favorite
(P 460) OUTCOMES OF LATER-LINES SYSTEMIC THERAPIES IN MALIGNANT PERIPHERAL NERVE SHEATH TUMORS (MPNST)
Pujita Munnangi
Favorite
Muramatsu, Shudai

National Cancer Center Hospital
(P 159) CHONDROSARCOMA IN JAPAN: A POPULATION-BASED ANALYSIS USING NATIONAL CANCER REGISTRY
Shudai Muramatsu
Favorite
Murata, Hideki

Shizuoka Cancer Center
(P 291) INTRA-ARTERIAL CHEMOTHERAPY WITH CONCOMITANT RADIATION THERAPY FOR UNRESECTABLE SARCOMA
Hideki Murata
Favorite
Murphy Jr., William A.

The University of Texas MD Anderson Cancer Center
(P 311) A FOLLOW-UP STUDY ON THE NOVEL USE OF CONTRAST-ENHANCED SUSCEPTIBILITY-WEIGHTED IMAGING FOR EXTREMITY DESMOID FIBROMATOSIS RESPONSE ASSESSMENT
William A. Murphy Jr.
Favorite
(P 317) BUILDING A PRE-SURGICAL MULTIPARAMETRIC-MRI-BASED PREDICTIVE TREATMENT RESPONSE MODEL FOR UNDIFFERENTIATED PLEOMORPHIC SARCOMA TO REPLACE RECIST
William A. Murphy Jr.
Favorite
(P 334) MRI VOLUMETRIC AND MODIFIED CHOI-BASED ASSESSMENT OF TREATMENT RESPONSE IN EXTREMITY DESMOID TUMORS TREATED WITH NIROGACESTAT OR SORAFENIB
William A. Murphy Jr.
Favorite
(P 406) PILOT STUDY: CAN A MULTIPARAMETRIC MRI-DERIVED MODEL OUTPERFORM RECIST PREDICTING PATHOLOGY RESPONSE IN RHABDOMYOSARCOMA?
William A. Murphy Jr.
Favorite
(P 420) THE EFFECT OF CHEMOTHERAPY AND RADIOTHERAPY IN THE MULTIPARAMETRIC MRI-BASED ASSESSMENT OF TREATMENT RESPONSE IN EXTREMITY SOFT-TISSUE UNDIFFERENTIATED PLEOMORPHIC SARCOMA
William A. Murphy Jr.
Favorite
Murphy, Erin

Cleveland Clinic
(P 284) THE IMPACT OF SARCOMA SBRT ON THE IMMUNE SYSTEM: EARLY RESULTS FROM A PROSPECTIVE TRIAL
Erin Murphy
Favorite
Murphy, Mary

Dana-Farber Cancer Institute
(P 427) PHASE 1/2 TRIAL TO EVALUATE THE SAFETY AND EFFICACY OF PEEL-224 IN COMBINATION WITH VINCRISTINE AND TEMOZOLOMIDE IN ADOLESCENTS AND YOUNG ADULTS WITH RELAPSED OR REFRACTORY SARCOMAS
Mary Murphy
Favorite
Murphy, William

Department of Dermatology, University of California, Davis
(P 244) INTRATUMORAL TIGIT BLOCKADE AUGMENTS ANTI-TUMOR RESPONSES AND BYPASSES HYPERFUNCTIONALITY OF PERIPHERAL TIGIT+ NK CELLS IN MOUSE AND HUMAN MODELS OF BONE AND SOFT TISSUE SARCOMA
William Murphy
Favorite
(P 245) SUBTYPE SPECIFIC CHARACTERIZATION OF IMMUNE INFILTRATION IN SOFT TISSE SARCOMAS
William Murphy
Favorite
Murray, Hazel

St Vincent's University Hospital
(P 211) HEALTH-RELATED QUALITY OF LIFE IN IRISH SARCOMA PATIENTS
Hazel Murray
Favorite
(P 213) FINANCIAL TOXICITY IN IRISH SARCOMA CARE: A SINGLE-CENTRE ANALYSIS
Hazel Murray
Favorite
Murray, Michael

Rush University Medical Center
(P 113) ASSESSING TREATMENT OUTCOMES OF CHONDROMYXOID FIBROMA: A CASE SERIES
Michael Murray
Favorite
Murugesan, Manikandan

Dept. of Surgery, Moores Cancer Center, University of California San Diego
(P 197) DIFFERENTIAL EFFECTS OF ANAGRELIDE IN GASTROINTESTINAL STROMAL TUMORS (GIST) IN VITRO
Manikandan Murugesan
Favorite
Musselman, Madelaine

Ohio State University
(P 309) RETROPERITONEAL LIPOMAS: MULTICENTER CLINICAL EXPERIENCE WITH AN EXTREMELY RARE DISEASE ENTITY
Madelaine Musselman
Favorite
Mutter, Robert

Mayo Clinic
(P 246) CTLA4 PATHWAY ACTIVATION IN RADIATION-INDUCED ANGIOSARCOMA: A TRANSCRIPTOMIC RATIONALE FOR IMMUNE CHECKPOINT BLOCKADE
Robert Mutter
Favorite
Myers, Sara

The James Cancer Hospital - The Ohio State University Comprehensive Cancer Center
(P 221) QUALITATIVE ANALYSIS OF THE PERIOPERATIVE EXPERIENCE OF YOUNG ADULT PATIENTS UNDERGOING EXTREMITY SARCOMA SURGERY
Sara Myers
Favorite
Myklebost, Ola

Oslo University Hospital
(P 38) VALIDATION OF THE SIGNIOS SEVEN-GENE SIGNATURE FOR PREDICTING ANTI-PD-1 INHIBITOR EFFICACY IN SARCOMA
Ola Myklebost
Favorite
N
Nörenberg, Dominik

Department of Radiology and Nuclear Medicine, University Medical Center Mannheim, Medical Faculty Mannheim, Heidelberg University
(P 165) EVALUATING LARGE LANGUAGE MODELS AS DECISION SUPPORT TOOLS IN MULTIDISCIPLINARY TUMOR BOARDS FOR GASTROINTESTINAL STROMAL TUMORS
Dominik Nörenberg
Favorite
(P 367) ADHERENCE TO GERMAN SARCOMA GUIDELINE FOR MRI SEQUENCING IN SOFT TISSUE SARCOMA: EVALUATION OF IMAGING PRACTICES AND COMPLIANCE
Dominik Nörenberg
Favorite
Nabeshima, Akira

Kyushu University
(P 472) LANDSCAPE OF ULTRA-RARE SARCOMAS: A NATIONWIDE STUDY FOR EPIDEMIOLOGY AND PROGNOSIS
Akira Nabeshima
Favorite
Nacev, Benjamin

University of Pittsburgh Medical Center-Hillman Cancer Center
(P 128) ISOCITRATE DEHYDROGENASE 1 (IDH1) MUTATION TESTING IN THE PHASE 3 STUDY OF IVOSIDENIB VS PLACEBO IN IDH1-MUTANT CONVENTIONAL CHONDROSARCOMA (CHONQUER)
Benjamin Nacev
Favorite
Nadesan, Puvi

Duke University
(P 380) INVESTIGATING THE ROLE OF HISTONE DEACETYLASE-3 IN METASTATIC UNDIFFERENTIATED PLEOMORPHIC SARCOMA
Puvi Nadesan
Favorite
Naghavi, Arash

Moffitt Cancer Center
(P 394) DUAL OR TRIMODALITY THERAPY VERSUS SURGERY ALONE IN RADIATION-ASSOCIATED ANGIOSARCOMA OF THE BREAST
Arash Naghavi
Favorite
(P 453) OUTCOMES OF PLEOMORPHIC LIPOSARCOMA PATIENTS FOLLOWING MULTI-DISCIPLINARY MANAGEMENT WITHIN A TERTIARY CANCER CENTER
Arash Naghavi
Favorite
Nakagawa, Makoto

Kyushu University
(P 472) LANDSCAPE OF ULTRA-RARE SARCOMAS: A NATIONWIDE STUDY FOR EPIDEMIOLOGY AND PROGNOSIS
Makoto Nakagawa
Favorite
Nakajima, Miho

Department of Pediatric Oncology, National Cancer Center Hospital
(P 271) SAFETY AND EFFICACY OF CABOZANTINIB IN PEDIATRIC PATIENTS WITH MALIGNANT SOLID TUMORS (CAMEL TRIAL/NCCH2106): A SINGLE-CENTRE PHASE I TRIAL
Miho Nakajima
Favorite
Nakashima, Yasuharu

Kyushu University
(P 472) LANDSCAPE OF ULTRA-RARE SARCOMAS: A NATIONWIDE STUDY FOR EPIDEMIOLOGY AND PROGNOSIS
Yasuharu Nakashima
Favorite
Nakazawa, Michael

The University of Texas MD Anderson Cancer Center
(P 83) OUTCOMES OF MULTIMODAL PERIOPERATIVE TREATMENT IN OSTEOSARCOMAS OF THE JAW
Michael Nakazawa
Favorite
(P 242) IMMUNE PROFILING OF UNDIFFERENTIATED PLEOMORPHIC SARCOMAS REVEALS DISTINCT PROGNOSTIC SUBGROUPS
Michael Nakazawa
Favorite
(P 411) TFCP2 FUSION-POSITVE RHABDOMYOSARCOMAS: A REPORT OF 10 CASES AND A REVIEW OF THE LITERATURE
Michael Nakazawa
Favorite
(P 430) A PH/2 STUDY OF THE RADIOPHARMACEUTICAL [AC-225]RTX-2358 IN THE TREATMENT OF RELAPSED / REFRACTORY (R/R) SOFT TISSUE SARCOMA (STS) THE ATLAS STUDY - ACTINIUM THERAPY FOR LATE-STAGE AGGRESSIVE SARCOMAS
Michael Nakazawa
Favorite
(P 451) TREATMENT OUTCOMES OF GEMCITABINE AND DOCETAXEL IN PATIENTS WITH CLEAR CELL SARCOMA (CCS) OR GASTROINTESTINAL NEUROECTODERMAL TUMOR (GNET): A CASE SERIES
Michael Nakazawa
Favorite
(P 460) OUTCOMES OF LATER-LINES SYSTEMIC THERAPIES IN MALIGNANT PERIPHERAL NERVE SHEATH TUMORS (MPNST)
Michael Nakazawa
Favorite
Nambiar, Prashant

Strand Therapeutics Inc.
(P 433) PHASE I DOSE ESCALATION TRIAL OF STX-001, AN LNP SELF-REPLICATING MRNA EXPRESSING IL-12, IN PATIENTS WITH REFRACTORY TUMORS INCLUDING SARCOMAS
Prashant Nambiar
Favorite
(P 440) CASE REPORT: COMPLETE CLINICAL AND MOLECULAR RESPONSE TO INTRATUMORAL STX-001, AN LNP-SELF REPLICATING MRNA EXPRESSING IL-12 IN A PATIENT WITH REFRACTORY ANGIOSARCOMA
Prashant Nambiar
Favorite
Namireddy, Srikar

Mayo Clinic, Rochester
(P 166) LARGE LANGUAGE MODEL EXTRACTION OF STRUCTURED DATA IN UNSTRUCTURED SARCOMA PATHOLOGY NOTES: A PILOT STUDY
Srikar Namireddy
Favorite
(P 167) LARGE LANGUAGE MODEL EXTRACTION OF STRUCTURED DATA FROM UNSTRUCTURED RADIATION ONCOLOGY NOTES: A PILOT STUDY
Srikar Namireddy
Favorite
Nam, Juhong

Seoul National University
(P 175) INTERPRETABLE DEEP LEARNING BASED CLASSIFICATION OF SARCOMA IMMUNE SUBTYPES FROM H&E SLIDES FOR IMMUNOTHERAPY STRATIFICATION
Juhong Nam
Favorite
Nannini, Margherita

Oncology Unit. Department of Medical and Surgical Sciences, University of Bologna
(P 231) INCREASED LIFETIME RISK (LTR) OF SOFT TISSUE SARCOMAS (STS) IN PATIENTS WITH LOW-RISK GASTROINTESTINAL STROMAL TUMORS (GIST): A RETROSPECTIVE ANALYSIS FROM THE ITALIAN SARCOMA GROUP (ISG)
Margherita Nannini
Favorite
Narang, Claire

University of Miami School of Medicine
(P 320) CLINICAL CHARACTERISTICS AND RECURRENCE PATTERNS IN HISPANIC VS. NON-HISPANIC PATIENTS WITH LEIOMYOSARCOMA: FINDINGS FROM A RETROSPECTIVE SINGLE-CENTER COHORT STUDY
Claire Narang
Favorite
(P 327) INITIAL TREATMENT MODALITY AND RECURRENCE IN NON-METASTATIC LEIOMYOSARCOMA: A RETROSPECTIVE COHORT STUDY
Claire Narang
Favorite
Nardi, Walter

Unidad de Sarcomas y Melanoma - Hospital Británico de Buenos Aires
(P 306) PROGNOSTIC NUTRITIONAL INDEX PREDICTS MAJOR POSTOPERATIVE COMPLICATIONS IN RETROPERITONEAL SARCOMA: RESULTS FROM THE LATAMSARC COHORT
Walter Nardi
Favorite
Narta, Kiran

Arnie Charbonneau Cancer Institute and McCaig Institute for Bone and Joint Health
(P 238) INVESTIGATING HOW MACROPHAGES INFILTRATE THE TUMOUR MICROENVIRONMENT AND INFLUENCE THE EFFICACY OF CAR T THERAPY IN A MURINE MODEL OF STS
Kiran Narta
Favorite
(P 378) HIGH DOSE RADIATION THERAPY PROMOTES IMMUNE SUPPRESSIVE MACROPHAGE PHENOTYPES, WHEREAS LOW DOSE RADIATION THERAPY PROMOTES IMMUNOGENIC MACROPHAGE PHENOTYPES IN A MURINE MODEL OF SOFT TISSUE SARCOMA
Kiran Narta
Favorite
Nascimento, Antonio Geraldo

A.C.Camargo Cancer Center
(P 278) NEOADJUVANT HYPOFRACTIONATED RADIOTHERAPY AND CHEMOTHERAPY IN EXTREMITY SOFT TISSUE SARCOMAS
Antonio Geraldo Nascimento
Favorite
Nash, Joshua

The Hospital for Sick Children
(P 73) TARGETABLE GENE DEPENDENCIES IN EWING SARCOMA SUBTYPES
Joshua Nash
Favorite
Nasri, Elham

University of Florida
(P 129) HIJACKED FUEL: GLYCOGEN-DRIVEN METABOLIC SHIFTS IN IDH1-MUTANT CHONDROSARCOMA
Elham Nasri
Favorite
Nassar de Castro Cardoso, Fabiano

University of Miami
(P 147) CONVENTIONAL AND DEDIFFERENTIATED CHONDROSARCOMA; IS ENCHONDROMA THE PRECURSOR LESION?
Fabiano Nassar de Castro Cardoso
Favorite
Nassif Haddad, Elise

MD Anderson Cancer Center
(P 83) OUTCOMES OF MULTIMODAL PERIOPERATIVE TREATMENT IN OSTEOSARCOMAS OF THE JAW
Elise Nassif Haddad
Favorite
(P 172) COMPARISON OF CELL SEGMENTATION METHODS IN SOFT TISSUE SARCOMA (STS) SPATIAL PROTEOMIC DATASETS
Elise Nassif Haddad
Favorite
(P 184) MTAP IN GASTROINTESTINAL STROMAL TUMOR (GIST): RATE OF MTAP LOSS AND CONCORDANCE BETWEEN GENOMIC SEQUENCING AND IMMUNOHISTOCHEMISTRY
Elise Nassif Haddad
Favorite
(P 242) IMMUNE PROFILING OF UNDIFFERENTIATED PLEOMORPHIC SARCOMAS REVEALS DISTINCT PROGNOSTIC SUBGROUPS
Elise Nassif Haddad
Favorite
(P 351) THE ROLE OF SOCIOECONOMIC DISPARITIES ON SURVIVAL OUTCOMES IN MALIGNANT PERIPHERAL NERVE SHEATH TUMORS
Elise Nassif Haddad
Favorite
(P 451) TREATMENT OUTCOMES OF GEMCITABINE AND DOCETAXEL IN PATIENTS WITH CLEAR CELL SARCOMA (CCS) OR GASTROINTESTINAL NEUROECTODERMAL TUMOR (GNET): A CASE SERIES
Elise Nassif Haddad
Favorite
(P 460) OUTCOMES OF LATER-LINES SYSTEMIC THERAPIES IN MALIGNANT PERIPHERAL NERVE SHEATH TUMORS (MPNST)
Elise Nassif Haddad
Favorite
Nathenson, Michael

US World Meds
(P 337) POOLED ANALYSIS OF TRABECTEDIN EFFICACY IN MYXOID/ROUND CELL LIPOSARCOMA FROM THREE PROSPECTIVE CLINICAL TRIALS
Michael Nathenson
Favorite
Nayak, Prakash

Tata Memorial Hospital
(P 103) EARLY OUTCOMES OF BONE PROSTHESIS COMPOSITE FOR RECONSTRUCTION IN LOWER LIMB TUMORS. A SINGLE INSTITUTION STUDY
Prakash Nayak
Favorite
(P 208) TRANSLATION, CROSS CULTURAL ADAPTATION AND VALIDATION OF TESS IN REGIONAL INDIAN LANGUAGES WITH ~500 MILLION GLOBAL DIASPORA
Prakash Nayak
Favorite
Nayak, Prakash

Tata Memorial Hospital, Mumbai
(P 286) INTERSTITIAL BRACHYTHERAPY FOR ORGAN AND FUNCTION PRESERVATION IN SOFT TISSUE SARCOMAS: LONG TERM OUTCOMES
Prakash Nayak
Favorite
Nayak, Prakash

Tata Memorial Hospital
(P 387) TREATMENT PATTERNS AND PROGNOSTIC FACTORS IN LOCALISED SYNOVIAL SARCOMA: A RETROSPECTIVE STUDY FROM A TERTIARY CANCER CENTRE IN INDIA
Prakash Nayak
Favorite
(P 438) RANDOMIZED, OPEN-LABEL, PHASE III TRIAL OF ADJUVANT CHEMOTHERAPY VERSUS OBSERVATION IN NON-METASTATIC, HIGH-RISK SOFT TISSUE SARCOMAS (ACO-SARC TRIAL)
Prakash Nayak
Favorite
Neal, Jill

Clear Cell Sarcoma Foundation
(P 450) OUTCOMES IN CLEAR CELL SARCOMA: UPDATED INSIGHTS FROM ELECTRONIC HEALTH RECORDS IN A PATIENT-LED REGISTRY
Jill Neal
Favorite
Neamati, Nouri

University of Michigan
(P 24) THE SIRTUIN SIRT5 SUPPORTS EWING SARCOMA SURVIVAL VIA REGULATION OF EWS-FLI1 STABILITY AND ACTIVITY
Nouri Neamati
Favorite
Neefjes, Jacques

Leiden University Medical Center
(P 260) MECHANISM AND EFFICACY OF ANTHRACYCLINE MEDIATED EPIGENETIC DISRUPTION IN BONE SARCOMAS.
Jacques Neefjes
Favorite
Neilson, John C

MCW
(P 111) DOES DOSE MATTER? POSTOPERATIVE RADIATION DOSE AND OUTCOMES FOLLOWING FIXATION OF METASTATIC EXTREMITY BONE LESIONS
John C Neilson
Favorite
Nelson, Alissa

Cell Signaling Technology
(P 198) EXPLOITING METABOLIC DYSREGULATION IN SUCCINATE DEHYDROGENASE-DEFICIENT GASTROINTESTINAL STROMAL TUMOR
Alissa Nelson
Favorite
Nessim, Carolyn

The Ottawa Hospital
(P 309) RETROPERITONEAL LIPOMAS: MULTICENTER CLINICAL EXPERIENCE WITH AN EXTREMELY RARE DISEASE ENTITY
Carolyn Nessim
Favorite
Neuhauser, Steven

PIVOT Coordinating Center
(P 267) THE RAF/MEK INHIBITOR VS-6766 SHOWS EFFICACY IN RAS-MUTANT PEDIATRIC PRECLINICAL XENOGRAFT MODELS- A REPORT FROM THE PEDIATRIC PRECLINICAL IN VIVO TESTING CONSORTIUM
Steven Neuhauser
Favorite
Neu, Natascha

Chrestos GmbH
(P 417) EFFICACY AND SAFETY OF LAROTRECTINIB (LARO) IN PATIENTS (PTS) WITH TRK FUSION SARCOMAS
Natascha Neu
Favorite
(P 419) PROSPECTIVE REAL-WORLD STUDY OF LAROTRECTINIB (LARO) IN PATIENTS (PTS) WITH TRK FUSION SOLID TUMORS: INTERIM ANALYSIS OF ON-TRK
Natascha Neu
Favorite
New, Christin

Stanford University
(P 93) INTERCALARY COMPRESSIVE OSSEOINTEGRATION OF DIAPHYSEAL TUMORS: A MULTI-INSTITUTIONAL CASE SERIES
Christin New
Favorite
(P 400) LONGITUDINAL EPIGENETIC AND TRANSCRIPTOMIC REMODELING ACROSS PRIMARY, IRRADIATED, AND LOCALLY RELAPSED SOFT TISSUE SARCOMAS
Christin New
Favorite
Newhal, Kathryn

Immunome, Inc.
(P 410) SUBGROUP ANALYSIS OF THE PHASE 2 PART OF THE RINGSIDE PHASE 2/3 TRIAL OF VAREGACESTAT FOR TREATMENT OF DESMOID TUMORS
Kathryn Newhal
Favorite
Newman, Erik

MGH, Harvard
(P 105) TREATMENT SUCCESS RATE AFTER SURGICAL MANAGEMENT OF PERIPROSTHETIC JOINT INFECTIONS IN ONCOLOGIC PROXIMAL TIBIA RECONSTRUCTION
Erik Newman
Favorite
Neyaz, Azfar

University of Pittsburgh
(P 256) THE SEAN KARL COHORT: A NATIONAL COLLABORATIVE SINGLE-CELL RNASEQ STUDY OF PAIRED PATIENT EWING SARCOMA SPECIMENS
Azfar Neyaz
Favorite
Ngo, Carine

Gustave roussy
(P 299) RECURRENCES AFTER PRIMARY RPS SURGERY IN A HIGH-VOLUME SARCOMA CENTER: A RETROSPECTIVE ANALYSIS ON 402 PATIENTS
Carine Ngo
Favorite
Nguyen, Marie Huong

Parabilis Medicines
(P 415) A PHASE 1/2 TRIAL OF FOG-001, A FIRST-IN-CLASS DIRECT β-CATENIN:TCF4 INHIBITOR: SAFETY AND PRELIMINARY ANTITUMOR ACTIVITY IN PATIENTS WITH DESMOID TUMORS (DT)
Marie Huong Nguyen
Favorite
Nguyen, Valerie

Duke University
(P 259) PRECLINICAL MODELING OF CHEMOTHERAPY RELEASE IDENTIFIES MITOCHONDRIAL ADAPTATIONS IN DOXORUBICIN TREATED OSTEOSARCOMA
Valerie Nguyen
Favorite
Nicolau, Ulisses R.

AC Camargo Cancer Center
(P 155) BRCA2-MUTATED CONVENTIONAL CHONDROSARCOMA RESPONDING TO PARP INHIBITION: A CASE REPORT
Ulisses R. Nicolau
Favorite
Nielsen, Gunnlaugur

Massachusetts General Hospital
(P 290) CLINICAL OUTCOMES AFTER RADIOTHERAPY FOR PATIENTS WITH POORLY DIFFERENTIATED CHORDOMA
Gunnlaugur Nielsen
Favorite
Nielsen, Morten

National Center for Cancer Immune Therapy, Department of Oncology, Copenhagen University Hospital, Herlev, Denmark
(P 249) IN VITRO EXPANSION OF TUMOR-INFILTRATING GAMMA-DELTA T-CELLS FROM PATIENTS WITH SOFT TISSUE SARCOMAS
Morten Nielsen
Favorite
(P 352) TIME TOXICITY AND EFFECT OF CHEMOTHERAPY FOR PATIENTS WITH METASTATIC SOFT TISSUE SARCOMA - A RETROSPECTIVE REAL-WORLD STUDY OF 244 PATIENTS
Morten Nielsen
Favorite
Nielsen, Ryan

Department of Dermatology, University of California, Davis
(P 244) INTRATUMORAL TIGIT BLOCKADE AUGMENTS ANTI-TUMOR RESPONSES AND BYPASSES HYPERFUNCTIONALITY OF PERIPHERAL TIGIT+ NK CELLS IN MOUSE AND HUMAN MODELS OF BONE AND SOFT TISSUE SARCOMA
Ryan Nielsen
Favorite
niemierko, Andrzej

Massachusetts General Hospital
(P 461) A RETROSPECTIVE ANALYSIS OF PATIENTS WITH CONVENTIONAL CHORDOMA TREATED WITH SYSTEMIC THERAPY
Andrzej niemierko
Favorite
Nilsson, Hanna

Karolinska Institute
(P 270) FEASIBILITY OF FERTILITY PRESERVATION IN CHILDREN, ADOLESCENTS AND YOUNG ADULTS WITH SARCOMAS - A PROSPECTIVE COHORT STUDY WITH LONG-TERM FOLLOW-UP
Hanna Nilsson
Favorite
Nishida, Yoshihiro

Nagoya University Hospital
(P 128) ISOCITRATE DEHYDROGENASE 1 (IDH1) MUTATION TESTING IN THE PHASE 3 STUDY OF IVOSIDENIB VS PLACEBO IN IDH1-MUTANT CONVENTIONAL CHONDROSARCOMA (CHONQUER)
Yoshihiro Nishida
Favorite
Niu, Xiaohui

Department of Orthopaedic Oncology Surgery, Beijing Jishuitan Hospital, Peking University
(P 361) PEXIDARTINIB FOR THE TREATMENT OF TENOSYNOVIAL GIANT CELL TUMORS: CLINICAL EXPERIENCE FROM FIVE CHINESE PATIENTS
Xiaohui Niu
Favorite
(P 407) PIMICOTINIB IN TENOSYNOVIAL GIANT CELL TUMOR (TGCT): LONG-TERM EFFICACY, SAFETY, AND PATIENT-REPORTED OUTCOMES FROM THE PHASE 3 MANEUVER STUDY
Xiaohui Niu
Favorite
Noronha, Anne Marie

Memorial Sloan Kettering Cancer Center
(P 409) RETROSPECTIVE ANALYSIS OF PROGNOSTIC FACTORS INCLUDING HLA GENOTYPE IN MYXOID LIPOSARCOMA
Anne Marie Noronha
Favorite
Noujaim, Jonathan

Hôpital Maisonneuve-Rosemont and McGill University Health Center
(P 46) INVESTIGATING THE IMPACT OF SARCOMA FUSION PROTEINS ON EPIGENETIC AND DNA-DEPENDENT PROCESSES THROUGH INTERACTOME PROFILING
Jonathan Noujaim
Favorite
(P 120) SURVIVAL OUTCOMES AND ROLE OF CHEMOTHERAPY IN PATIENTS OLDER THAN 40 YEARS WITH OSTEOSARCOMA (OLD-SARC STUDY).
Jonathan Noujaim
Favorite
(P 395) ERIBULIN IN RECURRENT PRETREATED METASTATIC SOFT TISSUE SARCOMA. A CANADIAN SARCOMA RESEARCH AND CLINICAL COLLABORATION (CANSARCC) REAL WORLD ANALYSIS
Jonathan Noujaim
Favorite
Nousome, Darryl

Natera
(P 04) EARLY ON-TREATMENT CIRCULATING TUMOR DNA DYNAMICS TO PREDICT RESPONSE IN PATIENTS WITH SARCOMA
Darryl Nousome
Favorite
Nouth, Serey

Stanford University
(P 400) LONGITUDINAL EPIGENETIC AND TRANSCRIPTOMIC REMODELING ACROSS PRIMARY, IRRADIATED, AND LOCALLY RELAPSED SOFT TISSUE SARCOMAS
Serey Nouth
Favorite
Novis, Elan

Royal Marsden Hospital NHS Foundation Trust
(P 298) RESECTION OF PARA-RENAL INFERIOR VENA CAVA LEIOMYOSARCOMA WITH RIGHT NEPHRECTOMY AND LEFT RENAL VEIN LIGATION WITHOUT VENOUS RECONSTRUCTION.
Elan Novis
Favorite
Nowak, Elizabeth

Cleveland Clinic
(P 10) COLLATERAL SENSITIVIES EMERGE DURING THE EVOLUTION OF CHEMORESISTANCE TO MAP CHEMOTHERAPY IN OSTEOSARCOMA
Elizabeth Nowak
Favorite
(P 457) A RETROSPECTIVE REVIEW OF LOW-GRADE FIBROMYXOID SARCOMA: SURGICAL MANAGEMENT, RADIATION THERAPY, AND OUTCOMES
Elizabeth Nowak
Favorite
Nuñez, Isaac

Hospital Universitario Nuestra Señora de Candelaria
(P 389) UNRESECTABLE AND METASTATIC DEDIFFERENTIATED LIPOSARCOMA (DDLPS): INSIGHTS FROM A MULTICENTER REAL-WORLD COHORT (RWC)
Isaac Nuñez
Favorite
Nunes, Crystal

University of Pittsburgh
(P 14) EVALUATING THE COMBINATION OF DISULFIRAM AND ENZALUTAMIDE IN OSTEOSARCOMA
Crystal Nunes
Favorite
Nunes, Hugo

Instituto Português de Oncologia de Lisboa Francisco Gentil
(P 372) CLINICOPATHOLOGICAL FEATURES AND OUTCOMES OF PATIENTS WITH KAPOSI SARCOMA: A SINGLE CENTER RETROSPECTIVE REAL WORLD ANALYSIS
Hugo Nunes
Favorite
Nunez, Osvaldo

University of Miami/Jackson Health Systems
(P 397) EXPLORING REAL WORLD DATA OF RECURRENCE IN NON-METASTATIC MYXOFIBROSAROMA: AN UPDATED RETROSPECTIVE COHORT STUDY
Osvaldo Nunez
Favorite
Nystrom, Lukas

Cleveland Clinic
(P 84) A MULTICENTER COMPARISON OF REVERSE TOTAL SHOULDER ARTHROPLASTY VERSUS HEMIARTHROPLASTY FOR ENDOPROSTHETIC RECONSTRUCTION FOLLOWING ONCOLOGIC RESECTION OF THE PROXIMAL HUMERUS
Lukas Nystrom
Favorite
(P 220) THE IMPACT OF WOUND HEALING COMPLICATIONS ON PATIENT-REPORTED OUTCOMES FOLLOWING SOFT TISSUE SARCOMA SURGERY
Lukas Nystrom
Favorite
(P 284) THE IMPACT OF SARCOMA SBRT ON THE IMMUNE SYSTEM: EARLY RESULTS FROM A PROSPECTIVE TRIAL
Lukas Nystrom
Favorite
(P 316) AREA DEPRIVATION INDEX (ADI) AND OUTCOMES IN LOCALIZED SOFT TISSUE SARCOMA: DO SOCIAL DETERMINANTS INFLUENCE SURVIVAL?
Lukas Nystrom
Favorite
(P 355) CLASSIFYING WOUND HEALING COMPLICATIONS IN SURGICALLY TREATED EXTREMITY SOFT TISSUE SARCOMA
Lukas Nystrom
Favorite
O
O’Nians Michalowicz, Rose

Adaptimmune
(P 337) POOLED ANALYSIS OF TRABECTEDIN EFFICACY IN MYXOID/ROUND CELL LIPOSARCOMA FROM THREE PROSPECTIVE CLINICAL TRIALS
Rose O’Nians Michalowicz
Favorite
Obeidin, Farres

Robert H. Lurie Comprehensive Cancer Center of Northwestern University
(P 183) ACTIONABLE GENOMICS IN GASTROINTESTINAL STROMAL TUMORS LACKING KIT OR PDGFRA MUTATIONS.
Farres Obeidin
Favorite
(P 236) EXCEPTIONAL RESPONSE TO COMBINATION IMMUNOTHERAPY WITH YH001 AND ENVAFOLIMAB IN METASTATIC SARCOMA.
Farres Obeidin
Favorite
Oberoi, Sapna

CancerCare Manitoba
(P 250) OUTCOME OF INFANTS WITH RHABDOMYOSARCOMA: A REPORT FROM THE INTERNATIONAL SOFT TISSUE SARCOMA CONSORTIUM
Sapna Oberoi
Favorite
O'Brien, Carmel

KU Leuven
(P 69) EPIDEMIOLOGY AND POTENTIAL CLINICAL RELEVANCE OF TOP1 AND TOP2A TOPOISOMERASES EXPRESSION IN SOFT TISSUE SARCOMA
Carmel O'Brien
Favorite
Ochs, Christina

The Life Raft Group
(P 190) TEMPORAL DECLINE IN PROGRESSION-FREE SURVIVAL, TIME ON MEDICATION, AND OVERALL SURVIVAL IN ADVANCED GASTROINTESTINAL STROMAL TUMOR
Christina Ochs
Favorite
Odeniyide, Patience

Johns Hopkins University
(P 405) PAN-RAS INHIBITION AS A NOVEL THERAPEUTIC STRATEGY FOR RAS-DRIVEN RHABDOMYOSARCOMA
Patience Odeniyide
Favorite
Offer, Katharine

Department of Pediatrics, Hackensack Meridian School of Medicine, Hackensack Meridian Health
(P 251) SPATIAL MULTI-OMIC ANALYSIS OF RHABDOMYOSARCOMA IDENTIFIES THERAPEUTIC VULNERABILITIES
Katharine Offer
Favorite
Ogawa, Chitose

Department of Pediatric Oncology, National Cancer Center Hospital
(P 271) SAFETY AND EFFICACY OF CABOZANTINIB IN PEDIATRIC PATIENTS WITH MALIGNANT SOLID TUMORS (CAMEL TRIAL/NCCH2106): A SINGLE-CENTRE PHASE I TRIAL
Chitose Ogawa
Favorite
(P 341) PROGNOSTIC RELEVANCE OF CYCLOPHOSPHAMIDE DOSE FOR HIGH-RISK RHABDOMYOSARCOMA IN ADULT PATIENTS TREATED WITH VAC THERAPY
Chitose Ogawa
Favorite
Oghumu, steve

The Ohio State University Wexner Medical Center
(P 153) DOES THE QUANTITY OF DEDIFFERENTIATION MATTER IN THE CLINICAL OUTCOMES OF DEDIFFERENTIATED CHONDROSARCOMA? A 10-YEAR SINGLE TERTIARY INSTITUTIONAL EXPERIENCE OF A SERIES.
steve Oghumu
Favorite
Ogura, Koichi

National Cancer Center Hospital
(P 159) CHONDROSARCOMA IN JAPAN: A POPULATION-BASED ANALYSIS USING NATIONAL CANCER REGISTRY
Koichi Ogura
Favorite
Oh, David

University of California, San Francisco
(P 439) AN OPEN LABEL MULTICENTER PHASE 2 STUDY WITH SAFETY LEAD IN OF INTRATUMORAL VUSOLIMOGENE ODERPAREPVEC IN COMBINATION WITH PEMBROLIZUMAB IN PATIENTS WITH ANGIOSARCOMA
David Oh
Favorite
Oh, Nakyung

MD Anderson Cancer Center
(P 172) COMPARISON OF CELL SEGMENTATION METHODS IN SOFT TISSUE SARCOMA (STS) SPATIAL PROTEOMIC DATASETS
Nakyung Oh
Favorite
Okimoto, Ross

UCSF Helen Diller Family Comprehensive Cancer Center
(P 439) AN OPEN LABEL MULTICENTER PHASE 2 STUDY WITH SAFETY LEAD IN OF INTRATUMORAL VUSOLIMOGENE ODERPAREPVEC IN COMBINATION WITH PEMBROLIZUMAB IN PATIENTS WITH ANGIOSARCOMA
Ross Okimoto
Favorite
Okuno, Scott

Mayo Clinic
(P 223) OUTCOMES OF GERIATRIC PATIENTS WITH DE NOVO SARCOMA AND LUNG METASTASES: ROLE OF TUMOR CHARACTERISTICS AND TREATMENT STRATEGY
Scott Okuno
Favorite
(P 246) CTLA4 PATHWAY ACTIVATION IN RADIATION-INDUCED ANGIOSARCOMA: A TRANSCRIPTOMIC RATIONALE FOR IMMUNE CHECKPOINT BLOCKADE
Scott Okuno
Favorite
(P 300) FEATURES AND OUTCOMES OF PATIENTS WITH GASTROINTESTINAL LEIYOMYOSARCOMA
Scott Okuno
Favorite
(P 424) AN OPEN-LABEL PHASE 1/2 STUDY OF DCC-3009 MONOTHERAPY IN PATIENTS (PTS) WITH ADVANCED GASTROINTESTINAL STROMAL TUMOR (GIST)
Scott Okuno
Favorite
Olecki, Elizabeth

Roswell Park Comprehensive Cancer Center
(P 340) PREDICTORS OF LATE RECURRENCE AFTER SARCOMA SURGICAL RESECTION
Elizabeth Olecki
Favorite
Oliveira, Andre

Mayo Clinic
(P 309) RETROPERITONEAL LIPOMAS: MULTICENTER CLINICAL EXPERIENCE WITH AN EXTREMELY RARE DISEASE ENTITY
Andre Oliveira
Favorite
Oliveira, Luanna

A.C.Camargo Cancer Center
(P 132) MOLECULAR LANDSCAPE AND CLINICAL HETEROGENEITY OF BRAZILIAN CHONDROSARCOMAS: INSIGHTS FROM IDH, TERT, AND GENOME-WIDE ANALYSIS
Luanna Oliveira
Favorite
Oliveira, Luanna

AC Camargo Cancer Center
(P 155) BRCA2-MUTATED CONVENTIONAL CHONDROSARCOMA RESPONDING TO PARP INHIBITION: A CASE REPORT
Luanna Oliveira
Favorite
Olofsson-Bagge, Roger

Institute of Clinical Scinces/Sahlgrenska Academy
(P 124) ISOLATED LIMB PERFUSION AS LIMB SALVAGING TREATMENT; A SINGLE CENTRE RETROSPECTIVE STUDY
Roger Olofsson-Bagge
Favorite
Olshinkaa, Noam

Orthopedic Department, Sharett Institute for Oncology, Hadassah Medical Center & Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel
(P 06) RAPID, POINT-OF-CARE DNA METHYLATION & MOLECULAR LANDSCAPE BASED SARCOMA CLASSIFICATION
Noam Olshinkaa
Favorite
Olvera Valencia, Mercedes

Instituto Politecnico Nacional
(P 39) BUB1 AN OVEREXPRESSED KINASE IN SARCOMA: FINDING NEW TARGET THERAPY FOR OSTEOSARCOMA, LIPOSARCOMA, SYNOVIAL SARCOMA AND LEIOMYOSARCOMA
Mercedes Olvera Valencia
Favorite
Olvera, Ramona

The Ohio State University
(P 221) QUALITATIVE ANALYSIS OF THE PERIOPERATIVE EXPERIENCE OF YOUNG ADULT PATIENTS UNDERGOING EXTREMITY SARCOMA SURGERY
Ramona Olvera
Favorite
Ong, Chin-Ann Johnny

National Cancer Center Singapore
(P 53) ESTABLISHMENT AND CHARACTERISATION OF LIPOSARCOMA-DERIVED CELLS AS RELEVANT PRE-CLINICAL MODELS FOR TARGET DISCOVERY
Chin-Ann Johnny Ong
Favorite
Onoe, Takuma

Hyogo Cancer Center
(P 192) OPTIMAL DOSING SCHEDULE OF SUNITINIB BASED ON PLATELET COUNT IN AN OLDER PATIENT WITH GASTROINTESTINAL STROMAL TUMOR
Takuma Onoe
Favorite
Onoe, Tsuyoshi

Shizuoka Cancer Center
(P 291) INTRA-ARTERIAL CHEMOTHERAPY WITH CONCOMITANT RADIATION THERAPY FOR UNRESECTABLE SARCOMA
Tsuyoshi Onoe
Favorite
Orbach, Daniel

SIREDO Oncology Center (Care, Innovation and Research for Children and AYA With Cancer), Institut Curie
(P 417) EFFICACY AND SAFETY OF LAROTRECTINIB (LARO) IN PATIENTS (PTS) WITH TRK FUSION SARCOMAS
Daniel Orbach
Favorite
Orford, Keith

Tagworks Pharmaceuticals
(P 415) A PHASE 1/2 TRIAL OF FOG-001, A FIRST-IN-CLASS DIRECT β-CATENIN:TCF4 INHIBITOR: SAFETY AND PRELIMINARY ANTITUMOR ACTIVITY IN PATIENTS WITH DESMOID TUMORS (DT)
Keith Orford
Favorite
Oristian, Kristianne

Sarcoma Foundation of America
(P 209) SARCOMA PATIENT COMMUNITY DATA COLLABORATION TO ADVANCE RESEARCH
Kristianne Oristian
Favorite
Orlando, Sarah

Fondazione Policlinico Universitario Campus Bio-Medico
(P 61) HER2 TARGETING IN CHORDOMA: PRECLINICAL INSIGHTS ON TRASTUZUMAB DERUXTECAN
Sarah Orlando
Favorite
Orlando, Sarah

Università Campus Bio-medico Roma
(P 183) ACTIONABLE GENOMICS IN GASTROINTESTINAL STROMAL TUMORS LACKING KIT OR PDGFRA MUTATIONS.
Sarah Orlando
Favorite
(P 236) EXCEPTIONAL RESPONSE TO COMBINATION IMMUNOTHERAPY WITH YH001 AND ENVAFOLIMAB IN METASTATIC SARCOMA.
Sarah Orlando
Favorite
(P 412) UNCOVERING HER2 OVEREXPRESSION IN SOFT TISSUE SARCOMAS (STS): INSIGHTS FROM THE CANCER GENOME ATLAS (TCGA)
Sarah Orlando
Favorite
(P 429) SINGLE-ARM, OPEN-LABEL PHASE II TRIAL OF XL092 (ZANZALINTINIB) IN PATIENTS WITH ADVANCED LEIOMYOSARCOMA: TRIAL IN PROGRESS
Sarah Orlando
Favorite
Orme, Lisa

Peter MacCallum Cancer Centre
(P 121) REAL-WORLD EXPERIENCE OF CABOZANTINIB MONOTHERAPY IN RELAPSED OR REFRACTORY OSTEOSARCOMA AND EWING SARCOMA: A SINGLE-CENTRE AUSTRALIAN STUDY
Lisa Orme
Favorite
Or, Omer

Orthopedic Department, Sharett Institute for Oncology, Hadassah Medical Center & Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel
(P 06) RAPID, POINT-OF-CARE DNA METHYLATION & MOLECULAR LANDSCAPE BASED SARCOMA CLASSIFICATION
Omer Or
Favorite
Ortega-Izquierdo, Eugenia

Hospital Universitario Miguel Servet
(P 389) UNRESECTABLE AND METASTATIC DEDIFFERENTIATED LIPOSARCOMA (DDLPS): INSIGHTS FROM A MULTICENTER REAL-WORLD COHORT (RWC)
Eugenia Ortega-Izquierdo
Favorite
Ortiz Cruz, Eduardo

Hospital Universitario La Paz
(P 151) SHOULD WE USE ADJUVANT CHEMOTHERAPY IN PATIENTS WITH LOCALIZED DEDIFFERENTIATED CHONDROSARCOMA (DDCS) OF THE PELVIS? AN ANALYSIS BY THE PELVIC DDCS STUDY GROUP
Eduardo Ortiz Cruz
Favorite
Ortiz-Requena, Domenika

University of Miami
(P 147) CONVENTIONAL AND DEDIFFERENTIATED CHONDROSARCOMA; IS ENCHONDROMA THE PRECURSOR LESION?
Domenika Ortiz-Requena
Favorite
(P 327) INITIAL TREATMENT MODALITY AND RECURRENCE IN NON-METASTATIC LEIOMYOSARCOMA: A RETROSPECTIVE COHORT STUDY
Domenika Ortiz-Requena
Favorite
(P 333) METABOLIC SYNDROME CORRELATION WITH LIPOSARCOMA INCIDENCE AND OUTCOMES: A RETROSPECTIVE ANALYSIS.
Domenika Ortiz-Requena
Favorite
Osman, Noha

The University of Texas MD Anderson Cancer Center
(P 172) COMPARISON OF CELL SEGMENTATION METHODS IN SOFT TISSUE SARCOMA (STS) SPATIAL PROTEOMIC DATASETS
Noha Osman
Favorite
(P 242) IMMUNE PROFILING OF UNDIFFERENTIATED PLEOMORPHIC SARCOMAS REVEALS DISTINCT PROGNOSTIC SUBGROUPS
Noha Osman
Favorite
Ossiani, Tara

MGH
(P 392) CLASSIFICATION AND DIFFERENTIATIONOF MYXOID LIPOSARCOMA AND MYXOMA WITH MACHINE LEARNING
Tara Ossiani
Favorite
(P 392) DIFFERENTIATION OF MYXOMA AND MYXOID LIPOSARCOMA BASED ON RADIOMICS PHENOTYPES
Tara Ossiani
Favorite
Otero Norza, Diana

Dr. Rafael Angel Calderón Guardia.
(P 306) PROGNOSTIC NUTRITIONAL INDEX PREDICTS MAJOR POSTOPERATIVE COMPLICATIONS IN RETROPERITONEAL SARCOMA: RESULTS FROM THE LATAMSARC COHORT
Diana Otero Norza
Favorite
Oton, Ana

SpringWorks Therapeutics
(P 413) EFFICACY OF NIROGACESTAT IN PATIENTS WITH DESMOID TUMORS AND PRESENCE OR ABSENCE OF POOR PROGNOSTIC FACTORS: POST HOC ANALYSES OF THE PHASE 3 DEFI TRIAL
Ana Oton
Favorite
(P 442) TRIAL IN PROGRESS: A SINGLE-ARM, OPEN-LABEL PHASE 4 TRIAL OF NIROGACESTAT IN ADULT PREMENOPAUSAL FEMALES WITH DESMOID TUMORS
Ana Oton
Favorite
O'Toole, Gary

St Vincent's University Hospital
(P 211) HEALTH-RELATED QUALITY OF LIFE IN IRISH SARCOMA PATIENTS
Gary O'Toole
Favorite
(P 213) FINANCIAL TOXICITY IN IRISH SARCOMA CARE: A SINGLE-CENTRE ANALYSIS
Gary O'Toole
Favorite
O'Toole, Riley

Cleveland Clinic
(P 220) THE IMPACT OF WOUND HEALING COMPLICATIONS ON PATIENT-REPORTED OUTCOMES FOLLOWING SOFT TISSUE SARCOMA SURGERY
Riley O'Toole
Favorite
(P 316) AREA DEPRIVATION INDEX (ADI) AND OUTCOMES IN LOCALIZED SOFT TISSUE SARCOMA: DO SOCIAL DETERMINANTS INFLUENCE SURVIVAL?
Riley O'Toole
Favorite
(P 355) CLASSIFYING WOUND HEALING COMPLICATIONS IN SURGICALLY TREATED EXTREMITY SOFT TISSUE SARCOMA
Riley O'Toole
Favorite
Ottestad, Anine

Oslo University Hospital
(P 200) DISSECTING INTRATUMORAL HETEROGENEITY IN GIST USING SPATIAL TRANSCRIPTOMICS
Anine Ottestad
Favorite
Oudeh, Ahmad

Memorial Sloan Kettering Cancer Center
(P 273) RADIOMIC PREDICTORS OF SPONTANEOUS PNEUMOTHORAX DURING TYROSINE KINASE INHIBITOR THERAPY FOR LUNG METASTASES
Ahmad Oudeh
Favorite
Ou, Jianhong

Duke University
(P 126) SINGLE-CELL RNA SEQUENCING AND PROTEOMIC SPATIAL PROFILING REVEAL COMPLEX TUMOR MICROENVIRONMENT AND NOVEL IMMUNE INTERACTIONS IN CHONDROSARCOMA
Jianhong Ou
Favorite
Oyem, Precious

Cleveland Clinic
(P 220) THE IMPACT OF WOUND HEALING COMPLICATIONS ON PATIENT-REPORTED OUTCOMES FOLLOWING SOFT TISSUE SARCOMA SURGERY
Precious Oyem
Favorite
Ozaki, Toshifumi

Okayama University Hospital
(P 79) AGE-BASED TREATMENT PATTERNS AND OUTCOMES OF LOCALIZED HIGH-GRADE OSTEOSARCOMA FROM A NATIONWIDE DATABASE: WHAT IS THE OPTIMAL STRATEGY FOR PATIENTS OLDER THAN 40 YEARS?
Toshifumi Ozaki
Favorite
Ozaniak Strizova, Zuzana

Department of Immunology, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic
(P 243) CLINICAL SIGNIFICANCE OF TUMOR-INFILTRATING IMMUNE CELL SUBSETS IN THE RETROPERITONEAL DEDIFFERENTIATED LIPOSARCOMAS AND LEIOMYOSARCOMAS
Zuzana Ozaniak Strizova
Favorite
Ozaniak, Andrej

Third Department of Surgery, 1st Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic
(P 243) CLINICAL SIGNIFICANCE OF TUMOR-INFILTRATING IMMUNE CELL SUBSETS IN THE RETROPERITONEAL DEDIFFERENTIATED LIPOSARCOMAS AND LEIOMYOSARCOMAS
Andrej Ozaniak
Favorite
P
Pérez-Velasco, Rocío

Hospital Universitario Virgen del Rocio
(P 115) SINGLE-CENTER EXPERIENCE WITH TYROSIN KINASA INHIBITORS IN ADVANCED BONE SARCOMA: EFFICACY AND SAFETY OUTCOMES
Rocío Pérez-Velasco
Favorite
Pablik, Jessica

Department of Pathology, University Hospital Carl Gustav Carus, Dresden, Germany
(P 243) CLINICAL SIGNIFICANCE OF TUMOR-INFILTRATING IMMUNE CELL SUBSETS IN THE RETROPERITONEAL DEDIFFERENTIATED LIPOSARCOMAS AND LEIOMYOSARCOMAS
Jessica Pablik
Favorite
Padilla, Catarina

The Netherlands Cancer Institute
(P 444) HEALTH-RELATED QUALITY OF LIFE (HRQOL) CHALLENGES IN PATIENTS WITH EPITHELIOID HEMANGIOENDOTHELIOMA (EHE): ANALYSIS OF AN ULTRA-RARE SARCOMA GROUP
Catarina Padilla
Favorite
Padilla, Karen

Texas Tech University Health Science Center El Paso
(P 78) MENTAL HEALTH DISORDERS FOLLOWING PATHOLOGICAL FRACTURE: A RETROSPECTIVE COHORT STUDY
Karen Padilla
Favorite
Paglia, Simona

IRCCS Rizzoli Orthopaedic Institute
(P 18) ESTABLISHMENT AND CHARACTERIZATION OF A NOVEL PRIMARY CELL LINE FROM A BONE METASTASIS OF OSTEOSARCOMA
Simona Paglia
Favorite
Pagnoni, Chiara

Fondazione Policlinico Universitario Campus Bio-Medico
(P 328) INNOVATING SARCOMA EDUCATION: EARLY OUTCOMES OF THE ITALIAN SOCIETY OF SURGICAL ONCOLOGY (SICO) SARCOMA SOCIAL MULTI-PLATFORM JOURNAL CLUB INITIATIVE
Chiara Pagnoni
Favorite
Paisan, Ana

Hospital Universitario Donostia
(P 389) UNRESECTABLE AND METASTATIC DEDIFFERENTIATED LIPOSARCOMA (DDLPS): INSIGHTS FROM A MULTICENTER REAL-WORLD COHORT (RWC)
Ana Paisan
Favorite
Palassini, Elena

Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan
(P 277) THE ROLE OF RADIOTHERAPY IN THE MULTIDISCIPLINARY MANAGEMENT OF RADIATION-ASSOCIATED ANGIOSARCOMA OF THE BREAST: A REFERRAL CENTER EXPERIENCE
Elena Palassini
Favorite
Palassini, Elena

Fondazione IRCCS Istituto Nazionale Tumori
(P 458) BETWEEN LYMPHOMAS AND SARCOMAS: A RETROSPECTIVE, MULTI-INSTITUTIONAL STUDY FROM THE ITALIAN SARCOMA GROUP (ISG) ON HISTIOCYTIC AND DENDRITIC CELL NEOPLASMS (HDCN)
Elena Palassini
Favorite
Paley, Lizz

National Disease Registration Service, NHS England
(P 156) CHONDROSARCOMA INCIDENCE, SURVIVAL AND MANAGEMENT IN ENGLAND 2013-2022; AN ANALYSIS FROM THE NATIONAL DISEASE REGISTRATION SERVICE
Lizz Paley
Favorite
Palmerini, Emanuela

Sylvester Comprehensive Cancer Center
(P 71) GERMLINE POLYMORPHISMS IN THE VEGF PATHWAY AS PROGNOSTIC BIOMARKERS IN LOCALIZED HIGH-GRADE OSTEOSARCOMA: A STUDY BASED ON DATA FROM THE GEIS-33 PROTOCOL
Emanuela Palmerini
Favorite
(P 139) IMMUNOGENOMIC PROFILING OF CHONDROSARCOMA REVEALS DISTINCT IMMUNE PHENOTYPES AND PROGNOSTIC MUTATIONS
Emanuela Palmerini
Favorite
(P 151) SHOULD WE USE ADJUVANT CHEMOTHERAPY IN PATIENTS WITH LOCALIZED DEDIFFERENTIATED CHONDROSARCOMA (DDCS) OF THE PELVIS? AN ANALYSIS BY THE PELVIC DDCS STUDY GROUP
Emanuela Palmerini
Favorite
(P 403) MEDICAL MANAGEMENT OF TENOSYNOVIAL GIANT CELL TUMOR
Emanuela Palmerini
Favorite
Palova Jelinkova, Lenka

SOTIO Biotech a.s.
(P 257) TARGETING LEUCINE-RICH REPEAT-CONTAINING PROTEIN 15 (LRRC15): SOT106 ANTIBODY-DRUG CONJUGATE FOR SOFT TISSUE SARCOMA AND OSTEOSARCOMA TREATMENT
Lenka Palova Jelinkova
Favorite
Pal, Rahul

Mass Eye and Ear
(P 62) INTRAOPERATIVE BONE AND SOFT TISSUE TUMOR MARGIN IDENTIFICATION WITH FLUORESCENCE LIFETIME (FLT) IMAGING
Rahul Pal
Favorite
Pan, Dean

The University of Texas MD Anderson Cancer Center
(P 391) ATRX LOSS BLOCKS THE DIFFERENTIATION OF MESENCHYMAL STEM CELLS AND ADVANCES UNDIFFERENTIATED SARCOMA DEVELOPMENT
Dean Pan
Favorite
Pandey, Rambha

All India Institute of Medical Sciences, New Delhi
(P 276) RADIATION-INDUCED SARCOMA (RIS): CLINICAL SPECTRUM AND ONCOLOGIC OUTCOMES FROM A TERTIARY INDIAN SARCOMA CLINIC
Rambha Pandey
Favorite
Pandey, Saurav

Boston Children's Hospital Department of Orthopaedic Surgery
(P 112) PEDIATRIC GIANT CELL TUMOR OF BONE
Saurav Pandey
Favorite
Panjwani, Poonam

Tata Memorial Hospital
(P 292) CRANIOVERTEBRAL EWINGS SARCOMA WITH MENINGEAL INFILTRATION - A CLINICAL OUTCOME ANALYSIS
Poonam Panjwani
Favorite
(P 338) POORLY DIFFERENTIATED SYNOVIAL SARCOMA: A HISTOLOGIC CHALLENGE OF AN AGGRESSIVE VARIANT
Poonam Panjwani
Favorite
(P 379) IMPACT OF EWSR1 GENE REARRANGEMENT TESTING ON DIAGNOSIS OF A WIDE RANGE OF SOLID TUMOURS
Poonam Panjwani
Favorite
(P 387) TREATMENT PATTERNS AND PROGNOSTIC FACTORS IN LOCALISED SYNOVIAL SARCOMA: A RETROSPECTIVE STUDY FROM A TERTIARY CANCER CENTRE IN INDIA
Poonam Panjwani
Favorite
Pan, Minggui

Stanford University
(P 37) DISSECTING THE TUMOR MICROENVIRONMENT OF UTERINE LEIOMYOSARCOMAS FOR TARGETED DRUG PREDICTIONS
Minggui Pan
Favorite
(P 297) ANALYSIS OF CTDNA KINETICS IN PATIENTS WITH METASTATIC LEIOMYOSARCOMA UNDERGOING LOCOREGIONAL PROCEDURAL INTERVENTION
Minggui Pan
Favorite
Pannucci, Abbe

University of Pittsburgh
(P 256) THE SEAN KARL COHORT: A NATIONAL COLLABORATIVE SINGLE-CELL RNASEQ STUDY OF PAIRED PATIENT EWING SARCOMA SPECIMENS
Abbe Pannucci
Favorite
Pantaleo, Maria Abbondanza

Oncology Unit. Department of Medical and Surgical Sciences, University of Bologna
(P 231) INCREASED LIFETIME RISK (LTR) OF SOFT TISSUE SARCOMAS (STS) IN PATIENTS WITH LOW-RISK GASTROINTESTINAL STROMAL TUMORS (GIST): A RETROSPECTIVE ANALYSIS FROM THE ITALIAN SARCOMA GROUP (ISG)
Maria Abbondanza Pantaleo
Favorite
Pantano, Francesco

Fondazione Policlinico Universitario Campus Bio-Medico
(P 61) HER2 TARGETING IN CHORDOMA: PRECLINICAL INSIGHTS ON TRASTUZUMAB DERUXTECAN
Francesco Pantano
Favorite
Pan, Yutong

The University of Texas Health Science Center at Houston
(P 172) COMPARISON OF CELL SEGMENTATION METHODS IN SOFT TISSUE SARCOMA (STS) SPATIAL PROTEOMIC DATASETS
Yutong Pan
Favorite
Papadopoulos, Kyriakos P.

START San Antonio
(P 415) A PHASE 1/2 TRIAL OF FOG-001, A FIRST-IN-CLASS DIRECT β-CATENIN:TCF4 INHIBITOR: SAFETY AND PRELIMINARY ANTITUMOR ACTIVITY IN PATIENTS WITH DESMOID TUMORS (DT)
Kyriakos P. Papadopoulos
Favorite
Papinska, Anna

Deciphera Pharmaceuticals, LLC
(P 424) AN OPEN-LABEL PHASE 1/2 STUDY OF DCC-3009 MONOTHERAPY IN PATIENTS (PTS) WITH ADVANCED GASTROINTESTINAL STROMAL TUMOR (GIST)
Anna Papinska
Favorite
Papke, David

Brigham and Women's Hospital
(P 34) EXPRESSION OF ONCOFETAL ANTIGEN 5T4 IN SARCOMA SUBTYPES AND PRECLINICAL ACTIVITY OF TUB-030, A NOVEL 5T4-TARGETING ANTIBODY-DRUG CONJUGATE (ADC)
David Papke
Favorite
(P 235) AGNOSTIC INDICATION OF IMMUNE CHECKPOINT INHIBITORS (ICI): PATTERNS OF RESPONSE OF SARCOMAS
David Papke
Favorite
Paralkar, Vishwas

Cybrexa Therapeutics
(P 40) PRECLINICAL EFFICACY OF A PH-SENSITIVE EXATECAN PEPTIDE-DRUG-CONJUGATE IN RHABDOMYOSARCOMA
Vishwas Paralkar
Favorite
parambil, badira

Tata Memorial Hospital
(P 379) IMPACT OF EWSR1 GENE REARRANGEMENT TESTING ON DIAGNOSIS OF A WIDE RANGE OF SOLID TUMOURS
badira parambil
Favorite
Paratala, Bhavna

Adaptimmune
(P 247) SINGLE-CELL RNA SEQUENCING OF AFAMITRESGENE AUTOLEUCEL INDICATES MECHANISMS OF PERSISTENCE AND ANTI-TUMOR ACTIVITY
Bhavna Paratala
Favorite
Parker, Dominique

Vanderbilt University
(P 51) OVEREXPRESSION OF GLI2 IN DEDIFFERENTIATED LIPOSARCOMA TUMORS INDUCES MICROENVIRONMENT REMODELING
Dominique Parker
Favorite
Park, Hyenmin

National Cancer Center
(P 109) FINITE ELEMENT ANALYSIS FOR FIXATION EVALUATION OF PATIENT-SPECIFIC ORTHOPEDIC IMPLANTS
Hyenmin Park
Favorite
Park, Jay Hoon

Department of Orthopaedic surgery, Seoul National University Hospital
(P 176) DEEP LEARNING MODEL FOR DIFFERENTIATING BETWEEN NEOPLASTIC PATHOLOGIC FRACTURE AND NONPATHOLOGIC FRACTURE FROM PLAIN HIP RADIOGRAPHS
Jay Hoon Park
Favorite
Park, Jong Woong

National Cancer Center
(P 101) METAL ION MONITORING AFTER CUSTOM 3D-PRINTED IMPLANTS IN BONE TUMOR SURGERY: COMPARISON WITH MODULAR SYSTEMS AND EARLY OBSERVATIONS
Jong Woong Park
Favorite
(P 109) FINITE ELEMENT ANALYSIS FOR FIXATION EVALUATION OF PATIENT-SPECIFIC ORTHOPEDIC IMPLANTS
Jong Woong Park
Favorite
(P 296) PULMONARY CEMENT EMBOLISM ASSOCIATED WITH PERCUTANEOUS CEMENTOPLASTY FOR BONE METASTASIS: MECHANISMS AND PROTECTIVE FACTORS
Jong Woong Park
Favorite
Parolia, Abhijit

University of Michigan
(P 24) THE SIRTUIN SIRT5 SUPPORTS EWING SARCOMA SURVIVAL VIA REGULATION OF EWS-FLI1 STABILITY AND ACTIVITY
Abhijit Parolia
Favorite
Parra, Tabita

Instituto Traumatologico Teodoro Gebauer
(P 212) MISINFORMATION IN SARCOMA CONTENT ON SOCIAL MEDIA PLATFORMS
Tabita Parra
Favorite
Parry, Michael

Royal Orthopaedic Hospital Birmingham
(P 156) CHONDROSARCOMA INCIDENCE, SURVIVAL AND MANAGEMENT IN ENGLAND 2013-2022; AN ANALYSIS FROM THE NATIONAL DISEASE REGISTRATION SERVICE
Michael Parry
Favorite
Parsons, Katelyn

Duke University School of Medicine
(P 119) DEVELOPMENT OF AN EXTINCTION THERAPY APPROACH FOR OSTEOSARCOMA USING ECO-EVOLUTIONARY PRINCIPLES
Katelyn Parsons
Favorite
(P 259) PRECLINICAL MODELING OF CHEMOTHERAPY RELEASE IDENTIFIES MITOCHONDRIAL ADAPTATIONS IN DOXORUBICIN TREATED OSTEOSARCOMA
Katelyn Parsons
Favorite
Pasqualini, Ignacio

Cleveland Clinic
(P 84) A MULTICENTER COMPARISON OF REVERSE TOTAL SHOULDER ARTHROPLASTY VERSUS HEMIARTHROPLASTY FOR ENDOPROSTHETIC RECONSTRUCTION FOLLOWING ONCOLOGIC RESECTION OF THE PROXIMAL HUMERUS
Ignacio Pasqualini
Favorite
Pasquali, Sandro

Fondazione IRCCS Istituto Nazionale dei Tumori
(P 32) EFFECTIVENESS OF LURBINECTEDIN PLUS IRINOTECAN IN PRECLINICAL MODEL OF DESMOPLASTIC SMALL ROUND CELL TUMOR
Sandro Pasquali
Favorite
(P 308) IMPACT OF PSOAS MUSCLE RESECTION ON OUTCOMES IN PRIMARY RETROPERITONEAL DEDIFFERENTIATED LIPOSARCOMA
Sandro Pasquali
Favorite
(P 446) GDF-15 AS A PROGNOSTIC FACTOR IN PATIENTS WITH EPITHELIOID HEMANGIOENDOTHELIOMA
Sandro Pasquali
Favorite
(P 447) PAIN ASSESSMENT CRITERIA (PAC) ANTICIPATE RECIST PROGRESSION AND CORRELATE WITH BLOOD LEVELS OF GROWTH DIFFERENTIATION FACTOR 15 (GDF15) IN EPITHELIOID HEMANGIOENDOTHELIOMA (EHE)
Sandro Pasquali
Favorite
(P 452) EFFECTIVENESS OF ERIBULIN FOR MYXOID PLEOMORPHIC LIPOSARCOMA: INSIGHTS FROM A PATIENT-DERIVED MODEL AND CLINICAL TRANSLATION IN A PATIENT WITH ADVANCED DISEASE
Sandro Pasquali
Favorite
Pastorino, Ugo

Fondazione IRCCS Istituto Nazionale dei Tumori
(P 452) EFFECTIVENESS OF ERIBULIN FOR MYXOID PLEOMORPHIC LIPOSARCOMA: INSIGHTS FROM A PATIENT-DERIVED MODEL AND CLINICAL TRANSLATION IN A PATIENT WITH ADVANCED DISEASE
Ugo Pastorino
Favorite
Patel, Kirtan

Stanley Manne Children's Research Institute
(P 252) NUCLEAR AND GENOMIC ORGANIZATION OF CHEMOTHERAPY RESISTANT RHABDOMYOSARCOMA CELLS
Kirtan Patel
Favorite
Patel, Rishi

University of Iowa Health Care
(P 370) CLINICAL OUTCOMES OF CUTANEOUS UNDIFFERENTIATED PLEOMORPHIC SARCOMA AND SUBCUTANEOUS MYXOFIBROSARCOMA: A RETROSPECTIVE REVIEW
Rishi Patel
Favorite
Patel, Rudra

University of Pittsburgh
(P 14) EVALUATING THE COMBINATION OF DISULFIRAM AND ENZALUTAMIDE IN OSTEOSARCOMA
Rudra Patel
Favorite
Patel, Rutulkumar

M.D. Anderson Cancer Center, University of Texas
(P 58) PLK1 AS A VULNERABLE TARGET OF BAP1-DRIVEN UNDIFFERENTIATED PLEOMORPHIC SARCOMAS
Rutulkumar Patel
Favorite
Patel, Shreyaskumar

University of Texas MD Anderson Cancer Center
(P 83) OUTCOMES OF MULTIMODAL PERIOPERATIVE TREATMENT IN OSTEOSARCOMAS OF THE JAW
Shreyaskumar Patel
Favorite
(P 242) IMMUNE PROFILING OF UNDIFFERENTIATED PLEOMORPHIC SARCOMAS REVEALS DISTINCT PROGNOSTIC SUBGROUPS
Shreyaskumar Patel
Favorite
(P 411) TFCP2 FUSION-POSITVE RHABDOMYOSARCOMAS: A REPORT OF 10 CASES AND A REVIEW OF THE LITERATURE
Shreyaskumar Patel
Favorite
(P 423) ZIFTOMENIB IN COMBINATION WITH IMATINIB IN ADVANCED GASTROINTESTINAL STROMAL TUMORS (GIST) AFTER IMATINIB FAILURE: PHASE 1A/B STUDY OF SAFETY, PHARMACOKINETICS, AND ANTITUMOR ACTIVITY
Shreyaskumar Patel
Favorite
(P 451) TREATMENT OUTCOMES OF GEMCITABINE AND DOCETAXEL IN PATIENTS WITH CLEAR CELL SARCOMA (CCS) OR GASTROINTESTINAL NEUROECTODERMAL TUMOR (GNET): A CASE SERIES
Shreyaskumar Patel
Favorite
(P 460) OUTCOMES OF LATER-LINES SYSTEMIC THERAPIES IN MALIGNANT PERIPHERAL NERVE SHEATH TUMORS (MPNST)
Shreyaskumar Patel
Favorite
Paternostro, Flavia

Università Campus Bio-medico Roma
(P 412) UNCOVERING HER2 OVEREXPRESSION IN SOFT TISSUE SARCOMAS (STS): INSIGHTS FROM THE CANCER GENOME ATLAS (TCGA)
Flavia Paternostro
Favorite
Patil, Vasundhara

Tata Memorial Hospital, Tata memorial Centre, Mumbai
(P 292) CRANIOVERTEBRAL EWINGS SARCOMA WITH MENINGEAL INFILTRATION - A CLINICAL OUTCOME ANALYSIS
Vasundhara Patil
Favorite
Patkar, Shraddha

Tata Memorial Hospital, Mumbai, India
(P 304) MANAGEMENT OF RECURRENT RETROPERITONEAL SARCOMAS: A RETROSPECTIVE STUDY FROM A TERTIARY CANCER CENTER.
Shraddha Patkar
Favorite
(P 463) EXTRANODAL FOLLICULAR DENDRITIC CELL SARCOMAS AND THEIR OLIGORECURRENCES: TRIUMPHS, TRIALS AND LESSONS LEARNT AT A SINGLE TERTIARY CANCER REFERRAL CENTRE, INDIA.
Shraddha Patkar
Favorite
Patt, Joshua

Atrium Health Levine Cancer Institute
(P 02) METHYLATION PROFILING AS A DIAGNOSTIC ADJUNCT FOR UNDIFFERENTIATED SARCOMAS: A REAL-WORLD EVALUATION
Joshua Patt
Favorite
Paudel, Amrit

University of Miami/Sylvester Comprehensive Cancer Center
(P 224) PAN-SARCOMA DATABASE (PSDB): AN UPDATE ON MIAMI'S COLLABORATIVE MULTI-USER DATA PIPELINE OF SARCOMA DATA USING REDCAP AND R CODING
Amrit Paudel
Favorite
(P 225) GLOBAL REGISTRY OF SOLITARY FIBROUS TUMORS (SFT): INTEGRATING CLINICAL, MOLECULAR, AND ENVIRONMENTAL DATA- THE HOROWITZ SFT INITIATIVE (HSFTI)
Amrit Paudel
Favorite
(P 320) CLINICAL CHARACTERISTICS AND RECURRENCE PATTERNS IN HISPANIC VS. NON-HISPANIC PATIENTS WITH LEIOMYOSARCOMA: FINDINGS FROM A RETROSPECTIVE SINGLE-CENTER COHORT STUDY
Amrit Paudel
Favorite
(P 327) INITIAL TREATMENT MODALITY AND RECURRENCE IN NON-METASTATIC LEIOMYOSARCOMA: A RETROSPECTIVE COHORT STUDY
Amrit Paudel
Favorite
(P 333) METABOLIC SYNDROME CORRELATION WITH LIPOSARCOMA INCIDENCE AND OUTCOMES: A RETROSPECTIVE ANALYSIS.
Amrit Paudel
Favorite
(P 362) SHOULD PAZOPANIB BE USED AS A MAINTENANCE THERAPY TO IMPROVE RECURRENCE-FREE SURVIVAL AND OVERALL SURVIVAL IN PATIENTS WHO RECEIVED MAI IN SOFT TISSUE SARCOMA?
Amrit Paudel
Favorite
(P 369) CLINICAL CHARACTERISTICS & TREATMENT OUTCOME PATTERNS OF SOLITARY FIBROUS TUMORS: A SINGLE-INSTITUTION RETROSPECTIVE ANALYSIS
Amrit Paudel
Favorite
(P 397) EXPLORING REAL WORLD DATA OF RECURRENCE IN NON-METASTATIC MYXOFIBROSAROMA: AN UPDATED RETROSPECTIVE COHORT STUDY
Amrit Paudel
Favorite
Pavisic, Jovana

Memorial Sloan Kettering Cancer Center
(P 22) SINGLE CELL SEQUENCING ENABLES LINEAGE-INFORMED TARGETING OF OSTEOSARCOMA
Jovana Pavisic
Favorite
(P 25) IDENTIFICATION AND VALIDATION OF NON-GENETICALLY ENCODED VULNERABILITIES IN EWING SARCOMA
Jovana Pavisic
Favorite
(P 256) THE SEAN KARL COHORT: A NATIONAL COLLABORATIVE SINGLE-CELL RNASEQ STUDY OF PAIRED PATIENT EWING SARCOMA SPECIMENS
Jovana Pavisic
Favorite
Peairs, Emily

Mayo Clinic
(P 96) AMPUTATION FOLLOWING MEGAPROSTHESIS USE IN LIMB SALVAGE
Emily Peairs
Favorite
(P 214) FINANCIAL TOXICITY IN PATIENTS WITH A HISTORY OF EXTREMITY AND PELVIC SARCOMA TREATMENT
Emily Peairs
Favorite
(P 348) SYNOVIAL SARCOMA INVOLVING NERVES: HIGH RATE OF MISIDENTIFICATION AS BENIGN TUMORS
Emily Peairs
Favorite
Pearce, Hayes

University of Miami Miller School of Medicine
(P 201) METASTATIC PATTERNS, TREATMENT MODALITIES, AND OVERALL SURVIVAL IN OLIGOMETASTATIC GIST: A SINGLE-CENTER RETROSPECTIVE STUDY
Hayes Pearce
Favorite
Pelster, Meredith

Sarah Cannon Research Institute
(P 415) A PHASE 1/2 TRIAL OF FOG-001, A FIRST-IN-CLASS DIRECT β-CATENIN:TCF4 INHIBITOR: SAFETY AND PRELIMINARY ANTITUMOR ACTIVITY IN PATIENTS WITH DESMOID TUMORS (DT)
Meredith Pelster
Favorite
Pemmanda, Mira

St John’s School
(P 460) OUTCOMES OF LATER-LINES SYSTEMIC THERAPIES IN MALIGNANT PERIPHERAL NERVE SHEATH TUMORS (MPNST)
Mira Pemmanda
Favorite
Penel, Nicolas

Centre Oscar Lambret
(P 434) A FIRST-IN-HUMAN PHASE 1, MULTICENTER, OPEN-LABEL STUDY OF M3554, A NOVEL ANTI-GD2 ANTIBODY-DRUG CONJUGATE, IN PATIENTS WITH ADVANCED SOLID TUMORS
Nicolas Penel
Favorite
Pennacchioli, Elisabetta

European Institute of Oncology, IRCCS
(P 231) INCREASED LIFETIME RISK (LTR) OF SOFT TISSUE SARCOMAS (STS) IN PATIENTS WITH LOW-RISK GASTROINTESTINAL STROMAL TUMORS (GIST): A RETROSPECTIVE ANALYSIS FROM THE ITALIAN SARCOMA GROUP (ISG)
Elisabetta Pennacchioli
Favorite
(P 328) INNOVATING SARCOMA EDUCATION: EARLY OUTCOMES OF THE ITALIAN SOCIETY OF SURGICAL ONCOLOGY (SICO) SARCOMA SOCIAL MULTI-PLATFORM JOURNAL CLUB INITIATIVE
Elisabetta Pennacchioli
Favorite
Penrose, Andrea

Northwestern Medicine
(P 353) TREATMENT OF ADVANCED EPITHELIOID SARCOMA WITH COMBINATION TAZEMETOSTAT AND PEMBROLIZUMAB
Andrea Penrose
Favorite
Perati, Shruthi

NCI/NIH
(P 181) THE DEVELOPMENT OF A NOVEL PDGFRA RESISTANCE MUTATION IN A RECURRENT KIT-MUTANT GASTROINTESTINAL STROMAL TUMOR (GIST)
Shruthi Perati
Favorite
Percio, Stefano

Fondazione IRCCS Istituto Nazionale dei Tumori
(P 452) EFFECTIVENESS OF ERIBULIN FOR MYXOID PLEOMORPHIC LIPOSARCOMA: INSIGHTS FROM A PATIENT-DERIVED MODEL AND CLINICAL TRANSLATION IN A PATIENT WITH ADVANCED DISEASE
Stefano Percio
Favorite
Pereira, Caio

Hospital de Amor
(P 128) ISOCITRATE DEHYDROGENASE 1 (IDH1) MUTATION TESTING IN THE PHASE 3 STUDY OF IVOSIDENIB VS PLACEBO IN IDH1-MUTANT CONVENTIONAL CHONDROSARCOMA (CHONQUER)
Caio Pereira
Favorite
Pereira, Janice

National Institutes of Health
(P 258) INVESTIGATING THE ROLE OF ALVEOLAR PNEUMOCYTES IN THE LUNG MICROENVIRONMENT OF OSTEOSARCOMA METASTASES
Janice Pereira
Favorite
Peretz Soroka, Hagit

Canadian Sarcoma Research and Clinical Collaboration (CanSaRCC) - Princess Margaret Cancer Centre
(P 143) IMPACT OF SURGICAL MARGINS IN CHEST WALL CHONDROSARCOMAS: A CANSARCC STUDY
Hagit Peretz Soroka
Favorite
(P 395) ERIBULIN IN RECURRENT PRETREATED METASTATIC SOFT TISSUE SARCOMA. A CANADIAN SARCOMA RESEARCH AND CLINICAL COLLABORATION (CANSARCC) REAL WORLD ANALYSIS
Hagit Peretz Soroka
Favorite
Perez Plasencia, Carlos

Universidad Nacional Autonoma de Mexico
(P 39) BUB1 AN OVEREXPRESSED KINASE IN SARCOMA: FINDING NEW TARGET THERAPY FOR OSTEOSARCOMA, LIPOSARCOMA, SYNOVIAL SARCOMA AND LEIOMYOSARCOMA
Carlos Perez Plasencia
Favorite
PEREZ YEPEZ, ELOY

Instituto Nacional de Cancerología
(P 39) BUB1 AN OVEREXPRESSED KINASE IN SARCOMA: FINDING NEW TARGET THERAPY FOR OSTEOSARCOMA, LIPOSARCOMA, SYNOVIAL SARCOMA AND LEIOMYOSARCOMA
ELOY PEREZ YEPEZ
Favorite
Perez, Juan Esteban

University of Pennsylvania
(P 185) CANCER TESTIS ANTIGENS AS TARGETS IN KIT11-MUTATED, IMATINIB-RESISTANT GIST
Juan Esteban Perez
Favorite
Perez, Melanie

Duke University
(P 19) SERUM EXOSOMES IDENTIFY AN ABERRANT PROTEOMIC SIGNATURE IN CANINE OSTEOSARCOMA PRECEDING METASTATIC PROGRESSION
Melanie Perez
Favorite
Perkins, Callum

Children's Cancer Institute
(P 11) ESTABLISHMENT, CHARACTERIZATION AND RESEARCH APPLICATION OF EIGHT NOVEL PATIENT-DERIVED OSTEOSARCOMA CELL LINES
Callum Perkins
Favorite
Perot, Gaelle

INSERM
(P 28) ADVANCING PRECISION ONCOLOGY IN SOFT TISSUE SARCOMAS: THE ROLE OF ITRAC IN METASTATIC RISK STRATIFICATION AND TREATMENT PERSONALIZATION
Gaelle Perot
Favorite
Perret, Raul

Institut Bergonié
(P 324) FULLY MATURE TERTIARY LYMHOID STRUCTURES AS PREDICTORS OF LOCAL RECURRENCE IN SOFT TISSUE SARCOMAS
Raul Perret
Favorite
Perrotta, Amanda

David Geffen School of Medicine at University of California Los Angeles
(P 16) MITOCHONDRIAL GENETIC VARIATION ORCHESTRATES COPZ1 TRANSCRIPT HETEROGENEITY AND REVEALS TELOMERE-MEDIATED VULNERABILITIES IN OSTEOSARCOMA
Amanda Perrotta
Favorite
(P 72) COUNTY-LEVEL ASSOCIATIONS BETWEEN AIRBORNE TOXICANT EMISSIONS AND EWING SARCOMA DIAGNOSIS IN THE UNITED STATES
Amanda Perrotta
Favorite
(P 81) ASSESSING PROGNOSTIC FACTORS OF CAUSE-SPECIFIC SURVIVAL IN PATIENTS WITH MALIGNANT GIANT CELL TUMORS: A POPULATION BASED STUDY FROM THE SEER DATABASE
Amanda Perrotta
Favorite
(P 92) PRIMARY TUMOR SIZE AS AN INDEPENDENT PROGNOSTIC FACTOR IN OSTEOSARCOMA: PROPENSITY SCORE-MATCHED ANALYSIS DEMONSTRATES A CONTINUOUS DOSE-RESPONSE RELATIONSHIP
Amanda Perrotta
Favorite
(P 100) THE ROLE OF CANCER TYPE IN THE DEVELOPMENT OF PERIPROSTHETIC JOINT INFECTION IN DISTAL FEMORAL REPLACEMENT
Amanda Perrotta
Favorite
(P 107) IS THERE A BETTER OPTION: INTRAMEDULLARY NAIL VERSUS PLATE OSTEOSYNTHESIS FOR PATHOLOGIC HUMERAL FRACTURES?
Amanda Perrotta
Favorite
(P 108) DISTANCE WEIGHTED MATCHING IN THE QUANTIFICATION OF EXCESS MORBIDITY IN EXTERNAL HEMIPELVECTOMY AND HIP DISARTICULATION
Amanda Perrotta
Favorite
(P 157) INCOME IMPACTS OVERALL BUT NOT CAUSE-SPECIFIC SURVIVAL IN PATIENTS WITH CHONDROSARCOMA: A POPULATION BASED STUDY FROM THE SEER DATABASE
Amanda Perrotta
Favorite
(P 232) IS THERE A ROLE FOR POSITRON EMISSION TOMOGRAPHY IN THE STAGING OF LANGERHANS CELL HISTIOCYTOSIS?
Amanda Perrotta
Favorite
(P 384) PELVIC LOCATION PREDICTS WORSE OUTCOMES IN ALVEOLAR RHABDOMYOSARCOMA: UNDERUSE OF RADIOTHERAPY AND MISSED SURVIVAL BENEFIT
Amanda Perrotta
Favorite
Pesenti, Anita

Fondazione IRCCS Istituto Nazionale dei Tumori di Milano
(P 447) PAIN ASSESSMENT CRITERIA (PAC) ANTICIPATE RECIST PROGRESSION AND CORRELATE WITH BLOOD LEVELS OF GROWTH DIFFERENTIATION FACTOR 15 (GDF15) IN EPITHELIOID HEMANGIOENDOTHELIOMA (EHE)
Anita Pesenti
Favorite
Pesic, Dusan

The Hospital for Sick Children (SickKids)
(P 73) TARGETABLE GENE DEPENDENCIES IN EWING SARCOMA SUBTYPES
Dusan Pesic
Favorite
Peters, Haley

University of Florida
(P 129) HIJACKED FUEL: GLYCOGEN-DRIVEN METABOLIC SHIFTS IN IDH1-MUTANT CHONDROSARCOMA
Haley Peters
Favorite
Petrova, Boryana

Boston Children's Hospital
(P 198) EXPLOITING METABOLIC DYSREGULATION IN SUCCINATE DEHYDROGENASE-DEFICIENT GASTROINTESTINAL STROMAL TUMOR
Boryana Petrova
Favorite
PEYRAUD, FLORENT

INSTITUT BERGONIE
(P 445) TEADES PH1/2 STUDY WITH ODM-212: PRELIMINARY RESULTS IN EHE PATIENTS
FLORENT PEYRAUD
Favorite
Philippon, Marc

University of Miami
(P 147) CONVENTIONAL AND DEDIFFERENTIATED CHONDROSARCOMA; IS ENCHONDROMA THE PRECURSOR LESION?
Marc Philippon
Favorite
Phua, Brandon Xuan Ming

A*STAR Bioinformatics Institute (BII)
(P 53) ESTABLISHMENT AND CHARACTERISATION OF LIPOSARCOMA-DERIVED CELLS AS RELEVANT PRE-CLINICAL MODELS FOR TARGET DISCOVERY
Brandon Xuan Ming Phua
Favorite
Pianykh, Oleg

MGH
(P 392) CLASSIFICATION AND DIFFERENTIATIONOF MYXOID LIPOSARCOMA AND MYXOMA WITH MACHINE LEARNING
Oleg Pianykh
Favorite
(P 392) DIFFERENTIATION OF MYXOMA AND MYXOID LIPOSARCOMA BASED ON RADIOMICS PHENOTYPES
Oleg Pianykh
Favorite
Piao, Zhegao

Department of Artificial Intelligence and Data Science, Sejong University, Seoul, Korea
(P 171) THREE-DIMENSIONAL DEEP LEARNING MODEL FOR PREDICTING PROXIMAL FEMORAL PATHOLOGIC FRACTURE USING OPPORTUNISTIC ABDOMINOPELVIC CT IN PATIENTS WITH ADVANCED CANCER: A PRELIMINARY REPORT
Zhegao Piao
Favorite
Piatkowski, Jakub

Institute of Genetics and Biology, Faculty of Biology, University of Warsaw
(P 27) MOLECULAR CHARACTERIZATION OF RESPONSE TO NEOADJUVANT CHEMORADIATION IN PATIENTS WITH LOCALLY ADVANCED SOFT TISSUE SARCOMAS
Jakub Piatkowski
Favorite
(P 134) INTEGRATIVE MICRORNA PROFILING IN CHONDROSARCOMA: TOWARD BIOMARKER DISCOVERY AND PROGNOSTIC SIGNATURE DEVELOPMENT
Jakub Piatkowski
Favorite
Piatkowski, Jakub

University of Warsaw
(P 139) IMMUNOGENOMIC PROFILING OF CHONDROSARCOMA REVEALS DISTINCT IMMUNE PHENOTYPES AND PROGNOSTIC MUTATIONS
Jakub Piatkowski
Favorite
Picarsic, Jennifer

University of Pittsburgh
(P 256) THE SEAN KARL COHORT: A NATIONAL COLLABORATIVE SINGLE-CELL RNASEQ STUDY OF PAIRED PATIENT EWING SARCOMA SPECIMENS
Jennifer Picarsic
Favorite
Pienkowski, Andrzej

Maria Sklodowska-Curie National Research Institute of Oncology
(P 149) SURGICAL TEXTBOOK OUTCOMES IN PATIENTS DIAGNOSED WITH CHONDROSARCOMA
Andrzej Pienkowski
Favorite
(P 164) LONG TERM OUTCOMES IN PATIENTS DIAGNOSED WITH SECONDARY CHONDROSARCOMA
Andrzej Pienkowski
Favorite
Pierce, Andrew

Owkin
(P 431) INVOKE: A PHASE 1 STUDY OF OKN4395, A FIRST-IN-CLASS EP2/EP4/DP1 TRIPLE PROSTANOID RECEPTOR ANTAGONIST, IN PATIENTS WITH ADVANCED SOLID TUMORS, INCLUDING SARCOMAS
Andrew Pierce
Favorite
Pierini, Michela

IRCCS Istituto Ortopedico Rizzoli
(P 139) IMMUNOGENOMIC PROFILING OF CHONDROSARCOMA REVEALS DISTINCT IMMUNE PHENOTYPES AND PROGNOSTIC MUTATIONS
Michela Pierini
Favorite
Pignoli, Emanuele

Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan
(P 277) THE ROLE OF RADIOTHERAPY IN THE MULTIDISCIPLINARY MANAGEMENT OF RADIATION-ASSOCIATED ANGIOSARCOMA OF THE BREAST: A REFERRAL CENTER EXPERIENCE
Emanuele Pignoli
Favorite
Piha-Paul, Sarina A.

University of Texas MD Anderson Cancer Center
(P 433) PHASE I DOSE ESCALATION TRIAL OF STX-001, AN LNP SELF-REPLICATING MRNA EXPRESSING IL-12, IN PATIENTS WITH REFRACTORY TUMORS INCLUDING SARCOMAS
Sarina A. Piha-Paul
Favorite
Pikabea, Fernando

Hospital Universitario Basurto
(P 389) UNRESECTABLE AND METASTATIC DEDIFFERENTIATED LIPOSARCOMA (DDLPS): INSIGHTS FROM A MULTICENTER REAL-WORLD COHORT (RWC)
Fernando Pikabea
Favorite
Pilar, Avinash

University College London Hospitals
(P 281) LOCAL CONTROL WITH MODERATELY HYPOFRACTIONATED DEFINITIVE RADIOTHERAPY DELIVERED WITH A SIMULTANEOUS INTEGRATED BOOST TECHNIQUE TO NON-EXTREMITY SOFT TISSUE AND BONE SARCOMAS
Avinash Pilar
Favorite
Pino, Lindsay

TalusBio
(P 260) MECHANISM AND EFFICACY OF ANTHRACYCLINE MEDIATED EPIGENETIC DISRUPTION IN BONE SARCOMAS.
Lindsay Pino
Favorite
Piotrowska, Zofia

Massachusetts General Hospital
(P 118) IMPACT OF TYROSINE KINASE INHIBITOR THERAPY ON BONE PROGRESSION IN PATIENTS WITH DRIVER-MUTATED METASTATIC NON-SMALL CELL LUNG CANCER WITH DE NOVO BONE METASTASES
Zofia Piotrowska
Favorite
Placzke, Joanna

Maria Sklodowska-Curie National Research Institute of Oncology
(P 470) OFF-LABEL TREATMENT AND ULTRARARE SARCOMAS - SINGLE INSTITUTION REPORT
Joanna Placzke
Favorite
Pollack, Seth

Northwestern University Feinberg School of Medicine
(P 183) ACTIONABLE GENOMICS IN GASTROINTESTINAL STROMAL TUMORS LACKING KIT OR PDGFRA MUTATIONS.
Seth Pollack
Favorite
(P 236) EXCEPTIONAL RESPONSE TO COMBINATION IMMUNOTHERAPY WITH YH001 AND ENVAFOLIMAB IN METASTATIC SARCOMA.
Seth Pollack
Favorite
(P 353) TREATMENT OF ADVANCED EPITHELIOID SARCOMA WITH COMBINATION TAZEMETOSTAT AND PEMBROLIZUMAB
Seth Pollack
Favorite
(P 373) COMPLETE RESPONSE TO FRONT-LINE PEXIDARTINIB IN SYMPTOMATIC TEMPOROMANDIBULAR JOINT TENOSYNOVIAL GIANT CELL TUMOR
Seth Pollack
Favorite
(P 412) UNCOVERING HER2 OVEREXPRESSION IN SOFT TISSUE SARCOMAS (STS): INSIGHTS FROM THE CANCER GENOME ATLAS (TCGA)
Seth Pollack
Favorite
(P 429) SINGLE-ARM, OPEN-LABEL PHASE II TRIAL OF XL092 (ZANZALINTINIB) IN PATIENTS WITH ADVANCED LEIOMYOSARCOMA: TRIAL IN PROGRESS
Seth Pollack
Favorite
Pollock, Brad

University of California Davis
(P 77) BARRIERS TO GUIDELINE CONCORDANT CARE IN AYA PATIENTS WITH BONE SARCOMAS
Brad Pollock
Favorite
Polymeropoulos, Alessio

Fondazione IRCCS Istituto Nazionale Tumori
(P 458) BETWEEN LYMPHOMAS AND SARCOMAS: A RETROSPECTIVE, MULTI-INSTITUTIONAL STUDY FROM THE ITALIAN SARCOMA GROUP (ISG) ON HISTIOCYTIC AND DENDRITIC CELL NEOPLASMS (HDCN)
Alessio Polymeropoulos
Favorite
Ponzoni, Adele

Center for Discovery and Innovation, Hackensack Meridian Health
(P 251) SPATIAL MULTI-OMIC ANALYSIS OF RHABDOMYOSARCOMA IDENTIFIES THERAPEUTIC VULNERABILITIES
Adele Ponzoni
Favorite
Potter, Samara

Institute for Genomic Medicine, Nationwide Children's Hospital
(P 377) GERMLINE RECQL4 VARIANT IN A PEDIATRIC PATIENT WITH EWING SARCOMA AND DESMOID FIBROMATOSIS
Samara Potter
Favorite
Powell, Andrece

University of Florida
(P 248) AN EX VIVO ASSAY TO PREDICT IMMUNOTHERAPY RESPONSE IN SARCOMA
Andrece Powell
Favorite
(P 401) LONG-TERM OUTCOMES OF IMATINIB-TREATED DERMATOFIBROSARCOMA PROTUBERANS: INSIGHTS FROM A SINGLE-INSTITUTION CASE SERIES
Andrece Powell
Favorite
Powers, Benjamin

The University of Kansas Health System
(P 354) UNEXPECTED RESPONSE TO ERIBULIN IN A REFRACTORY LEIOMYOSARCOMA PATIENT WITH HEREDITARY P53 MUTATION
Benjamin Powers
Favorite
(P 366) WOUND COMPLICATIONS AFTER ULTRA-HYPOFRACTIONATED NEOADJUVANT RADIATION FOR SOFT TISSUE SARCOMA: WHAT IS OPTIMAL SURGICAL TIMING?
Benjamin Powers
Favorite
Poysungnoen, August

Duke University
(P 126) SINGLE-CELL RNA SEQUENCING AND PROTEOMIC SPATIAL PROFILING REVEAL COMPLEX TUMOR MICROENVIRONMENT AND NOVEL IMMUNE INTERACTIONS IN CHONDROSARCOMA
August Poysungnoen
Favorite
Pozas, Javier

University College London Hospitals
(P 156) CHONDROSARCOMA INCIDENCE, SURVIVAL AND MANAGEMENT IN ENGLAND 2013-2022; AN ANALYSIS FROM THE NATIONAL DISEASE REGISTRATION SERVICE
Javier Pozas
Favorite
Pradhan, Nikash

University of Iowa Hospitals and Clinics
(P 371) CLINICAL PROFILE AND TREATMENT PATTERNS OF ANGIOSARCOMA IN THE REAL- WORLD SETTING: A SINGLE CENTER EXPERIENCE FROM 1991-2024.
Nikash Pradhan
Favorite
Prado, Juliano

University of Miami Miller School of Medicine, Department of Orthopaedic Surgery
(P 94) EFFECT OF POSTOPERATIVE PHYSICAL THERAPY ON FUNCTIONAL OUTCOMES FOLLOWING MUSCULOSKELETAL TUMOR RESECTION
Juliano Prado
Favorite
Prasad, Maya

Tata Memorial Hospital
(P 292) CRANIOVERTEBRAL EWINGS SARCOMA WITH MENINGEAL INFILTRATION - A CLINICAL OUTCOME ANALYSIS
Maya Prasad
Favorite
(P 379) IMPACT OF EWSR1 GENE REARRANGEMENT TESTING ON DIAGNOSIS OF A WIDE RANGE OF SOLID TUMOURS
Maya Prasad
Favorite
Pratilas, Christine

Johns Hopkins University
(P 405) PAN-RAS INHIBITION AS A NOVEL THERAPEUTIC STRATEGY FOR RAS-DRIVEN RHABDOMYOSARCOMA
Christine Pratilas
Favorite
Pressey, Joseph

University of Cincinnati College of Medicine and Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA
(P 416) A PHASE 2 MULTICENTER OPEN-LABEL BASKET STUDY OF TAZEMETOSTAT IN ADULT PATIENTS WITH INI1-NEGATIVE EPITHELIOID SARCOMA – FINAL ANALYSIS
Joseph Pressey
Favorite
Primo Basílio de Souza, Viviane

AC Camargo Cancer Center
(P 155) BRCA2-MUTATED CONVENTIONAL CHONDROSARCOMA RESPONDING TO PARP INHIBITION: A CASE REPORT
Viviane Primo Basílio de Souza
Favorite
Pruthi, Manish

Tata Memorial Hospital
(P 103) EARLY OUTCOMES OF BONE PROSTHESIS COMPOSITE FOR RECONSTRUCTION IN LOWER LIMB TUMORS. A SINGLE INSTITUTION STUDY
Manish Pruthi
Favorite
(P 208) TRANSLATION, CROSS CULTURAL ADAPTATION AND VALIDATION OF TESS IN REGIONAL INDIAN LANGUAGES WITH ~500 MILLION GLOBAL DIASPORA
Manish Pruthi
Favorite
(P 286) INTERSTITIAL BRACHYTHERAPY FOR ORGAN AND FUNCTION PRESERVATION IN SOFT TISSUE SARCOMAS: LONG TERM OUTCOMES
Manish Pruthi
Favorite
(P 338) POORLY DIFFERENTIATED SYNOVIAL SARCOMA: A HISTOLOGIC CHALLENGE OF AN AGGRESSIVE VARIANT
Manish Pruthi
Favorite
(P 379) IMPACT OF EWSR1 GENE REARRANGEMENT TESTING ON DIAGNOSIS OF A WIDE RANGE OF SOLID TUMOURS
Manish Pruthi
Favorite
(P 387) TREATMENT PATTERNS AND PROGNOSTIC FACTORS IN LOCALISED SYNOVIAL SARCOMA: A RETROSPECTIVE STUDY FROM A TERTIARY CANCER CENTRE IN INDIA
Manish Pruthi
Favorite
(P 438) RANDOMIZED, OPEN-LABEL, PHASE III TRIAL OF ADJUVANT CHEMOTHERAPY VERSUS OBSERVATION IN NON-METASTATIC, HIGH-RISK SOFT TISSUE SARCOMAS (ACO-SARC TRIAL)
Manish Pruthi
Favorite
przybojewski, Stefan

Foothills Medical Center
(P 293) CRYOABLATION FOR EXTRA-ABDOMINAL DESMOID TUMORS: A RETROSPECTIVE STUDY OF RADIOLOGIC AND CLINICAL OUTCOMES
Stefan przybojewski
Favorite
Przybyl, Joanna

McGill University
(P 68) MULTI-OMIC INTRA- AND INTER-TUMOR HETEROGENEITY OF BENIGN SMOOTH MUSCLE TUMORS
Joanna Przybyl
Favorite
Pulivendala, Gauthami

University of Miami
(P 393) DISTINCT SECONDARY MUTATIONAL LANDSCAPES ARE ASSOCIATED WITH NAB2–STAT6 FUSION BREAKPOINTS IN SOLITARY FIBROUS TUMORS
Gauthami Pulivendala
Favorite
(P 462) HDAC INHIBITORS AS POTENTIAL SFT THERAPIES
Gauthami Pulivendala
Favorite
Pullanhi, Anoopa

Sultan Qaboos Comprehensive Cancer Care and Research Center - University Medical City
(P 56) COMPARISON OF PATHOGENIC AND LIKELY PATHOGENIC VARIANTS DISTINCT FROM SPECIFIC DRIVERS IN DIFFERENT SARCOMA GROUPS
Anoopa Pullanhi
Favorite
Puntis, Nic

GIST CANCER UK
(P 202) TRAVEL GRANT
Nic Puntis
Favorite
Purandare, Nilendu

Tata Memorial Hospital, Mumbai
(P 286) INTERSTITIAL BRACHYTHERAPY FOR ORGAN AND FUNCTION PRESERVATION IN SOFT TISSUE SARCOMAS: LONG TERM OUTCOMES
Nilendu Purandare
Favorite
Puri, Ajay

Tata Memorial Hospital
(P 103) EARLY OUTCOMES OF BONE PROSTHESIS COMPOSITE FOR RECONSTRUCTION IN LOWER LIMB TUMORS. A SINGLE INSTITUTION STUDY
Ajay Puri
Favorite
Puri, Ajay

TATA Memorial Centre
(P 151) SHOULD WE USE ADJUVANT CHEMOTHERAPY IN PATIENTS WITH LOCALIZED DEDIFFERENTIATED CHONDROSARCOMA (DDCS) OF THE PELVIS? AN ANALYSIS BY THE PELVIC DDCS STUDY GROUP
Ajay Puri
Favorite
Puri, Ajay

Tata Memorial Hospital
(P 208) TRANSLATION, CROSS CULTURAL ADAPTATION AND VALIDATION OF TESS IN REGIONAL INDIAN LANGUAGES WITH ~500 MILLION GLOBAL DIASPORA
Ajay Puri
Favorite
(P 286) INTERSTITIAL BRACHYTHERAPY FOR ORGAN AND FUNCTION PRESERVATION IN SOFT TISSUE SARCOMAS: LONG TERM OUTCOMES
Ajay Puri
Favorite
(P 387) TREATMENT PATTERNS AND PROGNOSTIC FACTORS IN LOCALISED SYNOVIAL SARCOMA: A RETROSPECTIVE STUDY FROM A TERTIARY CANCER CENTRE IN INDIA
Ajay Puri
Favorite
(P 438) RANDOMIZED, OPEN-LABEL, PHASE III TRIAL OF ADJUVANT CHEMOTHERAPY VERSUS OBSERVATION IN NON-METASTATIC, HIGH-RISK SOFT TISSUE SARCOMAS (ACO-SARC TRIAL)
Ajay Puri
Favorite
Purl, Megan

Surgical Oncology, Department of Surgery, University of California, Davis
(P 244) INTRATUMORAL TIGIT BLOCKADE AUGMENTS ANTI-TUMOR RESPONSES AND BYPASSES HYPERFUNCTIONALITY OF PERIPHERAL TIGIT+ NK CELLS IN MOUSE AND HUMAN MODELS OF BONE AND SOFT TISSUE SARCOMA
Megan Purl
Favorite
Purohit, Rashi

Department of Pathology, Massachusetts General Hospital, Harvard Medical School
(P 45) MONITORING EWSR1 FUSIONS IN SARCOMA PATIENTS USING PERSONALIZED LIQUID BIOPSY ASSAYS
Rashi Purohit
Favorite
Pusztai, Ada

LMU Munich
(P 443) FIRST-LINE PAZOPANIB IN PATIENTS WITH EPITHELIOID HEMANGIOENDOTHELIOMA: A RETROSPECTIVE SINGLE-CENTER ANALYSIS
Ada Pusztai
Favorite
Puviindran, Vijitha

Duke University
(P 126) SINGLE-CELL RNA SEQUENCING AND PROTEOMIC SPATIAL PROFILING REVEAL COMPLEX TUMOR MICROENVIRONMENT AND NOVEL IMMUNE INTERACTIONS IN CHONDROSARCOMA
Vijitha Puviindran
Favorite
(P 380) INVESTIGATING THE ROLE OF HISTONE DEACETYLASE-3 IN METASTATIC UNDIFFERENTIATED PLEOMORPHIC SARCOMA
Vijitha Puviindran
Favorite
Q
Qi, Changsong

State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Beijing Key Laboratory of Carcinogenesis and Translational Research, Peking University Cancer Hospital & Institute
(P 417) EFFICACY AND SAFETY OF LAROTRECTINIB (LARO) IN PATIENTS (PTS) WITH TRK FUSION SARCOMAS
Changsong Qi
Favorite
Qin, Jiaxing

Peter MacCallum Cancer Centre
(P 121) REAL-WORLD EXPERIENCE OF CABOZANTINIB MONOTHERAPY IN RELAPSED OR REFRACTORY OSTEOSARCOMA AND EWING SARCOMA: A SINGLE-CENTRE AUSTRALIAN STUDY
Jiaxing Qin
Favorite
(P 344) REAL-WORLD EXPERIENCE OF SORAFENIB IN DESMOID TUMOURS: A SINGLE-CENTRE AUSTRALIAN STUDY
Jiaxing Qin
Favorite
Qin, Li-Xuan

Memorial Sloan Kettering Cancer Center
(P 409) RETROSPECTIVE ANALYSIS OF PROGNOSTIC FACTORS INCLUDING HLA GENOTYPE IN MYXOID LIPOSARCOMA
Li-Xuan Qin
Favorite
Quagliuolo, Vittorio Lorenzo

IRCCS Humanitas Research Hospital
(P 203) MINIMALLY INVASIVE RESECTION OF MULTIFOCAL DUODENO-JEJUNAL GISTS IN NEUROFIBROMATOSIS TYPE 1
Vittorio Lorenzo Quagliuolo
Favorite
(P 318) BURIED DE-EPITHELIALIZED FLAP RECONSTRUCTION AFTER WIDE EXCISION OF THIGH SARCOMAS: EARLY EXPERIENCE FROM A SPECIALIZED SARCOMA SURGERY UNIT
Vittorio Lorenzo Quagliuolo
Favorite
(P 339) POSTERIOR APPROACH FOR RADICAL RESECTION OF SACROCOCCYGEAL CHORDOMA: A SURGICAL PERSPECTIVE FROM A TERTIARY REFERRAL CENTER
Vittorio Lorenzo Quagliuolo
Favorite
(P 365) UROLOGICAL RECONSTRUCTION DURING RETROPERITONEAL AND PELVIC SARCOMA SURGERY: EXPERIENCE FROM A HIGH-VOLUME SARCOMA CENTER
Vittorio Lorenzo Quagliuolo
Favorite
Quildrian, Sergio

Angel H Roffo Institute of Oncology - University of Buenos Aires
(P 306) PROGNOSTIC NUTRITIONAL INDEX PREDICTS MAJOR POSTOPERATIVE COMPLICATIONS IN RETROPERITONEAL SARCOMA: RESULTS FROM THE LATAMSARC COHORT
Sergio Quildrian
Favorite
(P 386) RADIO-GUIDED SURGERY FOR NONPALPABLE SOFT-TISSUE SARCOMAS
Sergio Quildrian
Favorite
Quinion, Carl

Ohio State University
(P 84) A MULTICENTER COMPARISON OF REVERSE TOTAL SHOULDER ARTHROPLASTY VERSUS HEMIARTHROPLASTY FOR ENDOPROSTHETIC RECONSTRUCTION FOLLOWING ONCOLOGIC RESECTION OF THE PROXIMAL HUMERUS
Carl Quinion
Favorite
Quinion, Carl

The Ohio State University
(P 161) CLINICAL CHARACTERISTICS, PATTERNS OF CARE, AND TREATMENT OUTCOMES OF CHONDROSARCOMA: A SINGLE-INSTITUTIONAL EXPERIENCE
Carl Quinion
Favorite
(P 221) QUALITATIVE ANALYSIS OF THE PERIOPERATIVE EXPERIENCE OF YOUNG ADULT PATIENTS UNDERGOING EXTREMITY SARCOMA SURGERY
Carl Quinion
Favorite
Quinones, Julian

Strand Therapeutics Inc.
(P 433) PHASE I DOSE ESCALATION TRIAL OF STX-001, AN LNP SELF-REPLICATING MRNA EXPRESSING IL-12, IN PATIENTS WITH REFRACTORY TUMORS INCLUDING SARCOMAS
Julian Quinones
Favorite
Qu, Zhe

Servier
(P 128) ISOCITRATE DEHYDROGENASE 1 (IDH1) MUTATION TESTING IN THE PHASE 3 STUDY OF IVOSIDENIB VS PLACEBO IN IDH1-MUTANT CONVENTIONAL CHONDROSARCOMA (CHONQUER)
Zhe Qu
Favorite
R
Rabideau, Cathleen

University of Florida
(P 248) AN EX VIVO ASSAY TO PREDICT IMMUNOTHERAPY RESPONSE IN SARCOMA
Cathleen Rabideau
Favorite
Rabino, Martina

University Hospital S. Luigi Gonzaga
(P 231) INCREASED LIFETIME RISK (LTR) OF SOFT TISSUE SARCOMAS (STS) IN PATIENTS WITH LOW-RISK GASTROINTESTINAL STROMAL TUMORS (GIST): A RETROSPECTIVE ANALYSIS FROM THE ITALIAN SARCOMA GROUP (ISG)
Martina Rabino
Favorite
Radaelli, Stefano

Fondazione IRCCS Istituto Nazionale dei Tumori
(P 308) IMPACT OF PSOAS MUSCLE RESECTION ON OUTCOMES IN PRIMARY RETROPERITONEAL DEDIFFERENTIATED LIPOSARCOMA
Stefano Radaelli
Favorite
Ragbir, Maniram

The Newcastle upon Tyne Hospitals NHS Foundation Trust
(P 314) AN INTERNATIONAL, MULTI-CENTRE STUDY OF SURGICAL MARGINS IN INTERMEDIATE TO HIGH GRADE SARCOMA
Maniram Ragbir
Favorite
Rai, Kunal

MD Anderson Cancer Center
(P 47) EWSR1::WT1 FUSION ONCOPROTEIN ACTIVITY SHAPES LINEAGE HETEROGENEITY IN DESMOPLASTIC SMALL ROUND CELL TUMORS
Kunal Rai
Favorite
(P 391) ATRX LOSS BLOCKS THE DIFFERENTIATION OF MESENCHYMAL STEM CELLS AND ADVANCES UNDIFFERENTIATED SARCOMA DEVELOPMENT
Kunal Rai
Favorite
Rainusso, Nino

Texas Children's Hospital
(P 08) BUILDING A MEDICAL DONATION NETWORK TO ENHANCE DEVELOPMENT OF PEDIATRIC TUMOR MODELS
Nino Rainusso
Favorite
RAJA, ANAND

Cancer Institute (WIA), Adyar, Chennai
(P 110) DEFINITIVE RADIATION THERAPY IN "OPERABLE" EWING SARCOMA OF THE EXTREMITIES AND PELVIS
ANAND RAJA
Favorite
Rajamanickam, Venkatesh

Providence Cancer Institute
(P 58) PLK1 AS A VULNERABLE TARGET OF BAP1-DRIVEN UNDIFFERENTIATED PLEOMORPHIC SARCOMAS
Venkatesh Rajamanickam
Favorite
Raj, Aneesha

University of Miami
(P 333) METABOLIC SYNDROME CORRELATION WITH LIPOSARCOMA INCIDENCE AND OUTCOMES: A RETROSPECTIVE ANALYSIS.
Aneesha Raj
Favorite
Rajani, Rajiv

Texas Tech University Health Science Center El Paso
(P 78) MENTAL HEALTH DISORDERS FOLLOWING PATHOLOGICAL FRACTURE: A RETROSPECTIVE COHORT STUDY
Rajiv Rajani
Favorite
Raj, Reeja

MD Anderson Cancer Center
(P 351) THE ROLE OF SOCIOECONOMIC DISPARITIES ON SURVIVAL OUTCOMES IN MALIGNANT PERIPHERAL NERVE SHEATH TUMORS
Reeja Raj
Favorite
Raj, Reeja

The University of Texas MD Anderson Cancer Center
(P 460) OUTCOMES OF LATER-LINES SYSTEMIC THERAPIES IN MALIGNANT PERIPHERAL NERVE SHEATH TUMORS (MPNST)
Reeja Raj
Favorite
Ramadwar, Mukta

Tata Memorial Hospital
(P 286) INTERSTITIAL BRACHYTHERAPY FOR ORGAN AND FUNCTION PRESERVATION IN SOFT TISSUE SARCOMAS: LONG TERM OUTCOMES
Mukta Ramadwar
Favorite
(P 292) CRANIOVERTEBRAL EWINGS SARCOMA WITH MENINGEAL INFILTRATION - A CLINICAL OUTCOME ANALYSIS
Mukta Ramadwar
Favorite
(P 338) POORLY DIFFERENTIATED SYNOVIAL SARCOMA: A HISTOLOGIC CHALLENGE OF AN AGGRESSIVE VARIANT
Mukta Ramadwar
Favorite
(P 379) IMPACT OF EWSR1 GENE REARRANGEMENT TESTING ON DIAGNOSIS OF A WIDE RANGE OF SOLID TUMOURS
Mukta Ramadwar
Favorite
(P 387) TREATMENT PATTERNS AND PROGNOSTIC FACTORS IN LOCALISED SYNOVIAL SARCOMA: A RETROSPECTIVE STUDY FROM A TERTIARY CANCER CENTRE IN INDIA
Mukta Ramadwar
Favorite
(P 438) RANDOMIZED, OPEN-LABEL, PHASE III TRIAL OF ADJUVANT CHEMOTHERAPY VERSUS OBSERVATION IN NON-METASTATIC, HIGH-RISK SOFT TISSUE SARCOMAS (ACO-SARC TRIAL)
Mukta Ramadwar
Favorite
Ramakrishnan, Subhash

Childrens Oncology Group
(P 168) LEVERAGING LARGE LANGUAGE MODELS FOR STRUCTURED INFORMATION EXTRACTION FROM EWING SARCOMA PATHOLOGY REPORTS
Subhash Ramakrishnan
Favorite
Ramírez de Olano, Amaya

Hospital Santa Creu i Sant Pau
(P 218) THE IMPACT OF BROADENED GENETIC COUNSELLING REFERRAL CRITERIA IN SARCOMA PATIENTS: A REFERENCE CENTRE'S EXPERIENCE
Amaya Ramírez de Olano
Favorite
Ramon y Cajal Asensio, Teresa

Hospital Clínic, Barcelona
(P 218) THE IMPACT OF BROADENED GENETIC COUNSELLING REFERRAL CRITERIA IN SARCOMA PATIENTS: A REFERENCE CENTRE'S EXPERIENCE
Teresa Ramon y Cajal Asensio
Favorite
Ramos, Jorge D.

Parabilis Medicines
(P 415) A PHASE 1/2 TRIAL OF FOG-001, A FIRST-IN-CLASS DIRECT β-CATENIN:TCF4 INHIBITOR: SAFETY AND PRELIMINARY ANTITUMOR ACTIVITY IN PATIENTS WITH DESMOID TUMORS (DT)
Jorge D. Ramos
Favorite
Ramsey, Duncan

Oregon Health & Science University
(P 93) INTERCALARY COMPRESSIVE OSSEOINTEGRATION OF DIAPHYSEAL TUMORS: A MULTI-INSTITUTIONAL CASE SERIES
Duncan Ramsey
Favorite
(P 364) TRENDS IN SURGICAL MANAGEMENT OF DESMOID TUMOR IN THE VETERANS AFFAIRS (VA) NATIONAL DATABASE
Duncan Ramsey
Favorite
Rana, Chahat

University of Texas Southwestern Medical Center
(P 03) CONGRUENCE OF CIRCULATING TUMOR DNA & RADIOGRAPHIC RESPONSE IN BONE AND SOFT TISSUE SARCOMA
Chahat Rana
Favorite
Randall, Lor

University of California Davis School of Medicine
(P 77) BARRIERS TO GUIDELINE CONCORDANT CARE IN AYA PATIENTS WITH BONE SARCOMAS
Lor Randall
Favorite
Randall, R. Lor

UC Davis Health
(P 95) COMPARATIVE OUTCOMES OF OPERATIVE AND NON-OPERATIVE TREATMENT FOR METASTATIC HUMERAL PATHOLOGIC FRACTURES
R. Lor Randall
Favorite
(P 106) REPAIR: A PRELIMINARY REPORT ON AN ONGOING MULTI-CENTER TRIAL FOR PATIENTS UNDERGOING SURGICAL STABILIZATION FOR METASTATIC BONE DISEASE OF THE FEMUR
R. Lor Randall
Favorite
(P 349) THE COST OF SURVEILLANCE IN CALIFORNIA: MRI UTILIZATION IN RECURRENT EXTREMITY SOFT TISSUE SARCOMA
R. Lor Randall
Favorite
(P 360) MRI SURVEILLANCE PRACTICES AND RECURRENCE DETECTION IN EXTREMITY SOFT TISSUE SARCOMA: A RETROSPECTIVE STUDY
R. Lor Randall
Favorite
Ranger, Ann

SOTIO Biotech Inc.
(P 257) TARGETING LEUCINE-RICH REPEAT-CONTAINING PROTEIN 15 (LRRC15): SOT106 ANTIBODY-DRUG CONJUGATE FOR SOFT TISSUE SARCOMA AND OSTEOSARCOMA TREATMENT
Ann Ranger
Favorite
Ranjbarian, Tannaz

University of California San Diego
(P 179) NEOADJUVANT AVAPRITINIB IN PDGFRA-MUTANT GIST: NEAR COMPLETE PATHOLOGICAL RESPONSES AT THE COST OF HIGH ADVERSE EVENT RATES
Tannaz Ranjbarian
Favorite
(P 180) COMPARATIVE EFFICACY OF GENERIC AND BRAND-NAME IMATINIB IN NEOADJUVANT TREATMENT OF KIT EXON 11 MUTANT GIST
Tannaz Ranjbarian
Favorite
Rankin, Kenneth

The Newcastle upon Tyne Hospitals NHS Foundation Trust, United Kingdom
(P 133) INVESTIGATION OF COMBINING MDM2 INHIBITORS WITH DR5 AGONISTS FOR BONE SARCOMA TREATMENT
Kenneth Rankin
Favorite
(P 135) EXPLORING THE ROLE OF CLUSTER OF DIFFERENTIATION 44 IN CHONDROSARCOMA
Kenneth Rankin
Favorite
Rankin, Kenneth

The Newcastle upon Tyne Hospitals NHS Foundation Trust
(P 314) AN INTERNATIONAL, MULTI-CENTRE STUDY OF SURGICAL MARGINS IN INTERMEDIATE TO HIGH GRADE SARCOMA
Kenneth Rankin
Favorite
Raskin, Kevin

MGH, Harvard
(P 105) TREATMENT SUCCESS RATE AFTER SURGICAL MANAGEMENT OF PERIPROSTHETIC JOINT INFECTIONS IN ONCOLOGIC PROXIMAL TIBIA RECONSTRUCTION
Kevin Raskin
Favorite
Raso, Jon

Moffitt Cancer Center
(P 102) FACTORS RELATED TO ASEPTIC LOOSENING IN ENDOPROSTHESIS RECONSTRUCTION OF THE PROXIMAL TIBIA
Jon Raso
Favorite
Rasool, Ghulam

Moffitt Cancer Center
(P 138) A MULTI-INSTITUTIONAL ARCHIVE AND DEEP LEARNING PIPELINE FOR QUANTIFYING CHONDROSARCOMA COMPOSITION
Ghulam Rasool
Favorite
RASTOGI, SAMEER

All India Institute Of Medical Sciences
(P 276) RADIATION-INDUCED SARCOMA (RIS): CLINICAL SPECTRUM AND ONCOLOGIC OUTCOMES FROM A TERTIARY INDIAN SARCOMA CLINIC
SAMEER RASTOGI
Favorite
(P 435) A PHASE II STUDY OF HIGH DOSE IFOSFAMIDE IN METASTATIC/LOCALLY ADVANCED SYNOVIAL SARCOMA FROM A TERTIARY CARE CENTER IN INDIA
SAMEER RASTOGI
Favorite
(P 468) CLINICAL UTILITY OF TARGETED NEXT-GENERATION SEQUENCING IN GUIDING SARCOMA DIAGNOSIS AND PERSONALIZED MANAGEMENT: A SINGLE-CENTER STUDY FROM INDIA
SAMEER RASTOGI
Favorite
Rastrelli, Marco

Veneto Institute of Oncology IOV-IRCCS
(P 328) INNOVATING SARCOMA EDUCATION: EARLY OUTCOMES OF THE ITALIAN SOCIETY OF SURGICAL ONCOLOGY (SICO) SARCOMA SOCIAL MULTI-PLATFORM JOURNAL CLUB INITIATIVE
Marco Rastrelli
Favorite
Ratan, Ravin

University of Texas MD Anderson Cancer Center
(P 47) EWSR1::WT1 FUSION ONCOPROTEIN ACTIVITY SHAPES LINEAGE HETEROGENEITY IN DESMOPLASTIC SMALL ROUND CELL TUMORS
Ravin Ratan
Favorite
(P 83) OUTCOMES OF MULTIMODAL PERIOPERATIVE TREATMENT IN OSTEOSARCOMAS OF THE JAW
Ravin Ratan
Favorite
(P 242) IMMUNE PROFILING OF UNDIFFERENTIATED PLEOMORPHIC SARCOMAS REVEALS DISTINCT PROGNOSTIC SUBGROUPS
Ravin Ratan
Favorite
(P 315) ANALYSIS OF CHANGES IN T2-WEIGHTED SIGNAL INTENSITY AND TUMOR VOLUME AND EXPOSURE-RESPONSE IN THE RINGSIDE PHASE 2 STUDY OF VAREGACESTAT FOR DESMOID TUMORS
Ravin Ratan
Favorite
(P 410) SUBGROUP ANALYSIS OF THE PHASE 2 PART OF THE RINGSIDE PHASE 2/3 TRIAL OF VAREGACESTAT FOR TREATMENT OF DESMOID TUMORS
Ravin Ratan
Favorite
(P 416) A PHASE 2 MULTICENTER OPEN-LABEL BASKET STUDY OF TAZEMETOSTAT IN ADULT PATIENTS WITH INI1-NEGATIVE EPITHELIOID SARCOMA – FINAL ANALYSIS
Ravin Ratan
Favorite
(P 451) TREATMENT OUTCOMES OF GEMCITABINE AND DOCETAXEL IN PATIENTS WITH CLEAR CELL SARCOMA (CCS) OR GASTROINTESTINAL NEUROECTODERMAL TUMOR (GNET): A CASE SERIES
Ravin Ratan
Favorite
(P 460) OUTCOMES OF LATER-LINES SYSTEMIC THERAPIES IN MALIGNANT PERIPHERAL NERVE SHEATH TUMORS (MPNST)
Ravin Ratan
Favorite
Rath, Sushmita

TATA MEMORIAL HOSPITAL
(P 286) INTERSTITIAL BRACHYTHERAPY FOR ORGAN AND FUNCTION PRESERVATION IN SOFT TISSUE SARCOMAS: LONG TERM OUTCOMES
Sushmita Rath
Favorite
(P 292) CRANIOVERTEBRAL EWINGS SARCOMA WITH MENINGEAL INFILTRATION - A CLINICAL OUTCOME ANALYSIS
Sushmita Rath
Favorite
(P 387) TREATMENT PATTERNS AND PROGNOSTIC FACTORS IN LOCALISED SYNOVIAL SARCOMA: A RETROSPECTIVE STUDY FROM A TERTIARY CANCER CENTRE IN INDIA
Sushmita Rath
Favorite
(P 438) RANDOMIZED, OPEN-LABEL, PHASE III TRIAL OF ADJUVANT CHEMOTHERAPY VERSUS OBSERVATION IN NON-METASTATIC, HIGH-RISK SOFT TISSUE SARCOMAS (ACO-SARC TRIAL)
Sushmita Rath
Favorite
Raut, Chandrajit

Brigham and Women's Hospital
(P 228) FREQUENCY AND CLARITY OF SURGICAL GOALS FOR TUMOR RESECTION IN ADVANCED SARCOMA
Chandrajit Raut
Favorite
(P 309) RETROPERITONEAL LIPOMAS: MULTICENTER CLINICAL EXPERIENCE WITH AN EXTREMELY RARE DISEASE ENTITY
Chandrajit Raut
Favorite
Ravi, Vinod

The University of Texas MD Anderson Cancer Center
(P 407) PIMICOTINIB IN TENOSYNOVIAL GIANT CELL TUMOR (TGCT): LONG-TERM EFFICACY, SAFETY, AND PATIENT-REPORTED OUTCOMES FROM THE PHASE 3 MANEUVER STUDY
Vinod Ravi
Favorite
(P 422) EFFICACY WITH VIMSELTINIB IN PATIENTS (PTS) WITH TENOSYNOVIAL GIANT CELL TUMOR (TGCT) AND PRIOR COLONY-STIMULATING FACTOR 1 (CSF1) INHIBITOR THERAPY: A PHASE 2 CASE SERIES
Vinod Ravi
Favorite
(P 451) TREATMENT OUTCOMES OF GEMCITABINE AND DOCETAXEL IN PATIENTS WITH CLEAR CELL SARCOMA (CCS) OR GASTROINTESTINAL NEUROECTODERMAL TUMOR (GNET): A CASE SERIES
Vinod Ravi
Favorite
(P 460) OUTCOMES OF LATER-LINES SYSTEMIC THERAPIES IN MALIGNANT PERIPHERAL NERVE SHEATH TUMORS (MPNST)
Vinod Ravi
Favorite
Rayman, Pat

Cleveland Clinic
(P 284) THE IMPACT OF SARCOMA SBRT ON THE IMMUNE SYSTEM: EARLY RESULTS FROM A PROSPECTIVE TRIAL
Pat Rayman
Favorite
Razak, Albiruni

Princess Margaret Cancer Centre
(P 346) SURROGATE ENDPOINTS FOR OVERALL SURVIVAL IN ADVANCED SOFT TISSUE SARCOMA TRIALS: A SYSTEMATIC REVIEW AND META-ANALYSIS
Albiruni Razak
Favorite
(P 395) ERIBULIN IN RECURRENT PRETREATED METASTATIC SOFT TISSUE SARCOMA. A CANADIAN SARCOMA RESEARCH AND CLINICAL COLLABORATION (CANSARCC) REAL WORLD ANALYSIS
Albiruni Razak
Favorite
Razak, Albiruni

Princess Margaret Cancer Center
(P 407) PIMICOTINIB IN TENOSYNOVIAL GIANT CELL TUMOR (TGCT): LONG-TERM EFFICACY, SAFETY, AND PATIENT-REPORTED OUTCOMES FROM THE PHASE 3 MANEUVER STUDY
Albiruni Razak
Favorite
Razmara, Aryana

Surgical Oncology, Department of Surgery, University of California, Davis
(P 244) INTRATUMORAL TIGIT BLOCKADE AUGMENTS ANTI-TUMOR RESPONSES AND BYPASSES HYPERFUNCTIONALITY OF PERIPHERAL TIGIT+ NK CELLS IN MOUSE AND HUMAN MODELS OF BONE AND SOFT TISSUE SARCOMA
Aryana Razmara
Favorite
Rechenauer, Vera Valerie

LMU Munich
(P 443) FIRST-LINE PAZOPANIB IN PATIENTS WITH EPITHELIOID HEMANGIOENDOTHELIOMA: A RETROSPECTIVE SINGLE-CENTER ANALYSIS
Vera Valerie Rechenauer
Favorite
Redding, Joseph

Moffitt Cancer Center
(P 138) A MULTI-INSTITUTIONAL ARCHIVE AND DEEP LEARNING PIPELINE FOR QUANTIFYING CHONDROSARCOMA COMPOSITION
Joseph Redding
Favorite
Redding, Joseph

USF Health Morsani College of Medicine
(P 140) REFINING PRE-SURGICAL ASSESSMENT OF LONG-BONE CHONDROSARCOMA THROUGH THE RADIOLOGIC AGGRESSIVENESS SCORE
Joseph Redding
Favorite
(P 141) A RETROSPECTIVE ANALYSIS OF THE BIRMINGHAM ATYPICAL CARTILAGE TUMOUR IMAGING PROTOCOL (BACTIP) IN MANAGING CENTRAL CARTILAGE TUMORS OF THE LONG BONES
Joseph Redding
Favorite
(P 142) ARE THERE INDEPENDENT PREDICTORS OF DEDIFFERENTIATED CHONDROSARCOMA ON MAGNETIC RESONANCE IMAGING? A MULTIVARIATE ANALYSIS
Joseph Redding
Favorite
(P 145) PATHOLOGIC FRACTURE IN CHONDROSARCOMA OF LONG BONES: A RETROSPECTIVE COHORT STUDY
Joseph Redding
Favorite
(P 160) A COMPARATIVE ANALYSIS OF DEDIFFERENTIATED AND CONVENTIONAL CHONDROSARCOMA OUTCOMES
Joseph Redding
Favorite
Reddy, Chandana

Cleveland Clinic
(P 284) THE IMPACT OF SARCOMA SBRT ON THE IMMUNE SYSTEM: EARLY RESULTS FROM A PROSPECTIVE TRIAL
Chandana Reddy
Favorite
Redmond, Christine

Ratio Therapeutics
(P 430) A PH/2 STUDY OF THE RADIOPHARMACEUTICAL [AC-225]RTX-2358 IN THE TREATMENT OF RELAPSED / REFRACTORY (R/R) SOFT TISSUE SARCOMA (STS) THE ATLAS STUDY - ACTINIUM THERAPY FOR LATE-STAGE AGGRESSIVE SARCOMAS
Christine Redmond
Favorite
Redmond, William

Providence Cancer Institute
(P 58) PLK1 AS A VULNERABLE TARGET OF BAP1-DRIVEN UNDIFFERENTIATED PLEOMORPHIC SARCOMAS
William Redmond
Favorite
Redston, Mark

Brigham and Women's Hospital
(P 235) AGNOSTIC INDICATION OF IMMUNE CHECKPOINT INHIBITORS (ICI): PATTERNS OF RESPONSE OF SARCOMAS
Mark Redston
Favorite
Reed, Damon

Memorial Sloan Kettering
(P 22) SINGLE CELL SEQUENCING ENABLES LINEAGE-INFORMED TARGETING OF OSTEOSARCOMA
Damon Reed
Favorite
(P 187) THERAPEUTIC OUTCOMES IN NF1-ALTERED GIST TREATED WITH MEK INHIBITION: A SINGLE-CENTER EXPERIENCE
Damon Reed
Favorite
(P 256) THE SEAN KARL COHORT: A NATIONAL COLLABORATIVE SINGLE-CELL RNASEQ STUDY OF PAIRED PATIENT EWING SARCOMA SPECIMENS
Damon Reed
Favorite
(P 273) RADIOMIC PREDICTORS OF SPONTANEOUS PNEUMOTHORAX DURING TYROSINE KINASE INHIBITOR THERAPY FOR LUNG METASTASES
Damon Reed
Favorite
(P 467) TREATMENT OUTCOMES IN AGGRESSIVE ANGIOMYXOMA: A SINGLE INSTITUTION EXPERIENCE
Damon Reed
Favorite
Reed, Rebecca

Aveni Foundation
(P 233) DNG64-CAR-V+ REGIMEN SHOWS CLINICAL BENEFIT IN PATIENTS WITH ADVANCED CCNG1 ONCOGENE EXPRESSING SARCOMAS (NCT04091295)
Rebecca Reed
Favorite
Regueiro, Alexandra

Complejo Hospitalario Universitario de Santiago
(P 71) GERMLINE POLYMORPHISMS IN THE VEGF PATHWAY AS PROGNOSTIC BIOMARKERS IN LOCALIZED HIGH-GRADE OSTEOSARCOMA: A STUDY BASED ON DATA FROM THE GEIS-33 PROTOCOL
Alexandra Regueiro
Favorite
Rehman, Shahyan

Yale School of Medicine / Yale New Haven Hospital
(P 40) PRECLINICAL EFFICACY OF A PH-SENSITIVE EXATECAN PEPTIDE-DRUG-CONJUGATE IN RHABDOMYOSARCOMA
Shahyan Rehman
Favorite
Reichardt, Peter

Oncology and Palliative Care / Sarcoma Center Professor of Oncology, Medical School Berlin Chairman of the German Sarcoma Foundation, Helios Klinikum Berlin-Buch
(P 194) UPDATED RESULTS FROM STRATEGIST 1: A PHASE 1/1B STUDY OF IDRX-42 (GSK6042981A) IN PATIENTS (PTS) WITH ADVANCED GASTROINTESTINAL STROMAL TUMORS (GIST)
Peter Reichardt
Favorite
(P 437) CLINICAL DATA CONFIRM GALENIC PRINCIPLE AND DEMONSTRATE THERAPEUTIC POTENTIAL OF THE001 (DPPG2-TSL-DOX) PLUS REGIONAL HYPERTHERMIA IN SOFT TISSUE SARCOMA
Peter Reichardt
Favorite
Reinhorn, Daniel

Memorial Sloan Kettering Cancer Center
(P 186) BRAF V600E-MUTATED GASTROINTESTINAL STROMAL TUMORS: A CASE SERIES AND ANALYSIS OF IMMUNE TUMOR INFILTRATE
Daniel Reinhorn
Favorite
(P 187) THERAPEUTIC OUTCOMES IN NF1-ALTERED GIST TREATED WITH MEK INHIBITION: A SINGLE-CENTER EXPERIENCE
Daniel Reinhorn
Favorite
(P 467) TREATMENT OUTCOMES IN AGGRESSIVE ANGIOMYXOMA: A SINGLE INSTITUTION EXPERIENCE
Daniel Reinhorn
Favorite
Reinisch, Mattea

Department of Gynecology and Obstetrics, University Medical Centre Mannheim, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
(P 454) TREATMENT PATTERNS AND OUTCOMES IN RADIATION-INDUCED SARCOMA: FIRST RESULTS OF THE TETRIS-PROJECT - A MULTIMODAL RETROSPECTIVE ANALYSIS FROM A TERTIARY CENTER
Mattea Reinisch
Favorite
Reinke, Denise

Sarcoma Patient Advocacy Global Network e.V.
(P 229) DETERMINANTS OF DIAGNOSTIC INTERVAL IN EPITHELIOID HEMANGIOENDOTHELIOMA: A LINEAR AND QUANTILE REGRESSION ANALYSIS OF PATIENT-REPORTED DATA FROM THE SPAGN GLOBAL SARCOMA DIAGNOSIS PATHWAY SURVEY
Denise Reinke
Favorite
(P 450) OUTCOMES IN CLEAR CELL SARCOMA: UPDATED INSIGHTS FROM ELECTRONIC HEALTH RECORDS IN A PATIENT-LED REGISTRY
Denise Reinke
Favorite
Reissfelder, Christoph

Department of Surgery, University Medical Centre Mannheim, Medical Faculty Mannheim, Heidelberg University
(P 165) EVALUATING LARGE LANGUAGE MODELS AS DECISION SUPPORT TOOLS IN MULTIDISCIPLINARY TUMOR BOARDS FOR GASTROINTESTINAL STROMAL TUMORS
Christoph Reissfelder
Favorite
(P 169) BENCHMARKING LARGE LANGUAGE MODELS VS MULTIDISCIPLINARY TUMOR BOARDS OF 21 SARCOMA CENTERS
Christoph Reissfelder
Favorite
(P 303) MULTIVISCERAL RESECTIONS AND URINARY TRACT RECONSTRUCTION TECHNIQUES IN THE SURGERY OF RETROPERITONEAL SARCOMAS: A CASE SERIES.
Christoph Reissfelder
Favorite
(P 312) APOSST: A PROSPECTIVE TRIAL TO EVALUATE ACUPUNCTURE AFTER SURGERY OF EXTREMITY SOFT TISSUE TUMORS
Christoph Reissfelder
Favorite
(P 367) ADHERENCE TO GERMAN SARCOMA GUIDELINE FOR MRI SEQUENCING IN SOFT TISSUE SARCOMA: EVALUATION OF IMAGING PRACTICES AND COMPLIANCE
Christoph Reissfelder
Favorite
(P 441) COLOSARC-Q: A PROSPECTIVE MULTICENTER STUDY FOR EVALUATING SURGICAL STRATEGIES FOR COLORECTAL RESECTIONS AND POSTOPERATIVE QUALITY OF LIFE IN RETROPERITONEAL SARCOMA PATIENTS
Christoph Reissfelder
Favorite
(P 454) TREATMENT PATTERNS AND OUTCOMES IN RADIATION-INDUCED SARCOMA: FIRST RESULTS OF THE TETRIS-PROJECT - A MULTIMODAL RETROSPECTIVE ANALYSIS FROM A TERTIARY CENTER
Christoph Reissfelder
Favorite
Rejas Mateo, Alicia

Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan
(P 277) THE ROLE OF RADIOTHERAPY IN THE MULTIDISCIPLINARY MANAGEMENT OF RADIATION-ASSOCIATED ANGIOSARCOMA OF THE BREAST: A REFERRAL CENTER EXPERIENCE
Alicia Rejas Mateo
Favorite
Rekhi, Bharat

Tata Memorial Hospital
(P 286) INTERSTITIAL BRACHYTHERAPY FOR ORGAN AND FUNCTION PRESERVATION IN SOFT TISSUE SARCOMAS: LONG TERM OUTCOMES
Bharat Rekhi
Favorite
(P 338) POORLY DIFFERENTIATED SYNOVIAL SARCOMA: A HISTOLOGIC CHALLENGE OF AN AGGRESSIVE VARIANT
Bharat Rekhi
Favorite
(P 379) IMPACT OF EWSR1 GENE REARRANGEMENT TESTING ON DIAGNOSIS OF A WIDE RANGE OF SOLID TUMOURS
Bharat Rekhi
Favorite
(P 387) TREATMENT PATTERNS AND PROGNOSTIC FACTORS IN LOCALISED SYNOVIAL SARCOMA: A RETROSPECTIVE STUDY FROM A TERTIARY CANCER CENTRE IN INDIA
Bharat Rekhi
Favorite
(P 438) RANDOMIZED, OPEN-LABEL, PHASE III TRIAL OF ADJUVANT CHEMOTHERAPY VERSUS OBSERVATION IN NON-METASTATIC, HIGH-RISK SOFT TISSUE SARCOMAS (ACO-SARC TRIAL)
Bharat Rekhi
Favorite
(P 463) EXTRANODAL FOLLICULAR DENDRITIC CELL SARCOMAS AND THEIR OLIGORECURRENCES: TRIUMPHS, TRIALS AND LESSONS LEARNT AT A SINGLE TERTIARY CANCER REFERRAL CENTRE, INDIA.
Bharat Rekhi
Favorite
Rekulapelli, Akhil

Vanderbilt University School of Medicine
(P 97) RISK FACTORS ASSOCIATED WITH AMPUTATION VERSUS CONTINUED LIMB SALVAGE IN LOWER EXTREMITY ENDOPROSTHETIC RECONSTRUCTION
Akhil Rekulapelli
Favorite
Remiszewski, Piotr

Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland
(P 134) INTEGRATIVE MICRORNA PROFILING IN CHONDROSARCOMA: TOWARD BIOMARKER DISCOVERY AND PROGNOSTIC SIGNATURE DEVELOPMENT
Piotr Remiszewski
Favorite
(P 146) LOCALISED CHONDROSARCOMA PERIOPERATIVE TREATMENT: REAL-WORLD OUTCOMES AND CHALLENGES ACROSS HISTOLOGIC SUBTYPES
Piotr Remiszewski
Favorite
(P 149) SURGICAL TEXTBOOK OUTCOMES IN PATIENTS DIAGNOSED WITH CHONDROSARCOMA
Piotr Remiszewski
Favorite
(P 152) EFFICACY OF PALLIATIVE CHEMOTHERAPY AND LOCAL TREATMENTS IN ADVANCED CHONDROSARCOMA: A SUBTYPE-SPECIFIC RETROSPECTIVE ANALYSIS
Piotr Remiszewski
Favorite
(P 164) LONG TERM OUTCOMES IN PATIENTS DIAGNOSED WITH SECONDARY CHONDROSARCOMA
Piotr Remiszewski
Favorite
Ren, Tingting

Peking University People's Hospital
(P 74) TERTIARY LYMPHOID STRUCTURES PREDICT PROGNOSIS AND IMMUNE LANDSCAPE IN OSTEOSARCOMA: A MACHINE LEARNING-BASED TRANSCRIPTOMIC STUDY
Tingting Ren
Favorite
(P 75) CD248 AS A PROGNOSTIC MARKER IN OSTEOSARCOMA
Tingting Ren
Favorite
Rerko, Matthew

Cleveland Clinic
(P 316) AREA DEPRIVATION INDEX (ADI) AND OUTCOMES IN LOCALIZED SOFT TISSUE SARCOMA: DO SOCIAL DETERMINANTS INFLUENCE SURVIVAL?
Matthew Rerko
Favorite
Restrepo, Juliana

Fundación Colombiana de Cancerología Clínica Vida, Clínica Astorga
(P 219) RETROPERITONEAL SARCOMA: HEALTH SYSTEM BARRIERS AND THE RATIONALE FOR A SPECIALIZED SARCOMA UNIT
Juliana Restrepo
Favorite
(P 301) RETROPERITONEAL SARCOMA: SINGLE CENTER EXPERIENCE IN LATIN AMERICA. DO WE HAVE DIFFERENT SARCOMAS WHEN COMPARED TO THE REST OF THE WORLD?
Juliana Restrepo
Favorite
Restrepo, Sofia

University of South Florida, Morsani College of Medicine
(P 163) CHONDROSARCOMA IN THE AYA POPULATION
Sofia Restrepo
Favorite
Reu, Frederic

Deciphera Pharmaceuticals, LLC
(P 424) AN OPEN-LABEL PHASE 1/2 STUDY OF DCC-3009 MONOTHERAPY IN PATIENTS (PTS) WITH ADVANCED GASTROINTESTINAL STROMAL TUMOR (GIST)
Frederic Reu
Favorite
Rey, Christophe

Institut Bergonié
(P 59) TARGETING ADORA2B TO HALT METASTASIS IN UNDIFFERENTIATED PLEOMORPHIC SARCOMA: FROM MULTI-OMICS TO THERAPEUTIC INHIBITION
Christophe Rey
Favorite
Rhoades, Julie

Vanderbilt University Medical Center
(P 51) OVEREXPRESSION OF GLI2 IN DEDIFFERENTIATED LIPOSARCOMA TUMORS INDUCES MICROENVIRONMENT REMODELING
Julie Rhoades
Favorite
Rhodes, Whitney

Genesis Research Group
(P 464) EFFICACY OUTCOMES AMONG PATIENTS WITH ADVANCED EPITHELIOID SARCOMAS OF PROXIMAL-TYPE AND DISTAL-TYPE TREATED WITH TAZ: POST HOC ANALYSIS OF STUDY EZH-202
Whitney Rhodes
Favorite
Ribas, Roberto

University of Florida
(P 129) HIJACKED FUEL: GLYCOGEN-DRIVEN METABOLIC SHIFTS IN IDH1-MUTANT CHONDROSARCOMA
Roberto Ribas
Favorite
Ribeiro, Mauricio

Moffitt Cancer Center
(P 394) DUAL OR TRIMODALITY THERAPY VERSUS SURGERY ALONE IN RADIATION-ASSOCIATED ANGIOSARCOMA OF THE BREAST
Mauricio Ribeiro
Favorite
(P 453) OUTCOMES OF PLEOMORPHIC LIPOSARCOMA PATIENTS FOLLOWING MULTI-DISCIPLINARY MANAGEMENT WITHIN A TERTIARY CANCER CENTER
Mauricio Ribeiro
Favorite
Ricchinin, Francesca

Fondazione IRCCS Istituto Nazionale dei Tumori di Milano
(P 447) PAIN ASSESSMENT CRITERIA (PAC) ANTICIPATE RECIST PROGRESSION AND CORRELATE WITH BLOOD LEVELS OF GROWTH DIFFERENTIATION FACTOR 15 (GDF15) IN EPITHELIOID HEMANGIOENDOTHELIOMA (EHE)
Francesca Ricchinin
Favorite
Richardson, Spencer

Indiana University
(P 82) DISPARITIES IN OSTEOSARCOMA BY SOCIOECONOMIC STATUS
Spencer Richardson
Favorite
(P 84) A MULTICENTER COMPARISON OF REVERSE TOTAL SHOULDER ARTHROPLASTY VERSUS HEMIARTHROPLASTY FOR ENDOPROSTHETIC RECONSTRUCTION FOLLOWING ONCOLOGIC RESECTION OF THE PROXIMAL HUMERUS
Spencer Richardson
Favorite
(P 269) INCIDENCE OF MALIGNANCY IN BIOPSIED PEDIATRIC SOFT TISSUE MASSES
Spencer Richardson
Favorite
(P 272) THE HAZARDS OF BIOPSY IN PEDIATRIC SOFT TISSUE SARCOMAS
Spencer Richardson
Favorite
Ridgway, Paul

St Vincent's University Hospital
(P 211) HEALTH-RELATED QUALITY OF LIFE IN IRISH SARCOMA PATIENTS
Paul Ridgway
Favorite
(P 213) FINANCIAL TOXICITY IN IRISH SARCOMA CARE: A SINGLE-CENTRE ANALYSIS
Paul Ridgway
Favorite
Riedel, Richard

Duke Cancer Institute
(P 413) EFFICACY OF NIROGACESTAT IN PATIENTS WITH DESMOID TUMORS AND PRESENCE OR ABSENCE OF POOR PROGNOSTIC FACTORS: POST HOC ANALYSES OF THE PHASE 3 DEFI TRIAL
Richard Riedel
Favorite
Riesterer, Oliver

Center of Radiation Oncology, Cantonal Hospital Aarau
(P 436) SAKK 57/24 FEASIBILITY OF TOTAL NEOADJUVANT TREATMENT WITH HYPERTHERMIA IN PATIENTS WITH HIGH-RISK EXTREMITY AND TRUNK SOFT TISSUE SARCOMA. A MULTICENTER, SINGLE ARM, OPEN LABEL, PHASE II TRIAL
Oliver Riesterer
Favorite
Rieth, John

University of Iowa
(P 343) PROGRESSION FREE SURVIVAL OF IMMUNE CHECKPOINT INHIBITORS IN THE FIRST-LINE TREATMENT OF METASTATIC SARCOMA: A SINGLE CENTER RETROSPECTIVE ANALYSIS.
John Rieth
Favorite
(P 370) CLINICAL OUTCOMES OF CUTANEOUS UNDIFFERENTIATED PLEOMORPHIC SARCOMA AND SUBCUTANEOUS MYXOFIBROSARCOMA: A RETROSPECTIVE REVIEW
John Rieth
Favorite
(P 371) CLINICAL PROFILE AND TREATMENT PATTERNS OF ANGIOSARCOMA IN THE REAL- WORLD SETTING: A SINGLE CENTER EXPERIENCE FROM 1991-2024.
John Rieth
Favorite
(P 439) AN OPEN LABEL MULTICENTER PHASE 2 STUDY WITH SAFETY LEAD IN OF INTRATUMORAL VUSOLIMOGENE ODERPAREPVEC IN COMBINATION WITH PEMBROLIZUMAB IN PATIENTS WITH ANGIOSARCOMA
John Rieth
Favorite
Riggs, Keegan

Indiana University School of Medicine
(P 269) INCIDENCE OF MALIGNANCY IN BIOPSIED PEDIATRIC SOFT TISSUE MASSES
Keegan Riggs
Favorite
(P 272) THE HAZARDS OF BIOPSY IN PEDIATRIC SOFT TISSUE SARCOMAS
Keegan Riggs
Favorite
Righi, Alberto

IRCCS Istituto Ortopedico Rizzoli
(P 139) IMMUNOGENOMIC PROFILING OF CHONDROSARCOMA REVEALS DISTINCT IMMUNE PHENOTYPES AND PROGNOSTIC MUTATIONS
Alberto Righi
Favorite
(P 151) SHOULD WE USE ADJUVANT CHEMOTHERAPY IN PATIENTS WITH LOCALIZED DEDIFFERENTIATED CHONDROSARCOMA (DDCS) OF THE PELVIS? AN ANALYSIS BY THE PELVIC DDCS STUDY GROUP
Alberto Righi
Favorite
Riley, Dylan

Rush University Medical Center
(P 104) 3D PRINTED CUTTING GUIDES FOR LONG BONE SARCOMA RESECTION AND INTERCALARY ALLOGRAFT RECONSTRUCTION: A CASE SERIES
Dylan Riley
Favorite
(P 113) ASSESSING TREATMENT OUTCOMES OF CHONDROMYXOID FIBROMA: A CASE SERIES
Dylan Riley
Favorite
(P 206) IMPACT OF PROXIMITY TO HEALTH CENTER ON ADHERENCE TO NATIONAL COMPREHENSIVE CANCER NETWORK GUIDELINES IN PATIENTS WITH SOFT TISSUE SARCOMAS
Dylan Riley
Favorite
Risi Ambrogioni, Laura

Università Campus Bio-Medico di Roma
(P 412) UNCOVERING HER2 OVEREXPRESSION IN SOFT TISSUE SARCOMAS (STS): INSIGHTS FROM THE CANCER GENOME ATLAS (TCGA)
Laura Risi Ambrogioni
Favorite
Ritterhouse, Lauren

Department of Pathology, Center for Integrated Diagnostics, Massachusetts General Hospital and Harvard Medical School
(P 45) MONITORING EWSR1 FUSIONS IN SARCOMA PATIENTS USING PERSONALIZED LIQUID BIOPSY ASSAYS
Lauren Ritterhouse
Favorite
Rivera Carrasquillo, Paula

University of Puerto Rico
(P 40) PRECLINICAL EFFICACY OF A PH-SENSITIVE EXATECAN PEPTIDE-DRUG-CONJUGATE IN RHABDOMYOSARCOMA
Paula Rivera Carrasquillo
Favorite
Rivera, Dyani

Children's Hospital of Philadelphia
(P 262) EVALUATING FRONT-LINE THERAPY ACCORDANCE WITH CURRENT SYNOVIAL SARCOMA GUIDELINES
Dyani Rivera
Favorite
(P 263) DESCRIBING THE CHARACTERISTICS AND TREATMENT OF SYNOVIAL SARCOMA IN THE RECURRENT SETTING
Dyani Rivera
Favorite
Rivera, Miguel

Massachusetts General Hospital
(P 24) THE SIRTUIN SIRT5 SUPPORTS EWING SARCOMA SURVIVAL VIA REGULATION OF EWS-FLI1 STABILITY AND ACTIVITY
Miguel Rivera
Favorite
Robba, Tiziana

Radiology, Ospedale CTO, AOU Città della Salute e della Scienza di Torino
(P 231) INCREASED LIFETIME RISK (LTR) OF SOFT TISSUE SARCOMAS (STS) IN PATIENTS WITH LOW-RISK GASTROINTESTINAL STROMAL TUMORS (GIST): A RETROSPECTIVE ANALYSIS FROM THE ITALIAN SARCOMA GROUP (ISG)
Tiziana Robba
Favorite
Robbins, Elizabeth

Cure 4 The Kids Foundation
(P 261) SUSTAINED RESPONSE WITH RIVOCERANIB AND DENOSUMAB IN RELASPED OSTEOSARCOMA
Elizabeth Robbins
Favorite
Robbins, Julia

TalusBio
(P 260) MECHANISM AND EFFICACY OF ANTHRACYCLINE MEDIATED EPIGENETIC DISRUPTION IN BONE SARCOMAS.
Julia Robbins
Favorite
Roberts, Evan

3. Sylvester Comprehensive Cancer Center
(P 31) TARGETING CANCER STEM CELLS BY TYROSINE PEPTIDE ANALOGUE IN REFRACTORY SARCOMA
Evan Roberts
Favorite
Roberts, Jesse

Fred Hutchinson Cancer Center
(P 287) A PHASE 1 STUDY OF NEOADJUVANT CABOZANTINIB IN COMBINATION WITH RADIATION THERAPY FOR SARCOMAS OF THE EXTREMITIES
Jesse Roberts
Favorite
Roberts, Ryan

Nationwide Children's Hospital
(P 08) BUILDING A MEDICAL DONATION NETWORK TO ENHANCE DEVELOPMENT OF PEDIATRIC TUMOR MODELS
Ryan Roberts
Favorite
(P 13) TRANSCRIPTIONAL DIVERSITY AND NICHE REMODELING AT THE METASTATIC BOTTLENECK IN OSTEOSARCOMA
Ryan Roberts
Favorite
Robinson, Denise

The EHE Foundation
(P 444) HEALTH-RELATED QUALITY OF LIFE (HRQOL) CHALLENGES IN PATIENTS WITH EPITHELIOID HEMANGIOENDOTHELIOMA (EHE): ANALYSIS OF AN ULTRA-RARE SARCOMA GROUP
Denise Robinson
Favorite
(P 446) GDF-15 AS A PROGNOSTIC FACTOR IN PATIENTS WITH EPITHELIOID HEMANGIOENDOTHELIOMA
Denise Robinson
Favorite
(P 447) PAIN ASSESSMENT CRITERIA (PAC) ANTICIPATE RECIST PROGRESSION AND CORRELATE WITH BLOOD LEVELS OF GROWTH DIFFERENTIATION FACTOR 15 (GDF15) IN EPITHELIOID HEMANGIOENDOTHELIOMA (EHE)
Denise Robinson
Favorite
(P 448) OVERCOMING CHALLENGES IN ULTRA-RARE SARCOMAS: A CENTRALIZED BIOBANK FOR EPITHELIOID HEMANGIOENDOTHELIOMA AS A RESOURCE TO ACCELERATE DISCOVERY
Denise Robinson
Favorite
(P 449) UNDERSTANDING GAPS IN KNOWLEDGE AND PATIENT-REPORTED PAIN IN EPITHELIOID HEMANGIOENDOTHELIOMA: RESULTS FROM A GLOBAL PATIENT REGISTRY
Denise Robinson
Favorite
Robinson, James

Children's Hospital of Philadelphia
(P 262) EVALUATING FRONT-LINE THERAPY ACCORDANCE WITH CURRENT SYNOVIAL SARCOMA GUIDELINES
James Robinson
Favorite
(P 263) DESCRIBING THE CHARACTERISTICS AND TREATMENT OF SYNOVIAL SARCOMA IN THE RECURRENT SETTING
James Robinson
Favorite
Robinson, Steven

Mayo Clinic
(P 223) OUTCOMES OF GERIATRIC PATIENTS WITH DE NOVO SARCOMA AND LUNG METASTASES: ROLE OF TUMOR CHARACTERISTICS AND TREATMENT STRATEGY
Steven Robinson
Favorite
(P 246) CTLA4 PATHWAY ACTIVATION IN RADIATION-INDUCED ANGIOSARCOMA: A TRANSCRIPTOMIC RATIONALE FOR IMMUNE CHECKPOINT BLOCKADE
Steven Robinson
Favorite
(P 300) FEATURES AND OUTCOMES OF PATIENTS WITH GASTROINTESTINAL LEIYOMYOSARCOMA
Steven Robinson
Favorite
Rochaix, Philippe

OCR
(P 28) ADVANCING PRECISION ONCOLOGY IN SOFT TISSUE SARCOMAS: THE ROLE OF ITRAC IN METASTATIC RISK STRATIFICATION AND TREATMENT PERSONALIZATION
Philippe Rochaix
Favorite
Rodenbarger, Lauren

LabCorp Central Laboratory Services
(P 24) THE SIRTUIN SIRT5 SUPPORTS EWING SARCOMA SURVIVAL VIA REGULATION OF EWS-FLI1 STABILITY AND ACTIVITY
Lauren Rodenbarger
Favorite
Rodon, Jordi

The University of Texas MD Anderson Cancer Center
(P 184) MTAP IN GASTROINTESTINAL STROMAL TUMOR (GIST): RATE OF MTAP LOSS AND CONCORDANCE BETWEEN GENOMIC SEQUENCING AND IMMUNOHISTOCHEMISTRY
Jordi Rodon
Favorite
(P 415) A PHASE 1/2 TRIAL OF FOG-001, A FIRST-IN-CLASS DIRECT β-CATENIN:TCF4 INHIBITOR: SAFETY AND PRELIMINARY ANTITUMOR ACTIVITY IN PATIENTS WITH DESMOID TUMORS (DT)
Jordi Rodon
Favorite
(P 434) A FIRST-IN-HUMAN PHASE 1, MULTICENTER, OPEN-LABEL STUDY OF M3554, A NOVEL ANTI-GD2 ANTIBODY-DRUG CONJUGATE, IN PATIENTS WITH ADVANCED SOLID TUMORS
Jordi Rodon
Favorite
Rodriguez Izquierdo, Frida

Universidad Autónoma Metropolitana
(P 39) BUB1 AN OVEREXPRESSED KINASE IN SARCOMA: FINDING NEW TARGET THERAPY FOR OSTEOSARCOMA, LIPOSARCOMA, SYNOVIAL SARCOMA AND LEIOMYOSARCOMA
Frida Rodriguez Izquierdo
Favorite
Rodriguez Morales, Miguel

Instituto Nacional de Pediatria
(P 39) BUB1 AN OVEREXPRESSED KINASE IN SARCOMA: FINDING NEW TARGET THERAPY FOR OSTEOSARCOMA, LIPOSARCOMA, SYNOVIAL SARCOMA AND LEIOMYOSARCOMA
Miguel Rodriguez Morales
Favorite
Rodriguez, Maressa

University of California Davis School of Medicine
(P 77) BARRIERS TO GUIDELINE CONCORDANT CARE IN AYA PATIENTS WITH BONE SARCOMAS
Maressa Rodriguez
Favorite
Rodriguez-Wallberg, Kenny

Karolinska Hospital and Institute
(P 270) FEASIBILITY OF FERTILITY PRESERVATION IN CHILDREN, ADOLESCENTS AND YOUNG ADULTS WITH SARCOMAS - A PROSPECTIVE COHORT STUDY WITH LONG-TERM FOLLOW-UP
Kenny Rodriguez-Wallberg
Favorite
Rogala, Pawel

National Research Institute of Oncology Warsaw Poland
(P 123) OFF-LABEL DENOSUMAB IN LOCALLY AGGRESSIVE BENIGN BONE TUMORS OTHER THAN GIANT CELL TUMOR OF BONE.
Pawel Rogala
Favorite
Rogala, Pawel

Maria Sklodowska-Curie National Research Institute of Oncology
(P 470) OFF-LABEL TREATMENT AND ULTRARARE SARCOMAS - SINGLE INSTITUTION REPORT
Pawel Rogala
Favorite
Rogers, Alan

The Ohio State University
(P 153) DOES THE QUANTITY OF DEDIFFERENTIATION MATTER IN THE CLINICAL OUTCOMES OF DEDIFFERENTIATED CHONDROSARCOMA? A 10-YEAR SINGLE TERTIARY INSTITUTIONAL EXPERIENCE OF A SERIES.
Alan Rogers
Favorite
Rojas, Santiago

Fundación Colombiana de Cancerología Clínica Vida, Hospital San Vicente Fundación
(P 219) RETROPERITONEAL SARCOMA: HEALTH SYSTEM BARRIERS AND THE RATIONALE FOR A SPECIALIZED SARCOMA UNIT
Santiago Rojas
Favorite
(P 301) RETROPERITONEAL SARCOMA: SINGLE CENTER EXPERIENCE IN LATIN AMERICA. DO WE HAVE DIFFERENT SARCOMAS WHEN COMPARED TO THE REST OF THE WORLD?
Santiago Rojas
Favorite
Rojo, Jonathan

Parabilis Medicines
(P 415) A PHASE 1/2 TRIAL OF FOG-001, A FIRST-IN-CLASS DIRECT β-CATENIN:TCF4 INHIBITOR: SAFETY AND PRELIMINARY ANTITUMOR ACTIVITY IN PATIENTS WITH DESMOID TUMORS (DT)
Jonathan Rojo
Favorite
Roland, Christina

The University of Texas MD Anderson Cancer Center
(P 172) COMPARISON OF CELL SEGMENTATION METHODS IN SOFT TISSUE SARCOMA (STS) SPATIAL PROTEOMIC DATASETS
Christina Roland
Favorite
(P 242) IMMUNE PROFILING OF UNDIFFERENTIATED PLEOMORPHIC SARCOMAS REVEALS DISTINCT PROGNOSTIC SUBGROUPS
Christina Roland
Favorite
(P 351) THE ROLE OF SOCIOECONOMIC DISPARITIES ON SURVIVAL OUTCOMES IN MALIGNANT PERIPHERAL NERVE SHEATH TUMORS
Christina Roland
Favorite
Romandini, Davide

Università Campus Bio-Medico di Roma
(P 412) UNCOVERING HER2 OVEREXPRESSION IN SOFT TISSUE SARCOMAS (STS): INSIGHTS FROM THE CANCER GENOME ATLAS (TCGA)
Davide Romandini
Favorite
Romano Cardozo, Alejandra

Hospital Santa Creu i Sant Pau
(P 218) THE IMPACT OF BROADENED GENETIC COUNSELLING REFERRAL CRITERIA IN SARCOMA PATIENTS: A REFERENCE CENTRE'S EXPERIENCE
Alejandra Romano Cardozo
Favorite
Ronan, Karine

St Vincent's University Hospital
(P 211) HEALTH-RELATED QUALITY OF LIFE IN IRISH SARCOMA PATIENTS
Karine Ronan
Favorite
(P 213) FINANCIAL TOXICITY IN IRISH SARCOMA CARE: A SINGLE-CENTRE ANALYSIS
Karine Ronan
Favorite
Roohani, Siyer

Department of Radiation Oncology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin
(P 169) BENCHMARKING LARGE LANGUAGE MODELS VS MULTIDISCIPLINARY TUMOR BOARDS OF 21 SARCOMA CENTERS
Siyer Roohani
Favorite
Rosales, Wesley

Providence Cancer Institute
(P 58) PLK1 AS A VULNERABLE TARGET OF BAP1-DRIVEN UNDIFFERENTIATED PLEOMORPHIC SARCOMAS
Wesley Rosales
Favorite
Rose, Brandon

University of Texas Southwestern Medical Center
(P 217) PATIENT QUESTIONNAIRE EXPLORING THE PRE-SARCOMA DIAGNOSIS CHARACTERISTICS OF SARCOMA PATIENTS
Brandon Rose
Favorite
(P 224) PAN-SARCOMA DATABASE (PSDB): AN UPDATE ON MIAMI'S COLLABORATIVE MULTI-USER DATA PIPELINE OF SARCOMA DATA USING REDCAP AND R CODING
Brandon Rose
Favorite
(P 320) CLINICAL CHARACTERISTICS AND RECURRENCE PATTERNS IN HISPANIC VS. NON-HISPANIC PATIENTS WITH LEIOMYOSARCOMA: FINDINGS FROM A RETROSPECTIVE SINGLE-CENTER COHORT STUDY
Brandon Rose
Favorite
(P 327) INITIAL TREATMENT MODALITY AND RECURRENCE IN NON-METASTATIC LEIOMYOSARCOMA: A RETROSPECTIVE COHORT STUDY
Brandon Rose
Favorite
(P 333) METABOLIC SYNDROME CORRELATION WITH LIPOSARCOMA INCIDENCE AND OUTCOMES: A RETROSPECTIVE ANALYSIS.
Brandon Rose
Favorite
(P 362) SHOULD PAZOPANIB BE USED AS A MAINTENANCE THERAPY TO IMPROVE RECURRENCE-FREE SURVIVAL AND OVERALL SURVIVAL IN PATIENTS WHO RECEIVED MAI IN SOFT TISSUE SARCOMA?
Brandon Rose
Favorite
(P 369) CLINICAL CHARACTERISTICS & TREATMENT OUTCOME PATTERNS OF SOLITARY FIBROUS TUMORS: A SINGLE-INSTITUTION RETROSPECTIVE ANALYSIS
Brandon Rose
Favorite
(P 397) EXPLORING REAL WORLD DATA OF RECURRENCE IN NON-METASTATIC MYXOFIBROSAROMA: AN UPDATED RETROSPECTIVE COHORT STUDY
Brandon Rose
Favorite
Rosenbaum, Evan

Memorial Sloan Kettering Cancer Center
(P 187) THERAPEUTIC OUTCOMES IN NF1-ALTERED GIST TREATED WITH MEK INHIBITION: A SINGLE-CENTER EXPERIENCE
Evan Rosenbaum
Favorite
(P 409) RETROSPECTIVE ANALYSIS OF PROGNOSTIC FACTORS INCLUDING HLA GENOTYPE IN MYXOID LIPOSARCOMA
Evan Rosenbaum
Favorite
(P 421) CHARACTERIZING THE IMMUNE RESPONSE TO INTRATUMORAL TIGILANOL TIGLATE (TT) IN PATIENTS WITH ADVANCED AND/OR METASTATIC SOFT TISSUE SARCOMA (STS) IN A PHASE IIA TRIAL (NCT05755113)
Evan Rosenbaum
Favorite
(P 467) TREATMENT OUTCOMES IN AGGRESSIVE ANGIOMYXOMA: A SINGLE INSTITUTION EXPERIENCE
Evan Rosenbaum
Favorite
Rosenberg, Andrew

University of Miami
(P 147) CONVENTIONAL AND DEDIFFERENTIATED CHONDROSARCOMA; IS ENCHONDROMA THE PRECURSOR LESION?
Andrew Rosenberg
Favorite
(P 154) BCOR-MUTATED CONVENTIONAL AND DEDIFFERENTIATED CHONDROSARCOMA: A CLINICOPATHOLOGIC STUDY
Andrew Rosenberg
Favorite
(P 225) GLOBAL REGISTRY OF SOLITARY FIBROUS TUMORS (SFT): INTEGRATING CLINICAL, MOLECULAR, AND ENVIRONMENTAL DATA- THE HOROWITZ SFT INITIATIVE (HSFTI)
Andrew Rosenberg
Favorite
(P 289) SIX YEAR FOLLOW-UP ON CIVASHEET® USE FOR SOFT TISSUE SARCOMA: A SINGLE INSTITUTION EXPERIENCE
Andrew Rosenberg
Favorite
(P 320) CLINICAL CHARACTERISTICS AND RECURRENCE PATTERNS IN HISPANIC VS. NON-HISPANIC PATIENTS WITH LEIOMYOSARCOMA: FINDINGS FROM A RETROSPECTIVE SINGLE-CENTER COHORT STUDY
Andrew Rosenberg
Favorite
(P 327) INITIAL TREATMENT MODALITY AND RECURRENCE IN NON-METASTATIC LEIOMYOSARCOMA: A RETROSPECTIVE COHORT STUDY
Andrew Rosenberg
Favorite
(P 362) SHOULD PAZOPANIB BE USED AS A MAINTENANCE THERAPY TO IMPROVE RECURRENCE-FREE SURVIVAL AND OVERALL SURVIVAL IN PATIENTS WHO RECEIVED MAI IN SOFT TISSUE SARCOMA?
Andrew Rosenberg
Favorite
(P 369) CLINICAL CHARACTERISTICS & TREATMENT OUTCOME PATTERNS OF SOLITARY FIBROUS TUMORS: A SINGLE-INSTITUTION RETROSPECTIVE ANALYSIS
Andrew Rosenberg
Favorite
(P 393) DISTINCT SECONDARY MUTATIONAL LANDSCAPES ARE ASSOCIATED WITH NAB2–STAT6 FUSION BREAKPOINTS IN SOLITARY FIBROUS TUMORS
Andrew Rosenberg
Favorite
Rosenthal, Howard

University of Kansas Medical Center
(P 366) WOUND COMPLICATIONS AFTER ULTRA-HYPOFRACTIONATED NEOADJUVANT RADIATION FOR SOFT TISSUE SARCOMA: WHAT IS OPTIMAL SURGICAL TIMING?
Howard Rosenthal
Favorite
Rose, Peter

Mayo Clinic
(P 223) OUTCOMES OF GERIATRIC PATIENTS WITH DE NOVO SARCOMA AND LUNG METASTASES: ROLE OF TUMOR CHARACTERISTICS AND TREATMENT STRATEGY
Peter Rose
Favorite
Rose, Raven

Memorial Sloan Kettering Cancer Center
(P 08) BUILDING A MEDICAL DONATION NETWORK TO ENHANCE DEVELOPMENT OF PEDIATRIC TUMOR MODELS
Raven Rose
Favorite
Rosinski, Jenna

Seattle Children's Research Institute
(P 260) MECHANISM AND EFFICACY OF ANTHRACYCLINE MEDIATED EPIGENETIC DISRUPTION IN BONE SARCOMAS.
Jenna Rosinski
Favorite
Rossing, Maria

Center for Genomic Medicine, Copenhagen University Hospital, Rigshospitalet
(P 05) CONCORDANCE OF GENOMIC ALTERATIONS WITH CIRCULATING TUMOR DNA: INITIAL FINDINGS FROM A PILOT STUDY
Maria Rossing
Favorite
Ross, Jeffrey

SUNY Upstate Medical University
(P 393) DISTINCT SECONDARY MUTATIONAL LANDSCAPES ARE ASSOCIATED WITH NAB2–STAT6 FUSION BREAKPOINTS IN SOLITARY FIBROUS TUMORS
Jeffrey Ross
Favorite
Roth, Clark

University of Pittsburgh Medical Center
(P 63) EVALUATING SURGICAL MARGINS IN SARCOMA RESECTION WITH INDOCYANINE GREEN FLUORESCENCE IMAGING
Clark Roth
Favorite
Roth, Mike

MD Anderson
(P 77) BARRIERS TO GUIDELINE CONCORDANT CARE IN AYA PATIENTS WITH BONE SARCOMAS
Mike Roth
Favorite
Rothschild, Sara

Life Raft Group
(P 190) TEMPORAL DECLINE IN PROGRESSION-FREE SURVIVAL, TIME ON MEDICATION, AND OVERALL SURVIVAL IN ADVANCED GASTROINTESTINAL STROMAL TUMOR
Sara Rothschild
Favorite
(P 226) REAL-WORLD MANAGEMENT OF SYMPTOMATIC VS ASYMPTOMATIC TGCT FROM AN OBSERVATIONAL REGISTRY
Sara Rothschild
Favorite
Rotondo, Ronny

University of Kansas Medical Center
(P 366) WOUND COMPLICATIONS AFTER ULTRA-HYPOFRACTIONATED NEOADJUVANT RADIATION FOR SOFT TISSUE SARCOMA: WHAT IS OPTIMAL SURGICAL TIMING?
Ronny Rotondo
Favorite
Rougraff, Bruce

IndyOrtho
(P 272) THE HAZARDS OF BIOPSY IN PEDIATRIC SOFT TISSUE SARCOMAS
Bruce Rougraff
Favorite
Rousi, Emma

ORION PHARMA
(P 445) TEADES PH1/2 STUDY WITH ODM-212: PRELIMINARY RESULTS IN EHE PATIENTS
Emma Rousi
Favorite
Roussel, Natacha

Toulouse Cancer Research Center - INSERM
(P 20) IDENTIFICATION OF A PROGNOSTIC GENE SIGNATURE FOR OSTEOSARCOMA RELAPSE BASED ON RESIDUAL TUMOR DISEASE AND ITS MICROENVIRONMENT
Natacha Roussel
Favorite
Ruano, Dina

Leiden University Medical Center
(P 127) AN INTEGRATED CLINICAL GENOMIC AND TRANSCRIPTOMIC SUBGROUPING OF CENTRAL CHONDROSARCOMA
Dina Ruano
Favorite
Rubin, Brian

Cleveland Clinic
(P 284) THE IMPACT OF SARCOMA SBRT ON THE IMMUNE SYSTEM: EARLY RESULTS FROM A PROSPECTIVE TRIAL
Brian Rubin
Favorite
Ruffing, Cooper

Duke University
(P 130) INVESTIGATING LCP1-MEDIATED ONCOGENIC SIGNALING IN CHONDROSARCOMA METASTASIS
Cooper Ruffing
Favorite
Rumana, Rachel

Universtity of Miami Miller School of Medicine
(P 89) PATELLAR HEIGHT AND ITS INFLUENCE ON FUNCTIONAL OUTCOMES FOR MEGAPROSTHESES AROUND THE KNEE PERFORMED FOR ONCOLOGICAL INDICATIONS
Rachel Rumana
Favorite
Ruppert, Nathaniel

Case Western Reserve University School of Medicine
(P 457) A RETROSPECTIVE REVIEW OF LOW-GRADE FIBROMYXOID SARCOMA: SURGICAL MANAGEMENT, RADIATION THERAPY, AND OUTCOMES
Nathaniel Ruppert
Favorite
Rupp, Luise

Institute of Immunology, Faculty of Medicine Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany
(P 243) CLINICAL SIGNIFICANCE OF TUMOR-INFILTRATING IMMUNE CELL SUBSETS IN THE RETROPERITONEAL DEDIFFERENTIATED LIPOSARCOMAS AND LEIOMYOSARCOMAS
Luise Rupp
Favorite
Rush, Laura

The Ohio State University
(P 221) QUALITATIVE ANALYSIS OF THE PERIOPERATIVE EXPERIENCE OF YOUNG ADULT PATIENTS UNDERGOING EXTREMITY SARCOMA SURGERY
Laura Rush
Favorite
Ruspi, Laura

IRCCS Humanitas Research Hospital
(P 203) MINIMALLY INVASIVE RESECTION OF MULTIFOCAL DUODENO-JEJUNAL GISTS IN NEUROFIBROMATOSIS TYPE 1
Laura Ruspi
Favorite
(P 318) BURIED DE-EPITHELIALIZED FLAP RECONSTRUCTION AFTER WIDE EXCISION OF THIGH SARCOMAS: EARLY EXPERIENCE FROM A SPECIALIZED SARCOMA SURGERY UNIT
Laura Ruspi
Favorite
(P 339) POSTERIOR APPROACH FOR RADICAL RESECTION OF SACROCOCCYGEAL CHORDOMA: A SURGICAL PERSPECTIVE FROM A TERTIARY REFERRAL CENTER
Laura Ruspi
Favorite
(P 365) UROLOGICAL RECONSTRUCTION DURING RETROPERITONEAL AND PELVIC SARCOMA SURGERY: EXPERIENCE FROM A HIGH-VOLUME SARCOMA CENTER
Laura Ruspi
Favorite
Russo, Luigi

BC Cancer Agency
(P 143) IMPACT OF SURGICAL MARGINS IN CHEST WALL CHONDROSARCOMAS: A CANSARCC STUDY
Luigi Russo
Favorite
(P 395) ERIBULIN IN RECURRENT PRETREATED METASTATIC SOFT TISSUE SARCOMA. A CANADIAN SARCOMA RESEARCH AND CLINICAL COLLABORATION (CANSARCC) REAL WORLD ANALYSIS
Luigi Russo
Favorite
Rutkowski, Piotr

Maria Sklodowska-Curie National Research Institute of Oncology
(P 27) MOLECULAR CHARACTERIZATION OF RESPONSE TO NEOADJUVANT CHEMORADIATION IN PATIENTS WITH LOCALLY ADVANCED SOFT TISSUE SARCOMAS
Piotr Rutkowski
Favorite
(P 134) INTEGRATIVE MICRORNA PROFILING IN CHONDROSARCOMA: TOWARD BIOMARKER DISCOVERY AND PROGNOSTIC SIGNATURE DEVELOPMENT
Piotr Rutkowski
Favorite
(P 139) IMMUNOGENOMIC PROFILING OF CHONDROSARCOMA REVEALS DISTINCT IMMUNE PHENOTYPES AND PROGNOSTIC MUTATIONS
Piotr Rutkowski
Favorite
(P 146) LOCALISED CHONDROSARCOMA PERIOPERATIVE TREATMENT: REAL-WORLD OUTCOMES AND CHALLENGES ACROSS HISTOLOGIC SUBTYPES
Piotr Rutkowski
Favorite
(P 149) SURGICAL TEXTBOOK OUTCOMES IN PATIENTS DIAGNOSED WITH CHONDROSARCOMA
Piotr Rutkowski
Favorite
(P 152) EFFICACY OF PALLIATIVE CHEMOTHERAPY AND LOCAL TREATMENTS IN ADVANCED CHONDROSARCOMA: A SUBTYPE-SPECIFIC RETROSPECTIVE ANALYSIS
Piotr Rutkowski
Favorite
(P 164) LONG TERM OUTCOMES IN PATIENTS DIAGNOSED WITH SECONDARY CHONDROSARCOMA
Piotr Rutkowski
Favorite
(P 191) EFFICACY OF SYSTEMIC PALLIATIVE THERAPIES IN PATIENTS WITH ADVANCED GASTROINTESTINAL STROMAL TUMORS (GIST) PREVIOUSLY TREATED WITH ADJUVANT IMATINIB - REAL-WORLD CLINICAL PRACTICE DATA
Piotr Rutkowski
Favorite
(P 216) VIRTUAL MULTIDISCIPLINARY MEETINGS IN THE CARE OF SARCOMA PATIENTS
Piotr Rutkowski
Favorite
(P 313) SIGNIFICANCE OF LYMPH NODE PROCEDURES IN SOFT TISSUE SARCOMA PATIENTS
Piotr Rutkowski
Favorite
(P 407) PIMICOTINIB IN TENOSYNOVIAL GIANT CELL TUMOR (TGCT): LONG-TERM EFFICACY, SAFETY, AND PATIENT-REPORTED OUTCOMES FROM THE PHASE 3 MANEUVER STUDY
Piotr Rutkowski
Favorite
(P 470) OFF-LABEL TREATMENT AND ULTRARARE SARCOMAS - SINGLE INSTITUTION REPORT
Piotr Rutkowski
Favorite
R, VINITH

All India Institute Of Medical Sciences
(P 435) A PHASE II STUDY OF HIGH DOSE IFOSFAMIDE IN METASTATIC/LOCALLY ADVANCED SYNOVIAL SARCOMA FROM A TERTIARY CARE CENTER IN INDIA
VINITH R
Favorite
Ryan, Christopher

OHSU Knight Cancer Institute, South Waterfront
(P 422) EFFICACY WITH VIMSELTINIB IN PATIENTS (PTS) WITH TENOSYNOVIAL GIANT CELL TUMOR (TGCT) AND PRIOR COLONY-STIMULATING FACTOR 1 (CSF1) INHIBITOR THERAPY: A PHASE 2 CASE SERIES
Christopher Ryan
Favorite
Rytlewski, Jeffrey

University of Colorado School of Medicine
(P 234) DOXORUBICIN PLUS BOTENSILIMAB, A NEXT GENERATION CTLA4 INHIBITOR, WITH OR WITHOUT BALSTILIMAB, A PD1 INHIBITOR, IN PATIENTS WITH ADVANCED SOFT TISSUE SARCOMAS
Jeffrey Rytlewski
Favorite
Ryu, Faith

Stanford Medicine
(P 400) LONGITUDINAL EPIGENETIC AND TRANSCRIPTOMIC REMODELING ACROSS PRIMARY, IRRADIATED, AND LOCALLY RELAPSED SOFT TISSUE SARCOMAS
Faith Ryu
Favorite
Ryu, Min-Hee

Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine
(P 194) UPDATED RESULTS FROM STRATEGIST 1: A PHASE 1/1B STUDY OF IDRX-42 (GSK6042981A) IN PATIENTS (PTS) WITH ADVANCED GASTROINTESTINAL STROMAL TUMORS (GIST)
Min-Hee Ryu
Favorite
S
Sałamacha, Maciej

Maria Sklodowska-Curie National Research Institute of Oncology
(P 313) SIGNIFICANCE OF LYMPH NODE PROCEDURES IN SOFT TISSUE SARCOMA PATIENTS
Maciej Sałamacha
Favorite
Saade, Jamal

Hôpital Maisonneuve-Rosemont, Montreal, Quebec
(P 143) IMPACT OF SURGICAL MARGINS IN CHEST WALL CHONDROSARCOMAS: A CANSARCC STUDY
Jamal Saade
Favorite
Sabeth-Rashedi, Manije

German Cancer Society
(P 204) ANALYSIS OF QUALITY INDICATORS OF SOFT TISSUE SARCOMA TREATMENT WITH CANCER REGISTRY DATA IN GERMANY 2015-2021
Manije Sabeth-Rashedi
Favorite
Sabnis, Amit

UCSF Benioff Children's Hospital
(P 427) PHASE 1/2 TRIAL TO EVALUATE THE SAFETY AND EFFICACY OF PEEL-224 IN COMBINATION WITH VINCRISTINE AND TEMOZOLOMIDE IN ADOLESCENTS AND YOUNG ADULTS WITH RELAPSED OR REFRACTORY SARCOMAS
Amit Sabnis
Favorite
Sachs, Elizabeth

Duke University
(P 84) A MULTICENTER COMPARISON OF REVERSE TOTAL SHOULDER ARTHROPLASTY VERSUS HEMIARTHROPLASTY FOR ENDOPROSTHETIC RECONSTRUCTION FOLLOWING ONCOLOGIC RESECTION OF THE PROXIMAL HUMERUS
Elizabeth Sachs
Favorite
(P 214) FINANCIAL TOXICITY IN PATIENTS WITH A HISTORY OF EXTREMITY AND PELVIC SARCOMA TREATMENT
Elizabeth Sachs
Favorite
Saita, Alberto

IRCCS Humanitas Research Hospital
(P 365) UROLOGICAL RECONSTRUCTION DURING RETROPERITONEAL AND PELVIC SARCOMA SURGERY: EXPERIENCE FROM A HIGH-VOLUME SARCOMA CENTER
Alberto Saita
Favorite
Sakai, Hideki

Hyogo Cancer Center
(P 192) OPTIMAL DOSING SCHEDULE OF SUNITINIB BASED ON PLATELET COUNT IN AN OLDER PATIENT WITH GASTROINTESTINAL STROMAL TUMOR
Hideki Sakai
Favorite
Sala, Alexandra

Dana-Farber Cancer Institute
(P 427) PHASE 1/2 TRIAL TO EVALUATE THE SAFETY AND EFFICACY OF PEEL-224 IN COMBINATION WITH VINCRISTINE AND TEMOZOLOMIDE IN ADOLESCENTS AND YOUNG ADULTS WITH RELAPSED OR REFRACTORY SARCOMAS
Alexandra Sala
Favorite
Sala, Maria Angeles

Hospital Universitario Basurto
(P 389) UNRESECTABLE AND METASTATIC DEDIFFERENTIATED LIPOSARCOMA (DDLPS): INSIGHTS FROM A MULTICENTER REAL-WORLD COHORT (RWC)
Maria Angeles Sala
Favorite
Salawu, Abdulazeez

Princess Margaret and Mt Sinai Hospitals
(P 128) ISOCITRATE DEHYDROGENASE 1 (IDH1) MUTATION TESTING IN THE PHASE 3 STUDY OF IVOSIDENIB VS PLACEBO IN IDH1-MUTANT CONVENTIONAL CHONDROSARCOMA (CHONQUER)
Abdulazeez Salawu
Favorite
(P 346) SURROGATE ENDPOINTS FOR OVERALL SURVIVAL IN ADVANCED SOFT TISSUE SARCOMA TRIALS: A SYSTEMATIC REVIEW AND META-ANALYSIS
Abdulazeez Salawu
Favorite
(P 395) ERIBULIN IN RECURRENT PRETREATED METASTATIC SOFT TISSUE SARCOMA. A CANADIAN SARCOMA RESEARCH AND CLINICAL COLLABORATION (CANSARCC) REAL WORLD ANALYSIS
Abdulazeez Salawu
Favorite
Salazar-Arcila, Carolina

University of Calgary
(P 238) INVESTIGATING HOW MACROPHAGES INFILTRATE THE TUMOUR MICROENVIRONMENT AND INFLUENCE THE EFFICACY OF CAR T THERAPY IN A MURINE MODEL OF STS
Carolina Salazar-Arcila
Favorite
(P 239) CHARACTERIZING THE ROLES OF T-CELLS IN THE CONTEXT OF TUMOR CLEARANCE AND MEMORY IN THE KP MODEL OF SARCOMA FOLLOWING STING THERAPY
Carolina Salazar-Arcila
Favorite
(P 378) HIGH DOSE RADIATION THERAPY PROMOTES IMMUNE SUPPRESSIVE MACROPHAGE PHENOTYPES, WHEREAS LOW DOSE RADIATION THERAPY PROMOTES IMMUNOGENIC MACROPHAGE PHENOTYPES IN A MURINE MODEL OF SOFT TISSUE SARCOMA
Carolina Salazar-Arcila
Favorite
Salazar, Juliana

Institut de Recerca Sant Pau (IR Sant Pau)
(P 71) GERMLINE POLYMORPHISMS IN THE VEGF PATHWAY AS PROGNOSTIC BIOMARKERS IN LOCALIZED HIGH-GRADE OSTEOSARCOMA: A STUDY BASED ON DATA FROM THE GEIS-33 PROTOCOL
Juliana Salazar
Favorite
Saldanha, Erick

Princess Margaret Cancer Centre
(P 346) SURROGATE ENDPOINTS FOR OVERALL SURVIVAL IN ADVANCED SOFT TISSUE SARCOMA TRIALS: A SYSTEMATIC REVIEW AND META-ANALYSIS
Erick Saldanha
Favorite
Salehi, Mohammad Amin

Research Institute of the McGill University Health Centre (RI-MUHC)
(P 120) SURVIVAL OUTCOMES AND ROLE OF CHEMOTHERAPY IN PATIENTS OLDER THAN 40 YEARS WITH OSTEOSARCOMA (OLD-SARC STUDY).
Mohammad Amin Salehi
Favorite
Saleh, Mohammed

University of Miami Hospital, Department of Radiology
(P 201) METASTATIC PATTERNS, TREATMENT MODALITIES, AND OVERALL SURVIVAL IN OLIGOMETASTATIC GIST: A SINGLE-CENTER RETROSPECTIVE STUDY
Mohammed Saleh
Favorite
Saleh, Ramy

Cedars Cancer Center, McGill University Health Center
(P 120) SURVIVAL OUTCOMES AND ROLE OF CHEMOTHERAPY IN PATIENTS OLDER THAN 40 YEARS WITH OSTEOSARCOMA (OLD-SARC STUDY).
Ramy Saleh
Favorite
Saleh, Ramy

McGill University Health Center
(P 226) REAL-WORLD MANAGEMENT OF SYMPTOMATIC VS ASYMPTOMATIC TGCT FROM AN OBSERVATIONAL REGISTRY
Ramy Saleh
Favorite
Saleh, Ramy

Cedars Cancer Center, McGill University Health Center
(P 407) PIMICOTINIB IN TENOSYNOVIAL GIANT CELL TUMOR (TGCT): LONG-TERM EFFICACY, SAFETY, AND PATIENT-REPORTED OUTCOMES FROM THE PHASE 3 MANEUVER STUDY
Ramy Saleh
Favorite
Salib, Alice

Children's Cancer Institute
(P 11) ESTABLISHMENT, CHARACTERIZATION AND RESEARCH APPLICATION OF EIGHT NOVEL PATIENT-DERIVED OSTEOSARCOMA CELL LINES
Alice Salib
Favorite
Salinas, Melisa

Angel H Roffo Institute of Oncology
(P 386) RADIO-GUIDED SURGERY FOR NONPALPABLE SOFT-TISSUE SARCOMAS
Melisa Salinas
Favorite
Salvatore, Daniela

Fondazione IRCCS Istituto Nazionale dei Tumori, Milan
(P 210) TOWARDS INTERNATIONALIZATION OF THE CLINICAL RESEARCH COORDINATOR ROLE: THE FIRST DROP OF THE NIAGARA FALLS PROJECT
Daniela Salvatore
Favorite
(P 307) STRATEGIES FOR DATA QUALITY IN TARPSWG RETROPERITONEAL SARCOMA REGISTRY (RESAR)
Daniela Salvatore
Favorite
Samà, Laura

IRCCS Humanitas Research Hospital
(P 203) MINIMALLY INVASIVE RESECTION OF MULTIFOCAL DUODENO-JEJUNAL GISTS IN NEUROFIBROMATOSIS TYPE 1
Laura Samà
Favorite
(P 318) BURIED DE-EPITHELIALIZED FLAP RECONSTRUCTION AFTER WIDE EXCISION OF THIGH SARCOMAS: EARLY EXPERIENCE FROM A SPECIALIZED SARCOMA SURGERY UNIT
Laura Samà
Favorite
(P 328) INNOVATING SARCOMA EDUCATION: EARLY OUTCOMES OF THE ITALIAN SOCIETY OF SURGICAL ONCOLOGY (SICO) SARCOMA SOCIAL MULTI-PLATFORM JOURNAL CLUB INITIATIVE
Laura Samà
Favorite
(P 339) POSTERIOR APPROACH FOR RADICAL RESECTION OF SACROCOCCYGEAL CHORDOMA: A SURGICAL PERSPECTIVE FROM A TERTIARY REFERRAL CENTER
Laura Samà
Favorite
(P 365) UROLOGICAL RECONSTRUCTION DURING RETROPERITONEAL AND PELVIC SARCOMA SURGERY: EXPERIENCE FROM A HIGH-VOLUME SARCOMA CENTER
Laura Samà
Favorite
Sam, Xin Xiu

Singapore General Hospital
(P 53) ESTABLISHMENT AND CHARACTERISATION OF LIPOSARCOMA-DERIVED CELLS AS RELEVANT PRE-CLINICAL MODELS FOR TARGET DISCOVERY
Xin Xiu Sam
Favorite
San Martin, Gabriela

Angel H Roffo Institute of Oncology
(P 386) RADIO-GUIDED SURGERY FOR NONPALPABLE SOFT-TISSUE SARCOMAS
Gabriela San Martin
Favorite
Sanchez-Fdez, Adrian

Dept. of Surgery, Moores Cancer Center, University of California San Diego
(P 197) DIFFERENTIAL EFFECTS OF ANAGRELIDE IN GASTROINTESTINAL STROMAL TUMORS (GIST) IN VITRO
Adrian Sanchez-Fdez
Favorite
SANCHO MARQUEZ, MARIA DEL PILAR

HOSPITAL VIRGEN DEL ROCÍO
(P 321) COMPARATIVE ANALYSIS OF FIRST-LINE DOXORUBICIN-BASED COMBINATION REGIMENS IN METASTATIC LEIOMYOSARCOMA: IMPACT ON SURVIVAL AND DISEASE CONTROL
MARIA DEL PILAR SANCHO MARQUEZ
Favorite
Sancho-Márquez, Pilar

Hospital Universitario Virgen del Rocio
(P 115) SINGLE-CENTER EXPERIENCE WITH TYROSIN KINASA INHIBITORS IN ADVANCED BONE SARCOMA: EFFICACY AND SAFETY OUTCOMES
Pilar Sancho-Márquez
Favorite
Sandroni, Giulia

Humanitas University
(P 365) UROLOGICAL RECONSTRUCTION DURING RETROPERITONEAL AND PELVIC SARCOMA SURGERY: EXPERIENCE FROM A HIGH-VOLUME SARCOMA CENTER
Giulia Sandroni
Favorite
Sandrucci, Sergio

University of Turin
(P 328) INNOVATING SARCOMA EDUCATION: EARLY OUTCOMES OF THE ITALIAN SOCIETY OF SURGICAL ONCOLOGY (SICO) SARCOMA SOCIAL MULTI-PLATFORM JOURNAL CLUB INITIATIVE
Sergio Sandrucci
Favorite
Sanfilippo, Roberta

Fondazione IRCCS Istituto nazionale dei tumori
(P 308) IMPACT OF PSOAS MUSCLE RESECTION ON OUTCOMES IN PRIMARY RETROPERITONEAL DEDIFFERENTIATED LIPOSARCOMA
Roberta Sanfilippo
Favorite
(P 331) MAINTENANCE THERAPY (M-TP) WITH DACARBAZINE (DTIC) AFTER FIRST-LINE ANTHRACYCLINE-BASED DOUBLET IN ADVANCED LEIOMYOSARCOMA (LMS) PATIENTS (PTS): OUTCOMES OF A CASE SERIES IN A SINGLE REFERRAL CENTER
Roberta Sanfilippo
Favorite
(P 452) EFFECTIVENESS OF ERIBULIN FOR MYXOID PLEOMORPHIC LIPOSARCOMA: INSIGHTS FROM A PATIENT-DERIVED MODEL AND CLINICAL TRANSLATION IN A PATIENT WITH ADVANCED DISEASE
Roberta Sanfilippo
Favorite
Sangalli, Claudia

Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan
(P 277) THE ROLE OF RADIOTHERAPY IN THE MULTIDISCIPLINARY MANAGEMENT OF RADIATION-ASSOCIATED ANGIOSARCOMA OF THE BREAST: A REFERRAL CENTER EXPERIENCE
Claudia Sangalli
Favorite
(P 308) IMPACT OF PSOAS MUSCLE RESECTION ON OUTCOMES IN PRIMARY RETROPERITONEAL DEDIFFERENTIATED LIPOSARCOMA
Claudia Sangalli
Favorite
(P 458) BETWEEN LYMPHOMAS AND SARCOMAS: A RETROSPECTIVE, MULTI-INSTITUTIONAL STUDY FROM THE ITALIAN SARCOMA GROUP (ISG) ON HISTIOCYTIC AND DENDRITIC CELL NEOPLASMS (HDCN)
Claudia Sangalli
Favorite
Saniei, Sami

Mayo Clinic, Rochester
(P 166) LARGE LANGUAGE MODEL EXTRACTION OF STRUCTURED DATA IN UNSTRUCTURED SARCOMA PATHOLOGY NOTES: A PILOT STUDY
Sami Saniei
Favorite
(P 167) LARGE LANGUAGE MODEL EXTRACTION OF STRUCTURED DATA FROM UNSTRUCTURED RADIATION ONCOLOGY NOTES: A PILOT STUDY
Sami Saniei
Favorite
Sankar, Neil

Strand Therapeutics Inc.
(P 433) PHASE I DOSE ESCALATION TRIAL OF STX-001, AN LNP SELF-REPLICATING MRNA EXPRESSING IL-12, IN PATIENTS WITH REFRACTORY TUMORS INCLUDING SARCOMAS
Neil Sankar
Favorite
Sankhala, Esha

Precision NextGen Oncology and Research Center
(P 230) CIRCULATING TUMOR DNA AS AN EARLY INDICATOR OF RESPONSE, PROGRESSION, AND RECURRENCE OF SARCOMAS
Esha Sankhala
Favorite
Sankhala, Esha

Precision NextGen Oncology
(P 433) PHASE I DOSE ESCALATION TRIAL OF STX-001, AN LNP SELF-REPLICATING MRNA EXPRESSING IL-12, IN PATIENTS WITH REFRACTORY TUMORS INCLUDING SARCOMAS
Esha Sankhala
Favorite
(P 440) CASE REPORT: COMPLETE CLINICAL AND MOLECULAR RESPONSE TO INTRATUMORAL STX-001, AN LNP-SELF REPLICATING MRNA EXPRESSING IL-12 IN A PATIENT WITH REFRACTORY ANGIOSARCOMA
Esha Sankhala
Favorite
Sankhala, Esha

Precision NextGen Oncology & Research Center
(P 471) COMBINATION CHEMOTHERAPY WITH GEMCITABINE AND PACLITAXEL: A HIGHLY EFFICACIOUS AND BETTER TOLERATED OPTION FOR ANGIOSARCOMA
Esha Sankhala
Favorite
Sankhala, Kamlesh

Precision NextGen Oncology and Research Center
(P 230) CIRCULATING TUMOR DNA AS AN EARLY INDICATOR OF RESPONSE, PROGRESSION, AND RECURRENCE OF SARCOMAS
Kamlesh Sankhala
Favorite
(P 407) PIMICOTINIB IN TENOSYNOVIAL GIANT CELL TUMOR (TGCT): LONG-TERM EFFICACY, SAFETY, AND PATIENT-REPORTED OUTCOMES FROM THE PHASE 3 MANEUVER STUDY
Kamlesh Sankhala
Favorite
(P 431) INVOKE: A PHASE 1 STUDY OF OKN4395, A FIRST-IN-CLASS EP2/EP4/DP1 TRIPLE PROSTANOID RECEPTOR ANTAGONIST, IN PATIENTS WITH ADVANCED SOLID TUMORS, INCLUDING SARCOMAS
Kamlesh Sankhala
Favorite
(P 433) PHASE I DOSE ESCALATION TRIAL OF STX-001, AN LNP SELF-REPLICATING MRNA EXPRESSING IL-12, IN PATIENTS WITH REFRACTORY TUMORS INCLUDING SARCOMAS
Kamlesh Sankhala
Favorite
Sankhala, Kamlesh

Precision NextGen Oncology
(P 440) CASE REPORT: COMPLETE CLINICAL AND MOLECULAR RESPONSE TO INTRATUMORAL STX-001, AN LNP-SELF REPLICATING MRNA EXPRESSING IL-12 IN A PATIENT WITH REFRACTORY ANGIOSARCOMA
Kamlesh Sankhala
Favorite
Sankhala, Kamlesh

Precision NextGen Oncology and Research Center
(P 471) COMBINATION CHEMOTHERAPY WITH GEMCITABINE AND PACLITAXEL: A HIGHLY EFFICACIOUS AND BETTER TOLERATED OPTION FOR ANGIOSARCOMA
Kamlesh Sankhala
Favorite
Sanz Beltrán, Judit

Hospital de la Santa Creu i Sant Pau
(P 385) PROGNOSTIC IMPACT OF PERIPHERAL BLOOD CELL RATIO VALUES IN PATIENTS WITH ADVANCED LEIOMYOSARCOMA: A REFERENCE CENTER EXPERIENCE.
Judit Sanz Beltrán
Favorite
Sanz, Vanesa

the healthcare business of Merck KGaA, Darmstadt, Germany
(P 434) A FIRST-IN-HUMAN PHASE 1, MULTICENTER, OPEN-LABEL STUDY OF M3554, A NOVEL ANTI-GD2 ANTIBODY-DRUG CONJUGATE, IN PATIENTS WITH ADVANCED SOLID TUMORS
Vanesa Sanz
Favorite
Saraee, Mo

Salford University
(P 392) CLASSIFICATION AND DIFFERENTIATIONOF MYXOID LIPOSARCOMA AND MYXOMA WITH MACHINE LEARNING
Mo Saraee
Favorite
(P 392) DIFFERENTIATION OF MYXOMA AND MYXOID LIPOSARCOMA BASED ON RADIOMICS PHENOTYPES
Mo Saraee
Favorite
Sarmento, Frederico

Instituto Português de Oncologia de Lisboa Francisco Gentil
(P 372) CLINICOPATHOLOGICAL FEATURES AND OUTCOMES OF PATIENTS WITH KAPOSI SARCOMA: A SINGLE CENTER RETROSPECTIVE REAL WORLD ANALYSIS
Frederico Sarmento
Favorite
Sarno, Shirley

University of California San Diego
(P 179) NEOADJUVANT AVAPRITINIB IN PDGFRA-MUTANT GIST: NEAR COMPLETE PATHOLOGICAL RESPONSES AT THE COST OF HIGH ADVERSE EVENT RATES
Shirley Sarno
Favorite
(P 180) COMPARATIVE EFFICACY OF GENERIC AND BRAND-NAME IMATINIB IN NEOADJUVANT TREATMENT OF KIT EXON 11 MUTANT GIST
Shirley Sarno
Favorite
Sarre-Lazcano, Catherine

Department of Surgery, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán
(P 306) PROGNOSTIC NUTRITIONAL INDEX PREDICTS MAJOR POSTOPERATIVE COMPLICATIONS IN RETROPERITONEAL SARCOMA: RESULTS FROM THE LATAMSARC COHORT
Catherine Sarre-Lazcano
Favorite
Sarthy, Jay

Seattle Children's Research Institute
(P 260) MECHANISM AND EFFICACY OF ANTHRACYCLINE MEDIATED EPIGENETIC DISRUPTION IN BONE SARCOMAS.
Jay Sarthy
Favorite
Satake, Ryo

Shizuoka Cancer Center
(P 291) INTRA-ARTERIAL CHEMOTHERAPY WITH CONCOMITANT RADIATION THERAPY FOR UNRESECTABLE SARCOMA
Ryo Satake
Favorite
Satake, Tomoyuki

National Cancer Center Hospital East
(P 159) CHONDROSARCOMA IN JAPAN: A POPULATION-BASED ANALYSIS USING NATIONAL CANCER REGISTRY
Tomoyuki Satake
Favorite
Saunders, Amanda

Deciphera Pharmaceuticals, LLC
(P 422) EFFICACY WITH VIMSELTINIB IN PATIENTS (PTS) WITH TENOSYNOVIAL GIANT CELL TUMOR (TGCT) AND PRIOR COLONY-STIMULATING FACTOR 1 (CSF1) INHIBITOR THERAPY: A PHASE 2 CASE SERIES
Amanda Saunders
Favorite
Sayles, Leanne

UCSF
(P 08) BUILDING A MEDICAL DONATION NETWORK TO ENHANCE DEVELOPMENT OF PEDIATRIC TUMOR MODELS
Leanne Sayles
Favorite
Sayour, Elias

University of Florida
(P 248) AN EX VIVO ASSAY TO PREDICT IMMUNOTHERAPY RESPONSE IN SARCOMA
Elias Sayour
Favorite
(P 426) A PHASE I/II TRIAL USING RNA LIPID NANOPARTICLES FOR RECURRENT OSTEOSARCOMA: A REPORT FROM THE NATIONAL PEDIATRIC CANCER FOUNDATION
Elias Sayour
Favorite
Sbanchi, Giulia

IRCCS Rizzoli Orthopaedic Institute
(P 18) ESTABLISHMENT AND CHARACTERIZATION OF A NOVEL PRIMARY CELL LINE FROM A BONE METASTASIS OF OSTEOSARCOMA
Giulia Sbanchi
Favorite
Sbaraglia, Marta

University of Padua, Padua, Italy
(P 231) INCREASED LIFETIME RISK (LTR) OF SOFT TISSUE SARCOMAS (STS) IN PATIENTS WITH LOW-RISK GASTROINTESTINAL STROMAL TUMORS (GIST): A RETROSPECTIVE ANALYSIS FROM THE ITALIAN SARCOMA GROUP (ISG)
Marta Sbaraglia
Favorite
Sbaraglia, Marta

Azianda Ospedaliera di Padova
(P 458) BETWEEN LYMPHOMAS AND SARCOMAS: A RETROSPECTIVE, MULTI-INSTITUTIONAL STUDY FROM THE ITALIAN SARCOMA GROUP (ISG) ON HISTIOCYTIC AND DENDRITIC CELL NEOPLASMS (HDCN)
Marta Sbaraglia
Favorite
Scally, Christopher

MD Anderson Cancer Center
(P 351) THE ROLE OF SOCIOECONOMIC DISPARITIES ON SURVIVAL OUTCOMES IN MALIGNANT PERIPHERAL NERVE SHEATH TUMORS
Christopher Scally
Favorite
Scarborough, Mark T.

University of Florida
(P 129) HIJACKED FUEL: GLYCOGEN-DRIVEN METABOLIC SHIFTS IN IDH1-MUTANT CHONDROSARCOMA
Mark T. Scarborough
Favorite
Schöffski, Patrick

General Medical Oncology, University Hospitals Leuven, Leuven Cancer Institute
(P 33) THE NOVEL TRANSCRIPTIONAL INHIBITORS ECUBECTEDIN AND PM54 DEMONSTRATE ANTITUMOR ACTIVITY IN PATIENT-DERIVED XENOGRAFT MODELS OF SOFT TISSUE SARCOMA
Patrick Schöffski
Favorite
(P 69) EPIDEMIOLOGY AND POTENTIAL CLINICAL RELEVANCE OF TOP1 AND TOP2A TOPOISOMERASES EXPRESSION IN SOFT TISSUE SARCOMA
Patrick Schöffski
Favorite
(P 70) EPIDEMIOLOGY AND POTENTIAL CLINICAL RELEVANCE OF CONTACTIN-4 EXPRESSION IN SOFT TISSUE SARCOMA
Patrick Schöffski
Favorite
(P 194) UPDATED RESULTS FROM STRATEGIST 1: A PHASE 1/1B STUDY OF IDRX-42 (GSK6042981A) IN PATIENTS (PTS) WITH ADVANCED GASTROINTESTINAL STROMAL TUMORS (GIST)
Patrick Schöffski
Favorite
(P 416) A PHASE 2 MULTICENTER OPEN-LABEL BASKET STUDY OF TAZEMETOSTAT IN ADULT PATIENTS WITH INI1-NEGATIVE EPITHELIOID SARCOMA – FINAL ANALYSIS
Patrick Schöffski
Favorite
(P 434) A FIRST-IN-HUMAN PHASE 1, MULTICENTER, OPEN-LABEL STUDY OF M3554, A NOVEL ANTI-GD2 ANTIBODY-DRUG CONJUGATE, IN PATIENTS WITH ADVANCED SOLID TUMORS
Patrick Schöffski
Favorite
Schüller, Ulrich

University Medical Center Hamburg-Eppendorf, Hamburg, Germany
(P 64) ATRX EXPRESSION CORRELATES WITH REDUCED IMMUNE CHECKPOINT EXPRESSION AND POOR SURVIVAL IN HIGH-RISK SOFT TISSUE SARCOMAS
Ulrich Schüller
Favorite
Scharpf, Katrin R.

Psycho-oncology service in cooperation with the Central Institute for Mental Health Mannheim, University Medical Center Mannheim, Medical Faculty Mannheim, Heidelberg University
(P 441) COLOSARC-Q: A PROSPECTIVE MULTICENTER STUDY FOR EVALUATING SURGICAL STRATEGIES FOR COLORECTAL RESECTIONS AND POSTOPERATIVE QUALITY OF LIFE IN RETROPERITONEAL SARCOMA PATIENTS
Katrin R. Scharpf
Favorite
Scharschmidt, Thomas

The Ohio State University
(P 161) CLINICAL CHARACTERISTICS, PATTERNS OF CARE, AND TREATMENT OUTCOMES OF CHONDROSARCOMA: A SINGLE-INSTITUTIONAL EXPERIENCE
Thomas Scharschmidt
Favorite
Schaub, Stephanie

Fred Hutchinson Cancer Center
(P 287) A PHASE 1 STUDY OF NEOADJUVANT CABOZANTINIB IN COMBINATION WITH RADIATION THERAPY FOR SARCOMAS OF THE EXTREMITIES
Stephanie Schaub
Favorite
Scheid, Meghan

University of Colorado School of Medicine
(P 234) DOXORUBICIN PLUS BOTENSILIMAB, A NEXT GENERATION CTLA4 INHIBITOR, WITH OR WITHOUT BALSTILIMAB, A PD1 INHIBITOR, IN PATIENTS WITH ADVANCED SOFT TISSUE SARCOMAS
Meghan Scheid
Favorite
Scheidt, Matthew

MCW
(P 111) DOES DOSE MATTER? POSTOPERATIVE RADIATION DOSE AND OUTCOMES FOLLOWING FIXATION OF METASTATIC EXTREMITY BONE LESIONS
Matthew Scheidt
Favorite
Scheuplein, Nicolas

Cancer Information Service, German Cancer Research Center (DKFZ)
(P 455) DEVELOPMENT OF PATIENT-CENTERED INFORMATION MATERIAL ON RADIATION-INDUCED SARCOMA: QUALITATIVE RESULTS FROM FOCUS GROUPS OF THE TETRIS-PROJECT
Nicolas Scheuplein
Favorite
Schieffer, Kathleen

Steve and Cindy Rasmussen Institute for Genomic Medicine, The Abigail Wexner Research Institute, Nationwide Children’s Hospital
(P 264) RARE CASE OF INFLAMMATORY MYOFIBROBLASTIC TUMOR (IMT) IN NEWBORN
Kathleen Schieffer
Favorite
(P 377) GERMLINE RECQL4 VARIANT IN A PEDIATRIC PATIENT WITH EWING SARCOMA AND DESMOID FIBROMATOSIS
Kathleen Schieffer
Favorite
Schilling, Freimut

Luzerner Kantonsspital (LUKS)
(P 419) PROSPECTIVE REAL-WORLD STUDY OF LAROTRECTINIB (LARO) IN PATIENTS (PTS) WITH TRK FUSION SOLID TUMORS: INTERIM ANALYSIS OF ON-TRK
Freimut Schilling
Favorite
Schloss, Jennifer

Memorial Sloan Kettering Cancer Center
(P 265) MULTI-SITE SINGLE CELL TRANSCRIPTOMICS REVEAL DISTINCT IMMUNE INFILTRATIVE PATTERNS IN DESMOPLASTIC SMALL ROUND CELL TUMOR
Jennifer Schloss
Favorite
Schmitt, Saskia

Tubulis
(P 34) EXPRESSION OF ONCOFETAL ANTIGEN 5T4 IN SARCOMA SUBTYPES AND PRECLINICAL ACTIVITY OF TUB-030, A NOVEL 5T4-TARGETING ANTIBODY-DRUG CONJUGATE (ADC)
Saskia Schmitt
Favorite
Schmitz, Erika

University of British Columbia
(P 196) SURVEILLANCE STRATEGIES AND LONG-TERM OUTCOMES IN LOW-RISK GASTRIC GASTROINTESTINAL STROMAL TUMORS (GGISTS)
Erika Schmitz
Favorite
Schmitz, Marc

Institute of Immunology, Faculty of Medicine Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany,National Center for Tumor Diseases (NCT), Dresden, Germany, German Cancer Consortium (DKTK), Partner Site Dresden, and German Cancer Research Center (DKFZ), Heidelberg, Germany
(P 243) CLINICAL SIGNIFICANCE OF TUMOR-INFILTRATING IMMUNE CELL SUBSETS IN THE RETROPERITONEAL DEDIFFERENTIATED LIPOSARCOMAS AND LEIOMYOSARCOMAS
Marc Schmitz
Favorite
Schoedel, Karen

University of Pittsburgh School of Medicine
(P 65) INVESTIGATING MACROPHAGE POPULATIONS IN PRIMARY AND METASTATIC SARCOMA SAMPLES
Karen Schoedel
Favorite
Scholte, Claire

LUMC
(P 127) AN INTEGRATED CLINICAL GENOMIC AND TRANSCRIPTOMIC SUBGROUPING OF CENTRAL CHONDROSARCOMA
Claire Scholte
Favorite
(P 144) THE RISK OF PATHOLOGICAL FRACTURES AFTER INTRALESIONAL CURETTAGE IN ATYPICAL CARTILAGINOUS TUMOURS: A RETROSPECTIVE COHORT STUDY
Claire Scholte
Favorite
Schuebbe, Gesa

Department of Medicine III, LMU University Hospital, Munich, Germany
(P 437) CLINICAL DATA CONFIRM GALENIC PRINCIPLE AND DEMONSTRATE THERAPEUTIC POTENTIAL OF THE001 (DPPG2-TSL-DOX) PLUS REGIONAL HYPERTHERMIA IN SOFT TISSUE SARCOMA
Gesa Schuebbe
Favorite
Schuetze, Scott

University of Michigan
(P 227) TREATMENT PATTERNS IN PATIENTS WITH TENOSYNOVIAL GIANT CELL TUMORS: ADDRESSING COMMUNICATION IN A NEW THERAPEUTIC LANDSCAPE
Scott Schuetze
Favorite
Schuldt, Samantha

Northwestern University Feinberg School of Medicine
(P 429) SINGLE-ARM, OPEN-LABEL PHASE II TRIAL OF XL092 (ZANZALINTINIB) IN PATIENTS WITH ADVANCED LEIOMYOSARCOMA: TRIAL IN PROGRESS
Samantha Schuldt
Favorite
Schulte, Brian

UCSF Helen Diller Comprehensive Cancer Center
(P 439) AN OPEN LABEL MULTICENTER PHASE 2 STUDY WITH SAFETY LEAD IN OF INTRATUMORAL VUSOLIMOGENE ODERPAREPVEC IN COMBINATION WITH PEMBROLIZUMAB IN PATIENTS WITH ANGIOSARCOMA
Brian Schulte
Favorite
Schuster, Kathrin

Sarcoma Patient Advocacy Global Network e.V./Assoc.
(P 229) DETERMINANTS OF DIAGNOSTIC INTERVAL IN EPITHELIOID HEMANGIOENDOTHELIOMA: A LINEAR AND QUANTILE REGRESSION ANALYSIS OF PATIENT-REPORTED DATA FROM THE SPAGN GLOBAL SARCOMA DIAGNOSIS PATHWAY SURVEY
Kathrin Schuster
Favorite
Schutz, John

University of Colorado Department of Orthopedics
(P 268) QUALITY OF LIFE OUTCOMES IN PEDIATRIC PATIENTS UNDERGOING SURGICAL INTERVENTION FOR LOWER EXTREMITY BONE SARCOMAS
John Schutz
Favorite
Schwartzbaum, Daniel

Jackson Memorial Hospital/University of Miami Health System
(P 254) EOSINOPHILIC FASCIITIS (EF) AS A COMPLICATION OF NATURAL KILLER (NK) CELL-BASED IMMUNOTHERAPY IN A YOUNG ADULT WITH RECURRENT METASTATIC EWING SARCOMA
Daniel Schwartzbaum
Favorite
Schwartz, Gary

Cleveland Clinic
(P 284) THE IMPACT OF SARCOMA SBRT ON THE IMMUNE SYSTEM: EARLY RESULTS FROM A PROSPECTIVE TRIAL
Gary Schwartz
Favorite
Schwartz, Gary

Case Comprehensive Cancer Center
(P 430) A PH/2 STUDY OF THE RADIOPHARMACEUTICAL [AC-225]RTX-2358 IN THE TREATMENT OF RELAPSED / REFRACTORY (R/R) SOFT TISSUE SARCOMA (STS) THE ATLAS STUDY - ACTINIUM THERAPY FOR LATE-STAGE AGGRESSIVE SARCOMAS
Gary Schwartz
Favorite
Schwartz, Herbert

Vanderbilt University Medical Center
(P 84) A MULTICENTER COMPARISON OF REVERSE TOTAL SHOULDER ARTHROPLASTY VERSUS HEMIARTHROPLASTY FOR ENDOPROSTHETIC RECONSTRUCTION FOLLOWING ONCOLOGIC RESECTION OF THE PROXIMAL HUMERUS
Herbert Schwartz
Favorite
(P 85) MAKING NEGATIVE MARGIN MUSCULOSKELETAL TUMOR SURGERY A VIRTUAL REALITY USING 3D SPECIMEN SCANNING
Herbert Schwartz
Favorite
(P 97) RISK FACTORS ASSOCIATED WITH AMPUTATION VERSUS CONTINUED LIMB SALVAGE IN LOWER EXTREMITY ENDOPROSTHETIC RECONSTRUCTION
Herbert Schwartz
Favorite
Schwenke, Kay

Department of Vascular Surgery, University Medical Centre Mannheim, Medical Faculty Mannheim, Heidelberg University
(P 303) MULTIVISCERAL RESECTIONS AND URINARY TRACT RECONSTRUCTION TECHNIQUES IN THE SURGERY OF RETROPERITONEAL SARCOMAS: A CASE SERIES.
Kay Schwenke
Favorite
Sciandra, Marika

IRCCS Rizzoli Orthopaedic Institute
(P 18) ESTABLISHMENT AND CHARACTERIZATION OF A NOVEL PRIMARY CELL LINE FROM A BONE METASTASIS OF OSTEOSARCOMA
Marika Sciandra
Favorite
Sciot, Raf

KU Leuven
(P 70) EPIDEMIOLOGY AND POTENTIAL CLINICAL RELEVANCE OF CONTACTIN-4 EXPRESSION IN SOFT TISSUE SARCOMA
Raf Sciot
Favorite
Scott, Jacob

Cleveland Clinic
(P 10) COLLATERAL SENSITIVIES EMERGE DURING THE EVOLUTION OF CHEMORESISTANCE TO MAP CHEMOTHERAPY IN OSTEOSARCOMA
Jacob Scott
Favorite
(P 284) THE IMPACT OF SARCOMA SBRT ON THE IMMUNE SYSTEM: EARLY RESULTS FROM A PROSPECTIVE TRIAL
Jacob Scott
Favorite
Scott, Susan

SpringWorks Therapeutics
(P 364) TRENDS IN SURGICAL MANAGEMENT OF DESMOID TUMOR IN THE VETERANS AFFAIRS (VA) NATIONAL DATABASE
Susan Scott
Favorite
Sebio García, Ana

Hospital de la Santa Creu i Sant Pau, IR Sant Pau
(P 71) GERMLINE POLYMORPHISMS IN THE VEGF PATHWAY AS PROGNOSTIC BIOMARKERS IN LOCALIZED HIGH-GRADE OSTEOSARCOMA: A STUDY BASED ON DATA FROM THE GEIS-33 PROTOCOL
Ana Sebio García
Favorite
(P 218) THE IMPACT OF BROADENED GENETIC COUNSELLING REFERRAL CRITERIA IN SARCOMA PATIENTS: A REFERENCE CENTRE'S EXPERIENCE
Ana Sebio García
Favorite
(P 383) MULTIDISCIPLINARY TREATMENT OF INGUINOSCROTAL SARCOMAS: ANALYSIS OF 39 CASES TREATED BY SURGICAL APPROACH
Ana Sebio García
Favorite
(P 385) PROGNOSTIC IMPACT OF PERIPHERAL BLOOD CELL RATIO VALUES IN PATIENTS WITH ADVANCED LEIOMYOSARCOMA: A REFERENCE CENTER EXPERIENCE.
Ana Sebio García
Favorite
(P 389) UNRESECTABLE AND METASTATIC DEDIFFERENTIATED LIPOSARCOMA (DDLPS): INSIGHTS FROM A MULTICENTER REAL-WORLD COHORT (RWC)
Ana Sebio García
Favorite
Seddon, Beatrice

University College London Hospitals
(P 281) LOCAL CONTROL WITH MODERATELY HYPOFRACTIONATED DEFINITIVE RADIOTHERAPY DELIVERED WITH A SIMULTANEOUS INTEGRATED BOOST TECHNIQUE TO NON-EXTREMITY SOFT TISSUE AND BONE SARCOMAS
Beatrice Seddon
Favorite
Segers, Blair

Children's Hospital of Philadelphia
(P 262) EVALUATING FRONT-LINE THERAPY ACCORDANCE WITH CURRENT SYNOVIAL SARCOMA GUIDELINES
Blair Segers
Favorite
(P 263) DESCRIBING THE CHARACTERISTICS AND TREATMENT OF SYNOVIAL SARCOMA IN THE RECURRENT SETTING
Blair Segers
Favorite
Seier, Kenneth

Memorial Sloan Kettering Cancer Center
(P 409) RETROSPECTIVE ANALYSIS OF PROGNOSTIC FACTORS INCLUDING HLA GENOTYPE IN MYXOID LIPOSARCOMA
Kenneth Seier
Favorite
Seitz, Guido

University Hospital Giessen-Marburg
(P 250) OUTCOME OF INFANTS WITH RHABDOMYOSARCOMA: A REPORT FROM THE INTERNATIONAL SOFT TISSUE SARCOMA CONSORTIUM
Guido Seitz
Favorite
Selby, Luke

University of Kansas Medical Center
(P 366) WOUND COMPLICATIONS AFTER ULTRA-HYPOFRACTIONATED NEOADJUVANT RADIATION FOR SOFT TISSUE SARCOMA: WHAT IS OPTIMAL SURGICAL TIMING?
Luke Selby
Favorite
Seliga, Katarzyna

Cancer Molecular and Genetic Diagnostics Laboratory, Maria Sklodowska-Curie National Research Institute of Oncology
(P 27) MOLECULAR CHARACTERIZATION OF RESPONSE TO NEOADJUVANT CHEMORADIATION IN PATIENTS WITH LOCALLY ADVANCED SOFT TISSUE SARCOMAS
Katarzyna Seliga
Favorite
Seligson, Nathan

University of Florida
(P 275) NEXT GENERATION SEQUENCING IN ADOLESCENT AND YOUNG ADULT (AYA) SARCOMAS: CLINICAL IMPACT, DIAGNOSTIC UTILITY, AND IMPLICATIONS
Nathan Seligson
Favorite
Selmek, Aubrie

Ohio State University
(P 19) SERUM EXOSOMES IDENTIFY AN ABERRANT PROTEOMIC SIGNATURE IN CANINE OSTEOSARCOMA PRECEDING METASTATIC PROGRESSION
Aubrie Selmek
Favorite
Selmic, Laura

Ohio State University
(P 259) PRECLINICAL MODELING OF CHEMOTHERAPY RELEASE IDENTIFIES MITOCHONDRIAL ADAPTATIONS IN DOXORUBICIN TREATED OSTEOSARCOMA
Laura Selmic
Favorite
Semrau, Sabine

Department of Radiation Oncology, Universitätsstraße 27, 91054 Erlangen, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Germany
(P 288) IDENTIFICATION OF A DNA REPAIR INHIBITOR FOR THE COMBINATION WITH LURBINECTEDIN AND RADIOTHERAPY IN SARCOMA CELL LINES
Sabine Semrau
Favorite
Sen, Jasmine

Deciphera Pharmaceuticals, LLC
(P 422) EFFICACY WITH VIMSELTINIB IN PATIENTS (PTS) WITH TENOSYNOVIAL GIANT CELL TUMOR (TGCT) AND PRIOR COLONY-STIMULATING FACTOR 1 (CSF1) INHIBITOR THERAPY: A PHASE 2 CASE SERIES
Jasmine Sen
Favorite
Serra, Massimo

IRCCS Rizzoli Orthopaedic Institute
(P 18) ESTABLISHMENT AND CHARACTERIZATION OF A NOVEL PRIMARY CELL LINE FROM A BONE METASTASIS OF OSTEOSARCOMA
Massimo Serra
Favorite
(P 71) GERMLINE POLYMORPHISMS IN THE VEGF PATHWAY AS PROGNOSTIC BIOMARKERS IN LOCALIZED HIGH-GRADE OSTEOSARCOMA: A STUDY BASED ON DATA FROM THE GEIS-33 PROTOCOL
Massimo Serra
Favorite
Serrano, César

Sarcoma Translational Research Program, Hospital Universitari Vall d'Hebron – Vall d'Hebron Institut d'Oncologia
(P 194) UPDATED RESULTS FROM STRATEGIST 1: A PHASE 1/1B STUDY OF IDRX-42 (GSK6042981A) IN PATIENTS (PTS) WITH ADVANCED GASTROINTESTINAL STROMAL TUMORS (GIST)
César Serrano
Favorite
(P 389) UNRESECTABLE AND METASTATIC DEDIFFERENTIATED LIPOSARCOMA (DDLPS): INSIGHTS FROM A MULTICENTER REAL-WORLD COHORT (RWC)
César Serrano
Favorite
(P 407) PIMICOTINIB IN TENOSYNOVIAL GIANT CELL TUMOR (TGCT): LONG-TERM EFFICACY, SAFETY, AND PATIENT-REPORTED OUTCOMES FROM THE PHASE 3 MANEUVER STUDY
César Serrano
Favorite
seshadri, namratha

Tata Memorial Hospital
(P 379) IMPACT OF EWSR1 GENE REARRANGEMENT TESTING ON DIAGNOSIS OF A WIDE RANGE OF SOLID TUMOURS
namratha seshadri
Favorite
Sesser, Andrew

University of Miami, Department of Radiation Oncology
(P 289) SIX YEAR FOLLOW-UP ON CIVASHEET® USE FOR SOFT TISSUE SARCOMA: A SINGLE INSTITUTION EXPERIENCE
Andrew Sesser
Favorite
Seto, Andrew

University Health Network
(P 323) EVALUATION OF COSMIC MUTATIONAL SIGNATURES IN SOFT TISSUE SARCOMA
Andrew Seto
Favorite
Setty, Bhuvana

Nationwide Children's Hospital
(P 254) EOSINOPHILIC FASCIITIS (EF) AS A COMPLICATION OF NATURAL KILLER (NK) CELL-BASED IMMUNOTHERAPY IN A YOUNG ADULT WITH RECURRENT METASTATIC EWING SARCOMA
Bhuvana Setty
Favorite
(P 264) RARE CASE OF INFLAMMATORY MYOFIBROBLASTIC TUMOR (IMT) IN NEWBORN
Bhuvana Setty
Favorite
(P 377) GERMLINE RECQL4 VARIANT IN A PEDIATRIC PATIENT WITH EWING SARCOMA AND DESMOID FIBROMATOSIS
Bhuvana Setty
Favorite
Severe, Nicolas

Pyxis Oncology
(P 29) ANTI-TUMOR ACTIVITY OF MICVOTABART PELIDOTIN IS ASSOCIATED WITH ENZYME GENE EXPRESSION IN PATIENT-DERIVED XENOGRAFT SARCOMA MODELS
Nicolas Severe
Favorite
Sevilla-Garcia, Isabel

Hospital Universitario Virgen de la Victoria, Clinical and Translational Cancer Research/Malaga Biomedical Research Institute (IBIMA) Málaga
(P 389) UNRESECTABLE AND METASTATIC DEDIFFERENTIATED LIPOSARCOMA (DDLPS): INSIGHTS FROM A MULTICENTER REAL-WORLD COHORT (RWC)
Isabel Sevilla-Garcia
Favorite
Seward, David

University of Vermont, Dept of Pathology and Laboratory Medicine
(P 24) THE SIRTUIN SIRT5 SUPPORTS EWING SARCOMA SURVIVAL VIA REGULATION OF EWS-FLI1 STABILITY AND ACTIVITY
David Seward
Favorite
Sexton, Sarah

Dana-Farber Cancer Institute
(P 427) PHASE 1/2 TRIAL TO EVALUATE THE SAFETY AND EFFICACY OF PEEL-224 IN COMBINATION WITH VINCRISTINE AND TEMOZOLOMIDE IN ADOLESCENTS AND YOUNG ADULTS WITH RELAPSED OR REFRACTORY SARCOMAS
Sarah Sexton
Favorite
Shafer, Amanda

University of Michigan
(P 50) A NEW MURINE MODEL OF DEDIFFERENTIATED LIPOSARCOMA DEFINED BY HIGH PROLIFERATION AND METABOLIC ADAPTABILITY
Amanda Shafer
Favorite
(P 52) VALIDATION OF SYNGENEIC MURINE DEDIFFERENTIATED LIPOSARCOMA MODELS FOR PRECLINICAL EVALUATION OF THERAPEUTIC SENSITIVITY
Amanda Shafer
Favorite
Shafi, Saba

The Ohio State University Wexner Medical Center
(P 153) DOES THE QUANTITY OF DEDIFFERENTIATION MATTER IN THE CLINICAL OUTCOMES OF DEDIFFERENTIATED CHONDROSARCOMA? A 10-YEAR SINGLE TERTIARY INSTITUTIONAL EXPERIENCE OF A SERIES.
Saba Shafi
Favorite
Shah, Karan

The University of Sheffield
(P 136) ESTROGEN HAS A PROTECTIVE EFFECT ON CHONDROSARCOMA GROWTH IN VITRO AND IN VIVO
Karan Shah
Favorite
Shah, Pooja

MD Anderson Cancer Center
(P 184) MTAP IN GASTROINTESTINAL STROMAL TUMOR (GIST): RATE OF MTAP LOSS AND CONCORDANCE BETWEEN GENOMIC SEQUENCING AND IMMUNOHISTOCHEMISTRY
Pooja Shah
Favorite
Shahzad, Hania

UC Davis Health
(P 349) THE COST OF SURVEILLANCE IN CALIFORNIA: MRI UTILIZATION IN RECURRENT EXTREMITY SOFT TISSUE SARCOMA
Hania Shahzad
Favorite
Shamim, Shamim

All India Institute of Medical Sciences, New Delhi
(P 276) RADIATION-INDUCED SARCOMA (RIS): CLINICAL SPECTRUM AND ONCOLOGIC OUTCOMES FROM A TERTIARY INDIAN SARCOMA CLINIC
Shamim Shamim
Favorite
Shamsutdinova, Diana

MD Anderson Cancer Center
(P 47) EWSR1::WT1 FUSION ONCOPROTEIN ACTIVITY SHAPES LINEAGE HETEROGENEITY IN DESMOPLASTIC SMALL ROUND CELL TUMORS
Diana Shamsutdinova
Favorite
(P 184) MTAP IN GASTROINTESTINAL STROMAL TUMOR (GIST): RATE OF MTAP LOSS AND CONCORDANCE BETWEEN GENOMIC SEQUENCING AND IMMUNOHISTOCHEMISTRY
Diana Shamsutdinova
Favorite
(P 242) IMMUNE PROFILING OF UNDIFFERENTIATED PLEOMORPHIC SARCOMAS REVEALS DISTINCT PROGNOSTIC SUBGROUPS
Diana Shamsutdinova
Favorite
Shang, Lulu

The University of Texas MD Anderson Cancer Center
(P 172) COMPARISON OF CELL SEGMENTATION METHODS IN SOFT TISSUE SARCOMA (STS) SPATIAL PROTEOMIC DATASETS
Lulu Shang
Favorite
Shao, James

Biostatistics, IDRx
(P 194) UPDATED RESULTS FROM STRATEGIST 1: A PHASE 1/1B STUDY OF IDRX-42 (GSK6042981A) IN PATIENTS (PTS) WITH ADVANCED GASTROINTESTINAL STROMAL TUMORS (GIST)
James Shao
Favorite
Sharma, Maitreyi

Deciphera Pharmaceuticals, LLC
(P 358) EFFECT OF A HIGH-FAT MEAL ON THE PHARMACOKINETICS (PK) OF VIMSELTINIB, AN ORAL INHIBITOR OF THE COLONY-STIMULATING FACTOR 1 RECEPTOR (CSF1R), IN HEALTHY PARTICIPANTS
Maitreyi Sharma
Favorite
(P 376) EFFECT OF ITRACONAZOLE (ITZ) AND RABEPRAZOLE (RBP) ON THE PHARMACOKINETICS (PK) OF VIMSELTINIB, AN ORAL INHIBITOR OF THE COLONY-STIMULATING FACTOR 1 RECEPTOR, IN HEALTHY PARTICIPANTS
Maitreyi Sharma
Favorite
(P 422) EFFICACY WITH VIMSELTINIB IN PATIENTS (PTS) WITH TENOSYNOVIAL GIANT CELL TUMOR (TGCT) AND PRIOR COLONY-STIMULATING FACTOR 1 (CSF1) INHIBITOR THERAPY: A PHASE 2 CASE SERIES
Maitreyi Sharma
Favorite
Sharma, Nikita

University of Miami Miller School of Medicine
(P 201) METASTATIC PATTERNS, TREATMENT MODALITIES, AND OVERALL SURVIVAL IN OLIGOMETASTATIC GIST: A SINGLE-CENTER RETROSPECTIVE STUDY
Nikita Sharma
Favorite
Sharma, Sunil

Honor Health
(P 415) A PHASE 1/2 TRIAL OF FOG-001, A FIRST-IN-CLASS DIRECT β-CATENIN:TCF4 INHIBITOR: SAFETY AND PRELIMINARY ANTITUMOR ACTIVITY IN PATIENTS WITH DESMOID TUMORS (DT)
Sunil Sharma
Favorite
Sharp, Andrew

MGH
(P 392) CLASSIFICATION AND DIFFERENTIATIONOF MYXOID LIPOSARCOMA AND MYXOMA WITH MACHINE LEARNING
Andrew Sharp
Favorite
(P 392) DIFFERENTIATION OF MYXOMA AND MYXOID LIPOSARCOMA BASED ON RADIOMICS PHENOTYPES
Andrew Sharp
Favorite
Shaw, Matthew

Huntsman Cancer Institute
(P 01) FEASIBILITY OF A QUANTITATIVE METHYLATION-BASED CTDNA ASSAY IN PATIENTS WITH ADVANCED SARCOMAS
Matthew Shaw
Favorite
Shay, Bracha

Ohio State University
(P 19) SERUM EXOSOMES IDENTIFY AN ABERRANT PROTEOMIC SIGNATURE IN CANINE OSTEOSARCOMA PRECEDING METASTATIC PROGRESSION
Bracha Shay
Favorite
Sheel, Ankur

The Ohio State University
(P 170) GEMSARC: AN AI BASED PREDICTIVE GENE SIGNATURE FOR GEMCITABINE EFFICACY IN ADVANCED SOFT-TISSUE SARCOMAS
Ankur Sheel
Favorite
(P 408) REAL-WORLD SINGLE-CENTER INSIGHTS INTO CT-DNA DYNAMICS ACROSS SOFT TISSUE SARCOMAS
Ankur Sheel
Favorite
Shelmidine, Katherine

Emory University
(P 21) EXAMINING THE THERAPEUTIC EFFECT OF TBL1/ β-CATENIN TARGETED COMBINATION THERAPIES ON METASTATIC OSTEOSARCOMA
Katherine Shelmidine
Favorite
Shen, Chuan

Pyxis Oncology
(P 29) ANTI-TUMOR ACTIVITY OF MICVOTABART PELIDOTIN IS ASSOCIATED WITH ENZYME GENE EXPRESSION IN PATIENT-DERIVED XENOGRAFT SARCOMA MODELS
Chuan Shen
Favorite
Sheng, Michael

Department of Dermatology, University of California, Davis
(P 244) INTRATUMORAL TIGIT BLOCKADE AUGMENTS ANTI-TUMOR RESPONSES AND BYPASSES HYPERFUNCTIONALITY OF PERIPHERAL TIGIT+ NK CELLS IN MOUSE AND HUMAN MODELS OF BONE AND SOFT TISSUE SARCOMA
Michael Sheng
Favorite
Shen, Jingnan

Musculoskeletal Oncology, 1st Affiliated Hospital of Sun Yat-sen University
(P 407) PIMICOTINIB IN TENOSYNOVIAL GIANT CELL TUMOR (TGCT): LONG-TERM EFFICACY, SAFETY, AND PATIENT-REPORTED OUTCOMES FROM THE PHASE 3 MANEUVER STUDY
Jingnan Shen
Favorite
Shenoy, Devika

Duke University School of Medicine
(P 214) FINANCIAL TOXICITY IN PATIENTS WITH A HISTORY OF EXTREMITY AND PELVIC SARCOMA TREATMENT
Devika Shenoy
Favorite
Sheoran, Varun

All India Institute of Medical Sciences, New Delhi
(P 276) RADIATION-INDUCED SARCOMA (RIS): CLINICAL SPECTRUM AND ONCOLOGIC OUTCOMES FROM A TERTIARY INDIAN SARCOMA CLINIC
Varun Sheoran
Favorite
Shepard, Dale

Cleveland Clinic
(P 284) THE IMPACT OF SARCOMA SBRT ON THE IMMUNE SYSTEM: EARLY RESULTS FROM A PROSPECTIVE TRIAL
Dale Shepard
Favorite
Sheppard, Heather

St. Jude Children's Research Hospital
(P 241) MACROPHAGE INHIBITION ENHANCES PERIPHERAL CAR T CELL EXPANSION AND TUMOR CONTROL IN A PATIENT-DERIVED HUMANIZED MODEL OF AUTOLOGOUS CAR T CELL EFFICACY IN PEDIATRIC OSTEOSARCOMA (OS)
Heather Sheppard
Favorite
Sheridan, Aine

St Vincent's University Hospital
(P 211) HEALTH-RELATED QUALITY OF LIFE IN IRISH SARCOMA PATIENTS
Aine Sheridan
Favorite
(P 213) FINANCIAL TOXICITY IN IRISH SARCOMA CARE: A SINGLE-CENTRE ANALYSIS
Aine Sheridan
Favorite
Sherman, Matthew

Deciphera Pharmaceuticals, LLC
(P 358) EFFECT OF A HIGH-FAT MEAL ON THE PHARMACOKINETICS (PK) OF VIMSELTINIB, AN ORAL INHIBITOR OF THE COLONY-STIMULATING FACTOR 1 RECEPTOR (CSF1R), IN HEALTHY PARTICIPANTS
Matthew Sherman
Favorite
(P 376) EFFECT OF ITRACONAZOLE (ITZ) AND RABEPRAZOLE (RBP) ON THE PHARMACOKINETICS (PK) OF VIMSELTINIB, AN ORAL INHIBITOR OF THE COLONY-STIMULATING FACTOR 1 RECEPTOR, IN HEALTHY PARTICIPANTS
Matthew Sherman
Favorite
(P 422) EFFICACY WITH VIMSELTINIB IN PATIENTS (PTS) WITH TENOSYNOVIAL GIANT CELL TUMOR (TGCT) AND PRIOR COLONY-STIMULATING FACTOR 1 (CSF1) INHIBITOR THERAPY: A PHASE 2 CASE SERIES
Matthew Sherman
Favorite
(P 424) AN OPEN-LABEL PHASE 1/2 STUDY OF DCC-3009 MONOTHERAPY IN PATIENTS (PTS) WITH ADVANCED GASTROINTESTINAL STROMAL TUMOR (GIST)
Matthew Sherman
Favorite
shetty, om shree

Tata Memorial Hospital
(P 338) POORLY DIFFERENTIATED SYNOVIAL SARCOMA: A HISTOLOGIC CHALLENGE OF AN AGGRESSIVE VARIANT
om shree shetty
Favorite
(P 379) IMPACT OF EWSR1 GENE REARRANGEMENT TESTING ON DIAGNOSIS OF A WIDE RANGE OF SOLID TUMOURS
om shree shetty
Favorite
Shih, Helen

Massachusetts General Hospital
(P 461) A RETROSPECTIVE ANALYSIS OF PATIENTS WITH CONVENTIONAL CHORDOMA TREATED WITH SYSTEMIC THERAPY
Helen Shih
Favorite
Shimada, Eijiro

Duke University
(P 126) SINGLE-CELL RNA SEQUENCING AND PROTEOMIC SPATIAL PROFILING REVEAL COMPLEX TUMOR MICROENVIRONMENT AND NOVEL IMMUNE INTERACTIONS IN CHONDROSARCOMA
Eijiro Shimada
Favorite
(P 380) INVESTIGATING THE ROLE OF HISTONE DEACETYLASE-3 IN METASTATIC UNDIFFERENTIATED PLEOMORPHIC SARCOMA
Eijiro Shimada
Favorite
(P 472) LANDSCAPE OF ULTRA-RARE SARCOMAS: A NATIONWIDE STUDY FOR EPIDEMIOLOGY AND PROGNOSIS
Eijiro Shimada
Favorite
Shimoi, Tatsunori

Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan
(P 341) PROGNOSTIC RELEVANCE OF CYCLOPHOSPHAMIDE DOSE FOR HIGH-RISK RHABDOMYOSARCOMA IN ADULT PATIENTS TREATED WITH VAC THERAPY
Tatsunori Shimoi
Favorite
Shine, Robert

Apollo Therapeutics; Strand Therapeutics
(P 433) PHASE I DOSE ESCALATION TRIAL OF STX-001, AN LNP SELF-REPLICATING MRNA EXPRESSING IL-12, IN PATIENTS WITH REFRACTORY TUMORS INCLUDING SARCOMAS
Robert Shine
Favorite
Shin, Kyoungseob

Seoul National University
(P 175) INTERPRETABLE DEEP LEARNING BASED CLASSIFICATION OF SARCOMA IMMUNE SUBTYPES FROM H&E SLIDES FOR IMMUNOTHERAPY STRATIFICATION
Kyoungseob Shin
Favorite
(P 176) DEEP LEARNING MODEL FOR DIFFERENTIATING BETWEEN NEOPLASTIC PATHOLOGIC FRACTURE AND NONPATHOLOGIC FRACTURE FROM PLAIN HIP RADIOGRAPHS
Kyoungseob Shin
Favorite
Shin, Seung Han

Department of Orthopaedic Surgery, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea
(P 171) THREE-DIMENSIONAL DEEP LEARNING MODEL FOR PREDICTING PROXIMAL FEMORAL PATHOLOGIC FRACTURE USING OPPORTUNISTIC ABDOMINOPELVIC CT IN PATIENTS WITH ADVANCED CANCER: A PRELIMINARY REPORT
Seung Han Shin
Favorite
Shishak, Sorun

Medanta the Medicity
(P 276) RADIATION-INDUCED SARCOMA (RIS): CLINICAL SPECTRUM AND ONCOLOGIC OUTCOMES FROM A TERTIARY INDIAN SARCOMA CLINIC
Sorun Shishak
Favorite
Shlien, Adam

The Hospital for Sick Children
(P 73) TARGETABLE GENE DEPENDENCIES IN EWING SARCOMA SUBTYPES
Adam Shlien
Favorite
(P 256) THE SEAN KARL COHORT: A NATIONAL COLLABORATIVE SINGLE-CELL RNASEQ STUDY OF PAIRED PATIENT EWING SARCOMA SPECIMENS
Adam Shlien
Favorite
Sholevar, Cyrus

Surgical Oncology, Department of Surgery, University of California, Davis
(P 244) INTRATUMORAL TIGIT BLOCKADE AUGMENTS ANTI-TUMOR RESPONSES AND BYPASSES HYPERFUNCTIONALITY OF PERIPHERAL TIGIT+ NK CELLS IN MOUSE AND HUMAN MODELS OF BONE AND SOFT TISSUE SARCOMA
Cyrus Sholevar
Favorite
(P 245) SUBTYPE SPECIFIC CHARACTERIZATION OF IMMUNE INFILTRATION IN SOFT TISSE SARCOMAS
Cyrus Sholevar
Favorite
Shulman, David

Dana-Farber/Boston Children’s Cancer and Blood Disorders Center
(P 427) PHASE 1/2 TRIAL TO EVALUATE THE SAFETY AND EFFICACY OF PEEL-224 IN COMBINATION WITH VINCRISTINE AND TEMOZOLOMIDE IN ADOLESCENTS AND YOUNG ADULTS WITH RELAPSED OR REFRACTORY SARCOMAS
David Shulman
Favorite
Shultz, David

Princess Margaret Cancer Centre
(P 57) STUDYING HYPOXIA-INDUCED METASTASIS IN GENETICALLY ENGINEERED MOUSE MODELS OF UPS
David Shultz
Favorite
(P 430) A PH/2 STUDY OF THE RADIOPHARMACEUTICAL [AC-225]RTX-2358 IN THE TREATMENT OF RELAPSED / REFRACTORY (R/R) SOFT TISSUE SARCOMA (STS) THE ATLAS STUDY - ACTINIUM THERAPY FOR LATE-STAGE AGGRESSIVE SARCOMAS
David Shultz
Favorite
Siatis, Dimitrios

Candiolo Cancer Institute, FPO – IRCCS
(P 328) INNOVATING SARCOMA EDUCATION: EARLY OUTCOMES OF THE ITALIAN SOCIETY OF SURGICAL ONCOLOGY (SICO) SARCOMA SOCIAL MULTI-PLATFORM JOURNAL CLUB INITIATIVE
Dimitrios Siatis
Favorite
Sicinska, Ewa

Dana-Farber
(P 198) EXPLOITING METABOLIC DYSREGULATION IN SUCCINATE DEHYDROGENASE-DEFICIENT GASTROINTESTINAL STROMAL TUMOR
Ewa Sicinska
Favorite
Sicklick, Jason

Dept. of Surgery, Moores Cancer Center, University of California San Diego
(P 179) NEOADJUVANT AVAPRITINIB IN PDGFRA-MUTANT GIST: NEAR COMPLETE PATHOLOGICAL RESPONSES AT THE COST OF HIGH ADVERSE EVENT RATES
Jason Sicklick
Favorite
(P 180) COMPARATIVE EFFICACY OF GENERIC AND BRAND-NAME IMATINIB IN NEOADJUVANT TREATMENT OF KIT EXON 11 MUTANT GIST
Jason Sicklick
Favorite
(P 197) DIFFERENTIAL EFFECTS OF ANAGRELIDE IN GASTROINTESTINAL STROMAL TUMORS (GIST) IN VITRO
Jason Sicklick
Favorite
(P 423) ZIFTOMENIB IN COMBINATION WITH IMATINIB IN ADVANCED GASTROINTESTINAL STROMAL TUMORS (GIST) AFTER IMATINIB FAILURE: PHASE 1A/B STUDY OF SAFETY, PHARMACOKINETICS, AND ANTITUMOR ACTIVITY
Jason Sicklick
Favorite
Sicoli, Federico

IRCCS Humanitas Research Hospital
(P 203) MINIMALLY INVASIVE RESECTION OF MULTIFOCAL DUODENO-JEJUNAL GISTS IN NEUROFIBROMATOSIS TYPE 1
Federico Sicoli
Favorite
(P 318) BURIED DE-EPITHELIALIZED FLAP RECONSTRUCTION AFTER WIDE EXCISION OF THIGH SARCOMAS: EARLY EXPERIENCE FROM A SPECIALIZED SARCOMA SURGERY UNIT
Federico Sicoli
Favorite
(P 339) POSTERIOR APPROACH FOR RADICAL RESECTION OF SACROCOCCYGEAL CHORDOMA: A SURGICAL PERSPECTIVE FROM A TERTIARY REFERRAL CENTER
Federico Sicoli
Favorite
(P 365) UROLOGICAL RECONSTRUCTION DURING RETROPERITONEAL AND PELVIC SARCOMA SURGERY: EXPERIENCE FROM A HIGH-VOLUME SARCOMA CENTER
Federico Sicoli
Favorite
Siddiquee, Armaan

Memorial Sloan Kettering Cancer Center
(P 237) DEVELOPMENT OF EPHA2 CAR T CELL THERAPY FOR OSTEOSARCOMA
Armaan Siddiquee
Favorite
(P 267) THE RAF/MEK INHIBITOR VS-6766 SHOWS EFFICACY IN RAS-MUTANT PEDIATRIC PRECLINICAL XENOGRAFT MODELS- A REPORT FROM THE PEDIATRIC PRECLINICAL IN VIVO TESTING CONSORTIUM
Armaan Siddiquee
Favorite
Siegel, Geoffrey

University of Michigan Rogel Comprehensive Cancer Center
(P 227) TREATMENT PATTERNS IN PATIENTS WITH TENOSYNOVIAL GIANT CELL TUMORS: ADDRESSING COMMUNICATION IN A NEW THERAPEUTIC LANDSCAPE
Geoffrey Siegel
Favorite
Sihto, Harri

Dept. of Pathology, University of Helsinki and Helsinki University Hospital
(P 197) DIFFERENTIAL EFFECTS OF ANAGRELIDE IN GASTROINTESTINAL STROMAL TUMORS (GIST) IN VITRO
Harri Sihto
Favorite
Sikorski, Robert

Woodside Way Ventures
(P 440) CASE REPORT: COMPLETE CLINICAL AND MOLECULAR RESPONSE TO INTRATUMORAL STX-001, AN LNP-SELF REPLICATING MRNA EXPRESSING IL-12 IN A PATIENT WITH REFRACTORY ANGIOSARCOMA
Robert Sikorski
Favorite
Silberman, Allen

Cedars Sinai Medical Center
(P 230) CIRCULATING TUMOR DNA AS AN EARLY INDICATOR OF RESPONSE, PROGRESSION, AND RECURRENCE OF SARCOMAS
Allen Silberman
Favorite
(P 433) PHASE I DOSE ESCALATION TRIAL OF STX-001, AN LNP SELF-REPLICATING MRNA EXPRESSING IL-12, IN PATIENTS WITH REFRACTORY TUMORS INCLUDING SARCOMAS
Allen Silberman
Favorite
(P 440) CASE REPORT: COMPLETE CLINICAL AND MOLECULAR RESPONSE TO INTRATUMORAL STX-001, AN LNP-SELF REPLICATING MRNA EXPRESSING IL-12 IN A PATIENT WITH REFRACTORY ANGIOSARCOMA
Allen Silberman
Favorite
(P 471) COMBINATION CHEMOTHERAPY WITH GEMCITABINE AND PACLITAXEL: A HIGHLY EFFICACIOUS AND BETTER TOLERATED OPTION FOR ANGIOSARCOMA
Allen Silberman
Favorite
Silletta, Marianna

Fondazione Policlinico Campus Bio-medico di Roma
(P 412) UNCOVERING HER2 OVEREXPRESSION IN SOFT TISSUE SARCOMAS (STS): INSIGHTS FROM THE CANCER GENOME ATLAS (TCGA)
Marianna Silletta
Favorite
Silva, Carolina

Grupo Oncoclinicas
(P 285) MULTICENTER STUDY OF SPATIALLY FRACTIONATED RADIOTHERAPY (LATTICE) FOR LARGE-VOLUME RADIORESISTANT SARCOMAS
Carolina Silva
Favorite
Silvaggio, Maria

University of Pittsburgh
(P 63) EVALUATING SURGICAL MARGINS IN SARCOMA RESECTION WITH INDOCYANINE GREEN FLUORESCENCE IMAGING
Maria Silvaggio
Favorite
Silver, Kate

National Institutes of Health
(P 258) INVESTIGATING THE ROLE OF ALVEOLAR PNEUMOCYTES IN THE LUNG MICROENVIRONMENT OF OSTEOSARCOMA METASTASES
Kate Silver
Favorite
Silvia, Nadia

Stanford University
(P 400) LONGITUDINAL EPIGENETIC AND TRANSCRIPTOMIC REMODELING ACROSS PRIMARY, IRRADIATED, AND LOCALLY RELAPSED SOFT TISSUE SARCOMAS
Nadia Silvia
Favorite
Simões, Anderson

Federal University of São Paulo, São Paulo, Brazil
(P 404) OUTCOMES OF NEOADJUVANT THERAPY IN ANGIOSARCOMA PATIENTS: A KAPLAN-MEIER-RECONSTRUCTED INDIVIDUAL PATIENT-LEVEL META-ANALYSIS
Anderson Simões
Favorite
Simonelli, Leonardo

University of Miami Miller School of Medicine
(P 201) METASTATIC PATTERNS, TREATMENT MODALITIES, AND OVERALL SURVIVAL IN OLIGOMETASTATIC GIST: A SINGLE-CENTER RETROSPECTIVE STUDY
Leonardo Simonelli
Favorite
(P 369) CLINICAL CHARACTERISTICS & TREATMENT OUTCOME PATTERNS OF SOLITARY FIBROUS TUMORS: A SINGLE-INSTITUTION RETROSPECTIVE ANALYSIS
Leonardo Simonelli
Favorite
Simonetti, Sonia

Fondazione Policlinico Universitario Campus Bio-Medico
(P 61) HER2 TARGETING IN CHORDOMA: PRECLINICAL INSIGHTS ON TRASTUZUMAB DERUXTECAN
Sonia Simonetti
Favorite
Simon, Eugenio

University of Florida
(P 426) A PHASE I/II TRIAL USING RNA LIPID NANOPARTICLES FOR RECURRENT OSTEOSARCOMA: A REPORT FROM THE NATIONAL PEDIATRIC CANCER FOUNDATION
Eugenio Simon
Favorite
Singer, Samuel

Memorial Sloan Kettering Cancer Center
(P 409) RETROSPECTIVE ANALYSIS OF PROGNOSTIC FACTORS INCLUDING HLA GENOTYPE IN MYXOID LIPOSARCOMA
Samuel Singer
Favorite
(P 421) CHARACTERIZING THE IMMUNE RESPONSE TO INTRATUMORAL TIGILANOL TIGLATE (TT) IN PATIENTS WITH ADVANCED AND/OR METASTATIC SOFT TISSUE SARCOMA (STS) IN A PHASE IIA TRIAL (NCT05755113)
Samuel Singer
Favorite
Singh, Akash

AIIMS Delhi
(P 276) RADIATION-INDUCED SARCOMA (RIS): CLINICAL SPECTRUM AND ONCOLOGIC OUTCOMES FROM A TERTIARY INDIAN SARCOMA CLINIC
Akash Singh
Favorite
(P 468) CLINICAL UTILITY OF TARGETED NEXT-GENERATION SEQUENCING IN GUIDING SARCOMA DIAGNOSIS AND PERSONALIZED MANAGEMENT: A SINGLE-CENTER STUDY FROM INDIA
Akash Singh
Favorite
Singh, Arun

University of California
(P 315) ANALYSIS OF CHANGES IN T2-WEIGHTED SIGNAL INTENSITY AND TUMOR VOLUME AND EXPOSURE-RESPONSE IN THE RINGSIDE PHASE 2 STUDY OF VAREGACESTAT FOR DESMOID TUMORS
Arun Singh
Favorite
(P 410) SUBGROUP ANALYSIS OF THE PHASE 2 PART OF THE RINGSIDE PHASE 2/3 TRIAL OF VAREGACESTAT FOR TREATMENT OF DESMOID TUMORS
Arun Singh
Favorite
(P 430) A PH/2 STUDY OF THE RADIOPHARMACEUTICAL [AC-225]RTX-2358 IN THE TREATMENT OF RELAPSED / REFRACTORY (R/R) SOFT TISSUE SARCOMA (STS) THE ATLAS STUDY - ACTINIUM THERAPY FOR LATE-STAGE AGGRESSIVE SARCOMAS
Arun Singh
Favorite
Singh, Gursimar

Carnegie Mellon University
(P 14) EVALUATING THE COMBINATION OF DISULFIRAM AND ENZALUTAMIDE IN OSTEOSARCOMA
Gursimar Singh
Favorite
SINGH, KINJAL

All India Institute of Medical Sciences, Delhi, India
(P 276) RADIATION-INDUCED SARCOMA (RIS): CLINICAL SPECTRUM AND ONCOLOGIC OUTCOMES FROM A TERTIARY INDIAN SARCOMA CLINIC
KINJAL SINGH
Favorite
(P 468) CLINICAL UTILITY OF TARGETED NEXT-GENERATION SEQUENCING IN GUIDING SARCOMA DIAGNOSIS AND PERSONALIZED MANAGEMENT: A SINGLE-CENTER STUDY FROM INDIA
KINJAL SINGH
Favorite
Singh, Reena

Vanderbilt University Medical Center
(P 85) MAKING NEGATIVE MARGIN MUSCULOSKELETAL TUMOR SURGERY A VIRTUAL REALITY USING 3D SPECIMEN SCANNING
Reena Singh
Favorite
(P 310) ATYPICAL SPINDLE CELL PLEOMORPHIC LIPOMATOUS TUMORS OF THE RETROPERITONEUM ARE HETEROGENOUS: A REPORT OF FOUR DISPARATE CASES
Reena Singh
Favorite
Singh, Rishika

University of Virginia
(P 199) CHARACTERISTICS OF AN IMMUNOHISTOCHEMICAL AND MOLECULARLY DISCORDANT POPULATION OF GIST PATIENTS: A SINGLE CENTER RETROSPECTIVE REVIEW
Rishika Singh
Favorite
Siontis, Brittany

Mayo Clinic
(P 223) OUTCOMES OF GERIATRIC PATIENTS WITH DE NOVO SARCOMA AND LUNG METASTASES: ROLE OF TUMOR CHARACTERISTICS AND TREATMENT STRATEGY
Brittany Siontis
Favorite
(P 246) CTLA4 PATHWAY ACTIVATION IN RADIATION-INDUCED ANGIOSARCOMA: A TRANSCRIPTOMIC RATIONALE FOR IMMUNE CHECKPOINT BLOCKADE
Brittany Siontis
Favorite
(P 300) FEATURES AND OUTCOMES OF PATIENTS WITH GASTROINTESTINAL LEIYOMYOSARCOMA
Brittany Siontis
Favorite
(P 430) A PH/2 STUDY OF THE RADIOPHARMACEUTICAL [AC-225]RTX-2358 IN THE TREATMENT OF RELAPSED / REFRACTORY (R/R) SOFT TISSUE SARCOMA (STS) THE ATLAS STUDY - ACTINIUM THERAPY FOR LATE-STAGE AGGRESSIVE SARCOMAS
Brittany Siontis
Favorite
Sisakyan, Janna

Yerevan State Medical University
(P 158) GLOBAL INEQUITIES IN CHONDROSARCOMA CLINICAL TRIALS: A COMPREHENSIVE ANALYSIS ACROSS THREE DECADES
Janna Sisakyan
Favorite
Sittiju, Pattaralawan

Chiang Mai University, Thailand
(P 116) A DUAL-TARGETED SYSTEMIC THERAPEUTIC APPROACH FOR THE SELECTIVE ELIMINATION OF TUMOR CELLS IN PRIMARY AND METASTATIC SARCOMA.
Pattaralawan Sittiju
Favorite
Sivarajah, Gausihi

Royal Hobart Hospital
(P 414) PATTERNS OF RELAPSE OF BORDERLINE AND MALIGNANT PHYLLODES TUMOUR- RESULTS FROM SARCOMA REFERENCE CENTRE (SRC)
Gausihi Sivarajah
Favorite
Skinner, Mary

University of Michigan
(P 24) THE SIRTUIN SIRT5 SUPPORTS EWING SARCOMA SURVIVAL VIA REGULATION OF EWS-FLI1 STABILITY AND ACTIVITY
Mary Skinner
Favorite
Skoczylas, Jacek

Maria Sklodowska-Curie National Research Institute of Oncology
(P 313) SIGNIFICANCE OF LYMPH NODE PROCEDURES IN SOFT TISSUE SARCOMA PATIENTS
Jacek Skoczylas
Favorite
Skornja, Iris

university of amsterdam
(P 105) TREATMENT SUCCESS RATE AFTER SURGICAL MANAGEMENT OF PERIPROSTHETIC JOINT INFECTIONS IN ONCOLOGIC PROXIMAL TIBIA RECONSTRUCTION
Iris Skornja
Favorite
Skubitz, Keith

University of Minnesota
(P 418) INTEGRATING SARCULATOR AND PET RESPONSE TO GUIDE NEOADJUVANT TREATMENT DECISIONS IN HIGH-RISK SOFT TISSUE SARCOMA
Keith Skubitz
Favorite
Slater, Olga

Great Ormond Street Hospital for Children
(P 250) OUTCOME OF INFANTS WITH RHABDOMYOSARCOMA: A REPORT FROM THE INTERNATIONAL SOFT TISSUE SARCOMA CONSORTIUM
Olga Slater
Favorite
Sleator, Jade

St Vincent's University Hospital
(P 211) HEALTH-RELATED QUALITY OF LIFE IN IRISH SARCOMA PATIENTS
Jade Sleator
Favorite
(P 213) FINANCIAL TOXICITY IN IRISH SARCOMA CARE: A SINGLE-CENTRE ANALYSIS
Jade Sleator
Favorite
Sloan, Caroline

Duke University School of Medicine
(P 214) FINANCIAL TOXICITY IN PATIENTS WITH A HISTORY OF EXTREMITY AND PELVIC SARCOMA TREATMENT
Caroline Sloan
Favorite
Slopis, John

MD Anderson Cancer Center
(P 351) THE ROLE OF SOCIOECONOMIC DISPARITIES ON SURVIVAL OUTCOMES IN MALIGNANT PERIPHERAL NERVE SHEATH TUMORS
John Slopis
Favorite
Slotkin, Emily

Memorial Sloan Kettering Cancer Center
(P 265) MULTI-SITE SINGLE CELL TRANSCRIPTOMICS REVEAL DISTINCT IMMUNE INFILTRATIVE PATTERNS IN DESMOPLASTIC SMALL ROUND CELL TUMOR
Emily Slotkin
Favorite
Smith, Amber

Rare Cancer Research Foundation
(P 350) THE PATTERN.ORG SARCOMA CONSORTIUM: BUILDING A MULTI-INSTITUTIONAL DATA RESOURCE FOR THE SARCOMA RESEARCH COMMUNITY
Amber Smith
Favorite
Smith, Jimmy

UC Davis Health
(P 95) COMPARATIVE OUTCOMES OF OPERATIVE AND NON-OPERATIVE TREATMENT FOR METASTATIC HUMERAL PATHOLOGIC FRACTURES
Jimmy Smith
Favorite
(P 106) REPAIR: A PRELIMINARY REPORT ON AN ONGOING MULTI-CENTER TRIAL FOR PATIENTS UNDERGOING SURGICAL STABILIZATION FOR METASTATIC BONE DISEASE OF THE FEMUR
Jimmy Smith
Favorite
(P 349) THE COST OF SURVEILLANCE IN CALIFORNIA: MRI UTILIZATION IN RECURRENT EXTREMITY SOFT TISSUE SARCOMA
Jimmy Smith
Favorite
(P 360) MRI SURVEILLANCE PRACTICES AND RECURRENCE DETECTION IN EXTREMITY SOFT TISSUE SARCOMA: A RETROSPECTIVE STUDY
Jimmy Smith
Favorite
Smith, Kaitlyn

University of California San Francisco
(P 93) INTERCALARY COMPRESSIVE OSSEOINTEGRATION OF DIAPHYSEAL TUMORS: A MULTI-INSTITUTIONAL CASE SERIES
Kaitlyn Smith
Favorite
Smith, Malcolm

National Cancer Institute
(P 267) THE RAF/MEK INHIBITOR VS-6766 SHOWS EFFICACY IN RAS-MUTANT PEDIATRIC PRECLINICAL XENOGRAFT MODELS- A REPORT FROM THE PEDIATRIC PRECLINICAL IN VIVO TESTING CONSORTIUM
Malcolm Smith
Favorite
Smith, Megan

Deciphera Pharmaceuticals, LLC
(P 195) IMPACT OF EXPERT-LED EDUCATION PROGRAMS ON HEALTH CARE PROVIDER (HCP) KNOWLEDGE OF GASTROINTESTINAL STROMAL TUMOR (GIST)
Megan Smith
Favorite
Smith, Myles

Royal Marsden Hospital NHS Foundation Trust
(P 298) RESECTION OF PARA-RENAL INFERIOR VENA CAVA LEIOMYOSARCOMA WITH RIGHT NEPHRECTOMY AND LEFT RENAL VEIN LIGATION WITHOUT VENOUS RECONSTRUCTION.
Myles Smith
Favorite
(P 414) PATTERNS OF RELAPSE OF BORDERLINE AND MALIGNANT PHYLLODES TUMOUR- RESULTS FROM SARCOMA REFERENCE CENTRE (SRC)
Myles Smith
Favorite
Smith, Vanessa

University of Virginia
(P 199) CHARACTERISTICS OF AN IMMUNOHISTOCHEMICAL AND MOLECULARLY DISCORDANT POPULATION OF GIST PATIENTS: A SINGLE CENTER RETROSPECTIVE REVIEW
Vanessa Smith
Favorite
Smrke, Alannah

University of British Columbia
(P 178) TREATMENT RESPONSE AND SURVIVAL OUTCOMES IN GASTROINTESTINAL STROMAL TUMORS FOLLOWING NEOADJUVANT THERAPY
Alannah Smrke
Favorite
Sneed, Shay

St. Jude Children's Research Hospital
(P 267) THE RAF/MEK INHIBITOR VS-6766 SHOWS EFFICACY IN RAS-MUTANT PEDIATRIC PRECLINICAL XENOGRAFT MODELS- A REPORT FROM THE PEDIATRIC PRECLINICAL IN VIVO TESTING CONSORTIUM
Shay Sneed
Favorite
Sobczuk, Paweł

Maria Sklodowska-Curie National Research Institute of Oncology
(P 191) EFFICACY OF SYSTEMIC PALLIATIVE THERAPIES IN PATIENTS WITH ADVANCED GASTROINTESTINAL STROMAL TUMORS (GIST) PREVIOUSLY TREATED WITH ADJUVANT IMATINIB - REAL-WORLD CLINICAL PRACTICE DATA
Paweł Sobczuk
Favorite
Solans Solerdelcoll, Mireia

Hospital de la Santa Creu i Sant Pau
(P 383) MULTIDISCIPLINARY TREATMENT OF INGUINOSCROTAL SARCOMAS: ANALYSIS OF 39 CASES TREATED BY SURGICAL APPROACH
Mireia Solans Solerdelcoll
Favorite
Solimini, Nicole

Dana-Farber Cancer Institute
(P 34) EXPRESSION OF ONCOFETAL ANTIGEN 5T4 IN SARCOMA SUBTYPES AND PRECLINICAL ACTIVITY OF TUB-030, A NOVEL 5T4-TARGETING ANTIBODY-DRUG CONJUGATE (ADC)
Nicole Solimini
Favorite
(P 235) AGNOSTIC INDICATION OF IMMUNE CHECKPOINT INHIBITORS (ICI): PATTERNS OF RESPONSE OF SARCOMAS
Nicole Solimini
Favorite
Solorzano, Felipe

Fundación Colombiana de Cancerología Clínica Vida
(P 219) RETROPERITONEAL SARCOMA: HEALTH SYSTEM BARRIERS AND THE RATIONALE FOR A SPECIALIZED SARCOMA UNIT
Felipe Solorzano
Favorite
(P 301) RETROPERITONEAL SARCOMA: SINGLE CENTER EXPERIENCE IN LATIN AMERICA. DO WE HAVE DIFFERENT SARCOMAS WHEN COMPARED TO THE REST OF THE WORLD?
Felipe Solorzano
Favorite
Somaiah, Neeta

Department of Sarcoma Medical Oncology, Division of Cancer Medicine, MD Anderson Cancer Center
(P 54) PRECLINICAL MODELS REVEALING MDM2-P53 INTERACTION AND DEPENDENCY FOR TUMOR CELL SURVIVAL IN WELL-DIFFERENTIATED (WD) AND DEDIFFERENTIATED (DD) LIPOSARCOMA (LPS).
Neeta Somaiah
Favorite
(P 83) OUTCOMES OF MULTIMODAL PERIOPERATIVE TREATMENT IN OSTEOSARCOMAS OF THE JAW
Neeta Somaiah
Favorite
(P 184) MTAP IN GASTROINTESTINAL STROMAL TUMOR (GIST): RATE OF MTAP LOSS AND CONCORDANCE BETWEEN GENOMIC SEQUENCING AND IMMUNOHISTOCHEMISTRY
Neeta Somaiah
Favorite
(P 194) UPDATED RESULTS FROM STRATEGIST 1: A PHASE 1/1B STUDY OF IDRX-42 (GSK6042981A) IN PATIENTS (PTS) WITH ADVANCED GASTROINTESTINAL STROMAL TUMORS (GIST)
Neeta Somaiah
Favorite
(P 242) IMMUNE PROFILING OF UNDIFFERENTIATED PLEOMORPHIC SARCOMAS REVEALS DISTINCT PROGNOSTIC SUBGROUPS
Neeta Somaiah
Favorite
(P 274) RACIAL DISPARITIES IN INCIDENCE AND MORTALITY OVER 20 YEARS AMONG AYA PATIENTS WITH SARCOMA IN THE US: A SEER DATABASE ANALYSIS
Neeta Somaiah
Favorite
(P 337) POOLED ANALYSIS OF TRABECTEDIN EFFICACY IN MYXOID/ROUND CELL LIPOSARCOMA FROM THREE PROSPECTIVE CLINICAL TRIALS
Neeta Somaiah
Favorite
(P 351) THE ROLE OF SOCIOECONOMIC DISPARITIES ON SURVIVAL OUTCOMES IN MALIGNANT PERIPHERAL NERVE SHEATH TUMORS
Neeta Somaiah
Favorite
(P 430) A PH/2 STUDY OF THE RADIOPHARMACEUTICAL [AC-225]RTX-2358 IN THE TREATMENT OF RELAPSED / REFRACTORY (R/R) SOFT TISSUE SARCOMA (STS) THE ATLAS STUDY - ACTINIUM THERAPY FOR LATE-STAGE AGGRESSIVE SARCOMAS
Neeta Somaiah
Favorite
(P 451) TREATMENT OUTCOMES OF GEMCITABINE AND DOCETAXEL IN PATIENTS WITH CLEAR CELL SARCOMA (CCS) OR GASTROINTESTINAL NEUROECTODERMAL TUMOR (GNET): A CASE SERIES
Neeta Somaiah
Favorite
(P 460) OUTCOMES OF LATER-LINES SYSTEMIC THERAPIES IN MALIGNANT PERIPHERAL NERVE SHEATH TUMORS (MPNST)
Neeta Somaiah
Favorite
Somarelli, Jason

Duke University Department of Medicine
(P 19) SERUM EXOSOMES IDENTIFY AN ABERRANT PROTEOMIC SIGNATURE IN CANINE OSTEOSARCOMA PRECEDING METASTATIC PROGRESSION
Jason Somarelli
Favorite
(P 119) DEVELOPMENT OF AN EXTINCTION THERAPY APPROACH FOR OSTEOSARCOMA USING ECO-EVOLUTIONARY PRINCIPLES
Jason Somarelli
Favorite
(P 125) TARGETING LCP1-MEDIATED METASTASIS IN CHONDROSARCOMA WITH OROXYLIN A
Jason Somarelli
Favorite
(P 130) INVESTIGATING LCP1-MEDIATED ONCOGENIC SIGNALING IN CHONDROSARCOMA METASTASIS
Jason Somarelli
Favorite
(P 259) PRECLINICAL MODELING OF CHEMOTHERAPY RELEASE IDENTIFIES MITOCHONDRIAL ADAPTATIONS IN DOXORUBICIN TREATED OSTEOSARCOMA
Jason Somarelli
Favorite
Song, Eric

Immunome, Inc.
(P 315) ANALYSIS OF CHANGES IN T2-WEIGHTED SIGNAL INTENSITY AND TUMOR VOLUME AND EXPOSURE-RESPONSE IN THE RINGSIDE PHASE 2 STUDY OF VAREGACESTAT FOR DESMOID TUMORS
Eric Song
Favorite
(P 410) SUBGROUP ANALYSIS OF THE PHASE 2 PART OF THE RINGSIDE PHASE 2/3 TRIAL OF VAREGACESTAT FOR TREATMENT OF DESMOID TUMORS
Eric Song
Favorite
Song, Hyojin

Cumming School of Medicine, University of Calgary
(P 238) INVESTIGATING HOW MACROPHAGES INFILTRATE THE TUMOUR MICROENVIRONMENT AND INFLUENCE THE EFFICACY OF CAR T THERAPY IN A MURINE MODEL OF STS
Hyojin Song
Favorite
(P 378) HIGH DOSE RADIATION THERAPY PROMOTES IMMUNE SUPPRESSIVE MACROPHAGE PHENOTYPES, WHEREAS LOW DOSE RADIATION THERAPY PROMOTES IMMUNOGENIC MACROPHAGE PHENOTYPES IN A MURINE MODEL OF SOFT TISSUE SARCOMA
Hyojin Song
Favorite
Song, Julia

Brigham and Women's Hospital
(P 228) FREQUENCY AND CLARITY OF SURGICAL GOALS FOR TUMOR RESECTION IN ADVANCED SARCOMA
Julia Song
Favorite
Sonkin, Ben

Penn State University
(P 85) MAKING NEGATIVE MARGIN MUSCULOSKELETAL TUMOR SURGERY A VIRTUAL REALITY USING 3D SPECIMEN SCANNING
Ben Sonkin
Favorite
Soto Pernudi, Susan

Hospital México
(P 306) PROGNOSTIC NUTRITIONAL INDEX PREDICTS MAJOR POSTOPERATIVE COMPLICATIONS IN RETROPERITONEAL SARCOMA: RESULTS FROM THE LATAMSARC COHORT
Susan Soto Pernudi
Favorite
Soudi, Shaghayegh

Stanford University
(P 400) LONGITUDINAL EPIGENETIC AND TRANSCRIPTOMIC REMODELING ACROSS PRIMARY, IRRADIATED, AND LOCALLY RELAPSED SOFT TISSUE SARCOMAS
Shaghayegh Soudi
Favorite
Souza, Mariana

A.C.Camargo Cancer Center
(P 132) MOLECULAR LANDSCAPE AND CLINICAL HETEROGENEITY OF BRAZILIAN CHONDROSARCOMAS: INSIGHTS FROM IDH, TERT, AND GENOME-WIDE ANALYSIS
Mariana Souza
Favorite
(P 137) GENOMIC ALTERATIONS IN RARE CARTILAGINOUS TUMOR SYNDROMES ASSOCIATED WITH CHONDROSARCOMA DEVELOPMENT
Mariana Souza
Favorite
Sowell, Ryan

Strand Therapeutics Inc.
(P 433) PHASE I DOSE ESCALATION TRIAL OF STX-001, AN LNP SELF-REPLICATING MRNA EXPRESSING IL-12, IN PATIENTS WITH REFRACTORY TUMORS INCLUDING SARCOMAS
Ryan Sowell
Favorite
(P 440) CASE REPORT: COMPLETE CLINICAL AND MOLECULAR RESPONSE TO INTRATUMORAL STX-001, AN LNP-SELF REPLICATING MRNA EXPRESSING IL-12 IN A PATIENT WITH REFRACTORY ANGIOSARCOMA
Ryan Sowell
Favorite
Sowers, Madison

University of Florida
(P 248) AN EX VIVO ASSAY TO PREDICT IMMUNOTHERAPY RESPONSE IN SARCOMA
Madison Sowers
Favorite
Spałek, Mateusz

Maria Sklodowska-Curie National Research Institute of Oncology; Warsaw Poland
(P 216) VIRTUAL MULTIDISCIPLINARY MEETINGS IN THE CARE OF SARCOMA PATIENTS
Mateusz Spałek
Favorite
SPALATO CERUSO, Mariella

Institut Bergonié
(P 59) TARGETING ADORA2B TO HALT METASTASIS IN UNDIFFERENTIATED PLEOMORPHIC SARCOMA: FROM MULTI-OMICS TO THERAPEUTIC INHIBITION
Mariella SPALATO CERUSO
Favorite
Spalek, Mateusz

Maria Sklodowska-Curie National Research Institute of Oncology
(P 27) MOLECULAR CHARACTERIZATION OF RESPONSE TO NEOADJUVANT CHEMORADIATION IN PATIENTS WITH LOCALLY ADVANCED SOFT TISSUE SARCOMAS
Mateusz Spalek
Favorite
(P 146) LOCALISED CHONDROSARCOMA PERIOPERATIVE TREATMENT: REAL-WORLD OUTCOMES AND CHALLENGES ACROSS HISTOLOGIC SUBTYPES
Mateusz Spalek
Favorite
(P 152) EFFICACY OF PALLIATIVE CHEMOTHERAPY AND LOCAL TREATMENTS IN ADVANCED CHONDROSARCOMA: A SUBTYPE-SPECIFIC RETROSPECTIVE ANALYSIS
Mateusz Spalek
Favorite
Spanheimer, Philip M.

UNC
(P 350) THE PATTERN.ORG SARCOMA CONSORTIUM: BUILDING A MULTI-INSTITUTIONAL DATA RESOURCE FOR THE SARCOMA RESEARCH COMMUNITY
Philip M. Spanheimer
Favorite
Sparber-Sauer, Monika

Stuttgart Cancer Center
(P 250) OUTCOME OF INFANTS WITH RHABDOMYOSARCOMA: A REPORT FROM THE INTERNATIONAL SOFT TISSUE SARCOMA CONSORTIUM
Monika Sparber-Sauer
Favorite
Sparks, Othneil

UCLA DGSOM
(P 16) MITOCHONDRIAL GENETIC VARIATION ORCHESTRATES COPZ1 TRANSCRIPT HETEROGENEITY AND REVEALS TELOMERE-MEDIATED VULNERABILITIES IN OSTEOSARCOMA
Othneil Sparks
Favorite
(P 72) COUNTY-LEVEL ASSOCIATIONS BETWEEN AIRBORNE TOXICANT EMISSIONS AND EWING SARCOMA DIAGNOSIS IN THE UNITED STATES
Othneil Sparks
Favorite
(P 81) ASSESSING PROGNOSTIC FACTORS OF CAUSE-SPECIFIC SURVIVAL IN PATIENTS WITH MALIGNANT GIANT CELL TUMORS: A POPULATION BASED STUDY FROM THE SEER DATABASE
Othneil Sparks
Favorite
(P 92) PRIMARY TUMOR SIZE AS AN INDEPENDENT PROGNOSTIC FACTOR IN OSTEOSARCOMA: PROPENSITY SCORE-MATCHED ANALYSIS DEMONSTRATES A CONTINUOUS DOSE-RESPONSE RELATIONSHIP
Othneil Sparks
Favorite
(P 100) THE ROLE OF CANCER TYPE IN THE DEVELOPMENT OF PERIPROSTHETIC JOINT INFECTION IN DISTAL FEMORAL REPLACEMENT
Othneil Sparks
Favorite
(P 107) IS THERE A BETTER OPTION: INTRAMEDULLARY NAIL VERSUS PLATE OSTEOSYNTHESIS FOR PATHOLOGIC HUMERAL FRACTURES?
Othneil Sparks
Favorite
(P 108) DISTANCE WEIGHTED MATCHING IN THE QUANTIFICATION OF EXCESS MORBIDITY IN EXTERNAL HEMIPELVECTOMY AND HIP DISARTICULATION
Othneil Sparks
Favorite
(P 157) INCOME IMPACTS OVERALL BUT NOT CAUSE-SPECIFIC SURVIVAL IN PATIENTS WITH CHONDROSARCOMA: A POPULATION BASED STUDY FROM THE SEER DATABASE
Othneil Sparks
Favorite
(P 232) IS THERE A ROLE FOR POSITRON EMISSION TOMOGRAPHY IN THE STAGING OF LANGERHANS CELL HISTIOCYTOSIS?
Othneil Sparks
Favorite
(P 384) PELVIC LOCATION PREDICTS WORSE OUTCOMES IN ALVEOLAR RHABDOMYOSARCOMA: UNDERUSE OF RADIOTHERAPY AND MISSED SURVIVAL BENEFIT
Othneil Sparks
Favorite
Speer, Tobias

Independent Researcher
(P 165) EVALUATING LARGE LANGUAGE MODELS AS DECISION SUPPORT TOOLS IN MULTIDISCIPLINARY TUMOR BOARDS FOR GASTROINTESTINAL STROMAL TUMORS
Tobias Speer
Favorite
Spencer, Christine

Rare Cancer Research Foundation
(P 350) THE PATTERN.ORG SARCOMA CONSORTIUM: BUILDING A MULTI-INSTITUTIONAL DATA RESOURCE FOR THE SARCOMA RESEARCH COMMUNITY
Christine Spencer
Favorite
Spentzos, Dimitrios

Massachusetts General Hospital
(P 17) EXTRASKELETAL OSTEOSARCOMA: MICRORNA PATTERNS PROVIDE INSIGHTS INTO SIMILARITIES AND CONTRASTS WITH OTHER SARCOMAS
Dimitrios Spentzos
Favorite
Spickard, Erik

Natera
(P 04) EARLY ON-TREATMENT CIRCULATING TUMOR DNA DYNAMICS TO PREDICT RESPONSE IN PATIENTS WITH SARCOMA
Erik Spickard
Favorite
Spiguel, Andre

Univeristy of Florida
(P 129) HIJACKED FUEL: GLYCOGEN-DRIVEN METABOLIC SHIFTS IN IDH1-MUTANT CHONDROSARCOMA
Andre Spiguel
Favorite
(P 220) THE IMPACT OF WOUND HEALING COMPLICATIONS ON PATIENT-REPORTED OUTCOMES FOLLOWING SOFT TISSUE SARCOMA SURGERY
Andre Spiguel
Favorite
Spinner, William

Adaptimmune
(P 247) SINGLE-CELL RNA SEQUENCING OF AFAMITRESGENE AUTOLEUCEL INDICATES MECHANISMS OF PERSISTENCE AND ANTI-TUMOR ACTIVITY
William Spinner
Favorite
Spruill, Laura

Medical University of South Carolina
(P 279) IMPACT OF PREOPERATIVE 5-DAY HYPOFRACTIONATED RADIOTHERAPY (HFRT) FOR SOFT TISSUE SARCOMA (STS) ON BARRIERS TO TREATMENT AT A HIGH-VOLUME SARCOMA CENTER (HV-SC)
Laura Spruill
Favorite
Sreenath, Dr. Nihanty

Saroj Gupta Cancer Centre and Research Institute
(P 468) CLINICAL UTILITY OF TARGETED NEXT-GENERATION SEQUENCING IN GUIDING SARCOMA DIAGNOSIS AND PERSONALIZED MANAGEMENT: A SINGLE-CENTER STUDY FROM INDIA
Dr. Nihanty Sreenath
Favorite
Sridhar, Sindhura

Vanderbilt University Medical Center
(P 85) MAKING NEGATIVE MARGIN MUSCULOSKELETAL TUMOR SURGERY A VIRTUAL REALITY USING 3D SPECIMEN SCANNING
Sindhura Sridhar
Favorite
Srikanthan, Amirrtha

Department of Medical Oncology, The Ottawa Hospital, Ottawa, ON, Canada
(P 395) ERIBULIN IN RECURRENT PRETREATED METASTATIC SOFT TISSUE SARCOMA. A CANADIAN SARCOMA RESEARCH AND CLINICAL COLLABORATION (CANSARCC) REAL WORLD ANALYSIS
Amirrtha Srikanthan
Favorite
Stacchiotti, Silvia

Fondazione IRCCS Istituto Nazionale dei Tumori
(P 32) EFFECTIVENESS OF LURBINECTEDIN PLUS IRINOTECAN IN PRECLINICAL MODEL OF DESMOPLASTIC SMALL ROUND CELL TUMOR
Silvia Stacchiotti
Favorite
(P 128) ISOCITRATE DEHYDROGENASE 1 (IDH1) MUTATION TESTING IN THE PHASE 3 STUDY OF IVOSIDENIB VS PLACEBO IN IDH1-MUTANT CONVENTIONAL CHONDROSARCOMA (CHONQUER)
Silvia Stacchiotti
Favorite
(P 210) TOWARDS INTERNATIONALIZATION OF THE CLINICAL RESEARCH COORDINATOR ROLE: THE FIRST DROP OF THE NIAGARA FALLS PROJECT
Silvia Stacchiotti
Favorite
(P 231) INCREASED LIFETIME RISK (LTR) OF SOFT TISSUE SARCOMAS (STS) IN PATIENTS WITH LOW-RISK GASTROINTESTINAL STROMAL TUMORS (GIST): A RETROSPECTIVE ANALYSIS FROM THE ITALIAN SARCOMA GROUP (ISG)
Silvia Stacchiotti
Favorite
Stacchiotti, Silvia

Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan
(P 277) THE ROLE OF RADIOTHERAPY IN THE MULTIDISCIPLINARY MANAGEMENT OF RADIATION-ASSOCIATED ANGIOSARCOMA OF THE BREAST: A REFERRAL CENTER EXPERIENCE
Silvia Stacchiotti
Favorite
Stacchiotti, Silvia

Fondazione IRCCS Istituto Nazionale dei Tumori
(P 308) IMPACT OF PSOAS MUSCLE RESECTION ON OUTCOMES IN PRIMARY RETROPERITONEAL DEDIFFERENTIATED LIPOSARCOMA
Silvia Stacchiotti
Favorite
(P 407) PIMICOTINIB IN TENOSYNOVIAL GIANT CELL TUMOR (TGCT): LONG-TERM EFFICACY, SAFETY, AND PATIENT-REPORTED OUTCOMES FROM THE PHASE 3 MANEUVER STUDY
Silvia Stacchiotti
Favorite
(P 416) A PHASE 2 MULTICENTER OPEN-LABEL BASKET STUDY OF TAZEMETOSTAT IN ADULT PATIENTS WITH INI1-NEGATIVE EPITHELIOID SARCOMA – FINAL ANALYSIS
Silvia Stacchiotti
Favorite
(P 422) EFFICACY WITH VIMSELTINIB IN PATIENTS (PTS) WITH TENOSYNOVIAL GIANT CELL TUMOR (TGCT) AND PRIOR COLONY-STIMULATING FACTOR 1 (CSF1) INHIBITOR THERAPY: A PHASE 2 CASE SERIES
Silvia Stacchiotti
Favorite
(P 446) GDF-15 AS A PROGNOSTIC FACTOR IN PATIENTS WITH EPITHELIOID HEMANGIOENDOTHELIOMA
Silvia Stacchiotti
Favorite
(P 447) PAIN ASSESSMENT CRITERIA (PAC) ANTICIPATE RECIST PROGRESSION AND CORRELATE WITH BLOOD LEVELS OF GROWTH DIFFERENTIATION FACTOR 15 (GDF15) IN EPITHELIOID HEMANGIOENDOTHELIOMA (EHE)
Silvia Stacchiotti
Favorite
(P 452) EFFECTIVENESS OF ERIBULIN FOR MYXOID PLEOMORPHIC LIPOSARCOMA: INSIGHTS FROM A PATIENT-DERIVED MODEL AND CLINICAL TRANSLATION IN A PATIENT WITH ADVANCED DISEASE
Silvia Stacchiotti
Favorite
(P 458) BETWEEN LYMPHOMAS AND SARCOMAS: A RETROSPECTIVE, MULTI-INSTITUTIONAL STUDY FROM THE ITALIAN SARCOMA GROUP (ISG) ON HISTIOCYTIC AND DENDRITIC CELL NEOPLASMS (HDCN)
Silvia Stacchiotti
Favorite
(P 464) EFFICACY OUTCOMES AMONG PATIENTS WITH ADVANCED EPITHELIOID SARCOMAS OF PROXIMAL-TYPE AND DISTAL-TYPE TREATED WITH TAZ: POST HOC ANALYSIS OF STUDY EZH-202
Silvia Stacchiotti
Favorite
Stammberger, Antonia

Institute of Immunology, Faculty of Medicine Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany
(P 243) CLINICAL SIGNIFICANCE OF TUMOR-INFILTRATING IMMUNE CELL SUBSETS IN THE RETROPERITONEAL DEDIFFERENTIATED LIPOSARCOMAS AND LEIOMYOSARCOMAS
Antonia Stammberger
Favorite
Stearns, Timothy

PIVOT Coordinating Center
(P 267) THE RAF/MEK INHIBITOR VS-6766 SHOWS EFFICACY IN RAS-MUTANT PEDIATRIC PRECLINICAL XENOGRAFT MODELS- A REPORT FROM THE PEDIATRIC PRECLINICAL IN VIVO TESTING CONSORTIUM
Timothy Stearns
Favorite
Steeghs, Neeltje

Department of Medical Oncology, Netherlands Cancer Institute and Department of Medical Oncology, University Medical Center Utrecht
(P 41) THE IMPACT OF PAZOPANIB AND EXTREMITY RADIOTHERAPY ON TRANSAMINASES
Neeltje Steeghs
Favorite
(P 194) UPDATED RESULTS FROM STRATEGIST 1: A PHASE 1/1B STUDY OF IDRX-42 (GSK6042981A) IN PATIENTS (PTS) WITH ADVANCED GASTROINTESTINAL STROMAL TUMORS (GIST)
Neeltje Steeghs
Favorite
Steegmaier, Martin

Sotio Biotech a.s.
(P 257) TARGETING LEUCINE-RICH REPEAT-CONTAINING PROTEIN 15 (LRRC15): SOT106 ANTIBODY-DRUG CONJUGATE FOR SOFT TISSUE SARCOMA AND OSTEOSARCOMA TREATMENT
Martin Steegmaier
Favorite
Steffner, Robert

Stanford University
(P 400) LONGITUDINAL EPIGENETIC AND TRANSCRIPTOMIC REMODELING ACROSS PRIMARY, IRRADIATED, AND LOCALLY RELAPSED SOFT TISSUE SARCOMAS
Robert Steffner
Favorite
Steinberg, Jeffrey

St. Jude Children's Research Hospital
(P 241) MACROPHAGE INHIBITION ENHANCES PERIPHERAL CAR T CELL EXPANSION AND TUMOR CONTROL IN A PATIENT-DERIVED HUMANIZED MODEL OF AUTOLOGOUS CAR T CELL EFFICACY IN PEDIATRIC OSTEOSARCOMA (OS)
Jeffrey Steinberg
Favorite
Stein, Jacob

UNC
(P 350) THE PATTERN.ORG SARCOMA CONSORTIUM: BUILDING A MULTI-INSTITUTIONAL DATA RESOURCE FOR THE SARCOMA RESEARCH COMMUNITY
Jacob Stein
Favorite
Stenehjem, David

Department of Pharmacy Practice and Pharmaceutical Sciences, College of Pharmacy, University of Minnesota
(P 357) DEVELOPMENT OF AN ALGORITHM TO IDENTIFY PATIENTS (PT) WITH DESMOID TUMORS (DT) IN A UNITED STATES (US) CLAIMS DATASET
David Stenehjem
Favorite
Sterba, Katherine

Medical University of South Carolina
(P 279) IMPACT OF PREOPERATIVE 5-DAY HYPOFRACTIONATED RADIOTHERAPY (HFRT) FOR SOFT TISSUE SARCOMA (STS) ON BARRIERS TO TREATMENT AT A HIGH-VOLUME SARCOMA CENTER (HV-SC)
Katherine Sterba
Favorite
Stern, Sydney

TGCT Support/ Life Raft Group
(P 226) REAL-WORLD MANAGEMENT OF SYMPTOMATIC VS ASYMPTOMATIC TGCT FROM AN OBSERVATIONAL REGISTRY
Sydney Stern
Favorite
Steuerwald, Nury

Atrium Health Levine Cancer Institute
(P 02) METHYLATION PROFILING AS A DIAGNOSTIC ADJUNCT FOR UNDIFFERENTIATED SARCOMAS: A REAL-WORLD EVALUATION
Nury Steuerwald
Favorite
Stevenson, Jonathan

The Royal Orthopaedic Hospital NHS Foundation Trust
(P 136) ESTROGEN HAS A PROTECTIVE EFFECT ON CHONDROSARCOMA GROWTH IN VITRO AND IN VIVO
Jonathan Stevenson
Favorite
Stewart, Elizabeth

St. Jude Children's Research Hospital
(P 08) BUILDING A MEDICAL DONATION NETWORK TO ENHANCE DEVELOPMENT OF PEDIATRIC TUMOR MODELS
Elizabeth Stewart
Favorite
(P 267) THE RAF/MEK INHIBITOR VS-6766 SHOWS EFFICACY IN RAS-MUTANT PEDIATRIC PRECLINICAL XENOGRAFT MODELS- A REPORT FROM THE PEDIATRIC PRECLINICAL IN VIVO TESTING CONSORTIUM
Elizabeth Stewart
Favorite
Stockfisch, Emily

MSKCC
(P 256) THE SEAN KARL COHORT: A NATIONAL COLLABORATIVE SINGLE-CELL RNASEQ STUDY OF PAIRED PATIENT EWING SARCOMA SPECIMENS
Emily Stockfisch
Favorite
Stokes, Matthew

Cell Signaling Technology
(P 198) EXPLOITING METABOLIC DYSREGULATION IN SUCCINATE DEHYDROGENASE-DEFICIENT GASTROINTESTINAL STROMAL TUMOR
Matthew Stokes
Favorite
Stosky, Jordan

Arnie Charbonneau Cancer Institute and McCaig Institute for Bone and Joint Health
(P 378) HIGH DOSE RADIATION THERAPY PROMOTES IMMUNE SUPPRESSIVE MACROPHAGE PHENOTYPES, WHEREAS LOW DOSE RADIATION THERAPY PROMOTES IMMUNOGENIC MACROPHAGE PHENOTYPES IN A MURINE MODEL OF SOFT TISSUE SARCOMA
Jordan Stosky
Favorite
Strübing, Felix

Department of Hand, Plastic and Reconstructive Surgery, Microsurgery, Burn Trauma Center, BG Trauma Center Ludwigshafen, University of Heidelberg, Ludwigshafen, 67071 Germany.
(P 454) TREATMENT PATTERNS AND OUTCOMES IN RADIATION-INDUCED SARCOMA: FIRST RESULTS OF THE TETRIS-PROJECT - A MULTIMODAL RETROSPECTIVE ANALYSIS FROM A TERTIARY CENTER
Felix Strübing
Favorite
Strauss, Dirk

The Royal Marsden Hospital NHS Foundation Trust
(P 298) RESECTION OF PARA-RENAL INFERIOR VENA CAVA LEIOMYOSARCOMA WITH RIGHT NEPHRECTOMY AND LEFT RENAL VEIN LIGATION WITHOUT VENOUS RECONSTRUCTION.
Dirk Strauss
Favorite
(P 414) PATTERNS OF RELAPSE OF BORDERLINE AND MALIGNANT PHYLLODES TUMOUR- RESULTS FROM SARCOMA REFERENCE CENTRE (SRC)
Dirk Strauss
Favorite
Strauss, Morgen

Providence Cancer Institute
(P 58) PLK1 AS A VULNERABLE TARGET OF BAP1-DRIVEN UNDIFFERENTIATED PLEOMORPHIC SARCOMAS
Morgen Strauss
Favorite
Strauss, Sandra

UCL Cancer Institute, London, UK
(P 156) CHONDROSARCOMA INCIDENCE, SURVIVAL AND MANAGEMENT IN ENGLAND 2013-2022; AN ANALYSIS FROM THE NATIONAL DISEASE REGISTRATION SERVICE
Sandra Strauss
Favorite
Streller, Tino

Radiation Oncology LUKS
(P 282) LOCAL FAILURE ANALYSIS OF SOFT TISSUE SARCOMA TREATED WITH PREOPERATIVE ULTRA-HYPOFRACTIONATED RADIATION: UPDATE
Tino Streller
Favorite
(P 283) PALLIATIVE LATTICE RADIATION THERAPY IN SOFT TISSUE SARCOMA VERSUS CARCINOMA AND MELANOMA: OUTCOME COMPARISON
Tino Streller
Favorite
Strike, Sarah

Moffitt Cancer Center
(P 307) STRATEGIES FOR DATA QUALITY IN TARPSWG RETROPERITONEAL SARCOMA REGISTRY (RESAR)
Sarah Strike
Favorite
(P 394) DUAL OR TRIMODALITY THERAPY VERSUS SURGERY ALONE IN RADIATION-ASSOCIATED ANGIOSARCOMA OF THE BREAST
Sarah Strike
Favorite
(P 453) OUTCOMES OF PLEOMORPHIC LIPOSARCOMA PATIENTS FOLLOWING MULTI-DISCIPLINARY MANAGEMENT WITHIN A TERTIARY CANCER CENTER
Sarah Strike
Favorite
Strohmeyer, Ava

Duke University
(P 125) TARGETING LCP1-MEDIATED METASTASIS IN CHONDROSARCOMA WITH OROXYLIN A
Ava Strohmeyer
Favorite
(P 130) INVESTIGATING LCP1-MEDIATED ONCOGENIC SIGNALING IN CHONDROSARCOMA METASTASIS
Ava Strohmeyer
Favorite
Strong, Laura

Parabilis Medicines
(P 415) A PHASE 1/2 TRIAL OF FOG-001, A FIRST-IN-CLASS DIRECT β-CATENIN:TCF4 INHIBITOR: SAFETY AND PRELIMINARY ANTITUMOR ACTIVITY IN PATIENTS WITH DESMOID TUMORS (DT)
Laura Strong
Favorite
Studenski, Matthew

University of Miami, Department of Radiation Oncology
(P 289) SIX YEAR FOLLOW-UP ON CIVASHEET® USE FOR SOFT TISSUE SARCOMA: A SINGLE INSTITUTION EXPERIENCE
Matthew Studenski
Favorite
Studer, Gabriela

Luzerner Kantonsspital, Klinik für Radio-Onkologie
(P 215) SHAPEHUB: A MULTICENTRE REAL-WORLD-TIME DATA PLATFORM WITH DIGITAL TWIN ENGINE FOR A LEARNING HEALTH SYSTEM IN SARCOMA
Gabriela Studer
Favorite
(P 282) LOCAL FAILURE ANALYSIS OF SOFT TISSUE SARCOMA TREATED WITH PREOPERATIVE ULTRA-HYPOFRACTIONATED RADIATION: UPDATE
Gabriela Studer
Favorite
(P 283) PALLIATIVE LATTICE RADIATION THERAPY IN SOFT TISSUE SARCOMA VERSUS CARCINOMA AND MELANOMA: OUTCOME COMPARISON
Gabriela Studer
Favorite
(P 285) MULTICENTER STUDY OF SPATIALLY FRACTIONATED RADIOTHERAPY (LATTICE) FOR LARGE-VOLUME RADIORESISTANT SARCOMAS
Gabriela Studer
Favorite
Stutz, Emanuel

Inselspital, Bern University Hospital, University of Bern, Bern
(P 436) SAKK 57/24 FEASIBILITY OF TOTAL NEOADJUVANT TREATMENT WITH HYPERTHERMIA IN PATIENTS WITH HIGH-RISK EXTREMITY AND TRUNK SOFT TISSUE SARCOMA. A MULTICENTER, SINGLE ARM, OPEN LABEL, PHASE II TRIAL
Emanuel Stutz
Favorite
Styves, Hugo

Division of Hematology, Oncology and Cellular Therapy, Department of Medicine, Hôpital Maisonneuve-Rosemont, Université de Montréal, Montreal, Quebec, Canada.
(P 395) ERIBULIN IN RECURRENT PRETREATED METASTATIC SOFT TISSUE SARCOMA. A CANADIAN SARCOMA RESEARCH AND CLINICAL COLLABORATION (CANSARCC) REAL WORLD ANALYSIS
Hugo Styves
Favorite
Subhawong, Ty

University of Miami
(P 147) CONVENTIONAL AND DEDIFFERENTIATED CHONDROSARCOMA; IS ENCHONDROMA THE PRECURSOR LESION?
Ty Subhawong
Favorite
(P 289) SIX YEAR FOLLOW-UP ON CIVASHEET® USE FOR SOFT TISSUE SARCOMA: A SINGLE INSTITUTION EXPERIENCE
Ty Subhawong
Favorite
(P 397) EXPLORING REAL WORLD DATA OF RECURRENCE IN NON-METASTATIC MYXOFIBROSAROMA: AN UPDATED RETROSPECTIVE COHORT STUDY
Ty Subhawong
Favorite
subing, guo

Department of Anesthesiology，Peking University Medical Rehabilitation Hospital
(P 469) THE IMPACT OF PREOPERATIVE ANEMIA ON POSTOPERATIVE COMPLICATIONS AND SHORT-TERM PROGNOSIS IN RETROPERITONEAL TUMOR SURGERY PATIENTS.
guo subing
Favorite
Subramaniam, Vignesh

University of Florida
(P 248) AN EX VIVO ASSAY TO PREDICT IMMUNOTHERAPY RESPONSE IN SARCOMA
Vignesh Subramaniam
Favorite
Subramanian, Ajay

Stanford University
(P 400) LONGITUDINAL EPIGENETIC AND TRANSCRIPTOMIC REMODELING ACROSS PRIMARY, IRRADIATED, AND LOCALLY RELAPSED SOFT TISSUE SARCOMAS
Ajay Subramanian
Favorite
Sudo, Kazuki

Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan
(P 341) PROGNOSTIC RELEVANCE OF CYCLOPHOSPHAMIDE DOSE FOR HIGH-RISK RHABDOMYOSARCOMA IN ADULT PATIENTS TREATED WITH VAC THERAPY
Kazuki Sudo
Favorite
Suh, Yang-Gun

National Cancer Center
(P 296) PULMONARY CEMENT EMBOLISM ASSOCIATED WITH PERCUTANEOUS CEMENTOPLASTY FOR BONE METASTASIS: MECHANISMS AND PROTECTIVE FACTORS
Yang-Gun Suh
Favorite
Sulem, Eva

Gustave roussy
(P 299) RECURRENCES AFTER PRIMARY RPS SURGERY IN A HIGH-VOLUME SARCOMA CENTER: A RETROSPECTIVE ANALYSIS ON 402 PATIENTS
Eva Sulem
Favorite
Sullivan, Ciara

Massachusetts General Hospital
(P 173) DEVELOPMENT AND EXTERNAL VALIDATION OF A MACHINE LEARNING ALGORITHM TO PREDICT OVERALL SURVIVAL IN PATIENTS WITH PELVIC OR APPENDICULAR LIPOSARCOMA
Ciara Sullivan
Favorite
Sullivan, Francis

Cogent Biosciences
(P 425) BEZUCLASTINIB EXPANDED ACCESS PROGRAM (EAP) FOR PATIENTS WITH GASTROINTESTINAL STROMAL TUMORS (GIST)
Francis Sullivan
Favorite
Sullivan, Mikaela

Mayo Clinic
(P 150) LOCAL RECURRENCE OF CHONDROSARCOMA: IMPACT ON SURVIVAL AND RECURRENCE AT AN INCREASED GRADE
Mikaela Sullivan
Favorite
Sullivan, Mikaela

Mayo Clinic, Rochester
(P 162) CHONDROSARCOMA OUTCOMES IN YOUNG VERSUS ADULT POPULATIONS
Mikaela Sullivan
Favorite
Sullivan, Molly

NCI/NIH
(P 181) THE DEVELOPMENT OF A NOVEL PDGFRA RESISTANCE MUTATION IN A RECURRENT KIT-MUTANT GASTROINTESTINAL STROMAL TUMOR (GIST)
Molly Sullivan
Favorite
Sundaram, Ranjini

Yale School of Medicine
(P 40) PRECLINICAL EFFICACY OF A PH-SENSITIVE EXATECAN PEPTIDE-DRUG-CONJUGATE IN RHABDOMYOSARCOMA
Ranjini Sundaram
Favorite
Sun, Ramon C.

University of Florida
(P 129) HIJACKED FUEL: GLYCOGEN-DRIVEN METABOLIC SHIFTS IN IDH1-MUTANT CHONDROSARCOMA
Ramon C. Sun
Favorite
Sun, Steven

Sutter West Bay Medical Group
(P 309) RETROPERITONEAL LIPOMAS: MULTICENTER CLINICAL EXPERIENCE WITH AN EXTREMELY RARE DISEASE ENTITY
Steven Sun
Favorite
Sun, Wei

Department of Orthopaedics, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
(P 07) A LIVING MULTI-OMICS BIOBANK OF PATIENT-DERIVED XENOGRAFT MODELS FOR SARCOMA
Wei Sun
Favorite
Sun, Yutong

The University of Texas MD Anderson Cancer Center
(P 391) ATRX LOSS BLOCKS THE DIFFERENTIATION OF MESENCHYMAL STEM CELLS AND ADVANCES UNDIFFERENTIATED SARCOMA DEVELOPMENT
Yutong Sun
Favorite
Sun, Zhaoyu

Providence Cancer Institute
(P 58) PLK1 AS A VULNERABLE TARGET OF BAP1-DRIVEN UNDIFFERENTIATED PLEOMORPHIC SARCOMAS
Zhaoyu Sun
Favorite
Suraweera, Harini

Princess Margaret Cancer Centre, University Health Network and Mount Sinai Hospital
(P 210) TOWARDS INTERNATIONALIZATION OF THE CLINICAL RESEARCH COORDINATOR ROLE: THE FIRST DROP OF THE NIAGARA FALLS PROJECT
Harini Suraweera
Favorite
Sureshkumar, Keerthana

University of Miami Miller School of Medicine
(P 369) CLINICAL CHARACTERISTICS & TREATMENT OUTCOME PATTERNS OF SOLITARY FIBROUS TUMORS: A SINGLE-INSTITUTION RETROSPECTIVE ANALYSIS
Keerthana Sureshkumar
Favorite
Surrey, Lea

CHOP
(P 256) THE SEAN KARL COHORT: A NATIONAL COLLABORATIVE SINGLE-CELL RNASEQ STUDY OF PAIRED PATIENT EWING SARCOMA SPECIMENS
Lea Surrey
Favorite
Susic, Nikola

University of Miami Miller School of Medicine
(P 98) PERCUTANEOUS STABILIZATION OF METASTATIC BONE LESIONS WITH A PHOTODYNAMIC INTRAMEDULLARY SYSTEM: EXPERIENCE FROM A 15-PATIENT CASE SERIES
Nikola Susic
Favorite
(P 99) LIMB SALVAGE FOR PROXIMAL TIBIA TUMORS: OUTCOMES OF ALLOGRAFT-PROSTHESIS COMPOSITE AND ENDOPROSTHETIC RECONSTRUCTION
Nikola Susic
Favorite
(P 224) PAN-SARCOMA DATABASE (PSDB): AN UPDATE ON MIAMI'S COLLABORATIVE MULTI-USER DATA PIPELINE OF SARCOMA DATA USING REDCAP AND R CODING
Nikola Susic
Favorite
Suto, Hirotaka

Hyogo Cancer Center
(P 192) OPTIMAL DOSING SCHEDULE OF SUNITINIB BASED ON PLATELET COUNT IN AN OLDER PATIENT WITH GASTROINTESTINAL STROMAL TUMOR
Hirotaka Suto
Favorite
Sutton, Jeffrey

Division of Oncologic and Endocrine Surgery, Department of Surgery, Medical University of South Carolina
(P 279) IMPACT OF PREOPERATIVE 5-DAY HYPOFRACTIONATED RADIOTHERAPY (HFRT) FOR SOFT TISSUE SARCOMA (STS) ON BARRIERS TO TREATMENT AT A HIGH-VOLUME SARCOMA CENTER (HV-SC)
Jeffrey Sutton
Favorite
Suwan, Keittisak

Imperial College London
(P 116) A DUAL-TARGETED SYSTEMIC THERAPEUTIC APPROACH FOR THE SELECTIVE ELIMINATION OF TUMOR CELLS IN PRIMARY AND METASTATIC SARCOMA.
Keittisak Suwan
Favorite
Svane, Inge Marie

National Center for Cancer Immune Therapy, Department of Oncology, Herlev University Hospital
(P 249) IN VITRO EXPANSION OF TUMOR-INFILTRATING GAMMA-DELTA T-CELLS FROM PATIENTS WITH SOFT TISSUE SARCOMAS
Inge Marie Svane
Favorite
Swallow, Carol

Princess Margaret Cancer Centre, University Health Network and Mount Sinai Hospital
(P 210) TOWARDS INTERNATIONALIZATION OF THE CLINICAL RESEARCH COORDINATOR ROLE: THE FIRST DROP OF THE NIAGARA FALLS PROJECT
Carol Swallow
Favorite
(P 307) STRATEGIES FOR DATA QUALITY IN TARPSWG RETROPERITONEAL SARCOMA REGISTRY (RESAR)
Carol Swallow
Favorite
Swayambunathan, Jay

Duke University School of Medicine
(P 138) A MULTI-INSTITUTIONAL ARCHIVE AND DEEP LEARNING PIPELINE FOR QUANTIFYING CHONDROSARCOMA COMPOSITION
Jay Swayambunathan
Favorite
(P 177) DEEP LEARNING AND DIMENSIONALITY REDUCTION FOR SARCOMA SUBTYPING
Jay Swayambunathan
Favorite
Sweeney, Jackson

Stanley Manne Children's Research Institute
(P 252) NUCLEAR AND GENOMIC ORGANIZATION OF CHEMOTHERAPY RESISTANT RHABDOMYOSARCOMA CELLS
Jackson Sweeney
Favorite
Sweeney, Kyle

University of Kansas School of Medicine
(P 359) EVALUATION OF PREOPERATIVE MYXOFIBROSARCOMA GROWTH AND SURGICAL MORBIDITY AFTER NEOADJUVANT RADIATION USING SEMI-AUTOMATED VOLUMETRIC ANALYSIS
Kyle Sweeney
Favorite
(P 366) WOUND COMPLICATIONS AFTER ULTRA-HYPOFRACTIONATED NEOADJUVANT RADIATION FOR SOFT TISSUE SARCOMA: WHAT IS OPTIMAL SURGICAL TIMING?
Kyle Sweeney
Favorite
(P 382) METHOD FOR VOLUMETRIC ASSESMENT OF TUMOR RESPONSE FOLLOWING NEOADJUVANT RADIATION IN PRIMARY MYXOFIBROSARCOMA
Kyle Sweeney
Favorite
Sweet-Cordero, Alejandro

UCSF
(P 08) BUILDING A MEDICAL DONATION NETWORK TO ENHANCE DEVELOPMENT OF PEDIATRIC TUMOR MODELS
Alejandro Sweet-Cordero
Favorite
Swilling, Aubrey

University of Kansas Medical Center
(P 366) WOUND COMPLICATIONS AFTER ULTRA-HYPOFRACTIONATED NEOADJUVANT RADIATION FOR SOFT TISSUE SARCOMA: WHAT IS OPTIMAL SURGICAL TIMING?
Aubrey Swilling
Favorite
Switaj, Tomasz

Maria Sklodowska-Curie National Research Institute of Oncology
(P 470) OFF-LABEL TREATMENT AND ULTRARARE SARCOMAS - SINGLE INSTITUTION REPORT
Tomasz Switaj
Favorite
Syed, Sarosh

Sarcoma Oncology Center
(P 233) DNG64-CAR-V+ REGIMEN SHOWS CLINICAL BENEFIT IN PATIENTS WITH ADVANCED CCNG1 ONCOGENE EXPRESSING SARCOMAS (NCT04091295)
Sarosh Syed
Favorite
(P 388) TRIAL IN PROGRESS: A PHASE 2 STUDY OF METRONOMIC TRABECTEDIN, GEMCITIBAINE, AND DACARBAZINE IN PREVIOUSLY TREATED ADVANCED SOFT TISSUE SARCOMA (NCT04535271)
Sarosh Syed
Favorite
(P 396) EVALUATING THE SAFETY AND EFFICACY OF METRONOMIC GEMCITABINE, DOXORUBICIN, AND DOCETAXEL PLUS NIVOLUMAB IN PREVIOUSLY TREATED ADVANCED LEIOMYOSARCOMA AND LIPOSARCOMA: A PHASE 2 STUDY (NCT04535713)
Sarosh Syed
Favorite
(P 398) INVESTIGATING THE SAFETY AND EFFICACY OF LURBINECTEDIN WITH IPILIMUMAB AND NIVOLUMAB FOR ADVANCED SOFT TISSUE SARCOMA: LINNOVATE PHASE 1/2 STUDY (NCT05876715)
Sarosh Syed
Favorite
Symss, Nathan

University Health Network
(P 57) STUDYING HYPOXIA-INDUCED METASTASIS IN GENETICALLY ENGINEERED MOUSE MODELS OF UPS
Nathan Symss
Favorite
Szanto, Attila

Ipsen, Cambridge, MA, USA
(P 416) A PHASE 2 MULTICENTER OPEN-LABEL BASKET STUDY OF TAZEMETOSTAT IN ADULT PATIENTS WITH INI1-NEGATIVE EPITHELIOID SARCOMA – FINAL ANALYSIS
Attila Szanto
Favorite
Szepessy, Ava

Children's Hospital of Philadelphia
(P 262) EVALUATING FRONT-LINE THERAPY ACCORDANCE WITH CURRENT SYNOVIAL SARCOMA GUIDELINES
Ava Szepessy
Favorite
(P 263) DESCRIBING THE CHARACTERISTICS AND TREATMENT OF SYNOVIAL SARCOMA IN THE RECURRENT SETTING
Ava Szepessy
Favorite
Szostakowski, Bartłomiej

Maria Sklodowska-Curie National Research Institute of Oncology; Warsaw Poland
(P 123) OFF-LABEL DENOSUMAB IN LOCALLY AGGRESSIVE BENIGN BONE TUMORS OTHER THAN GIANT CELL TUMOR OF BONE.
Bartłomiej Szostakowski
Favorite
(P 216) VIRTUAL MULTIDISCIPLINARY MEETINGS IN THE CARE OF SARCOMA PATIENTS
Bartłomiej Szostakowski
Favorite
Szostakowski, Bartlomiej

Maria Sklodowska-Curie National Research Institute of Oncology
(P 149) SURGICAL TEXTBOOK OUTCOMES IN PATIENTS DIAGNOSED WITH CHONDROSARCOMA
Bartlomiej Szostakowski
Favorite
(P 164) LONG TERM OUTCOMES IN PATIENTS DIAGNOSED WITH SECONDARY CHONDROSARCOMA
Bartlomiej Szostakowski
Favorite
Szumera-Cieckiewicz, Anna

Maria Sklodowska-Curie National Research Institute of Oncology
(P 27) MOLECULAR CHARACTERIZATION OF RESPONSE TO NEOADJUVANT CHEMORADIATION IN PATIENTS WITH LOCALLY ADVANCED SOFT TISSUE SARCOMAS
Anna Szumera-Cieckiewicz
Favorite
(P 139) IMMUNOGENOMIC PROFILING OF CHONDROSARCOMA REVEALS DISTINCT IMMUNE PHENOTYPES AND PROGNOSTIC MUTATIONS
Anna Szumera-Cieckiewicz
Favorite
T
Tabatabai, Ghazaleh

Department for Neurology & Neuro-Oncology, University Hospital Tübingen and Hertie Institute for Clinical Brain Research, Center for Neuro-Oncology, Comprehensive Cancer Center, Eberhard Karls University Tübingen
(P 419) PROSPECTIVE REAL-WORLD STUDY OF LAROTRECTINIB (LARO) IN PATIENTS (PTS) WITH TRK FUSION SOLID TUMORS: INTERIM ANALYSIS OF ON-TRK
Ghazaleh Tabatabai
Favorite
Taebi, Arshia

Department of Surgery, University Medical Center Mannheim, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany
(P 165) EVALUATING LARGE LANGUAGE MODELS AS DECISION SUPPORT TOOLS IN MULTIDISCIPLINARY TUMOR BOARDS FOR GASTROINTESTINAL STROMAL TUMORS
Arshia Taebi
Favorite
Takahashi, Mitsuru

Shizuoka Cancer Center
(P 291) INTRA-ARTERIAL CHEMOTHERAPY WITH CONCOMITANT RADIATION THERAPY FOR UNRESECTABLE SARCOMA
Mitsuru Takahashi
Favorite
Takemori, Toshiyuki

National Cancer Center Hospital
(P 159) CHONDROSARCOMA IN JAPAN: A POPULATION-BASED ANALYSIS USING NATIONAL CANCER REGISTRY
Toshiyuki Takemori
Favorite
Takenaka, Satoshi

Osaka International Cancer Institute
(P 128) ISOCITRATE DEHYDROGENASE 1 (IDH1) MUTATION TESTING IN THE PHASE 3 STUDY OF IVOSIDENIB VS PLACEBO IN IDH1-MUTANT CONVENTIONAL CHONDROSARCOMA (CHONQUER)
Satoshi Takenaka
Favorite
Tala, Ilona

Servier
(P 128) ISOCITRATE DEHYDROGENASE 1 (IDH1) MUTATION TESTING IN THE PHASE 3 STUDY OF IVOSIDENIB VS PLACEBO IN IDH1-MUTANT CONVENTIONAL CHONDROSARCOMA (CHONQUER)
Ilona Tala
Favorite
Talbot, Lindsay

St. Jude Children's Research Hospital
(P 241) MACROPHAGE INHIBITION ENHANCES PERIPHERAL CAR T CELL EXPANSION AND TUMOR CONTROL IN A PATIENT-DERIVED HUMANIZED MODEL OF AUTOLOGOUS CAR T CELL EFFICACY IN PEDIATRIC OSTEOSARCOMA (OS)
Lindsay Talbot
Favorite
Tamamyan, Gevorg

Yerevan State Medical University
(P 158) GLOBAL INEQUITIES IN CHONDROSARCOMA CLINICAL TRIALS: A COMPREHENSIVE ANALYSIS ACROSS THREE DECADES
Gevorg Tamamyan
Favorite
Tanaka, Kazuhiro

Oita University
(P 128) ISOCITRATE DEHYDROGENASE 1 (IDH1) MUTATION TESTING IN THE PHASE 3 STUDY OF IVOSIDENIB VS PLACEBO IN IDH1-MUTANT CONVENTIONAL CHONDROSARCOMA (CHONQUER)
Kazuhiro Tanaka
Favorite
Tanaka, Yutaro

Dana-Farber Cancer Institute
(P 256) THE SEAN KARL COHORT: A NATIONAL COLLABORATIVE SINGLE-CELL RNASEQ STUDY OF PAIRED PATIENT EWING SARCOMA SPECIMENS
Yutaro Tanaka
Favorite
Tan, Chia Jie

Department of Pharmacotherapy, College of Pharmacy, University of Utah
(P 357) DEVELOPMENT OF AN ALGORITHM TO IDENTIFY PATIENTS (PT) WITH DESMOID TUMORS (DT) IN A UNITED STATES (US) CLAIMS DATASET
Chia Jie Tan
Favorite
Tang, Chih-Min

Dept. of Surgery, Moores Cancer Center, University of California San Diego
(P 197) DIFFERENTIAL EFFECTS OF ANAGRELIDE IN GASTROINTESTINAL STROMAL TUMORS (GIST) IN VITRO
Chih-Min Tang
Favorite
TANG, XIAO DONG

Peking University People's Hospital
(P 74) TERTIARY LYMPHOID STRUCTURES PREDICT PROGNOSIS AND IMMUNE LANDSCAPE IN OSTEOSARCOMA: A MACHINE LEARNING-BASED TRANSCRIPTOMIC STUDY
XIAO DONG TANG
Favorite
Tang, Xiaodong

Musculoskeletal Tumor Centre, Peking University People's Hospital
(P 75) CD248 AS A PROGNOSTIC MARKER IN OSTEOSARCOMA
Xiaodong Tang
Favorite
Tan, Li

University of Michigan
(P 24) THE SIRTUIN SIRT5 SUPPORTS EWING SARCOMA SURVIVAL VIA REGULATION OF EWS-FLI1 STABILITY AND ACTIVITY
Li Tan
Favorite
Tan, Lisa

UCSF Helen Diller Family Comprehensive Cancer Center
(P 439) AN OPEN LABEL MULTICENTER PHASE 2 STUDY WITH SAFETY LEAD IN OF INTRATUMORAL VUSOLIMOGENE ODERPAREPVEC IN COMBINATION WITH PEMBROLIZUMAB IN PATIENTS WITH ANGIOSARCOMA
Lisa Tan
Favorite
Tan, Marcus

Vanderbilt University Medical Center
(P 310) ATYPICAL SPINDLE CELL PLEOMORPHIC LIPOMATOUS TUMORS OF THE RETROPERITONEUM ARE HETEROGENOUS: A REPORT OF FOUR DISPARATE CASES
Marcus Tan
Favorite
Tanwar, Puneet

All India Institute of Medical Sciences, New Delhi
(P 276) RADIATION-INDUCED SARCOMA (RIS): CLINICAL SPECTRUM AND ONCOLOGIC OUTCOMES FROM A TERTIARY INDIAN SARCOMA CLINIC
Puneet Tanwar
Favorite
Tao, Wensi

University of Miami
(P 148) CHARACTERISTICS AND OUTCOMES OF CHONDROSARCOMA PATIENTS TREATED WITH PROTON THERAPY: A SYSTEMATIC REVIEW OF PUBLISHED SERIES
Wensi Tao
Favorite
Tap, William

Memorial Sloan Kettering Cancer Center
(P 128) ISOCITRATE DEHYDROGENASE 1 (IDH1) MUTATION TESTING IN THE PHASE 3 STUDY OF IVOSIDENIB VS PLACEBO IN IDH1-MUTANT CONVENTIONAL CHONDROSARCOMA (CHONQUER)
William Tap
Favorite
(P 186) BRAF V600E-MUTATED GASTROINTESTINAL STROMAL TUMORS: A CASE SERIES AND ANALYSIS OF IMMUNE TUMOR INFILTRATE
William Tap
Favorite
(P 187) THERAPEUTIC OUTCOMES IN NF1-ALTERED GIST TREATED WITH MEK INHIBITION: A SINGLE-CENTER EXPERIENCE
William Tap
Favorite
(P 409) RETROSPECTIVE ANALYSIS OF PROGNOSTIC FACTORS INCLUDING HLA GENOTYPE IN MYXOID LIPOSARCOMA
William Tap
Favorite
(P 421) CHARACTERIZING THE IMMUNE RESPONSE TO INTRATUMORAL TIGILANOL TIGLATE (TT) IN PATIENTS WITH ADVANCED AND/OR METASTATIC SOFT TISSUE SARCOMA (STS) IN A PHASE IIA TRIAL (NCT05755113)
William Tap
Favorite
(P 422) EFFICACY WITH VIMSELTINIB IN PATIENTS (PTS) WITH TENOSYNOVIAL GIANT CELL TUMOR (TGCT) AND PRIOR COLONY-STIMULATING FACTOR 1 (CSF1) INHIBITOR THERAPY: A PHASE 2 CASE SERIES
William Tap
Favorite
(P 430) A PH/2 STUDY OF THE RADIOPHARMACEUTICAL [AC-225]RTX-2358 IN THE TREATMENT OF RELAPSED / REFRACTORY (R/R) SOFT TISSUE SARCOMA (STS) THE ATLAS STUDY - ACTINIUM THERAPY FOR LATE-STAGE AGGRESSIVE SARCOMAS
William Tap
Favorite
(P 467) TREATMENT OUTCOMES IN AGGRESSIVE ANGIOMYXOMA: A SINGLE INSTITUTION EXPERIENCE
William Tap
Favorite
Taqi, Kadhim

Arthur Child Cancer Center
(P 293) CRYOABLATION FOR EXTRA-ABDOMINAL DESMOID TUMORS: A RETROSPECTIVE STUDY OF RADIOLOGIC AND CLINICAL OUTCOMES
Kadhim Taqi
Favorite
Taroni, Jaclyn

Alex's CC Data Lab
(P 256) THE SEAN KARL COHORT: A NATIONAL COLLABORATIVE SINGLE-CELL RNASEQ STUDY OF PAIRED PATIENT EWING SARCOMA SPECIMENS
Jaclyn Taroni
Favorite
Taslim, Cenny

Nationwide Children's Hospital
(P 23) DEFINING THE NONENZYMATIC FUNCTIONS OF LSD1 IN EWING SARCOMA
Cenny Taslim
Favorite
Taswell, Crystal

University of Miami, Department of Radiation Oncology
(P 289) SIX YEAR FOLLOW-UP ON CIVASHEET® USE FOR SOFT TISSUE SARCOMA: A SINGLE INSTITUTION EXPERIENCE
Crystal Taswell
Favorite
Tattersall, Luke

The University of Sheffield
(P 136) ESTROGEN HAS A PROTECTIVE EFFECT ON CHONDROSARCOMA GROWTH IN VITRO AND IN VIVO
Luke Tattersall
Favorite
Taverna, Silvia

Fondazione IRCCS Istituto Nazionale dei Tumori di Milano
(P 447) PAIN ASSESSMENT CRITERIA (PAC) ANTICIPATE RECIST PROGRESSION AND CORRELATE WITH BLOOD LEVELS OF GROWTH DIFFERENTIATION FACTOR 15 (GDF15) IN EPITHELIOID HEMANGIOENDOTHELIOMA (EHE)
Silvia Taverna
Favorite
Tawbi, Hussein

M.D. Anderson Cancer Center, Houston
(P 38) VALIDATION OF THE SIGNIOS SEVEN-GENE SIGNATURE FOR PREDICTING ANTI-PD-1 INHIBITOR EFFICACY IN SARCOMA
Hussein Tawbi
Favorite
Taylor-Black, Quinn

Massachusetts General Hospital
(P 173) DEVELOPMENT AND EXTERNAL VALIDATION OF A MACHINE LEARNING ALGORITHM TO PREDICT OVERALL SURVIVAL IN PATIENTS WITH PELVIC OR APPENDICULAR LIPOSARCOMA
Quinn Taylor-Black
Favorite
Tay, Timothy Kwang Yong

Singapore General Hospital
(P 53) ESTABLISHMENT AND CHARACTERISATION OF LIPOSARCOMA-DERIVED CELLS AS RELEVANT PRE-CLINICAL MODELS FOR TARGET DISCOVERY
Timothy Kwang Yong Tay
Favorite
Tecson, Kristen

Evidence Generation, Daiichi Sankyo, Inc., Basking Ridge, NJ, USA
(P 336) PEXIDARTINIB RISK EVALUATION AND MITIGATION STRATEGY PROGRAM: 5-YEAR RETROSPECTIVE HEPATIC SAFETY ASSESSMENT
Kristen Tecson
Favorite
Tedesco, Nicholas

Western University of Health Sciences
(P 106) REPAIR: A PRELIMINARY REPORT ON AN ONGOING MULTI-CENTER TRIAL FOR PATIENTS UNDERGOING SURGICAL STABILIZATION FOR METASTATIC BONE DISEASE OF THE FEMUR
Nicholas Tedesco
Favorite
Teicher, Beverly

National Cancer Institute
(P 267) THE RAF/MEK INHIBITOR VS-6766 SHOWS EFFICACY IN RAS-MUTANT PEDIATRIC PRECLINICAL XENOGRAFT MODELS- A REPORT FROM THE PEDIATRIC PRECLINICAL IN VIVO TESTING CONSORTIUM
Beverly Teicher
Favorite
Temple, H.T.

1.University of Miami , Miller School of Medicine, Department of Orthopedic Surgery
(P 31) TARGETING CANCER STEM CELLS BY TYROSINE PEPTIDE ANALOGUE IN REFRACTORY SARCOMA
H.T. Temple
Favorite
(P 89) PATELLAR HEIGHT AND ITS INFLUENCE ON FUNCTIONAL OUTCOMES FOR MEGAPROSTHESES AROUND THE KNEE PERFORMED FOR ONCOLOGICAL INDICATIONS
H.T. Temple
Favorite
(P 90) MEGAPROSTHESIS CONVERSION FROM FAILED OSTEOARTICULAR ALLOGRAFT VERSUS PRIMARY RECONSTRUCTION FOR DISTAL FEMUR AND PROXIMAL TIBIA TUMORS: A PROPENSITY MATCHED-PAIR ANALYSIS
H.T. Temple
Favorite
(P 99) LIMB SALVAGE FOR PROXIMAL TIBIA TUMORS: OUTCOMES OF ALLOGRAFT-PROSTHESIS COMPOSITE AND ENDOPROSTHETIC RECONSTRUCTION
H.T. Temple
Favorite
(P 397) EXPLORING REAL WORLD DATA OF RECURRENCE IN NON-METASTATIC MYXOFIBROSAROMA: AN UPDATED RETROSPECTIVE COHORT STUDY
H.T. Temple
Favorite
Tepper, Sarah

Moffitt Cancer Center
(P 102) FACTORS RELATED TO ASEPTIC LOOSENING IN ENDOPROSTHESIS RECONSTRUCTION OF THE PROXIMAL TIBIA
Sarah Tepper
Favorite
(P 138) A MULTI-INSTITUTIONAL ARCHIVE AND DEEP LEARNING PIPELINE FOR QUANTIFYING CHONDROSARCOMA COMPOSITION
Sarah Tepper
Favorite
(P 140) REFINING PRE-SURGICAL ASSESSMENT OF LONG-BONE CHONDROSARCOMA THROUGH THE RADIOLOGIC AGGRESSIVENESS SCORE
Sarah Tepper
Favorite
(P 141) A RETROSPECTIVE ANALYSIS OF THE BIRMINGHAM ATYPICAL CARTILAGE TUMOUR IMAGING PROTOCOL (BACTIP) IN MANAGING CENTRAL CARTILAGE TUMORS OF THE LONG BONES
Sarah Tepper
Favorite
(P 142) ARE THERE INDEPENDENT PREDICTORS OF DEDIFFERENTIATED CHONDROSARCOMA ON MAGNETIC RESONANCE IMAGING? A MULTIVARIATE ANALYSIS
Sarah Tepper
Favorite
(P 145) PATHOLOGIC FRACTURE IN CHONDROSARCOMA OF LONG BONES: A RETROSPECTIVE COHORT STUDY
Sarah Tepper
Favorite
(P 160) A COMPARATIVE ANALYSIS OF DEDIFFERENTIATED AND CONVENTIONAL CHONDROSARCOMA OUTCOMES
Sarah Tepper
Favorite
Terés Lleida, Raúl

Hospital Santa Creu i Sant Pau
(P 128) ISOCITRATE DEHYDROGENASE 1 (IDH1) MUTATION TESTING IN THE PHASE 3 STUDY OF IVOSIDENIB VS PLACEBO IN IDH1-MUTANT CONVENTIONAL CHONDROSARCOMA (CHONQUER)
Raúl Terés Lleida
Favorite
(P 218) THE IMPACT OF BROADENED GENETIC COUNSELLING REFERRAL CRITERIA IN SARCOMA PATIENTS: A REFERENCE CENTRE'S EXPERIENCE
Raúl Terés Lleida
Favorite
(P 385) PROGNOSTIC IMPACT OF PERIPHERAL BLOOD CELL RATIO VALUES IN PATIENTS WITH ADVANCED LEIOMYOSARCOMA: A REFERENCE CENTER EXPERIENCE.
Raúl Terés Lleida
Favorite
(P 389) UNRESECTABLE AND METASTATIC DEDIFFERENTIATED LIPOSARCOMA (DDLPS): INSIGHTS FROM A MULTICENTER REAL-WORLD COHORT (RWC)
Raúl Terés Lleida
Favorite
Terrasi, Andrea

Oslo University Hospital
(P 200) DISSECTING INTRATUMORAL HETEROGENEITY IN GIST USING SPATIAL TRANSCRIPTOMICS
Andrea Terrasi
Favorite
Tesselaar, Margot

The Netherlands Cancer Institute
(P 444) HEALTH-RELATED QUALITY OF LIFE (HRQOL) CHALLENGES IN PATIENTS WITH EPITHELIOID HEMANGIOENDOTHELIOMA (EHE): ANALYSIS OF AN ULTRA-RARE SARCOMA GROUP
Margot Tesselaar
Favorite
Teterycz, Pawel

Maria Sklodowska-Curie National Research Institute of Oncology
(P 139) IMMUNOGENOMIC PROFILING OF CHONDROSARCOMA REVEALS DISTINCT IMMUNE PHENOTYPES AND PROGNOSTIC MUTATIONS
Pawel Teterycz
Favorite
(P 149) SURGICAL TEXTBOOK OUTCOMES IN PATIENTS DIAGNOSED WITH CHONDROSARCOMA
Pawel Teterycz
Favorite
(P 313) SIGNIFICANCE OF LYMPH NODE PROCEDURES IN SOFT TISSUE SARCOMA PATIENTS
Pawel Teterycz
Favorite
(P 470) OFF-LABEL TREATMENT AND ULTRARARE SARCOMAS - SINGLE INSTITUTION REPORT
Pawel Teterycz
Favorite
Teuber, Alina

MSKCC
(P 182) USING IN VITRO MODELS TO PREDICT IMATINIB RESPONSES OF PDGFRA EXON 18-MUTANT GIST
Alina Teuber
Favorite
Thacker, Christine

UCSF Helen Diller Family Comprehensive Cancer Center
(P 439) AN OPEN LABEL MULTICENTER PHASE 2 STUDY WITH SAFETY LEAD IN OF INTRATUMORAL VUSOLIMOGENE ODERPAREPVEC IN COMBINATION WITH PEMBROLIZUMAB IN PATIENTS WITH ANGIOSARCOMA
Christine Thacker
Favorite
Thakur, rudra Pratap

Balco
(P 103) EARLY OUTCOMES OF BONE PROSTHESIS COMPOSITE FOR RECONSTRUCTION IN LOWER LIMB TUMORS. A SINGLE INSTITUTION STUDY
rudra Pratap Thakur
Favorite
Theisen, Emily

Nationwide Children's Hospital
(P 23) DEFINING THE NONENZYMATIC FUNCTIONS OF LSD1 IN EWING SARCOMA
Emily Theisen
Favorite
Thiels, Cornelius

Mayo Clinic
(P 300) FEATURES AND OUTCOMES OF PATIENTS WITH GASTROINTESTINAL LEIYOMYOSARCOMA
Cornelius Thiels
Favorite
Thierauf, Julia

Department of Pathology, Massachusetts General Hospital, Harvard Medical School
(P 45) MONITORING EWSR1 FUSIONS IN SARCOMA PATIENTS USING PERSONALIZED LIQUID BIOPSY ASSAYS
Julia Thierauf
Favorite
Thirasastr, Prapassorn

The University of Texas MD Anderson Cancer Center
(P 54) PRECLINICAL MODELS REVEALING MDM2-P53 INTERACTION AND DEPENDENCY FOR TUMOR CELL SURVIVAL IN WELL-DIFFERENTIATED (WD) AND DEDIFFERENTIATED (DD) LIPOSARCOMA (LPS).
Prapassorn Thirasastr
Favorite
(P 184) MTAP IN GASTROINTESTINAL STROMAL TUMOR (GIST): RATE OF MTAP LOSS AND CONCORDANCE BETWEEN GENOMIC SEQUENCING AND IMMUNOHISTOCHEMISTRY
Prapassorn Thirasastr
Favorite
(P 274) RACIAL DISPARITIES IN INCIDENCE AND MORTALITY OVER 20 YEARS AMONG AYA PATIENTS WITH SARCOMA IN THE US: A SEER DATABASE ANALYSIS
Prapassorn Thirasastr
Favorite
(P 351) THE ROLE OF SOCIOECONOMIC DISPARITIES ON SURVIVAL OUTCOMES IN MALIGNANT PERIPHERAL NERVE SHEATH TUMORS
Prapassorn Thirasastr
Favorite
(P 451) TREATMENT OUTCOMES OF GEMCITABINE AND DOCETAXEL IN PATIENTS WITH CLEAR CELL SARCOMA (CCS) OR GASTROINTESTINAL NEUROECTODERMAL TUMOR (GNET): A CASE SERIES
Prapassorn Thirasastr
Favorite
(P 460) OUTCOMES OF LATER-LINES SYSTEMIC THERAPIES IN MALIGNANT PERIPHERAL NERVE SHEATH TUMORS (MPNST)
Prapassorn Thirasastr
Favorite
Thng, Dexter Kai Hao

National University of Singapore
(P 53) ESTABLISHMENT AND CHARACTERISATION OF LIPOSARCOMA-DERIVED CELLS AS RELEVANT PRE-CLINICAL MODELS FOR TARGET DISCOVERY
Dexter Kai Hao Thng
Favorite
Thomas, David

Centre for Molecular Oncology
(P 49) GENETIC INTERACTION BETWEEN SPRED3 AND SMARCB1 CAUSES EXPLOSIVE MULTIFOCAL MALIGNANT PERIPHERAL NERVE SHEATH TUMORS
David Thomas
Favorite
Thomas, Shari

Strand Therapeutics Inc.
(P 433) PHASE I DOSE ESCALATION TRIAL OF STX-001, AN LNP SELF-REPLICATING MRNA EXPRESSING IL-12, IN PATIENTS WITH REFRACTORY TUMORS INCLUDING SARCOMAS
Shari Thomas
Favorite
Thomas, Stefanie

Cleveland Clinic
(P 284) THE IMPACT OF SARCOMA SBRT ON THE IMMUNE SYSTEM: EARLY RESULTS FROM A PROSPECTIVE TRIAL
Stefanie Thomas
Favorite
Thompson, Austen

Mayo Clinic
(P 96) AMPUTATION FOLLOWING MEGAPROSTHESIS USE IN LIMB SALVAGE
Austen Thompson
Favorite
(P 150) LOCAL RECURRENCE OF CHONDROSARCOMA: IMPACT ON SURVIVAL AND RECURRENCE AT AN INCREASED GRADE
Austen Thompson
Favorite
(P 348) SYNOVIAL SARCOMA INVOLVING NERVES: HIGH RATE OF MISIDENTIFICATION AS BENIGN TUMORS
Austen Thompson
Favorite
Thompson, Marshall

Rare Cancer Research Foundation
(P 350) THE PATTERN.ORG SARCOMA CONSORTIUM: BUILDING A MULTI-INSTITUTIONAL DATA RESOURCE FOR THE SARCOMA RESEARCH COMMUNITY
Marshall Thompson
Favorite
Thompson, Matthew

Fred Hutchinson Cancer Center
(P 287) A PHASE 1 STUDY OF NEOADJUVANT CABOZANTINIB IN COMBINATION WITH RADIATION THERAPY FOR SARCOMAS OF THE EXTREMITIES
Matthew Thompson
Favorite
Thompson, Wayne

Nationwide Children's Hospital
(P 377) GERMLINE RECQL4 VARIANT IN A PEDIATRIC PATIENT WITH EWING SARCOMA AND DESMOID FIBROMATOSIS
Wayne Thompson
Favorite
Thorkildsen, Joachim

Oslo University Hospital
(P 151) SHOULD WE USE ADJUVANT CHEMOTHERAPY IN PATIENTS WITH LOCALIZED DEDIFFERENTIATED CHONDROSARCOMA (DDCS) OF THE PELVIS? AN ANALYSIS BY THE PELVIC DDCS STUDY GROUP
Joachim Thorkildsen
Favorite
Thornell, Anders

Institute of Clinical Sciences/Sahlgrenska Academy
(P 124) ISOLATED LIMB PERFUSION AS LIMB SALVAGING TREATMENT; A SINGLE CENTRE RETROSPECTIVE STUDY
Anders Thornell
Favorite
Thornton, Mason

University of Miami Miller School of Medicine
(P 224) PAN-SARCOMA DATABASE (PSDB): AN UPDATE ON MIAMI'S COLLABORATIVE MULTI-USER DATA PIPELINE OF SARCOMA DATA USING REDCAP AND R CODING
Mason Thornton
Favorite
(P 369) CLINICAL CHARACTERISTICS & TREATMENT OUTCOME PATTERNS OF SOLITARY FIBROUS TUMORS: A SINGLE-INSTITUTION RETROSPECTIVE ANALYSIS
Mason Thornton
Favorite
Thorpe, Steven

University of Colorado Department of Orthopedics
(P 106) REPAIR: A PRELIMINARY REPORT ON AN ONGOING MULTI-CENTER TRIAL FOR PATIENTS UNDERGOING SURGICAL STABILIZATION FOR METASTATIC BONE DISEASE OF THE FEMUR
Steven Thorpe
Favorite
Thorpe, Steven

Orthopedic Surgery, University of California, Davis
(P 244) INTRATUMORAL TIGIT BLOCKADE AUGMENTS ANTI-TUMOR RESPONSES AND BYPASSES HYPERFUNCTIONALITY OF PERIPHERAL TIGIT+ NK CELLS IN MOUSE AND HUMAN MODELS OF BONE AND SOFT TISSUE SARCOMA
Steven Thorpe
Favorite
Thorpe, Steven

University of Colorado Department of Orthopedics
(P 268) QUALITY OF LIFE OUTCOMES IN PEDIATRIC PATIENTS UNDERGOING SURGICAL INTERVENTION FOR LOWER EXTREMITY BONE SARCOMAS
Steven Thorpe
Favorite
Thway, Khin

The Royal Marsden NHS Foundation Trust
(P 414) PATTERNS OF RELAPSE OF BORDERLINE AND MALIGNANT PHYLLODES TUMOUR- RESULTS FROM SARCOMA REFERENCE CENTRE (SRC)
Khin Thway
Favorite
Tian, Kai

Department of Orthopaedics, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
(P 07) A LIVING MULTI-OMICS BIOBANK OF PATIENT-DERIVED XENOGRAFT MODELS FOR SARCOMA
Kai Tian
Favorite
Timmermann, Beate

West German Proton Therapy Centre Essen
(P 250) OUTCOME OF INFANTS WITH RHABDOMYOSARCOMA: A REPORT FROM THE INTERNATIONAL SOFT TISSUE SARCOMA CONSORTIUM
Beate Timmermann
Favorite
Tinè, Gabriele

Fondazione IRCCS Istituto Nazionale dei Tumori, Mialno
(P 331) MAINTENANCE THERAPY (M-TP) WITH DACARBAZINE (DTIC) AFTER FIRST-LINE ANTHRACYCLINE-BASED DOUBLET IN ADVANCED LEIOMYOSARCOMA (LMS) PATIENTS (PTS): OUTCOMES OF A CASE SERIES IN A SINGLE REFERRAL CENTER
Gabriele Tinè
Favorite
(P 446) GDF-15 AS A PROGNOSTIC FACTOR IN PATIENTS WITH EPITHELIOID HEMANGIOENDOTHELIOMA
Gabriele Tinè
Favorite
(P 447) PAIN ASSESSMENT CRITERIA (PAC) ANTICIPATE RECIST PROGRESSION AND CORRELATE WITH BLOOD LEVELS OF GROWTH DIFFERENTIATION FACTOR 15 (GDF15) IN EPITHELIOID HEMANGIOENDOTHELIOMA (EHE)
Gabriele Tinè
Favorite
Tin, Antony

Natera
(P 04) EARLY ON-TREATMENT CIRCULATING TUMOR DNA DYNAMICS TO PREDICT RESPONSE IN PATIENTS WITH SARCOMA
Antony Tin
Favorite
Tinoco, Gabriel

The Ohio State University Comprehensive Cancer Center
(P 128) ISOCITRATE DEHYDROGENASE 1 (IDH1) MUTATION TESTING IN THE PHASE 3 STUDY OF IVOSIDENIB VS PLACEBO IN IDH1-MUTANT CONVENTIONAL CHONDROSARCOMA (CHONQUER)
Gabriel Tinoco
Favorite
(P 161) CLINICAL CHARACTERISTICS, PATTERNS OF CARE, AND TREATMENT OUTCOMES OF CHONDROSARCOMA: A SINGLE-INSTITUTIONAL EXPERIENCE
Gabriel Tinoco
Favorite
(P 170) GEMSARC: AN AI BASED PREDICTIVE GENE SIGNATURE FOR GEMCITABINE EFFICACY IN ADVANCED SOFT-TISSUE SARCOMAS
Gabriel Tinoco
Favorite
(P 408) REAL-WORLD SINGLE-CENTER INSIGHTS INTO CT-DNA DYNAMICS ACROSS SOFT TISSUE SARCOMAS
Gabriel Tinoco
Favorite
Tipping, Alex

Adaptimmune
(P 247) SINGLE-CELL RNA SEQUENCING OF AFAMITRESGENE AUTOLEUCEL INDICATES MECHANISMS OF PERSISTENCE AND ANTI-TUMOR ACTIVITY
Alex Tipping
Favorite
Tipps, Megan

Parabilis Medicines
(P 415) A PHASE 1/2 TRIAL OF FOG-001, A FIRST-IN-CLASS DIRECT β-CATENIN:TCF4 INHIBITOR: SAFETY AND PRELIMINARY ANTITUMOR ACTIVITY IN PATIENTS WITH DESMOID TUMORS (DT)
Megan Tipps
Favorite
Toda, Yu

National Cancer Center Hospital
(P 159) CHONDROSARCOMA IN JAPAN: A POPULATION-BASED ANALYSIS USING NATIONAL CANCER REGISTRY
Yu Toda
Favorite
Todi, Niket

UC Davis Health
(P 95) COMPARATIVE OUTCOMES OF OPERATIVE AND NON-OPERATIVE TREATMENT FOR METASTATIC HUMERAL PATHOLOGIC FRACTURES
Niket Todi
Favorite
(P 106) REPAIR: A PRELIMINARY REPORT ON AN ONGOING MULTI-CENTER TRIAL FOR PATIENTS UNDERGOING SURGICAL STABILIZATION FOR METASTATIC BONE DISEASE OF THE FEMUR
Niket Todi
Favorite
(P 349) THE COST OF SURVEILLANCE IN CALIFORNIA: MRI UTILIZATION IN RECURRENT EXTREMITY SOFT TISSUE SARCOMA
Niket Todi
Favorite
(P 360) MRI SURVEILLANCE PRACTICES AND RECURRENCE DETECTION IN EXTREMITY SOFT TISSUE SARCOMA: A RETROSPECTIVE STUDY
Niket Todi
Favorite
Toh, Tan Boon

National University of Singapore
(P 53) ESTABLISHMENT AND CHARACTERISATION OF LIPOSARCOMA-DERIVED CELLS AS RELEVANT PRE-CLINICAL MODELS FOR TARGET DISCOVERY
Tan Boon Toh
Favorite
Toki, Shunichi

Shizuoka Cancer Center
(P 291) INTRA-ARTERIAL CHEMOTHERAPY WITH CONCOMITANT RADIATION THERAPY FOR UNRESECTABLE SARCOMA
Shunichi Toki
Favorite
Toledano, Helen

Schneider Children's Medical Center, Petah Tikva, Israel
(P 417) EFFICACY AND SAFETY OF LAROTRECTINIB (LARO) IN PATIENTS (PTS) WITH TRK FUSION SARCOMAS
Helen Toledano
Favorite
Tolomeo, Francesco

Oncology Unit, Candiolo Cancer Institute, FPO – IRCCS
(P 231) INCREASED LIFETIME RISK (LTR) OF SOFT TISSUE SARCOMAS (STS) IN PATIENTS WITH LOW-RISK GASTROINTESTINAL STROMAL TUMORS (GIST): A RETROSPECTIVE ANALYSIS FROM THE ITALIAN SARCOMA GROUP (ISG)
Francesco Tolomeo
Favorite
Tomassoni, Lorenzo

Columbia University Irving Medical Center
(P 25) IDENTIFICATION AND VALIDATION OF NON-GENETICALLY ENCODED VULNERABILITIES IN EWING SARCOMA
Lorenzo Tomassoni
Favorite
Tomkinson, Blake

Kura Oncology, Inc.
(P 423) ZIFTOMENIB IN COMBINATION WITH IMATINIB IN ADVANCED GASTROINTESTINAL STROMAL TUMORS (GIST) AFTER IMATINIB FAILURE: PHASE 1A/B STUDY OF SAFETY, PHARMACOKINETICS, AND ANTITUMOR ACTIVITY
Blake Tomkinson
Favorite
Tonini, Giuseppe

Fondazione Policlinico Universitario Campus Bio-Medico
(P 61) HER2 TARGETING IN CHORDOMA: PRECLINICAL INSIGHTS ON TRASTUZUMAB DERUXTECAN
Giuseppe Tonini
Favorite
Topf, Michael

Department of Otolaryngology-Head & Neck Surgery, Vanderbilt University Medical Center
(P 85) MAKING NEGATIVE MARGIN MUSCULOSKELETAL TUMOR SURGERY A VIRTUAL REALITY USING 3D SPECIMEN SCANNING
Michael Topf
Favorite
Torner Marchessi, Elena

Hospital Universitario de Toledo
(P 218) THE IMPACT OF BROADENED GENETIC COUNSELLING REFERRAL CRITERIA IN SARCOMA PATIENTS: A REFERENCE CENTRE'S EXPERIENCE
Elena Torner Marchessi
Favorite
(P 385) PROGNOSTIC IMPACT OF PERIPHERAL BLOOD CELL RATIO VALUES IN PATIENTS WITH ADVANCED LEIOMYOSARCOMA: A REFERENCE CENTER EXPERIENCE.
Elena Torner Marchessi
Favorite
Torralbas Fitz, Sergio

University of Miami
(P 89) PATELLAR HEIGHT AND ITS INFLUENCE ON FUNCTIONAL OUTCOMES FOR MEGAPROSTHESES AROUND THE KNEE PERFORMED FOR ONCOLOGICAL INDICATIONS
Sergio Torralbas Fitz
Favorite
(P 90) MEGAPROSTHESIS CONVERSION FROM FAILED OSTEOARTICULAR ALLOGRAFT VERSUS PRIMARY RECONSTRUCTION FOR DISTAL FEMUR AND PROXIMAL TIBIA TUMORS: A PROPENSITY MATCHED-PAIR ANALYSIS
Sergio Torralbas Fitz
Favorite
Torres, Keila

MD Anderson Cancer Center
(P 242) IMMUNE PROFILING OF UNDIFFERENTIATED PLEOMORPHIC SARCOMAS REVEALS DISTINCT PROGNOSTIC SUBGROUPS
Keila Torres
Favorite
(P 351) THE ROLE OF SOCIOECONOMIC DISPARITIES ON SURVIVAL OUTCOMES IN MALIGNANT PERIPHERAL NERVE SHEATH TUMORS
Keila Torres
Favorite
(P 460) OUTCOMES OF LATER-LINES SYSTEMIC THERAPIES IN MALIGNANT PERIPHERAL NERVE SHEATH TUMORS (MPNST)
Keila Torres
Favorite
Torrezan, Giovana T.

AC Camargo Cancer Center
(P 132) MOLECULAR LANDSCAPE AND CLINICAL HETEROGENEITY OF BRAZILIAN CHONDROSARCOMAS: INSIGHTS FROM IDH, TERT, AND GENOME-WIDE ANALYSIS
Giovana T. Torrezan
Favorite
(P 137) GENOMIC ALTERATIONS IN RARE CARTILAGINOUS TUMOR SYNDROMES ASSOCIATED WITH CHONDROSARCOMA DEVELOPMENT
Giovana T. Torrezan
Favorite
(P 155) BRCA2-MUTATED CONVENTIONAL CHONDROSARCOMA RESPONDING TO PARP INHIBITION: A CASE REPORT
Giovana T. Torrezan
Favorite
Torsello, Monica

IRCCS Rizzoli Orthopaedic Institute
(P 18) ESTABLISHMENT AND CHARACTERIZATION OF A NOVEL PRIMARY CELL LINE FROM A BONE METASTASIS OF OSTEOSARCOMA
Monica Torsello
Favorite
Toureille, Maîlys

Institut Bergonié
(P 324) FULLY MATURE TERTIARY LYMHOID STRUCTURES AS PREDICTORS OF LOCAL RECURRENCE IN SOFT TISSUE SARCOMAS
Maîlys Toureille
Favorite
Towler, Jonathan

University College London Hospitals
(P 281) LOCAL CONTROL WITH MODERATELY HYPOFRACTIONATED DEFINITIVE RADIOTHERAPY DELIVERED WITH A SIMULTANEOUS INTEGRATED BOOST TECHNIQUE TO NON-EXTREMITY SOFT TISSUE AND BONE SARCOMAS
Jonathan Towler
Favorite
Town, Ajia

OHSU Knight Cancer Institute
(P 182) USING IN VITRO MODELS TO PREDICT IMATINIB RESPONSES OF PDGFRA EXON 18-MUTANT GIST
Ajia Town
Favorite
Tram, Nam
(P 462) HDAC INHIBITORS AS POTENTIAL SFT THERAPIES
Nam Tram
Favorite
Travis, Levi

University of Miami Miller School of Medicine, Department of Orthopaedic Surgery
(P 94) EFFECT OF POSTOPERATIVE PHYSICAL THERAPY ON FUNCTIONAL OUTCOMES FOLLOWING MUSCULOSKELETAL TUMOR RESECTION
Levi Travis
Favorite
(P 98) PERCUTANEOUS STABILIZATION OF METASTATIC BONE LESIONS WITH A PHOTODYNAMIC INTRAMEDULLARY SYSTEM: EXPERIENCE FROM A 15-PATIENT CASE SERIES
Levi Travis
Favorite
Travis, Levi

University of Miami
(P 99) LIMB SALVAGE FOR PROXIMAL TIBIA TUMORS: OUTCOMES OF ALLOGRAFT-PROSTHESIS COMPOSITE AND ENDOPROSTHETIC RECONSTRUCTION
Levi Travis
Favorite
Trenholm, Ryan

Nova Scotia Health Authority
(P 143) IMPACT OF SURGICAL MARGINS IN CHEST WALL CHONDROSARCOMAS: A CANSARCC STUDY
Ryan Trenholm
Favorite
Trent, Jonathan

Sarcoma Medical Research Program, University of Miami – Sylvester Comprehensive Cancer Center
(P 117) THERAPEUTIC POTENTIAL OF DOXORUBICIN AND DASATINIB COMBINATION IN OSTEOSARCOMA
Jonathan Trent
Favorite
(P 131) GLUCOSE TRANSPORTER 1 (GLUT1) INHIBITION DECREASES THE GROWTH AND PROLIFERATION OF CHONDROSARCOMA
Jonathan Trent
Favorite
(P 148) CHARACTERISTICS AND OUTCOMES OF CHONDROSARCOMA PATIENTS TREATED WITH PROTON THERAPY: A SYSTEMATIC REVIEW OF PUBLISHED SERIES
Jonathan Trent
Favorite
(P 194) UPDATED RESULTS FROM STRATEGIST 1: A PHASE 1/1B STUDY OF IDRX-42 (GSK6042981A) IN PATIENTS (PTS) WITH ADVANCED GASTROINTESTINAL STROMAL TUMORS (GIST)
Jonathan Trent
Favorite
(P 201) METASTATIC PATTERNS, TREATMENT MODALITIES, AND OVERALL SURVIVAL IN OLIGOMETASTATIC GIST: A SINGLE-CENTER RETROSPECTIVE STUDY
Jonathan Trent
Favorite
(P 217) PATIENT QUESTIONNAIRE EXPLORING THE PRE-SARCOMA DIAGNOSIS CHARACTERISTICS OF SARCOMA PATIENTS
Jonathan Trent
Favorite
(P 224) PAN-SARCOMA DATABASE (PSDB): AN UPDATE ON MIAMI'S COLLABORATIVE MULTI-USER DATA PIPELINE OF SARCOMA DATA USING REDCAP AND R CODING
Jonathan Trent
Favorite
(P 225) GLOBAL REGISTRY OF SOLITARY FIBROUS TUMORS (SFT): INTEGRATING CLINICAL, MOLECULAR, AND ENVIRONMENTAL DATA- THE HOROWITZ SFT INITIATIVE (HSFTI)
Jonathan Trent
Favorite
(P 289) SIX YEAR FOLLOW-UP ON CIVASHEET® USE FOR SOFT TISSUE SARCOMA: A SINGLE INSTITUTION EXPERIENCE
Jonathan Trent
Favorite
(P 320) CLINICAL CHARACTERISTICS AND RECURRENCE PATTERNS IN HISPANIC VS. NON-HISPANIC PATIENTS WITH LEIOMYOSARCOMA: FINDINGS FROM A RETROSPECTIVE SINGLE-CENTER COHORT STUDY
Jonathan Trent
Favorite
(P 327) INITIAL TREATMENT MODALITY AND RECURRENCE IN NON-METASTATIC LEIOMYOSARCOMA: A RETROSPECTIVE COHORT STUDY
Jonathan Trent
Favorite
(P 333) METABOLIC SYNDROME CORRELATION WITH LIPOSARCOMA INCIDENCE AND OUTCOMES: A RETROSPECTIVE ANALYSIS.
Jonathan Trent
Favorite
(P 362) SHOULD PAZOPANIB BE USED AS A MAINTENANCE THERAPY TO IMPROVE RECURRENCE-FREE SURVIVAL AND OVERALL SURVIVAL IN PATIENTS WHO RECEIVED MAI IN SOFT TISSUE SARCOMA?
Jonathan Trent
Favorite
(P 369) CLINICAL CHARACTERISTICS & TREATMENT OUTCOME PATTERNS OF SOLITARY FIBROUS TUMORS: A SINGLE-INSTITUTION RETROSPECTIVE ANALYSIS
Jonathan Trent
Favorite
(P 397) EXPLORING REAL WORLD DATA OF RECURRENCE IN NON-METASTATIC MYXOFIBROSAROMA: AN UPDATED RETROSPECTIVE COHORT STUDY
Jonathan Trent
Favorite
(P 403) MEDICAL MANAGEMENT OF TENOSYNOVIAL GIANT CELL TUMOR
Jonathan Trent
Favorite
(P 419) PROSPECTIVE REAL-WORLD STUDY OF LAROTRECTINIB (LARO) IN PATIENTS (PTS) WITH TRK FUSION SOLID TUMORS: INTERIM ANALYSIS OF ON-TRK
Jonathan Trent
Favorite
(P 424) AN OPEN-LABEL PHASE 1/2 STUDY OF DCC-3009 MONOTHERAPY IN PATIENTS (PTS) WITH ADVANCED GASTROINTESTINAL STROMAL TUMOR (GIST)
Jonathan Trent
Favorite
Trickett, Justin

Pyxis Oncology
(P 29) ANTI-TUMOR ACTIVITY OF MICVOTABART PELIDOTIN IS ASSOCIATED WITH ENZYME GENE EXPRESSION IN PATIENT-DERIVED XENOGRAFT SARCOMA MODELS
Justin Trickett
Favorite
Troulis, Maria

Department of Oral and Maxillofacial Surgery, Massachusetts General Hospital
(P 45) MONITORING EWSR1 FUSIONS IN SARCOMA PATIENTS USING PERSONALIZED LIQUID BIOPSY ASSAYS
Maria Troulis
Favorite
Trucco, Matteo

Cleveland Clinic
(P 284) THE IMPACT OF SARCOMA SBRT ON THE IMMUNE SYSTEM: EARLY RESULTS FROM A PROSPECTIVE TRIAL
Matteo Trucco
Favorite
(P 426) A PHASE I/II TRIAL USING RNA LIPID NANOPARTICLES FOR RECURRENT OSTEOSARCOMA: A REPORT FROM THE NATIONAL PEDIATRIC CANCER FOUNDATION
Matteo Trucco
Favorite
Truong, Danh

MD Anderson Cancer Center
(P 22) SINGLE CELL SEQUENCING ENABLES LINEAGE-INFORMED TARGETING OF OSTEOSARCOMA
Danh Truong
Favorite
(P 47) EWSR1::WT1 FUSION ONCOPROTEIN ACTIVITY SHAPES LINEAGE HETEROGENEITY IN DESMOPLASTIC SMALL ROUND CELL TUMORS
Danh Truong
Favorite
Tsai, Hui-Jen

National Health Research Institute
(P 428) MAINTENANCE PEGYLATED LIPOSOMAL DOXORUBICIN VERSUS ACTIVE SURVEILLANCE FOR ADVANCED SOFT TISSUE SARCOMA PATIENTS WHO HAD CONTROLLED DISEASE AFTER STANDARD ANTHRACYCLINE-BASED TREATMENT (MELODY)
Hui-Jen Tsai
Favorite
Tseng, William

City of Hope National Medical Center
(P 307) STRATEGIES FOR DATA QUALITY IN TARPSWG RETROPERITONEAL SARCOMA REGISTRY (RESAR)
William Tseng
Favorite
(P 308) IMPACT OF PSOAS MUSCLE RESECTION ON OUTCOMES IN PRIMARY RETROPERITONEAL DEDIFFERENTIATED LIPOSARCOMA
William Tseng
Favorite
(P 309) RETROPERITONEAL LIPOMAS: MULTICENTER CLINICAL EXPERIENCE WITH AN EXTREMELY RARE DISEASE ENTITY
William Tseng
Favorite
(P 452) EFFECTIVENESS OF ERIBULIN FOR MYXOID PLEOMORPHIC LIPOSARCOMA: INSIGHTS FROM A PATIENT-DERIVED MODEL AND CLINICAL TRANSLATION IN A PATIENT WITH ADVANCED DISEASE
William Tseng
Favorite
Tsoi, Kim

Department of Surgery, Sinai Health
(P 55) THE EFFECT OF STAT1 Y701 PHOSPHORYLATION ON GENE EXPRESSION IN UPS
Kim Tsoi
Favorite
(P 88) THE RAY CHALLENGE: HOW MANY RAY RESECTIONS CAN PATIENTS TOLERATE AND WHICH RAY RESECTIONS AFFECTS FUNCTIONAL OUTCOME THE MOST IN ORTHOPEDIC ONCOLOGY?
Kim Tsoi
Favorite
(P 323) EVALUATION OF COSMIC MUTATIONAL SIGNATURES IN SOFT TISSUE SARCOMA
Kim Tsoi
Favorite
(P 332) MARGINAL EXCISION OF EXTREMITY DEDIFFERENTIATED LIPOSARCOMA WITHOUT RADIATION MAY BE SAFE IN SELECT PATIENTS
Kim Tsoi
Favorite
(P 374) DISTINCT PATTERNS OF METASTATIC SPREAD IN LEIOMYOSARCOMA: A COMPARATIVE ANALYSIS OF TRUNCAL AND EXTREMITY TUMOURS
Kim Tsoi
Favorite
(P 375) DOES STAGED RESECTION WITH TEMPORIZING WOUND VACUUM INFLUENCE LOCAL RECURRENCE RISK? A MULTI-INSTITUTIONAL MATCHED COHORT ANALYSIS
Kim Tsoi
Favorite
Tsuchiya, Karen

Steve and Cindy Rasmussen Institute for Genomic Medicine, The Abigail Wexner Research Institute, Nationwide Children’s Hospital
(P 264) RARE CASE OF INFLAMMATORY MYOFIBROBLASTIC TUMOR (IMT) IN NEWBORN
Karen Tsuchiya
Favorite
Tumminello, Brad

Springworks Therapeutics, Inc.
(P 357) DEVELOPMENT OF AN ALGORITHM TO IDENTIFY PATIENTS (PT) WITH DESMOID TUMORS (DT) IN A UNITED STATES (US) CLAIMS DATASET
Brad Tumminello
Favorite
(P 364) TRENDS IN SURGICAL MANAGEMENT OF DESMOID TUMOR IN THE VETERANS AFFAIRS (VA) NATIONAL DATABASE
Brad Tumminello
Favorite
(P 368) ASSESSMENT OF PAIN DIAGNOSIS AND PAIN MEDICATION USE IN ADULTS TREATED WITH NIROGACESTAT: A UNITED STATES REAL-WORLD ANALYSIS
Brad Tumminello
Favorite
Tuohy, Joanne

Virginia-Maryland Regional College of Veterinary Medicine
(P 259) PRECLINICAL MODELING OF CHEMOTHERAPY RELEASE IDENTIFIES MITOCHONDRIAL ADAPTATIONS IN DOXORUBICIN TREATED OSTEOSARCOMA
Joanne Tuohy
Favorite
turcotte, Robert

McGill university and RI-MUHC
(P 15) EZHIP: A NOVEL EPIGENETIC DRIVER OF OSTEOSARCOMA PATHOGENESIS
Robert turcotte
Favorite
Tuziak, Justyna

Maria Sklodowska-Curie National Research Institute of Oncology
(P 139) IMMUNOGENOMIC PROFILING OF CHONDROSARCOMA REVEALS DISTINCT IMMUNE PHENOTYPES AND PROGNOSTIC MUTATIONS
Justyna Tuziak
Favorite
Tysarowski, Andrzej

Cancer Molecular and Genetic Diagnostics Laboratory, Maria Sklodowska-Curie National Research Institute of Oncology
(P 27) MOLECULAR CHARACTERIZATION OF RESPONSE TO NEOADJUVANT CHEMORADIATION IN PATIENTS WITH LOCALLY ADVANCED SOFT TISSUE SARCOMAS
Andrzej Tysarowski
Favorite
(P 139) IMMUNOGENOMIC PROFILING OF CHONDROSARCOMA REVEALS DISTINCT IMMUNE PHENOTYPES AND PROGNOSTIC MUTATIONS
Andrzej Tysarowski
Favorite
U
Ubong, Sonia

Massachusetts General Hospital
(P 173) DEVELOPMENT AND EXTERNAL VALIDATION OF A MACHINE LEARNING ALGORITHM TO PREDICT OVERALL SURVIVAL IN PATIENTS WITH PELVIC OR APPENDICULAR LIPOSARCOMA
Sonia Ubong
Favorite
(P 402) LYMPH NODE METASTASES IN SOFT TISSUE SARCOMA: A DATABASE ANALYSIS
Sonia Ubong
Favorite
Uchida, Eriko

Department of Pediatric Oncology, National Cancer Center Hospital
(P 271) SAFETY AND EFFICACY OF CABOZANTINIB IN PEDIATRIC PATIENTS WITH MALIGNANT SOLID TUMORS (CAMEL TRIAL/NCCH2106): A SINGLE-CENTRE PHASE I TRIAL
Eriko Uchida
Favorite
Ulrich, Marisa

Mayo Clinic, Rochester
(P 162) CHONDROSARCOMA OUTCOMES IN YOUNG VERSUS ADULT POPULATIONS
Marisa Ulrich
Favorite
(P 166) LARGE LANGUAGE MODEL EXTRACTION OF STRUCTURED DATA IN UNSTRUCTURED SARCOMA PATHOLOGY NOTES: A PILOT STUDY
Marisa Ulrich
Favorite
(P 167) LARGE LANGUAGE MODEL EXTRACTION OF STRUCTURED DATA FROM UNSTRUCTURED RADIATION ONCOLOGY NOTES: A PILOT STUDY
Marisa Ulrich
Favorite
Um, Jasmine

Memorial Sloan Kettering Cancer Center
(P 237) DEVELOPMENT OF EPHA2 CAR T CELL THERAPY FOR OSTEOSARCOMA
Jasmine Um
Favorite
Urba, Walter

Providence Cancer Institute
(P 58) PLK1 AS A VULNERABLE TARGET OF BAP1-DRIVEN UNDIFFERENTIATED PLEOMORPHIC SARCOMAS
Walter Urba
Favorite
Urrehman, Burrak

University Health Network
(P 143) IMPACT OF SURGICAL MARGINS IN CHEST WALL CHONDROSARCOMAS: A CANSARCC STUDY
Burrak Urrehman
Favorite
Utzig, Martin

German Cancer Society
(P 204) ANALYSIS OF QUALITY INDICATORS OF SOFT TISSUE SARCOMA TREATMENT WITH CANCER REGISTRY DATA IN GERMANY 2015-2021
Martin Utzig
Favorite
V
Vélasco, Valérie

Institut Bergonié
(P 59) TARGETING ADORA2B TO HALT METASTASIS IN UNDIFFERENTIATED PLEOMORPHIC SARCOMA: FROM MULTI-OMICS TO THERAPEUTIC INHIBITION
Valérie Vélasco
Favorite
(P 324) FULLY MATURE TERTIARY LYMHOID STRUCTURES AS PREDICTORS OF LOCAL RECURRENCE IN SOFT TISSUE SARCOMAS
Valérie Vélasco
Favorite
Völkl, Michael

Department of Medicine III, LMU University Hospital, Munich, Germany
(P 64) ATRX EXPRESSION CORRELATES WITH REDUCED IMMUNE CHECKPOINT EXPRESSION AND POOR SURVIVAL IN HIGH-RISK SOFT TISSUE SARCOMAS
Michael Völkl
Favorite
(P 437) CLINICAL DATA CONFIRM GALENIC PRINCIPLE AND DEMONSTRATE THERAPEUTIC POTENTIAL OF THE001 (DPPG2-TSL-DOX) PLUS REGIONAL HYPERTHERMIA IN SOFT TISSUE SARCOMA
Michael Völkl
Favorite
(P 443) FIRST-LINE PAZOPANIB IN PATIENTS WITH EPITHELIOID HEMANGIOENDOTHELIOMA: A RETROSPECTIVE SINGLE-CENTER ANALYSIS
Michael Völkl
Favorite
Vainer, Gilad W

Pathology Department, Sharett Institute for Oncology, Hadassah Medical Center & Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel
(P 06) RAPID, POINT-OF-CARE DNA METHYLATION & MOLECULAR LANDSCAPE BASED SARCOMA CLASSIFICATION
Gilad W Vainer
Favorite
Valentin, Thibaud

OCR
(P 28) ADVANCING PRECISION ONCOLOGY IN SOFT TISSUE SARCOMAS: THE ROLE OF ITRAC IN METASTATIC RISK STRATIFICATION AND TREATMENT PERSONALIZATION
Thibaud Valentin
Favorite
Valentova, Iva

SOTIO Biotech a.s.
(P 257) TARGETING LEUCINE-RICH REPEAT-CONTAINING PROTEIN 15 (LRRC15): SOT106 ANTIBODY-DRUG CONJUGATE FOR SOFT TISSUE SARCOMA AND OSTEOSARCOMA TREATMENT
Iva Valentova
Favorite
Valenzuela, Raul

MD Anderson Cancer Center
(P 311) A FOLLOW-UP STUDY ON THE NOVEL USE OF CONTRAST-ENHANCED SUSCEPTIBILITY-WEIGHTED IMAGING FOR EXTREMITY DESMOID FIBROMATOSIS RESPONSE ASSESSMENT
Raul Valenzuela
Favorite
(P 317) BUILDING A PRE-SURGICAL MULTIPARAMETRIC-MRI-BASED PREDICTIVE TREATMENT RESPONSE MODEL FOR UNDIFFERENTIATED PLEOMORPHIC SARCOMA TO REPLACE RECIST
Raul Valenzuela
Favorite
(P 334) MRI VOLUMETRIC AND MODIFIED CHOI-BASED ASSESSMENT OF TREATMENT RESPONSE IN EXTREMITY DESMOID TUMORS TREATED WITH NIROGACESTAT OR SORAFENIB
Raul Valenzuela
Favorite
(P 351) THE ROLE OF SOCIOECONOMIC DISPARITIES ON SURVIVAL OUTCOMES IN MALIGNANT PERIPHERAL NERVE SHEATH TUMORS
Raul Valenzuela
Favorite
(P 406) PILOT STUDY: CAN A MULTIPARAMETRIC MRI-DERIVED MODEL OUTPERFORM RECIST PREDICTING PATHOLOGY RESPONSE IN RHABDOMYOSARCOMA?
Raul Valenzuela
Favorite
(P 420) THE EFFECT OF CHEMOTHERAPY AND RADIOTHERAPY IN THE MULTIPARAMETRIC MRI-BASED ASSESSMENT OF TREATMENT RESPONSE IN EXTREMITY SOFT-TISSUE UNDIFFERENTIATED PLEOMORPHIC SARCOMA
Raul Valenzuela
Favorite
Valeri, Sergio

Fondazione Policlinico Universitario Campus Bio-Medico
(P 328) INNOVATING SARCOMA EDUCATION: EARLY OUTCOMES OF THE ITALIAN SOCIETY OF SURGICAL ONCOLOGY (SICO) SARCOMA SOCIAL MULTI-PLATFORM JOURNAL CLUB INITIATIVE
Sergio Valeri
Favorite
Valverde Morales, Claudia

Vall d’Hebron University Hospital
(P 71) GERMLINE POLYMORPHISMS IN THE VEGF PATHWAY AS PROGNOSTIC BIOMARKERS IN LOCALIZED HIGH-GRADE OSTEOSARCOMA: A STUDY BASED ON DATA FROM THE GEIS-33 PROTOCOL
Claudia Valverde Morales
Favorite
(P 389) UNRESECTABLE AND METASTATIC DEDIFFERENTIATED LIPOSARCOMA (DDLPS): INSIGHTS FROM A MULTICENTER REAL-WORLD COHORT (RWC)
Claudia Valverde Morales
Favorite
Valverde-Timana, Yanina

Institut Bergonié
(P 59) TARGETING ADORA2B TO HALT METASTASIS IN UNDIFFERENTIATED PLEOMORPHIC SARCOMA: FROM MULTI-OMICS TO THERAPEUTIC INHIBITION
Yanina Valverde-Timana
Favorite
VAN ACKER, Nathalie

Institut Universitaire du Cancer de Toulouse
(P 12) DNA REPLICATION STRESS AND DEFICIENT HOMOLOGOUS RECOMBINATION IN OSTEOSARCOMA RISK AND THERAPY
Nathalie VAN ACKER
Favorite
van de Rijn, Matt

Stanford University
(P 37) DISSECTING THE TUMOR MICROENVIRONMENT OF UTERINE LEIOMYOSARCOMAS FOR TARGETED DRUG PREDICTIONS
Matt van de Rijn
Favorite
(P 68) MULTI-OMIC INTRA- AND INTER-TUMOR HETEROGENEITY OF BENIGN SMOOTH MUSCLE TUMORS
Matt van de Rijn
Favorite
(P 400) LONGITUDINAL EPIGENETIC AND TRANSCRIPTOMIC REMODELING ACROSS PRIMARY, IRRADIATED, AND LOCALLY RELAPSED SOFT TISSUE SARCOMAS
Matt van de Rijn
Favorite
(P 466) PATHOGENESIS AND THERAPEUTIC TARGETS IN KERATIN-POSITIVE GIANT CELL-RICH TUMOR
Matt van de Rijn
Favorite
van de Sande, Michiel

Leiden University Medical Center
(P 127) AN INTEGRATED CLINICAL GENOMIC AND TRANSCRIPTOMIC SUBGROUPING OF CENTRAL CHONDROSARCOMA
Michiel van de Sande
Favorite
(P 144) THE RISK OF PATHOLOGICAL FRACTURES AFTER INTRALESIONAL CURETTAGE IN ATYPICAL CARTILAGINOUS TUMOURS: A RETROSPECTIVE COHORT STUDY
Michiel van de Sande
Favorite
van den Akker, Brendy

Leiden University Medical Center
(P 127) AN INTEGRATED CLINICAL GENOMIC AND TRANSCRIPTOMIC SUBGROUPING OF CENTRAL CHONDROSARCOMA
Brendy van den Akker
Favorite
van der Graaf, Winette T.A.

Netherlands Cancer Institute
(P 315) ANALYSIS OF CHANGES IN T2-WEIGHTED SIGNAL INTENSITY AND TUMOR VOLUME AND EXPOSURE-RESPONSE IN THE RINGSIDE PHASE 2 STUDY OF VAREGACESTAT FOR DESMOID TUMORS
Winette T.A. van der Graaf
Favorite
(P 410) SUBGROUP ANALYSIS OF THE PHASE 2 PART OF THE RINGSIDE PHASE 2/3 TRIAL OF VAREGACESTAT FOR TREATMENT OF DESMOID TUMORS
Winette T.A. van der Graaf
Favorite
(P 442) TRIAL IN PROGRESS: A SINGLE-ARM, OPEN-LABEL PHASE 4 TRIAL OF NIROGACESTAT IN ADULT PREMENOPAUSAL FEMALES WITH DESMOID TUMORS
Winette T.A. van der Graaf
Favorite
(P 444) HEALTH-RELATED QUALITY OF LIFE (HRQOL) CHALLENGES IN PATIENTS WITH EPITHELIOID HEMANGIOENDOTHELIOMA (EHE): ANALYSIS OF AN ULTRA-RARE SARCOMA GROUP
Winette T.A. van der Graaf
Favorite
van der Linde, Robert

Stanford University
(P 466) PATHOGENESIS AND THERAPEUTIC TARGETS IN KERATIN-POSITIVE GIANT CELL-RICH TUMOR
Robert van der Linde
Favorite
van der Wal, Robert

LUMC
(P 144) THE RISK OF PATHOLOGICAL FRACTURES AFTER INTRALESIONAL CURETTAGE IN ATYPICAL CARTILAGINOUS TUMOURS: A RETROSPECTIVE COHORT STUDY
Robert van der Wal
Favorite
van Dijk, Merel

Radboud University Medical Center
(P 197) DIFFERENTIAL EFFECTS OF ANAGRELIDE IN GASTROINTESTINAL STROMAL TUMORS (GIST) IN VITRO
Merel van Dijk
Favorite
Van Hare, Barbara

Rare Cancer Research Foundation
(P 350) THE PATTERN.ORG SARCOMA CONSORTIUM: BUILDING A MULTI-INSTITUTIONAL DATA RESOURCE FOR THE SARCOMA RESEARCH COMMUNITY
Barbara Van Hare
Favorite
van Houdt, W.J.

The Netherlands Cancer Institute
(P 456) OUTCOMES OF FIRST-LINE CHEMOTHERAPY IN ADVANCED ADULT-TYPE RHABDOMYOSARCOMAS: POOLED ANALYSIS OF CLINICAL TRIALS FROM THE EORTC SOFT TISSUE AND BONE SARCOMA GROUP
W.J. van Houdt
Favorite
van Ijzendoorn, David

Stanford University
(P 466) PATHOGENESIS AND THERAPEUTIC TARGETS IN KERATIN-POSITIVE GIANT CELL-RICH TUMOR
David van Ijzendoorn
Favorite
van Langevelde, Kirsen

LUMC
(P 144) THE RISK OF PATHOLOGICAL FRACTURES AFTER INTRALESIONAL CURETTAGE IN ATYPICAL CARTILAGINOUS TUMOURS: A RETROSPECTIVE COHORT STUDY
Kirsen van Langevelde
Favorite
van Praag, Veroniek

Leiden University Medical Center
(P 127) AN INTEGRATED CLINICAL GENOMIC AND TRANSCRIPTOMIC SUBGROUPING OF CENTRAL CHONDROSARCOMA
Veroniek van Praag
Favorite
van Riet, Bauke

Department of Radiotherapy, the Netherlands Cancer Institute
(P 41) THE IMPACT OF PAZOPANIB AND EXTREMITY RADIOTHERAPY ON TRANSAMINASES
Bauke van Riet
Favorite
van Tilburg, Cornelis

Hopp Children’s Cancer Center Heidelberg (KiTZ), Heidelberg University Hospital and German Cancer Research Center (DKFZ)
(P 417) EFFICACY AND SAFETY OF LAROTRECTINIB (LARO) IN PATIENTS (PTS) WITH TRK FUSION SARCOMAS
Cornelis van Tilburg
Favorite
Van Tine, Brian

Washington University in St Louis School of Medicine
(P 315) ANALYSIS OF CHANGES IN T2-WEIGHTED SIGNAL INTENSITY AND TUMOR VOLUME AND EXPOSURE-RESPONSE IN THE RINGSIDE PHASE 2 STUDY OF VAREGACESTAT FOR DESMOID TUMORS
Brian Van Tine
Favorite
(P 410) SUBGROUP ANALYSIS OF THE PHASE 2 PART OF THE RINGSIDE PHASE 2/3 TRIAL OF VAREGACESTAT FOR TREATMENT OF DESMOID TUMORS
Brian Van Tine
Favorite
(P 413) EFFICACY OF NIROGACESTAT IN PATIENTS WITH DESMOID TUMORS AND PRESENCE OR ABSENCE OF POOR PROGNOSTIC FACTORS: POST HOC ANALYSES OF THE PHASE 3 DEFI TRIAL
Brian Van Tine
Favorite
(P 416) A PHASE 2 MULTICENTER OPEN-LABEL BASKET STUDY OF TAZEMETOSTAT IN ADULT PATIENTS WITH INI1-NEGATIVE EPITHELIOID SARCOMA – FINAL ANALYSIS
Brian Van Tine
Favorite
(P 439) AN OPEN LABEL MULTICENTER PHASE 2 STUDY WITH SAFETY LEAD IN OF INTRATUMORAL VUSOLIMOGENE ODERPAREPVEC IN COMBINATION WITH PEMBROLIZUMAB IN PATIENTS WITH ANGIOSARCOMA
Brian Van Tine
Favorite
Vana, Pranaya

Tata Memorial Hospital
(P 387) TREATMENT PATTERNS AND PROGNOSTIC FACTORS IN LOCALISED SYNOVIAL SARCOMA: A RETROSPECTIVE STUDY FROM A TERTIARY CANCER CENTRE IN INDIA
Pranaya Vana
Favorite
Vance, Filipa

University of Bath
(P 207) LONG-TERM FOLLOW-UP AND LATE EFECTS MONITORING FOR UK BONE SARCOMA PATIENTS: A SERVICE MAPPING EXCERCISE
Filipa Vance
Favorite
Vanhersecke, Lucile

Institut Bergonié
(P 59) TARGETING ADORA2B TO HALT METASTASIS IN UNDIFFERENTIATED PLEOMORPHIC SARCOMA: FROM MULTI-OMICS TO THERAPEUTIC INHIBITION
Lucile Vanhersecke
Favorite
(P 324) FULLY MATURE TERTIARY LYMHOID STRUCTURES AS PREDICTORS OF LOCAL RECURRENCE IN SOFT TISSUE SARCOMAS
Lucile VANHERSECKE
Favorite
Vanleeuw, Ulla

KU Leuven
(P 33) THE NOVEL TRANSCRIPTIONAL INHIBITORS ECUBECTEDIN AND PM54 DEMONSTRATE ANTITUMOR ACTIVITY IN PATIENT-DERIVED XENOGRAFT MODELS OF SOFT TISSUE SARCOMA
Ulla Vanleeuw
Favorite
(P 70) EPIDEMIOLOGY AND POTENTIAL CLINICAL RELEVANCE OF CONTACTIN-4 EXPRESSION IN SOFT TISSUE SARCOMA
Ulla Vanleeuw
Favorite
Vanzulli, Andrea

Fondazione IRCCS Istituto nazionale dei tumori
(P 308) IMPACT OF PSOAS MUSCLE RESECTION ON OUTCOMES IN PRIMARY RETROPERITONEAL DEDIFFERENTIATED LIPOSARCOMA
Andrea Vanzulli
Favorite
(P 446) GDF-15 AS A PROGNOSTIC FACTOR IN PATIENTS WITH EPITHELIOID HEMANGIOENDOTHELIOMA
Andrea Vanzulli
Favorite
(P 447) PAIN ASSESSMENT CRITERIA (PAC) ANTICIPATE RECIST PROGRESSION AND CORRELATE WITH BLOOD LEVELS OF GROWTH DIFFERENTIATION FACTOR 15 (GDF15) IN EPITHELIOID HEMANGIOENDOTHELIOMA (EHE)
Andrea Vanzulli
Favorite
Vaseva, Angelina

Knight Cancer Institute at Oregon Health & Science University
(P 405) PAN-RAS INHIBITION AS A NOVEL THERAPEUTIC STRATEGY FOR RAS-DRIVEN RHABDOMYOSARCOMA
Angelina Vaseva
Favorite
Vasquez, Juan

Yale School of Medicine
(P 40) PRECLINICAL EFFICACY OF A PH-SENSITIVE EXATECAN PEPTIDE-DRUG-CONJUGATE IN RHABDOMYOSARCOMA
Juan Vasquez
Favorite
Vaz salgado, Maria Angeles

Hospital Universitario Ramón y Cajal
(P 71) GERMLINE POLYMORPHISMS IN THE VEGF PATHWAY AS PROGNOSTIC BIOMARKERS IN LOCALIZED HIGH-GRADE OSTEOSARCOMA: A STUDY BASED ON DATA FROM THE GEIS-33 PROTOCOL
Maria Angeles Vaz salgado
Favorite
Vaz, Fátima

Instituto Português de Oncologia de Lisboa Francisco Gentil
(P 372) CLINICOPATHOLOGICAL FEATURES AND OUTCOMES OF PATIENTS WITH KAPOSI SARCOMA: A SINGLE CENTER RETROSPECTIVE REAL WORLD ANALYSIS
Fátima Vaz
Favorite
Vaz, Maria Angeles

Hospital Universitario Ramón y Cajal
(P 389) UNRESECTABLE AND METASTATIC DEDIFFERENTIATED LIPOSARCOMA (DDLPS): INSIGHTS FROM A MULTICENTER REAL-WORLD COHORT (RWC)
Maria Angeles Vaz
Favorite
Veazey, Kylee

Ipsen
(P 464) EFFICACY OUTCOMES AMONG PATIENTS WITH ADVANCED EPITHELIOID SARCOMAS OF PROXIMAL-TYPE AND DISTAL-TYPE TREATED WITH TAZ: POST HOC ANALYSIS OF STUDY EZH-202
Kylee Veazey
Favorite
Veguilla, Fabiana

The University of Texas MD Anderson Cancer Center
(P 172) COMPARISON OF CELL SEGMENTATION METHODS IN SOFT TISSUE SARCOMA (STS) SPATIAL PROTEOMIC DATASETS
Fabiana Veguilla
Favorite
Velez Torres, Jaylou

University of Miami
(P 154) BCOR-MUTATED CONVENTIONAL AND DEDIFFERENTIATED CHONDROSARCOMA: A CLINICOPATHOLOGIC STUDY
Jaylou Velez Torres
Favorite
Venkataraman, Vinayak

Dana-Farber Cancer Institute
(P 235) AGNOSTIC INDICATION OF IMMUNE CHECKPOINT INHIBITORS (ICI): PATTERNS OF RESPONSE OF SARCOMAS
Vinayak Venkataraman
Favorite
Venkatramani, Raj

Texas Children's Cancer Center, Baylor College of Medicine
(P 250) OUTCOME OF INFANTS WITH RHABDOMYOSARCOMA: A REPORT FROM THE INTERNATIONAL SOFT TISSUE SARCOMA CONSORTIUM
Raj Venkatramani
Favorite
Vennam, Sujay

Stanford University
(P 68) MULTI-OMIC INTRA- AND INTER-TUMOR HETEROGENEITY OF BENIGN SMOOTH MUSCLE TUMORS
Sujay Vennam
Favorite
Venneker, Sanne

Leiden University Medical Center
(P 127) AN INTEGRATED CLINICAL GENOMIC AND TRANSCRIPTOMIC SUBGROUPING OF CENTRAL CHONDROSARCOMA
Sanne Venneker
Favorite
Vennik, Annabel

Massachusetts general hospital - Harvard medical school & Amsterdam University Medical Center Amsterdam
(P 294) RISK FACTORS FOR RECURRENCE AND COMPLICATIONS OF CT-GUIDED RADIOFREQUENCY ABLATION FOR THE TREATMENT OF OSTEOID OSTEOMA: A MULTI-INSTITUTIONAL ANALYSIS.
Annabel Vennik
Favorite
Verbeeck, Kimberly

KU Leuven
(P 33) THE NOVEL TRANSCRIPTIONAL INHIBITORS ECUBECTEDIN AND PM54 DEMONSTRATE ANTITUMOR ACTIVITY IN PATIENT-DERIVED XENOGRAFT MODELS OF SOFT TISSUE SARCOMA
Kimberly Verbeeck
Favorite
(P 70) EPIDEMIOLOGY AND POTENTIAL CLINICAL RELEVANCE OF CONTACTIN-4 EXPRESSION IN SOFT TISSUE SARCOMA
Kimberly Verbeeck
Favorite
Verbeke, Stéphanie

Institut Bergonié, INSERM U1312 BRIC
(P 42) PRECLINICAL VALIDATION OF M3554, A NOVEL ANTI-GD2 ANTIBODY-DRUG CONJUGATE, AND EPIGENETIC SENSITIZATION STRATEGIES IN SOFT TISSUE SARCOMAS
Stéphanie Verbeke
Favorite
(P 59) TARGETING ADORA2B TO HALT METASTASIS IN UNDIFFERENTIATED PLEOMORPHIC SARCOMA: FROM MULTI-OMICS TO THERAPEUTIC INHIBITION
Stéphanie Verbeke
Favorite
Verheul, Henk

Erasmus MC Cancer Institute, Erasmus Medical Center
(P 194) UPDATED RESULTS FROM STRATEGIST 1: A PHASE 1/1B STUDY OF IDRX-42 (GSK6042981A) IN PATIENTS (PTS) WITH ADVANCED GASTROINTESTINAL STROMAL TUMORS (GIST)
Henk Verheul
Favorite
Verhey, Ted

Arnie Charbonneau Cancer Institute and McCaig Institute for Bone and Joint Health
(P 238) INVESTIGATING HOW MACROPHAGES INFILTRATE THE TUMOUR MICROENVIRONMENT AND INFLUENCE THE EFFICACY OF CAR T THERAPY IN A MURINE MODEL OF STS
Ted Verhey
Favorite
(P 378) HIGH DOSE RADIATION THERAPY PROMOTES IMMUNE SUPPRESSIVE MACROPHAGE PHENOTYPES, WHEREAS LOW DOSE RADIATION THERAPY PROMOTES IMMUNOGENIC MACROPHAGE PHENOTYPES IN A MURINE MODEL OF SOFT TISSUE SARCOMA
Ted Verhey
Favorite
Verret, Benjamin

Gustave roussy
(P 299) RECURRENCES AFTER PRIMARY RPS SURGERY IN A HIGH-VOLUME SARCOMA CENTER: A RETROSPECTIVE ANALYSIS ON 402 PATIENTS
Benjamin Verret
Favorite
Verspoor, Floortje

Amsterdam University Medical Center Amsterdam
(P 294) RISK FACTORS FOR RECURRENCE AND COMPLICATIONS OF CT-GUIDED RADIOFREQUENCY ABLATION FOR THE TREATMENT OF OSTEOID OSTEOMA: A MULTI-INSTITUTIONAL ANALYSIS.
Floortje Verspoor
Favorite
Verweij, Jaap

IDRx
(P 194) UPDATED RESULTS FROM STRATEGIST 1: A PHASE 1/1B STUDY OF IDRX-42 (GSK6042981A) IN PATIENTS (PTS) WITH ADVANCED GASTROINTESTINAL STROMAL TUMORS (GIST)
Jaap Verweij
Favorite
Vianna, Karina

Centro Integrado de Oncologia de Curitiba
(P 128) ISOCITRATE DEHYDROGENASE 1 (IDH1) MUTATION TESTING IN THE PHASE 3 STUDY OF IVOSIDENIB VS PLACEBO IN IDH1-MUTANT CONVENTIONAL CHONDROSARCOMA (CHONQUER)
Karina Vianna
Favorite
Viator, Melissa

MGH
(P 392) CLASSIFICATION AND DIFFERENTIATIONOF MYXOID LIPOSARCOMA AND MYXOMA WITH MACHINE LEARNING
Melissa Viator
Favorite
(P 392) DIFFERENTIATION OF MYXOMA AND MYXOID LIPOSARCOMA BASED ON RADIOMICS PHENOTYPES
Melissa Viator
Favorite
vibert, Julien

Gustave Roussy
(P 299) RECURRENCES AFTER PRIMARY RPS SURGERY IN A HIGH-VOLUME SARCOMA CENTER: A RETROSPECTIVE ANALYSIS ON 402 PATIENTS
Julien vibert
Favorite
Victor, Adrienne

University of Rochester
(P 04) EARLY ON-TREATMENT CIRCULATING TUMOR DNA DYNAMICS TO PREDICT RESPONSE IN PATIENTS WITH SARCOMA
Adrienne Victor
Favorite
Victor, Kristen

Memorial Sloan Kettering Cancer Center
(P 25) IDENTIFICATION AND VALIDATION OF NON-GENETICALLY ENCODED VULNERABILITIES IN EWING SARCOMA
Kristen Victor
Favorite
(P 48) PRECLINICAL ACTIVITY OF MEK INHIBITION IN COMBINATION WITH CHEMOTHERAPY IN MALIGNANT PERIPHERAL NERVE SHEATH TUMOR
Kristen Victor
Favorite
Vigorito, Raffaella

Fondazione IRCCS Istituto Nazionale Tumori
(P 331) MAINTENANCE THERAPY (M-TP) WITH DACARBAZINE (DTIC) AFTER FIRST-LINE ANTHRACYCLINE-BASED DOUBLET IN ADVANCED LEIOMYOSARCOMA (LMS) PATIENTS (PTS): OUTCOMES OF A CASE SERIES IN A SINGLE REFERRAL CENTER
Raffaella Vigorito
Favorite
Villavicencio-Valencia, Veronica

National Cancer Institute Mexico
(P 302) PREDICTORS AND OUTCOMES OF RECURRENT RETROPERITONEAL SARCOMA: A SINGLE-CENTER LATIN AMERICAN COHORT STUDY
Veronica Villavicencio-Valencia
Favorite
Vilson, Reshma

University of North Texas Health Science center Fort Worth
(P 460) OUTCOMES OF LATER-LINES SYSTEMIC THERAPIES IN MALIGNANT PERIPHERAL NERVE SHEATH TUMORS (MPNST)
Reshma Vilson
Favorite
Vinader, Victoria

Bone Cancer Research Trust
(P 207) LONG-TERM FOLLOW-UP AND LATE EFECTS MONITORING FOR UK BONE SARCOMA PATIENTS: A SERVICE MAPPING EXCERCISE
Victoria Vinader
Favorite
Vincenzi, Bruno

Fondazione Policlinico Universitario Campus Bio-Medico
(P 61) HER2 TARGETING IN CHORDOMA: PRECLINICAL INSIGHTS ON TRASTUZUMAB DERUXTECAN
Bruno Vincenzi
Favorite
(P 70) EPIDEMIOLOGY AND POTENTIAL CLINICAL RELEVANCE OF CONTACTIN-4 EXPRESSION IN SOFT TISSUE SARCOMA
Bruno Vincenzi
Favorite
(P 231) INCREASED LIFETIME RISK (LTR) OF SOFT TISSUE SARCOMAS (STS) IN PATIENTS WITH LOW-RISK GASTROINTESTINAL STROMAL TUMORS (GIST): A RETROSPECTIVE ANALYSIS FROM THE ITALIAN SARCOMA GROUP (ISG)
Bruno Vincenzi
Favorite
(P 412) UNCOVERING HER2 OVEREXPRESSION IN SOFT TISSUE SARCOMAS (STS): INSIGHTS FROM THE CANCER GENOME ATLAS (TCGA)
Bruno Vincenzi
Favorite
Vincenzi, Bruno

Policlinico Universitario Campus Bio-Medico
(P 413) EFFICACY OF NIROGACESTAT IN PATIENTS WITH DESMOID TUMORS AND PRESENCE OR ABSENCE OF POOR PROGNOSTIC FACTORS: POST HOC ANALYSES OF THE PHASE 3 DEFI TRIAL
Bruno Vincenzi
Favorite
Vincenzi, Bruno

Fondazione Policlinico Universitario Campus Bio-Medico
(P 458) BETWEEN LYMPHOMAS AND SARCOMAS: A RETROSPECTIVE, MULTI-INSTITUTIONAL STUDY FROM THE ITALIAN SARCOMA GROUP (ISG) ON HISTIOCYTIC AND DENDRITIC CELL NEOPLASMS (HDCN)
Bruno Vincenzi
Favorite
Visgauss, Julia

Duke University
(P 84) A MULTICENTER COMPARISON OF REVERSE TOTAL SHOULDER ARTHROPLASTY VERSUS HEMIARTHROPLASTY FOR ENDOPROSTHETIC RECONSTRUCTION FOLLOWING ONCOLOGIC RESECTION OF THE PROXIMAL HUMERUS
Julia Visgauss
Favorite
(P 125) TARGETING LCP1-MEDIATED METASTASIS IN CHONDROSARCOMA WITH OROXYLIN A
Julia Visgauss
Favorite
(P 126) SINGLE-CELL RNA SEQUENCING AND PROTEOMIC SPATIAL PROFILING REVEAL COMPLEX TUMOR MICROENVIRONMENT AND NOVEL IMMUNE INTERACTIONS IN CHONDROSARCOMA
Julia Visgauss
Favorite
(P 130) INVESTIGATING LCP1-MEDIATED ONCOGENIC SIGNALING IN CHONDROSARCOMA METASTASIS
Julia Visgauss
Favorite
(P 138) A MULTI-INSTITUTIONAL ARCHIVE AND DEEP LEARNING PIPELINE FOR QUANTIFYING CHONDROSARCOMA COMPOSITION
Julia Visgauss
Favorite
(P 177) DEEP LEARNING AND DIMENSIONALITY REDUCTION FOR SARCOMA SUBTYPING
Julia Visgauss
Favorite
(P 214) FINANCIAL TOXICITY IN PATIENTS WITH A HISTORY OF EXTREMITY AND PELVIC SARCOMA TREATMENT
Julia Visgauss
Favorite
Vitfell-Rasmussen, Joanna

Department of Oncology, Herlev University Hospital
(P 05) CONCORDANCE OF GENOMIC ALTERATIONS WITH CIRCULATING TUMOR DNA: INITIAL FINDINGS FROM A PILOT STUDY
Joanna Vitfell-Rasmussen
Favorite
(P 319) CARDIOTOXICITY AND OVERALL SURVIVAL IN PATIENTS WITH SARCOMA TREATED WITH DOXORUBICIN, OLARATUMAB AND DEXRAZOXANE: A REAL-WORLD EXPERIENCE IN DENMARK
Joanna Vitfell-Rasmussen
Favorite
Viza Gomes, Paula

Duke University School of Medicine
(P 138) A MULTI-INSTITUTIONAL ARCHIVE AND DEEP LEARNING PIPELINE FOR QUANTIFYING CHONDROSARCOMA COMPOSITION
Paula Viza Gomes
Favorite
(P 177) DEEP LEARNING AND DIMENSIONALITY REDUCTION FOR SARCOMA SUBTYPING
Paula Viza Gomes
Favorite
Vogl, Annette

Tubulis GmbH
(P 34) EXPRESSION OF ONCOFETAL ANTIGEN 5T4 IN SARCOMA SUBTYPES AND PRECLINICAL ACTIVITY OF TUB-030, A NOVEL 5T4-TARGETING ANTIBODY-DRUG CONJUGATE (ADC)
Annette Vogl
Favorite
Vokuhl, Christian

University Bonn
(P 250) OUTCOME OF INFANTS WITH RHABDOMYOSARCOMA: A REPORT FROM THE INTERNATIONAL SOFT TISSUE SARCOMA CONSORTIUM
Christian Vokuhl
Favorite
Volken, Larissa

Children's Cancer Institute
(P 266) TARGETING THE DNA DAMAGE RESPONSE TO ADVANCE PRECISION THERAPIES IN PAEDIATRIC SARCOMA
Larissa Volken
Favorite
von Bergwelt-Baildon, Michael

Department of Medicine III, LMU University Hospital, Munich, Germany
(P 64) ATRX EXPRESSION CORRELATES WITH REDUCED IMMUNE CHECKPOINT EXPRESSION AND POOR SURVIVAL IN HIGH-RISK SOFT TISSUE SARCOMAS
Michael von Bergwelt-Baildon
Favorite
(P 437) CLINICAL DATA CONFIRM GALENIC PRINCIPLE AND DEMONSTRATE THERAPEUTIC POTENTIAL OF THE001 (DPPG2-TSL-DOX) PLUS REGIONAL HYPERTHERMIA IN SOFT TISSUE SARCOMA
Michael von Bergwelt-Baildon
Favorite
(P 443) FIRST-LINE PAZOPANIB IN PATIENTS WITH EPITHELIOID HEMANGIOENDOTHELIOMA: A RETROSPECTIVE SINGLE-CENTER ANALYSIS
Michael von Bergwelt-Baildon
Favorite
von Kalle, Thekla

Institute of Radiology Olgahospital
(P 250) OUTCOME OF INFANTS WITH RHABDOMYOSARCOMA: A REPORT FROM THE INTERNATIONAL SOFT TISSUE SARCOMA CONSORTIUM
Thekla von Kalle
Favorite
von Mehren, Margaret

Division of Sarcoma Medical Oncology, Fox Chance Cancer Center
(P 194) UPDATED RESULTS FROM STRATEGIST 1: A PHASE 1/1B STUDY OF IDRX-42 (GSK6042981A) IN PATIENTS (PTS) WITH ADVANCED GASTROINTESTINAL STROMAL TUMORS (GIST)
Margaret von Mehren
Favorite
(P 423) ZIFTOMENIB IN COMBINATION WITH IMATINIB IN ADVANCED GASTROINTESTINAL STROMAL TUMORS (GIST) AFTER IMATINIB FAILURE: PHASE 1A/B STUDY OF SAFETY, PHARMACOKINETICS, AND ANTITUMOR ACTIVITY
Margaret von Mehren
Favorite
Vornicova, Olga

Division of Medical Oncology, BC Cancer, University of British Columbia, Vancouver, British Columbia, Canada.
(P 395) ERIBULIN IN RECURRENT PRETREATED METASTATIC SOFT TISSUE SARCOMA. A CANADIAN SARCOMA RESEARCH AND CLINICAL COLLABORATION (CANSARCC) REAL WORLD ANALYSIS
Olga Vornicova
Favorite
Voss, Rachel

Moffitt Cancer Center
(P 394) DUAL OR TRIMODALITY THERAPY VERSUS SURGERY ALONE IN RADIATION-ASSOCIATED ANGIOSARCOMA OF THE BREAST
Rachel Voss
Favorite
(P 453) OUTCOMES OF PLEOMORPHIC LIPOSARCOMA PATIENTS FOLLOWING MULTI-DISCIPLINARY MANAGEMENT WITHIN A TERTIARY CANCER CENTER
Rachel Voss
Favorite
Vyrva, Oleg

Ukrainian Academy of Medical Sciences
(P 151) SHOULD WE USE ADJUVANT CHEMOTHERAPY IN PATIENTS WITH LOCALIZED DEDIFFERENTIATED CHONDROSARCOMA (DDCS) OF THE PELVIS? AN ANALYSIS BY THE PELVIC DDCS STUDY GROUP
Oleg Vyrva
Favorite
W
Wągrodzki, Michał

Department of Radiotherapy I, Maria Sklodowska-Curie National Research Institute of Oncology, 02-718 Warsaw, Poland
(P 146) LOCALISED CHONDROSARCOMA PERIOPERATIVE TREATMENT: REAL-WORLD OUTCOMES AND CHALLENGES ACROSS HISTOLOGIC SUBTYPES
Michał Wągrodzki
Favorite
Wagner, Andrew

Dana-Farber Cancer Institute
(P 184) MTAP IN GASTROINTESTINAL STROMAL TUMOR (GIST): RATE OF MTAP LOSS AND CONCORDANCE BETWEEN GENOMIC SEQUENCING AND IMMUNOHISTOCHEMISTRY
Andrew Wagner
Favorite
(P 422) EFFICACY WITH VIMSELTINIB IN PATIENTS (PTS) WITH TENOSYNOVIAL GIANT CELL TUMOR (TGCT) AND PRIOR COLONY-STIMULATING FACTOR 1 (CSF1) INHIBITOR THERAPY: A PHASE 2 CASE SERIES
Andrew Wagner
Favorite
(P 425) BEZUCLASTINIB EXPANDED ACCESS PROGRAM (EAP) FOR PATIENTS WITH GASTROINTESTINAL STROMAL TUMORS (GIST)
Andrew Wagner
Favorite
Wagner, Michael

Dana-Farber Cancer Institute
(P 235) AGNOSTIC INDICATION OF IMMUNE CHECKPOINT INHIBITORS (ICI): PATTERNS OF RESPONSE OF SARCOMAS
Michael Wagner
Favorite
(P 287) A PHASE 1 STUDY OF NEOADJUVANT CABOZANTINIB IN COMBINATION WITH RADIATION THERAPY FOR SARCOMAS OF THE EXTREMITIES
Michael Wagner
Favorite
(P 427) PHASE 1/2 TRIAL TO EVALUATE THE SAFETY AND EFFICACY OF PEEL-224 IN COMBINATION WITH VINCRISTINE AND TEMOZOLOMIDE IN ADOLESCENTS AND YOUNG ADULTS WITH RELAPSED OR REFRACTORY SARCOMAS
Michael Wagner
Favorite
Wagner, Othilia Elise

Dept. of Clinical Physiology & Nuclear Medicine, Rigshospitalet - Copenhagen University Hospital
(P 322) DYNAMIC PET/MRI REVEALS METABOLIC-DIFFUSION INTERACTIONS IN SUSPECTED SOFT TISSUE SARCOMAS
Othilia Elise Wagner
Favorite
Wagrodzki, Michal

Maria Sklodowska-Curie National Research Institute of Oncology,
(P 27) MOLECULAR CHARACTERIZATION OF RESPONSE TO NEOADJUVANT CHEMORADIATION IN PATIENTS WITH LOCALLY ADVANCED SOFT TISSUE SARCOMAS
Michal Wagrodzki
Favorite
(P 139) IMMUNOGENOMIC PROFILING OF CHONDROSARCOMA REVEALS DISTINCT IMMUNE PHENOTYPES AND PROGNOSTIC MUTATIONS
Michal Wagrodzki
Favorite
(P 149) SURGICAL TEXTBOOK OUTCOMES IN PATIENTS DIAGNOSED WITH CHONDROSARCOMA
Michal Wagrodzki
Favorite
(P 152) EFFICACY OF PALLIATIVE CHEMOTHERAPY AND LOCAL TREATMENTS IN ADVANCED CHONDROSARCOMA: A SUBTYPE-SPECIFIC RETROSPECTIVE ANALYSIS
Michal Wagrodzki
Favorite
(P 164) LONG TERM OUTCOMES IN PATIENTS DIAGNOSED WITH SECONDARY CHONDROSARCOMA
Michal Wagrodzki
Favorite
Wagrodzki, Michal

Maria Sklodowska-Curie National Research Institute of Oncology
(P 470) OFF-LABEL TREATMENT AND ULTRARARE SARCOMAS - SINGLE INSTITUTION REPORT
Michal Wagrodzki
Favorite
Waheed Rajper, Abdul

Clinical Safety & Pharmacovigilance, Daiichi Sankyo, Inc., Basking Ridge, NJ, USA
(P 336) PEXIDARTINIB RISK EVALUATION AND MITIGATION STRATEGY PROGRAM: 5-YEAR RETROSPECTIVE HEPATIC SAFETY ASSESSMENT
Abdul Waheed Rajper
Favorite
(P 381) KNOWLEDGE, ATTITUDES, AND BEHAVIOR OF HEALTHCARE PROVIDERS ENROLLED IN THE PEXIDARTINIB RISK MITIGATION AND EVALUATION PROGRAM
Abdul Waheed Rajper
Favorite
Walker, Robert

University of Miami
(P 117) THERAPEUTIC POTENTIAL OF DOXORUBICIN AND DASATINIB COMBINATION IN OSTEOSARCOMA
Robert Walker
Favorite
Walker, Robert L.

University of Miami
(P 131) GLUCOSE TRANSPORTER 1 (GLUT1) INHIBITION DECREASES THE GROWTH AND PROLIFERATION OF CHONDROSARCOMA
Robert L. Walker
Favorite
Walkley, Janelle

Memorial Sloan Kettering Cancer Center
(P 08) BUILDING A MEDICAL DONATION NETWORK TO ENHANCE DEVELOPMENT OF PEDIATRIC TUMOR MODELS
Janelle Walkley
Favorite
Wallace, Asjah

Duke University
(P 380) INVESTIGATING THE ROLE OF HISTONE DEACETYLASE-3 IN METASTATIC UNDIFFERENTIATED PLEOMORPHIC SARCOMA
Asjah Wallace
Favorite
Walter, Harriet

University Hospitals of Leicester NHS Trust
(P 431) INVOKE: A PHASE 1 STUDY OF OKN4395, A FIRST-IN-CLASS EP2/EP4/DP1 TRIPLE PROSTANOID RECEPTOR ANTAGONIST, IN PATIENTS WITH ADVANCED SOLID TUMORS, INCLUDING SARCOMAS
Harriet Walter
Favorite
Walter, Stephanie

Seattle Children's Research Institute
(P 260) MECHANISM AND EFFICACY OF ANTHRACYCLINE MEDIATED EPIGENETIC DISRUPTION IN BONE SARCOMAS.
Stephanie Walter
Favorite
Wan, Derrick

Stanford University
(P 37) DISSECTING THE TUMOR MICROENVIRONMENT OF UTERINE LEIOMYOSARCOMAS FOR TARGETED DRUG PREDICTIONS
Derrick Wan
Favorite
Wang, Bo

Department of Anesthesiology, Peking University International Hospital
(P 305) COMPARISON OF GOAL-DIRECTED VERSUS EMPIRICAL TRANSFUSION MANAGEMENT IN PATIENTS WITH SEVERE HEMORRHAGE DURING RETROPERITONEAL TUMOR SURGERY
Bo Wang
Favorite
(P 469) THE IMPACT OF PREOPERATIVE ANEMIA ON POSTOPERATIVE COMPLICATIONS AND SHORT-TERM PROGNOSIS IN RETROPERITONEAL TUMOR SURGERY PATIENTS.
Bo Wang
Favorite
Wang, Chao-Chi

KU Leuven
(P 33) THE NOVEL TRANSCRIPTIONAL INHIBITORS ECUBECTEDIN AND PM54 DEMONSTRATE ANTITUMOR ACTIVITY IN PATIENT-DERIVED XENOGRAFT MODELS OF SOFT TISSUE SARCOMA
Chao-Chi Wang
Favorite
(P 70) EPIDEMIOLOGY AND POTENTIAL CLINICAL RELEVANCE OF CONTACTIN-4 EXPRESSION IN SOFT TISSUE SARCOMA
Chao-Chi Wang
Favorite
Wang, Daniel

University of Texas Southwestern Medical Center
(P 03) CONGRUENCE OF CIRCULATING TUMOR DNA & RADIOGRAPHIC RESPONSE IN BONE AND SOFT TISSUE SARCOMA
Daniel Wang
Favorite
(P 280) PERSONALIZED ULTRA-FRACTIONATED STEREOTACTIC ADAPTIVE RADIOTHERAPY (PULSAR) FOR ADULT AND PEDIATRIC SARCOMAS
Daniel Wang
Favorite
Wang, Danny

Massachusetts General Hospital
(P 118) IMPACT OF TYROSINE KINASE INHIBITOR THERAPY ON BONE PROGRESSION IN PATIENTS WITH DRIVER-MUTATED METASTATIC NON-SMALL CELL LUNG CANCER WITH DE NOVO BONE METASTASES
Danny Wang
Favorite
Wang, Ergang

Duke University
(P 126) SINGLE-CELL RNA SEQUENCING AND PROTEOMIC SPATIAL PROFILING REVEAL COMPLEX TUMOR MICROENVIRONMENT AND NOVEL IMMUNE INTERACTIONS IN CHONDROSARCOMA
Ergang Wang
Favorite
Wang, Frank

Pyxis Oncology
(P 29) ANTI-TUMOR ACTIVITY OF MICVOTABART PELIDOTIN IS ASSOCIATED WITH ENZYME GENE EXPRESSION IN PATIENT-DERIVED XENOGRAFT SARCOMA MODELS
Frank Wang
Favorite
Wang, Huanmin

Beijing Children’s Hospital, Capital Medical University
(P 419) PROSPECTIVE REAL-WORLD STUDY OF LAROTRECTINIB (LARO) IN PATIENTS (PTS) WITH TRK FUSION SOLID TUMORS: INTERIM ANALYSIS OF ON-TRK
Huanmin Wang
Favorite
Wang, Jing

The University of Texas MD Anderson Cancer Center
(P 172) COMPARISON OF CELL SEGMENTATION METHODS IN SOFT TISSUE SARCOMA (STS) SPATIAL PROTEOMIC DATASETS
Jing Wang
Favorite
Wang, Jing

Hunan Provincial People's Hospital
(P 407) PIMICOTINIB IN TENOSYNOVIAL GIANT CELL TUMOR (TGCT): LONG-TERM EFFICACY, SAFETY, AND PATIENT-REPORTED OUTCOMES FROM THE PHASE 3 MANEUVER STUDY
Jing Wang
Favorite
Wang, Jiping

Brigham and Women's Hospital
(P 228) FREQUENCY AND CLARITY OF SURGICAL GOALS FOR TUMOR RESECTION IN ADVANCED SARCOMA
Jiping Wang
Favorite
Wang, Jun

Peking University People's Hospital
(P 75) CD248 AS A PROGNOSTIC MARKER IN OSTEOSARCOMA
Jun Wang
Favorite
Wang, Ruoxi

Adaptimmune
(P 247) SINGLE-CELL RNA SEQUENCING OF AFAMITRESGENE AUTOLEUCEL INDICATES MECHANISMS OF PERSISTENCE AND ANTI-TUMOR ACTIVITY
Ruoxi Wang
Favorite
Wang, Victoria

Division of Hematology/Oncology, UCSF
(P 439) AN OPEN LABEL MULTICENTER PHASE 2 STUDY WITH SAFETY LEAD IN OF INTRATUMORAL VUSOLIMOGENE ODERPAREPVEC IN COMBINATION WITH PEMBROLIZUMAB IN PATIENTS WITH ANGIOSARCOMA
Victoria Wang
Favorite
Wang, Wei-Lien

MD Anderson Cancer Center
(P 38) VALIDATION OF THE SIGNIOS SEVEN-GENE SIGNATURE FOR PREDICTING ANTI-PD-1 INHIBITOR EFFICACY IN SARCOMA
Wei-Lien Wang
Favorite
(P 54) PRECLINICAL MODELS REVEALING MDM2-P53 INTERACTION AND DEPENDENCY FOR TUMOR CELL SURVIVAL IN WELL-DIFFERENTIATED (WD) AND DEDIFFERENTIATED (DD) LIPOSARCOMA (LPS).
Wei-Lien Wang
Favorite
(P 83) OUTCOMES OF MULTIMODAL PERIOPERATIVE TREATMENT IN OSTEOSARCOMAS OF THE JAW
Wei-Lien Wang
Favorite
(P 184) MTAP IN GASTROINTESTINAL STROMAL TUMOR (GIST): RATE OF MTAP LOSS AND CONCORDANCE BETWEEN GENOMIC SEQUENCING AND IMMUNOHISTOCHEMISTRY
Wei-Lien Wang
Favorite
Wang, Xiaoru

Department of Anesthesiology, Peking University International Hospital,
(P 305) COMPARISON OF GOAL-DIRECTED VERSUS EMPIRICAL TRANSFUSION MANAGEMENT IN PATIENTS WITH SEVERE HEMORRHAGE DURING RETROPERITONEAL TUMOR SURGERY
Xiaoru Wang
Favorite
Wang, Xinyi

Memorial Sloan Kettering Cancer Center
(P 08) BUILDING A MEDICAL DONATION NETWORK TO ENHANCE DEVELOPMENT OF PEDIATRIC TUMOR MODELS
Xinyi Wang
Favorite
Wang, Zhuoying

Department of Orthopaedics, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
(P 07) A LIVING MULTI-OMICS BIOBANK OF PATIENT-DERIVED XENOGRAFT MODELS FOR SARCOMA
Zhuoying Wang
Favorite
Wani, Khalida

MD Anderson Cancer Center
(P 38) VALIDATION OF THE SIGNIOS SEVEN-GENE SIGNATURE FOR PREDICTING ANTI-PD-1 INHIBITOR EFFICACY IN SARCOMA
Khalida Wani
Favorite
(P 172) COMPARISON OF CELL SEGMENTATION METHODS IN SOFT TISSUE SARCOMA (STS) SPATIAL PROTEOMIC DATASETS
Khalida Wani
Favorite
(P 184) MTAP IN GASTROINTESTINAL STROMAL TUMOR (GIST): RATE OF MTAP LOSS AND CONCORDANCE BETWEEN GENOMIC SEQUENCING AND IMMUNOHISTOCHEMISTRY
Khalida Wani
Favorite
(P 242) IMMUNE PROFILING OF UNDIFFERENTIATED PLEOMORPHIC SARCOMAS REVEALS DISTINCT PROGNOSTIC SUBGROUPS
Khalida Wani
Favorite
(P 411) TFCP2 FUSION-POSITVE RHABDOMYOSARCOMAS: A REPORT OF 10 CASES AND A REVIEW OF THE LITERATURE
Khalida Wani
Favorite
Wannaphut, Chalothorn

University of Hawai`i John A.Burns School of Medicine
(P 274) RACIAL DISPARITIES IN INCIDENCE AND MORTALITY OVER 20 YEARS AMONG AYA PATIENTS WITH SARCOMA IN THE US: A SEER DATABASE ANALYSIS
Chalothorn Wannaphut
Favorite
(P 451) TREATMENT OUTCOMES OF GEMCITABINE AND DOCETAXEL IN PATIENTS WITH CLEAR CELL SARCOMA (CCS) OR GASTROINTESTINAL NEUROECTODERMAL TUMOR (GNET): A CASE SERIES
Chalothorn Wannaphut
Favorite
Warren, Mary

Memorial Sloan Kettering Cancer Center
(P 08) BUILDING A MEDICAL DONATION NETWORK TO ENHANCE DEVELOPMENT OF PEDIATRIC TUMOR MODELS
Mary Warren
Favorite
Wartenberg, Markus

Deutsche Sarkom-Stiftung (DSS) / German Sarcoma Foundation, patient support.
(P 454) TREATMENT PATTERNS AND OUTCOMES IN RADIATION-INDUCED SARCOMA: FIRST RESULTS OF THE TETRIS-PROJECT - A MULTIMODAL RETROSPECTIVE ANALYSIS FROM A TERTIARY CENTER
Markus Wartenberg
Favorite
Wasa, Junji

Shizuoka Cancer Center
(P 291) INTRA-ARTERIAL CHEMOTHERAPY WITH CONCOMITANT RADIATION THERAPY FOR UNRESECTABLE SARCOMA
Junji Wasa
Favorite
Watson, Caleb

Duke
(P 125) TARGETING LCP1-MEDIATED METASTASIS IN CHONDROSARCOMA WITH OROXYLIN A
Caleb Watson
Favorite
(P 130) INVESTIGATING LCP1-MEDIATED ONCOGENIC SIGNALING IN CHONDROSARCOMA METASTASIS
Caleb Watson
Favorite
Watt, Tanya

University of Texas Southwestern Medical Center
(P 419) PROSPECTIVE REAL-WORLD STUDY OF LAROTRECTINIB (LARO) IN PATIENTS (PTS) WITH TRK FUSION SOLID TUMORS: INTERIM ANALYSIS OF ON-TRK
Tanya Watt
Favorite
Weadick, Catherine

Princess Margaret Cancer Centre, Toronto
(P 346) SURROGATE ENDPOINTS FOR OVERALL SURVIVAL IN ADVANCED SOFT TISSUE SARCOMA TRIALS: A SYSTEMATIC REVIEW AND META-ANALYSIS
Catherine Weadick
Favorite
weber, Winja

Cancer Information Service, German Cancer Research Center (DKFZ)
(P 455) DEVELOPMENT OF PATIENT-CENTERED INFORMATION MATERIAL ON RADIATION-INDUCED SARCOMA: QUALITATIVE RESULTS FROM FOCUS GROUPS OF THE TETRIS-PROJECT
Winja weber
Favorite
Wedekind, Mary

National Cancer Institute
(P 290) CLINICAL OUTCOMES AFTER RADIOTHERAPY FOR PATIENTS WITH POORLY DIFFERENTIATED CHORDOMA
Mary Wedekind
Favorite
Weg-Remers, Susanne

Cancer Information Service, German Cancer Research Center (DKFZ)
(P 455) DEVELOPMENT OF PATIENT-CENTERED INFORMATION MATERIAL ON RADIATION-INDUCED SARCOMA: QUALITATIVE RESULTS FROM FOCUS GROUPS OF THE TETRIS-PROJECT
Susanne Weg-Remers
Favorite
Wehner, Rebekka

Institute of Immunology, Faculty of Medicine Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany,National Center for Tumor Diseases (NCT), Dresden, Germany, German Cancer Consortium (DKTK), Partner Site Dresden, and German Cancer Research Center (DKFZ), Heidelberg, Germany
(P 243) CLINICAL SIGNIFICANCE OF TUMOR-INFILTRATING IMMUNE CELL SUBSETS IN THE RETROPERITONEAL DEDIFFERENTIATED LIPOSARCOMAS AND LEIOMYOSARCOMAS
Rebekka Wehner
Favorite
Weigl, Helene

Sarcoma Unit, Department of Surgery, University Medical Centre Mannheim, Medical Faculty Mannheim, Heidelberg University
(P 303) MULTIVISCERAL RESECTIONS AND URINARY TRACT RECONSTRUCTION TECHNIQUES IN THE SURGERY OF RETROPERITONEAL SARCOMAS: A CASE SERIES.
Helene Weigl
Favorite
(P 312) APOSST: A PROSPECTIVE TRIAL TO EVALUATE ACUPUNCTURE AFTER SURGERY OF EXTREMITY SOFT TISSUE TUMORS
Helene Weigl
Favorite
Weiss, Aaron

MaineHealth Maine Medical Center
(P 48) PRECLINICAL ACTIVITY OF MEK INHIBITION IN COMBINATION WITH CHEMOTHERAPY IN MALIGNANT PERIPHERAL NERVE SHEATH TUMOR
Aaron Weiss
Favorite
Weiss, Christel

Department of Medical Statistics and Biomathematics, Medical Faculty Mannheim, Heidelberg University
(P 312) APOSST: A PROSPECTIVE TRIAL TO EVALUATE ACUPUNCTURE AFTER SURGERY OF EXTREMITY SOFT TISSUE TUMORS
Christel Weiss
Favorite
Weiss, Kurt

University of Pittsburgh Medical Center
(P 14) EVALUATING THE COMBINATION OF DISULFIRAM AND ENZALUTAMIDE IN OSTEOSARCOMA
Kurt Weiss
Favorite
(P 63) EVALUATING SURGICAL MARGINS IN SARCOMA RESECTION WITH INDOCYANINE GREEN FLUORESCENCE IMAGING
Kurt Weiss
Favorite
(P 65) INVESTIGATING MACROPHAGE POPULATIONS IN PRIMARY AND METASTATIC SARCOMA SAMPLES
Kurt Weiss
Favorite
(P 80) UTILIZATION OF THE MUSCULOSKELETAL ONCOLOGY TUMOR REGISTRY AND TISSUE BANK (MOTOR) FOR THE ACCELERATION OF SARCOMA RESEARCH
Kurt Weiss
Favorite
Weiss, Mia

Washington University
(P 128) ISOCITRATE DEHYDROGENASE 1 (IDH1) MUTATION TESTING IN THE PHASE 3 STUDY OF IVOSIDENIB VS PLACEBO IN IDH1-MUTANT CONVENTIONAL CHONDROSARCOMA (CHONQUER)
Mia Weiss
Favorite
Weistuch, Corey

Memorial Sloan Kettering Cancer Center
(P 22) SINGLE CELL SEQUENCING ENABLES LINEAGE-INFORMED TARGETING OF OSTEOSARCOMA
Corey Weistuch
Favorite
Welliver, Meng

Mayo Clinic
(P 223) OUTCOMES OF GERIATRIC PATIENTS WITH DE NOVO SARCOMA AND LUNG METASTASES: ROLE OF TUMOR CHARACTERISTICS AND TREATMENT STRATEGY
Meng Welliver
Favorite
(P 246) CTLA4 PATHWAY ACTIVATION IN RADIATION-INDUCED ANGIOSARCOMA: A TRANSCRIPTOMIC RATIONALE FOR IMMUNE CHECKPOINT BLOCKADE
Meng Welliver
Favorite
Wells, Amber L.

Parabilis Medicines
(P 415) A PHASE 1/2 TRIAL OF FOG-001, A FIRST-IN-CLASS DIRECT β-CATENIN:TCF4 INHIBITOR: SAFETY AND PRELIMINARY ANTITUMOR ACTIVITY IN PATIENTS WITH DESMOID TUMORS (DT)
Amber L. Wells
Favorite
Wennergren, David

Institute of Clinical Scinces/Sahlgrenska Academy
(P 124) ISOLATED LIMB PERFUSION AS LIMB SALVAGING TREATMENT; A SINGLE CENTRE RETROSPECTIVE STUDY
David Wennergren
Favorite
Wen, Timmy

The Hospital for Sick Children (SickKids)
(P 73) TARGETABLE GENE DEPENDENCIES IN EWING SARCOMA SUBTYPES
Timmy Wen
Favorite
Werenski, Joseph

Massachusetts General Hospital Department of Orthopaedic Surgery
(P 17) EXTRASKELETAL OSTEOSARCOMA: MICRORNA PATTERNS PROVIDE INSIGHTS INTO SIMILARITIES AND CONTRASTS WITH OTHER SARCOMAS
Joseph Werenski
Favorite
(P 62) INTRAOPERATIVE BONE AND SOFT TISSUE TUMOR MARGIN IDENTIFICATION WITH FLUORESCENCE LIFETIME (FLT) IMAGING
Joseph Werenski
Favorite
(P 112) PEDIATRIC GIANT CELL TUMOR OF BONE
Joseph Werenski
Favorite
Werier, Joel

University of Ottawa
(P 143) IMPACT OF SURGICAL MARGINS IN CHEST WALL CHONDROSARCOMAS: A CANSARCC STUDY
Joel Werier
Favorite
Wessel, Lauren

Department of Orthopaedic Surgery, University of California Los Angeles
(P 16) MITOCHONDRIAL GENETIC VARIATION ORCHESTRATES COPZ1 TRANSCRIPT HETEROGENEITY AND REVEALS TELOMERE-MEDIATED VULNERABILITIES IN OSTEOSARCOMA
Lauren Wessel
Favorite
(P 72) COUNTY-LEVEL ASSOCIATIONS BETWEEN AIRBORNE TOXICANT EMISSIONS AND EWING SARCOMA DIAGNOSIS IN THE UNITED STATES
Lauren Wessel
Favorite
(P 81) ASSESSING PROGNOSTIC FACTORS OF CAUSE-SPECIFIC SURVIVAL IN PATIENTS WITH MALIGNANT GIANT CELL TUMORS: A POPULATION BASED STUDY FROM THE SEER DATABASE
Lauren Wessel
Favorite
(P 92) PRIMARY TUMOR SIZE AS AN INDEPENDENT PROGNOSTIC FACTOR IN OSTEOSARCOMA: PROPENSITY SCORE-MATCHED ANALYSIS DEMONSTRATES A CONTINUOUS DOSE-RESPONSE RELATIONSHIP
Lauren Wessel
Favorite
(P 100) THE ROLE OF CANCER TYPE IN THE DEVELOPMENT OF PERIPROSTHETIC JOINT INFECTION IN DISTAL FEMORAL REPLACEMENT
Lauren Wessel
Favorite
(P 107) IS THERE A BETTER OPTION: INTRAMEDULLARY NAIL VERSUS PLATE OSTEOSYNTHESIS FOR PATHOLOGIC HUMERAL FRACTURES?
Lauren Wessel
Favorite
(P 108) DISTANCE WEIGHTED MATCHING IN THE QUANTIFICATION OF EXCESS MORBIDITY IN EXTERNAL HEMIPELVECTOMY AND HIP DISARTICULATION
Lauren Wessel
Favorite
(P 157) INCOME IMPACTS OVERALL BUT NOT CAUSE-SPECIFIC SURVIVAL IN PATIENTS WITH CHONDROSARCOMA: A POPULATION BASED STUDY FROM THE SEER DATABASE
Lauren Wessel
Favorite
(P 232) IS THERE A ROLE FOR POSITRON EMISSION TOMOGRAPHY IN THE STAGING OF LANGERHANS CELL HISTIOCYTOSIS?
Lauren Wessel
Favorite
(P 384) PELVIC LOCATION PREDICTS WORSE OUTCOMES IN ALVEOLAR RHABDOMYOSARCOMA: UNDERUSE OF RADIOTHERAPY AND MISSED SURVIVAL BENEFIT
Lauren Wessel
Favorite
White, Charlie

Memorial Sloan Kettering Cancer Center
(P 273) RADIOMIC PREDICTORS OF SPONTANEOUS PNEUMOTHORAX DURING TYROSINE KINASE INHIBITOR THERAPY FOR LUNG METASTASES
Charlie White
Favorite
White, Jeremy

University of Oklahoma
(P 220) THE IMPACT OF WOUND HEALING COMPLICATIONS ON PATIENT-REPORTED OUTCOMES FOLLOWING SOFT TISSUE SARCOMA SURGERY
Jeremy White
Favorite
Wijers-Koster, Pauline

Leiden University Medical Center
(P 127) AN INTEGRATED CLINICAL GENOMIC AND TRANSCRIPTOMIC SUBGROUPING OF CENTRAL CHONDROSARCOMA
Pauline Wijers-Koster
Favorite
Wikinson, Michelle

The Royal Marsden Hospial
(P 414) PATTERNS OF RELAPSE OF BORDERLINE AND MALIGNANT PHYLLODES TUMOUR- RESULTS FROM SARCOMA REFERENCE CENTRE (SRC)
Michelle Wikinson
Favorite
Wilkinson, Michelle

The Royal Marsden Hospital NHS Foundation Trust
(P 298) RESECTION OF PARA-RENAL INFERIOR VENA CAVA LEIOMYOSARCOMA WITH RIGHT NEPHRECTOMY AND LEFT RENAL VEIN LIGATION WITHOUT VENOUS RECONSTRUCTION.
Michelle Wilkinson
Favorite
(P 307) STRATEGIES FOR DATA QUALITY IN TARPSWG RETROPERITONEAL SARCOMA REGISTRY (RESAR)
Michelle Wilkinson
Favorite
Wilkowski, Jodi

University of Michigan
(P 52) VALIDATION OF SYNGENEIC MURINE DEDIFFERENTIATED LIPOSARCOMA MODELS FOR PRECLINICAL EVALUATION OF THERAPEUTIC SENSITIVITY
Jodi Wilkowski
Favorite
Wilky, Breelyn

University of Colorado School of Medicine
(P 234) DOXORUBICIN PLUS BOTENSILIMAB, A NEXT GENERATION CTLA4 INHIBITOR, WITH OR WITHOUT BALSTILIMAB, A PD1 INHIBITOR, IN PATIENTS WITH ADVANCED SOFT TISSUE SARCOMAS
Breelyn Wilky
Favorite
Williams, Dennis

Adaptimmune
(P 337) POOLED ANALYSIS OF TRABECTEDIN EFFICACY IN MYXOID/ROUND CELL LIPOSARCOMA FROM THREE PROSPECTIVE CLINICAL TRIALS
Dennis Williams
Favorite
Williams, Erik

Sylvester Comprehensive Cancer Center
(P 369) CLINICAL CHARACTERISTICS & TREATMENT OUTCOME PATTERNS OF SOLITARY FIBROUS TUMORS: A SINGLE-INSTITUTION RETROSPECTIVE ANALYSIS
Erik Williams
Favorite
Williams, Erik

University of Miami
(P 393) DISTINCT SECONDARY MUTATIONAL LANDSCAPES ARE ASSOCIATED WITH NAB2–STAT6 FUSION BREAKPOINTS IN SOLITARY FIBROUS TUMORS
Erik Williams
Favorite
Williams, Taylor

The Ohio State University Medical Center
(P 335) OUTCOMES OF TALIMOGENE LAHERPAREPVEC IN SOFT TISSUE SARCOMA
Taylor Williams
Favorite
Willis, Connor

Department of Pharmacotherapy, College of Pharmacy, University of Utah
(P 357) DEVELOPMENT OF AN ALGORITHM TO IDENTIFY PATIENTS (PT) WITH DESMOID TUMORS (DT) IN A UNITED STATES (US) CLAIMS DATASET
Connor Willis
Favorite
Willis, Olivia

University College London Hospitals
(P 281) LOCAL CONTROL WITH MODERATELY HYPOFRACTIONATED DEFINITIVE RADIOTHERAPY DELIVERED WITH A SIMULTANEOUS INTEGRATED BOOST TECHNIQUE TO NON-EXTREMITY SOFT TISSUE AND BONE SARCOMAS
Olivia Willis
Favorite
Wilson, David

Nova Scotia Health Authority
(P 143) IMPACT OF SURGICAL MARGINS IN CHEST WALL CHONDROSARCOMAS: A CANSARCC STUDY
David Wilson
Favorite
Wilson, Roger

Sarcoma Patient Advocacy Global Network e.V.
(P 229) DETERMINANTS OF DIAGNOSTIC INTERVAL IN EPITHELIOID HEMANGIOENDOTHELIOMA: A LINEAR AND QUANTILE REGRESSION ANALYSIS OF PATIENT-REPORTED DATA FROM THE SPAGN GLOBAL SARCOMA DIAGNOSIS PATHWAY SURVEY
Roger Wilson
Favorite
Wiltink, L.M.

Leiden University Medical Center
(P 295) FROM HISTORICAL REFERENCE TO MODERN PRACTICE: WOUND COMPLICATION RATES IN SOFT TISSUE SARCOMA TREATED WITH RADIOTHERAPY ACROSS ERAS
L.M. Wiltink
Favorite
Wiltsie, Laura

Massachusetts General Hospital
(P 290) CLINICAL OUTCOMES AFTER RADIOTHERAPY FOR PATIENTS WITH POORLY DIFFERENTIATED CHORDOMA
Laura Wiltsie
Favorite
Winski, Shannon

Cogent Biosciences
(P 425) BEZUCLASTINIB EXPANDED ACCESS PROGRAM (EAP) FOR PATIENTS WITH GASTROINTESTINAL STROMAL TUMORS (GIST)
Shannon Winski
Favorite
Witt, Russell

University of Virginia
(P 172) COMPARISON OF CELL SEGMENTATION METHODS IN SOFT TISSUE SARCOMA (STS) SPATIAL PROTEOMIC DATASETS
Russell Witt
Favorite
(P 404) OUTCOMES OF NEOADJUVANT THERAPY IN ANGIOSARCOMA PATIENTS: A KAPLAN-MEIER-RECONSTRUCTED INDIVIDUAL PATIENT-LEVEL META-ANALYSIS
Russell Witt
Favorite
Woźniak, Oliwia

Maria Sklodowska-Curie National Research Institute of Oncology
(P 313) SIGNIFICANCE OF LYMPH NODE PROCEDURES IN SOFT TISSUE SARCOMA PATIENTS
Oliwia Woźniak
Favorite
Wong, Chao-Jen

Seattle Children's Research Institute
(P 260) MECHANISM AND EFFICACY OF ANTHRACYCLINE MEDIATED EPIGENETIC DISRUPTION IN BONE SARCOMAS.
Chao-Jen Wong
Favorite
Woodcock, Mark

UNC
(P 350) THE PATTERN.ORG SARCOMA CONSORTIUM: BUILDING A MULTI-INSTITUTIONAL DATA RESOURCE FOR THE SARCOMA RESEARCH COMMUNITY
Mark Woodcock
Favorite
Woodcock, Victoria

University of Oxford NHS Foundation Trust
(P 431) INVOKE: A PHASE 1 STUDY OF OKN4395, A FIRST-IN-CLASS EP2/EP4/DP1 TRIPLE PROSTANOID RECEPTOR ANTAGONIST, IN PATIENTS WITH ADVANCED SOLID TUMORS, INCLUDING SARCOMAS
Victoria Woodcock
Favorite
Wooddell, Margaret

Global Oncology Medical Aﬀairs, Daiichi Sankyo, Inc., Basking Ridge, NJ, USA
(P 336) PEXIDARTINIB RISK EVALUATION AND MITIGATION STRATEGY PROGRAM: 5-YEAR RETROSPECTIVE HEPATIC SAFETY ASSESSMENT
Margaret Wooddell
Favorite
(P 381) KNOWLEDGE, ATTITUDES, AND BEHAVIOR OF HEALTHCARE PROVIDERS ENROLLED IN THE PEXIDARTINIB RISK MITIGATION AND EVALUATION PROGRAM
Margaret Wooddell
Favorite
Woodruff, Garrett

MD Anderson Cancer Center
(P 351) THE ROLE OF SOCIOECONOMIC DISPARITIES ON SURVIVAL OUTCOMES IN MALIGNANT PERIPHERAL NERVE SHEATH TUMORS
Garrett Woodruff
Favorite
Woods, Lennie

Clear Cell Sarcoma Foundation
(P 450) OUTCOMES IN CLEAR CELL SARCOMA: UPDATED INSIGHTS FROM ELECTRONIC HEALTH RECORDS IN A PATIENT-LED REGISTRY
Lennie Woods
Favorite
Wooldridge, Adam

MCW
(P 111) DOES DOSE MATTER? POSTOPERATIVE RADIATION DOSE AND OUTCOMES FOLLOWING FIXATION OF METASTATIC EXTREMITY BONE LESIONS
Adam Wooldridge
Favorite
Woolsey, Lauren

Sarcoma Oncology Center
(P 233) DNG64-CAR-V+ REGIMEN SHOWS CLINICAL BENEFIT IN PATIENTS WITH ADVANCED CCNG1 ONCOGENE EXPRESSING SARCOMAS (NCT04091295)
Lauren Woolsey
Favorite
Woo, Xing Yi

A*STAR Bioinformatics Institute (BII)
(P 53) ESTABLISHMENT AND CHARACTERISATION OF LIPOSARCOMA-DERIVED CELLS AS RELEVANT PRE-CLINICAL MODELS FOR TARGET DISCOVERY
Xing Yi Woo
Favorite
Worst, Thomas

Department of Urology and Urosurgery, University Medical Centre Mannheim, Medical Faculty Mannheim, Heidelberg University
(P 303) MULTIVISCERAL RESECTIONS AND URINARY TRACT RECONSTRUCTION TECHNIQUES IN THE SURGERY OF RETROPERITONEAL SARCOMAS: A CASE SERIES.
Thomas Worst
Favorite
Wortley, Dionne

The Royal Orthopaedic Hospital NHS Foundation Trust
(P 136) ESTROGEN HAS A PROTECTIVE EFFECT ON CHONDROSARCOMA GROWTH IN VITRO AND IN VIVO
Dionne Wortley
Favorite
Wozniak, Agnieszka

KU Leuven
(P 33) THE NOVEL TRANSCRIPTIONAL INHIBITORS ECUBECTEDIN AND PM54 DEMONSTRATE ANTITUMOR ACTIVITY IN PATIENT-DERIVED XENOGRAFT MODELS OF SOFT TISSUE SARCOMA
Agnieszka Wozniak
Favorite
(P 69) EPIDEMIOLOGY AND POTENTIAL CLINICAL RELEVANCE OF TOP1 AND TOP2A TOPOISOMERASES EXPRESSION IN SOFT TISSUE SARCOMA
Agnieszka Wozniak
Favorite
(P 70) EPIDEMIOLOGY AND POTENTIAL CLINICAL RELEVANCE OF CONTACTIN-4 EXPRESSION IN SOFT TISSUE SARCOMA
Agnieszka Wozniak
Favorite
Wunder, Jay

Department of Surgery, Sinai Health
(P 55) THE EFFECT OF STAT1 Y701 PHOSPHORYLATION ON GENE EXPRESSION IN UPS
Jay Wunder
Favorite
(P 88) THE RAY CHALLENGE: HOW MANY RAY RESECTIONS CAN PATIENTS TOLERATE AND WHICH RAY RESECTIONS AFFECTS FUNCTIONAL OUTCOME THE MOST IN ORTHOPEDIC ONCOLOGY?
Jay Wunder
Favorite
(P 323) EVALUATION OF COSMIC MUTATIONAL SIGNATURES IN SOFT TISSUE SARCOMA
Jay Wunder
Favorite
(P 332) MARGINAL EXCISION OF EXTREMITY DEDIFFERENTIATED LIPOSARCOMA WITHOUT RADIATION MAY BE SAFE IN SELECT PATIENTS
Jay Wunder
Favorite
(P 374) DISTINCT PATTERNS OF METASTATIC SPREAD IN LEIOMYOSARCOMA: A COMPARATIVE ANALYSIS OF TRUNCAL AND EXTREMITY TUMOURS
Jay Wunder
Favorite
(P 375) DOES STAGED RESECTION WITH TEMPORIZING WOUND VACUUM INFLUENCE LOCAL RECURRENCE RISK? A MULTI-INSTITUTIONAL MATCHED COHORT ANALYSIS
Jay Wunder
Favorite
Wurtz, Daniel

Indiana University
(P 82) DISPARITIES IN OSTEOSARCOMA BY SOCIOECONOMIC STATUS
Daniel Wurtz
Favorite
(P 84) A MULTICENTER COMPARISON OF REVERSE TOTAL SHOULDER ARTHROPLASTY VERSUS HEMIARTHROPLASTY FOR ENDOPROSTHETIC RECONSTRUCTION FOLLOWING ONCOLOGIC RESECTION OF THE PROXIMAL HUMERUS
Daniel Wurtz
Favorite
(P 269) INCIDENCE OF MALIGNANCY IN BIOPSIED PEDIATRIC SOFT TISSUE MASSES
Daniel Wurtz
Favorite
(P 272) THE HAZARDS OF BIOPSY IN PEDIATRIC SOFT TISSUE SARCOMAS
Daniel Wurtz
Favorite
Wustrack, Rosanna

University of California San Francisco
(P 93) INTERCALARY COMPRESSIVE OSSEOINTEGRATION OF DIAPHYSEAL TUMORS: A MULTI-INSTITUTIONAL CASE SERIES
Rosanna Wustrack
Favorite
Wu, Yaping

Providence Cancer Institute
(P 58) PLK1 AS A VULNERABLE TARGET OF BAP1-DRIVEN UNDIFFERENTIATED PLEOMORPHIC SARCOMAS
Yaping Wu
Favorite
Wyles, Cody

Mayo Clinic, Rochester
(P 166) LARGE LANGUAGE MODEL EXTRACTION OF STRUCTURED DATA IN UNSTRUCTURED SARCOMA PATHOLOGY NOTES: A PILOT STUDY
Cody Wyles
Favorite
(P 167) LARGE LANGUAGE MODEL EXTRACTION OF STRUCTURED DATA FROM UNSTRUCTURED RADIATION ONCOLOGY NOTES: A PILOT STUDY
Cody Wyles
Favorite
Wynne, Kristine

University of Florida
(P 426) A PHASE I/II TRIAL USING RNA LIPID NANOPARTICLES FOR RECURRENT OSTEOSARCOMA: A REPORT FROM THE NATIONAL PEDIATRIC CANCER FOUNDATION
Kristine Wynne
Favorite
Wyns, Karo

KU Leuven
(P 33) THE NOVEL TRANSCRIPTIONAL INHIBITORS ECUBECTEDIN AND PM54 DEMONSTRATE ANTITUMOR ACTIVITY IN PATIENT-DERIVED XENOGRAFT MODELS OF SOFT TISSUE SARCOMA
Karo Wyns
Favorite
Wytiaz, Victoria

University of Michigan Rogel Comprehensive Cancer Center
(P 227) TREATMENT PATTERNS IN PATIENTS WITH TENOSYNOVIAL GIANT CELL TUMORS: ADDRESSING COMMUNICATION IN A NEW THERAPEUTIC LANDSCAPE
Victoria Wytiaz
Favorite
X
Xayasak, Vanessa

Sarcoma Oncology Center
(P 233) DNG64-CAR-V+ REGIMEN SHOWS CLINICAL BENEFIT IN PATIENTS WITH ADVANCED CCNG1 ONCOGENE EXPRESSING SARCOMAS (NCT04091295)
Vanessa Xayasak
Favorite
(P 388) TRIAL IN PROGRESS: A PHASE 2 STUDY OF METRONOMIC TRABECTEDIN, GEMCITIBAINE, AND DACARBAZINE IN PREVIOUSLY TREATED ADVANCED SOFT TISSUE SARCOMA (NCT04535271)
Vanessa Xayasak
Favorite
(P 396) EVALUATING THE SAFETY AND EFFICACY OF METRONOMIC GEMCITABINE, DOXORUBICIN, AND DOCETAXEL PLUS NIVOLUMAB IN PREVIOUSLY TREATED ADVANCED LEIOMYOSARCOMA AND LIPOSARCOMA: A PHASE 2 STUDY (NCT04535713)
Vanessa Xayasak
Favorite
Xhabija, Besa

University of Michigan
(P 50) A NEW MURINE MODEL OF DEDIFFERENTIATED LIPOSARCOMA DEFINED BY HIGH PROLIFERATION AND METABOLIC ADAPTABILITY
Besa Xhabija
Favorite
Xiao, Guanghua

UT Southwestern Medical Center
(P 168) LEVERAGING LARGE LANGUAGE MODELS FOR STRUCTURED INFORMATION EXTRACTION FROM EWING SARCOMA PATHOLOGY REPORTS
Guanghua Xiao
Favorite
Xia, Yanzhe

Sun Yat-sen University
(P 193) CLINICAL ANALYSIS OF RIPRETINIB DOSE ESCALATION IN ADVANCED GISTS AFTER STANDARD DOSE PROGRESSION
Yanzhe Xia
Favorite
Xie, Chao

University of Florida
(P 248) AN EX VIVO ASSAY TO PREDICT IMMUNOTHERAPY RESPONSE IN SARCOMA
Chao Xie
Favorite
Xie, Jinhan

Children's Cancer Institute
(P 11) ESTABLISHMENT, CHARACTERIZATION AND RESEARCH APPLICATION OF EIGHT NOVEL PATIENT-DERIVED OSTEOSARCOMA CELL LINES
Jinhan Xie
Favorite
Xie, Lu

Musculoskeletal Tumor Centre, Peking University People's Hospital
(P 75) CD248 AS A PROGNOSTIC MARKER IN OSTEOSARCOMA
Lu Xie
Favorite
Xu, Eric

Duke University Medical Center
(P 58) PLK1 AS A VULNERABLE TARGET OF BAP1-DRIVEN UNDIFFERENTIATED PLEOMORPHIC SARCOMAS
Eric Xu
Favorite
Xue, Wei

COG Data Center
(P 250) OUTCOME OF INFANTS WITH RHABDOMYOSARCOMA: A REPORT FROM THE INTERNATIONAL SOFT TISSUE SARCOMA CONSORTIUM
Wei Xue
Favorite
Xu, Hairong

Department of Orthopaedic Oncology Surgery, Beijing Jishuitan Hospital, Peking University
(P 361) PEXIDARTINIB FOR THE TREATMENT OF TENOSYNOVIAL GIANT CELL TUMORS: CLINICAL EXPERIENCE FROM FIVE CHINESE PATIENTS
Hairong Xu
Favorite
(P 407) PIMICOTINIB IN TENOSYNOVIAL GIANT CELL TUMOR (TGCT): LONG-TERM EFFICACY, SAFETY, AND PATIENT-REPORTED OUTCOMES FROM THE PHASE 3 MANEUVER STUDY
Hairong Xu
Favorite
XU, Jie

Peking University People's Hospital
(P 255) AN OPEN-LABEL, TWO-COHORT, PHASE 1A/B STUDY OF WEEKLY IRINOTECAN HYDROCHLORIDE LIPOSOME INJECTION COMBINED WITH VINCRISTINE AND TEMOZOLOMIDE (NALIRI-VT) IN PATIENTS WITH ADVANCED EWING SARCOMA
Jie XU
Favorite
Xu, Rui-Hua

Sun Yat-sen University Cancer Center
(P 417) EFFICACY AND SAFETY OF LAROTRECTINIB (LARO) IN PATIENTS (PTS) WITH TRK FUSION SARCOMAS
Rui-Hua Xu
Favorite
Y
Yadukumar, Lekha

University of Iowa Hospitals and Clinics
(P 371) CLINICAL PROFILE AND TREATMENT PATTERNS OF ANGIOSARCOMA IN THE REAL- WORLD SETTING: A SINGLE CENTER EXPERIENCE FROM 1991-2024.
Lekha Yadukumar
Favorite
Yaeger, Rona

Memorial Sloan Kettering Cancer Center
(P 415) A PHASE 1/2 TRIAL OF FOG-001, A FIRST-IN-CLASS DIRECT β-CATENIN:TCF4 INHIBITOR: SAFETY AND PRELIMINARY ANTITUMOR ACTIVITY IN PATIENTS WITH DESMOID TUMORS (DT)
Rona Yaeger
Favorite
Yakovich, Adam

Replimune Group
(P 439) AN OPEN LABEL MULTICENTER PHASE 2 STUDY WITH SAFETY LEAD IN OF INTRATUMORAL VUSOLIMOGENE ODERPAREPVEC IN COMBINATION WITH PEMBROLIZUMAB IN PATIENTS WITH ANGIOSARCOMA
Adam Yakovich
Favorite
Yalamanchili, Sudha

University of Texas MD Anderson Cancer Center
(P 83) OUTCOMES OF MULTIMODAL PERIOPERATIVE TREATMENT IN OSTEOSARCOMAS OF THE JAW
Sudha Yalamanchili
Favorite
Yanai, Risa

1) Department of Pediatric Oncology, National Cancer Center Hospital, Tokyo, Japan
(P 341) PROGNOSTIC RELEVANCE OF CYCLOPHOSPHAMIDE DOSE FOR HIGH-RISK RHABDOMYOSARCOMA IN ADULT PATIENTS TREATED WITH VAC THERAPY
Risa Yanai
Favorite
Yanez, Giussepe

Duke University School of Medicine
(P 214) FINANCIAL TOXICITY IN PATIENTS WITH A HISTORY OF EXTREMITY AND PELVIC SARCOMA TREATMENT
Giussepe Yanez
Favorite
Yang, Cui

Department of Surgery, Medical Faculty Mannheim, Mannheim School of Medicine, Heidelberg University
(P 165) EVALUATING LARGE LANGUAGE MODELS AS DECISION SUPPORT TOOLS IN MULTIDISCIPLINARY TUMOR BOARDS FOR GASTROINTESTINAL STROMAL TUMORS
Cui Yang
Favorite
(P 169) BENCHMARKING LARGE LANGUAGE MODELS VS MULTIDISCIPLINARY TUMOR BOARDS OF 21 SARCOMA CENTERS
Cui Yang
Favorite
(P 312) APOSST: A PROSPECTIVE TRIAL TO EVALUATE ACUPUNCTURE AFTER SURGERY OF EXTREMITY SOFT TISSUE TUMORS
Cui Yang
Favorite
Yang, Eunkyu

Department of Orthopaedic surgery, Seoul National University Hospital
(P 09) ESTABLISHMENT AND CHARACTERIZATION OF 18 SARCOMA CELL LINES: UNRAVELING THE MOLECULAR MECHANISMS OF DOXORUBICIN RESISTANCE IN SARCOMA CELL LINES
Eunkyu Yang
Favorite
(P 66) ARHGEF4 EXPRESSION IN SOFT TISSUE SARCOMA CORRELATES WITH LOCAL GROWTH PATTERN: WHOLE TRANSCRIPTOME SEQUENCING ON SPATIALLY SEPARATED REGIONS, PATIENT-DERIVED MODELS, AND ORTHOTOPIC IN VIVO ANALYSIS
Eunkyu Yang
Favorite
(P 399) LATE LOCAL RECURRENCE (>5YEARS) OF SOFT TISSUE SARCOMA OF THE EXTREMITIES AND TRUNK WALL: PREDICTIVE FACTORS AND ONCOLOGIC OUTCOMES
Eunkyu Yang
Favorite
Yang, Hao

Memorial Sloan Kettering Cancer Center
(P 273) RADIOMIC PREDICTORS OF SPONTANEOUS PNEUMOTHORAX DURING TYROSINE KINASE INHIBITOR THERAPY FOR LUNG METASTASES
Hao Yang
Favorite
Yang, Linjun

Mayo Clinic, Rochester
(P 166) LARGE LANGUAGE MODEL EXTRACTION OF STRUCTURED DATA IN UNSTRUCTURED SARCOMA PATHOLOGY NOTES: A PILOT STUDY
Linjun Yang
Favorite
(P 167) LARGE LANGUAGE MODEL EXTRACTION OF STRUCTURED DATA FROM UNSTRUCTURED RADIATION ONCOLOGY NOTES: A PILOT STUDY
Linjun Yang
Favorite
Yang, Liping

Oregon State University
(P 19) SERUM EXOSOMES IDENTIFY AN ABERRANT PROTEOMIC SIGNATURE IN CANINE OSTEOSARCOMA PRECEDING METASTATIC PROGRESSION
Liping Yang
Favorite
Yang, Valerie

OncoCare Cancer Centre
(P 53) ESTABLISHMENT AND CHARACTERISATION OF LIPOSARCOMA-DERIVED CELLS AS RELEVANT PRE-CLINICAL MODELS FOR TARGET DISCOVERY
Valerie Yang
Favorite
Yang, Xiaoqian

University of Miami
(P 117) THERAPEUTIC POTENTIAL OF DOXORUBICIN AND DASATINIB COMBINATION IN OSTEOSARCOMA
Xiaoqian Yang
Favorite
(P 131) GLUCOSE TRANSPORTER 1 (GLUT1) INHIBITION DECREASES THE GROWTH AND PROLIFERATION OF CHONDROSARCOMA
Xiaoqian Yang
Favorite
Yang, Xiaoyan

Kura Oncology, Inc.
(P 423) ZIFTOMENIB IN COMBINATION WITH IMATINIB IN ADVANCED GASTROINTESTINAL STROMAL TUMORS (GIST) AFTER IMATINIB FAILURE: PHASE 1A/B STUDY OF SAFETY, PHARMACOKINETICS, AND ANTITUMOR ACTIVITY
Xiaoyan Yang
Favorite
Yang, Yuqin

Department of Laboratory Animal Center, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
(P 07) A LIVING MULTI-OMICS BIOBANK OF PATIENT-DERIVED XENOGRAFT MODELS FOR SARCOMA
Yuqin Yang
Favorite
Yang, Zecheng

The University of Texas MD Anderson Cancer Center
(P 391) ATRX LOSS BLOCKS THE DIFFERENTIATION OF MESENCHYMAL STEM CELLS AND ADVANCES UNDIFFERENTIATED SARCOMA DEVELOPMENT
Zecheng Yang
Favorite
Yan, Wangjun

Fudan University Shanghai Cancer Center, Shanghai, China
(P 361) PEXIDARTINIB FOR THE TREATMENT OF TENOSYNOVIAL GIANT CELL TUMORS: CLINICAL EXPERIENCE FROM FIVE CHINESE PATIENTS
Wangjun Yan
Favorite
Yao, Jun

The University of Texas MD Anderson Cancer Center
(P 54) PRECLINICAL MODELS REVEALING MDM2-P53 INTERACTION AND DEPENDENCY FOR TUMOR CELL SURVIVAL IN WELL-DIFFERENTIATED (WD) AND DEDIFFERENTIATED (DD) LIPOSARCOMA (LPS).
Jun Yao
Favorite
(P 391) ATRX LOSS BLOCKS THE DIFFERENTIATION OF MESENCHYMAL STEM CELLS AND ADVANCES UNDIFFERENTIATED SARCOMA DEVELOPMENT
Jun Yao
Favorite
Yao, Lan

Department of Anesthesiology,Peking University International Hosptial,Beijing
(P 469) THE IMPACT OF PREOPERATIVE ANEMIA ON POSTOPERATIVE COMPLICATIONS AND SHORT-TERM PROGNOSIS IN RETROPERITONEAL TUMOR SURGERY PATIENTS.
Lan Yao
Favorite
Yao, Wantong

The University of Texas MD Anderson Cancer Center
(P 54) PRECLINICAL MODELS REVEALING MDM2-P53 INTERACTION AND DEPENDENCY FOR TUMOR CELL SURVIVAL IN WELL-DIFFERENTIATED (WD) AND DEDIFFERENTIATED (DD) LIPOSARCOMA (LPS).
Wantong Yao
Favorite
(P 391) ATRX LOSS BLOCKS THE DIFFERENTIATION OF MESENCHYMAL STEM CELLS AND ADVANCES UNDIFFERENTIATED SARCOMA DEVELOPMENT
Wantong Yao
Favorite
YAP, Zheng Xi

National University of Singapore
(P 53) ESTABLISHMENT AND CHARACTERISATION OF LIPOSARCOMA-DERIVED CELLS AS RELEVANT PRE-CLINICAL MODELS FOR TARGET DISCOVERY
Zheng Xi YAP
Favorite
Yaron, Tomer

Weill Cornell Medicine
(P 198) EXPLOITING METABOLIC DYSREGULATION IN SUCCINATE DEHYDROGENASE-DEFICIENT GASTROINTESTINAL STROMAL TUMOR
Tomer Yaron
Favorite
Yassin, Samer

Northwestern University Feinberg School of Medicine
(P 183) ACTIONABLE GENOMICS IN GASTROINTESTINAL STROMAL TUMORS LACKING KIT OR PDGFRA MUTATIONS.
Samer Yassin
Favorite
(P 236) EXCEPTIONAL RESPONSE TO COMBINATION IMMUNOTHERAPY WITH YH001 AND ENVAFOLIMAB IN METASTATIC SARCOMA.
Samer Yassin
Favorite
Yeager, Nicholas

Department of Hematology/Oncology, Nationwide Children's Hospital
(P 264) RARE CASE OF INFLAMMATORY MYOFIBROBLASTIC TUMOR (IMT) IN NEWBORN
Nicholas Yeager
Favorite
Yechieli, Raphael

University of Miami, Department of Radiation Oncology
(P 289) SIX YEAR FOLLOW-UP ON CIVASHEET® USE FOR SOFT TISSUE SARCOMA: A SINGLE INSTITUTION EXPERIENCE
Raphael Yechieli
Favorite
Ye, Fei

Miller School of Medicine, University of Miami
(P 151) SHOULD WE USE ADJUVANT CHEMOTHERAPY IN PATIENTS WITH LOCALIZED DEDIFFERENTIATED CHONDROSARCOMA (DDCS) OF THE PELVIS? AN ANALYSIS BY THE PELVIC DDCS STUDY GROUP
Fei Ye
Favorite
Ye, Zhaoming

Orthopedics, The Second Affiliated Hospital Zhejiang University School of Medicine
(P 128) ISOCITRATE DEHYDROGENASE 1 (IDH1) MUTATION TESTING IN THE PHASE 3 STUDY OF IVOSIDENIB VS PLACEBO IN IDH1-MUTANT CONVENTIONAL CHONDROSARCOMA (CHONQUER)
Zhaoming Ye
Favorite
yi, liu

Anesthesiology Department, Shanxi Cancer Hospital
(P 469) THE IMPACT OF PREOPERATIVE ANEMIA ON POSTOPERATIVE COMPLICATIONS AND SHORT-TERM PROGNOSIS IN RETROPERITONEAL TUMOR SURGERY PATIENTS.
liu yi
Favorite
Yi, Min

MD Anderson Cancer Center
(P 351) THE ROLE OF SOCIOECONOMIC DISPARITIES ON SURVIVAL OUTCOMES IN MALIGNANT PERIPHERAL NERVE SHEATH TUMORS
Min Yi
Favorite
Ying, Haoqiang

MD Anderson Cancer Center
(P 54) PRECLINICAL MODELS REVEALING MDM2-P53 INTERACTION AND DEPENDENCY FOR TUMOR CELL SURVIVAL IN WELL-DIFFERENTIATED (WD) AND DEDIFFERENTIATED (DD) LIPOSARCOMA (LPS).
Haoqiang Ying
Favorite
(P 391) ATRX LOSS BLOCKS THE DIFFERENTIATION OF MESENCHYMAL STEM CELLS AND ADVANCES UNDIFFERENTIATED SARCOMA DEVELOPMENT
Haoqiang Ying
Favorite
Yin, Jun

Moffitt Cancer Center
(P 426) A PHASE I/II TRIAL USING RNA LIPID NANOPARTICLES FOR RECURRENT OSTEOSARCOMA: A REPORT FROM THE NATIONAL PEDIATRIC CANCER FOUNDATION
Jun Yin
Favorite
Yohe, Marielle

National Cancer Institute
(P 405) PAN-RAS INHIBITION AS A NOVEL THERAPEUTIC STRATEGY FOR RAS-DRIVEN RHABDOMYOSARCOMA
Marielle Yohe
Favorite
Yokoyama, Nobuhiko

Kyushu University
(P 472) LANDSCAPE OF ULTRA-RARE SARCOMAS: A NATIONWIDE STUDY FOR EPIDEMIOLOGY AND PROGNOSIS
Nobuhiko Yokoyama
Favorite
Yonemori, Kan

National Cancer Center Hospital
(P 128) ISOCITRATE DEHYDROGENASE 1 (IDH1) MUTATION TESTING IN THE PHASE 3 STUDY OF IVOSIDENIB VS PLACEBO IN IDH1-MUTANT CONVENTIONAL CHONDROSARCOMA (CHONQUER)
Kan Yonemori
Favorite
(P 341) PROGNOSTIC RELEVANCE OF CYCLOPHOSPHAMIDE DOSE FOR HIGH-RISK RHABDOMYOSARCOMA IN ADULT PATIENTS TREATED WITH VAC THERAPY
Kan Yonemori
Favorite
(P 434) A FIRST-IN-HUMAN PHASE 1, MULTICENTER, OPEN-LABEL STUDY OF M3554, A NOVEL ANTI-GD2 ANTIBODY-DRUG CONJUGATE, IN PATIENTS WITH ADVANCED SOLID TUMORS
Kan Yonemori
Favorite
yongjie, chen

Department of Anesthesiology,Peking University International Hosptial,Beijing
(P 469) THE IMPACT OF PREOPERATIVE ANEMIA ON POSTOPERATIVE COMPLICATIONS AND SHORT-TERM PROGNOSIS IN RETROPERITONEAL TUMOR SURGERY PATIENTS.
chen yongjie
Favorite
Yong, Taylor

Texas Tech University Health Science Center El Paso
(P 78) MENTAL HEALTH DISORDERS FOLLOWING PATHOLOGICAL FRACTURE: A RETROSPECTIVE COHORT STUDY
Taylor Yong
Favorite
Yoon, Janet

City of Hope Comprehensive Cancer Center
(P 315) ANALYSIS OF CHANGES IN T2-WEIGHTED SIGNAL INTENSITY AND TUMOR VOLUME AND EXPOSURE-RESPONSE IN THE RINGSIDE PHASE 2 STUDY OF VAREGACESTAT FOR DESMOID TUMORS
Janet Yoon
Favorite
(P 410) SUBGROUP ANALYSIS OF THE PHASE 2 PART OF THE RINGSIDE PHASE 2/3 TRIAL OF VAREGACESTAT FOR TREATMENT OF DESMOID TUMORS
Janet Yoon
Favorite
(P 452) EFFECTIVENESS OF ERIBULIN FOR MYXOID PLEOMORPHIC LIPOSARCOMA: INSIGHTS FROM A PATIENT-DERIVED MODEL AND CLINICAL TRANSLATION IN A PATIENT WITH ADVANCED DISEASE
Janet Yoon
Favorite
Yoshida, Akihiko

Department of Pathology, National Cancer Center Hospital, Tokyo, Japan
(P 341) PROGNOSTIC RELEVANCE OF CYCLOPHOSPHAMIDE DOSE FOR HIGH-RISK RHABDOMYOSARCOMA IN ADULT PATIENTS TREATED WITH VAC THERAPY
Akihiko Yoshida
Favorite
You, Daoqi

Memorial Sloan Kettering Cancer Center
(P 08) BUILDING A MEDICAL DONATION NETWORK TO ENHANCE DEVELOPMENT OF PEDIATRIC TUMOR MODELS
Daoqi You
Favorite
(P 25) IDENTIFICATION AND VALIDATION OF NON-GENETICALLY ENCODED VULNERABILITIES IN EWING SARCOMA
Daoqi You
Favorite
(P 48) PRECLINICAL ACTIVITY OF MEK INHIBITION IN COMBINATION WITH CHEMOTHERAPY IN MALIGNANT PERIPHERAL NERVE SHEATH TUMOR
Daoqi You
Favorite
(P 237) DEVELOPMENT OF EPHA2 CAR T CELL THERAPY FOR OSTEOSARCOMA
Daoqi You
Favorite
(P 267) THE RAF/MEK INHIBITOR VS-6766 SHOWS EFFICACY IN RAS-MUTANT PEDIATRIC PRECLINICAL XENOGRAFT MODELS- A REPORT FROM THE PEDIATRIC PRECLINICAL IN VIVO TESTING CONSORTIUM
Daoqi You
Favorite
You, James

The University of Texas MD Anderson Cancer Center
(P 391) ATRX LOSS BLOCKS THE DIFFERENTIATION OF MESENCHYMAL STEM CELLS AND ADVANCES UNDIFFERENTIATED SARCOMA DEVELOPMENT
James You
Favorite
Young, Eleanor

University of Michigan
(P 24) THE SIRTUIN SIRT5 SUPPORTS EWING SARCOMA SURVIVAL VIA REGULATION OF EWS-FLI1 STABILITY AND ACTIVITY
Eleanor Young
Favorite
Youn, Susie

University of British Columbia
(P 178) TREATMENT RESPONSE AND SURVIVAL OUTCOMES IN GASTROINTESTINAL STROMAL TUMORS FOLLOWING NEOADJUVANT THERAPY
Susie Youn
Favorite
Yovell, Jonathan

Immunome, Inc.
(P 315) ANALYSIS OF CHANGES IN T2-WEIGHTED SIGNAL INTENSITY AND TUMOR VOLUME AND EXPOSURE-RESPONSE IN THE RINGSIDE PHASE 2 STUDY OF VAREGACESTAT FOR DESMOID TUMORS
Jonathan Yovell
Favorite
(P 410) SUBGROUP ANALYSIS OF THE PHASE 2 PART OF THE RINGSIDE PHASE 2/3 TRIAL OF VAREGACESTAT FOR TREATMENT OF DESMOID TUMORS
Jonathan Yovell
Favorite
Yuan, Ying

Deciphera Pharmaceuticals, LLC
(P 424) AN OPEN-LABEL PHASE 1/2 STUDY OF DCC-3009 MONOTHERAPY IN PATIENTS (PTS) WITH ADVANCED GASTROINTESTINAL STROMAL TUMOR (GIST)
Ying Yuan
Favorite
Yu, Austin

Samaritan Health Services
(P 113) ASSESSING TREATMENT OUTCOMES OF CHONDROMYXOID FIBROMA: A CASE SERIES
Austin Yu
Favorite
Yustein, Jason

Emory University School of Medicine, Children's Healthcare of Atlanta
(P 21) EXAMINING THE THERAPEUTIC EFFECT OF TBL1/ β-CATENIN TARGETED COMBINATION THERAPIES ON METASTATIC OSTEOSARCOMA
Jason Yustein
Favorite
Yu, Ziyang

Parabilis Medicines
(P 415) A PHASE 1/2 TRIAL OF FOG-001, A FIRST-IN-CLASS DIRECT β-CATENIN:TCF4 INHIBITOR: SAFETY AND PRELIMINARY ANTITUMOR ACTIVITY IN PATIENTS WITH DESMOID TUMORS (DT)
Ziyang Yu
Favorite
Z
Zachariah, Ralph

Department of Medical Oncology and Hematology, Kantonsspital Winterthur
(P 436) SAKK 57/24 FEASIBILITY OF TOTAL NEOADJUVANT TREATMENT WITH HYPERTHERMIA IN PATIENTS WITH HIGH-RISK EXTREMITY AND TRUNK SOFT TISSUE SARCOMA. A MULTICENTER, SINGLE ARM, OPEN LABEL, PHASE II TRIAL
Ralph Zachariah
Favorite
Zadeh, Gelareh

Mayo Clinic
(P 465) JAK/STAT PATHWAY CO-OPERATES WITH CIC-FUSIONS TODRIVE CIC-REARRANGED SARCOMAS
Gelareh Zadeh
Favorite
Zaffaroni, Nadia

Fondazione IRCCS Istituto Nazionale dei Tumori
(P 32) EFFECTIVENESS OF LURBINECTEDIN PLUS IRINOTECAN IN PRECLINICAL MODEL OF DESMOPLASTIC SMALL ROUND CELL TUMOR
Nadia Zaffaroni
Favorite
(P 446) GDF-15 AS A PROGNOSTIC FACTOR IN PATIENTS WITH EPITHELIOID HEMANGIOENDOTHELIOMA
Nadia Zaffaroni
Favorite
Zahler, Stacey

Cleveland Clinic
(P 284) THE IMPACT OF SARCOMA SBRT ON THE IMMUNE SYSTEM: EARLY RESULTS FROM A PROSPECTIVE TRIAL
Stacey Zahler
Favorite
Zaidi, Shane

The Royal Marsden Hospital
(P 414) PATTERNS OF RELAPSE OF BORDERLINE AND MALIGNANT PHYLLODES TUMOUR- RESULTS FROM SARCOMA REFERENCE CENTRE (SRC)
Shane Zaidi
Favorite
Zając, Agnieszka

Maria Sklodowska-Curie National Research Institute of Oncology
(P 139) IMMUNOGENOMIC PROFILING OF CHONDROSARCOMA REVEALS DISTINCT IMMUNE PHENOTYPES AND PROGNOSTIC MUTATIONS
Agnieszka Zając
Favorite
(P 149) SURGICAL TEXTBOOK OUTCOMES IN PATIENTS DIAGNOSED WITH CHONDROSARCOMA
Agnieszka Zając
Favorite
Zambelli, Luca

Fondazione IRCCS Istituto Nazionale dei Tumori di Milano
(P 446) GDF-15 AS A PROGNOSTIC FACTOR IN PATIENTS WITH EPITHELIOID HEMANGIOENDOTHELIOMA
Luca Zambelli
Favorite
(P 447) PAIN ASSESSMENT CRITERIA (PAC) ANTICIPATE RECIST PROGRESSION AND CORRELATE WITH BLOOD LEVELS OF GROWTH DIFFERENTIATION FACTOR 15 (GDF15) IN EPITHELIOID HEMANGIOENDOTHELIOMA (EHE)
Luca Zambelli
Favorite
Zarins, Fiona

Deciphera Pharmaceuticals, LLC
(P 358) EFFECT OF A HIGH-FAT MEAL ON THE PHARMACOKINETICS (PK) OF VIMSELTINIB, AN ORAL INHIBITOR OF THE COLONY-STIMULATING FACTOR 1 RECEPTOR (CSF1R), IN HEALTHY PARTICIPANTS
Fiona Zarins
Favorite
Zarzour, Maria Alejandra

The University of Texas MD Anderson Cancer Center
(P 83) OUTCOMES OF MULTIMODAL PERIOPERATIVE TREATMENT IN OSTEOSARCOMAS OF THE JAW
Maria Alejandra Zarzour
Favorite
(P 451) TREATMENT OUTCOMES OF GEMCITABINE AND DOCETAXEL IN PATIENTS WITH CLEAR CELL SARCOMA (CCS) OR GASTROINTESTINAL NEUROECTODERMAL TUMOR (GNET): A CASE SERIES
Maria Alejandra Zarzour
Favorite
(P 460) OUTCOMES OF LATER-LINES SYSTEMIC THERAPIES IN MALIGNANT PERIPHERAL NERVE SHEATH TUMORS (MPNST)
Maria Alejandra Zarzour
Favorite
Zdzienicki, Marcin

Maria Sklodowska-Curie National Research Institute of Oncology; Warsaw Poland
(P 216) VIRTUAL MULTIDISCIPLINARY MEETINGS IN THE CARE OF SARCOMA PATIENTS
Marcin Zdzienicki
Favorite
Zdzienicki, Marcin

Maria Sklodowska-Curie National Research Institute of Oncology
(P 313) SIGNIFICANCE OF LYMPH NODE PROCEDURES IN SOFT TISSUE SARCOMA PATIENTS
Marcin Zdzienicki
Favorite
Zecca, Ernesto

Fondazione IRCCS Istituto Nazionale dei Tumori di Milano
(P 447) PAIN ASSESSMENT CRITERIA (PAC) ANTICIPATE RECIST PROGRESSION AND CORRELATE WITH BLOOD LEVELS OF GROWTH DIFFERENTIATION FACTOR 15 (GDF15) IN EPITHELIOID HEMANGIOENDOTHELIOMA (EHE)
Ernesto Zecca
Favorite
Zedlitz Johansen, Astrid

National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital—Herlev and Gentofte, Herlev, Denmark
(P 36) MODULATION OF THE SARCOMA MICROENVIRONMENT THROUGH β-ADRENERGIC BLOCKADE
Astrid Zedlitz Johansen
Favorite
Zeissig, Sylke

Bavarian Cancer Registry, Regional Center Würzburg, Bavarian Health and Food Safety Authority
(P 204) ANALYSIS OF QUALITY INDICATORS OF SOFT TISSUE SARCOMA TREATMENT WITH CANCER REGISTRY DATA IN GERMANY 2015-2021
Sylke Zeissig
Favorite
Zemp, Franz

Arnie Charbonneau Cancer Institute and McCaig Institute for Bone and Joint Health
(P 238) INVESTIGATING HOW MACROPHAGES INFILTRATE THE TUMOUR MICROENVIRONMENT AND INFLUENCE THE EFFICACY OF CAR T THERAPY IN A MURINE MODEL OF STS
Franz Zemp
Favorite
(P 378) HIGH DOSE RADIATION THERAPY PROMOTES IMMUNE SUPPRESSIVE MACROPHAGE PHENOTYPES, WHEREAS LOW DOSE RADIATION THERAPY PROMOTES IMMUNOGENIC MACROPHAGE PHENOTYPES IN A MURINE MODEL OF SOFT TISSUE SARCOMA
Franz Zemp
Favorite
Zer, Alona

Rambam Health Care Campus
(P 346) SURROGATE ENDPOINTS FOR OVERALL SURVIVAL IN ADVANCED SOFT TISSUE SARCOMA TRIALS: A SYSTEMATIC REVIEW AND META-ANALYSIS
Alona Zer
Favorite
Zeringo, Nicholas

Deciphera Pharmaceuticals, LLC
(P 422) EFFICACY WITH VIMSELTINIB IN PATIENTS (PTS) WITH TENOSYNOVIAL GIANT CELL TUMOR (TGCT) AND PRIOR COLONY-STIMULATING FACTOR 1 (CSF1) INHIBITOR THERAPY: A PHASE 2 CASE SERIES
Nicholas Zeringo
Favorite
Zervoudakis, Guston

Moffitt Cancer Center
(P 114) DENOSUMAB THERAPY AND MIRELS ADJUSTED ODDS OF PATHOLOGIC FRACTURE OR PROPHYLACTIC STABILIZATION IN APPENDICULAR SKELETAL METASTASES
Guston Zervoudakis
Favorite
Zhang, Chengyue

Deciphera Pharmaceuticals, LLC
(P 358) EFFECT OF A HIGH-FAT MEAL ON THE PHARMACOKINETICS (PK) OF VIMSELTINIB, AN ORAL INHIBITOR OF THE COLONY-STIMULATING FACTOR 1 RECEPTOR (CSF1R), IN HEALTHY PARTICIPANTS
Chengyue Zhang
Favorite
(P 376) EFFECT OF ITRACONAZOLE (ITZ) AND RABEPRAZOLE (RBP) ON THE PHARMACOKINETICS (PK) OF VIMSELTINIB, AN ORAL INHIBITOR OF THE COLONY-STIMULATING FACTOR 1 RECEPTOR, IN HEALTHY PARTICIPANTS
Chengyue Zhang
Favorite
Zhang, Ellen

Stanford Health Care
(P 122) INTERVAL-COMPRESSED CHEMOTHERAPY FOR TREATMENT OF EWING SARCOMA IN ADULTS: A SINGLE INSTITUTION STUDY
Ellen Zhang
Favorite
Zhang, Hua

Clinical Epidemiology Research Center, Peking University Third Hospital
(P 305) COMPARISON OF GOAL-DIRECTED VERSUS EMPIRICAL TRANSFUSION MANAGEMENT IN PATIENTS WITH SEVERE HEMORRHAGE DURING RETROPERITONEAL TUMOR SURGERY
Hua Zhang
Favorite
(P 469) THE IMPACT OF PREOPERATIVE ANEMIA ON POSTOPERATIVE COMPLICATIONS AND SHORT-TERM PROGNOSIS IN RETROPERITONEAL TUMOR SURGERY PATIENTS.
Hua Zhang
Favorite
Zhang, Lingxin

Mount Sinai
(P 15) EZHIP: A NOVEL EPIGENETIC DRIVER OF OSTEOSARCOMA PATHOGENESIS
Lingxin Zhang
Favorite
Zhang, Xiaojing

Liaoning Cancer Hospital & Institute
(P 407) PIMICOTINIB IN TENOSYNOVIAL GIANT CELL TUMOR (TGCT): LONG-TERM EFFICACY, SAFETY, AND PATIENT-REPORTED OUTCOMES FROM THE PHASE 3 MANEUVER STUDY
Xiaojing Zhang
Favorite
Zhang, Xinhua

Sun Yat-sen University
(P 193) CLINICAL ANALYSIS OF RIPRETINIB DOSE ESCALATION IN ADVANCED GISTS AFTER STANDARD DOSE PROGRESSION
Xinhua Zhang
Favorite
Zhao, Binsheng

Memorial Sloan Kettering Cancer Center
(P 273) RADIOMIC PREDICTORS OF SPONTANEOUS PNEUMOTHORAX DURING TYROSINE KINASE INHIBITOR THERAPY FOR LUNG METASTASES
Binsheng Zhao
Favorite
Zhao, Weisong

Department of Orthopaedics, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
(P 07) A LIVING MULTI-OMICS BIOBANK OF PATIENT-DERIVED XENOGRAFT MODELS FOR SARCOMA
Weisong Zhao
Favorite
Zhe, Wang

MGH
(P 392) CLASSIFICATION AND DIFFERENTIATIONOF MYXOID LIPOSARCOMA AND MYXOMA WITH MACHINE LEARNING
Wang Zhe
Favorite
(P 392) DIFFERENTIATION OF MYXOMA AND MYXOID LIPOSARCOMA BASED ON RADIOMICS PHENOTYPES
Wang Zhe
Favorite
Zhou, Lisa

City of Hope National Medical Center
(P 309) RETROPERITONEAL LIPOMAS: MULTICENTER CLINICAL EXPERIENCE WITH AN EXTREMELY RARE DISEASE ENTITY
Lisa Zhou
Favorite
Zhou, Maggie

Stanford University
(P 297) ANALYSIS OF CTDNA KINETICS IN PATIENTS WITH METASTATIC LEIOMYOSARCOMA UNDERGOING LOCOREGIONAL PROCEDURAL INTERVENTION
Maggie Zhou
Favorite
Zhou, Shengfan

Springworks Therapeutics, Inc.
(P 357) DEVELOPMENT OF AN ALGORITHM TO IDENTIFY PATIENTS (PT) WITH DESMOID TUMORS (DT) IN A UNITED STATES (US) CLAIMS DATASET
Shengfan Zhou
Favorite
(P 368) ASSESSMENT OF PAIN DIAGNOSIS AND PAIN MEDICATION USE IN ADULTS TREATED WITH NIROGACESTAT: A UNITED STATES REAL-WORLD ANALYSIS
Shengfan Zhou
Favorite
Zhou, Yong

West China Hospital, Sichuan University
(P 407) PIMICOTINIB IN TENOSYNOVIAL GIANT CELL TUMOR (TGCT): LONG-TERM EFFICACY, SAFETY, AND PATIENT-REPORTED OUTCOMES FROM THE PHASE 3 MANEUVER STUDY
Yong Zhou
Favorite
Zhu, Hong

University of Virginia School of Medicine, Department of Public Health Sciences, Charlottesville, VA, USA
(P 404) OUTCOMES OF NEOADJUVANT THERAPY IN ANGIOSARCOMA PATIENTS: A KAPLAN-MEIER-RECONSTRUCTED INDIVIDUAL PATIENT-LEVEL META-ANALYSIS
Hong Zhu
Favorite
Zhu, Hongwen

New York Medical College
(P 76) CD47 BLOCKADE SYNERGIZES WITH CHEMOTHERAPY IN ENHANCING MACROPHAGE PHAGOCYTOSIS OF EWING SARCOMA CELLS
Hongwen Zhu
Favorite
Zick, Aviad

Oncology Department, Sharett Institute for Oncology, Hadassah Medical Center & Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel
(P 06) RAPID, POINT-OF-CARE DNA METHYLATION & MOLECULAR LANDSCAPE BASED SARCOMA CLASSIFICATION
Aviad Zick
Favorite
Ziegler, Jordan

PrecisionNextGen Oncology and Research Center
(P 230) CIRCULATING TUMOR DNA AS AN EARLY INDICATOR OF RESPONSE, PROGRESSION, AND RECURRENCE OF SARCOMAS
Jordan Ziegler
Favorite
(P 433) PHASE I DOSE ESCALATION TRIAL OF STX-001, AN LNP SELF-REPLICATING MRNA EXPRESSING IL-12, IN PATIENTS WITH REFRACTORY TUMORS INCLUDING SARCOMAS
Jordan Ziegler
Favorite
(P 440) CASE REPORT: COMPLETE CLINICAL AND MOLECULAR RESPONSE TO INTRATUMORAL STX-001, AN LNP-SELF REPLICATING MRNA EXPRESSING IL-12 IN A PATIENT WITH REFRACTORY ANGIOSARCOMA
Jordan Ziegler
Favorite
(P 471) COMBINATION CHEMOTHERAPY WITH GEMCITABINE AND PACLITAXEL: A HIGHLY EFFICACIOUS AND BETTER TOLERATED OPTION FOR ANGIOSARCOMA
Jordan Ziegler
Favorite
Zijlstra, IJsbrand

Department of Radiology, Amsterdam University Medical Center
(P 294) RISK FACTORS FOR RECURRENCE AND COMPLICATIONS OF CT-GUIDED RADIOFREQUENCY ABLATION FOR THE TREATMENT OF OSTEOID OSTEOMA: A MULTI-INSTITUTIONAL ANALYSIS.
IJsbrand Zijlstra
Favorite
Zilli, Thomas

Department of Radiation Oncology, Institute of Southern Switzerland
(P 436) SAKK 57/24 FEASIBILITY OF TOTAL NEOADJUVANT TREATMENT WITH HYPERTHERMIA IN PATIENTS WITH HIGH-RISK EXTREMITY AND TRUNK SOFT TISSUE SARCOMA. A MULTICENTER, SINGLE ARM, OPEN LABEL, PHASE II TRIAL
Thomas Zilli
Favorite
Zimel, Melissa

University of California San Francisco
(P 93) INTERCALARY COMPRESSIVE OSSEOINTEGRATION OF DIAPHYSEAL TUMORS: A MULTI-INSTITUTIONAL CASE SERIES
Melissa Zimel
Favorite
Zoghbi, Marianne

MD Anderson Cancer Center
(P 184) MTAP IN GASTROINTESTINAL STROMAL TUMOR (GIST): RATE OF MTAP LOSS AND CONCORDANCE BETWEEN GENOMIC SEQUENCING AND IMMUNOHISTOCHEMISTRY
Marianne Zoghbi
Favorite
Zokaasadi, Mohammad

Duke University
(P 259) PRECLINICAL MODELING OF CHEMOTHERAPY RELEASE IDENTIFIES MITOCHONDRIAL ADAPTATIONS IN DOXORUBICIN TREATED OSTEOSARCOMA
Mohammad Zokaasadi
Favorite
Zuco, Valentina

Fondazione IRCCS Istituto Nazionale dei Tumori
(P 32) EFFECTIVENESS OF LURBINECTEDIN PLUS IRINOTECAN IN PRECLINICAL MODEL OF DESMOPLASTIC SMALL ROUND CELL TUMOR
Valentina Zuco
Favorite
(P 446) GDF-15 AS A PROGNOSTIC FACTOR IN PATIENTS WITH EPITHELIOID HEMANGIOENDOTHELIOMA
Valentina Zuco
Favorite
(P 447) PAIN ASSESSMENT CRITERIA (PAC) ANTICIPATE RECIST PROGRESSION AND CORRELATE WITH BLOOD LEVELS OF GROWTH DIFFERENTIATION FACTOR 15 (GDF15) IN EPITHELIOID HEMANGIOENDOTHELIOMA (EHE)
Valentina Zuco
Favorite
(P 452) EFFECTIVENESS OF ERIBULIN FOR MYXOID PLEOMORPHIC LIPOSARCOMA: INSIGHTS FROM A PATIENT-DERIVED MODEL AND CLINICAL TRANSLATION IN A PATIENT WITH ADVANCED DISEASE
Valentina Zuco
Favorite
Zugazagoitia, Jon

HOSPITAL UNIVERSITRIO 12 OCTUBRE
(P 445) TEADES PH1/2 STUDY WITH ODM-212: PRELIMINARY RESULTS IN EHE PATIENTS
Jon Zugazagoitia
Favorite
Zumarraga, Juan

Foundation Metrofraternidad
(P 151) SHOULD WE USE ADJUVANT CHEMOTHERAPY IN PATIENTS WITH LOCALIZED DEDIFFERENTIATED CHONDROSARCOMA (DDCS) OF THE PELVIS? AN ANALYSIS BY THE PELVIC DDCS STUDY GROUP
Juan Zumarraga
Favorite